accession,experiment,study,sample,title,attributes.loader,attributes.ENA-FIRST-PUBLIC,attributes.ENA-LAST-UPDATE,files.ftp,files.aws,files.gcp,files.ncbi,attributes.ENA-SPOT-COUNT,attributes.ENA-BASE-COUNT,experiment.accession,experiment.title,experiment.platform,experiment.instrument,study.accession,study.title,study.abstract,sample.accession,sample.title,sample.organism,sample.attributes.source_name,sample.attributes.treatment,sample.attributes.strain,sample.attributes.ENA-SPOT-COUNT,sample.attributes.ENA-BASE-COUNT,sample.attributes.ENA-FIRST-PUBLIC,sample.attributes.ENA-LAST-UPDATE,files,sample.attributes.tissue,sample.attributes.developmental stage,sample.attributes.development stage,sample.attributes.cell source,sample.attributes.embryo age,sample.attributes.cell type,sample.attributes.genotype,sample.attributes.age,sample.attributes.Sex,attributes.assembly,attributes.dangling_references,sample.attributes.stain,attributes.options,sample.attributes.Stage,sample.attributes.dissection,sample.attributes.protocol,sample.attributes.protocol notes,sample.attributes.animal line,sample.attributes.group,sample.attributes.injury,sample.attributes.cell markers,sample.attributes.ctx-injury day,sample.attributes.infection status,sample.attributes.timepoint,sample.attributes.label retaining,sample.attributes.activated,sample.attributes.time,sample.attributes.10x chemistry,sample.attributes.cell population,sample.attributes.sex,sample.attributes.cell_type,sample.attributes.BioSampleModel,sample.attributes.number of mice,sample.attributes.time point,sample.attributes.sequencing parameters,sample.attributes.collected_by,sample.attributes.disease,sample.attributes.disease_stage,sample.attributes.condition,sample.attributes.barcode coordinate,sample.attributes.umi coordinate,sample.attributes.agent,sample.attributes.antibody treatment,sample.attributes.actd treatment,sample.attributes.disease status,sample.attributes.cell types,sample.attributes.sample type,sample.attributes.biosource,sample.attributes.tag,sample.attributes.location,sample.attributes.cell line,sample.attributes.material,sample.attributes.time of harvest
SRR17936867,SRX14094802,SRP358869,SRS11920232,Illumina HiSeq 4000 paired end sequencing; GSM5872769: muscle_Treg_D3_VMNA_vs_Vehicle_Mafko_vs_Mafwt_scRNAseq; Mus musculus; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR179/067/SRR17936867/SRR17936867.fastq.gz', 'md5': '88d2631ec263fdf4b21ce02dacd82ea8', 'size': 23535274519}]","[{'url': 's3://sra-pub-src-7/SRR17936867/BH_072220_reanalysis_S1_L008_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR17936867/BH_072220_reanalysis_S1_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR17936867/BH_072220_reanalysis_S1_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR17936867/SRR17936867'}, {'url': 's3://sra-pub-run-3/SRR17936867/SRR17936867.1'}]","[{'url': 'gs://sra-pub-src-18/SRR17936867/BH_072220_reanalysis_S1_L008_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR17936867/BH_072220_reanalysis_S1_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR17936867/BH_072220_reanalysis_S1_L008_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR17936867/SRR17936867.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra66/SRR/017516/SRR17936867'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17936868,SRX14094802,SRP358869,SRS11920232,Illumina HiSeq 4000 paired end sequencing; GSM5872769: muscle_Treg_D3_VMNA_vs_Vehicle_Mafko_vs_Mafwt_scRNAseq; Mus musculus; RNA-Seq,,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR179/068/SRR17936868/SRR17936868_1.fastq.gz', 'md5': '60e932e614b807c737abaea16bc96002', 'size': 1158108665}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR179/068/SRR17936868/SRR17936868_2.fastq.gz', 'md5': 'e9b3a95bbd7f2a69cdd60f1e9eaf0c58', 'size': 2857201528}]","[{'url': 's3://sra-pub-src-10/SRR17936868/Undetermined_S0_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR17936868/Undetermined_S0_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR17936868/SRR17936868'}]","[{'url': 'gs://sra-pub-src-17/SRR17936868/Undetermined_S0_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR17936868/Undetermined_S0_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/017516/SRR17936868'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17936869,SRX14094801,SRP358869,SRS11920231,Illumina HiSeq 4000 paired end sequencing; GSM5872768: muscle_Treg_D3_scRNAseq_counts; Mus musculus; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR179/069/SRR17936869/SRR17936869.fastq.gz', 'md5': 'b3b798e71bdc1ff03ff2bd0f55d87654', 'size': 9094870609}]","[{'url': 's3://sra-pub-src-17/SRR17936869/MuscleDay3_S3_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR17936869/MuscleDay3_S3_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR17936869/MuscleDay3_S3_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR17936869/SRR17936869'}, {'url': 's3://sra-pub-run-13/SRR17936869/SRR17936869.1'}]","[{'url': 'gs://sra-pub-src-16/SRR17936869/MuscleDay3_S3_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR17936869/MuscleDay3_S3_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR17936869/MuscleDay3_S3_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR17936869/SRR17936869.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra71/SRR/017516/SRR17936869'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17936870,SRX14094801,SRP358869,SRS11920231,Illumina HiSeq 4000 paired end sequencing; GSM5872768: muscle_Treg_D3_scRNAseq_counts; Mus musculus; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR179/070/SRR17936870/SRR17936870.fastq.gz', 'md5': 'd7465cf36928bd329ce55c787ae2dd83', 'size': 7725025937}]","[{'url': 's3://sra-pub-src-14/SRR17936870/MuscleDay3_S2_L005_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR17936870/MuscleDay3_S2_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR17936870/MuscleDay3_S2_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR17936870/SRR17936870'}]","[{'url': 'gs://sra-pub-src-9/SRR17936870/MuscleDay3_S2_L005_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR17936870/MuscleDay3_S2_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR17936870/MuscleDay3_S2_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra2/SRR/017516/SRR17936870'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306146,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/046/SRR13306146/SRR13306146_1.fastq.gz', 'md5': '0c244b112602d4ae939170616eff50c3', 'size': 404579367}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/046/SRR13306146/SRR13306146_2.fastq.gz', 'md5': '4d159ec89c272529d6aacb3fbd0d68b1', 'size': 662721508}]","[{'url': 's3://sra-pub-src-16/SRR13306146/4-1_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13306146/4-1_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306146/SRR13306146'}]","[{'url': 'gs://sra-pub-src-15/SRR13306146/4-1_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13306146/4-1_S5_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR13306146/SRR13306146.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306146/SRR13306146.1'}],19956219,1676322396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306147,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/047/SRR13306147/SRR13306147_1.fastq.gz', 'md5': '94fed5e4bf626714f602d9b7dca3089c', 'size': 4255400}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/047/SRR13306147/SRR13306147_2.fastq.gz', 'md5': 'f434c5b6039507091df70c037f4017b2', 'size': 7054133}]","[{'url': 's3://sra-pub-src-18/SRR13306147/4-3_S7_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13306147/4-3_S7_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306147/SRR13306147'}]","[{'url': 'gs://sra-pub-src-16/SRR13306147/4-3_S7_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306147/4-3_S7_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13306147/SRR13306147.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13306147/SRR13306147.1'}],209488,17596992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306148,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/048/SRR13306148/SRR13306148_1.fastq.gz', 'md5': 'e7db7d0ddc00818bee07e78276e738cb', 'size': 4493745}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/048/SRR13306148/SRR13306148_2.fastq.gz', 'md5': 'b463c210aa386071ea1b6f33790e00fa', 'size': 7418801}]","[{'url': 's3://sra-pub-src-18/SRR13306148/4-3_S7_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13306148/4-3_S7_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306148/SRR13306148'}]","[{'url': 'gs://sra-pub-src-16/SRR13306148/4-3_S7_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306148/4-3_S7_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13306148/SRR13306148.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13306148/SRR13306148.1'}],224107,18824988,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306149,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/049/SRR13306149/SRR13306149_1.fastq.gz', 'md5': '1779a178397185a07bc523d2ea2c3410', 'size': 4324071}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/049/SRR13306149/SRR13306149_2.fastq.gz', 'md5': '77ef726c6788a5c86ebe1066a512451f', 'size': 7198926}]","[{'url': 's3://sra-pub-src-15/SRR13306149/4-3_S7_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13306149/4-3_S7_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306149/SRR13306149'}]","[{'url': 'gs://sra-pub-src-16/SRR13306149/4-3_S7_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13306149/4-3_S7_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13306149/SRR13306149.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13306149/SRR13306149.1'}],215785,18125940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306150,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/050/SRR13306150/SRR13306150_1.fastq.gz', 'md5': 'c3d77bbfb11ca9cff650c05a9422aa48', 'size': 454248535}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/050/SRR13306150/SRR13306150_2.fastq.gz', 'md5': '5fae6f86f66f6c558c96a2790793632d', 'size': 748640728}]","[{'url': 's3://sra-pub-src-16/SRR13306150/4-4_S8_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13306150/4-4_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306150/SRR13306150'}]","[{'url': 'gs://sra-pub-src-15/SRR13306150/4-4_S8_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13306150/4-4_S8_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR13306150/SRR13306150.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306150/SRR13306150.1'}],22395301,1881205284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306151,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/051/SRR13306151/SRR13306151_1.fastq.gz', 'md5': '78dd2230bf53d4faeea13aaa167a89cc', 'size': 452700958}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/051/SRR13306151/SRR13306151_2.fastq.gz', 'md5': '4d17ba889f6fba9b91887f05c70447b5', 'size': 746616848}]","[{'url': 's3://sra-pub-src-18/SRR13306151/4-4_S8_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13306151/4-4_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306151/SRR13306151'}]","[{'url': 'gs://sra-pub-src-16/SRR13306151/4-4_S8_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306151/4-4_S8_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR13306151/SRR13306151.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306151/SRR13306151.1'}],22185879,1863613836,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306152,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/052/SRR13306152/SRR13306152_1.fastq.gz', 'md5': '56de859114e46aa83dcc53cd15e26090', 'size': 466641213}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/052/SRR13306152/SRR13306152_2.fastq.gz', 'md5': '5c921648d7e8db956268798ec9bd0506', 'size': 765314925}]","[{'url': 's3://sra-pub-src-15/SRR13306152/4-4_S8_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13306152/4-4_S8_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306152/SRR13306152'}]","[{'url': 'gs://sra-pub-src-16/SRR13306152/4-4_S8_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306152/4-4_S8_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13306152/SRR13306152.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306152/SRR13306152.1'}],23140336,1943788224,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306153,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/053/SRR13306153/SRR13306153_1.fastq.gz', 'md5': '4558e2d91b4cd048b5020d31b80dcac7', 'size': 459114759}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/053/SRR13306153/SRR13306153_2.fastq.gz', 'md5': '8c7f49ada5f3b9c034a00003cf196a33', 'size': 759727076}]","[{'url': 's3://sra-pub-src-15/SRR13306153/4-4_S8_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13306153/4-4_S8_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306153/SRR13306153'}]","[{'url': 'gs://sra-pub-src-18/SRR13306153/4-4_S8_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13306153/4-4_S8_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR13306153/SRR13306153.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306153/SRR13306153.1'}],22774051,1913020284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306154,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/054/SRR13306154/SRR13306154_1.fastq.gz', 'md5': 'f5ca135a2109b4fe9c6f70a4b74369ea', 'size': 402507161}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/054/SRR13306154/SRR13306154_2.fastq.gz', 'md5': 'c5eea19895b3ed57078bda1a80591dfc', 'size': 659563684}]","[{'url': 's3://sra-pub-src-18/SRR13306154/4-1_S5_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13306154/4-1_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306154/SRR13306154'}]","[{'url': 'gs://sra-pub-src-16/SRR13306154/4-1_S5_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306154/4-1_S5_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR13306154/SRR13306154.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306154/SRR13306154.1'}],19735748,1657802832,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306155,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/055/SRR13306155/SRR13306155_1.fastq.gz', 'md5': '2c5e6267cc0b6e66428ff5d6f6a80eb2', 'size': 415961477}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/055/SRR13306155/SRR13306155_2.fastq.gz', 'md5': 'e24ad6524b6aca1fc9be1e2e7768baa6', 'size': 677878055}]","[{'url': 's3://sra-pub-src-18/SRR13306155/4-1_S5_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13306155/4-1_S5_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306155/SRR13306155'}]","[{'url': 'gs://sra-pub-src-16/SRR13306155/4-1_S5_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306155/4-1_S5_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13306155/SRR13306155.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306155/SRR13306155.1'}],20637868,1733580912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306156,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/056/SRR13306156/SRR13306156_1.fastq.gz', 'md5': 'd9c553e418f3445a7b6aafcd9a438408', 'size': 408717304}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/056/SRR13306156/SRR13306156_2.fastq.gz', 'md5': '829747c500b9835df99c1cb3f59bbc78', 'size': 671693468}]","[{'url': 's3://sra-pub-src-18/SRR13306156/4-1_S5_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13306156/4-1_S5_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306156/SRR13306156'}]","[{'url': 'gs://sra-pub-src-16/SRR13306156/4-1_S5_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13306156/4-1_S5_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR13306156/SRR13306156.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306156/SRR13306156.1'}],20277935,1703346540,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306157,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/057/SRR13306157/SRR13306157_1.fastq.gz', 'md5': '40ef537ae7176747ef1363e18ad263cd', 'size': 451937226}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/057/SRR13306157/SRR13306157_2.fastq.gz', 'md5': '3b3e6fb5339d1980b3940018dad251ca', 'size': 742395618}]","[{'url': 's3://sra-pub-src-17/SRR13306157/4-2_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13306157/4-2_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306157/SRR13306157'}]","[{'url': 'gs://sra-pub-src-18/SRR13306157/4-2_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13306157/4-2_S6_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR13306157/SRR13306157.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306157/SRR13306157.1'}],22329318,1875662712,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306158,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/058/SRR13306158/SRR13306158_1.fastq.gz', 'md5': 'd4f42f58c7e9490584b921cce9772a4c', 'size': 451733729}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/058/SRR13306158/SRR13306158_2.fastq.gz', 'md5': 'd51beab26a285af34efc0084e2cd23ab', 'size': 743232118}]","[{'url': 's3://sra-pub-src-15/SRR13306158/4-2_S6_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13306158/4-2_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306158/SRR13306158'}]","[{'url': 'gs://sra-pub-src-18/SRR13306158/4-2_S6_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13306158/4-2_S6_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR13306158/SRR13306158.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306158/SRR13306158.1'}],22185100,1863548400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306159,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/059/SRR13306159/SRR13306159_1.fastq.gz', 'md5': 'bde64441fa0c3749198b1fc0163d1cbc', 'size': 463709035}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/059/SRR13306159/SRR13306159_2.fastq.gz', 'md5': '67f06da0ded2c1aa61ed43112ed6b8d3', 'size': 758005056}]","[{'url': 's3://sra-pub-src-15/SRR13306159/4-2_S6_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13306159/4-2_S6_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306159/SRR13306159'}]","[{'url': 'gs://sra-pub-src-18/SRR13306159/4-2_S6_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13306159/4-2_S6_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR13306159/SRR13306159.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306159/SRR13306159.1'}],23048360,1936062240,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306160,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/060/SRR13306160/SRR13306160_1.fastq.gz', 'md5': 'c084c03e84e2b67d8453512f9e117050', 'size': 457804071}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/060/SRR13306160/SRR13306160_2.fastq.gz', 'md5': '6ee795f784c38511eb7d094d19c35485', 'size': 755267359}]","[{'url': 's3://sra-pub-src-17/SRR13306160/4-2_S6_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13306160/4-2_S6_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13306160/SRR13306160'}]","[{'url': 'gs://sra-pub-src-18/SRR13306160/4-2_S6_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13306160/4-2_S6_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR13306160/SRR13306160.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR13306160/SRR13306160.1'}],22757114,1911597576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13306161,SRX9734406,SRP299449,SRS7929067,NextSeq 500 paired end sequencing; GSM4988787: Dissociated Muscle; Mus musculus; RNA-Seq,,2021-02-01,2021-02-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/061/SRR13306161/SRR13306161_1.fastq.gz', 'md5': '59e42348142e23cd847bc44471f554a7', 'size': 4370438}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR133/061/SRR13306161/SRR13306161_2.fastq.gz', 'md5': 'cf6ec0ac6d2edbbf8e61de0a0bcb7a1d', 'size': 7246770}]","[{'url': 's3://sra-pub-src-15/SRR13306161/4-3_S7_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13306161/4-3_S7_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13306161/4-3_S7_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13306161/4-3_S7_L001_R2_001.fastq.gz.1'}]",[],216611,18195324,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610990,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094343,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339944,Matrigel only,Mus musculus,Ectopic mass cells,matrigel alone,CD1,119170640,10844528240,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/090/SRR12610990/SRR12610990.fastq.gz', 'md5': 'a5df29d609c93415934e95a133c7f9e7', 'size': '1316382939'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610991,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094343,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339944,Matrigel only,Mus musculus,Ectopic mass cells,matrigel alone,CD1,119170640,10844528240,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/091/SRR12610991/SRR12610991.fastq.gz', 'md5': '40ee95f09b5afcbd79f3cbddbe40d302', 'size': '1283986285'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610992,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094343,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339944,Matrigel only,Mus musculus,Ectopic mass cells,matrigel alone,CD1,119170640,10844528240,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/092/SRR12610992/SRR12610992.fastq.gz', 'md5': 'b00ae76d95461dae4f03fe80e6e8e02d', 'size': '1228396909'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610993,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094343,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339944,Matrigel only,Mus musculus,Ectopic mass cells,matrigel alone,CD1,119170640,10844528240,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/093/SRR12610993/SRR12610993.fastq.gz', 'md5': 'c722459aa960343460762754b3735469', 'size': '1212156439'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610994,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094343,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339944,Matrigel only,Mus musculus,Ectopic mass cells,matrigel alone,CD1,119170640,10844528240,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/094/SRR12610994/SRR12610994.fastq.gz', 'md5': '581acbc2d24554988a5bc7cecc4c062b', 'size': '1237730165'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610995,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094343,Illumina HiSeq 2500 paired end sequencing; GSM4773188: Matrigel only; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339944,Matrigel only,Mus musculus,Ectopic mass cells,matrigel alone,CD1,119170640,10844528240,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/095/SRR12610995/SRR12610995.fastq.gz', 'md5': '723b1be50cce0166e874b680fabe2f16', 'size': '1247601656'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610996,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094344,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339945,Matrigel/rhBMP2+IgG,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+IgG,CD1,117510320,10693439120,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/096/SRR12610996/SRR12610996.fastq.gz', 'md5': '2b6690b279c8f8533185e2674962cb0e', 'size': '1205371591'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610997,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094344,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339945,Matrigel/rhBMP2+IgG,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+IgG,CD1,117510320,10693439120,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/097/SRR12610997/SRR12610997.fastq.gz', 'md5': '1a6623d044c8c91aa4763c4ce76b5c10', 'size': '1215010645'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610998,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094344,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339945,Matrigel/rhBMP2+IgG,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+IgG,CD1,117510320,10693439120,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/098/SRR12610998/SRR12610998.fastq.gz', 'md5': 'c61281ff9faed0c92c71a58e0805e125', 'size': '1307596266'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12610999,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094344,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339945,Matrigel/rhBMP2+IgG,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+IgG,CD1,117510320,10693439120,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/099/SRR12610999/SRR12610999.fastq.gz', 'md5': '1a11a5064a99952df7455393c2b50e11', 'size': '1275527022'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611000,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094344,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339945,Matrigel/rhBMP2+IgG,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+IgG,CD1,117510320,10693439120,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/000/SRR12611000/SRR12611000.fastq.gz', 'md5': 'd0e273012ccf41fe1ba463b4b855a54e', 'size': '1239362613'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611001,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094344,Illumina HiSeq 2500 paired end sequencing; GSM4773189: Matrigel/rhBMP2+IgG; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339945,Matrigel/rhBMP2+IgG,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+IgG,CD1,117510320,10693439120,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/001/SRR12611001/SRR12611001.fastq.gz', 'md5': '5a9d18126ff7e1c41aa1024974fc2495', 'size': '1223757677'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611002,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094345,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339946,Matrigel/rhBMP2+nAct Ab,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+nAct Ab,CD1,128946622,11734142602,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/002/SRR12611002/SRR12611002.fastq.gz', 'md5': 'ac37a84f9a8220e942388926160df58d', 'size': '1376103280'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611003,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094345,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339946,Matrigel/rhBMP2+nAct Ab,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+nAct Ab,CD1,128946622,11734142602,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/003/SRR12611003/SRR12611003.fastq.gz', 'md5': 'ac36dd77c1a6c9b7e3ede8d6e213689a', 'size': '1356479046'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611004,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094345,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339946,Matrigel/rhBMP2+nAct Ab,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+nAct Ab,CD1,128946622,11734142602,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/004/SRR12611004/SRR12611004.fastq.gz', 'md5': 'b791c6999cc6f2902ecf82de8368c82a', 'size': '1334596206'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611005,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094345,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339946,Matrigel/rhBMP2+nAct Ab,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+nAct Ab,CD1,128946622,11734142602,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/005/SRR12611005/SRR12611005.fastq.gz', 'md5': '983bbdd8932aab5e8430c130ec91fd5e', 'size': '1345466333'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611006,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094345,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339946,Matrigel/rhBMP2+nAct Ab,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+nAct Ab,CD1,128946622,11734142602,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/006/SRR12611006/SRR12611006.fastq.gz', 'md5': '3b7deb29f16d3d427fb948ebaca0cdb0', 'size': '1444960417'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12611007,,,,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,,,,,,,,,,SRX9094345,Illumina HiSeq 2500 paired end sequencing; GSM4773190: Matrigel/rhBMP2+nAct Ab; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP281605,Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice,"Heterotopic ossification (HO) is a common, potentially debilitating, acquired pathology that is instigated by tissue damage or other insults and involves inflammation followed by  chondrogenesis, osteogenesis and extraskeletal bone accumulation. Current standard of care are not very effective and have side effects, making the search for new treatments urgent. Activin A is a member of the transforming growth factor-b (TGF-b) superfamily, is produced by activated macrophages and other inflammatory cells and signals through activation of canonical SMAD2 and SMAD3 (SMAD2/3) intracellular effectors. Because HO starts with inflammation and because pSMAD2/3 activation is chondrogenic, here we tested whether activin A stimulates HO development. Using standard mouse models of acquired intramuscular and subdermal HO, we found that systemic administration of a neutralizing activin A antibody markedly reduced HO development and bone accumulation. Single-cell RNAseq and developmental trajectories showed that the antibody treatment had sharply reduced the number of Sox9+ skeletal progenitors, many of which also expressed the gene encoding activin A (Inhba), that were recruited to the HO site. In line with the latter finding, gain-of-function assays showed that treatment of progenitors with recombinant activin A enhanced their chondrogenic differentiation and did so through SMAD2/3 signaling, and inclusion of activin A to HO-inducing in vivo implants enhanced HO development. Together, our data reveal that activin A is a critical upstream signaling stimulator of HO in mice and could represent an effective therapeutic target against acquired forms of this pathology in patients. Overall design: Single cell RNA seq of cells from Ectopic masses were harvested on day 5  from mice implanted with Matrigel alone or Matrigel/rhBMP2 mixture, with the latter mice treated systemically with pre-immune control IgG or activin A neutralizing antibody",SRS7339946,Matrigel/rhBMP2+nAct Ab,Mus musculus,Ectopic mass cells,matrigel/rhBMP2+nAct Ab,CD1,128946622,11734142602,2021-01-04,2021-01-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR126/007/SRR12611007/SRR12611007.fastq.gz', 'md5': 'a25aeffdf1201f853c7b35fa31f36209', 'size': '1408771715'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901270,,,,HiSeq X Ten paired end sequencing; GSM4274191: CS20_longbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569448,HiSeq X Ten paired end sequencing; GSM4274191: CS20_longbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005481,CS20_longbone_10x,Homo sapiens,human embryonic cells,,,421787410,127379797820,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/070/SRR10901270/SRR10901270_1.fastq.gz', 'md5': '7e68af5ca29a23a38b26880e64c34d10', 'size': '34932077548'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/070/SRR10901270/SRR10901270_2.fastq.gz', 'md5': '79f4f8f69baf562ea6c2e5734f21db4d', 'size': '35874173243'}]",Long bone,Week 8 (CS20),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901271,,,,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569449,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005482,CS22_longbone_10x,Homo sapiens,human embryonic cells,,,426252087,127875626100,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/071/SRR10901271/SRR10901271_1.fastq.gz', 'md5': '9a51c9bc5e77e261d0ab8c732e12b709', 'size': '10473216773'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/071/SRR10901271/SRR10901271_2.fastq.gz', 'md5': '249bf6cc2f6e1e2bf7c0bcd75a4c243c', 'size': '10610078751'}]",Long bone,Week 8 (CS22),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901272,,,,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569449,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005482,CS22_longbone_10x,Homo sapiens,human embryonic cells,,,426252087,127875626100,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/072/SRR10901272/SRR10901272_1.fastq.gz', 'md5': '85438d124a6524e8035dfd3b129d5f68', 'size': '9254661291'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/072/SRR10901272/SRR10901272_2.fastq.gz', 'md5': '9c82ad717d37bd24fc9c009a767b690e', 'size': '9326461118'}]",Long bone,Week 8 (CS22),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901273,,,,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569449,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005482,CS22_longbone_10x,Homo sapiens,human embryonic cells,,,426252087,127875626100,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/073/SRR10901273/SRR10901273_1.fastq.gz', 'md5': '10f7d4dc1ea94c8e2504485a41e374df', 'size': '10236767224'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/073/SRR10901273/SRR10901273_2.fastq.gz', 'md5': '4c9477d1d0f12c5b3ac27d6e4a9e58f3', 'size': '10344578080'}]",Long bone,Week 8 (CS22),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901274,,,,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569449,HiSeq X Ten paired end sequencing; GSM4274192: CS22_longbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005482,CS22_longbone_10x,Homo sapiens,human embryonic cells,,,426252087,127875626100,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/074/SRR10901274/SRR10901274_1.fastq.gz', 'md5': '488ebc03a007120ff9049734a03258d9', 'size': '7062065917'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/074/SRR10901274/SRR10901274_2.fastq.gz', 'md5': '041b631592c70130cda4cb3d211f1f51', 'size': '7115243040'}]",Long bone,Week 8 (CS22),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901275,,,,HiSeq X Ten paired end sequencing; GSM4274193: CS22(2)_longbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569450,HiSeq X Ten paired end sequencing; GSM4274193: CS22(2)_longbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005483,CS22(2)_longbone_10x,Homo sapiens,human embryonic cells,,,448307720,135388931440,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/075/SRR10901275/SRR10901275_1.fastq.gz', 'md5': 'ec02af1ab0ebb66b72b335fcad705760', 'size': '40485918190'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/075/SRR10901275/SRR10901275_2.fastq.gz', 'md5': 'f221c5e91b94b91b08f58885f4b23fb4', 'size': '39812394244'}]",Long bone,Week 8 (CS22),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901276,,,,HiSeq X Ten paired end sequencing; GSM4274194: CS23_calvarialbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569451,HiSeq X Ten paired end sequencing; GSM4274194: CS23_calvarialbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005484,CS23_calvarialbone_10x,Homo sapiens,human embryonic cells,,,473610575,143030393650,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/076/SRR10901276/SRR10901276_1.fastq.gz', 'md5': '8c9e085d4bc53d4164d5b532f8faffd5', 'size': '42431174219'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/076/SRR10901276/SRR10901276_2.fastq.gz', 'md5': '4ded271398ce4e9c92acfb9b9a623d48', 'size': '40782000379'}]",Calvarial bone,Week 8 (CS23),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11977450,,,,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8520854,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6816328,CS23(2)_calvarialbone_10x,Homo sapiens,human embryonic cells,,,503613527,75542029050,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR119/050/SRR11977450/SRR11977450.fastq.gz', 'md5': '6fcb35243c4b11ad0eaae8e6cb9ec722', 'size': '9326186693'}]",Calvarial bone,,Week 8(CS23),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11977451,,,,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8520854,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6816328,CS23(2)_calvarialbone_10x,Homo sapiens,human embryonic cells,,,503613527,75542029050,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR119/051/SRR11977451/SRR11977451.fastq.gz', 'md5': 'ed5cd3102b684a11a970851665b9c0a7', 'size': '9014889236'}]",Calvarial bone,,Week 8(CS23),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11977452,,,,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8520854,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6816328,CS23(2)_calvarialbone_10x,Homo sapiens,human embryonic cells,,,503613527,75542029050,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR119/052/SRR11977452/SRR11977452.fastq.gz', 'md5': 'be79345e8197b3f9d7c31ca30865ee8d', 'size': '9169143364'}]",Calvarial bone,,Week 8(CS23),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11977453,,,,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8520854,HiSeq X Ten paired end sequencing; GSM4609136: CS23(2)_calvarialbone_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6816328,CS23(2)_calvarialbone_10x,Homo sapiens,human embryonic cells,,,503613527,75542029050,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR119/053/SRR11977453/SRR11977453.fastq.gz', 'md5': '83891178c5acef54fe08a282b0d7f9ad', 'size': '8848557106'}]",Calvarial bone,,Week 8(CS23),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764280,SRX10150780,SRP307529,SRS8303093,Illumina HiSeq 4000 paired end sequencing; GSM5100206: H1 Osteogenic + H1 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/080/SRR13764280/SRR13764280_1.fastq.gz', 'md5': '330e4cfe921f9d669fac96cb51a0a860', 'size': 778935825}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/080/SRR13764280/SRR13764280_2.fastq.gz', 'md5': '6788d931bad2ff77045fc89e68782476', 'size': 3103370982}]","[{'url': 's3://sra-pub-src-18/SRR13764280/GHO-4_S4_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13764280/GHO-4_S4_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR13764280/GHO-4_S4_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13764280/GHO-4_S4_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764280/SRR13764280.1'}],45757965,5765503590,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764281,SRX10150780,SRP307529,SRS8303093,Illumina HiSeq 4000 paired end sequencing; GSM5100206: H1 Osteogenic + H1 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/081/SRR13764281/SRR13764281_1.fastq.gz', 'md5': '8abecd579956ba124ea5c4e9546521b7', 'size': 925074924}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/081/SRR13764281/SRR13764281_2.fastq.gz', 'md5': 'b22154aed380265ff8d5476ebddaeaef', 'size': 3901122414}]","[{'url': 's3://sra-pub-src-16/SRR13764281/GHO-4_S4_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13764281/GHO-4_S4_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13764281/GHO-4_S4_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13764281/GHO-4_S4_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764281/SRR13764281.1'}],53316494,6717878244,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764282,SRX10150780,SRP307529,SRS8303093,Illumina HiSeq 4000 paired end sequencing; GSM5100206: H1 Osteogenic + H1 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/082/SRR13764282/SRR13764282_1.fastq.gz', 'md5': '749b7709d00bec4196e12290eb4976c4', 'size': 1638940692}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/082/SRR13764282/SRR13764282_2.fastq.gz', 'md5': '441aa3870a9f144445b031f7ca5a8048', 'size': 6845899993}]","[{'url': 's3://sra-pub-src-4/SRR13764282/GHO-4_S4_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR13764282/GHO-4_S4_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-4/SRR13764282/GHO-4_S4_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR13764282/GHO-4_S4_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764282/SRR13764282.1'}],93774335,11815566210,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764283,SRX10150780,SRP307529,SRS8303093,Illumina HiSeq 4000 paired end sequencing; GSM5100206: H1 Osteogenic + H1 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/083/SRR13764283/SRR13764283_1.fastq.gz', 'md5': 'd8d7cf06a78e22d8065c60dc22cbb6fc', 'size': 1657995815}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/083/SRR13764283/SRR13764283_2.fastq.gz', 'md5': '95bf066e0d3d611c442e5513cf6e627a', 'size': 6457406508}]",[{'url': 's3://sra-pub-src-18/SRR13764283/GHO-4_S4_L003_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-15/SRR13764283/GHO-4_S4_L003_R1_001.fastq.gz.1'}],[],95096158,11982115908,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390077,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/077/SRR15390077/SRR15390077_1.fastq.gz', 'md5': '87bca9daebdfc5cf5b48b6568bdb1aec', 'size': 538203874}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/077/SRR15390077/SRR15390077_2.fastq.gz', 'md5': 'c23c7b50c6dd19f0c1a4c6cea8e6608e', 'size': 2082225889}]","[{'url': 's3://sra-pub-src-9/SRR15390077/HOU-16_S12_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390077/HOU-16_S12_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390077/SRR15390077'}, {'url': 's3://sra-pub-run-6/SRR15390077/SRR15390077.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390077/HOU-16_S12_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390077/HOU-16_S12_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390077/SRR15390077.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390077'}],30220437,3868215936,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390078,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/078/SRR15390078/SRR15390078_1.fastq.gz', 'md5': '79771a259e9d440d6937d881a79d6ec3', 'size': 536195857}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/078/SRR15390078/SRR15390078_2.fastq.gz', 'md5': '26c9b47c1575c5cb0430d6214bed1fc9', 'size': 2075859215}]","[{'url': 's3://sra-pub-src-16/SRR15390078/HOU-16_S12_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15390078/HOU-16_S12_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390078/SRR15390078'}, {'url': 's3://sra-pub-run-1/SRR15390078/SRR15390078.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390078/HOU-16_S12_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR15390078/HOU-16_S12_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR15390078/SRR15390078.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390078'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390079,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/079/SRR15390079/SRR15390079_1.fastq.gz', 'md5': '22222e3a8cff84941094d5e4e4851bdc', 'size': 542504248}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/079/SRR15390079/SRR15390079_2.fastq.gz', 'md5': 'c75ec08400067181f890eb1cfcffea73', 'size': 2082119916}]","[{'url': 's3://sra-pub-src-17/SRR15390079/HOU-16_S12_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390079/HOU-16_S12_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390079/SRR15390079'}, {'url': 's3://sra-pub-run-11/SRR15390079/SRR15390079.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390079/HOU-16_S12_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390079/HOU-16_S12_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390079/SRR15390079.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra28/SRR/015029/SRR15390079'}],30292319,3877416832,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390080,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/080/SRR15390080/SRR15390080_1.fastq.gz', 'md5': '0c9eab51ea70c52ec6f3155bc149e8ba', 'size': 542126289}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/080/SRR15390080/SRR15390080_2.fastq.gz', 'md5': '4403271347d3c6f35e7639dfaea3b748', 'size': 2069217528}]","[{'url': 's3://sra-pub-src-12/SRR15390080/HOU-16_S12_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390080/HOU-16_S12_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390080/SRR15390080'}, {'url': 's3://sra-pub-run-12/SRR15390080/SRR15390080.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390080/HOU-16_S12_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390080/HOU-16_S12_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR15390080/SRR15390080.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390080'}],30387985,3889662080,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390081,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/081/SRR15390081/SRR15390081_1.fastq.gz', 'md5': 'fc3522169c99a9588f6b243405bdac05', 'size': 531738951}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/081/SRR15390081/SRR15390081_2.fastq.gz', 'md5': 'b780670e42e17b87055ea8982cc49f96', 'size': 1996328341}]","[{'url': 's3://sra-pub-src-16/SRR15390081/HOU-16_S12_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390081/HOU-16_S12_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390081/SRR15390081'}, {'url': 's3://sra-pub-run-1/SRR15390081/SRR15390081.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390081/HOU-16_S12_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390081/HOU-16_S12_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR15390081/SRR15390081.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra1/SRR/015029/SRR15390081'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390082,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/082/SRR15390082/SRR15390082_1.fastq.gz', 'md5': '1a76653d8a15ea19f8d8856036cc97a7', 'size': 520668624}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/082/SRR15390082/SRR15390082_2.fastq.gz', 'md5': 'a0e6fa041aae2fd68d27f56ce0f615af', 'size': 1968973331}]","[{'url': 's3://sra-pub-src-6/SRR15390082/HOU-16_S12_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR15390082/HOU-16_S12_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR15390082/HOU-16_S12_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR15390082/HOU-16_S12_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390082/SRR15390082.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390083,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/083/SRR15390083/SRR15390083_1.fastq.gz', 'md5': 'ada26ab5737ccd562bb409ef1efebf70', 'size': 501194167}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/083/SRR15390083/SRR15390083_2.fastq.gz', 'md5': '7f36f133c0ba9f8fb44c19ff67595dbf', 'size': 1934323416}]","[{'url': 's3://sra-pub-src-15/SRR15390083/HOU-16_S12_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390083/HOU-16_S12_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15390083/HOU-16_S12_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390083/HOU-16_S12_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390083/SRR15390083.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390084,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/084/SRR15390084/SRR15390084_1.fastq.gz', 'md5': '3e7ab749f58c5da73f98967e2864a6f0', 'size': 492230710}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/084/SRR15390084/SRR15390084_2.fastq.gz', 'md5': '6327f48912042e1db027c08c747e294a', 'size': 1918894624}]","[{'url': 's3://sra-pub-src-4/SRR15390084/HOU-16_S12_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15390084/HOU-16_S12_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR15390084/HOU-16_S12_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR15390084/HOU-16_S12_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390084/SRR15390084.1'}],27021687,3458775936,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390085,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/085/SRR15390085/SRR15390085_1.fastq.gz', 'md5': 'ca4ef65bdb076b6a6b3ff994f55b2a57', 'size': 529746715}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/085/SRR15390085/SRR15390085_2.fastq.gz', 'md5': '0c9773e66c1692a70b6a033f84452d1b', 'size': 2012421662}]","[{'url': 's3://sra-pub-src-3/SRR15390085/HOU-16_S12_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390085/HOU-16_S12_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390085/SRR15390085'}]","[{'url': 'gs://sra-pub-src-5/SRR15390085/HOU-16_S12_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390085/HOU-16_S12_L009_R2_001.fastq.gz.1'}]",[],29768807,3810407296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390104,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/004/SRR15390104/SRR15390104_1.fastq.gz', 'md5': 'cb29d311ab9cb49b032c16f59fab5c78', 'size': 526638328}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/004/SRR15390104/SRR15390104_2.fastq.gz', 'md5': '2b9b39b490f71ff44e75aacb86038498', 'size': 2021817517}]","[{'url': 's3://sra-pub-src-10/SRR15390104/HOU-4_S3_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390104/HOU-4_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390104/SRR15390104'}, {'url': 's3://sra-pub-run-10/SRR15390104/SRR15390104.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15390104/HOU-4_S3_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390104/HOU-4_S3_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR15390104/SRR15390104.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra67/SRR/015029/SRR15390104'}],29577617,3785934976,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390105,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/005/SRR15390105/SRR15390105_1.fastq.gz', 'md5': '3725066b64e2186e1244545929afdea0', 'size': 525340550}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/005/SRR15390105/SRR15390105_2.fastq.gz', 'md5': '947fddedc413d69624fe6a0d09c7c61d', 'size': 2017618805}]","[{'url': 's3://sra-pub-src-10/SRR15390105/HOU-4_S3_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15390105/HOU-4_S3_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390105/SRR15390105'}, {'url': 's3://sra-pub-run-9/SRR15390105/SRR15390105.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15390105/HOU-4_S3_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15390105/HOU-4_S3_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR15390105/SRR15390105.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra28/SRR/015029/SRR15390105'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390106,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/006/SRR15390106/SRR15390106_1.fastq.gz', 'md5': '95358f8bcab18e640a4b27c4c381e1f5', 'size': 530926176}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/006/SRR15390106/SRR15390106_2.fastq.gz', 'md5': '00fed93135a835f2606738542eb2f0ff', 'size': 2022859765}]","[{'url': 's3://sra-pub-src-16/SRR15390106/HOU-4_S3_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390106/HOU-4_S3_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390106/HOU-4_S3_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390106/HOU-4_S3_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390106/SRR15390106.1'}],29655446,3795897088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390107,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/007/SRR15390107/SRR15390107_1.fastq.gz', 'md5': 'b1518ed159fc9b1ae9a76cb3808bc1ad', 'size': 531519505}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/007/SRR15390107/SRR15390107_2.fastq.gz', 'md5': '69ca04ab9e0f8aa729f3fc442050b809', 'size': 2012454857}]","[{'url': 's3://sra-pub-src-6/SRR15390107/HOU-4_S3_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR15390107/HOU-4_S3_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR15390107/HOU-4_S3_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR15390107/HOU-4_S3_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390107/SRR15390107.1'}],29802190,3814680320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390108,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/008/SRR15390108/SRR15390108_1.fastq.gz', 'md5': 'de2a7698bb461ba834c709eabeefae9a', 'size': 519336314}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/008/SRR15390108/SRR15390108_2.fastq.gz', 'md5': 'f275d417dff203f84f3b6664e4499bb8', 'size': 1939033522}]","[{'url': 's3://sra-pub-src-7/SRR15390108/HOU-4_S3_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15390108/HOU-4_S3_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390108/SRR15390108'}, {'url': 's3://sra-pub-run-9/SRR15390108/SRR15390108.1'}]","[{'url': 'gs://sra-pub-src-12/SRR15390108/HOU-4_S3_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15390108/HOU-4_S3_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR15390108/SRR15390108.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra31/SRR/015029/SRR15390108'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390109,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/009/SRR15390109/SRR15390109_1.fastq.gz', 'md5': '487129c1868f2d4f0dd90735edfca439', 'size': 509410515}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/009/SRR15390109/SRR15390109_2.fastq.gz', 'md5': 'ba8618befe667dc4bebebf6785848159', 'size': 1916175746}]","[{'url': 's3://sra-pub-src-3/SRR15390109/HOU-4_S3_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390109/HOU-4_S3_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390109/SRR15390109'}, {'url': 's3://sra-pub-run-5/SRR15390109/SRR15390109.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390109/HOU-4_S3_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390109/HOU-4_S3_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-8/SRR15390109/SRR15390109.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra11/SRR/015029/SRR15390109'}],28472203,3644441984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390109,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/009/SRR15390109/SRR15390109_1.fastq.gz', 'md5': '487129c1868f2d4f0dd90735edfca439', 'size': 509410515}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/009/SRR15390109/SRR15390109_2.fastq.gz', 'md5': 'ba8618befe667dc4bebebf6785848159', 'size': 1916175746}]","[{'url': 's3://sra-pub-src-3/SRR15390109/HOU-4_S3_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390109/HOU-4_S3_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390109/SRR15390109'}, {'url': 's3://sra-pub-run-5/SRR15390109/SRR15390109.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390109/HOU-4_S3_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390109/HOU-4_S3_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-8/SRR15390109/SRR15390109.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra11/SRR/015029/SRR15390109'}],28472203,3644441984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390110,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/010/SRR15390110/SRR15390110_1.fastq.gz', 'md5': '09a82d71ed8b368ce6bbc2bcc18d4dd5', 'size': 546023244}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/010/SRR15390110/SRR15390110_2.fastq.gz', 'md5': '2fcc23eed4b9d14c5269ecc83c9ce5c1', 'size': 2073216668}]","[{'url': 's3://sra-pub-src-13/SRR15390110/HOU-4_S3_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390110/HOU-4_S3_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390110/HOU-4_S3_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390110/HOU-4_S3_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390110/SRR15390110.1'}],29733544,3805893632,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390112,SRX11692398,SRP331750,SRS9723994,Illumina HiSeq 4000 paired end sequencing; GSM5510237: H2 Osteogenic + C2 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/012/SRR15390112/SRR15390112_1.fastq.gz', 'md5': 'ae837ad4462d45fd956fbf935cf0fca3', 'size': 517766093}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/012/SRR15390112/SRR15390112_2.fastq.gz', 'md5': 'b5582f8f0def04b419d8dfbca82c85ed', 'size': 1956625632}]","[{'url': 's3://sra-pub-src-13/SRR15390112/HOU-4_S3_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390112/HOU-4_S3_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390112/SRR15390112'}]","[{'url': 'gs://sra-pub-src-3/SRR15390112/HOU-4_S3_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390112/HOU-4_S3_L009_R2_001.fastq.gz.1'}]",[],29112403,3726387584,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390131,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/031/SRR15390131/SRR15390131_1.fastq.gz', 'md5': '9d1cf8978851c4a6faf785e6f1e5a13a', 'size': 475297799}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/031/SRR15390131/SRR15390131_2.fastq.gz', 'md5': 'd610f858d1151972581d1164b99a7cae', 'size': 1870458836}]","[{'url': 's3://sra-pub-src-9/SRR15390131/HOU-15_S11_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390131/HOU-15_S11_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390131/SRR15390131'}, {'url': 's3://sra-pub-run-6/SRR15390131/SRR15390131.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390131/HOU-15_S11_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390131/HOU-15_S11_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390131/SRR15390131.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390131'}],27003664,3456468992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390132,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/032/SRR15390132/SRR15390132_1.fastq.gz', 'md5': 'a10e6ad96498b7cc53296c2cedd6fe63', 'size': 473382763}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/032/SRR15390132/SRR15390132_2.fastq.gz', 'md5': '27f0d1ad8570fbe9ad850cb4cca746fd', 'size': 1862951957}]","[{'url': 's3://sra-pub-src-13/SRR15390132/HOU-15_S11_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390132/HOU-15_S11_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390132/HOU-15_S11_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390132/HOU-15_S11_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390132/SRR15390132.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390133,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/033/SRR15390133/SRR15390133_1.fastq.gz', 'md5': '0b86e809099d47822ad580ac6f36fecb', 'size': 479055885}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/033/SRR15390133/SRR15390133_2.fastq.gz', 'md5': '2eef6b35050b2ec591cbea6f098d7caf', 'size': 1871029447}]","[{'url': 's3://sra-pub-src-11/SRR15390133/HOU-15_S11_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR15390133/HOU-15_S11_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390133/SRR15390133'}, {'url': 's3://sra-pub-run-4/SRR15390133/SRR15390133.1'}]","[{'url': 'gs://sra-pub-src-18/SRR15390133/HOU-15_S11_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR15390133/HOU-15_S11_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR15390133/SRR15390133.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390133'}],27053847,3462892416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390134,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/034/SRR15390134/SRR15390134_1.fastq.gz', 'md5': 'b2d088bc1ae3d4e38acc5020f7cf26a0', 'size': 478181092}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/034/SRR15390134/SRR15390134_2.fastq.gz', 'md5': '2130aec112dd4386428dd43e4fd70b26', 'size': 1857104922}]","[{'url': 's3://sra-pub-src-4/SRR15390134/HOU-15_S11_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390134/HOU-15_S11_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR15390134/HOU-15_S11_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390134/HOU-15_S11_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390134/SRR15390134.1'}],27109056,3469959168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390135,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/035/SRR15390135/SRR15390135_1.fastq.gz', 'md5': '1b1aa8a1aaf62d07a4adfd0ce7d87bc9', 'size': 469301487}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/035/SRR15390135/SRR15390135_2.fastq.gz', 'md5': '64ffd37abe8f20e8ff301153d966f433', 'size': 1798256760}]","[{'url': 's3://sra-pub-src-16/SRR15390135/HOU-15_S11_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390135/HOU-15_S11_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390135/HOU-15_S11_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390135/HOU-15_S11_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390135/SRR15390135.1'}],26650755,3411296640,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390136,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/036/SRR15390136/SRR15390136_1.fastq.gz', 'md5': 'dfdea5e467b3a21cb3ce25eaa2ff6d7f', 'size': 459950502}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/036/SRR15390136/SRR15390136_2.fastq.gz', 'md5': 'e7fec05a5d3d9e377c2d024b28a6a058', 'size': 1773726149}]","[{'url': 's3://sra-pub-src-13/SRR15390136/HOU-15_S11_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390136/HOU-15_S11_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390136/HOU-15_S11_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390136/HOU-15_S11_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390136/SRR15390136.1'}],25996363,3327534464,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390137,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/037/SRR15390137/SRR15390137_1.fastq.gz', 'md5': '9c20e96c0e3c016a6e1b6c4863b4c45b', 'size': 660952862}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/037/SRR15390137/SRR15390137_2.fastq.gz', 'md5': 'fdb327197c903fb7777f8236fbaf801e', 'size': 2547961487}]","[{'url': 's3://sra-pub-src-15/SRR15390137/HOU-15_S11_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390137/HOU-15_S11_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390137/SRR15390137'}, {'url': 's3://sra-pub-run-4/SRR15390137/SRR15390137.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15390137/HOU-15_S11_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390137/HOU-15_S11_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR15390137/SRR15390137.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390137'}],36045115,4613774720,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390138,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/038/SRR15390138/SRR15390138_1.fastq.gz', 'md5': '57fffb54ca06a109d798b91c6891fa64', 'size': 650863024}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/038/SRR15390138/SRR15390138_2.fastq.gz', 'md5': '16459881bc987be1ea55a425e26cd4d8', 'size': 2542785430}]","[{'url': 's3://sra-pub-src-5/SRR15390138/HOU-15_S11_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR15390138/HOU-15_S11_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15390138/HOU-15_S11_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390138/HOU-15_S11_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390138/SRR15390138.1'}],35674275,4566307200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390139,SRX11692401,SRP331750,SRS9723997,Illumina HiSeq 4000 paired end sequencing; GSM5510240: H3 Osteogenic + C3 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/039/SRR15390139/SRR15390139_1.fastq.gz', 'md5': '15b545c613511714b7127c421281960e', 'size': 467571398}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/039/SRR15390139/SRR15390139_2.fastq.gz', 'md5': '3944ba2bffdc6f941b559a858eea3f79', 'size': 1810161005}]",[{'url': 's3://sra-pub-src-7/SRR15390139/HOU-15_S11_L009_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-12/SRR15390139/HOU-15_S11_L009_R1_001.fastq.gz.1'}],[],26579082,3402122496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390158,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/058/SRR15390158/SRR15390158_1.fastq.gz', 'md5': '09efdc3b7966be4d7986e8c52226db4a', 'size': 502882379}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/058/SRR15390158/SRR15390158_2.fastq.gz', 'md5': '352f0b561cc881463bd7a8b16dd12b85', 'size': 1977846315}]","[{'url': 's3://sra-pub-src-14/SRR15390158/HOU-8_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390158/HOU-8_S6_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15390158/HOU-8_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390158/HOU-8_S6_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390158/SRR15390158.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390159,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/059/SRR15390159/SRR15390159_1.fastq.gz', 'md5': 'a26d00cb402f02449c988703fca369cb', 'size': 507350122}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/059/SRR15390159/SRR15390159_2.fastq.gz', 'md5': '199eb92fc79cb3937f847842597da74e', 'size': 1997197905}]","[{'url': 's3://sra-pub-src-7/SRR15390159/HOU-8_S6_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR15390159/HOU-8_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390159/SRR15390159'}, {'url': 's3://sra-pub-run-9/SRR15390159/SRR15390159.1'}]","[{'url': 'gs://sra-pub-src-12/SRR15390159/HOU-8_S6_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR15390159/HOU-8_S6_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR15390159/SRR15390159.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390159'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390160,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/060/SRR15390160/SRR15390160_1.fastq.gz', 'md5': '991d926dcb2d1e4f1814d85495ec8908', 'size': 512069524}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/060/SRR15390160/SRR15390160_2.fastq.gz', 'md5': '900829c7df19cae161750d6bd2cb2e7f', 'size': 1998921037}]","[{'url': 's3://sra-pub-src-8/SRR15390160/HOU-8_S6_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390160/HOU-8_S6_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390160/SRR15390160'}, {'url': 's3://sra-pub-run-2/SRR15390160/SRR15390160.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390160/HOU-8_S6_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390160/HOU-8_S6_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390160/SRR15390160.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390160'}],28717951,3675897728,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390161,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/061/SRR15390161/SRR15390161_1.fastq.gz', 'md5': '86f2ffd74cfb762c74262b4d6cec895e', 'size': 517595549}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/061/SRR15390161/SRR15390161_2.fastq.gz', 'md5': '828a9adf90696b517eb429bc0fb75a3b', 'size': 2008588631}]","[{'url': 's3://sra-pub-src-3/SRR15390161/HOU-8_S6_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390161/HOU-8_S6_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390161/HOU-8_S6_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390161/HOU-8_S6_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390161/SRR15390161.1'}],29144263,3730465664,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390162,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/062/SRR15390162/SRR15390162_1.fastq.gz', 'md5': 'e873389e77580b0b21f37dcf8495ff38', 'size': 496232999}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/062/SRR15390162/SRR15390162_2.fastq.gz', 'md5': '726d132ffa12881102f1ba943176fb2e', 'size': 1901862582}]","[{'url': 's3://sra-pub-src-17/SRR15390162/HOU-8_S6_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390162/HOU-8_S6_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390162/SRR15390162'}, {'url': 's3://sra-pub-run-11/SRR15390162/SRR15390162.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390162/HOU-8_S6_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390162/HOU-8_S6_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390162/SRR15390162.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra11/SRR/015029/SRR15390162'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390163,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/063/SRR15390163/SRR15390163_1.fastq.gz', 'md5': '2a66e657d58370632877cbb0ab0b44f9', 'size': 489912960}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/063/SRR15390163/SRR15390163_2.fastq.gz', 'md5': 'f2408312eba26bffc80c677685c461b6', 'size': 1889151522}]","[{'url': 's3://sra-pub-src-18/SRR15390163/HOU-8_S6_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390163/HOU-8_S6_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390163/HOU-8_S6_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390163/HOU-8_S6_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390163/SRR15390163.1'}],27505393,3520690304,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390164,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/064/SRR15390164/SRR15390164_1.fastq.gz', 'md5': 'd7230b3f7e855d50a3ea65c3b014d497', 'size': 569852641}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/064/SRR15390164/SRR15390164_2.fastq.gz', 'md5': 'fecaa6ec3a501ab662bba5acb557d610', 'size': 2211081309}]","[{'url': 's3://sra-pub-src-9/SRR15390164/HOU-8_S6_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390164/HOU-8_S6_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390164/SRR15390164'}, {'url': 's3://sra-pub-run-6/SRR15390164/SRR15390164.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390164/HOU-8_S6_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390164/HOU-8_S6_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390164/SRR15390164.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra59/SRR/015029/SRR15390164'}],31192174,3992598272,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390165,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/065/SRR15390165/SRR15390165_1.fastq.gz', 'md5': 'a891e32b89249510002ad21bac3bf966', 'size': 557303326}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/065/SRR15390165/SRR15390165_2.fastq.gz', 'md5': '1d2737af5b14e018608a74c217399f7d', 'size': 2192798805}]","[{'url': 's3://sra-pub-src-3/SRR15390165/HOU-8_S6_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390165/HOU-8_S6_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390165/SRR15390165'}, {'url': 's3://sra-pub-run-5/SRR15390165/SRR15390165.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390165/HOU-8_S6_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390165/HOU-8_S6_L008_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-9/SRR15390165/SRR15390165.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390165'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390166,SRX11692404,SRP331750,SRS9724000,Illumina HiSeq 4000 paired end sequencing; GSM5510243: H4 Osteogenic + C4 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/066/SRR15390166/SRR15390166_1.fastq.gz', 'md5': 'da84c57a45168ebf9d1247805aeb98ed', 'size': 496339387}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/066/SRR15390166/SRR15390166_2.fastq.gz', 'md5': '5cede52925bec04079806d931b5d3804', 'size': 1923245362}]","[{'url': 's3://sra-pub-src-13/SRR15390166/HOU-8_S6_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390166/HOU-8_S6_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390166/SRR15390166'}]","[{'url': 'gs://sra-pub-src-3/SRR15390166/HOU-8_S6_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390166/HOU-8_S6_L009_R2_001.fastq.gz.1'}]",[],28039916,3589109248,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390175,SRX11692407,SRP331750,SRS9724003,Illumina HiSeq 4000 paired end sequencing; GSM5510246: H5 Osteogenic + C5 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/075/SRR15390175/SRR15390175_1.fastq.gz', 'md5': '96372d0239a97ea9171243958ef8d753', 'size': 1149390959}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/075/SRR15390175/SRR15390175_2.fastq.gz', 'md5': '3146be129687af35b79ae6f3ee62aac8', 'size': 4411489673}]","[{'url': 's3://sra-pub-src-8/SRR15390175/HOU-21_S5_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390175/HOU-21_S5_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390175/HOU-21_S5_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390175/HOU-21_S5_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390175/SRR15390175.1'}],64716468,8283707904,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390176,SRX11692407,SRP331750,SRS9724003,Illumina HiSeq 4000 paired end sequencing; GSM5510246: H5 Osteogenic + C5 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/076/SRR15390176/SRR15390176_1.fastq.gz', 'md5': '81b54cb043fb29b69c54c32890397ee1', 'size': 808295190}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/076/SRR15390176/SRR15390176_2.fastq.gz', 'md5': '7955bc305e1e4baeaaec52314c2c8510', 'size': 3151739403}]","[{'url': 's3://sra-pub-src-12/SRR15390176/HOU-21_S5_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390176/HOU-21_S5_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390176/HOU-21_S5_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390176/HOU-21_S5_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390176/SRR15390176.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390177,SRX11692407,SRP331750,SRS9724003,Illumina HiSeq 4000 paired end sequencing; GSM5510246: H5 Osteogenic + C5 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-28,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/077/SRR15390177/SRR15390177_1.fastq.gz', 'md5': '7f085bf9d2f99a4ae3e0512b41748371', 'size': 989255768}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/077/SRR15390177/SRR15390177_2.fastq.gz', 'md5': 'c1eec38c9086546015a236340b93d46b', 'size': 3671213983}]","[{'url': 's3://sra-pub-src-13/SRR15390177/HOU-21_S5_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390177/HOU-21_S5_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390177/HOU-21_S5_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390177/HOU-21_S5_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390177/SRR15390177.1'}],55601975,7117052800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390178,SRX11692407,SRP331750,SRS9724003,Illumina HiSeq 4000 paired end sequencing; GSM5510246: H5 Osteogenic + C5 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/078/SRR15390178/SRR15390178_1.fastq.gz', 'md5': '600166d4d98e60ca570c835e9ef83d60', 'size': 1111492689}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/078/SRR15390178/SRR15390178_2.fastq.gz', 'md5': '691870831edd99683bbbac59f93b20ab', 'size': 4165040369}]","[{'url': 's3://sra-pub-src-8/SRR15390178/HOU-21_S5_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390178/HOU-21_S5_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390178/SRR15390178'}]","[{'url': 'gs://sra-pub-src-11/SRR15390178/HOU-21_S5_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390178/HOU-21_S5_L008_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390187,SRX11692410,SRP331750,SRS9724006,Illumina HiSeq 4000 paired end sequencing; GSM5510249: H6 Osteogenic + C6 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/087/SRR15390187/SRR15390187_1.fastq.gz', 'md5': '79972ed374b3afe29329f534de4a17f8', 'size': 811822719}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/087/SRR15390187/SRR15390187_2.fastq.gz', 'md5': '8e7f1a3c6e1baacdb69d498f435316a2', 'size': 2992357746}]","[{'url': 's3://sra-pub-src-3/SRR15390187/HOU-22_S6_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390187/HOU-22_S6_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390187/HOU-22_S6_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390187/HOU-22_S6_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390187/SRR15390187.1'}],45476279,5820963712,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390188,SRX11692410,SRP331750,SRS9724006,Illumina HiSeq 4000 paired end sequencing; GSM5510249: H6 Osteogenic + C6 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/088/SRR15390188/SRR15390188_1.fastq.gz', 'md5': '7a230bba2071539f82b9a23fabbabdc2', 'size': 1118858369}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/088/SRR15390188/SRR15390188_2.fastq.gz', 'md5': 'f1ed50698dd3429195f82f7dd68844aa', 'size': 4138829661}]","[{'url': 's3://sra-pub-src-9/SRR15390188/HOU-22_S6_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390188/HOU-22_S6_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390188/HOU-22_S6_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390188/HOU-22_S6_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390188/SRR15390188.1'}],63796558,8165959424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390189,SRX11692410,SRP331750,SRS9724006,Illumina HiSeq 4000 paired end sequencing; GSM5510249: H6 Osteogenic + C6 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/089/SRR15390189/SRR15390189_1.fastq.gz', 'md5': '6c54354a0d7c4da47267416c7f396091', 'size': 1395001844}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/089/SRR15390189/SRR15390189_2.fastq.gz', 'md5': 'deed6343f7524eb6ed839386b6f3cbd8', 'size': 4943145878}]","[{'url': 's3://sra-pub-src-4/SRR15390189/HOU-22_S6_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15390189/HOU-22_S6_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390189/SRR15390189'}, {'url': 's3://sra-pub-run-1/SRR15390189/SRR15390189.1'}]","[{'url': 'gs://sra-pub-src-17/SRR15390189/HOU-22_S6_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR15390189/HOU-22_S6_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390189/SRR15390189.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra70/SRR/015029/SRR15390189'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390190,SRX11692410,SRP331750,SRS9724006,Illumina HiSeq 4000 paired end sequencing; GSM5510249: H6 Osteogenic + C6 Osteogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/090/SRR15390190/SRR15390190_1.fastq.gz', 'md5': 'f92792c713f63d232604c67aab11bf2d', 'size': 794857213}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/090/SRR15390190/SRR15390190_2.fastq.gz', 'md5': 'e83406ed2ace880b9b4b82fbd90da6c8', 'size': 2856245803}]",[{'url': 's3://sra-pub-src-13/SRR15390190/HOU-22_S6_L008_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-3/SRR15390190/HOU-22_S6_L008_R1_001.fastq.gz.1'}],[],44710857,5722989696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666749,SRX10058322,SRP305495,SRS8220575,NextSeq 500 paired end sequencing; GSM5071238: 2_month_old_fractured 1; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/049/SRR13666749/SRR13666749_1.fastq.gz', 'md5': '504f2f2755728d5fc3bf622f73bfba3b', 'size': 2473824320}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/049/SRR13666749/SRR13666749_2.fastq.gz', 'md5': '266e9d8bd1f0395e24ecdba75a007a36', 'size': 2543575053}]","[{'url': 's3://sra-pub-src-16/SRR13666749/DD_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13666749/DD_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13666749/DD_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13666749/DD_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666749/SRR13666749.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666750,SRX10058323,SRP305495,SRS8220576,NextSeq 500 paired end sequencing; GSM5071239: 2_month_old_fractured 2; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/050/SRR13666750/SRR13666750_1.fastq.gz', 'md5': 'c6b6c767105654ebf5c706259524b70e', 'size': 2383366135}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/050/SRR13666750/SRR13666750_2.fastq.gz', 'md5': 'b14ac3f3d70833e793b7939dfafb645e', 'size': 2424882154}]","[{'url': 's3://sra-pub-src-18/SRR13666750/EE_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13666750/EE_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR13666750/EE_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13666750/EE_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666750/SRR13666750.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666751,SRX10058315,SRP305495,SRS8220568,NextSeq 500 paired end sequencing; GSM5071240: 2_month_old_fractured 3; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/051/SRR13666751/SRR13666751_1.fastq.gz', 'md5': 'af3b8fcc5fb809cdf650be0b49fd86df', 'size': 2849393206}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/051/SRR13666751/SRR13666751_2.fastq.gz', 'md5': 'bc102aeab5423df98ebf2ff912b7840e', 'size': 2905346816}]","[{'url': 's3://sra-pub-src-15/SRR13666751/FF_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13666751/FF_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13666751/FF_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13666751/FF_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666751/SRR13666751.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666752,SRX10058316,SRP305495,SRS8220569,NextSeq 500 paired end sequencing; GSM5071241: 12_month_old_fractured 1; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/052/SRR13666752/SRR13666752_1.fastq.gz', 'md5': 'd13f6455c4bbe1f5ddc646d5a189d294', 'size': 1832014098}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/052/SRR13666752/SRR13666752_2.fastq.gz', 'md5': '7ac3b148c985238ae8b61ca56c3eb512', 'size': 1904377768}]","[{'url': 's3://sra-pub-src-15/SRR13666752/JJ_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13666752/JJ_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13666752/JJ_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13666752/JJ_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666752/SRR13666752.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666753,SRX10058317,SRP305495,SRS8220570,NextSeq 500 paired end sequencing; GSM5071242: 12_month_old_fractured 2; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/053/SRR13666753/SRR13666753_1.fastq.gz', 'md5': 'f7c10c0c0cab1c522fb01e1081fa9833', 'size': 2574512863}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/053/SRR13666753/SRR13666753_2.fastq.gz', 'md5': 'fc0239a48fce395c92898e076b8bd424', 'size': 2634653468}]","[{'url': 's3://sra-pub-src-15/SRR13666753/KK_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13666753/KK_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13666753/KK_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13666753/KK_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666753/SRR13666753.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666754,SRX10058318,SRP305495,SRS8220571,NextSeq 500 paired end sequencing; GSM5071243: 12_month_old_fractured 3; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/054/SRR13666754/SRR13666754_1.fastq.gz', 'md5': '55323ce6823ecf2ead6e8c42f751d8d6', 'size': 2092691375}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/054/SRR13666754/SRR13666754_2.fastq.gz', 'md5': '9e4e7e16eaa5a69b4b6e02842749d738', 'size': 2150284491}]","[{'url': 's3://sra-pub-src-17/SRR13666754/LL_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13666754/LL_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR13666754/LL_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13666754/LL_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666754/SRR13666754.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666755,SRX10058319,SRP305495,SRS8220572,NextSeq 500 paired end sequencing; GSM5071244: 24_month_old_fractured 1; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/055/SRR13666755/SRR13666755_1.fastq.gz', 'md5': 'e6f6aba1fe5daaf06276f836bfbd433d', 'size': 2507850882}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/055/SRR13666755/SRR13666755_2.fastq.gz', 'md5': '2d474d46bbf190ebf6022fde200db92a', 'size': 2581027847}]","[{'url': 's3://sra-pub-src-16/SRR13666755/PP_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13666755/PP_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13666755/PP_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13666755/PP_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666755/SRR13666755.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666756,SRX10058320,SRP305495,SRS8220573,NextSeq 500 paired end sequencing; GSM5071245: 24_month_old_fractured 2; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/056/SRR13666756/SRR13666756_1.fastq.gz', 'md5': '26a357772a718546f8a9cb9793adc331', 'size': 2332083131}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/056/SRR13666756/SRR13666756_2.fastq.gz', 'md5': 'c54bd8c896ca443ba39083e42fa44e3b', 'size': 2383069273}]","[{'url': 's3://sra-pub-src-18/SRR13666756/QQ_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13666756/QQ_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR13666756/QQ_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13666756/QQ_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666756/SRR13666756.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13666757,SRX10058321,SRP305495,SRS8220574,NextSeq 500 paired end sequencing; GSM5071246: 24_month_old_fractured 3; Mus musculus; RNA-Seq,,2021-06-15,2021-06-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/057/SRR13666757/SRR13666757_1.fastq.gz', 'md5': '0bc0a50f965f26ec032fbccffade216a', 'size': 2392956187}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/057/SRR13666757/SRR13666757_2.fastq.gz', 'md5': '4b9b37e2e817f957bdb929ef073b9544', 'size': 2472582264}]","[{'url': 's3://sra-pub-src-16/SRR13666757/RR_S1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13666757/RR_S1_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13666757/RR_S1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13666757/RR_S1_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR13666757/SRR13666757.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10560003,,,,Illumina HiSeq 2500 sequencing; GSM4196529: single cell RNA sequencing of dissected mouse mandibular prominence at embryonic day 11.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7241718,Illumina HiSeq 2500 sequencing; GSM4196529: single cell RNA sequencing of dissected mouse mandibular prominence at embryonic day 11.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP234027,Single cell sequencing of dissected mouse mandibular prominence at embryonic day e11.5 and e13.5,Single cell sequencing of dissected mouse mandibular prominence at embryonic day e11.5 and e13.5 Overall design: Mouse mandibular prominences were dissected at embryonic day 11.5 and 13.5. Tissue were dissociated into single cell suspension and used for single cell RNA library preparation and sequencing using 10X Genomics platform.,SRS5741203,single cell RNA sequencing of dissected mouse mandibular prominence at embryonic day 11.5,Mus musculus,E11.5_MNP,,CD1,,,2020-10-01,2020-10-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR105/SRR10560003/E11.5_MNP.bam', 'md5': '2ef3b1cf3e4d2d7ca476702872588187', 'size': '43441014697'}]",,,,micro-dissected mandibular prominence,embryonic day 11.5,epithelium and mesenchyme of mandibular prominence including developing tongue bud.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10560004,,,,Illumina HiSeq 2500 sequencing; GSM4196530: single cell RNA sequencing of dissected mouse mandibular prominence at embryonic day 13.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7241719,Illumina HiSeq 2500 sequencing; GSM4196530: single cell RNA sequencing of dissected mouse mandibular prominence at embryonic day 13.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP234027,Single cell sequencing of dissected mouse mandibular prominence at embryonic day e11.5 and e13.5,Single cell sequencing of dissected mouse mandibular prominence at embryonic day e11.5 and e13.5 Overall design: Mouse mandibular prominences were dissected at embryonic day 11.5 and 13.5. Tissue were dissociated into single cell suspension and used for single cell RNA library preparation and sequencing using 10X Genomics platform.,SRS5741204,single cell RNA sequencing of dissected mouse mandibular prominence at embryonic day 13.5,Mus musculus,E13.5_MNP,,CD1,,,2020-10-01,2020-10-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR105/SRR10560004/E13.5_MNP.bam', 'md5': '933572fbbee4f6bf50621a3505d05c61', 'size': '31024999306'}]",,,,micro-dissected mandibular tissues,embryonic day 13.5,epithelium and mesenchyme of mandibular prominence including developing tongue and skeletal elements,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713193,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556893: S+-01; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008780,Illumina NovaSeq 6000 paired end sequencing; GSM5556893: S+-01; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014927,S+-01,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,616590461,73990855320,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/093/SRR15713193/SRR15713193.fastq.gz', 'md5': 'd789b8d1e8807206ffb5db18468a5ebc', 'size': '34954647658'}]",,,,,,Polyclonal colonies of skeletal stem cells,STAT1+/-Sox2Cre+/-,3 weeks old,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713194,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556894: S+-02; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008781,Illumina NovaSeq 6000 paired end sequencing; GSM5556894: S+-02; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014928,S+-02,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,332668743,39920249160,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/094/SRR15713194/SRR15713194.fastq.gz', 'md5': 'b882a31214fea5144f4e9cd8957b4091', 'size': '19694685216'}]",,,,,,Polyclonal colonies of skeletal stem cells,STAT1+/-Sox2Cre+/-,3 weeks old,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713195,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556895: S--01; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008782,Illumina NovaSeq 6000 paired end sequencing; GSM5556895: S--01; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014930,S--01,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,514052795,61686335400,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/095/SRR15713195/SRR15713195.fastq.gz', 'md5': '2d34286a8a454120bc96972bd7e164a3', 'size': '28984508049'}]",,,,,,Polyclonal colonies of skeletal stem cells,STAT1-/-Sox2Cre+/-,3 weeks old,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713196,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556896: S--02; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008783,Illumina NovaSeq 6000 paired end sequencing; GSM5556896: S--02; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014929,S--02,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,339651405,40758168600,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/096/SRR15713196/SRR15713196.fastq.gz', 'md5': '820b8f8aad10a499bd79dae8caab6ed5', 'size': '20413455502'}]",,,,,,Polyclonal colonies of skeletal stem cells,STAT1-/-Sox2Cre+/-,3 weeks old,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713197,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556897: KS+-01; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008784,Illumina NovaSeq 6000 paired end sequencing; GSM5556897: KS+-01; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014931,KS+-01,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,502065095,60247811400,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/097/SRR15713197/SRR15713197.fastq.gz', 'md5': '7f8374c0a0ae619fce05c399594e7d17', 'size': '28626559474'}]",,,,,,Polyclonal colonies of skeletal stem cells,PDGFRbD849V+/-STAT1+/-Sox2Cre+/-,3 weeks old,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713198,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556898: KS+-02; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008785,Illumina NovaSeq 6000 paired end sequencing; GSM5556898: KS+-02; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014932,KS+-02,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,442394016,40257855456,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/098/SRR15713198/SRR15713198.fastq.gz', 'md5': 'e9d62da764d84814db2427fab107d7c3', 'size': '10881867657'}]",,,,,,Polyclonal colonies of skeletal stem cells,PDGFRbD849V+/-STAT1+/-Sox2Cre+/-,3 weeks old,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713199,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556898: KS+-02; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008785,Illumina NovaSeq 6000 paired end sequencing; GSM5556898: KS+-02; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014932,KS+-02,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,442394016,40257855456,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/099/SRR15713199/SRR15713199.fastq.gz', 'md5': '9733537e5d9974ca5c3bc70a7d7441a2', 'size': '10489519308'}]",,,,,,Polyclonal colonies of skeletal stem cells,PDGFRbD849V+/-STAT1+/-Sox2Cre+/-,3 weeks old,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713200,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556899: KS--01; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008786,Illumina NovaSeq 6000 paired end sequencing; GSM5556899: KS--01; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014933,KS--01,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,504851609,60582193080,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/000/SRR15713200/SRR15713200.fastq.gz', 'md5': '7d40e60a698b9c6314cf3871529e7eb6', 'size': '28653034249'}]",,,,,,Polyclonal colonies of skeletal stem cells,PDGFRbD849V+/-STAT1-/-Sox2Cre+/-,3 weeks old,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713201,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556900: KS--02; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008787,Illumina NovaSeq 6000 paired end sequencing; GSM5556900: KS--02; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014934,KS--02,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,418159652,38052528332,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/001/SRR15713201/SRR15713201.fastq.gz', 'md5': 'd3f94319ca2c5298813e83c734cd7203', 'size': '10388822587'}]",,,,,,Polyclonal colonies of skeletal stem cells,PDGFRbD849V+/-STAT1-/-Sox2Cre+/-,3 weeks old,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15713202,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5556900: KS--02; Mus musculus; RNA-Seq,,,,,,,,,,SRX12008787,Illumina NovaSeq 6000 paired end sequencing; GSM5556900: KS--02; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP335579,Single-cell transcriptomics of cultured skeletal stem cells with a PDGFRbeta D849V mutation,"We demonstrate that skeletal stem cells (SSCs) isolated from mice with a gain-of-function D849V point mutation in PDGFRbeta exhibit colony formation defects that parallel the wasting or overgrowth phenotypes of the mice. Single-cell RNA transcriptomics with SSC-derived polyclonal colonies was performed to characterize single-cell differentiation potential and molecular signatures. This study indicates multi-lineage potential of cultured SSCs and identifies molecular alterations in osteogenic and chondrogenic precursors. Overall design: Single-cell RNA sequencing of sorted and cultured PDGFRalpha+/Sca-1+ skeletal stem cells of 3-weeks-old limb of four genotypes (STAT1+/-, STAT1-/-, PDGFRbD849V+/-STAT1+/-,PDGFRbD849V+/-STAT1-/-) of mice",SRS10014934,KS--02,Mus musculus,PDGFRa+/Sca1+ skeketal stem cells,,,418159652,38052528332,2021-11-10,2021-11-10,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/002/SRR15713202/SRR15713202.fastq.gz', 'md5': 'ec944002b4e281ec1f92d3fb890009b6', 'size': '9965632770'}]",,,,,,Polyclonal colonies of skeletal stem cells,PDGFRbD849V+/-STAT1-/-Sox2Cre+/-,3 weeks old,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18534318,SRX14664389,SRP366669,SRS12428991,NextSeq 500 paired end sequencing; GSM5983932: aged; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/018/SRR18534318/SRR18534318_1.fastq.gz', 'md5': '57166863ca3f8357bdde09a4190af8d2', 'size': 9016858770}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/018/SRR18534318/SRR18534318_2.fastq.gz', 'md5': '4a28e236c8eb6144be9d94267bfe86f8', 'size': 18398572906}]","[{'url': 's3://sra-pub-src-11/SRR18534318/Age_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR18534318/Age_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-2/SRR18534318/SRR18534318.1'}]","[{'url': 'gs://sra-pub-src-18/SRR18534318/Age_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR18534318/Age_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR18534318/SRR18534318.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra74/SRR/018099/SRR18534318'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18534319,SRX14664389,SRP366669,SRS12428991,NextSeq 500 paired end sequencing; GSM5983932: aged; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/019/SRR18534319/SRR18534319_2.fastq.gz', 'md5': '2e43cc1dd40c509fcf8604399b847295', 'size': 18122100994}]","[{'url': 's3://sra-pub-src-6/SRR18534319/Age_1_S2_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR18534319/Age_1_S2_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR18534319/Age_1_S2_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR18534319/Age_1_S2_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra16/SRR/018099/SRR18534319'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18534320,SRX14664388,SRP366669,SRS12428990,NextSeq 500 paired end sequencing; GSM5983931: young; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,[],"[{'url': 's3://sra-pub-src-11/SRR18534320/Young_2_S1_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR18534320/Young_2_S1_L001_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-2/SRR18534320/SRR18534320.1'}]","[{'url': 'gs://sra-pub-src-18/SRR18534320/Young_2_S1_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR18534320/Young_2_S1_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR18534320/SRR18534320.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra74/SRR/018099/SRR18534320'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18534321,SRX14664388,SRP366669,SRS12428990,NextSeq 500 paired end sequencing; GSM5983931: young; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/021/SRR18534321/SRR18534321_1.fastq.gz', 'md5': 'ad84b702b6c5782aa23fc6c14de52666', 'size': 7743502735}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/021/SRR18534321/SRR18534321_2.fastq.gz', 'md5': 'aaa8ea6228c052eb6119316d9340d46b', 'size': 16157508658}]","[{'url': 's3://sra-pub-src-4/SRR18534321/Young_2_S1_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR18534321/Young_2_S1_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR18534321/Young_2_S1_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR18534321/Young_2_S1_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra43/SRR/018099/SRR18534321'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17190652,SRX13372477,SRP350159,SRS11276821,NextSeq 500 paired end sequencing; GSM5726705: Col10a1-Cre;R26-tdTomato total bone cells e16.5 post-FACS; Mus musculus; RNA-Seq,,2022-02-18,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR171/SRR17190652/possorted_genome_bam.bam.1', 'md5': 'b2603f71898aa2404b85e82898fd9993', 'size': 21620549961}]",[{'url': 'https://sra-pub-src-1.s3.amazonaws.com/SRR17190652/possorted_genome_bam.bam.1'}],[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR17190652/possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra71/SRZ/017190/SRR17190652/possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,treat_as_unmapped,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16230855,SRX12512614,SRP340363,SRS10474078,Illumina HiSeq 4000 paired end sequencing; GSM5616860: HO + Callus 10X-scRNA-seq; Mus musculus; RNA-Seq,,2021-10-11,2021-10-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/055/SRR16230855/SRR16230855_1.fastq.gz', 'md5': 'a45a7737bd7d216e7893a3f43c56b44f', 'size': 8619798942}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/055/SRR16230855/SRR16230855_2.fastq.gz', 'md5': 'f18c44f7c81e59be585feaf5d8f07c0a', 'size': 26263545872}]","[{'url': 's3://sra-pub-src-16/SRR16230855/10XDavisLibrary_S1_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR16230855/10XDavisLibrary_S1_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR16230855/10XDavisLibrary_S1_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR16230855/10XDavisLibrary_S1_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra38/SRR/015850/SRR16230855'}],463489621,57472713004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10257243,,,,HiSeq X Ten paired end sequencing; GSM4116165: MCY_Adult; Mus musculus; RNA-Seq,,,,,,,,,,SRX6975194,HiSeq X Ten paired end sequencing; GSM4116165: MCY_Adult; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS5500579,MCY_Adult,Mus musculus,Long bones,Nomal feeding,,481613803,144484140900,2021-01-04,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/043/SRR10257243/SRR10257243_1.fastq.gz', 'md5': '3dc87b5c75e92d6d98e5d02a2af755e9', 'size': '46747860330'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/043/SRR10257243/SRR10257243_2.fastq.gz', 'md5': '88a7574f552fcee9d5748e7ab54cce04', 'size': '36951762496'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,8-week-old,,,,C57BL/6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10257244,,,,HiSeq X Ten paired end sequencing; GSM4116166: MCY_Aging; Mus musculus; RNA-Seq,,,,,,,,,,SRX6975195,HiSeq X Ten paired end sequencing; GSM4116166: MCY_Aging; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS5500580,MCY_Aging,Mus musculus,Long bones,Nomal feeding,,180762532,54228759600,2021-01-04,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/044/SRR10257244/SRR10257244_1.fastq.gz', 'md5': 'c377e1885849956e81b7b46353462e1f', 'size': '16171756043'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/044/SRR10257244/SRR10257244_2.fastq.gz', 'md5': 'fde4900f6a6350c70aef7c35c7ecdac5', 'size': '16990930461'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,12-month-old,,,,C57BL/6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10257245,,,,HiSeq X Ten paired end sequencing; GSM4116167: MCY_Rosiglitazone; Mus musculus; RNA-Seq,,,,,,,,,,SRX6975196,HiSeq X Ten paired end sequencing; GSM4116167: MCY_Rosiglitazone; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS5500581,MCY_Rosiglitazone,Mus musculus,Long bones,"Fed with 20 g/kg rosiglitazone-containing chow at 5 weeks old, analyzed after 5 weeks",,212855595,63856678500,2021-01-04,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/045/SRR10257245/SRR10257245_1.fastq.gz', 'md5': '7d8693c9b847eedfd400272d2e28dc41', 'size': '18211395447'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/045/SRR10257245/SRR10257245_2.fastq.gz', 'md5': 'a99bebb9fcf9d75e19bac8ec9397dfe0', 'size': '19198467196'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,10-week-old,,,,C57BL/6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10257246,,,,HiSeq X Ten paired end sequencing; GSM4116168: MCY_Irradiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX6975197,HiSeq X Ten paired end sequencing; GSM4116168: MCY_Irradiation; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS5500582,MCY_Irradiation,Mus musculus,Long bones,"Sub-lethally irradiated (5 Gy) at 7 weeks old, analyzed after one week",,245338921,73601676300,2021-01-04,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/046/SRR10257246/SRR10257246_1.fastq.gz', 'md5': '1f6d01e6f9f68ad23e8e6489107baee7', 'size': '20932582081'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/046/SRR10257246/SRR10257246_2.fastq.gz', 'md5': '97c5c23cbaa08cf347c8356ae95f28d9', 'size': '23522425951'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,8-week-old,,,,C57BL/6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10257247,,,,HiSeq X Ten paired end sequencing; GSM4116169: MCY_Fracture; Mus musculus; RNA-Seq,,,,,,,,,,SRX6975198,HiSeq X Ten paired end sequencing; GSM4116169: MCY_Fracture; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS5500583,MCY_Fracture,Mus musculus,Long bones,"Femur fractured at 7 weeks old, analyzed after one week",,222677855,66803356500,2021-01-04,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/047/SRR10257247/SRR10257247_1.fastq.gz', 'md5': '579c2d7e99759938979786a6d1a10a1d', 'size': '18452530551'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/047/SRR10257247/SRR10257247_2.fastq.gz', 'md5': '22aba115b558aa46108127d26957f34b', 'size': '21596149459'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,8-week-old,,,,C57BL/6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10257249,,,,HiSeq X Ten paired end sequencing; GSM4116171: Prx1_BM; Mus musculus; RNA-Seq,,,,,,,,,,SRX6975200,HiSeq X Ten paired end sequencing; GSM4116171: Prx1_BM; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS5500585,Prx1_BM,Mus musculus,Long bones,Nomal feeding,,497008499,149102549700,2021-01-04,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/049/SRR10257249/SRR10257249_1.fastq.gz', 'md5': '2080f48b0b48aaf56c9844db7f207bbc', 'size': '42843750541'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/049/SRR10257249/SRR10257249_2.fastq.gz', 'md5': '1d2f33b0f5b9591e293f6e195c861373', 'size': '38870451249'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Prrx1-Cre+ Col2.3-GFP- cells,,8 weeks,,,,C57BL/6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16021511,,,,HiSeq X Ten paired end sequencing; GSM5594805: MCY_Adult2; Mus musculus; RNA-Seq,,,,,,,,,,SRX12308462,HiSeq X Ten paired end sequencing; GSM5594805: MCY_Adult2; Mus musculus; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS10283328,MCY_Adult2,Mus musculus,Long bones,Normal feeding,C57BL/6,,,2021-11-18,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR160/011/SRR16021511/SRR16021511_1.fastq.gz', 'md5': '69cd959260fcd028cb44a314b89a6743', 'size': '42349446118'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR160/011/SRR16021511/SRR16021511_2.fastq.gz', 'md5': '1859ef1a40136b3bc86f12254f07a81c', 'size': '39652110086'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,8-week-old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16021513,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5594806: MCY-IRRA; Mus musculus; RNA-Seq,,,,,,,,,,SRX12308463,Illumina NovaSeq 6000 paired end sequencing; GSM5594806: MCY-IRRA; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225051,Transcriptomic and functional analysis of skeletal stem and progenitor cells under homeostatic and stress conditions,"Leptin receptor+ (LepR+) cells are key components of the bone marrow hematopoietic microenvironment, and highly enrich skeletal stem and progenitor cells (SSPCs) that maintain homeostasis of the adult skeleton. However, the heterogeneity and lineage hierarchy within this population has been elusive. By genetic lineage tracing and single-cell RNA-sequencing, we found that Lepr-Cre labels most bone marrow stromal cells (BMSCs) and osteogenic lineage cells in adult long bones. Integrated analysis of Lepr-Cre-traced cells under homeostatic and stress conditions revealed dynamic changes of the adipogenic, osteogenic and periosteal lineages. Importantly, we discovered a Notch3+ BMSC subpopulation that is more quiescent and closely associated with the vasculatures, as well as key transcriptional networks promoting osteo-chondrogenic differentiation. We also identified a Sca-1+ periosteal subpopulation with high clonogenic activity but limited osteo-chondrogenic potential. Together, we mapped the transcriptomic landscape of adult SSPCs, and uncovered important cellular and molecular mechanisms underlying their maintenance and lineage specification. Overall design: Single-cell transcriptomic profiling of Prrx1-Cre- and Lepr-Cre-traced stromal cells in steady state long bones from Prrx1-Cre;tdTomato;Col2.3-GFP and Lepr-Cre;tdTomato mice, respectively, as well as Lepr-Cre-traced stromal cells from Lepr-Cre;tdTomato mice under stress conditions such as aging, rosiglitazone feeding, irradiation and bone fracture. Bulk transcriptomic profiling of wild-type bone marrow stromal cells (BMSCs) cultured in 3D GelMA hydrogel alone, or 3D co-cultured with bone marrow endothelial cells (ECs).",SRS10283329,MCY-IRRA,Mus musculus,Long bones,"Sub-lethally irradiated (5 Gy) at 7 weeks old, analyzed after one week",C57BL/6,248515957,44235840346,2021-11-18,2021-11-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR160/013/SRR16021513/SRR16021513_1.fastq.gz', 'md5': 'a528b742459bbe455430e2f6d088740c', 'size': '5050464533'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR160/013/SRR16021513/SRR16021513_2.fastq.gz', 'md5': 'e55a749e2a8d4d7df1f8d16996fb2175', 'size': '18381160577'}]",Bone marrows and bone fragments,,,,,CD45-Ter119-Tie2-Lepr-Cre+ cells,,8-week-old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12492372,,,,NextSeq 500 paired end sequencing; GSM4735393: BSC rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX8983987,NextSeq 500 paired end sequencing; GSM4735393: BSC rep1; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP278393,Regional specialization and fate specification of mesenchymal stromal cells in skeletal development [scRNA-seq],"To identify cellular heterogeneity and molecular signatures of bone marrow stromal (BMSCs) cells, we performed scRNA-seq of non-hematopoietic stromal cells from 3-week-old mice. In addition, to gain further insight into MSC differentiation in vivo, Pdgfrb-CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double transgenic mice were treated with tamoxifen at P1-3 and sacrificed at P21 for the isolation of GFP+ cells from long bone followed by scRNA-seq analysis. Overall design: Single cell -RNA sequencing of non-hematopoietic  bone stromal cells (BSC) postnatal day 21 old bone and PdgfrbCre-R26 mTmG GFP+ sorted cells using  10X genomics.",SRS7238317,BSC rep1,Mus musculus,Bone stromal cells,,C57BL/6,,,2020-08-23,2020-08-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/072/SRR12492372/SRR12492372_1.fastq.gz', 'md5': '6a3e7aeb67d97f84ae6ccfbf48a1bf40', 'size': '3807716192'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/072/SRR12492372/SRR12492372_2.fastq.gz', 'md5': 'c55505be4b22ecf9a231036a101ce225', 'size': '11932317829'}]",Bone,,,,,Bone stromal cells,,postnatal day 21,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12492373,,,,NextSeq 500 paired end sequencing; GSM4735394: BSC rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX8983988,NextSeq 500 paired end sequencing; GSM4735394: BSC rep2; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP278393,Regional specialization and fate specification of mesenchymal stromal cells in skeletal development [scRNA-seq],"To identify cellular heterogeneity and molecular signatures of bone marrow stromal (BMSCs) cells, we performed scRNA-seq of non-hematopoietic stromal cells from 3-week-old mice. In addition, to gain further insight into MSC differentiation in vivo, Pdgfrb-CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double transgenic mice were treated with tamoxifen at P1-3 and sacrificed at P21 for the isolation of GFP+ cells from long bone followed by scRNA-seq analysis. Overall design: Single cell -RNA sequencing of non-hematopoietic  bone stromal cells (BSC) postnatal day 21 old bone and PdgfrbCre-R26 mTmG GFP+ sorted cells using  10X genomics.",SRS7238318,BSC rep2,Mus musculus,Bone stromal cells,,C57BL/6,,,2020-08-23,2020-08-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/073/SRR12492373/SRR12492373_1.fastq.gz', 'md5': '91657c6a58f142227805b67cb35c462e', 'size': '3850535889'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/073/SRR12492373/SRR12492373_2.fastq.gz', 'md5': '0ee570fb8ba47ff3402e257a672ea341', 'size': '12103746337'}]",Bone,,,,,Bone stromal cells,,postnatal day 21,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12492374,,,,NextSeq 500 paired end sequencing; GSM4735395: BSC rep3; Mus musculus; RNA-Seq,,,,,,,,,,SRX8983989,NextSeq 500 paired end sequencing; GSM4735395: BSC rep3; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP278393,Regional specialization and fate specification of mesenchymal stromal cells in skeletal development [scRNA-seq],"To identify cellular heterogeneity and molecular signatures of bone marrow stromal (BMSCs) cells, we performed scRNA-seq of non-hematopoietic stromal cells from 3-week-old mice. In addition, to gain further insight into MSC differentiation in vivo, Pdgfrb-CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double transgenic mice were treated with tamoxifen at P1-3 and sacrificed at P21 for the isolation of GFP+ cells from long bone followed by scRNA-seq analysis. Overall design: Single cell -RNA sequencing of non-hematopoietic  bone stromal cells (BSC) postnatal day 21 old bone and PdgfrbCre-R26 mTmG GFP+ sorted cells using  10X genomics.",SRS7238319,BSC rep3,Mus musculus,Bone stromal cells,,C57BL/6,,,2020-08-23,2020-08-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/074/SRR12492374/SRR12492374_1.fastq.gz', 'md5': '666489d8ba0d95fd25584bb4602d629d', 'size': '3455755782'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/074/SRR12492374/SRR12492374_2.fastq.gz', 'md5': 'a09170cec26993a6ca21746735e81c33', 'size': '10553310490'}]",Bone,,,,,Bone stromal cells,,postnatal day 21,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12492375,,,,NextSeq 500 paired end sequencing; GSM4735396: BSC rep4; Mus musculus; RNA-Seq,,,,,,,,,,SRX8983990,NextSeq 500 paired end sequencing; GSM4735396: BSC rep4; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP278393,Regional specialization and fate specification of mesenchymal stromal cells in skeletal development [scRNA-seq],"To identify cellular heterogeneity and molecular signatures of bone marrow stromal (BMSCs) cells, we performed scRNA-seq of non-hematopoietic stromal cells from 3-week-old mice. In addition, to gain further insight into MSC differentiation in vivo, Pdgfrb-CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double transgenic mice were treated with tamoxifen at P1-3 and sacrificed at P21 for the isolation of GFP+ cells from long bone followed by scRNA-seq analysis. Overall design: Single cell -RNA sequencing of non-hematopoietic  bone stromal cells (BSC) postnatal day 21 old bone and PdgfrbCre-R26 mTmG GFP+ sorted cells using  10X genomics.",SRS7238320,BSC rep4,Mus musculus,Bone stromal cells,,C57BL/6,,,2020-08-23,2020-08-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/075/SRR12492375/SRR12492375_1.fastq.gz', 'md5': '750d63d996fac8d921d1016eaa55f55e', 'size': '4322870490'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/075/SRR12492375/SRR12492375_2.fastq.gz', 'md5': '67d4a70327acd85eb1d09f8416d62416', 'size': '13249029278'}]",Bone,,,,,Bone stromal cells,,postnatal day 21,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199772,SRX8710651,SRP271372,SRS6987004,NextSeq 500 paired end sequencing; GSM4667551: BSC Control-1 rep1; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-12/SRR12199772/AdultF1-1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR12199772/AdultF1-1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR12199772/AdultF1-1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR12199772/AdultF1-1_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199772/SRR12199772.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199773,SRX8710652,SRP271372,SRS6987005,NextSeq 500 paired end sequencing; GSM4667552: BSC Control-1 rep2; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-9/SRR12199773/AdultF1-2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR12199773/AdultF1-2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR12199773/AdultF1-2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR12199773/AdultF1-2_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199773/SRR12199773.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199774,SRX8710653,SRP271372,SRS6987006,NextSeq 500 paired end sequencing; GSM4667553: BSC Control-2 rep1; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-12/SRR12199774/AdultF2-1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR12199774/AdultF2-1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR12199774/AdultF2-1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR12199774/AdultF2-1_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199774/SRR12199774.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199775,SRX8710654,SRP271372,SRS6987007,NextSeq 500 paired end sequencing; GSM4667554: BSC Control-2 rep2; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-13/SRR12199775/AdultF2-2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR12199775/AdultF2-2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR12199775/AdultF2-2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR12199775/AdultF2-2_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199775/SRR12199775.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199776,SRX8710655,SRP271372,SRS6987009,NextSeq 500 paired end sequencing; GSM4667555: BSC Fracture-1 rep1; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-12/SRR12199776/fbSC1-1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR12199776/fbSC1-1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR12199776/fbSC1-1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR12199776/fbSC1-1_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199776/SRR12199776.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199777,SRX8710656,SRP271372,SRS6987008,NextSeq 500 paired end sequencing; GSM4667556: BSC Fracture-1 rep2; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-5/SRR12199777/fbSC1-2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12199777/fbSC1-2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR12199777/fbSC1-2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12199777/fbSC1-2_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199777/SRR12199777.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199778,SRX8710657,SRP271372,SRS6987010,NextSeq 500 paired end sequencing; GSM4667557: BSC Fracture-2 rep1; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-9/SRR12199778/fbSC2-1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR12199778/fbSC2-1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR12199778/fbSC2-1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR12199778/fbSC2-1_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199778/SRR12199778.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12199779,SRX8710658,SRP271372,SRS6987011,NextSeq 500 paired end sequencing; GSM4667558: BSC Fracture-2 rep2; Mus musculus; RNA-Seq,,2021-12-12,2021-12-12,[],"[{'url': 's3://sra-pub-src-12/SRR12199779/fbSC2-2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR12199779/fbSC2-2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR12199779/fbSC2-2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR12199779/fbSC2-2_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR012/12199/SRR12199779/SRR12199779.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR9317818,SRX6085362,SRP201715,SRS4987056,HiSeq X Ten paired end sequencing; GSM3895612: control group; Mus musculus; RNA-Seq,,2021-11-03,2021-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/008/SRR9317818/SRR9317818_1.fastq.gz', 'md5': '87e46f7ce38bc0bb53cba882b3b4a5a1', 'size': 20269434743}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/008/SRR9317818/SRR9317818_2.fastq.gz', 'md5': '38ce87c574681bd48aef63ff14b0057d', 'size': 19136608156}]","[{'url': 's3://sra-pub-src-11/SRR9317818/youer_S8_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR9317818/youer_S8_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR9317818/youer_S8_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR9317818/youer_S8_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR009/9317/SRR9317818/SRR9317818.1'}],251923783,76080982466,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR9317819,SRX6085363,SRP201715,SRS4987057,HiSeq X Ten paired end sequencing; GSM3895613: third day; Mus musculus; RNA-Seq,,2021-11-03,2021-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/009/SRR9317819/SRR9317819_1.fastq.gz', 'md5': 'fc20628f70b383072b1894e46f38f334', 'size': 19306265659}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/009/SRR9317819/SRR9317819_2.fastq.gz', 'md5': 'd362ccbc0f83ed88bc2a7d2ea338d37a', 'size': 18187733052}]","[{'url': 's3://sra-pub-src-11/SRR9317819/zuoer_S7_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR9317819/zuoer_S7_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR9317819/SRR9317819'}]","[{'url': 'gs://sra-pub-src-11/SRR9317819/zuoer_S7_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR9317819/zuoer_S7_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR009/9317/SRR9317819/SRR9317819.1'}],238366558,71986700516,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR9317820,SRX6085364,SRP201715,SRS4987058,HiSeq X Ten paired end sequencing; GSM3895614: seventh day; Mus musculus; RNA-Seq,,2021-11-03,2021-11-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/000/SRR9317820/SRR9317820_1.fastq.gz', 'md5': 'f3df71e237b5a560ce5e469c6f1f8502', 'size': 23247203688}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/000/SRR9317820/SRR9317820_2.fastq.gz', 'md5': '24e8bb475b8b92f5a30c5957a423adf1', 'size': 22135992845}]","[{'url': 's3://sra-pub-src-11/SRR9317820/WRK_MACS_S43_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR9317820/WRK_MACS_S43_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR9317820/SRR9317820'}]","[{'url': 'gs://sra-pub-src-11/SRR9317820/WRK_MACS_S43_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR9317820/WRK_MACS_S43_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR009/9317/SRR9317820/SRR9317820.1'}],269150823,81283548546,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR9317821,SRX6085365,SRP201715,SRS4987059,HiSeq X Ten paired end sequencing; GSM3895615: 14th day; Mus musculus; RNA-Seq,,2021-11-03,2021-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/001/SRR9317821/SRR9317821_1.fastq.gz', 'md5': 'fbb0496641c49a8f424d4aaff9091c50', 'size': 21679685280}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR931/001/SRR9317821/SRR9317821_2.fastq.gz', 'md5': 'e72b07412592c871ca8bfed6cbcd5ca3', 'size': 20620503267}]","[{'url': 's3://sra-pub-src-11/SRR9317821/WRK_1_S74_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR9317821/WRK_1_S74_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR9317821/WRK_1_S74_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR9317821/WRK_1_S74_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR009/9317/SRR9317821/SRR9317821.1'}],258557491,78084362282,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097825,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/025/SRR15097825/SRR15097825_1.fastq.gz', 'md5': '68b938bdf55e8f3742bb95c14d2bb636', 'size': 847853152}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/025/SRR15097825/SRR15097825_2.fastq.gz', 'md5': '4fe936b773527eef48ec167a54d966d4', 'size': 2013829054}]","[{'url': 's3://sra-pub-src-16/SRR15097825/WT_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097825/WT_S1_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15097825/WT_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097825/WT_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097825/SRR15097825'}, {'url': 's3://sra-pub-run-3/SRR15097825/SRR15097825.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15097825/WT_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097825/WT_S1_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15097825/WT_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097825/WT_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097825/SRR15097825'}, {'url': 'gs://sra-pub-run-13/SRR15097825/SRR15097825.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15097/SRR15097825/SRR15097825.1'}],45532415,5418357385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097826,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/026/SRR15097826/SRR15097826_1.fastq.gz', 'md5': '29da7a4544437b7dfec540d05e5d1226', 'size': 863312579}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/026/SRR15097826/SRR15097826_2.fastq.gz', 'md5': 'a338983e8452501bd302ed840d75f4e0', 'size': 2046572805}]","[{'url': 's3://sra-pub-src-12/SRR15097826/WT_S1_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097826/WT_S1_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15097826/WT_S1_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097826/WT_S1_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097826/SRR15097826'}, {'url': 's3://sra-pub-run-1/SRR15097826/SRR15097826.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15097826/WT_S1_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097826/WT_S1_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15097826/WT_S1_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097826/WT_S1_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097826/SRR15097826'}, {'url': 'gs://sra-pub-run-13/SRR15097826/SRR15097826.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15097/SRR15097826/SRR15097826.1'}],46967527,5589135713,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097827,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/027/SRR15097827/SRR15097827_1.fastq.gz', 'md5': '97e4fb06e36a5b61e6bf5480531f13e7', 'size': 930088154}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/027/SRR15097827/SRR15097827_2.fastq.gz', 'md5': '36441ab5ebb671ad1eb378be8980295f', 'size': 2199115598}]","[{'url': 's3://sra-pub-src-8/SRR15097827/WT_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097827/WT_S2_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15097827/WT_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097827/WT_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097827/SRR15097827'}, {'url': 's3://sra-pub-run-9/SRR15097827/SRR15097827.1'}]","[{'url': 'gs://sra-pub-src-12/SRR15097827/WT_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097827/WT_S2_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR15097827/WT_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097827/WT_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097827/SRR15097827'}, {'url': 'gs://sra-pub-run-4/SRR15097827/SRR15097827.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15097/SRR15097827/SRR15097827.1'}],50212109,5975240971,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097828,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/028/SRR15097828/SRR15097828_1.fastq.gz', 'md5': '5e82462f153daa70ffd852fa38093622', 'size': 946791288}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/028/SRR15097828/SRR15097828_2.fastq.gz', 'md5': 'e1baf602bf006276268f4107bf3824d4', 'size': 2232840224}]","[{'url': 's3://sra-pub-src-13/SRR15097828/WT_S2_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097828/WT_S2_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15097828/WT_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097828/WT_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097828/SRR15097828'}, {'url': 's3://sra-pub-run-4/SRR15097828/SRR15097828.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15097828/WT_S2_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097828/WT_S2_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15097828/WT_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097828/WT_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097828/SRR15097828'}, {'url': 'gs://sra-pub-run-1/SRR15097828/SRR15097828.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra25/SRR/014743/SRR15097828'}],51767646,6160349874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097829,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/029/SRR15097829/SRR15097829_1.fastq.gz', 'md5': '9b187181d12df778a39bd3c6833d8f32', 'size': 876701395}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/029/SRR15097829/SRR15097829_2.fastq.gz', 'md5': '8d25f52ce1756bc8c6d360920d824b06', 'size': 2068743314}]","[{'url': 's3://sra-pub-src-7/SRR15097829/WT_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097829/WT_S3_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR15097829/WT_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097829/WT_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097829/SRR15097829'}, {'url': 's3://sra-pub-run-2/SRR15097829/SRR15097829.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15097829/WT_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097829/WT_S3_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15097829/WT_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097829/WT_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097829/SRR15097829'}, {'url': 'gs://sra-pub-run-3/SRR15097829/SRR15097829.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra42/SRR/014743/SRR15097829'}],47229631,5620326089,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097830,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/030/SRR15097830/SRR15097830_1.fastq.gz', 'md5': '61acd260f7fad669bfe547cc58b6bf54', 'size': 891330802}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/030/SRR15097830/SRR15097830_2.fastq.gz', 'md5': '1ee7071d0b858f74e1c7e70251174e65', 'size': 2098134657}]","[{'url': 's3://sra-pub-src-16/SRR15097830/WT_S3_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097830/WT_S3_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15097830/WT_S3_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097830/WT_S3_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097830/SRR15097830'}, {'url': 's3://sra-pub-run-3/SRR15097830/SRR15097830.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15097830/WT_S3_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097830/WT_S3_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15097830/WT_S3_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097830/WT_S3_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097830/SRR15097830'}, {'url': 'gs://sra-pub-run-12/SRR15097830/SRR15097830.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra38/SRR/014743/SRR15097830'}],48613448,5785000312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097831,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/031/SRR15097831/SRR15097831_1.fastq.gz', 'md5': 'f8f56cf52e6b7afea996ea4b5f5b5fae', 'size': 832225713}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/031/SRR15097831/SRR15097831_2.fastq.gz', 'md5': '21b335c0e82f95db98db03858bdfb2db', 'size': 1965990538}]","[{'url': 's3://sra-pub-src-12/SRR15097831/WT_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097831/WT_S4_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15097831/WT_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097831/WT_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097831/SRR15097831'}, {'url': 's3://sra-pub-run-1/SRR15097831/SRR15097831.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15097831/WT_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097831/WT_S4_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15097831/WT_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097831/WT_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097831/SRR15097831'}, {'url': 'gs://sra-pub-run-13/SRR15097831/SRR15097831.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra6/SRR/014743/SRR15097831'}],44945154,5348473326,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097832,SRX11407658,SRP327862,SRS9451352,Illumina NovaSeq 6000 paired end sequencing; GSM5436554: p75 floxed mice (p75fl/fl); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/032/SRR15097832/SRR15097832_1.fastq.gz', 'md5': 'ed058b84fce8376f048c8b41784aa424', 'size': 852937863}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/032/SRR15097832/SRR15097832_2.fastq.gz', 'md5': '041056ca0f57060b1873536f0fc05978', 'size': 2010599296}]","[{'url': 's3://sra-pub-src-17/SRR15097832/WT_S4_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097832/WT_S4_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15097832/WT_S4_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097832/WT_S4_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097832/SRR15097832'}]","[{'url': 'gs://sra-pub-src-8/SRR15097832/WT_S4_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097832/WT_S4_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15097832/WT_S4_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097832/WT_S4_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097832/SRR15097832'}]",[],46633088,5549337472,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097833,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/033/SRR15097833/SRR15097833_1.fastq.gz', 'md5': 'a2635b4e15fe67fc35578b94915d4055', 'size': 798307597}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/033/SRR15097833/SRR15097833_2.fastq.gz', 'md5': '6d3525f98ecafe6d2c02ff9cb4f14cf8', 'size': 1903587687}]","[{'url': 's3://sra-pub-src-10/SRR15097833/KO_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097833/KO_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15097833/KO_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097833/KO_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097833/SRR15097833'}, {'url': 's3://sra-pub-run-10/SRR15097833/SRR15097833.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15097833/KO_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097833/KO_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15097833/KO_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097833/KO_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097833/SRR15097833'}, {'url': 'gs://sra-pub-run-12/SRR15097833/SRR15097833.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15097/SRR15097833/SRR15097833.1'}],43074198,5125829562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097834,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/034/SRR15097834/SRR15097834_1.fastq.gz', 'md5': '174f4363ee4576ed94df0dae78aef4d7', 'size': 815005726}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/034/SRR15097834/SRR15097834_2.fastq.gz', 'md5': 'eeb58f6645a5b4f09d5acbed66363105', 'size': 1938637069}]","[{'url': 's3://sra-pub-src-8/SRR15097834/KO_S5_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097834/KO_S5_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15097834/KO_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097834/KO_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097834/SRR15097834'}, {'url': 's3://sra-pub-run-9/SRR15097834/SRR15097834.1'}]","[{'url': 'gs://sra-pub-src-12/SRR15097834/KO_S5_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097834/KO_S5_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR15097834/KO_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097834/KO_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097834/SRR15097834'}, {'url': 'gs://sra-pub-run-4/SRR15097834/SRR15097834.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra79/SRR/014743/SRR15097834'}],44528086,5298842234,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097835,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/035/SRR15097835/SRR15097835_1.fastq.gz', 'md5': 'dde799000e78fd09c358615dc47f638c', 'size': 817393104}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/035/SRR15097835/SRR15097835_2.fastq.gz', 'md5': '132268bf43d96ca8ba567c8227e802d7', 'size': 1949178833}]","[{'url': 's3://sra-pub-src-10/SRR15097835/KO_S6_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097835/KO_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15097835/KO_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097835/KO_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097835/SRR15097835'}, {'url': 's3://sra-pub-run-10/SRR15097835/SRR15097835.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15097835/KO_S6_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097835/KO_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15097835/KO_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097835/KO_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097835/SRR15097835'}, {'url': 'gs://sra-pub-run-12/SRR15097835/SRR15097835.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra75/SRR/014743/SRR15097835'}],43896217,5223649823,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097836,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/036/SRR15097836/SRR15097836_1.fastq.gz', 'md5': '2b828cad3b0b87aa8924e1ffd76fc772', 'size': 831021512}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/036/SRR15097836/SRR15097836_2.fastq.gz', 'md5': 'cdec1baf29e6085dbca710265f330373', 'size': 1975876221}]","[{'url': 's3://sra-pub-src-12/SRR15097836/KO_S6_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097836/KO_S6_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15097836/KO_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097836/KO_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097836/SRR15097836'}, {'url': 's3://sra-pub-run-3/SRR15097836/SRR15097836.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15097836/KO_S6_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097836/KO_S6_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15097836/KO_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097836/KO_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097836/SRR15097836'}, {'url': 'gs://sra-pub-run-13/SRR15097836/SRR15097836.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15097/SRR15097836/SRR15097836.1'}],45210866,5380093054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097837,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/037/SRR15097837/SRR15097837_1.fastq.gz', 'md5': 'aa7da3070c0017bd58df71181fc465f2', 'size': 838305494}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/037/SRR15097837/SRR15097837_2.fastq.gz', 'md5': 'fe1f4a7303c3b1f0798a11cb1fd917d8', 'size': 1999408457}]","[{'url': 's3://sra-pub-src-5/SRR15097837/KO_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097837/KO_S7_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15097837/KO_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097837/KO_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097837/SRR15097837'}, {'url': 's3://sra-pub-run-8/SRR15097837/SRR15097837.1'}]","[{'url': 'gs://sra-pub-src-18/SRR15097837/KO_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097837/KO_S7_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR15097837/KO_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097837/KO_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097837/SRR15097837'}, {'url': 'gs://sra-pub-run-5/SRR15097837/SRR15097837.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra75/SRR/014743/SRR15097837'}],45312425,5392178575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097838,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/038/SRR15097838/SRR15097838_1.fastq.gz', 'md5': 'b3aa70a4d3d9360769c35b27d14b7136', 'size': 861792302}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/038/SRR15097838/SRR15097838_2.fastq.gz', 'md5': '13ef8e6a56ef27cfd60ead5f7fcda303', 'size': 2050374642}]","[{'url': 's3://sra-pub-src-13/SRR15097838/KO_S7_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097838/KO_S7_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15097838/KO_S7_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097838/KO_S7_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097838/SRR15097838'}, {'url': 's3://sra-pub-run-4/SRR15097838/SRR15097838.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15097838/KO_S7_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097838/KO_S7_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15097838/KO_S7_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097838/KO_S7_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097838/SRR15097838'}, {'url': 'gs://sra-pub-run-1/SRR15097838/SRR15097838.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra70/SRR/014743/SRR15097838'}],47174044,5613711236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097839,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/039/SRR15097839/SRR15097839_1.fastq.gz', 'md5': '41b95787cc8c00d549ee4a41d717088a', 'size': 475325804}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/039/SRR15097839/SRR15097839_2.fastq.gz', 'md5': '453c051fda01d214d8ca2b86459378c2', 'size': 1133483379}]","[{'url': 's3://sra-pub-src-15/SRR15097839/KO_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097839/KO_S8_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15097839/KO_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097839/KO_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097839/SRR15097839'}, {'url': 's3://sra-pub-run-12/SRR15097839/SRR15097839.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15097839/KO_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097839/KO_S8_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15097839/KO_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097839/KO_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097839/SRR15097839'}, {'url': 'gs://sra-pub-run-10/SRR15097839/SRR15097839.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15097/SRR15097839/SRR15097839.1'}],25650910,3052458290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15097840,SRX11407659,SRP327862,SRS9451353,Illumina NovaSeq 6000 paired end sequencing; GSM5436555: p75 conditional knockout mice (p75PDGFR); Mus musculus; RNA-Seq,,2021-12-25,2021-12-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/040/SRR15097840/SRR15097840_1.fastq.gz', 'md5': 'd4ec87efd50e6815bd3ae7deb2b50cf5', 'size': 485671306}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR150/040/SRR15097840/SRR15097840_2.fastq.gz', 'md5': 'c2c7396cca7fd7d3be64f0fde4804823', 'size': 1155127556}]","[{'url': 's3://sra-pub-src-12/SRR15097840/KO_S8_L002_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097840/KO_S8_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15097840/KO_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR15097840/KO_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR15097840/SRR15097840'}]","[{'url': 'gs://sra-pub-src-6/SRR15097840/KO_S8_L002_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097840/KO_S8_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15097840/KO_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR15097840/KO_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR15097840/SRR15097840'}]",[],26549617,3159404423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048704,SRX10424647,SRP311831,SRS8545516,Illumina HiSeq 2500 paired end sequencing; GSM5203389: normal1; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048704/normal1_possorted_bam.bam', 'md5': '9bbcf68b2bdb927daf8b11f169a45dd0', 'size': 26832592360}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra49/SRZ/014048/SRR14048704/normal1_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048705,SRX10424648,SRP311831,SRS8545517,Illumina HiSeq 2500 paired end sequencing; GSM5203390: normal2; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048705/normal2_possorted_bam.bam', 'md5': 'b641447678441efd479c023b4085a297', 'size': 15804175962}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra74/SRZ/014048/SRR14048705/normal2_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048706,SRX10424649,SRP311831,SRS8545518,Illumina HiSeq 2500 paired end sequencing; GSM5203391: normal3; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048706/normal3_possorted_bam.bam', 'md5': 'a8a8cbb223b118601ee0cc0c05e8d177', 'size': 21649415103}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra8/SRZ/014048/SRR14048706/normal3_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048707,SRX10424650,SRP311831,SRS8545519,Illumina HiSeq 2500 paired end sequencing; GSM5203392: OA1; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048707/oa1_possorted_bam.bam', 'md5': '27fe13075e9ce34df26c621b8dd73f0a', 'size': 22268513071}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra77/SRZ/014048/SRR14048707/oa1_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048708,SRX10424651,SRP311831,SRS8545520,Illumina HiSeq 2500 paired end sequencing; GSM5203393: OA2; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048708/oa2_possorted_bam.bam', 'md5': '3b3f82445a5266dd3d683c94f1badbab', 'size': 18722293548}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra72/SRZ/014048/SRR14048708/oa2_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048709,SRX10424652,SRP311831,SRS8545521,Illumina HiSeq 2500 paired end sequencing; GSM5203394: OA3; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048709/oa3_possorted_bam.bam', 'md5': '049f181316017d1994ac1b137c92005a', 'size': 23019482350}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra50/SRZ/014048/SRR14048709/oa3_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14048710,SRX10424653,SRP311831,SRS8545522,Illumina HiSeq 2500 paired end sequencing; GSM5203395: OA4; Homo sapiens; RNA-Seq,,2022-03-12,2022-03-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14048710/oa4_possorted_bam.bam', 'md5': '0d911f241536455c036413634a9576c1', 'size': 23247829588}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra8/SRZ/014048/SRR14048710/oa4_possorted_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GRCh38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973953,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/053/SRR12973953/SRR12973953.fastq.gz', 'md5': '451fdc5447933de0e5ca90bb6ee46b42', 'size': 9056046273}]","[{'url': 's3://sra-pub-src-18/SRR12973953/h-NP-1_S1_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973953/h-NP-1_S1_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973953/h-NP-1_S1_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973953/SRR12973953'}]","[{'url': 'gs://sra-pub-src-18/SRR12973953/h-NP-1_S1_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973953/h-NP-1_S1_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973953/h-NP-1_S1_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR12973953/SRR12973953.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973953/SRR12973953.1'}],127339937,19100990550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S1_L002_I1_001.fastq.gz --read2PairFiles=h-NP-1_S1_L002_R1_001.fastq.gz --read3PairFiles=h-NP-1_S1_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973954,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/054/SRR12973954/SRR12973954.fastq.gz', 'md5': '1bb1cd0eab98d9fd52af66a4abfde9dc', 'size': 909104615}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR12973954/h-NP-1_S29_L004_I1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR12973954/h-NP-1_S29_L004_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR12973954/h-NP-1_S29_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR12973954/SRR12973954'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR12973954/h-NP-1_S29_L004_I1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR12973954/h-NP-1_S29_L004_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR12973954/h-NP-1_S29_L004_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR12973954/SRR12973954'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra48/SRR/012669/SRR12973954'}],12210226,1831533900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S29_L004_I1_001.fastq.gz --read2PairFiles=h-NP-1_S29_L004_R1_001.fastq.gz --read3PairFiles=h-NP-1_S29_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973955,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/055/SRR12973955/SRR12973955.fastq.gz', 'md5': '262085d3354f3ded9b779a8318fa7cc2', 'size': 7492290158}]","[{'url': 's3://sra-pub-src-16/SRR12973955/h-NP-1_S2_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973955/h-NP-1_S2_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973955/h-NP-1_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973955/SRR12973955'}]","[{'url': 'gs://sra-pub-src-15/SRR12973955/h-NP-1_S2_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973955/h-NP-1_S2_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973955/h-NP-1_S2_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973955/SRR12973955.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973955/SRR12973955.1'}],104860150,15729022500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S2_L002_I1_001.fastq.gz --read2PairFiles=h-NP-1_S2_L002_R1_001.fastq.gz --read3PairFiles=h-NP-1_S2_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973955,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/055/SRR12973955/SRR12973955.fastq.gz', 'md5': '262085d3354f3ded9b779a8318fa7cc2', 'size': 7492290158}]","[{'url': 's3://sra-pub-src-16/SRR12973955/h-NP-1_S2_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973955/h-NP-1_S2_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973955/h-NP-1_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973955/SRR12973955'}]","[{'url': 'gs://sra-pub-src-15/SRR12973955/h-NP-1_S2_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973955/h-NP-1_S2_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973955/h-NP-1_S2_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973955/SRR12973955.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973955/SRR12973955.1'}],104860150,15729022500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S2_L002_I1_001.fastq.gz --read2PairFiles=h-NP-1_S2_L002_R1_001.fastq.gz --read3PairFiles=h-NP-1_S2_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973956,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/056/SRR12973956/SRR12973956.fastq.gz', 'md5': '58a50558becd5896dc142e517a1963b3', 'size': 727857441}]","[{'url': 's3://sra-pub-src-13/SRR12973956/h-NP-1_S30_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR12973956/h-NP-1_S30_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR12973956/h-NP-1_S30_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973956/SRR12973956'}]","[{'url': 'gs://sra-pub-src-17/SRR12973956/h-NP-1_S30_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973956/h-NP-1_S30_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973956/h-NP-1_S30_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-8/SRR12973956/SRR12973956.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra11/SRR/012669/SRR12973956'}],9754088,1463113200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S30_L004_I1_001.fastq.gz --read2PairFiles=h-NP-1_S30_L004_R1_001.fastq.gz --read3PairFiles=h-NP-1_S30_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973957,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/057/SRR12973957/SRR12973957.fastq.gz', 'md5': '368cd4f7f8835614386e9643f0413031', 'size': 843627020}]","[{'url': 's3://sra-pub-src-15/SRR12973957/h-NP-1_S31_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR12973957/h-NP-1_S31_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR12973957/h-NP-1_S31_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973957/SRR12973957'}]","[{'url': 'gs://sra-pub-src-18/SRR12973957/h-NP-1_S31_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973957/h-NP-1_S31_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973957/h-NP-1_S31_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR12973957/SRR12973957.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/012669/SRR12973957'}],11313106,1696965900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S31_L004_I1_001.fastq.gz --read2PairFiles=h-NP-1_S31_L004_R1_001.fastq.gz --read3PairFiles=h-NP-1_S31_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973958,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/058/SRR12973958/SRR12973958.fastq.gz', 'md5': 'b55ad4159e3bc376d4fe8c1d15444dcf', 'size': 762617806}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR12973958/h-NP-1_S32_L004_I1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR12973958/h-NP-1_S32_L004_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR12973958/h-NP-1_S32_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR12973958/SRR12973958'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR12973958/h-NP-1_S32_L004_I1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR12973958/h-NP-1_S32_L004_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR12973958/h-NP-1_S32_L004_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR12973958/SRR12973958'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra23/SRR/012669/SRR12973958'}],10298034,1544705100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S32_L004_I1_001.fastq.gz --read2PairFiles=h-NP-1_S32_L004_R1_001.fastq.gz --read3PairFiles=h-NP-1_S32_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973959,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/059/SRR12973959/SRR12973959.fastq.gz', 'md5': '39762f3baadb39e6374ca367df4631d5', 'size': 8570736440}]","[{'url': 's3://sra-pub-src-17/SRR12973959/h-NP-1_S3_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973959/h-NP-1_S3_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR12973959/h-NP-1_S3_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973959/SRR12973959'}]","[{'url': 'gs://sra-pub-src-17/SRR12973959/h-NP-1_S3_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973959/h-NP-1_S3_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973959/h-NP-1_S3_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR12973959/SRR12973959.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973959/SRR12973959.1'}],119970491,17995573650,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S3_L002_I1_001.fastq.gz --read2PairFiles=h-NP-1_S3_L002_R1_001.fastq.gz --read3PairFiles=h-NP-1_S3_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973960,SRX9426285,SRP291007,SRS7641156,HiSeq X Ten paired end sequencing; GSM4878538: human_NP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/060/SRR12973960/SRR12973960.fastq.gz', 'md5': 'd3270fd10aa8783144de3ca55544f92a', 'size': 7915164669}]","[{'url': 's3://sra-pub-src-18/SRR12973960/h-NP-1_S4_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973960/h-NP-1_S4_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973960/h-NP-1_S4_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR12973960/h-NP-1_S4_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973960/h-NP-1_S4_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973960/h-NP-1_S4_L002_R2_001.fastq.gz.1'}]",[],111708510,16756276500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1_S4_L002_I1_001.fastq.gz --read2PairFiles=h-NP-1_S4_L002_R1_001.fastq.gz --read3PairFiles=h-NP-1_S4_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973961,SRX9426286,SRP291007,SRS7641157,HiSeq X Ten paired end sequencing; GSM4878539: human_NP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/061/SRR12973961/SRR12973961.fastq.gz', 'md5': '457d3e55b71c30c219466dbdafae8384', 'size': 8104377470}]","[{'url': 's3://sra-pub-src-16/SRR12973961/h-NP-1qing_S13_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973961/h-NP-1qing_S13_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973961/h-NP-1qing_S13_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973961/SRR12973961'}]","[{'url': 'gs://sra-pub-src-15/SRR12973961/h-NP-1qing_S13_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973961/h-NP-1qing_S13_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973961/h-NP-1qing_S13_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR12973961/SRR12973961.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973961/SRR12973961.1'}],112808315,16921247250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1qing_S13_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1qing_S13_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1qing_S13_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973962,SRX9426286,SRP291007,SRS7641157,HiSeq X Ten paired end sequencing; GSM4878539: human_NP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/062/SRR12973962/SRR12973962.fastq.gz', 'md5': 'e8d0be79bfa6a27b7222526f07779422', 'size': 7269382186}]","[{'url': 's3://sra-pub-src-18/SRR12973962/h-NP-1qing_S14_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973962/h-NP-1qing_S14_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973962/h-NP-1qing_S14_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973962/SRR12973962'}]","[{'url': 'gs://sra-pub-src-16/SRR12973962/h-NP-1qing_S14_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR12973962/h-NP-1qing_S14_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR12973962/h-NP-1qing_S14_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR12973962/SRR12973962.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973962/SRR12973962.1'}],100758301,15113745150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1qing_S14_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1qing_S14_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1qing_S14_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973963,SRX9426286,SRP291007,SRS7641157,HiSeq X Ten paired end sequencing; GSM4878539: human_NP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/063/SRR12973963/SRR12973963.fastq.gz', 'md5': 'dde303d1ba02104ea373ba6c5ed8cb7b', 'size': 10169647920}]","[{'url': 's3://sra-pub-src-16/SRR12973963/h-NP-1qing_S15_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973963/h-NP-1qing_S15_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973963/h-NP-1qing_S15_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973963/SRR12973963'}]","[{'url': 'gs://sra-pub-src-15/SRR12973963/h-NP-1qing_S15_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973963/h-NP-1qing_S15_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973963/h-NP-1qing_S15_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR12973963/SRR12973963.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973963/SRR12973963.1'}],132764457,19914668550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1qing_S15_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1qing_S15_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1qing_S15_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973964,SRX9426286,SRP291007,SRS7641157,HiSeq X Ten paired end sequencing; GSM4878539: human_NP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/064/SRR12973964/SRR12973964.fastq.gz', 'md5': 'b2aec6eef6165e4b29462abe73c2250a', 'size': 7487453374}]","[{'url': 's3://sra-pub-src-18/SRR12973964/h-NP-1qing_S16_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973964/h-NP-1qing_S16_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973964/h-NP-1qing_S16_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR12973964/h-NP-1qing_S16_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973964/h-NP-1qing_S16_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973964/h-NP-1qing_S16_L003_R2_001.fastq.gz.1'}]",[],103756582,15563487300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1qing_S16_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1qing_S16_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1qing_S16_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973965,SRX9426287,SRP291007,SRS7641158,HiSeq X Ten paired end sequencing; GSM4878540: human_NP_3; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/065/SRR12973965/SRR12973965.fastq.gz', 'md5': 'f2d3e6945489e4cde15e9ac90d17330f', 'size': 7058244438}]","[{'url': 's3://sra-pub-src-16/SRR12973965/h-NP-1zhong_S17_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973965/h-NP-1zhong_S17_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973965/h-NP-1zhong_S17_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973965/SRR12973965'}]","[{'url': 'gs://sra-pub-src-15/SRR12973965/h-NP-1zhong_S17_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973965/h-NP-1zhong_S17_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973965/h-NP-1zhong_S17_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR12973965/SRR12973965.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973965/SRR12973965.1'}],95851104,14377665600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1zhong_S17_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1zhong_S17_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1zhong_S17_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973966,SRX9426287,SRP291007,SRS7641158,HiSeq X Ten paired end sequencing; GSM4878540: human_NP_3; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/066/SRR12973966/SRR12973966.fastq.gz', 'md5': '6f323e0a0c5623a49ce3d44c94bd8042', 'size': 6718156687}]","[{'url': 's3://sra-pub-src-17/SRR12973966/h-NP-1zhong_S18_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973966/h-NP-1zhong_S18_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973966/h-NP-1zhong_S18_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973966/SRR12973966'}]","[{'url': 'gs://sra-pub-src-18/SRR12973966/h-NP-1zhong_S18_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973966/h-NP-1zhong_S18_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973966/h-NP-1zhong_S18_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR12973966/SRR12973966.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973966/SRR12973966.1'}],93904754,14085713100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1zhong_S18_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1zhong_S18_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1zhong_S18_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973967,SRX9426287,SRP291007,SRS7641158,HiSeq X Ten paired end sequencing; GSM4878540: human_NP_3; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/067/SRR12973967/SRR12973967.fastq.gz', 'md5': 'e1c4fd6f86e49e059b6235332cd8546b', 'size': 10484174863}]","[{'url': 's3://sra-pub-src-18/SRR12973967/h-NP-1zhong_S19_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973967/h-NP-1zhong_S19_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973967/h-NP-1zhong_S19_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973967/SRR12973967'}]","[{'url': 'gs://sra-pub-src-18/SRR12973967/h-NP-1zhong_S19_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973967/h-NP-1zhong_S19_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973967/h-NP-1zhong_S19_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR12973967/SRR12973967.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973967/SRR12973967.1'}],143113049,21466957350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1zhong_S19_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1zhong_S19_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1zhong_S19_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973968,SRX9426287,SRP291007,SRS7641158,HiSeq X Ten paired end sequencing; GSM4878540: human_NP_3; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/068/SRR12973968/SRR12973968.fastq.gz', 'md5': 'e2910b8a803062593d2c7f04559b66e8', 'size': 7563208469}]","[{'url': 's3://sra-pub-src-16/SRR12973968/h-NP-1zhong_S20_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973968/h-NP-1zhong_S20_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973968/h-NP-1zhong_S20_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR12973968/h-NP-1zhong_S20_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973968/h-NP-1zhong_S20_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973968/h-NP-1zhong_S20_L003_R2_001.fastq.gz.1'}]",[],103185677,15477851550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-NP-1zhong_S20_L003_I1_001.fastq.gz --read2PairFiles=h-NP-1zhong_S20_L003_R1_001.fastq.gz --read3PairFiles=h-NP-1zhong_S20_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973969,SRX9426288,SRP291007,SRS7641159,HiSeq X Ten paired end sequencing; GSM4878541: human_CEP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/069/SRR12973969/SRR12973969.fastq.gz', 'md5': 'f78bae40f6fbee892841b7c21698f2d0', 'size': 9585667607}]","[{'url': 's3://sra-pub-src-17/SRR12973969/h-CEP-1qing_S10_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973969/h-CEP-1qing_S10_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973969/h-CEP-1qing_S10_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973969/SRR12973969'}]","[{'url': 'gs://sra-pub-src-18/SRR12973969/h-CEP-1qing_S10_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973969/h-CEP-1qing_S10_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973969/h-CEP-1qing_S10_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR12973969/SRR12973969.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973969/SRR12973969.1'}],131667723,19750158450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1qing_S10_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1qing_S10_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1qing_S10_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973970,SRX9426288,SRP291007,SRS7641159,HiSeq X Ten paired end sequencing; GSM4878541: human_CEP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/070/SRR12973970/SRR12973970.fastq.gz', 'md5': 'f589f579ec298af397fcc0a4cb98a4d8', 'size': 6717452796}]","[{'url': 's3://sra-pub-src-16/SRR12973970/h-CEP-1qing_S11_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973970/h-CEP-1qing_S11_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973970/h-CEP-1qing_S11_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973970/SRR12973970'}]","[{'url': 'gs://sra-pub-src-15/SRR12973970/h-CEP-1qing_S11_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973970/h-CEP-1qing_S11_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973970/h-CEP-1qing_S11_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973970/SRR12973970.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973970/SRR12973970.1'}],90324188,13548628200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1qing_S11_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1qing_S11_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1qing_S11_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973971,SRX9426288,SRP291007,SRS7641159,HiSeq X Ten paired end sequencing; GSM4878541: human_CEP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/071/SRR12973971/SRR12973971.fastq.gz', 'md5': '9cd77f5bbed36cc70f375255afbb1047', 'size': 6629922938}]","[{'url': 's3://sra-pub-src-16/SRR12973971/h-CEP-1qing_S12_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973971/h-CEP-1qing_S12_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973971/h-CEP-1qing_S12_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973971/SRR12973971'}]","[{'url': 'gs://sra-pub-src-15/SRR12973971/h-CEP-1qing_S12_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973971/h-CEP-1qing_S12_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973971/h-CEP-1qing_S12_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR12973971/SRR12973971.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973971/SRR12973971.1'}],91393001,13708950150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1qing_S12_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1qing_S12_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1qing_S12_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973972,SRX9426288,SRP291007,SRS7641159,HiSeq X Ten paired end sequencing; GSM4878541: human_CEP_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/072/SRR12973972/SRR12973972.fastq.gz', 'md5': '426bf8192ea7c0fabfc77df4121e8375', 'size': 6748224548}]","[{'url': 's3://sra-pub-src-16/SRR12973972/h-CEP-1qing_S9_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973972/h-CEP-1qing_S9_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973972/h-CEP-1qing_S9_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR12973972/h-CEP-1qing_S9_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973972/h-CEP-1qing_S9_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973972/h-CEP-1qing_S9_L003_R2_001.fastq.gz.1'}]",[],93721204,14058180600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1qing_S9_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1qing_S9_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1qing_S9_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973973,SRX9426289,SRP291007,SRS7641160,HiSeq X Ten paired end sequencing; GSM4878542: human_CEP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/073/SRR12973973/SRR12973973.fastq.gz', 'md5': 'e4bcc5fec00b2e41d5016c3c3c749030', 'size': 8532440827}]","[{'url': 's3://sra-pub-src-16/SRR12973973/h-CEP-1zhong_S5_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973973/h-CEP-1zhong_S5_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973973/h-CEP-1zhong_S5_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973973/SRR12973973'}]","[{'url': 'gs://sra-pub-src-15/SRR12973973/h-CEP-1zhong_S5_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973973/h-CEP-1zhong_S5_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973973/h-CEP-1zhong_S5_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973973/SRR12973973.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973973/SRR12973973.1'}],114640970,17196145500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1zhong_S5_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1zhong_S5_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1zhong_S5_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973974,SRX9426289,SRP291007,SRS7641160,HiSeq X Ten paired end sequencing; GSM4878542: human_CEP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/074/SRR12973974/SRR12973974.fastq.gz', 'md5': '66e49faba69bb6c6ae8e178801daa4c8', 'size': 839894210}]","[{'url': 's3://sra-pub-src-7/SRR12973974/h-CEP-1zhong_S6_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR12973974/h-CEP-1zhong_S6_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR12973974/h-CEP-1zhong_S6_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973974/SRR12973974'}]","[{'url': 'gs://sra-pub-src-17/SRR12973974/h-CEP-1zhong_S6_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973974/h-CEP-1zhong_S6_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR12973974/h-CEP-1zhong_S6_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973974/SRR12973974.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra45/SRR/012669/SRR12973974'}],11728052,1759207800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1zhong_S6_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1zhong_S6_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1zhong_S6_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973975,SRX9426289,SRP291007,SRS7641160,HiSeq X Ten paired end sequencing; GSM4878542: human_CEP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/075/SRR12973975/SRR12973975.fastq.gz', 'md5': 'c987ec2d87c98084f57c6815440d661c', 'size': 10505446856}]","[{'url': 's3://sra-pub-src-16/SRR12973975/h-CEP-1zhong_S7_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973975/h-CEP-1zhong_S7_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973975/h-CEP-1zhong_S7_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973975/SRR12973975'}]","[{'url': 'gs://sra-pub-src-15/SRR12973975/h-CEP-1zhong_S7_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973975/h-CEP-1zhong_S7_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973975/h-CEP-1zhong_S7_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973975/SRR12973975.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973975/SRR12973975.1'}],144894259,21734138850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1zhong_S7_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1zhong_S7_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1zhong_S7_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973976,SRX9426289,SRP291007,SRS7641160,HiSeq X Ten paired end sequencing; GSM4878542: human_CEP_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/076/SRR12973976/SRR12973976.fastq.gz', 'md5': 'ddceb859d32e9059ba343f0a9260b8e5', 'size': 9463840957}]","[{'url': 's3://sra-pub-src-18/SRR12973976/h-CEP-1zhong_S8_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973976/h-CEP-1zhong_S8_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973976/h-CEP-1zhong_S8_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR12973976/h-CEP-1zhong_S8_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973976/h-CEP-1zhong_S8_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973976/h-CEP-1zhong_S8_L003_R2_001.fastq.gz.1'}]",[],131669215,19750382250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-CEP-1zhong_S8_L003_I1_001.fastq.gz --read2PairFiles=h-CEP-1zhong_S8_L003_R1_001.fastq.gz --read3PairFiles=h-CEP-1zhong_S8_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973977,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/077/SRR12973977/SRR12973977.fastq.gz', 'md5': '41ad68bf7859c30642ce856a06865a87', 'size': 7066555042}]","[{'url': 's3://sra-pub-src-17/SRR12973977/h-AF-1qing_S5_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973977/h-AF-1qing_S5_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973977/h-AF-1qing_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973977/SRR12973977'}]","[{'url': 'gs://sra-pub-src-18/SRR12973977/h-AF-1qing_S5_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973977/h-AF-1qing_S5_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973977/h-AF-1qing_S5_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR12973977/SRR12973977.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973977/SRR12973977.1'}],99084814,14862722100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S5_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S5_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S5_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973978,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/078/SRR12973978/SRR12973978.fastq.gz', 'md5': 'b2c87ca495a016e167f17e543db08231', 'size': 410159242}]","[{'url': 's3://sra-pub-src-16/SRR12973978/h-AF-1qing_S5_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973978/h-AF-1qing_S5_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973978/h-AF-1qing_S5_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973978/SRR12973978'}]","[{'url': 'gs://sra-pub-src-15/SRR12973978/h-AF-1qing_S5_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973978/h-AF-1qing_S5_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973978/h-AF-1qing_S5_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR12973978/SRR12973978.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra2/SRR/012669/SRR12973978'}],5753749,863062350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S5_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S5_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S5_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973979,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/079/SRR12973979/SRR12973979.fastq.gz', 'md5': 'fbe2ecf10d10109db7983ab169032ea1', 'size': 6691346636}]","[{'url': 's3://sra-pub-src-18/SRR12973979/h-AF-1qing_S6_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973979/h-AF-1qing_S6_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973979/h-AF-1qing_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973979/SRR12973979'}]","[{'url': 'gs://sra-pub-src-16/SRR12973979/h-AF-1qing_S6_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973979/h-AF-1qing_S6_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973979/h-AF-1qing_S6_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR12973979/SRR12973979.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973979/SRR12973979.1'}],94245550,14136832500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S6_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S6_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S6_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973980,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/080/SRR12973980/SRR12973980.fastq.gz', 'md5': '00a17b68ded04c3d6c82ac52854cd438', 'size': 387038472}]","[{'url': 's3://sra-pub-src-15/SRR12973980/h-AF-1qing_S6_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973980/h-AF-1qing_S6_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973980/h-AF-1qing_S6_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973980/SRR12973980'}]","[{'url': 'gs://sra-pub-src-18/SRR12973980/h-AF-1qing_S6_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973980/h-AF-1qing_S6_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973980/h-AF-1qing_S6_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR12973980/SRR12973980.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/012669/SRR12973980'}],5452150,817822500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S6_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S6_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S6_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973981,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/081/SRR12973981/SRR12973981.fastq.gz', 'md5': 'a12892ff0195192340c58967f48b29c2', 'size': 6823102593}]","[{'url': 's3://sra-pub-src-18/SRR12973981/h-AF-1qing_S7_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973981/h-AF-1qing_S7_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973981/h-AF-1qing_S7_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973981/SRR12973981'}]","[{'url': 'gs://sra-pub-src-7/SRR12973981/h-AF-1qing_S7_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973981/h-AF-1qing_S7_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973981/h-AF-1qing_S7_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973981/SRR12973981.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973981/SRR12973981.1'}],94236854,14135528100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S7_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S7_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S7_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973982,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/082/SRR12973982/SRR12973982.fastq.gz', 'md5': 'c162e7bd377adc7f8237c6fdf4328e0e', 'size': 394342662}]","[{'url': 's3://sra-pub-src-16/SRR12973982/h-AF-1qing_S7_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973982/h-AF-1qing_S7_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973982/h-AF-1qing_S7_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973982/SRR12973982'}]","[{'url': 'gs://sra-pub-src-15/SRR12973982/h-AF-1qing_S7_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973982/h-AF-1qing_S7_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973982/h-AF-1qing_S7_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973982/SRR12973982.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra19/SRR/012669/SRR12973982'}],5469739,820460850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S7_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S7_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S7_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973983,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/083/SRR12973983/SRR12973983.fastq.gz', 'md5': 'f6cae1888d5c2ca4465d074b334bd1b4', 'size': 7137241845}]","[{'url': 's3://sra-pub-src-16/SRR12973983/h-AF-1qing_S8_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973983/h-AF-1qing_S8_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973983/h-AF-1qing_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973983/SRR12973983'}]","[{'url': 'gs://sra-pub-src-15/SRR12973983/h-AF-1qing_S8_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973983/h-AF-1qing_S8_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973983/h-AF-1qing_S8_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR12973983/SRR12973983.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973983/SRR12973983.1'}],100280306,15042045900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S8_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S8_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S8_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973984,SRX9426290,SRP291007,SRS7641161,HiSeq X Ten paired end sequencing; GSM4878543: human_AF_1; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/084/SRR12973984/SRR12973984.fastq.gz', 'md5': '31fabd054f538d07dd4babf168659838', 'size': 411387691}]","[{'url': 's3://sra-pub-src-16/SRR12973984/h-AF-1qing_S8_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973984/h-AF-1qing_S8_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973984/h-AF-1qing_S8_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR12973984/h-AF-1qing_S8_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973984/h-AF-1qing_S8_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973984/h-AF-1qing_S8_L004_R2_001.fastq.gz.1'}]",[],5771426,865713900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1qing_S8_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1qing_S8_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1qing_S8_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973985,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/085/SRR12973985/SRR12973985.fastq.gz', 'md5': 'da3e9370f3c19bf8c8ad709e261978e8', 'size': 7460154767}]","[{'url': 's3://sra-pub-src-17/SRR12973985/h-AF-1zhong_S10_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973985/h-AF-1zhong_S10_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR12973985/h-AF-1zhong_S10_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973985/SRR12973985'}]","[{'url': 'gs://sra-pub-src-17/SRR12973985/h-AF-1zhong_S10_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973985/h-AF-1zhong_S10_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR12973985/h-AF-1zhong_S10_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR12973985/SRR12973985.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973985/SRR12973985.1'}],102831488,15424723200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S10_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S10_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S10_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973986,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/086/SRR12973986/SRR12973986.fastq.gz', 'md5': 'dfe96e71a3a654755af85fc2566b3678', 'size': 931216168}]","[{'url': 's3://sra-pub-src-16/SRR12973986/h-AF-1zhong_S10_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973986/h-AF-1zhong_S10_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973986/h-AF-1zhong_S10_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973986/SRR12973986'}]","[{'url': 'gs://sra-pub-src-15/SRR12973986/h-AF-1zhong_S10_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973986/h-AF-1zhong_S10_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973986/h-AF-1zhong_S10_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR12973986/SRR12973986.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra80/SRR/012669/SRR12973986'}],12808381,1921257150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S10_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S10_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S10_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973987,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/087/SRR12973987/SRR12973987.fastq.gz', 'md5': '9428ed9a48a7085178b7d3eb46fba0cc', 'size': 6916056597}]","[{'url': 's3://sra-pub-src-18/SRR12973987/h-AF-1zhong_S11_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973987/h-AF-1zhong_S11_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973987/h-AF-1zhong_S11_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973987/SRR12973987'}]","[{'url': 'gs://sra-pub-src-18/SRR12973987/h-AF-1zhong_S11_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973987/h-AF-1zhong_S11_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973987/h-AF-1zhong_S11_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR12973987/SRR12973987.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973987/SRR12973987.1'}],94828478,14224271700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S11_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S11_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S11_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973988,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/088/SRR12973988/SRR12973988.fastq.gz', 'md5': 'f8cf66a1ab3c57b82e32bf9acebe75dc', 'size': 858362697}]","[{'url': 's3://sra-pub-src-16/SRR12973988/h-AF-1zhong_S11_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973988/h-AF-1zhong_S11_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973988/h-AF-1zhong_S11_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973988/SRR12973988'}]","[{'url': 'gs://sra-pub-src-15/SRR12973988/h-AF-1zhong_S11_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973988/h-AF-1zhong_S11_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973988/h-AF-1zhong_S11_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR12973988/SRR12973988.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra0/SRR/012669/SRR12973988'}],11765299,1764794850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S11_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S11_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S11_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973989,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/089/SRR12973989/SRR12973989.fastq.gz', 'md5': 'ffa06e678ce735e779e7269ad5b499ca', 'size': 6652001827}]","[{'url': 's3://sra-pub-src-16/SRR12973989/h-AF-1zhong_S12_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973989/h-AF-1zhong_S12_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR12973989/h-AF-1zhong_S12_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973989/SRR12973989'}]","[{'url': 'gs://sra-pub-src-15/SRR12973989/h-AF-1zhong_S12_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973989/h-AF-1zhong_S12_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR12973989/h-AF-1zhong_S12_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR12973989/SRR12973989.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973989/SRR12973989.1'}],92925544,13938831600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S12_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S12_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S12_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973990,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/090/SRR12973990/SRR12973990.fastq.gz', 'md5': '4e5ab10d4580b753ccb6b2fac73aa770', 'size': 832270630}]","[{'url': 's3://sra-pub-src-17/SRR12973990/h-AF-1zhong_S12_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973990/h-AF-1zhong_S12_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR12973990/h-AF-1zhong_S12_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973990/SRR12973990'}]","[{'url': 'gs://sra-pub-src-18/SRR12973990/h-AF-1zhong_S12_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973990/h-AF-1zhong_S12_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973990/h-AF-1zhong_S12_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR12973990/SRR12973990.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/012669/SRR12973990'}],11525921,1728888150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S12_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S12_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S12_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973991,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/091/SRR12973991/SRR12973991.fastq.gz', 'md5': 'e248fc4526f4327dcaff274db448eadc', 'size': 6163171152}]","[{'url': 's3://sra-pub-src-18/SRR12973991/h-AF-1zhong_S9_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973991/h-AF-1zhong_S9_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR12973991/h-AF-1zhong_S9_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR12973991/SRR12973991'}]","[{'url': 'gs://sra-pub-src-18/SRR12973991/h-AF-1zhong_S9_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973991/h-AF-1zhong_S9_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973991/h-AF-1zhong_S9_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR12973991/SRR12973991.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-30/SRR012/12973/SRR12973991/SRR12973991.1'}],87180325,13077048750,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S9_L002_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S9_L002_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S9_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12973992,SRX9426291,SRP291007,SRS7641162,HiSeq X Ten paired end sequencing; GSM4878544: human_AF_2; Homo sapiens; RNA-Seq,fastq-load.py,2021-08-26,2021-08-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR129/092/SRR12973992/SRR12973992.fastq.gz', 'md5': 'b95103a93affc80bf0ba8c93140820ed', 'size': 771124961}]","[{'url': 's3://sra-pub-src-15/SRR12973992/h-AF-1zhong_S9_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR12973992/h-AF-1zhong_S9_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR12973992/h-AF-1zhong_S9_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR12973992/h-AF-1zhong_S9_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973992/h-AF-1zhong_S9_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR12973992/h-AF-1zhong_S9_L004_R2_001.fastq.gz.1'}]",[],10794854,1619228100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=h-AF-1zhong_S9_L004_I1_001.fastq.gz --read2PairFiles=h-AF-1zhong_S9_L004_R1_001.fastq.gz --read3PairFiles=h-AF-1zhong_S9_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972272,SRX11287778,SRP326057,SRS9316009,Illumina NovaSeq 6000 paired end sequencing; GSM5410484: C1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/072/SRR14972272/SRR14972272_1.fastq.gz', 'md5': '7134e22295acd11155a9f6f53f93aa49', 'size': 7486679482}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/072/SRR14972272/SRR14972272_2.fastq.gz', 'md5': 'fe2ca9faaedfe32512de15bf20a4a5c4', 'size': 7009880290}]","[{'url': 's3://sra-pub-src-8/SRR14972272/C1_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14972272/C1_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972272/SRR14972272'}]","[{'url': 'gs://sra-pub-src-12/SRR14972272/C1_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14972272/C1_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14972272/SRR14972272.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972272/SRR14972272.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972274,SRX11287778,SRP326057,SRS9316009,Illumina NovaSeq 6000 paired end sequencing; GSM5410484: C1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/074/SRR14972274/SRR14972274_1.fastq.gz', 'md5': 'b3617bfbdc1bd0dfa21fff7cc811656c', 'size': 7673841104}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/074/SRR14972274/SRR14972274_2.fastq.gz', 'md5': '050531b0898b152b05cd2a6bba76f3bd', 'size': 7047088135}]","[{'url': 's3://sra-pub-src-15/SRR14972274/C1_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14972274/C1_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972274/SRR14972274'}]","[{'url': 'gs://sra-pub-src-5/SRR14972274/C1_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14972274/C1_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14972274/SRR14972274.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972274/SRR14972274.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972276,SRX11287778,SRP326057,SRS9316009,Illumina NovaSeq 6000 paired end sequencing; GSM5410484: C1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/076/SRR14972276/SRR14972276_1.fastq.gz', 'md5': 'f0f66c81009646525319722ed53243fa', 'size': 8504143417}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/076/SRR14972276/SRR14972276_2.fastq.gz', 'md5': '52ac62272bb1e67fde66dcbee5f6627c', 'size': 7964984482}]","[{'url': 's3://sra-pub-src-10/SRR14972276/C1_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14972276/C1_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972276/SRR14972276'}]","[{'url': 'gs://sra-pub-src-8/SRR14972276/C1_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14972276/C1_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR14972276/SRR14972276.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972276/SRR14972276.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972278,SRX11287778,SRP326057,SRS9316009,Illumina NovaSeq 6000 paired end sequencing; GSM5410484: C1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/078/SRR14972278/SRR14972278_1.fastq.gz', 'md5': 'fa78c1e671134a5374f39c51cb7d9288', 'size': 6885984096}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/078/SRR14972278/SRR14972278_2.fastq.gz', 'md5': '058439803bc8a8ef558b92a694c92578', 'size': 6376798577}]","[{'url': 's3://sra-pub-src-10/SRR14972278/C1_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR14972278/C1_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR14972278/C1_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR14972278/C1_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972280,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/080/SRR14972280/SRR14972280_1.fastq.gz', 'md5': 'efa6d0fbe8e262d93a4525501c0e7026', 'size': 7309225548}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/080/SRR14972280/SRR14972280_2.fastq.gz', 'md5': 'c31add1145e9ebc19bda9b5336063823', 'size': 7017409708}]","[{'url': 's3://sra-pub-src-18/SRR14972280/C2_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR14972280/C2_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972280/SRR14972280'}]","[{'url': 'gs://sra-pub-src-9/SRR14972280/C2_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14972280/C2_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR14972280/SRR14972280.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972280/SRR14972280.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972282,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/082/SRR14972282/SRR14972282_1.fastq.gz', 'md5': '18799b05f6ec70e7acc4b8040e27cdb9', 'size': 1123068344}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/082/SRR14972282/SRR14972282_2.fastq.gz', 'md5': 'f9aa89d5b94b2b761f13e27bd0da1d88', 'size': 1088513656}]","[{'url': 's3://sra-pub-src-4/SRR14972282/C2_1_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14972282/C2_1_2_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972282/SRR14972282'}]","[{'url': 'gs://sra-pub-src-11/SRR14972282/C2_1_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14972282/C2_1_2_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR14972282/SRR14972282.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972282/SRR14972282.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972284,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/084/SRR14972284/SRR14972284_1.fastq.gz', 'md5': 'f2c047af18cbc2edf0c0476d640c1b0a', 'size': 5837137900}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/084/SRR14972284/SRR14972284_2.fastq.gz', 'md5': '9af29bf19f0b8a1c91b9e406a4536632', 'size': 5355594479}]","[{'url': 's3://sra-pub-src-5/SRR14972284/C2_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14972284/C2_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972284/SRR14972284'}]","[{'url': 'gs://sra-pub-src-13/SRR14972284/C2_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14972284/C2_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR14972284/SRR14972284.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972284/SRR14972284.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972286,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/086/SRR14972286/SRR14972286_1.fastq.gz', 'md5': '931cf0ef166a7527a8de97e61f0ea563', 'size': 896311353}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/086/SRR14972286/SRR14972286_2.fastq.gz', 'md5': '9bc82b65220c465620417d08cf4d5058', 'size': 837806379}]","[{'url': 's3://sra-pub-src-15/SRR14972286/C2_2_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14972286/C2_2_2_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972286/SRR14972286'}]","[{'url': 'gs://sra-pub-src-5/SRR14972286/C2_2_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14972286/C2_2_2_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14972286/SRR14972286.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972286/SRR14972286.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972288,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/088/SRR14972288/SRR14972288_1.fastq.gz', 'md5': '38934a76f3a361ce411804ded8e516e3', 'size': 6493735454}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/088/SRR14972288/SRR14972288_2.fastq.gz', 'md5': 'f286b46c7999a7a0fe6abd97d2a9987a', 'size': 6023885081}]","[{'url': 's3://sra-pub-src-11/SRR14972288/C2_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14972288/C2_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972288/SRR14972288'}]","[{'url': 'gs://sra-pub-src-17/SRR14972288/C2_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14972288/C2_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR14972288/SRR14972288.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972288/SRR14972288.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972290,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/090/SRR14972290/SRR14972290_1.fastq.gz', 'md5': '13b8803997149ce7eeefa1e5ad1b6156', 'size': 990293475}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/090/SRR14972290/SRR14972290_2.fastq.gz', 'md5': 'ce77674227fe0cff7f0fe7dc3a7e45f4', 'size': 932055880}]","[{'url': 's3://sra-pub-src-8/SRR14972290/C2_3_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14972290/C2_3_2_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972290/SRR14972290'}]","[{'url': 'gs://sra-pub-src-12/SRR14972290/C2_3_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14972290/C2_3_2_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR14972290/SRR14972290.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972290/SRR14972290.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972292,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/092/SRR14972292/SRR14972292_1.fastq.gz', 'md5': 'e13264b3c6fe43024df9c78d7d1fb005', 'size': 6644291442}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/092/SRR14972292/SRR14972292_2.fastq.gz', 'md5': '7c840f0a1f30ac5db71f7864bafc16d0', 'size': 6199071102}]","[{'url': 's3://sra-pub-src-8/SRR14972292/C2_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14972292/C2_4_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972292/SRR14972292'}]","[{'url': 'gs://sra-pub-src-12/SRR14972292/C2_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14972292/C2_4_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR14972292/SRR14972292.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972292/SRR14972292.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972294,SRX11287779,SRP326057,SRS9316010,Illumina NovaSeq 6000 paired end sequencing; GSM5410485: C2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/094/SRR14972294/SRR14972294_1.fastq.gz', 'md5': 'c64f91ad915b0876b0c045faabb62f07', 'size': 1011713672}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/094/SRR14972294/SRR14972294_2.fastq.gz', 'md5': '3dc51f5bfda7303c2a28a864da522681', 'size': 956910106}]","[{'url': 's3://sra-pub-src-13/SRR14972294/C2_4_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14972294/C2_4_2_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR14972294/C2_4_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14972294/C2_4_2_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972296,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/096/SRR14972296/SRR14972296_1.fastq.gz', 'md5': 'a01a580aa80e26a9f723c37051e3daea', 'size': 6305000269}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/096/SRR14972296/SRR14972296_2.fastq.gz', 'md5': '6dce52dd956ba928998417df7697c5d0', 'size': 5766282295}]","[{'url': 's3://sra-pub-src-5/SRR14972296/C3_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14972296/C3_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972296/SRR14972296'}]","[{'url': 'gs://sra-pub-src-13/SRR14972296/C3_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14972296/C3_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR14972296/SRR14972296.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972296/SRR14972296.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972298,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/098/SRR14972298/SRR14972298_1.fastq.gz', 'md5': 'b72cec480cf012f91b11c2ba4d9d31c7', 'size': 298399268}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/098/SRR14972298/SRR14972298_2.fastq.gz', 'md5': '8903d2a3905c858048cd8fb3096a8402', 'size': 270836443}]","[{'url': 's3://sra-pub-src-5/SRR14972298/C3_1_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14972298/C3_1_2_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972298/SRR14972298'}]","[{'url': 'gs://sra-pub-src-13/SRR14972298/C3_1_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14972298/C3_1_2_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR14972298/SRR14972298.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972298/SRR14972298.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972300,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/000/SRR14972300/SRR14972300_1.fastq.gz', 'md5': 'a2ccf1af06742336167b1b57283279df', 'size': 7717120411}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/000/SRR14972300/SRR14972300_2.fastq.gz', 'md5': '9d84a31225617ad8018bf56a19e87951', 'size': 7102092323}]","[{'url': 's3://sra-pub-src-5/SRR14972300/C3_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14972300/C3_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972300/SRR14972300'}]","[{'url': 'gs://sra-pub-src-13/SRR14972300/C3_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14972300/C3_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR14972300/SRR14972300.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972300/SRR14972300.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972302,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/002/SRR14972302/SRR14972302_1.fastq.gz', 'md5': 'a26931c0d03a10f7411d7a15aeb2167c', 'size': 268426022}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/002/SRR14972302/SRR14972302_2.fastq.gz', 'md5': '671ce173a3ca35a3d9e112aca0f72601', 'size': 246825771}]","[{'url': 's3://sra-pub-src-18/SRR14972302/C3_2_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14972302/C3_2_2_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972302/SRR14972302'}]","[{'url': 'gs://sra-pub-src-9/SRR14972302/C3_2_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14972302/C3_2_2_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR14972302/SRR14972302.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972302/SRR14972302.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972304,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/004/SRR14972304/SRR14972304_1.fastq.gz', 'md5': 'ba67d835c47f9e4af16258a8d081871b', 'size': 6993451265}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/004/SRR14972304/SRR14972304_2.fastq.gz', 'md5': 'a7bf053bbc46f2a9d05cf9c400a12fd6', 'size': 6423002170}]","[{'url': 's3://sra-pub-src-16/SRR14972304/C3_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14972304/C3_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972304/SRR14972304'}]","[{'url': 'gs://sra-pub-src-10/SRR14972304/C3_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14972304/C3_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR14972304/SRR14972304.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972304/SRR14972304.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972306,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/006/SRR14972306/SRR14972306_1.fastq.gz', 'md5': '3f9b83f46f7d6bc6e364b662e6b8264d', 'size': 331279341}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/006/SRR14972306/SRR14972306_2.fastq.gz', 'md5': '3db878baa2d6ebe99f8c7f1d8018e118', 'size': 300505889}]","[{'url': 's3://sra-pub-src-17/SRR14972306/C3_3_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14972306/C3_3_2_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972306/SRR14972306'}]","[{'url': 'gs://sra-pub-src-8/SRR14972306/C3_3_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14972306/C3_3_2_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR14972306/SRR14972306.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972306/SRR14972306.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972308,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/008/SRR14972308/SRR14972308_1.fastq.gz', 'md5': '6f9e06951fce8483ae8d7a94a67c5f14', 'size': 7238852185}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/008/SRR14972308/SRR14972308_2.fastq.gz', 'md5': '38f9d05f65182b5e4fb77856d7c52a83', 'size': 6698438673}]","[{'url': 's3://sra-pub-src-9/SRR14972308/C3_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14972308/C3_4_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972308/SRR14972308'}]","[{'url': 'gs://sra-pub-src-7/SRR14972308/C3_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14972308/C3_4_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR14972308/SRR14972308.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972308/SRR14972308.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972310,SRX11287780,SRP326057,SRS9316008,Illumina NovaSeq 6000 paired end sequencing; GSM5410486: C3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/010/SRR14972310/SRR14972310_1.fastq.gz', 'md5': '1e0739d5712951f379d99150e2e577d7', 'size': 343780773}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/010/SRR14972310/SRR14972310_2.fastq.gz', 'md5': 'd15e0717a339d0680dde72cdb380565e', 'size': 314354470}]","[{'url': 's3://sra-pub-src-15/SRR14972310/C3_4_2_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14972310/C3_4_2_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR14972310/C3_4_2_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14972310/C3_4_2_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972312,SRX11287781,SRP326057,SRS9316011,Illumina NovaSeq 6000 paired end sequencing; GSM5410487: C4; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/012/SRR14972312/SRR14972312_1.fastq.gz', 'md5': '62d67ee77bcbc59ca592b02acfd04169', 'size': 9802060979}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/012/SRR14972312/SRR14972312_2.fastq.gz', 'md5': 'aeb8c5605f0f64f747f3ff6d68deb745', 'size': 8451582404}]","[{'url': 's3://sra-pub-src-14/SRR14972312/C4_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14972312/C4_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972312/SRR14972312'}]","[{'url': 'gs://sra-pub-src-14/SRR14972312/C4_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR14972312/C4_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR14972312/SRR14972312.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972312/SRR14972312.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972314,SRX11287781,SRP326057,SRS9316011,Illumina NovaSeq 6000 paired end sequencing; GSM5410487: C4; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/014/SRR14972314/SRR14972314_1.fastq.gz', 'md5': 'cbb8cd2d8b2451f0aa357f2eaceb6888', 'size': 9361937071}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/014/SRR14972314/SRR14972314_2.fastq.gz', 'md5': '38ee03ecf8fc06278126476c7a68ee1c', 'size': 8055849243}]","[{'url': 's3://sra-pub-src-3/SRR14972314/C4_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR14972314/C4_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972314/SRR14972314'}]","[{'url': 'gs://sra-pub-src-5/SRR14972314/C4_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14972314/C4_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR14972314/SRR14972314.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972314/SRR14972314.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972316,SRX11287781,SRP326057,SRS9316011,Illumina NovaSeq 6000 paired end sequencing; GSM5410487: C4; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/016/SRR14972316/SRR14972316_1.fastq.gz', 'md5': 'b8e0dd25c2493cabb1812dacd9b84ff3', 'size': 8863202339}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/016/SRR14972316/SRR14972316_2.fastq.gz', 'md5': '9f24276d3c8ffd23a6367940c7e363bf', 'size': 7696891717}]","[{'url': 's3://sra-pub-src-7/SRR14972316/C4_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14972316/C4_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972316/SRR14972316'}]","[{'url': 'gs://sra-pub-src-16/SRR14972316/C4_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14972316/C4_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14972316/SRR14972316.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972316/SRR14972316.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972318,SRX11287781,SRP326057,SRS9316011,Illumina NovaSeq 6000 paired end sequencing; GSM5410487: C4; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/018/SRR14972318/SRR14972318_1.fastq.gz', 'md5': '403d5beacff828cf54867826158d57f7', 'size': 9061786402}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/018/SRR14972318/SRR14972318_2.fastq.gz', 'md5': 'bcb305ab5b149a31958f5d100feca6a9', 'size': 7781963796}]","[{'url': 's3://sra-pub-src-5/SRR14972318/C4_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14972318/C4_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR14972318/C4_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR14972318/C4_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972320,SRX11287782,SRP326057,SRS9322077,Illumina NovaSeq 6000 paired end sequencing; GSM5410488: C5; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/020/SRR14972320/SRR14972320_1.fastq.gz', 'md5': 'a1685eea2db86d35ed8f157be76dce33', 'size': 7104833642}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/020/SRR14972320/SRR14972320_2.fastq.gz', 'md5': '4155727d4b7cdbf2c97e985f65c23b81', 'size': 6510793552}]","[{'url': 's3://sra-pub-src-8/SRR14972320/C5_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14972320/C5_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972320/SRR14972320'}]","[{'url': 'gs://sra-pub-src-12/SRR14972320/C5_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14972320/C5_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14972320/SRR14972320.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972320/SRR14972320.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972322,SRX11287782,SRP326057,SRS9322077,Illumina NovaSeq 6000 paired end sequencing; GSM5410488: C5; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/022/SRR14972322/SRR14972322_1.fastq.gz', 'md5': '6129e8896c57a6428e5cb8cda2316b9a', 'size': 6895480007}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/022/SRR14972322/SRR14972322_2.fastq.gz', 'md5': 'f5fb356c117f859e3776988589d7571d', 'size': 6309629808}]","[{'url': 's3://sra-pub-src-15/SRR14972322/C5_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14972322/C5_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972322/SRR14972322'}]","[{'url': 'gs://sra-pub-src-5/SRR14972322/C5_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14972322/C5_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14972322/SRR14972322.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972322/SRR14972322.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972324,SRX11287782,SRP326057,SRS9322077,Illumina NovaSeq 6000 paired end sequencing; GSM5410488: C5; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/024/SRR14972324/SRR14972324_1.fastq.gz', 'md5': 'ed906636f268a10e40518b31251e60db', 'size': 9073224496}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/024/SRR14972324/SRR14972324_2.fastq.gz', 'md5': '895c9b059bd5b129f135cbeb95b527e9', 'size': 8302817498}]","[{'url': 's3://sra-pub-src-11/SRR14972324/C5_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14972324/C5_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972324/SRR14972324'}]","[{'url': 'gs://sra-pub-src-18/SRR14972324/C5_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14972324/C5_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14972324/SRR14972324.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972324/SRR14972324.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972326,SRX11287782,SRP326057,SRS9322077,Illumina NovaSeq 6000 paired end sequencing; GSM5410488: C5; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/026/SRR14972326/SRR14972326_1.fastq.gz', 'md5': '96512160cc0c43479885c325ef077d08', 'size': 7847354877}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/026/SRR14972326/SRR14972326_2.fastq.gz', 'md5': 'ed1b2eab6a0a903094f88b11767b2983', 'size': 7196566411}]","[{'url': 's3://sra-pub-src-10/SRR14972326/C5_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR14972326/C5_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR14972326/C5_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR14972326/C5_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972328,SRX11287783,SRP326057,SRS9322075,Illumina NovaSeq 6000 paired end sequencing; GSM5410489: C6; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/028/SRR14972328/SRR14972328_1.fastq.gz', 'md5': '497f7b8692d624be331c40940221610e', 'size': 11282600777}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/028/SRR14972328/SRR14972328_2.fastq.gz', 'md5': 'e6116905a9ad4f9911f553dc9d0f03dd', 'size': 10221730160}]","[{'url': 's3://sra-pub-src-7/SRR14972328/C6_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14972328/C6_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972328/SRR14972328'}]","[{'url': 'gs://sra-pub-src-16/SRR14972328/C6_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14972328/C6_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14972328/SRR14972328.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972328/SRR14972328.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972330,SRX11287783,SRP326057,SRS9322075,Illumina NovaSeq 6000 paired end sequencing; GSM5410489: C6; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/030/SRR14972330/SRR14972330_1.fastq.gz', 'md5': 'b73e37637b6995251b3fe65bbbe4e00d', 'size': 13126676237}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/030/SRR14972330/SRR14972330_2.fastq.gz', 'md5': '0cf034da5522bebdef7066e16750916b', 'size': 11854297174}]","[{'url': 's3://sra-pub-src-15/SRR14972330/C6_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14972330/C6_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972330/SRR14972330'}]","[{'url': 'gs://sra-pub-src-5/SRR14972330/C6_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14972330/C6_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14972330/SRR14972330.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972330/SRR14972330.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972332,SRX11287783,SRP326057,SRS9322075,Illumina NovaSeq 6000 paired end sequencing; GSM5410489: C6; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/032/SRR14972332/SRR14972332_1.fastq.gz', 'md5': '837b6efab8583e8280948101c1db3d47', 'size': 10803489185}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/032/SRR14972332/SRR14972332_2.fastq.gz', 'md5': '9e06d5d723fa1f74e3fb5f5e62448535', 'size': 9783302301}]","[{'url': 's3://sra-pub-src-17/SRR14972332/C6_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14972332/C6_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972332/SRR14972332'}]","[{'url': 'gs://sra-pub-src-13/SRR14972332/C6_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14972332/C6_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR14972332/SRR14972332.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972332/SRR14972332.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972334,SRX11287783,SRP326057,SRS9322075,Illumina NovaSeq 6000 paired end sequencing; GSM5410489: C6; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/034/SRR14972334/SRR14972334_1.fastq.gz', 'md5': '838b5d25fee50a471a1bccf17c231722', 'size': 10425091887}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/034/SRR14972334/SRR14972334_2.fastq.gz', 'md5': '8cbb56b869001c0decd256870b0f0a48', 'size': 9485454098}]","[{'url': 's3://sra-pub-src-18/SRR14972334/C6_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14972334/C6_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR14972334/C6_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14972334/C6_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972336,SRX11287784,SRP326057,SRS9322076,Illumina NovaSeq 6000 paired end sequencing; GSM5410490: M1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/036/SRR14972336/SRR14972336_1.fastq.gz', 'md5': '4fb6449d62d753072482ffe76acfa6da', 'size': 6700436391}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/036/SRR14972336/SRR14972336_2.fastq.gz', 'md5': '04e0d1eb51ea760e77cbf0c6f9c78377', 'size': 6154041126}]","[{'url': 's3://sra-pub-src-11/SRR14972336/M1_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14972336/M1_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972336/SRR14972336'}]","[{'url': 'gs://sra-pub-src-17/SRR14972336/M1_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR14972336/M1_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR14972336/SRR14972336.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972336/SRR14972336.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972337,SRX11287784,SRP326057,SRS9322076,Illumina NovaSeq 6000 paired end sequencing; GSM5410490: M1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/037/SRR14972337/SRR14972337_1.fastq.gz', 'md5': '38b1dd4c7c37fe618fc34b13a05b4ddc', 'size': 6241557350}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/037/SRR14972337/SRR14972337_2.fastq.gz', 'md5': '1b06bb4b3972889f0e7b2b6fc76b738a', 'size': 5834653150}]","[{'url': 's3://sra-pub-src-14/SRR14972337/M1_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR14972337/M1_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972337/SRR14972337'}]","[{'url': 'gs://sra-pub-src-4/SRR14972337/M1_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14972337/M1_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-8/SRR14972337/SRR14972337.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972337/SRR14972337.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972339,SRX11287784,SRP326057,SRS9322076,Illumina NovaSeq 6000 paired end sequencing; GSM5410490: M1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/039/SRR14972339/SRR14972339_1.fastq.gz', 'md5': 'b19d54612555289590e37ea356d2e625', 'size': 9615030025}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/039/SRR14972339/SRR14972339_2.fastq.gz', 'md5': '86de3b3396cae096d3fd8e68f2bb8229', 'size': 8949565758}]","[{'url': 's3://sra-pub-src-12/SRR14972339/M1_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR14972339/M1_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972339/SRR14972339'}]","[{'url': 'gs://sra-pub-src-14/SRR14972339/M1_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR14972339/M1_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR14972339/SRR14972339.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972339/SRR14972339.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972340,SRX11287784,SRP326057,SRS9322076,Illumina NovaSeq 6000 paired end sequencing; GSM5410490: M1; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/040/SRR14972340/SRR14972340_1.fastq.gz', 'md5': '32c813c879fd3ad4c0e72f684dc3f012', 'size': 6618696966}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/040/SRR14972340/SRR14972340_2.fastq.gz', 'md5': '8262ef753634fab2c0bb7a7c597d185b', 'size': 6137821791}]","[{'url': 's3://sra-pub-src-5/SRR14972340/M1_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14972340/M1_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR14972340/M1_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14972340/M1_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972342,SRX11287785,SRP326057,SRS9316012,Illumina NovaSeq 6000 paired end sequencing; GSM5410491: M2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/042/SRR14972342/SRR14972342_1.fastq.gz', 'md5': 'dae0d3339dfe10df0326ba59f07bc1a0', 'size': 6776393107}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/042/SRR14972342/SRR14972342_2.fastq.gz', 'md5': '1862782d79ee2e240f40557c1e8d67ea', 'size': 6330333393}]","[{'url': 's3://sra-pub-src-3/SRR14972342/M2_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR14972342/M2_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972342/SRR14972342'}]","[{'url': 'gs://sra-pub-src-4/SRR14972342/M2_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR14972342/M2_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14972342/SRR14972342.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972342/SRR14972342.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972343,SRX11287785,SRP326057,SRS9316012,Illumina NovaSeq 6000 paired end sequencing; GSM5410491: M2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/043/SRR14972343/SRR14972343_1.fastq.gz', 'md5': '046b594ec63a8430dd32841f4b01d2ba', 'size': 7958691546}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/043/SRR14972343/SRR14972343_2.fastq.gz', 'md5': '3ada6d98d4cc58f7230f5a27639e91ff', 'size': 7499139056}]","[{'url': 's3://sra-pub-src-15/SRR14972343/M2_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14972343/M2_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972343/SRR14972343'}]","[{'url': 'gs://sra-pub-src-6/SRR14972343/M2_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR14972343/M2_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR14972343/SRR14972343.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972343/SRR14972343.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972345,SRX11287785,SRP326057,SRS9316012,Illumina NovaSeq 6000 paired end sequencing; GSM5410491: M2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/045/SRR14972345/SRR14972345_1.fastq.gz', 'md5': '9e3e5c87fae25ce9291e86e25a4dde3d', 'size': 7501571357}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/045/SRR14972345/SRR14972345_2.fastq.gz', 'md5': 'e0801622445a26a4734f4b2f21973c4d', 'size': 7032295074}]","[{'url': 's3://sra-pub-src-9/SRR14972345/M2_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14972345/M2_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972345/SRR14972345'}]","[{'url': 'gs://sra-pub-src-8/SRR14972345/M2_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14972345/M2_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR14972345/SRR14972345.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972345/SRR14972345.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972346,SRX11287785,SRP326057,SRS9316012,Illumina NovaSeq 6000 paired end sequencing; GSM5410491: M2; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/046/SRR14972346/SRR14972346_1.fastq.gz', 'md5': '2d610a6f3cad6a9f6a3a8c029d0b4b42', 'size': 7794345870}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/046/SRR14972346/SRR14972346_2.fastq.gz', 'md5': '963f5601cd82b101d8cde114b9752449', 'size': 7264708834}]","[{'url': 's3://sra-pub-src-12/SRR14972346/M2_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR14972346/M2_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR14972346/M2_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR14972346/M2_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972348,SRX11287786,SRP326057,SRS9316013,Illumina NovaSeq 6000 paired end sequencing; GSM5410492: M3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/048/SRR14972348/SRR14972348_1.fastq.gz', 'md5': 'e23da7e76b116b2cc5fadbb80f6b1346', 'size': 8198172121}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/048/SRR14972348/SRR14972348_2.fastq.gz', 'md5': 'da23ea16f34a2e28553c303281298221', 'size': 7873906851}]","[{'url': 's3://sra-pub-src-12/SRR14972348/M3_1_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR14972348/M3_1_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972348/SRR14972348'}]","[{'url': 'gs://sra-pub-src-15/SRR14972348/M3_1_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR14972348/M3_1_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR14972348/SRR14972348.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972348/SRR14972348.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972349,SRX11287786,SRP326057,SRS9316013,Illumina NovaSeq 6000 paired end sequencing; GSM5410492: M3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/049/SRR14972349/SRR14972349_1.fastq.gz', 'md5': '4410891d14661020e4e3ee55b77b301a', 'size': 1403343440}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/049/SRR14972349/SRR14972349_2.fastq.gz', 'md5': '385679506d1b29af6335237914d5b593', 'size': 1289253077}]","[{'url': 's3://sra-pub-src-8/SRR14972349/M3_2_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14972349/M3_2_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972349/SRR14972349'}]","[{'url': 'gs://sra-pub-src-12/SRR14972349/M3_2_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14972349/M3_2_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14972349/SRR14972349.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972349/SRR14972349.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972351,SRX11287786,SRP326057,SRS9316013,Illumina NovaSeq 6000 paired end sequencing; GSM5410492: M3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/051/SRR14972351/SRR14972351_1.fastq.gz', 'md5': 'd8d3a3f5f3b67153d99e77265ffeaf73', 'size': 10590773142}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/051/SRR14972351/SRR14972351_2.fastq.gz', 'md5': 'c940d40c737b7cfab7c69958709c9de8', 'size': 9903839410}]","[{'url': 's3://sra-pub-src-13/SRR14972351/M3_3_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14972351/M3_3_1_R2.fq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14972351/SRR14972351'}]","[{'url': 'gs://sra-pub-src-9/SRR14972351/M3_3_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14972351/M3_3_1_R2.fq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR14972351/SRR14972351.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-run-25/SRR14972351/SRR14972351.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14972353,SRX11287786,SRP326057,SRS9316013,Illumina NovaSeq 6000 paired end sequencing; GSM5410492: M3; Homo sapiens; RNA-Seq,,2021-07-20,2021-07-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/053/SRR14972353/SRR14972353_1.fastq.gz', 'md5': 'd996a8abc11e4e7069d2c4702640eae1', 'size': 8480480189}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/053/SRR14972353/SRR14972353_2.fastq.gz', 'md5': 'e4ea9fd51586ca95073fd3e0db1dfd8d', 'size': 7865768495}]","[{'url': 's3://sra-pub-src-17/SRR14972353/M3_4_1_R1.fq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR14972353/M3_4_1_R2.fq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR14972353/M3_4_1_R1.fq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14972353/M3_4_1_R2.fq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764276,SRX10150779,SRP307529,SRS8303092,Illumina HiSeq 4000 paired end sequencing; GSM5100205: H1 Chondrogenic + C1 Chondrogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/076/SRR13764276/SRR13764276_1.fastq.gz', 'md5': '28b2a3d337423e7360caf6472dfe2617', 'size': 887480597}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/076/SRR13764276/SRR13764276_2.fastq.gz', 'md5': 'bd3421d2184fc63d4740265e22a307ed', 'size': 3494121701}]","[{'url': 's3://sra-pub-src-16/SRR13764276/GHO-3_S3_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13764276/GHO-3_S3_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13764276/GHO-3_S3_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13764276/GHO-3_S3_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764276/SRR13764276.1'}],52192108,6576205608,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764277,SRX10150779,SRP307529,SRS8303092,Illumina HiSeq 4000 paired end sequencing; GSM5100205: H1 Chondrogenic + C1 Chondrogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/077/SRR13764277/SRR13764277_1.fastq.gz', 'md5': '1cc4865b959ad72a08bd8b28d9faba33', 'size': 792199234}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/077/SRR13764277/SRR13764277_2.fastq.gz', 'md5': '3b0844e018b1fcfd12fa4041d53dc0bd', 'size': 3323324826}]","[{'url': 's3://sra-pub-src-5/SRR13764277/GHO-3_S3_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR13764277/GHO-3_S3_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR13764277/GHO-3_S3_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR13764277/GHO-3_S3_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764277/SRR13764277.1'}],45898990,5783272740,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764278,SRX10150779,SRP307529,SRS8303092,Illumina HiSeq 4000 paired end sequencing; GSM5100205: H1 Chondrogenic + C1 Chondrogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/078/SRR13764278/SRR13764278_1.fastq.gz', 'md5': 'ede9aed5f790e15d976f053f19983bbf', 'size': 1610762734}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/078/SRR13764278/SRR13764278_2.fastq.gz', 'md5': 'a0aaca9d42278a4d6f155d7165bd022b', 'size': 6679362275}]","[{'url': 's3://sra-pub-src-15/SRR13764278/GHO-3_S3_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13764278/GHO-3_S3_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13764278/GHO-3_S3_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13764278/GHO-3_S3_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764278/SRR13764278.1'}],92399447,11642330322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764279,SRX10150779,SRP307529,SRS8303092,Illumina HiSeq 4000 paired end sequencing; GSM5100205: H1 Chondrogenic + C1 Chondrogenic; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/079/SRR13764279/SRR13764279_1.fastq.gz', 'md5': '8727d13ac2ae71833ea5421b59e00f35', 'size': 1634709237}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/079/SRR13764279/SRR13764279_2.fastq.gz', 'md5': '21bc578a6a183b9db2acdf03f2521666', 'size': 6328251512}]",[{'url': 's3://sra-pub-src-10/SRR13764279/GHO-3_S3_L003_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-9/SRR13764279/GHO-3_S3_L003_R1_001.fastq.gz.1'}],[],94016994,11846141244,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14310180,SRX10665412,SRP316050,SRS8759818,Illumina NovaSeq 6000 paired end sequencing; GSM5261801: Cre; Mus musculus; RNA-Seq,,2021-09-03,2021-09-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR143/SRR14310180/SID115492_possorted_genome_bam.bam', 'md5': '8c5dd5d22aa729e9a69a7facc3aa3595', 'size': 4258809262}]","[{'url': 'https://sra-pub-src-1.s3.amazonaws.com/SRR14310180/SID115492_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14310180/SID115492_possorted_genome_bam.bam.1'}]",[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14310180/SID115492_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra3/SRZ/014310/SRR14310180/SID115492_possorted_genome_bam.bam'}],41748585,3882618405,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14310181,SRX10665413,SRP316050,SRS8759819,Illumina NovaSeq 6000 paired end sequencing; GSM5261802: CreTW; Mus musculus; RNA-Seq,,2021-09-03,2021-09-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR143/SRR14310181/SID115501_possorted_genome_bam.bam', 'md5': '77aef9ddfebedb8a3f83a4e5217be4f5', 'size': 4716209910}]","[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR14310181/SID115501_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14310181/SID115501_possorted_genome_bam.bam.1'}]",[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14310181/SID115501_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra53/SRZ/014310/SRR14310181/SID115501_possorted_genome_bam.bam'}],44202825,4110862725,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15965269,SRX12255073,SRP337787,SRS10230645,Illumina NovaSeq 6000 paired end sequencing; GSM5587074: Stat3fl/fl; Mus musculus; RNA-Seq,fastq-load.py,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/069/SRR15965269/SRR15965269_1.fastq.gz', 'md5': 'b934e068dceb4f0621c244c90bb73693', 'size': 5659785907}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/069/SRR15965269/SRR15965269_2.fastq.gz', 'md5': '5c6980447c9755a1eb67b8d9a70bc7eb', 'size': 11069610614}]","[{'url': 's3://sra-pub-src-13/SRR15965269/Stat3fl%3Afl_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15965269/Stat3fl%3Afl_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15965269/Stat3fl%3Afl_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15965269/Stat3fl%3Afl_R1.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15965/SRR15965269/SRR15965269.1'}],268004663,31892554897,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TBB --read1PairFiles=Stat3fl:fl_I1.fastq.gz --read2PairFiles=Stat3fl:fl_R1.fastq.gz --read3PairFiles=Stat3fl:fl_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15965270,SRX12255074,SRP337787,SRS10230646,Illumina NovaSeq 6000 paired end sequencing; GSM5587075: Acan-Cre+/Cre;Stat3fl/fl; Mus musculus; RNA-Seq,fastq-load.py,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/070/SRR15965270/SRR15965270_1.fastq.gz', 'md5': 'c2c710093930b00c210457024a1506c5', 'size': 3536947818}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/070/SRR15965270/SRR15965270_2.fastq.gz', 'md5': '5ce8820ce06f844518cc3af2f6950d5d', 'size': 6885532158}]","[{'url': 's3://sra-pub-src-13/SRR15965270/Acan-Cre%2B%3ACre_Stat3fl%3Afl_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15965270/Acan-Cre%2B%3ACre_Stat3fl%3Afl_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15965270/Acan-Cre%2B%3ACre_Stat3fl%3Afl_R2.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15965270/SRR15965270'}]","[{'url': 'gs://sra-pub-src-3/SRR15965270/Acan-Cre%2B%3ACre_Stat3fl%3Afl_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15965270/Acan-Cre%2B%3ACre_Stat3fl%3Afl_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15965270/Acan-Cre%2B%3ACre_Stat3fl%3Afl_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/015591/SRR15965270'}],165392664,19681727016,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TBB --read1PairFiles=Acan-Cre+:Cre_Stat3fl:fl_I1.fastq.gz --read2PairFiles=Acan-Cre+:Cre_Stat3fl:fl_R1.fastq.gz --read3PairFiles=Acan-Cre+:Cre_Stat3fl:fl_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14294973,SRX10652879,SRP315738,SRS8748218,NextSeq 500 paired end sequencing; GSM5258024: Uninjured; Mus musculus; RNA-Seq,,2021-10-06,2021-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR142/SRR14294973/Uninjured_possorted_genome_bam.bam.1', 'md5': 'a9b2a88ec73da3c5616bb1b698ac32fd', 'size': 14931788230}]","[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR14294973/Uninjured_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14294973/Uninjured_possorted_genome_bam.bam.1'}]",[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14294973/Uninjured_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra28/SRZ/014294/SRR14294973/Uninjured_possorted_genome_bam.bam'}],135015693,7560878808,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,treat_as_unmapped,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14294974,SRX10652880,SRP315738,SRS8748219,NextSeq 500 paired end sequencing; GSM5258025: 3 days post-injury; Mus musculus; RNA-Seq,,2021-10-05,2021-10-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR142/SRR14294974/3DPI_possorted_genome_bam.bam.1', 'md5': '99a29af0af98be7993f938c9d700f863', 'size': 10641762494}]","[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR14294974/3DPI_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14294974/3DPI_possorted_genome_bam.bam.1'}]",[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14294974/3DPI_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra47/SRZ/014294/SRR14294974/3DPI_possorted_genome_bam.bam'}],110151027,6168457512,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,treat_as_unmapped,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14294975,SRX10652881,SRP315738,SRS8748220,NextSeq 500 paired end sequencing; GSM5258026: 7 days post-injury; Mus musculus; RNA-Seq,,2021-10-05,2021-10-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR142/SRR14294975/7DPI_possorted_genome_bam.bam.1', 'md5': '6e84aceb6da3a05585810bb39dd72039', 'size': 9949710685}]",[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR14294975/7DPI_possorted_genome_bam.bam.1'}],[{'url': 'gs://sra-pub-src-2/SRR14294975/7DPI_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra34/SRZ/014294/SRR14294975/7DPI_possorted_genome_bam.bam'}],89103043,4989770408,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,treat_as_unmapped,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235599,SRX12515458,SRP340406,SRS10477206,NextSeq 500 paired end sequencing; GSM5617431: pluripotent NCRM1 cells replicate 1; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/099/SRR16235599/SRR16235599_1.fastq.gz', 'md5': 'b962e8d6e8ebeb7cb6f0c24b36094a49', 'size': 1387331818}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/099/SRR16235599/SRR16235599_2.fastq.gz', 'md5': 'c32a7c1704b2f6d701482012e9e44a63', 'size': 1452089774}]","[{'url': 's3://sra-pub-src-3/SRR16235599/iPSC_rep1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR16235599/iPSC_rep1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR16235599/iPSC_rep1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR16235599/iPSC_rep1_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra72/SRR/015855/SRR16235599'}],20945111,6283533300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235600,SRX12515459,SRP340406,SRS10477207,NextSeq 500 paired end sequencing; GSM5617432: pluripotent NCRM1 cells replicate 2; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/000/SRR16235600/SRR16235600_1.fastq.gz', 'md5': '93856b1b0a541f4ad123da08f0f87238', 'size': 1760307424}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/000/SRR16235600/SRR16235600_2.fastq.gz', 'md5': 'cf58ef8d6f1f6c59e0bcedb9d6623014', 'size': 1854395718}]","[{'url': 's3://sra-pub-src-17/SRR16235600/iPSC_rep2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR16235600/iPSC_rep2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR16235600/iPSC_rep2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR16235600/iPSC_rep2_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra25/SRR/015855/SRR16235600'}],26637992,7991397600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235601,SRX12515460,SRP340406,SRS10477208,NextSeq 500 paired end sequencing; GSM5617433: pluripotent NCRM1 cells replicate 3; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/001/SRR16235601/SRR16235601_1.fastq.gz', 'md5': '3c4180d1efcd01cd40157a4b547a713f', 'size': 1211743084}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/001/SRR16235601/SRR16235601_2.fastq.gz', 'md5': 'd2bbbe674eec77ddfdd895ed5912092e', 'size': 1271007181}]","[{'url': 's3://sra-pub-src-5/SRR16235601/iPSC_rep3_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR16235601/iPSC_rep3_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR16235601/iPSC_rep3_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR16235601/iPSC_rep3_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra42/SRR/015855/SRR16235601'}],18371410,5511423000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235602,SRX12515461,SRP340406,SRS10477209,NextSeq 500 paired end sequencing; GSM5617434: brown adipocyte differentiation on day +40 replicate 1; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/002/SRR16235602/SRR16235602_1.fastq.gz', 'md5': 'f30f89e8b6af848c4872aa5b7132a502', 'size': 1496251488}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/002/SRR16235602/SRR16235602_2.fastq.gz', 'md5': 'd12398357e3631116999505d83a98d5d', 'size': 1569341321}]","[{'url': 's3://sra-pub-src-18/SRR16235602/iPSC_BA_rep1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR16235602/iPSC_BA_rep1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR16235602/iPSC_BA_rep1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR16235602/iPSC_BA_rep1_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra48/SRR/015855/SRR16235602'}],22622595,6786778500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235603,SRX12515462,SRP340406,SRS10477210,NextSeq 500 paired end sequencing; GSM5617435: brown adipocyte differentiation on day +40 replicate 2; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/003/SRR16235603/SRR16235603_1.fastq.gz', 'md5': '5857217de9d2032079ad29024903d650', 'size': 1043229345}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/003/SRR16235603/SRR16235603_2.fastq.gz', 'md5': '560f4200440ac283c35a9e5533a1ce7e', 'size': 1099852073}]","[{'url': 's3://sra-pub-src-7/SRR16235603/iPSC_BA_rep2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR16235603/iPSC_BA_rep2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR16235603/iPSC_BA_rep2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR16235603/iPSC_BA_rep2_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra10/SRR/015855/SRR16235603'}],15812224,4743667200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235604,SRX12515463,SRP340406,SRS10477211,NextSeq 500 paired end sequencing; GSM5617436: brown adipocyte differentiation on day +40 replicate 3; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/004/SRR16235604/SRR16235604_1.fastq.gz', 'md5': 'e6748c0a6e0207a19e4f286e7ca6bfda', 'size': 1397714247}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/004/SRR16235604/SRR16235604_2.fastq.gz', 'md5': 'a61e61de3a72fe9a3e6697058f368214', 'size': 1466200863}]","[{'url': 's3://sra-pub-src-9/SRR16235604/iPSC_BA_rep3_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR16235604/iPSC_BA_rep3_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR16235604/iPSC_BA_rep3_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR16235604/iPSC_BA_rep3_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra9/SRR/015855/SRR16235604'}],21181207,6354362100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235605,SRX12515464,SRP340406,SRS10477212,NextSeq 500 paired end sequencing; GSM5617437: human fetal brown adipose tissue day 122; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/005/SRR16235605/SRR16235605_1.fastq.gz', 'md5': '1b4bf93bc31b233c32d3494bb1358511', 'size': 1354148321}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/005/SRR16235605/SRR16235605_2.fastq.gz', 'md5': 'f1f2b1aa5ccd21bdd20c7d876a371f0f', 'size': 1430970766}]","[{'url': 's3://sra-pub-src-8/SRR16235605/fBAT_rep1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR16235605/fBAT_rep1_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR16235605/fBAT_rep1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR16235605/fBAT_rep1_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra7/SRR/015855/SRR16235605'}],20488709,6146612700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235606,SRX12515465,SRP340406,SRS10477213,NextSeq 500 paired end sequencing; GSM5617438: human fetal brown adipose tissue day 115; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/006/SRR16235606/SRR16235606_1.fastq.gz', 'md5': '7f00bed3fa66bd8a170137cdf0af5214', 'size': 1367588203}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/006/SRR16235606/SRR16235606_2.fastq.gz', 'md5': '17506613859b85a758e144fbca8787f8', 'size': 1440293975}]","[{'url': 's3://sra-pub-src-6/SRR16235606/fBAT_rep2_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR16235606/fBAT_rep2_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-4/SRR16235606/fBAT_rep2_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR16235606/fBAT_rep2_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra56/SRR/015855/SRR16235606'}],20718756,6215626800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16235607,SRX12515466,SRP340406,SRS10477214,NextSeq 500 paired end sequencing; GSM5617439: human fetal brown adipose tissue day 125; Homo sapiens; RNA-Seq,fastq-load.py,2021-10-13,2021-10-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/007/SRR16235607/SRR16235607_1.fastq.gz', 'md5': '670c24cb814d26ee10334cfa46835c74', 'size': 1582336677}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR162/007/SRR16235607/SRR16235607_2.fastq.gz', 'md5': '991f6104458b2e6fe94423a939bb140f', 'size': 1669900427}]","[{'url': 's3://sra-pub-src-5/SRR16235607/fBAT_rep3_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR16235607/fBAT_rep3_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR16235607/fBAT_rep3_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR16235607/fBAT_rep3_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra60/SRR/015855/SRR16235607'}],24153437,7246031100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818942,,,,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/042/SRR17818942/SRR17818942.fastq.gz', 'md5': 'f63b70bddd78bbdb93d0eee58cf0e740', 'size': '1782388135'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818943,,,,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/043/SRR17818943/SRR17818943.fastq.gz', 'md5': '6e62f25b6e3e2fadcb10b7b6bd2ed18b', 'size': '1814703290'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818944,,,,NextSeq 500 sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/044/SRR17818944/SRR17818944.fastq.gz', 'md5': '670f44c639e9b364b9da55a7f046c4c4', 'size': '1809812263'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818945,,,,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980715,NextSeq 500 paired end sequencing; GSM5848681: RD cell line with LARRY barcodes after washing out Differentiation medium at third time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818038,RD cell line with LARRY barcodes after washing out Differentiation medium at third time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/045/SRR17818945/SRR17818945.fastq.gz', 'md5': 'ce04ed2b32ce0ead1395a10ef8a00cdf', 'size': '1830816188'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818954,,,,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17818954/SRR17818954.fastq.gz', 'md5': '25158b412e8833f512faa736cc8ede63', 'size': '2236224295'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818955,,,,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17818955/SRR17818955.fastq.gz', 'md5': '4bb4b4a019e433c0d1426e0513dcca52', 'size': '2263388708'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818956,,,,NextSeq 500 sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/056/SRR17818956/SRR17818956.fastq.gz', 'md5': '313915566949d53d2f28e65bd386257a', 'size': '2268458770'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818957,,,,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980713,NextSeq 500 paired end sequencing; GSM5848680: RD cell line with LARRY barcodes with Differentiation medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818036,RD cell line with LARRY barcodes with Differentiation medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/057/SRR17818957/SRR17818957.fastq.gz', 'md5': 'e835070df2afd0bf019b7539a197c329', 'size': '2286830846'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818958,,,,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/058/SRR17818958/SRR17818958.fastq.gz', 'md5': 'c4bcb2710ab0e08190d17edbe79a28b5', 'size': '2151521366'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818959,,,,NextSeq 500 sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/059/SRR17818959/SRR17818959.fastq.gz', 'md5': 'f501ce0fc93abffa5dcdbc434278de68', 'size': '2163967531'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818960,,,,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17818960/SRR17818960.fastq.gz', 'md5': '5a3d45192e386a4366eb6be4fd79b233', 'size': '2192886584'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818961,,,,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980712,NextSeq 500 paired end sequencing; GSM5848679: RD cell line with LARRY barcodes with Regular medium at second time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818035,RD cell line with LARRY barcodes with Regular medium at second time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/061/SRR17818961/SRR17818961.fastq.gz', 'md5': '7419fae90b701615574016ac494483dc', 'size': '2183900191'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818962,,,,NextSeq 500 sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/062/SRR17818962/SRR17818962.fastq.gz', 'md5': 'a4b4d68b8719bbadd68d27e2357fba54', 'size': '2022607976'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818963,,,,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/063/SRR17818963/SRR17818963.fastq.gz', 'md5': '7ab2011888ff077593e66c5bc601f9d6', 'size': '2036530338'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818964,,,,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/064/SRR17818964/SRR17818964.fastq.gz', 'md5': '424a1d45e56ac843206f2771e4b48222', 'size': '2061293023'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818965,,,,NextSeq 500 sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980711,NextSeq 500 paired end sequencing; GSM5848678: RD cell line with LARRY barcodes with Regular medium at first time point; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818034,RD cell line with LARRY barcodes with Regular medium at first time point,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/065/SRR17818965/SRR17818965.fastq.gz', 'md5': '3251a7a72b0163c1d58300a7b715389f', 'size': '2055031989'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818966,,,,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980710,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818033,RD cell line,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/066/SRR17818966/SRR17818966.fastq.gz', 'md5': '4e781700bdf044eb9d378b004deae082', 'size': '1492212535'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818967,,,,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980710,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818033,RD cell line,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/067/SRR17818967/SRR17818967.fastq.gz', 'md5': 'd466258d1cad25cca0e8bd82b2ebe7ce', 'size': '1483811879'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818968,,,,NextSeq 500 sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980710,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818033,RD cell line,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/068/SRR17818968/SRR17818968.fastq.gz', 'md5': '5e3b39df28dc0ba3d7b7d4a8d882b0d5', 'size': '1327105823'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818969,,,,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980710,NextSeq 500 paired end sequencing; GSM5848677: RD cell line; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818033,RD cell line,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/069/SRR17818969/SRR17818969.fastq.gz', 'md5': '6a60cf9a55fe66c3180272c61228eaca', 'size': '1348854332'}]",,,,,,RD cell line,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764268,SRX10150777,SRP307529,SRS8303090,Illumina HiSeq 4000 paired end sequencing; GSM5100203: H1 iPSC + C1 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/068/SRR13764268/SRR13764268_1.fastq.gz', 'md5': 'bd11344a098578647881f3f644716303', 'size': 957418978}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/068/SRR13764268/SRR13764268_2.fastq.gz', 'md5': 'dd9bd4b6410261a2ba32f51e6eae88ed', 'size': 3858564704}]","[{'url': 's3://sra-pub-src-5/SRR13764268/GHO-1_S1_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR13764268/GHO-1_S1_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR13764268/GHO-1_S1_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR13764268/GHO-1_S1_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764268/SRR13764268.1'}],55920369,7045966494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764269,SRX10150777,SRP307529,SRS8303090,Illumina HiSeq 4000 paired end sequencing; GSM5100203: H1 iPSC + C1 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/069/SRR13764269/SRR13764269_1.fastq.gz', 'md5': 'a2ab894cc56b812b4df9c58578c790ab', 'size': 746414440}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/069/SRR13764269/SRR13764269_2.fastq.gz', 'md5': 'ddcc4c174ee7bd89d3b4008c2865fe9c', 'size': 3177723767}]","[{'url': 's3://sra-pub-src-8/SRR13764269/GHO-1_S1_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR13764269/GHO-1_S1_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR13764269/GHO-1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR13764269/GHO-1_S1_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764269/SRR13764269.1'}],42846071,5398604946,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764270,SRX10150777,SRP307529,SRS8303090,Illumina HiSeq 4000 paired end sequencing; GSM5100203: H1 iPSC + C1 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/070/SRR13764270/SRR13764270_1.fastq.gz', 'md5': 'b4f321743e77357b5abfab1518dda7fa', 'size': 1602961705}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/070/SRR13764270/SRR13764270_2.fastq.gz', 'md5': 'a0a28630bf038b66d94e7dbe6f4f852b', 'size': 6756524008}]","[{'url': 's3://sra-pub-src-17/SRR13764270/GHO-1_S1_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13764270/GHO-1_S1_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR13764270/GHO-1_S1_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13764270/GHO-1_S1_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764270/SRR13764270.1'}],91008413,11467060038,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764271,SRX10150777,SRP307529,SRS8303090,Illumina HiSeq 4000 paired end sequencing; GSM5100203: H1 iPSC + C1 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/071/SRR13764271/SRR13764271_1.fastq.gz', 'md5': '31713efe12ff9453c83ee9401b7d8263', 'size': 1640340787}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/071/SRR13764271/SRR13764271_2.fastq.gz', 'md5': '636b80fb7fe1f336c3a3792c386e8dd9', 'size': 6521116820}]",[{'url': 's3://sra-pub-src-14/SRR13764271/GHO-1_S1_L003_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-11/SRR13764271/GHO-1_S1_L003_R1_001.fastq.gz.1'}],[],93310184,11757083184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390059,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/059/SRR15390059/SRR15390059_1.fastq.gz', 'md5': 'c9426e46c6114d0c52eac43683ada894', 'size': 536071740}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/059/SRR15390059/SRR15390059_2.fastq.gz', 'md5': '25e43daa48ef0f7cdaf7233a425f9c3c', 'size': 2037011964}]","[{'url': 's3://sra-pub-src-9/SRR15390059/HOU-10_S8_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390059/HOU-10_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390059/SRR15390059'}, {'url': 's3://sra-pub-run-6/SRR15390059/SRR15390059.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390059/HOU-10_S8_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390059/HOU-10_S8_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390059/SRR15390059.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra2/SRR/015029/SRR15390059'}],29753726,3808476928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390060,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/060/SRR15390060/SRR15390060_1.fastq.gz', 'md5': '3aeb826e6b4a31c7d251a4249ca0cb43', 'size': 532841358}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/060/SRR15390060/SRR15390060_2.fastq.gz', 'md5': '951e167b348f58446ba4d8feba570d2e', 'size': 2022779084}]","[{'url': 's3://sra-pub-src-12/SRR15390060/HOU-10_S8_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390060/HOU-10_S8_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390060/SRR15390060'}, {'url': 's3://sra-pub-run-12/SRR15390060/SRR15390060.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390060/HOU-10_S8_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390060/HOU-10_S8_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR15390060/SRR15390060.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra28/SRR/015029/SRR15390060'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390061,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/061/SRR15390061/SRR15390061_1.fastq.gz', 'md5': '7e8d9e23656a2a918aa0e929825d6adf', 'size': 538259184}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/061/SRR15390061/SRR15390061_2.fastq.gz', 'md5': '949a9d20fa109958c1ef7026bbb69796', 'size': 2029528721}]","[{'url': 's3://sra-pub-src-14/SRR15390061/HOU-10_S8_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390061/HOU-10_S8_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390061/SRR15390061'}, {'url': 's3://sra-pub-run-13/SRR15390061/SRR15390061.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15390061/HOU-10_S8_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390061/HOU-10_S8_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR15390061/SRR15390061.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390061'}],29715308,3803559424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390062,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/062/SRR15390062/SRR15390062_1.fastq.gz', 'md5': '7951dbc1eb51243f214732c71183d3cc', 'size': 536170428}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/062/SRR15390062/SRR15390062_2.fastq.gz', 'md5': '9883f67d7eb049b5025893311ce5902f', 'size': 2008956420}]","[{'url': 's3://sra-pub-src-17/SRR15390062/HOU-10_S8_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390062/HOU-10_S8_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390062/HOU-10_S8_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390062/HOU-10_S8_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390062/SRR15390062.1'}],29707992,3802622976,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390063,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/063/SRR15390063/SRR15390063_1.fastq.gz', 'md5': 'c6a25ee3f0dcfe03fea80d1df7862178', 'size': 528735569}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/063/SRR15390063/SRR15390063_2.fastq.gz', 'md5': 'b32acee14cb4235d47e12be05970679c', 'size': 1954825381}]","[{'url': 's3://sra-pub-src-3/SRR15390063/HOU-10_S8_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390063/HOU-10_S8_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390063/HOU-10_S8_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390063/HOU-10_S8_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390063/SRR15390063.1'}],29346219,3756316032,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390064,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/064/SRR15390064/SRR15390064_1.fastq.gz', 'md5': '4d870752cd24e1d66079b1c1365de3d0', 'size': 516174794}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/064/SRR15390064/SRR15390064_2.fastq.gz', 'md5': '3a8f232f218604a97b4de46eeb3d193f', 'size': 1921498422}]","[{'url': 's3://sra-pub-src-13/SRR15390064/HOU-10_S8_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390064/HOU-10_S8_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390064/HOU-10_S8_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390064/HOU-10_S8_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390064/SRR15390064.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390065,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/065/SRR15390065/SRR15390065_1.fastq.gz', 'md5': 'ba43fd17da342c3a381e47042a930389', 'size': 517837970}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/065/SRR15390065/SRR15390065_2.fastq.gz', 'md5': 'd17accd2a40b3e06ace5d0fd76382b48', 'size': 1938142859}]","[{'url': 's3://sra-pub-src-14/SRR15390065/HOU-10_S8_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390065/HOU-10_S8_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390065/SRR15390065'}, {'url': 's3://sra-pub-run-13/SRR15390065/SRR15390065.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15390065/HOU-10_S8_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390065/HOU-10_S8_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR15390065/SRR15390065.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra70/SRR/015029/SRR15390065'}],27867940,3567096320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390066,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/066/SRR15390066/SRR15390066_1.fastq.gz', 'md5': '91fe8d8383fa757675f3f455dc7c0cef', 'size': 507915367}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/066/SRR15390066/SRR15390066_2.fastq.gz', 'md5': '2ea8fe95e0a03aae6087f4944e3b385c', 'size': 1928441252}]","[{'url': 's3://sra-pub-src-17/SRR15390066/HOU-10_S8_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390066/HOU-10_S8_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390066/SRR15390066'}, {'url': 's3://sra-pub-run-11/SRR15390066/SRR15390066.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390066/HOU-10_S8_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390066/HOU-10_S8_L008_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390066/SRR15390066.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390066'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390067,SRX11692393,SRP331750,SRS9723990,Illumina HiSeq 4000 paired end sequencing; GSM5510232: H1 iPSC (replicate 2) + C1 iPSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/067/SRR15390067/SRR15390067_1.fastq.gz', 'md5': '5818b3b0a5b0c178a10301baa3a2d36b', 'size': 526235030}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/067/SRR15390067/SRR15390067_2.fastq.gz', 'md5': '811f0a2a555515e5594589db4b36ee79', 'size': 1966560431}]",[{'url': 's3://sra-pub-src-5/SRR15390067/HOU-10_S8_L009_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-4/SRR15390067/HOU-10_S8_L009_R1_001.fastq.gz.1'}],[],29239269,3742626432,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390068,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/068/SRR15390068/SRR15390068_1.fastq.gz', 'md5': 'f40ced5364dd7de9e8e5a844dd550e4a', 'size': 574125307}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/068/SRR15390068/SRR15390068_2.fastq.gz', 'md5': '444b50278ba402083f183732340c2ce5', 'size': 2221238258}]","[{'url': 's3://sra-pub-src-7/SRR15390068/HOU-12_S10_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR15390068/HOU-12_S10_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390068/SRR15390068'}, {'url': 's3://sra-pub-run-9/SRR15390068/SRR15390068.1'}]","[{'url': 'gs://sra-pub-src-12/SRR15390068/HOU-12_S10_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR15390068/HOU-12_S10_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR15390068/SRR15390068.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390068'}],31981411,4093620608,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390069,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/069/SRR15390069/SRR15390069_1.fastq.gz', 'md5': '6506aeaa935417bf3be328d5b499f25f', 'size': 574151385}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/069/SRR15390069/SRR15390069_2.fastq.gz', 'md5': 'be00f7fb766824cecc2114da08a75b7a', 'size': 2222038235}]","[{'url': 's3://sra-pub-src-4/SRR15390069/HOU-12_S10_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15390069/HOU-12_S10_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390069/SRR15390069'}, {'url': 's3://sra-pub-run-1/SRR15390069/SRR15390069.1'}]","[{'url': 'gs://sra-pub-src-17/SRR15390069/HOU-12_S10_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR15390069/HOU-12_S10_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390069/SRR15390069.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra73/SRR/015029/SRR15390069'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390070,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/070/SRR15390070/SRR15390070_1.fastq.gz', 'md5': '670e6e348703b43d8f261f621c525ce1', 'size': 580261044}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/070/SRR15390070/SRR15390070_2.fastq.gz', 'md5': 'e6e9b365d1c06ef1317c6b9a03652329', 'size': 2228275265}]","[{'url': 's3://sra-pub-src-8/SRR15390070/HOU-12_S10_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390070/HOU-12_S10_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390070/SRR15390070'}, {'url': 's3://sra-pub-run-2/SRR15390070/SRR15390070.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390070/HOU-12_S10_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390070/HOU-12_S10_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390070/SRR15390070.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra8/SRR/015029/SRR15390070'}],32143344,4114348032,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390071,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/071/SRR15390071/SRR15390071_1.fastq.gz', 'md5': '7ce23cf1bde5c850bfbfcc1849385338', 'size': 580423151}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/071/SRR15390071/SRR15390071_2.fastq.gz', 'md5': '303a69d159ad5445a601f990a8ac0a71', 'size': 2215255920}]","[{'url': 's3://sra-pub-src-5/SRR15390071/HOU-12_S10_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR15390071/HOU-12_S10_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390071/SRR15390071'}, {'url': 's3://sra-pub-run-7/SRR15390071/SRR15390071.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15390071/HOU-12_S10_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390071/HOU-12_S10_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR15390071/SRR15390071.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra59/SRR/015029/SRR15390071'}],32266959,4130170752,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390072,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/072/SRR15390072/SRR15390072_1.fastq.gz', 'md5': '072d010b52f5e718f8e005610d660c49', 'size': 566224239}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/072/SRR15390072/SRR15390072_2.fastq.gz', 'md5': 'a01eccea026a037c260e0b5f49b6d79d', 'size': 2126677477}]","[{'url': 's3://sra-pub-src-9/SRR15390072/HOU-12_S10_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390072/HOU-12_S10_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390072/SRR15390072'}, {'url': 's3://sra-pub-run-6/SRR15390072/SRR15390072.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390072/HOU-12_S10_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390072/HOU-12_S10_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390072/SRR15390072.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390072'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390073,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/073/SRR15390073/SRR15390073_1.fastq.gz', 'md5': 'd1a5419953b17f8b627f8368d596f482', 'size': 554967073}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/073/SRR15390073/SRR15390073_2.fastq.gz', 'md5': '5ff4df2485d3505aa8006c6b3ab74bb9', 'size': 2099524128}]","[{'url': 's3://sra-pub-src-4/SRR15390073/HOU-12_S10_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15390073/HOU-12_S10_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390073/SRR15390073'}, {'url': 's3://sra-pub-run-1/SRR15390073/SRR15390073.1'}]","[{'url': 'gs://sra-pub-src-17/SRR15390073/HOU-12_S10_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR15390073/HOU-12_S10_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390073/SRR15390073.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra21/SRR/015029/SRR15390073'}],30773794,3939045632,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390074,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/074/SRR15390074/SRR15390074_1.fastq.gz', 'md5': '8545ab31d682efed660cc9f04b82adc0', 'size': 463412425}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/074/SRR15390074/SRR15390074_2.fastq.gz', 'md5': '48d15afae5ef5336a52a4d267111808b', 'size': 1774696611}]","[{'url': 's3://sra-pub-src-9/SRR15390074/HOU-12_S10_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR15390074/HOU-12_S10_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390074/SRR15390074'}, {'url': 's3://sra-pub-run-6/SRR15390074/SRR15390074.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15390074/HOU-12_S10_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390074/HOU-12_S10_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390074/SRR15390074.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390074'}],25135858,3217389824,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390075,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/075/SRR15390075/SRR15390075_1.fastq.gz', 'md5': '1288c71551dc5fd1804b6328a39ccecc', 'size': 455281940}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/075/SRR15390075/SRR15390075_2.fastq.gz', 'md5': '3a8a38a978d73918d3d88250eee27ae5', 'size': 1764897903}]","[{'url': 's3://sra-pub-src-18/SRR15390075/HOU-12_S10_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390075/HOU-12_S10_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390075/SRR15390075'}, {'url': 's3://sra-pub-run-3/SRR15390075/SRR15390075.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390075/HOU-12_S10_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390075/HOU-12_S10_L008_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR15390075/SRR15390075.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390075'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390076,SRX11692394,SRP331750,SRS9723991,Illumina HiSeq 4000 paired end sequencing; GSM5510233: H1 MSC (replicate 2) + C1 MSC (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/076/SRR15390076/SRR15390076_1.fastq.gz', 'md5': 'd9f2359d40f355dea03d43a78f81ae8c', 'size': 564452736}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/076/SRR15390076/SRR15390076_2.fastq.gz', 'md5': '22f9d2d569ddb21022656faf47ca5856', 'size': 2145402965}]",[{'url': 's3://sra-pub-src-12/SRR15390076/HOU-12_S10_L009_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-14/SRR15390076/HOU-12_S10_L009_R1_001.fastq.gz.1'}],[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390085,SRX11692395,SRP331750,SRS9723989,Illumina HiSeq 4000 paired end sequencing; GSM5510234: H1 Osteogenic (replicate 2) + C1 Osteogenic (replicate 2); Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/085/SRR15390085/SRR15390085_1.fastq.gz', 'md5': 'ca4ef65bdb076b6a6b3ff994f55b2a57', 'size': 529746715}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/085/SRR15390085/SRR15390085_2.fastq.gz', 'md5': '0c9773e66c1692a70b6a033f84452d1b', 'size': 2012421662}]","[{'url': 's3://sra-pub-src-3/SRR15390085/HOU-16_S12_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390085/HOU-16_S12_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390085/SRR15390085'}]","[{'url': 'gs://sra-pub-src-5/SRR15390085/HOU-16_S12_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390085/HOU-16_S12_L009_R2_001.fastq.gz.1'}]",[],29768807,3810407296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390086,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/086/SRR15390086/SRR15390086_1.fastq.gz', 'md5': '6ff79d8352f1d67b5430bff30a5d1295', 'size': 506766107}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/086/SRR15390086/SRR15390086_2.fastq.gz', 'md5': 'bb624f05d4263ebe9d14c45d2fc8bfe9', 'size': 1992192834}]","[{'url': 's3://sra-pub-src-6/SRR15390086/HOU-1_S1_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR15390086/HOU-1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390086/SRR15390086'}, {'url': 's3://sra-pub-run-8/SRR15390086/SRR15390086.1'}]","[{'url': 'gs://sra-pub-src-8/SRR15390086/HOU-1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR15390086/HOU-1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR15390086/SRR15390086.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390086'}],28652029,3667459712,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390087,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/087/SRR15390087/SRR15390087_1.fastq.gz', 'md5': 'a1686c7cfd11f0acfed903cb18424457', 'size': 509658771}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/087/SRR15390087/SRR15390087_2.fastq.gz', 'md5': '2eb625a94db2983b258a074dfe78d23f', 'size': 2004499108}]","[{'url': 's3://sra-pub-src-11/SRR15390087/HOU-1_S1_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR15390087/HOU-1_S1_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390087/SRR15390087'}, {'url': 's3://sra-pub-run-4/SRR15390087/SRR15390087.1'}]","[{'url': 'gs://sra-pub-src-18/SRR15390087/HOU-1_S1_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR15390087/HOU-1_S1_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR15390087/SRR15390087.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra17/SRR/015029/SRR15390087'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390088,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/088/SRR15390088/SRR15390088_1.fastq.gz', 'md5': '9d087bdc12e98e32d5ab6105e1f01f63', 'size': 515362484}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/088/SRR15390088/SRR15390088_2.fastq.gz', 'md5': 'fa51801a00b24e593a6f3b08b18bb17a', 'size': 2010164534}]","[{'url': 's3://sra-pub-src-13/SRR15390088/HOU-1_S1_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390088/HOU-1_S1_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390088/SRR15390088'}, {'url': 's3://sra-pub-run-10/SRR15390088/SRR15390088.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390088/HOU-1_S1_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390088/HOU-1_S1_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR15390088/SRR15390088.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390088'}],28955977,3706365056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390089,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/089/SRR15390089/SRR15390089_1.fastq.gz', 'md5': '9eecf4dda3121458aaee002b9302c31e', 'size': 519058930}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/089/SRR15390089/SRR15390089_2.fastq.gz', 'md5': 'a3d9ac689f05eb30588684aa78c5b080', 'size': 2011667062}]","[{'url': 's3://sra-pub-src-8/SRR15390089/HOU-1_S1_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390089/HOU-1_S1_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390089/SRR15390089'}, {'url': 's3://sra-pub-run-2/SRR15390089/SRR15390089.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390089/HOU-1_S1_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390089/HOU-1_S1_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390089/SRR15390089.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390089'}],29266365,3746094720,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390090,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/090/SRR15390090/SRR15390090_1.fastq.gz', 'md5': '7060b8c9cec4a95eb7552c68b52c282d', 'size': 500510349}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/090/SRR15390090/SRR15390090_2.fastq.gz', 'md5': '269c29395c749ea1260eafb570f41658', 'size': 1913899046}]","[{'url': 's3://sra-pub-src-18/SRR15390090/HOU-1_S1_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390090/HOU-1_S1_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390090/SRR15390090'}, {'url': 's3://sra-pub-run-3/SRR15390090/SRR15390090.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390090/HOU-1_S1_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390090/HOU-1_S1_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390090/SRR15390090.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra1/SRR/015029/SRR15390090'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390091,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/091/SRR15390091/SRR15390091_1.fastq.gz', 'md5': 'cb2eb598a21bedc6aa2f2d6dd1cbb65a', 'size': 492899966}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/091/SRR15390091/SRR15390091_2.fastq.gz', 'md5': '288bb4541234a04c7228fe290dadfd2f', 'size': 1897964928}]","[{'url': 's3://sra-pub-src-8/SRR15390091/HOU-1_S1_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390091/HOU-1_S1_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390091/SRR15390091'}, {'url': 's3://sra-pub-run-6/SRR15390091/SRR15390091.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390091/HOU-1_S1_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390091/HOU-1_S1_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390091/SRR15390091.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra46/SRR/015029/SRR15390091'}],27736008,3550209024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390092,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/092/SRR15390092/SRR15390092_1.fastq.gz', 'md5': '8807e96c113e2c9538f8eec5973d66dd', 'size': 556001781}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/092/SRR15390092/SRR15390092_2.fastq.gz', 'md5': '6a4230b93045cc34cd2f240a8702afec', 'size': 2154900678}]","[{'url': 's3://sra-pub-src-18/SRR15390092/HOU-1_S1_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390092/HOU-1_S1_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390092/HOU-1_S1_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390092/HOU-1_S1_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390092/SRR15390092.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390093,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/093/SRR15390093/SRR15390093_1.fastq.gz', 'md5': '566d52339d8ffcf709928dafd000971f', 'size': 545638617}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/093/SRR15390093/SRR15390093_2.fastq.gz', 'md5': '43d86c71e1d36d82555038f18e8231c2', 'size': 2144765065}]","[{'url': 's3://sra-pub-src-5/SRR15390093/HOU-1_S1_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR15390093/HOU-1_S1_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15390093/HOU-1_S1_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390093/HOU-1_S1_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390093/SRR15390093.1'}],30035892,3844594176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390094,SRX11692396,SRP331750,SRS9723993,Illumina HiSeq 4000 paired end sequencing; GSM5510235: H2 iPSC + C2 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/094/SRR15390094/SRR15390094_1.fastq.gz', 'md5': '7a5681fa658abb2a78062e3353373b55', 'size': 499495559}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/094/SRR15390094/SRR15390094_2.fastq.gz', 'md5': 'a14f611d239a20f694977ec1a2110af0', 'size': 1933025183}]",[{'url': 's3://sra-pub-src-3/SRR15390094/HOU-1_S1_L009_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-5/SRR15390094/HOU-1_S1_L009_R1_001.fastq.gz.1'}],[],28285510,3620545280,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390095,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/095/SRR15390095/SRR15390095_1.fastq.gz', 'md5': '1cece76f858b2c1c7e98204cb83e3251', 'size': 644294225}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/095/SRR15390095/SRR15390095_2.fastq.gz', 'md5': 'c13b989de0285e30a04ab41d56ae22da', 'size': 2469475247}]","[{'url': 's3://sra-pub-src-8/SRR15390095/HOU-2_S2_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390095/HOU-2_S2_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390095/HOU-2_S2_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390095/HOU-2_S2_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390095/SRR15390095.1'}],34911976,4468732928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390096,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/096/SRR15390096/SRR15390096_1.fastq.gz', 'md5': 'ffbf4c74b746e884d3474e29bab48409', 'size': 647159567}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/096/SRR15390096/SRR15390096_2.fastq.gz', 'md5': 'a9d50d8b88146d2770873994ee882f2f', 'size': 2478984996}]","[{'url': 's3://sra-pub-src-14/SRR15390096/HOU-2_S2_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390096/HOU-2_S2_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390096/SRR15390096'}, {'url': 's3://sra-pub-run-13/SRR15390096/SRR15390096.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15390096/HOU-2_S2_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390096/HOU-2_S2_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR15390096/SRR15390096.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra31/SRR/015029/SRR15390096'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390097,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/097/SRR15390097/SRR15390097_1.fastq.gz', 'md5': '5358c76793f1907b17df47ce9ddea705', 'size': 652884642}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/097/SRR15390097/SRR15390097_2.fastq.gz', 'md5': '687fcadd8d7470ff1e4fdb238c72baf4', 'size': 2488777022}]","[{'url': 's3://sra-pub-src-14/SRR15390097/HOU-2_S2_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390097/HOU-2_S2_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390097/SRR15390097'}, {'url': 's3://sra-pub-run-13/SRR15390097/SRR15390097.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15390097/HOU-2_S2_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390097/HOU-2_S2_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR15390097/SRR15390097.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390097'}],35208117,4506638976,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390098,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/098/SRR15390098/SRR15390098_1.fastq.gz', 'md5': 'dc19c182ab6ff1ebb14e11e413d2b56c', 'size': 657412385}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/098/SRR15390098/SRR15390098_2.fastq.gz', 'md5': '60808ad2434927a66dee0aef0478a606', 'size': 2486371230}]","[{'url': 's3://sra-pub-src-13/SRR15390098/HOU-2_S2_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390098/HOU-2_S2_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390098/HOU-2_S2_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390098/HOU-2_S2_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390098/SRR15390098.1'}],35475193,4540824704,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390099,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/099/SRR15390099/SRR15390099_1.fastq.gz', 'md5': 'e875066d7fcedfbea396aa70dd5f09a1', 'size': 632462667}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/099/SRR15390099/SRR15390099_2.fastq.gz', 'md5': '6e88e245ddc849ed481167db915138d0', 'size': 2384048999}]","[{'url': 's3://sra-pub-src-8/SRR15390099/HOU-2_S2_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390099/HOU-2_S2_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390099/HOU-2_S2_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390099/HOU-2_S2_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390099/SRR15390099.1'}],34472788,4412516864,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390100,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/000/SRR15390100/SRR15390100_1.fastq.gz', 'md5': '2b082669ded0906475262d6f34e95c5e', 'size': 621515383}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/000/SRR15390100/SRR15390100_2.fastq.gz', 'md5': '41d4921c7990d727df141b4086b800e4', 'size': 2349543284}]","[{'url': 's3://sra-pub-src-5/SRR15390100/HOU-2_S2_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR15390100/HOU-2_S2_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390100/SRR15390100'}, {'url': 's3://sra-pub-run-7/SRR15390100/SRR15390100.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15390100/HOU-2_S2_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390100/HOU-2_S2_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR15390100/SRR15390100.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra21/SRR/015029/SRR15390100'}],33617720,4303068160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390101,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/001/SRR15390101/SRR15390101_1.fastq.gz', 'md5': '986712ec58ceb955108214e5c3f63f2f', 'size': 449417258}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/001/SRR15390101/SRR15390101_2.fastq.gz', 'md5': 'f01dc17a3ca016040b0e46720972a76d', 'size': 1683908028}]","[{'url': 's3://sra-pub-src-17/SRR15390101/HOU-2_S2_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390101/HOU-2_S2_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390101/SRR15390101'}, {'url': 's3://sra-pub-run-11/SRR15390101/SRR15390101.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390101/HOU-2_S2_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390101/HOU-2_S2_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390101/SRR15390101.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra9/SRR/015029/SRR15390101'}],23840977,3051645056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390102,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/002/SRR15390102/SRR15390102_1.fastq.gz', 'md5': 'e4b8cd69316164451c702c17573a8c3f', 'size': 476407574}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/002/SRR15390102/SRR15390102_2.fastq.gz', 'md5': 'df8dc5f14a3fdb010b2a58c14264048c', 'size': 1783716213}]","[{'url': 's3://sra-pub-src-4/SRR15390102/HOU-2_S2_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15390102/HOU-2_S2_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR15390102/HOU-2_S2_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR15390102/HOU-2_S2_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390102/SRR15390102.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390103,SRX11692397,SRP331750,SRS9723992,Illumina HiSeq 4000 paired end sequencing; GSM5510236: H2 MSC + C2 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/003/SRR15390103/SRR15390103_1.fastq.gz', 'md5': '8ea06c295bda5e9a4d51499387de9340', 'size': 632324513}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/003/SRR15390103/SRR15390103_2.fastq.gz', 'md5': 'a6902b6c7a67035f30a859af1179bcbc', 'size': 2402530260}]","[{'url': 's3://sra-pub-src-14/SRR15390103/HOU-2_S2_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390103/HOU-2_S2_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390103/SRR15390103'}]","[{'url': 'gs://sra-pub-src-15/SRR15390103/HOU-2_S2_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390103/HOU-2_S2_L009_R2_001.fastq.gz.1'}]",[],34412855,4404845440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390113,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/013/SRR15390113/SRR15390113_1.fastq.gz', 'md5': '62e75234dde20620f0758e1047d7c078', 'size': 536325595}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/013/SRR15390113/SRR15390113_2.fastq.gz', 'md5': '925beb8afe2d0dd9c17cd1a96923b080', 'size': 2128935717}]","[{'url': 's3://sra-pub-src-17/SRR15390113/HOU-9_S7_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390113/HOU-9_S7_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390113/HOU-9_S7_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390113/HOU-9_S7_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390113/SRR15390113.1'}],30192560,3864647680,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390114,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/014/SRR15390114/SRR15390114_1.fastq.gz', 'md5': '54dbb5ad6911c98ca39484abe48721d2', 'size': 543337829}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/014/SRR15390114/SRR15390114_2.fastq.gz', 'md5': 'f578288f8c8d0a01df58c4a2e4b12e87', 'size': 2160382767}]","[{'url': 's3://sra-pub-src-14/SRR15390114/HOU-9_S7_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390114/HOU-9_S7_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR15390114/HOU-9_S7_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390114/HOU-9_S7_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390114/SRR15390114.1'}],30805932,3943159296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390115,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/015/SRR15390115/SRR15390115_1.fastq.gz', 'md5': 'f3ad0fbc861c4e4c04f77afa704ca041', 'size': 547791080}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/015/SRR15390115/SRR15390115_2.fastq.gz', 'md5': '1245cc80fac09cfcfbe2f73d1f74218d', 'size': 2160134811}]","[{'url': 's3://sra-pub-src-18/SRR15390115/HOU-9_S7_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390115/HOU-9_S7_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390115/SRR15390115'}, {'url': 's3://sra-pub-run-3/SRR15390115/SRR15390115.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390115/HOU-9_S7_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390115/HOU-9_S7_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR15390115/SRR15390115.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra71/SRR/015029/SRR15390115'}],30674545,3926341760,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390116,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/016/SRR15390116/SRR15390116_1.fastq.gz', 'md5': '1c73b17953e5aae809e4d2de87baef4e', 'size': 555384986}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/016/SRR15390116/SRR15390116_2.fastq.gz', 'md5': '04db5138b82685c525445c91c4d69bde', 'size': 2179088610}]","[{'url': 's3://sra-pub-src-10/SRR15390116/HOU-9_S7_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15390116/HOU-9_S7_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15390116/HOU-9_S7_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15390116/HOU-9_S7_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390116/SRR15390116.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390117,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/017/SRR15390117/SRR15390117_1.fastq.gz', 'md5': '53668a361d7456716c9a5ab65a5c40a2', 'size': 527061371}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/017/SRR15390117/SRR15390117_2.fastq.gz', 'md5': '0bf98babd613eacd648de62e81999d5c', 'size': 2037545382}]","[{'url': 's3://sra-pub-src-8/SRR15390117/HOU-9_S7_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390117/HOU-9_S7_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390117/SRR15390117'}, {'url': 's3://sra-pub-run-2/SRR15390117/SRR15390117.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390117/HOU-9_S7_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390117/HOU-9_S7_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390117/SRR15390117.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390117'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390118,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/018/SRR15390118/SRR15390118_1.fastq.gz', 'md5': '7909b44574e4677c99282d208e586ee0', 'size': 521082694}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/018/SRR15390118/SRR15390118_2.fastq.gz', 'md5': '96a5283a26e0c4d896afd40abbd17417', 'size': 2026745162}]","[{'url': 's3://sra-pub-src-18/SRR15390118/HOU-9_S7_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390118/HOU-9_S7_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390118/HOU-9_S7_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390118/HOU-9_S7_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390118/SRR15390118.1'}],29220930,3740279040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390119,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/019/SRR15390119/SRR15390119_1.fastq.gz', 'md5': 'f8ba6280e3f293ede0535812000f5b18', 'size': 494101871}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/019/SRR15390119/SRR15390119_2.fastq.gz', 'md5': 'b5a8174b60d782f4b40429dd51eafdb7', 'size': 1931875601}]","[{'url': 's3://sra-pub-src-6/SRR15390119/HOU-9_S7_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR15390119/HOU-9_S7_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR15390119/HOU-9_S7_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR15390119/HOU-9_S7_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390119/SRR15390119.1'}],27088889,3467377792,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390120,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/020/SRR15390120/SRR15390120_1.fastq.gz', 'md5': '4efcbda72cb03a5ee58522cb9588be60', 'size': 481228818}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/020/SRR15390120/SRR15390120_2.fastq.gz', 'md5': '85e279c7310874c2745635c2e1330872', 'size': 1905131550}]","[{'url': 's3://sra-pub-src-15/SRR15390120/HOU-9_S7_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390120/HOU-9_S7_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15390120/HOU-9_S7_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390120/HOU-9_S7_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390120/SRR15390120.1'}],26540998,3397247744,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390121,SRX11692399,SRP331750,SRS9723995,Illumina HiSeq 4000 paired end sequencing; GSM5510238: H3 iPSC + C3 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/021/SRR15390121/SRR15390121_1.fastq.gz', 'md5': 'dce7b19540365b2baf32fcfd2816c5e5', 'size': 526754648}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/021/SRR15390121/SRR15390121_2.fastq.gz', 'md5': '609e9492240a29538ab9ef7bcebf3b37', 'size': 2059558005}]",[{'url': 's3://sra-pub-src-6/SRR15390121/HOU-9_S7_L009_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-8/SRR15390121/HOU-9_S7_L009_R1_001.fastq.gz.1'}],[],29729822,3805417216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390140,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/040/SRR15390140/SRR15390140_1.fastq.gz', 'md5': '054147470fa73120fd2c6d871d2448cd', 'size': 536485078}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/040/SRR15390140/SRR15390140_2.fastq.gz', 'md5': '31fefee1fa6a5db822a7d76fecff0dc8', 'size': 2082180757}]","[{'url': 's3://sra-pub-src-3/SRR15390140/HOU-5_S4_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390140/HOU-5_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390140/SRR15390140'}, {'url': 's3://sra-pub-run-5/SRR15390140/SRR15390140.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390140/HOU-5_S4_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390140/HOU-5_S4_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-9/SRR15390140/SRR15390140.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390140'}],30015681,3842007168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR1539014,SRX671981,SRP045337,SRS676481,Illumina MiSeq paired end sequencing; sequence of tumor sample 5569-2,,2015-03-28,2015-06-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/004/SRR1539014/SRR1539014_1.fastq.gz', 'md5': '6d89de1adf84c3de450a3aad99a996ac', 'size': 36525869}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/004/SRR1539014/SRR1539014_2.fastq.gz', 'md5': '7e99c94f8cee22fb8df98ab4c1986dc8', 'size': 38692394}]","[{'url': 's3://sra-pub-src-8/SRR1539014/5569-2_S15_L001_R1_001.fastq.gz'}, {'url': 's3://sra-pub-src-12/SRR1539014/5569-2_S15_L001_R2_001.fastq.gz'}]","[{'url': 'gs://sra-pub-src-8/SRR1539014/5569-2_S15_L001_R1_001.fastq.gz'}, {'url': 'gs://sra-pub-src-12/SRR1539014/5569-2_S15_L001_R2_001.fastq.gz'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos1/sra-pub-run-5/SRR1539014/SRR1539014.1'}],212357,106603214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390142,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/042/SRR15390142/SRR15390142_1.fastq.gz', 'md5': 'bed59232dce5683326d5f35b4df92993', 'size': 541950472}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/042/SRR15390142/SRR15390142_2.fastq.gz', 'md5': '5d373ac56b439e4123158026048b54a3', 'size': 2090192857}]","[{'url': 's3://sra-pub-src-10/SRR15390142/HOU-5_S4_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15390142/HOU-5_S4_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390142/SRR15390142'}, {'url': 's3://sra-pub-run-9/SRR15390142/SRR15390142.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15390142/HOU-5_S4_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15390142/HOU-5_S4_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR15390142/SRR15390142.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra77/SRR/015029/SRR15390142'}],30160903,3860595584,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390143,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/043/SRR15390143/SRR15390143_1.fastq.gz', 'md5': '959105f56ea4dcdda67a2aea5fcfb855', 'size': 542699134}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/043/SRR15390143/SRR15390143_2.fastq.gz', 'md5': '712b9c69bad9a0b9029d7a0328c91967', 'size': 2081654178}]","[{'url': 's3://sra-pub-src-11/SRR15390143/HOU-5_S4_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR15390143/HOU-5_S4_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR15390143/HOU-5_S4_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR15390143/HOU-5_S4_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390143/SRR15390143.1'}],30312776,3880035328,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390144,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-24,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/044/SRR15390144/SRR15390144_1.fastq.gz', 'md5': 'fdaf1bb04744659f1cbbb5231067f506', 'size': 528428425}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/044/SRR15390144/SRR15390144_2.fastq.gz', 'md5': '4feb27a740914305622fe6b4be814264', 'size': 1986423862}]","[{'url': 's3://sra-pub-src-9/SRR15390144/HOU-5_S4_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390144/HOU-5_S4_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390144/HOU-5_S4_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390144/HOU-5_S4_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390144/SRR15390144.1'}],29575104,3785613312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390145,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/045/SRR15390145/SRR15390145_1.fastq.gz', 'md5': 'c29b9511214d0c9ce8fa5df7eb2815db', 'size': 517138853}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/045/SRR15390145/SRR15390145_2.fastq.gz', 'md5': 'fe3b0702e74d5e989a38cf09e884d891', 'size': 1960309560}]","[{'url': 's3://sra-pub-src-9/SRR15390145/HOU-5_S4_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390145/HOU-5_S4_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390145/SRR15390145'}, {'url': 's3://sra-pub-run-6/SRR15390145/SRR15390145.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390145/HOU-5_S4_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390145/HOU-5_S4_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR15390145/SRR15390145.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390145'}],28819701,3688921728,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390146,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/046/SRR15390146/SRR15390146_1.fastq.gz', 'md5': 'ec9e29f178016682f80cd261e7ce2ed9', 'size': 531724511}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/046/SRR15390146/SRR15390146_2.fastq.gz', 'md5': '8bb40f04a89af1f8d9f910124d1fef44', 'size': 2047410464}]","[{'url': 's3://sra-pub-src-12/SRR15390146/HOU-5_S4_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390146/HOU-5_S4_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390146/HOU-5_S4_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390146/HOU-5_S4_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390146/SRR15390146.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390147,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/047/SRR15390147/SRR15390147_1.fastq.gz', 'md5': '76cb479d8a9eaa3de58e78e113c54da9', 'size': 519232255}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/047/SRR15390147/SRR15390147_2.fastq.gz', 'md5': 'f6c2422241daa876561f16a2109a474b', 'size': 2023774042}]","[{'url': 's3://sra-pub-src-16/SRR15390147/HOU-5_S4_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390147/HOU-5_S4_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390147/HOU-5_S4_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390147/HOU-5_S4_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390147/SRR15390147.1'}],28341072,3627657216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390148,SRX11692402,SRP331750,SRS9723998,Illumina HiSeq 4000 paired end sequencing; GSM5510241: H4 iPSC + C4 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/048/SRR15390148/SRR15390148_1.fastq.gz', 'md5': '059276d1d4a9358576713098d9987b7b', 'size': 526350544}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/048/SRR15390148/SRR15390148_2.fastq.gz', 'md5': 'cc967337f8bbe416c49f83f4cea1b934', 'size': 2005069730}]","[{'url': 's3://sra-pub-src-14/SRR15390148/HOU-5_S4_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390148/HOU-5_S4_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390148/SRR15390148'}]","[{'url': 'gs://sra-pub-src-15/SRR15390148/HOU-5_S4_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390148/HOU-5_S4_L009_R2_001.fastq.gz.1'}]",[],29499430,3775927040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390167,SRX11692405,SRP331750,SRS9724001,Illumina HiSeq 4000 paired end sequencing; GSM5510244: H5 iPSC + C5 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/067/SRR15390167/SRR15390167_1.fastq.gz', 'md5': 'ed658929b0ee7bcd629db0269520bbcd', 'size': 1184299489}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/067/SRR15390167/SRR15390167_2.fastq.gz', 'md5': 'e3d92c12182ed49b1ba97a7ebeaf58d3', 'size': 4586059386}]","[{'url': 's3://sra-pub-src-5/SRR15390167/HOU-17_S1_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR15390167/HOU-17_S1_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15390167/HOU-17_S1_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15390167/HOU-17_S1_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390167/SRR15390167.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390169,SRX11692405,SRP331750,SRS9724001,Illumina HiSeq 4000 paired end sequencing; GSM5510244: H5 iPSC + C5 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/069/SRR15390169/SRR15390169_1.fastq.gz', 'md5': '5ec47c214405e31284a925282941c3e4', 'size': 1201233876}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/069/SRR15390169/SRR15390169_2.fastq.gz', 'md5': '2d28edb19be811c8efc69990f0325a29', 'size': 4510930348}]","[{'url': 's3://sra-pub-src-17/SRR15390169/HOU-17_S1_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390169/HOU-17_S1_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390169/SRR15390169'}, {'url': 's3://sra-pub-run-11/SRR15390169/SRR15390169.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390169/HOU-17_S1_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390169/HOU-17_S1_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390169/SRR15390169.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra40/SRR/015029/SRR15390169'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390170,SRX11692405,SRP331750,SRS9724001,Illumina HiSeq 4000 paired end sequencing; GSM5510244: H5 iPSC + C5 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/070/SRR15390170/SRR15390170_1.fastq.gz', 'md5': 'f545b96c0013d6afc540d4cf9527a87b', 'size': 1138651438}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/070/SRR15390170/SRR15390170_2.fastq.gz', 'md5': '98fddbb868cccf50a3c7e3c99bad7d25', 'size': 4305967155}]",[{'url': 's3://sra-pub-src-12/SRR15390170/HOU-17_S1_L008_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-14/SRR15390170/HOU-17_S1_L008_R1_001.fastq.gz.1'}],[],63852372,8173103616,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390171,SRX11692406,SRP331750,SRS9724002,Illumina HiSeq 4000 paired end sequencing; GSM5510245: H5 MSC + C5 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/071/SRR15390171/SRR15390171_1.fastq.gz', 'md5': 'fd03a854ea7ba03c5212831c5f87ffe6', 'size': 1046551909}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/071/SRR15390171/SRR15390171_2.fastq.gz', 'md5': 'f24776fe385bada66044bcfd4a81cd05', 'size': 3998700053}]","[{'url': 's3://sra-pub-src-9/SRR15390171/HOU-19_S3_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390171/HOU-19_S3_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390171/HOU-19_S3_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390171/HOU-19_S3_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390171/SRR15390171.1'}],58106790,7437669120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390179,SRX11692408,SRP331750,SRS9724004,Illumina HiSeq 4000 paired end sequencing; GSM5510247: H6 iPSC + C6 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/079/SRR15390179/SRR15390179_1.fastq.gz', 'md5': 'a2fe5af1229c7d46e3b63a514654ac67', 'size': 1133899445}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/079/SRR15390179/SRR15390179_2.fastq.gz', 'md5': '36ed48c40f0c531189afae78e9375227', 'size': 4333280736}]","[{'url': 's3://sra-pub-src-17/SRR15390179/HOU-18_S2_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390179/HOU-18_S2_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390179/SRR15390179'}, {'url': 's3://sra-pub-run-11/SRR15390179/SRR15390179.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390179/HOU-18_S2_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390179/HOU-18_S2_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390179/SRR15390179.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390179'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390180,SRX11692408,SRP331750,SRS9724004,Illumina HiSeq 4000 paired end sequencing; GSM5510247: H6 iPSC + C6 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/080/SRR15390180/SRR15390180_1.fastq.gz', 'md5': 'be46baf207e61d572d71e10957df3cbd', 'size': 871890943}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/080/SRR15390180/SRR15390180_2.fastq.gz', 'md5': 'd43e8f1b0c298bc42a44ae74a1bf1deb', 'size': 3402127606}]","[{'url': 's3://sra-pub-src-16/SRR15390180/HOU-18_S2_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390180/HOU-18_S2_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390180/SRR15390180'}, {'url': 's3://sra-pub-run-13/SRR15390180/SRR15390180.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390180/HOU-18_S2_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390180/HOU-18_S2_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR15390180/SRR15390180.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra33/SRR/015029/SRR15390180'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390181,SRX11692408,SRP331750,SRS9724004,Illumina HiSeq 4000 paired end sequencing; GSM5510247: H6 iPSC + C6 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/081/SRR15390181/SRR15390181_1.fastq.gz', 'md5': '7ef7610823a68b2a492f7b8884be7404', 'size': 1088772889}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/081/SRR15390181/SRR15390181_2.fastq.gz', 'md5': '678887e36e0189ad74f6f663a8a8b66d', 'size': 4041340709}]","[{'url': 's3://sra-pub-src-3/SRR15390181/HOU-18_S2_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390181/HOU-18_S2_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390181/HOU-18_S2_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390181/HOU-18_S2_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390181/SRR15390181.1'}],60389647,7729874816,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390182,SRX11692408,SRP331750,SRS9724004,Illumina HiSeq 4000 paired end sequencing; GSM5510247: H6 iPSC + C6 iPSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/082/SRR15390182/SRR15390182_1.fastq.gz', 'md5': '866fb99a5f380d68a7794c1729d12fd1', 'size': 1098630792}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/082/SRR15390182/SRR15390182_2.fastq.gz', 'md5': '566f0acfe12107cd7255e3bd6f614b7d', 'size': 4104124825}]","[{'url': 's3://sra-pub-src-14/SRR15390182/HOU-18_S2_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390182/HOU-18_S2_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390182/SRR15390182'}]","[{'url': 'gs://sra-pub-src-15/SRR15390182/HOU-18_S2_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390182/HOU-18_S2_L008_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16522488,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5643793: MEF; Mus musculus; RNA-Seq,,,,,,,,,,SRX12725233,Illumina NovaSeq 6000 paired end sequencing; GSM5643793: MEF; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP310960,Integrative molecular roadmap for reprogramming mouse fibroblasts into induced myogenic stem and progenitor cells [single-cell RNA-seq],"Direct lineage reprogramming provides a unique system to study cell fate transitions and unearth molecular mechanisms that safeguard cellular identity. We previously reported on direct conversion of mouse fibroblasts into induced myogenic progenitor cells (iMPCs) by means of transient MyoD overexpression in concert with small molecules treatment. Here we employed integrative multi-omic assays to delineate the molecular landscape of fibroblast reprogramming into iMPCs in comparison to transdifferentiation into myogenic cells solely by MyoD overexpression. Utilizing bulk RNA-sequencing and mass spectrometry we characterized molecular regulators and pathways that endow a myogenic stem cell identity on fibroblasts only in the presence of small molecule treatment. We further demonstrate that iMPC reprogramming is a stepwise process, commencing with the appearance of myofibers and committed myogenic progenitors prior to the formation of satellite cell-like myogenic progenitors that express a suite of stem cell markers including Pax7, Dek, Myf5, Sox8, and Dmrt2. To directly compare iMPCs to satellite cell-derived primary myoblasts, we employed a fluorescent Pax7-GFP reporter to purify Pax7+ cells from the heterogenous iMPC cultures and assess their equivalency to FACS-purified Pax7-GFP+ myoblasts. We demonstrate that Pax7+ iMPCs share molecular attributes with myoblasts, however also express genes and signaling pathways that are indicative of activated satellite cells including Carm1, Dlk1, Lgr5, Fos, Dek, Calcr and Pitx3. We further establish that iMPC formation and maintenance is dependent on the Notch pathway, as small molecule inhibition of Notch abrogates iMPC formation and derails stable iMPC cultures via depletion of Pax7 expressing cells. Lastly, using single cell RNA-sequencing we determine the cell populations that comprise iMPCs in addition to reconstructing the differentiation trajectory present in these heterogenous cultures. We demonstrate that a highly proliferative activated satellite cell-like population differentiates into committed myoblasts and myocytes that further give rise to myofibers that express mature muscle markers, thus capturing a dynamic differentiation program in vitro. Collectively, this study charts a molecular blueprint for reprogramming fibroblasts into myogenic stem and progenitor cells and further establishes the fidelity of stable iMPC cultures in capturing skeletal muscle regeneration in vitro for disease modeling and basic research applications. Overall design: Identification of cell types in iMPCs and examination of myogenic differentiation trajectories present in a stable iMPC clone",SRS10674270,MEF,Mus musculus,Mouse Embryonic Fibroblasts,cultured in MEF media,,,,2022-01-08,2022-01-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR165/088/SRR16522488/SRR16522488.fastq.gz', 'md5': '93c18c7774cdc786a68019b5e4d63b2f', 'size': '11577825703'}]",,,,,,Fibroblasts,Tg:Pax7-nGFP/C57BL6;DBA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16522489,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5643793: MEF; Mus musculus; RNA-Seq,,,,,,,,,,SRX12725233,Illumina NovaSeq 6000 paired end sequencing; GSM5643793: MEF; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP310960,Integrative molecular roadmap for reprogramming mouse fibroblasts into induced myogenic stem and progenitor cells [single-cell RNA-seq],"Direct lineage reprogramming provides a unique system to study cell fate transitions and unearth molecular mechanisms that safeguard cellular identity. We previously reported on direct conversion of mouse fibroblasts into induced myogenic progenitor cells (iMPCs) by means of transient MyoD overexpression in concert with small molecules treatment. Here we employed integrative multi-omic assays to delineate the molecular landscape of fibroblast reprogramming into iMPCs in comparison to transdifferentiation into myogenic cells solely by MyoD overexpression. Utilizing bulk RNA-sequencing and mass spectrometry we characterized molecular regulators and pathways that endow a myogenic stem cell identity on fibroblasts only in the presence of small molecule treatment. We further demonstrate that iMPC reprogramming is a stepwise process, commencing with the appearance of myofibers and committed myogenic progenitors prior to the formation of satellite cell-like myogenic progenitors that express a suite of stem cell markers including Pax7, Dek, Myf5, Sox8, and Dmrt2. To directly compare iMPCs to satellite cell-derived primary myoblasts, we employed a fluorescent Pax7-GFP reporter to purify Pax7+ cells from the heterogenous iMPC cultures and assess their equivalency to FACS-purified Pax7-GFP+ myoblasts. We demonstrate that Pax7+ iMPCs share molecular attributes with myoblasts, however also express genes and signaling pathways that are indicative of activated satellite cells including Carm1, Dlk1, Lgr5, Fos, Dek, Calcr and Pitx3. We further establish that iMPC formation and maintenance is dependent on the Notch pathway, as small molecule inhibition of Notch abrogates iMPC formation and derails stable iMPC cultures via depletion of Pax7 expressing cells. Lastly, using single cell RNA-sequencing we determine the cell populations that comprise iMPCs in addition to reconstructing the differentiation trajectory present in these heterogenous cultures. We demonstrate that a highly proliferative activated satellite cell-like population differentiates into committed myoblasts and myocytes that further give rise to myofibers that express mature muscle markers, thus capturing a dynamic differentiation program in vitro. Collectively, this study charts a molecular blueprint for reprogramming fibroblasts into myogenic stem and progenitor cells and further establishes the fidelity of stable iMPC cultures in capturing skeletal muscle regeneration in vitro for disease modeling and basic research applications. Overall design: Identification of cell types in iMPCs and examination of myogenic differentiation trajectories present in a stable iMPC clone",SRS10674270,MEF,Mus musculus,Mouse Embryonic Fibroblasts,cultured in MEF media,,,,2022-01-08,2022-01-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR165/089/SRR16522489/SRR16522489.fastq.gz', 'md5': 'b15d9d8f7e8e5ce9915ad9fd37599707', 'size': '11431271389'}]",,,,,,Fibroblasts,Tg:Pax7-nGFP/C57BL6;DBA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741046,SRX10128168,SRP237632,SRS8282576,NextSeq 500 paired end sequencing; GSM5091920: Embryonic chondroprogenitor; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/046/SRR13741046/SRR13741046.fastq.gz', 'md5': '5b357e8898c82c61f1803c7d6b92624f', 'size': 14987199157}]","[{'url': 's3://sra-pub-src-9/SRR13741046/Embryonic_chondroprogenitor_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR13741046/Embryonic_chondroprogenitor_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR13741046/Embryonic_chondroprogenitor_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR13741046/Embryonic_chondroprogenitor_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR13741046/Embryonic_chondroprogenitor_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR13741046/Embryonic_chondroprogenitor_L001_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR13741046/SRR13741046.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741046/SRR13741046.1'}],315004266,28665388206,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Embryonic_chondroprogenitor_L001_I1.fastq.gz --read2PairFiles=Embryonic_chondroprogenitor_L001_R1.fastq.gz --read3PairFiles=Embryonic_chondroprogenitor_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741047,SRX10128168,SRP237632,SRS8282576,NextSeq 500 paired end sequencing; GSM5091920: Embryonic chondroprogenitor; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/047/SRR13741047/SRR13741047.fastq.gz', 'md5': 'f5bd1956cddec5123775686e2caf3999', 'size': 14997050572}]","[{'url': 's3://sra-pub-src-18/SRR13741047/Embryonic_chondroprogenitor_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13741047/Embryonic_chondroprogenitor_L002_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR13741047/Embryonic_chondroprogenitor_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13741047/Embryonic_chondroprogenitor_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741047/Embryonic_chondroprogenitor_L002_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741047/SRR13741047.1'}],316151100,28769750100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Embryonic_chondroprogenitor_L002_I1.fastq.gz --read2PairFiles=Embryonic_chondroprogenitor_L002_R1.fastq.gz --read3PairFiles=Embryonic_chondroprogenitor_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741048,SRX10128169,SRP237632,SRS8282577,NextSeq 500 paired end sequencing; GSM5091921: Fetal chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/048/SRR13741048/SRR13741048.fastq.gz', 'md5': '88d8fcc39678c5ce33854ebffb0579eb', 'size': 2437979711}]","[{'url': 's3://sra-pub-src-15/SRR13741048/Fetal_chondrocytes_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741048/Fetal_chondrocytes_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741048/Fetal_chondrocytes_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR13741048/Fetal_chondrocytes_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13741048/Fetal_chondrocytes_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13741048/Fetal_chondrocytes_L001_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741048/SRR13741048.1'}],66163405,3837477490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Fetal_chondrocytes_L001_I1.fastq.gz --read2PairFiles=Fetal_chondrocytes_L001_R1.fastq.gz --read3PairFiles=Fetal_chondrocytes_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741049,SRX10128169,SRP237632,SRS8282577,NextSeq 500 paired end sequencing; GSM5091921: Fetal chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/049/SRR13741049/SRR13741049.fastq.gz', 'md5': '42bf7877011f61355843a9c4aae356d0', 'size': 2415680234}]","[{'url': 's3://sra-pub-src-12/SRR13741049/Fetal_chondrocytes_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR13741049/Fetal_chondrocytes_L002_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR13741049/Fetal_chondrocytes_L002_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR13741049/Fetal_chondrocytes_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR13741049/Fetal_chondrocytes_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR13741049/Fetal_chondrocytes_L002_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR13741049/SRR13741049.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741049/SRR13741049.1'}],65619242,3805916036,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Fetal_chondrocytes_L002_I1.fastq.gz --read2PairFiles=Fetal_chondrocytes_L002_R1.fastq.gz --read3PairFiles=Fetal_chondrocytes_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741050,SRX10128169,SRP237632,SRS8282577,NextSeq 500 paired end sequencing; GSM5091921: Fetal chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/050/SRR13741050/SRR13741050.fastq.gz', 'md5': '89d8832042dfe0e609fdfefcbf15438a', 'size': 2442258445}]","[{'url': 's3://sra-pub-src-15/SRR13741050/Fetal_chondrocytes_L003_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741050/Fetal_chondrocytes_L003_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741050/Fetal_chondrocytes_L003_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR13741050/Fetal_chondrocytes_L003_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13741050/Fetal_chondrocytes_L003_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13741050/Fetal_chondrocytes_L003_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR13741050/SRR13741050.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741050/SRR13741050.1'}],66204666,3839870628,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Fetal_chondrocytes_L003_I1.fastq.gz --read2PairFiles=Fetal_chondrocytes_L003_R1.fastq.gz --read3PairFiles=Fetal_chondrocytes_L003_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741051,SRX10128169,SRP237632,SRS8282577,NextSeq 500 paired end sequencing; GSM5091921: Fetal chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/051/SRR13741051/SRR13741051.fastq.gz', 'md5': 'bc592a3e231e01cea6193081c815aa09', 'size': 2447255011}]","[{'url': 's3://sra-pub-src-15/SRR13741051/Fetal_chondrocytes_L004_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741051/Fetal_chondrocytes_L004_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741051/Fetal_chondrocytes_L004_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741051/Fetal_chondrocytes_L004_R1.fastq.gz.1'}]",[],66228880,3841275040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Fetal_chondrocytes_L004_I1.fastq.gz --read2PairFiles=Fetal_chondrocytes_L004_R1.fastq.gz --read3PairFiles=Fetal_chondrocytes_L004_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741052,SRX10128170,SRP237632,SRS8282578,NextSeq 500 paired end sequencing; GSM5091922: Juvenile chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/052/SRR13741052/SRR13741052.fastq.gz', 'md5': '5dbecb196324531ecab81bc525ae2661', 'size': 1970561422}]","[{'url': 's3://sra-pub-src-4/SRR13741052/Juvenile_chondrocytes_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741052/Juvenile_chondrocytes_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741052/Juvenile_chondrocytes_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-4/SRR13741052/Juvenile_chondrocytes_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741052/Juvenile_chondrocytes_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741052/Juvenile_chondrocytes_L001_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741052/SRR13741052.1'}],52863891,3066105678,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Juvenile_chondrocytes_L001_I1.fastq.gz --read2PairFiles=Juvenile_chondrocytes_L001_R1.fastq.gz --read3PairFiles=Juvenile_chondrocytes_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741053,SRX10128170,SRP237632,SRS8282578,NextSeq 500 paired end sequencing; GSM5091922: Juvenile chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/053/SRR13741053/SRR13741053.fastq.gz', 'md5': '2d109b5f458962935b4b351ad60fa4ac', 'size': 1951429783}]","[{'url': 's3://sra-pub-src-5/SRR13741053/Juvenile_chondrocytes_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR13741053/Juvenile_chondrocytes_L002_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR13741053/Juvenile_chondrocytes_L002_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR13741053/Juvenile_chondrocytes_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR13741053/Juvenile_chondrocytes_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR13741053/Juvenile_chondrocytes_L002_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741053/SRR13741053.1'}],52392715,3038777470,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Juvenile_chondrocytes_L002_I1.fastq.gz --read2PairFiles=Juvenile_chondrocytes_L002_R1.fastq.gz --read3PairFiles=Juvenile_chondrocytes_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741054,SRX10128170,SRP237632,SRS8282578,NextSeq 500 paired end sequencing; GSM5091922: Juvenile chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/054/SRR13741054/SRR13741054.fastq.gz', 'md5': '86c49e6316178a9b241385f8940aa4be', 'size': 1973813532}]","[{'url': 's3://sra-pub-src-16/SRR13741054/Juvenile_chondrocytes_L003_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741054/Juvenile_chondrocytes_L003_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741054/Juvenile_chondrocytes_L003_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13741054/Juvenile_chondrocytes_L003_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741054/Juvenile_chondrocytes_L003_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741054/Juvenile_chondrocytes_L003_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741054/SRR13741054.1'}],52884864,3067322112,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Juvenile_chondrocytes_L003_I1.fastq.gz --read2PairFiles=Juvenile_chondrocytes_L003_R1.fastq.gz --read3PairFiles=Juvenile_chondrocytes_L003_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741055,SRX10128170,SRP237632,SRS8282578,NextSeq 500 paired end sequencing; GSM5091922: Juvenile chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/055/SRR13741055/SRR13741055.fastq.gz', 'md5': '4b2ab498fb0b8d4f7b4f38ef518dda0c', 'size': 1976763888}]","[{'url': 's3://sra-pub-src-18/SRR13741055/Juvenile_chondrocytes_L004_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13741055/Juvenile_chondrocytes_L004_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR13741055/Juvenile_chondrocytes_L004_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13741055/Juvenile_chondrocytes_L004_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13741055/Juvenile_chondrocytes_L004_R2.fastq.gz.1'}]",[],52877046,3066868668,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Juvenile_chondrocytes_L004_I1.fastq.gz --read2PairFiles=Juvenile_chondrocytes_L004_R1.fastq.gz --read3PairFiles=Juvenile_chondrocytes_L004_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741056,SRX10128171,SRP237632,SRS8282579,NextSeq 500 paired end sequencing; GSM5091923: Adult chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/056/SRR13741056/SRR13741056.fastq.gz', 'md5': '1c3409862740c08de1e3adb20e8b1f94', 'size': 3977488196}]","[{'url': 's3://sra-pub-src-18/SRR13741056/Adult_chondrocytes_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13741056/Adult_chondrocytes_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13741056/Adult_chondrocytes_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741056/Adult_chondrocytes_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741056/Adult_chondrocytes_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741056/Adult_chondrocytes_L001_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13741056/SRR13741056.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741056/SRR13741056.1'}],106091164,6153287512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Adult_chondrocytes_L001_I1.fastq.gz --read2PairFiles=Adult_chondrocytes_L001_R1.fastq.gz --read3PairFiles=Adult_chondrocytes_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741057,SRX10128171,SRP237632,SRS8282579,NextSeq 500 paired end sequencing; GSM5091923: Adult chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/057/SRR13741057/SRR13741057.fastq.gz', 'md5': 'ee060d7c7b09fe8900af199fee255584', 'size': 4017267298}]","[{'url': 's3://sra-pub-src-7/SRR13741057/Adult_chondrocytes_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR13741057/Adult_chondrocytes_L002_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR13741057/Adult_chondrocytes_L002_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR13741057/Adult_chondrocytes_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR13741057/Adult_chondrocytes_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR13741057/Adult_chondrocytes_L002_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR13741057/SRR13741057.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741057/SRR13741057.1'}],107168698,6215784484,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Adult_chondrocytes_L002_I1.fastq.gz --read2PairFiles=Adult_chondrocytes_L002_R1.fastq.gz --read3PairFiles=Adult_chondrocytes_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741058,SRX10128171,SRP237632,SRS8282579,NextSeq 500 paired end sequencing; GSM5091923: Adult chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/058/SRR13741058/SRR13741058.fastq.gz', 'md5': '58ba3b9c0db74e8f92486d5a34bfe7a1', 'size': 4017634504}]","[{'url': 's3://sra-pub-src-17/SRR13741058/Adult_chondrocytes_L003_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13741058/Adult_chondrocytes_L003_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13741058/Adult_chondrocytes_L003_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR13741058/Adult_chondrocytes_L003_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR13741058/Adult_chondrocytes_L003_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR13741058/Adult_chondrocytes_L003_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR13741058/SRR13741058.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741058/SRR13741058.1'}],106866068,6198231944,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Adult_chondrocytes_L003_I1.fastq.gz --read2PairFiles=Adult_chondrocytes_L003_R1.fastq.gz --read3PairFiles=Adult_chondrocytes_L003_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741059,SRX10128171,SRP237632,SRS8282579,NextSeq 500 paired end sequencing; GSM5091923: Adult chondrocytes; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/059/SRR13741059/SRR13741059.fastq.gz', 'md5': '01cc1dde8993014787c0556d2b480e00', 'size': 3974468539}]","[{'url': 's3://sra-pub-src-17/SRR13741059/Adult_chondrocytes_L004_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13741059/Adult_chondrocytes_L004_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR13741059/Adult_chondrocytes_L004_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR13741059/Adult_chondrocytes_L004_R1.fastq.gz.1'}]",[],106073899,6152286142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=Adult_chondrocytes_L004_I1.fastq.gz --read2PairFiles=Adult_chondrocytes_L004_R1.fastq.gz --read3PairFiles=Adult_chondrocytes_L004_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13600604,SRX9995016,SRP304118,SRS8166493,"Illumina HiSeq 4000 paired end sequencing; GSM5051909: Single Cell GEM well 1 (NA19160, NA18855, NA18856); Homo sapiens; RNA-Seq",fastq-load.py,2022-02-16,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/004/SRR13600604/SRR13600604.fastq.gz', 'md5': '527e809162fe89e2bed36a33c5e74550', 'size': 13901199135}]","[{'url': 's3://sra-pub-src-15/SRR13600604/YG-AH-2S-ANT-1_S1_L008_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13600604/YG-AH-2S-ANT-1_S1_L008_R1_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13600604/YG-AH-2S-ANT-1_S1_L008_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13600604/YG-AH-2S-ANT-1_S1_L008_R1_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13600/SRR13600604/SRR13600604.1'}],192546655,19254665500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=YG-AH-2S-ANT-1_S1_L008_I1_001.fastq.gz --read2PairFiles=YG-AH-2S-ANT-1_S1_L008_R1_001.fastq.gz --read3PairFiles=YG-AH-2S-ANT-1_S1_L008_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13600605,SRX9995017,SRP304118,SRS8166492,"Illumina HiSeq 4000 paired end sequencing; GSM5051910: Single Cell GEM well 2 (NA19160, NA18855); Homo sapiens; RNA-Seq",fastq-load.py,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/005/SRR13600605/SRR13600605.fastq.gz', 'md5': '8029d970065fddce3fc05016dd9e5068', 'size': 13181490644}]","[{'url': 's3://sra-pub-src-17/SRR13600605/YG-AH-2S-ANT-2_S2_L008_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13600605/YG-AH-2S-ANT-2_S2_L008_R1_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR13600605/YG-AH-2S-ANT-2_S2_L008_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13600605/YG-AH-2S-ANT-2_S2_L008_R1_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13600/SRR13600605/SRR13600605.1'}],180694884,18069488400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=YG-AH-2S-ANT-2_S2_L008_I1_001.fastq.gz --read2PairFiles=YG-AH-2S-ANT-2_S2_L008_R1_001.fastq.gz --read3PairFiles=YG-AH-2S-ANT-2_S2_L008_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923950,SRX11237256,SRP325759,SRS9283130,NextSeq 550 paired end sequencing; GSM5402428: scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/050/SRR14923950/SRR14923950_1.fastq.gz', 'md5': '4211edfad82eb623bc0a20266a33d41d', 'size': 1624571108}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/050/SRR14923950/SRR14923950_2.fastq.gz', 'md5': '646dfc36c325a7a96fbc6bab1427186b', 'size': 5972790145}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923950/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923950/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923950/SRR14923950'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923950/SRR14923950'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923950/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923950/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923950/SRR14923950'}, {'url': 'gs://sra-pub-run-2/SRR14923950/SRR14923950.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra55/SRR/014574/SRR14923950'}],85909948,12664163429,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923951,SRX11237256,SRP325759,SRS9283130,NextSeq 550 paired end sequencing; GSM5402428: scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/051/SRR14923951/SRR14923951_1.fastq.gz', 'md5': '4701ffc141d8d4244c8d3f10e30c3f63', 'size': 1873380707}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/051/SRR14923951/SRR14923951_2.fastq.gz', 'md5': '68808299b3c5c1f4dfb9b744869a7f91', 'size': 6904288589}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923951/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923951/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923951/SRR14923951'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923951/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923951/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923951/SRR14923951'}, {'url': 'gs://sra-pub-run-13/SRR14923951/SRR14923951.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra62/SRR/014574/SRR14923951'}],99034572,14599490166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923952,SRX11237256,SRP325759,SRS9283130,NextSeq 550 paired end sequencing; GSM5402428: scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/052/SRR14923952/SRR14923952_1.fastq.gz', 'md5': 'dc131e8c2f6f85bacea12627e905a1b8', 'size': 1638894769}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/052/SRR14923952/SRR14923952_2.fastq.gz', 'md5': 'ca8ff72f9e102c5d0f56679d601b8df2', 'size': 6014266591}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923952/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923952/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923952/SRR14923952'}, {'url': 's3://sra-pub-run-8/SRR14923952/SRR14923952.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923952/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923952/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923952/SRR14923952'}, {'url': 'gs://sra-pub-run-13/SRR14923952/SRR14923952.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra10/SRR/014574/SRR14923952'}],87140553,12846018715,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923953,SRX11237256,SRP325759,SRS9283130,NextSeq 550 paired end sequencing; GSM5402428: scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/053/SRR14923953/SRR14923953_1.fastq.gz', 'md5': '262894ab73ac7d7e4f8bd6c223f4bc9c', 'size': 1035899886}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/053/SRR14923953/SRR14923953_2.fastq.gz', 'md5': '86de3ac4f9ab00b28d35abd8b4bee07f', 'size': 3799385672}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923953/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923953/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923953/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923953/scRNAseq_Sox10_Cre_bact_BtR_1.5dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}]",[],55005025,8108614905,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923954,SRX11237257,SRP325759,SRS9283132,NextSeq 550 paired end sequencing; GSM5402429: scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/054/SRR14923954/SRR14923954_1.fastq.gz', 'md5': '7100669b5bb9188c9de5268a9c8e6950', 'size': 1273141227}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/054/SRR14923954/SRR14923954_2.fastq.gz', 'md5': '179b50994e5dc38b3acd27cbd00606e3', 'size': 4154434553}]","[{'url': 's3://sra-pub-src-13/SRR14923954/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14923954/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923954/SRR14923954'}, {'url': 's3://sra-pub-run-13/SRR14923954/SRR14923954.1'}]","[{'url': 'gs://sra-pub-src-8/SRR14923954/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14923954/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S5_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR14923954/SRR14923954.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra35/SRR/014574/SRR14923954'}],67691516,8491189961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923955,SRX11237257,SRP325759,SRS9283132,NextSeq 550 paired end sequencing; GSM5402429: scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/055/SRR14923955/SRR14923955_1.fastq.gz', 'md5': '8937ae03a3d83d5222d7a2fc4437aed3', 'size': 1061089417}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/055/SRR14923955/SRR14923955_2.fastq.gz', 'md5': 'fcbaa738d57525541ad101dcd7c08ce3', 'size': 3462100799}]","[{'url': 's3://sra-pub-src-11/SRR14923955/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S6_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14923955/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923955/SRR14923955'}, {'url': 's3://sra-pub-run-7/SRR14923955/SRR14923955.1'}]","[{'url': 'gs://sra-pub-src-18/SRR14923955/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S6_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14923955/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S6_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR14923955/SRR14923955.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra76/SRR/014574/SRR14923955'}],56420723,7077449567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923956,SRX11237257,SRP325759,SRS9283132,NextSeq 550 paired end sequencing; GSM5402429: scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/056/SRR14923956/SRR14923956_1.fastq.gz', 'md5': 'b7727466841b733e3e9fc9dba71376dc', 'size': 782733315}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/056/SRR14923956/SRR14923956_2.fastq.gz', 'md5': '1ec35f263030883a8339ce9bb7e230cb', 'size': 2554570258}]","[{'url': 's3://sra-pub-src-9/SRR14923956/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S7_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14923956/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S7_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923956/SRR14923956'}, {'url': 's3://sra-pub-run-13/SRR14923956/SRR14923956.1'}]","[{'url': 'gs://sra-pub-src-16/SRR14923956/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S7_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14923956/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S7_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR14923956/SRR14923956.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra77/SRR/014574/SRR14923956'}],41661265,5225950053,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923957,SRX11237257,SRP325759,SRS9283132,NextSeq 550 paired end sequencing; GSM5402429: scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/057/SRR14923957/SRR14923957_1.fastq.gz', 'md5': 'f644464eb98af2f2f6ec5bd3ae243d5a', 'size': 1068266393}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/057/SRR14923957/SRR14923957_2.fastq.gz', 'md5': 'de0ef1326dd13ef1c28c592161f22a25', 'size': 3491949179}]","[{'url': 's3://sra-pub-src-15/SRR14923957/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S8_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14923957/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S8_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923957/SRR14923957'}]","[{'url': 'gs://sra-pub-src-9/SRR14923957/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S8_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14923957/scRNAseq_fliIa_eGFP_Sox10_dsRed_1.5dpf_rep_1_S8_L004_R2_001.fastq.gz.1'}]",[],56952127,7144119256,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923958,SRX11237258,SRP325759,SRS9283133,Illumina HiSeq 4000 paired end sequencing; GSM5402430: scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/058/SRR14923958/SRR14923958_1.fastq.gz', 'md5': 'fb47f53fef5910af5ee9a8c4a82ae402', 'size': 4403764694}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/058/SRR14923958/SRR14923958_2.fastq.gz', 'md5': '112c085b28f5cf989b2354b89a2ef18a', 'size': 18571601075}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923958/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923958/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923958/SRR14923958'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923958/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923958/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923958/SRR14923958'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra57/SRR/014574/SRR14923958'}],234007853,34509011947,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923959,SRX11237258,SRP325759,SRS9283133,Illumina HiSeq 4000 paired end sequencing; GSM5402430: scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/059/SRR14923959/SRR14923959_1.fastq.gz', 'md5': '89ab716a49b0b1f869707a1d87fd91b2', 'size': 3382590798}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/059/SRR14923959/SRR14923959_2.fastq.gz', 'md5': '5b68dba822a690e4f6303b30c3f571ca', 'size': 13857990807}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923959/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923959/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923959/SRR14923959'}, {'url': 's3://sra-pub-run-10/SRR14923959/SRR14923959.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923959/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923959/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923959/SRR14923959'}, {'url': 'gs://sra-pub-run-3/SRR14923959/SRR14923959.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra20/SRR/014574/SRR14923959'}],179583089,26483068005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923960,SRX11237258,SRP325759,SRS9283133,Illumina HiSeq 4000 paired end sequencing; GSM5402430: scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/060/SRR14923960/SRR14923960_1.fastq.gz', 'md5': 'a5c5bc665145fb2ad292afe2e173af9f', 'size': 3499093077}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/060/SRR14923960/SRR14923960_2.fastq.gz', 'md5': '251ff2ca19c3693b033c3a3605291331', 'size': 15004239740}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923960/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923960/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923960/SRR14923960'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923960/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923960/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923960/SRR14923960'}, {'url': 'gs://sra-pub-run-6/SRR14923960/SRR14923960.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra48/SRR/014574/SRR14923960'}],186073336,27440650225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923961,SRX11237258,SRP325759,SRS9283133,Illumina HiSeq 4000 paired end sequencing; GSM5402430: scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/061/SRR14923961/SRR14923961_1.fastq.gz', 'md5': '5698b80cd2594ae3f2f20fe6acd9815f', 'size': 1932214138}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/061/SRR14923961/SRR14923961_2.fastq.gz', 'md5': 'f8652db5076eafc83fde6f297ee4e44b', 'size': 8334213158}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923961/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923961/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923961/SRR14923961'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923961/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923961/scRNAseq_Sox10_Cre_bact_BtR_2dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923961/SRR14923961'}]",[],103076294,15200849836,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923962,SRX11237259,SRP325759,SRS9283131,NextSeq 550 paired end sequencing; GSM5402431: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/062/SRR14923962/SRR14923962_1.fastq.gz', 'md5': 'f246c83fcc2dadfc51b22441ecdb7495', 'size': 1700288020}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/062/SRR14923962/SRR14923962_2.fastq.gz', 'md5': '4105c812e96392a7f8d7ff791fa98395', 'size': 6863979643}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923962/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923962/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923962/SRR14923962'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923962/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923962/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923962/SRR14923962'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra79/SRR/014574/SRR14923962'}],88207503,13007671634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923963,SRX11237259,SRP325759,SRS9283131,NextSeq 550 paired end sequencing; GSM5402431: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/063/SRR14923963/SRR14923963_1.fastq.gz', 'md5': 'd424684cc36eda78bcc177c2bf5e2b04', 'size': 2108920580}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/063/SRR14923963/SRR14923963_2.fastq.gz', 'md5': 'eb3e8cd7ffa2270eea98ba69666c335b', 'size': 8538488871}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923963/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923963/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923963/SRR14923963'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923963/SRR14923963'}, {'url': 's3://sra-pub-run-9/SRR14923963/SRR14923963.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923963/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923963/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923963/SRR14923963'}, {'url': 'gs://sra-pub-run-4/SRR14923963/SRR14923963.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra18/SRR/014574/SRR14923963'}],109474407,16144028961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923964,SRX11237259,SRP325759,SRS9283131,NextSeq 550 paired end sequencing; GSM5402431: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/064/SRR14923964/SRR14923964_1.fastq.gz', 'md5': 'f52d6b782169b14ab7ef7eb338db20b7', 'size': 1631795276}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/064/SRR14923964/SRR14923964_2.fastq.gz', 'md5': 'b23008376bedde9f9729508f1cbd2713', 'size': 6594491743}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923964/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923964/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923964/SRR14923964'}, {'url': 's3://sra-pub-run-9/SRR14923964/SRR14923964.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923964/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923964/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923964/SRR14923964'}, {'url': 'gs://sra-pub-run-4/SRR14923964/SRR14923964.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra20/SRR/014574/SRR14923964'}],84851758,12513099683,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923965,SRX11237259,SRP325759,SRS9283131,NextSeq 550 paired end sequencing; GSM5402431: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/065/SRR14923965/SRR14923965_1.fastq.gz', 'md5': '7702ce3dcb5e859a049ec3b79b1de052', 'size': 1174524531}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/065/SRR14923965/SRR14923965_2.fastq.gz', 'md5': '0c7af4eeef4494ba02e5b1d7e79e3666', 'size': 4761909807}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923965/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923965/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923965/SRR14923965'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923965/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923965/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923965/SRR14923965'}]",[],61148061,9017297779,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923966,SRX11237260,SRP325759,SRS9283134,Illumina HiSeq 4000 paired end sequencing; GSM5402432: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/066/SRR14923966/SRR14923966_1.fastq.gz', 'md5': '12999966e194a276e1c607a07f67f37e', 'size': 3772921877}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/066/SRR14923966/SRR14923966_2.fastq.gz', 'md5': 'd028facd5429805cd0b4fc6fa9c6b252', 'size': 15058686616}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923966/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923966/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923966/SRR14923966'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923966/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923966/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923966/SRR14923966'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra36/SRR/014574/SRR14923966'}],192014455,28290264512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923967,SRX11237260,SRP325759,SRS9283134,Illumina HiSeq 4000 paired end sequencing; GSM5402432: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/067/SRR14923967/SRR14923967_1.fastq.gz', 'md5': '690ebc7df682b2dfa07d906f788b90f6', 'size': 3319681169}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/067/SRR14923967/SRR14923967_2.fastq.gz', 'md5': '73ce430adc7b0d73630138e60f99e88b', 'size': 12853418752}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923967/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S6_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923967/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923967/SRR14923967'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923967/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S6_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923967/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923967/SRR14923967'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra49/SRR/014574/SRR14923967'}],169468595,24968226454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923968,SRX11237260,SRP325759,SRS9283134,Illumina HiSeq 4000 paired end sequencing; GSM5402432: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/068/SRR14923968/SRR14923968_1.fastq.gz', 'md5': 'fd9e8f0684a19d1b577d63c02d3953a3', 'size': 2724219791}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/068/SRR14923968/SRR14923968_2.fastq.gz', 'md5': '0c905ef760ad443de3acd12b22d47fd4', 'size': 11147982881}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923968/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923968/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923968/SRR14923968'}, {'url': 's3://sra-pub-run-2/SRR14923968/SRR14923968.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923968/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923968/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923968/SRR14923968'}, {'url': 'gs://sra-pub-run-7/SRR14923968/SRR14923968.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra47/SRR/014574/SRR14923968'}],139276543,20521150940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923969,SRX11237260,SRP325759,SRS9283134,Illumina HiSeq 4000 paired end sequencing; GSM5402432: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/069/SRR14923969/SRR14923969_1.fastq.gz', 'md5': 'dd0299d5a6fd7e954047495ec7c74c7d', 'size': 2076442679}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/069/SRR14923969/SRR14923969_2.fastq.gz', 'md5': '52808c47b232e6b475d8959ad75be8c1', 'size': 8194503532}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923969/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923969/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S8_L001_R2_001.fastq.gz.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923969/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923969/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_2_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923969/SRR14923969'}]",[],106162536,15640912371,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923970,SRX11237261,SRP325759,SRS9283135,Illumina HiSeq 4000 paired end sequencing; GSM5402433: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/070/SRR14923970/SRR14923970_1.fastq.gz', 'md5': '33c2904979ec2b97885f4f4520a8807e', 'size': 1015525749}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/070/SRR14923970/SRR14923970_2.fastq.gz', 'md5': '7544349074b2caccb8d9c4ef9a1fd6e0', 'size': 4316733553}]","[{'url': 's3://sra-pub-src-3/SRR14923970/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR14923970/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923970/SRR14923970'}]","[{'url': 'gs://sra-pub-src-5/SRR14923970/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14923970/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S5_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-8/SRR14923970/SRR14923970.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra34/SRR/014574/SRR14923970'}],54984319,8105676106,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923971,SRX11237261,SRP325759,SRS9283135,Illumina HiSeq 4000 paired end sequencing; GSM5402433: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/071/SRR14923971/SRR14923971_1.fastq.gz', 'md5': 'ee9568b757428623ef8073804a892c18', 'size': 1209938911}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/071/SRR14923971/SRR14923971_2.fastq.gz', 'md5': '22aeab2d52c824b5928128d4c3185cbe', 'size': 5145480062}]","[{'url': 's3://sra-pub-src-4/SRR14923971/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14923971/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923971/SRR14923971'}, {'url': 's3://sra-pub-run-9/SRR14923971/SRR14923971.1'}]","[{'url': 'gs://sra-pub-src-17/SRR14923971/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR14923971/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S6_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14923971/SRR14923971.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra71/SRR/014574/SRR14923971'}],65400075,9641307826,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923972,SRX11237261,SRP325759,SRS9283135,Illumina HiSeq 4000 paired end sequencing; GSM5402433: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/072/SRR14923972/SRR14923972_1.fastq.gz', 'md5': 'e461d2208e1c206a131708a43ffd723b', 'size': 791797312}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/072/SRR14923972/SRR14923972_2.fastq.gz', 'md5': 'f3f1ee17a25f88c20ef41c69a7e6165f', 'size': 3354958590}]","[{'url': 's3://sra-pub-src-16/SRR14923972/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S7_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14923972/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923972/SRR14923972'}, {'url': 's3://sra-pub-run-4/SRR14923972/SRR14923972.1'}]","[{'url': 'gs://sra-pub-src-10/SRR14923972/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S7_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14923972/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S7_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR14923972/SRR14923972.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra19/SRR/014574/SRR14923972'}],42910955,6325954396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923973,SRX11237261,SRP325759,SRS9283135,Illumina HiSeq 4000 paired end sequencing; GSM5402433: scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/073/SRR14923973/SRR14923973_1.fastq.gz', 'md5': 'ac0cdaaaa166563a7294a5d95200f8d5', 'size': 1125801830}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/073/SRR14923973/SRR14923973_2.fastq.gz', 'md5': '2f807aa1ed133629317b7320eccb9538', 'size': 4726379040}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923973/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923973/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923973/SRR14923973'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923973/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923973/scRNAseq_Sox10_Cre_bact_BtR_3dpf_rep_3_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923973/SRR14923973'}]",[],60989036,8990939950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923974,SRX11237262,SRP325759,SRS9283136,Illumina HiSeq 4000 paired end sequencing; GSM5402434: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/074/SRR14923974/SRR14923974_1.fastq.gz', 'md5': '35b0cd782eafd6f15c1c8b55b0ebe117', 'size': 5114870953}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/074/SRR14923974/SRR14923974_2.fastq.gz', 'md5': '3f75872f8f06177e17c015ae48e7f17b', 'size': 23035624407}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923974/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923974/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923974/SRR14923974'}, {'url': 's3://sra-pub-run-11/SRR14923974/SRR14923974.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923974/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923974/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923974/SRR14923974'}, {'url': 'gs://sra-pub-run-10/SRR14923974/SRR14923974.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra36/SRR/014574/SRR14923974'}],264876364,39065541130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923975,SRX11237262,SRP325759,SRS9283136,Illumina HiSeq 4000 paired end sequencing; GSM5402434: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/075/SRR14923975/SRR14923975_1.fastq.gz', 'md5': '931a6a42a77c36327994b865f2c650a6', 'size': 6395891363}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/075/SRR14923975/SRR14923975_2.fastq.gz', 'md5': 'f47f35b5d1afb7f828ef518e576026d3', 'size': 28841892306}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923975/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923975/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923975/SRR14923975'}, {'url': 's3://sra-pub-run-9/SRR14923975/SRR14923975.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923975/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923975/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923975/SRR14923975'}, {'url': 'gs://sra-pub-run-4/SRR14923975/SRR14923975.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra3/SRR/014574/SRR14923975'}],331870682,48945439249,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923976,SRX11237262,SRP325759,SRS9283136,Illumina HiSeq 4000 paired end sequencing; GSM5402434: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/076/SRR14923976/SRR14923976_1.fastq.gz', 'md5': '09941b3c17f59915ecc387f14319baf8', 'size': 5520249012}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/076/SRR14923976/SRR14923976_2.fastq.gz', 'md5': '14423f10e35b868bb7852e1c4c23d5af', 'size': 25136430998}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923976/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923976/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923976/SRR14923976'}, {'url': 's3://sra-pub-run-13/SRR14923976/SRR14923976.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923976/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923976/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923976/SRR14923976'}, {'url': 'gs://sra-pub-run-1/SRR14923976/SRR14923976.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra3/SRR/014574/SRR14923976'}],285358628,42087792588,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923977,SRX11237262,SRP325759,SRS9283136,Illumina HiSeq 4000 paired end sequencing; GSM5402434: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/077/SRR14923977/SRR14923977_1.fastq.gz', 'md5': 'bbd2ed42e8ffdcf89db70455329f8c29', 'size': 6470442001}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/077/SRR14923977/SRR14923977_2.fastq.gz', 'md5': '15f5f006a9c8f70b588c5fb466c55a66', 'size': 30024749315}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923977/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923977/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923977/SRR14923977'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923977/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923977/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923977/SRR14923977'}]",[],335550801,49474243865,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923978,SRX11237263,SRP325759,SRS9283137,Illumina HiSeq 4000 paired end sequencing; GSM5402435: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/078/SRR14923978/SRR14923978_1.fastq.gz', 'md5': '630b4479c043e2d7a48fa97a63a30127', 'size': 932778886}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/078/SRR14923978/SRR14923978_2.fastq.gz', 'md5': '0245e60197aa6931fe70bc94fc3b469a', 'size': 3903610529}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923978/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S9_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923978/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S9_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923978/SRR14923978'}, {'url': 's3://sra-pub-run-13/SRR14923978/SRR14923978.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923978/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S9_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923978/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S9_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923978/SRR14923978'}, {'url': 'gs://sra-pub-run-1/SRR14923978/SRR14923978.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra24/SRR/014574/SRR14923978'}],50779677,7485579886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923979,SRX11237263,SRP325759,SRS9283137,Illumina HiSeq 4000 paired end sequencing; GSM5402435: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/079/SRR14923979/SRR14923979_1.fastq.gz', 'md5': '8547f8415b9c94f327e0d03e0c2a1e6a', 'size': 482120395}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/079/SRR14923979/SRR14923979_2.fastq.gz', 'md5': '61dfdb81ed333e74d9ef78aa9cac719c', 'size': 2017789661}]","[{'url': 's3://sra-pub-src-7/SRR14923979/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S10_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14923979/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S10_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923979/SRR14923979'}, {'url': 's3://sra-pub-run-10/SRR14923979/SRR14923979.1'}]","[{'url': 'gs://sra-pub-src-3/SRR14923979/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S10_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR14923979/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S10_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-3/SRR14923979/SRR14923979.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra44/SRR/014574/SRR14923979'}],26277040,3873586805,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923980,SRX11237263,SRP325759,SRS9283137,Illumina HiSeq 4000 paired end sequencing; GSM5402435: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/080/SRR14923980/SRR14923980_1.fastq.gz', 'md5': '5363f44c74b6ab60eee740f899c6bd9a', 'size': 1444622549}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/080/SRR14923980/SRR14923980_2.fastq.gz', 'md5': '027673cb3791ce20bbdf67c677ead7a0', 'size': 6124893795}]","[{'url': 's3://sra-pub-src-15/SRR14923980/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S11_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14923980/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S11_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923980/SRR14923980'}, {'url': 's3://sra-pub-run-7/SRR14923980/SRR14923980.1'}]","[{'url': 'gs://sra-pub-src-9/SRR14923980/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S11_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14923980/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S11_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR14923980/SRR14923980.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra28/SRR/014574/SRR14923980'}],78449449,11564459727,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923981,SRX11237263,SRP325759,SRS9283137,Illumina HiSeq 4000 paired end sequencing; GSM5402435: scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/081/SRR14923981/SRR14923981_1.fastq.gz', 'md5': '1a597f2732e822e2e933eec5a014d5e6', 'size': 784864555}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/081/SRR14923981/SRR14923981_2.fastq.gz', 'md5': '729ab302621dbafc29c2eba42c51c880', 'size': 3341821359}]","[{'url': 's3://sra-pub-src-11/SRR14923981/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S12_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14923981/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S12_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923981/SRR14923981'}]","[{'url': 'gs://sra-pub-src-18/SRR14923981/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S12_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14923981/scRNAseq_Sox10_Cre_bact_BtR_5dpf_rep_2_S12_L001_R2_001.fastq.gz.1'}]",[],42634610,6284929347,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923982,SRX11237264,SRP325759,SRS9283139,Illumina HiSeq 4000 paired end sequencing; GSM5402436: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/082/SRR14923982/SRR14923982_1.fastq.gz', 'md5': 'e2c2df99d035e67a9465494e805e5600', 'size': 2626255427}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/082/SRR14923982/SRR14923982_2.fastq.gz', 'md5': 'adbfae143332c99be014a74f82025132', 'size': 11090896310}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923982/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923982/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923982/SRR14923982'}, {'url': 's3://sra-pub-run-13/SRR14923982/SRR14923982.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923982/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923982/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923982/SRR14923982'}, {'url': 'gs://sra-pub-run-1/SRR14923982/SRR14923982.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra9/SRR/014574/SRR14923982'}],135871494,20032358385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923983,SRX11237264,SRP325759,SRS9283139,Illumina HiSeq 4000 paired end sequencing; GSM5402436: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/083/SRR14923983/SRR14923983_1.fastq.gz', 'md5': '45f14fb20ea96884bdd113951e611859', 'size': 3021638497}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/083/SRR14923983/SRR14923983_2.fastq.gz', 'md5': 'be62a2a8872652991052ea976e8fdf3d', 'size': 13164345128}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923983/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923983/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923983/SRR14923983'}, {'url': 's3://sra-pub-run-6/SRR14923983/SRR14923983.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923983/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923983/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923983/SRR14923983'}, {'url': 'gs://sra-pub-run-6/SRR14923983/SRR14923983.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra78/SRR/014574/SRR14923983'}],156246885,23037521261,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923984,SRX11237264,SRP325759,SRS9283139,Illumina HiSeq 4000 paired end sequencing; GSM5402436: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/084/SRR14923984/SRR14923984_1.fastq.gz', 'md5': '9bea44ac700fc9cf5f83b85f22c6adab', 'size': 2686978254}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/084/SRR14923984/SRR14923984_2.fastq.gz', 'md5': 'ad42ce3523c96e9aedf4499d5aa008f0', 'size': 11263377723}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923984/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923984/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923984/SRR14923984'}, {'url': 's3://sra-pub-run-4/SRR14923984/SRR14923984.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923984/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923984/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923984/SRR14923984'}, {'url': 'gs://sra-pub-run-11/SRR14923984/SRR14923984.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra22/SRR/014574/SRR14923984'}],138696229,20448513106,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923985,SRX11237264,SRP325759,SRS9283139,Illumina HiSeq 4000 paired end sequencing; GSM5402436: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/085/SRR14923985/SRR14923985_1.fastq.gz', 'md5': '97f846802084de59fa016d22bc55b781', 'size': 3131641433}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/085/SRR14923985/SRR14923985_2.fastq.gz', 'md5': '5c6a431496b32cdff5333e630b584dd0', 'size': 13109267238}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923985/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923985/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923985/SRR14923985'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923985/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923985/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923985/SRR14923985'}]",[],161590158,23823196304,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923986,SRX11237265,SRP325759,SRS9283138,Illumina HiSeq 4000 paired end sequencing; GSM5402437: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/086/SRR14923986/SRR14923986_1.fastq.gz', 'md5': '3b928260888106876420f72087dfe781', 'size': 3653467957}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/086/SRR14923986/SRR14923986_2.fastq.gz', 'md5': 'ae07bd59ef1a2dfa0dbc301863d38dc7', 'size': 16637088630}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923986/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923986/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923986/SRR14923986'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923986/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923986/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923986/SRR14923986'}, {'url': 'gs://sra-pub-run-1/SRR14923986/SRR14923986.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra77/SRR/014574/SRR14923986'}],188453210,27788179559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923987,SRX11237265,SRP325759,SRS9283138,Illumina HiSeq 4000 paired end sequencing; GSM5402437: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/087/SRR14923987/SRR14923987_1.fastq.gz', 'md5': '09108ddd25f3f5afeea225f3127cdb95', 'size': 2555229377}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/087/SRR14923987/SRR14923987_2.fastq.gz', 'md5': '5c53aac675da0154ef1d0a77d1b5b4fd', 'size': 10855344743}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923987/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S6_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923987/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923987/SRR14923987'}, {'url': 's3://sra-pub-run-10/SRR14923987/SRR14923987.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923987/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S6_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923987/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923987/SRR14923987'}, {'url': 'gs://sra-pub-run-3/SRR14923987/SRR14923987.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/014574/SRR14923987'}],132012979,19464894830,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923988,SRX11237265,SRP325759,SRS9283138,Illumina HiSeq 4000 paired end sequencing; GSM5402437: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/088/SRR14923988/SRR14923988_1.fastq.gz', 'md5': '7cb5a26afb1346081788ad7f60a4e38f', 'size': 2882871374}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/088/SRR14923988/SRR14923988_2.fastq.gz', 'md5': 'b430f8a8398a6a3d10ebfd912be08818', 'size': 12413333375}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923988/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923988/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923988/SRR14923988'}, {'url': 's3://sra-pub-run-5/SRR14923988/SRR14923988.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923988/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923988/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923988/SRR14923988'}, {'url': 'gs://sra-pub-run-9/SRR14923988/SRR14923988.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra31/SRR/014574/SRR14923988'}],148890700,21953986568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923989,SRX11237265,SRP325759,SRS9283138,Illumina HiSeq 4000 paired end sequencing; GSM5402437: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/089/SRR14923989/SRR14923989_1.fastq.gz', 'md5': '3016fa580a175c0b6c3baa82157ab994', 'size': 2399721155}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/089/SRR14923989/SRR14923989_2.fastq.gz', 'md5': '009a3d69eb359bb8c716505a324536c4', 'size': 10234451479}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923989/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923989/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923989/SRR14923989'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923989/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923989/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_2_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923989/SRR14923989'}]",[],123867689,18264036545,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923990,SRX11237266,SRP325759,SRS9283140,Illumina HiSeq 4000 paired end sequencing; GSM5402438: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/090/SRR14923990/SRR14923990_1.fastq.gz', 'md5': 'e0222881c42cc9dc0c9ac1e3b6250b87', 'size': 633938265}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/090/SRR14923990/SRR14923990_2.fastq.gz', 'md5': '7c1269d5c842e111c62d570d93bfec0b', 'size': 2904898322}]","[{'url': 's3://sra-pub-src-5/SRR14923990/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14923990/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923990/SRR14923990'}, {'url': 's3://sra-pub-run-2/SRR14923990/SRR14923990.1'}]","[{'url': 'gs://sra-pub-src-12/SRR14923990/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14923990/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S5_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR14923990/SRR14923990.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra4/SRR/014574/SRR14923990'}],33811472,4985227464,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923991,SRX11237266,SRP325759,SRS9283140,Illumina HiSeq 4000 paired end sequencing; GSM5402438: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/091/SRR14923991/SRR14923991_1.fastq.gz', 'md5': 'a5c16229943172f8954f5eddf8e8d261', 'size': 1049521848}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/091/SRR14923991/SRR14923991_2.fastq.gz', 'md5': '2459f28fbfa1950e833e4661e19cd4bb', 'size': 4797916088}]","[{'url': 's3://sra-pub-src-17/SRR14923991/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14923991/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923991/SRR14923991'}, {'url': 's3://sra-pub-run-8/SRR14923991/SRR14923991.1'}]","[{'url': 'gs://sra-pub-src-13/SRR14923991/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR14923991/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S6_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR14923991/SRR14923991.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra1/SRR/014574/SRR14923991'}],55921872,8244935284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923992,SRX11237266,SRP325759,SRS9283140,Illumina HiSeq 4000 paired end sequencing; GSM5402438: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/092/SRR14923992/SRR14923992_1.fastq.gz', 'md5': '129a39ff0bc1ead33ca10cd4449519f4', 'size': 626845668}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/092/SRR14923992/SRR14923992_2.fastq.gz', 'md5': 'a609099312a270027ce3077083996cb0', 'size': 2871700945}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923992/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923992/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923992/SRR14923992'}, {'url': 's3://sra-pub-run-7/SRR14923992/SRR14923992.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923992/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923992/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923992/SRR14923992'}, {'url': 'gs://sra-pub-run-7/SRR14923992/SRR14923992.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra53/SRR/014574/SRR14923992'}],33675129,4964928671,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923993,SRX11237266,SRP325759,SRS9283140,Illumina HiSeq 4000 paired end sequencing; GSM5402438: scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/093/SRR14923993/SRR14923993_1.fastq.gz', 'md5': 'fd89fbda5e22e5cc592a8b6bf8f37f0a', 'size': 656467329}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/093/SRR14923993/SRR14923993_2.fastq.gz', 'md5': 'a66a377866ceca025cbbf1bfd6f85a7b', 'size': 3076541815}]","[{'url': 's3://sra-pub-src-12/SRR14923993/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S8_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR14923993/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923993/SRR14923993'}]","[{'url': 'gs://sra-pub-src-14/SRR14923993/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S8_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR14923993/scRNAseq_Sox10_Cre_bact_BtR_14dpf_rep_ceratohyal_S8_L001_R2_001.fastq.gz.1'}]",[],35192567,5188680725,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923994,SRX11237267,SRP325759,SRS9283141,Illumina HiSeq 4000 paired end sequencing; GSM5402439: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/094/SRR14923994/SRR14923994_1.fastq.gz', 'md5': '3a2858db10354ac05b9f242183b95021', 'size': 1241999053}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/094/SRR14923994/SRR14923994_2.fastq.gz', 'md5': 'e821c251fad616a4cb92fe19623b266f', 'size': 5195742993}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923994/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S13_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923994/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S13_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923994/SRR14923994'}, {'url': 's3://sra-pub-run-6/SRR14923994/SRR14923994.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923994/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S13_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923994/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S13_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923994/SRR14923994'}, {'url': 'gs://sra-pub-run-1/SRR14923994/SRR14923994.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra9/SRR/014574/SRR14923994'}],67405339,9936865506,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923995,SRX11237267,SRP325759,SRS9283141,Illumina HiSeq 4000 paired end sequencing; GSM5402439: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/095/SRR14923995/SRR14923995_1.fastq.gz', 'md5': '2a6594c91f778598079b3cd3ea6c5203', 'size': 987080917}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/095/SRR14923995/SRR14923995_2.fastq.gz', 'md5': '6d6067140c06ebcc5fdaa6567503324a', 'size': 4413921720}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923995/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S14_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923995/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S14_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923995/SRR14923995'}, {'url': 's3://sra-pub-run-12/SRR14923995/SRR14923995.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923995/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S14_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923995/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S14_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923995/SRR14923995'}, {'url': 'gs://sra-pub-run-12/SRR14923995/SRR14923995.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra58/SRR/014574/SRR14923995'}],53567183,7897275260,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923996,SRX11237267,SRP325759,SRS9283141,Illumina HiSeq 4000 paired end sequencing; GSM5402439: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/096/SRR14923996/SRR14923996_1.fastq.gz', 'md5': 'e3c55fe355d025c1bdf113677b8c0737', 'size': 971499437}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/096/SRR14923996/SRR14923996_2.fastq.gz', 'md5': 'a53d642af7f290d52bc65c3d73dfda8f', 'size': 4114831600}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923996/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S15_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923996/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S15_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923996/SRR14923996'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923996/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S15_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923996/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S15_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923996/SRR14923996'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra60/SRR/014574/SRR14923996'}],52676458,7765136197,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923997,SRX11237267,SRP325759,SRS9283141,Illumina HiSeq 4000 paired end sequencing; GSM5402439: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/097/SRR14923997/SRR14923997_1.fastq.gz', 'md5': '1b24cd5a0ad067b051e04e864825b147', 'size': 1301843457}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/097/SRR14923997/SRR14923997_2.fastq.gz', 'md5': '5ab26a0070806e3be43cfa8d959e07b0', 'size': 5594686254}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923997/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S16_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923997/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S16_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923997/SRR14923997'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923997/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S16_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923997/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_1_S16_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923997/SRR14923997'}]",[],70754033,10430563739,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923998,SRX11237268,SRP325759,SRS9283142,Illumina HiSeq 4000 paired end sequencing; GSM5402440: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/098/SRR14923998/SRR14923998_1.fastq.gz', 'md5': '2b57f9d21f5a14cd801985d91e238551', 'size': 902262143}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/098/SRR14923998/SRR14923998_2.fastq.gz', 'md5': 'a62c56252e806f16e1eeee81237b56f3', 'size': 3817520682}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923998/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S17_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14923998/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S17_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14923998/SRR14923998'}, {'url': 's3://sra-pub-run-12/SRR14923998/SRR14923998.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923998/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S17_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14923998/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S17_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14923998/SRR14923998'}, {'url': 'gs://sra-pub-run-2/SRR14923998/SRR14923998.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra17/SRR/014574/SRR14923998'}],49499870,7297507744,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14923999,SRX11237268,SRP325759,SRS9283142,Illumina HiSeq 4000 paired end sequencing; GSM5402440: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/099/SRR14923999/SRR14923999_1.fastq.gz', 'md5': 'e926078f0ea647f6470a107880209aa8', 'size': 524423669}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/099/SRR14923999/SRR14923999_2.fastq.gz', 'md5': 'eb1f0e271124c640ba09d1a55e112515', 'size': 2249940394}]","[{'url': 's3://sra-pub-src-9/SRR14923999/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S18_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14923999/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S18_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14923999/SRR14923999'}, {'url': 's3://sra-pub-run-6/SRR14923999/SRR14923999.1'}]","[{'url': 'gs://sra-pub-src-16/SRR14923999/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S18_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14923999/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S18_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR14923999/SRR14923999.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra55/SRR/014574/SRR14923999'}],28889131,4258953868,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924000,SRX11237268,SRP325759,SRS9283142,Illumina HiSeq 4000 paired end sequencing; GSM5402440: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/000/SRR14924000/SRR14924000_1.fastq.gz', 'md5': '42f994d192930a3536d6070fe8b5b766', 'size': 498626039}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/000/SRR14924000/SRR14924000_2.fastq.gz', 'md5': '29e88b3e755465316493a104ff99ffa3', 'size': 2172034370}]","[{'url': 's3://sra-pub-src-6/SRR14924000/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S19_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR14924000/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S19_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14924000/SRR14924000'}, {'url': 's3://sra-pub-run-6/SRR14924000/SRR14924000.1'}]","[{'url': 'gs://sra-pub-src-4/SRR14924000/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S19_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14924000/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S19_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR14924000/SRR14924000.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra31/SRR/014574/SRR14924000'}],27477008,4050808878,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924001,SRX11237268,SRP325759,SRS9283142,Illumina HiSeq 4000 paired end sequencing; GSM5402440: scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/001/SRR14924001/SRR14924001_1.fastq.gz', 'md5': '9c02b34af2f4d690279ba3bafe16393a', 'size': 682127791}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/001/SRR14924001/SRR14924001_2.fastq.gz', 'md5': 'c1a63b8e5e663a6a289e7371e54fbf36', 'size': 2929791447}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924001/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S20_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924001/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S20_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924001/SRR14924001'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924001/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S20_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924001/scRNAseq_Sox10_Cre_bact_BtR_60dpf_rep_2_S20_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924001/SRR14924001'}]",[],37527113,5532406222,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924002,SRX11237269,SRP325759,SRS9283143,Illumina HiSeq 4000 paired end sequencing; GSM5402441: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/002/SRR14924002/SRR14924002_1.fastq.gz', 'md5': '73156f4efd102a664193004251517f6b', 'size': 2384857964}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/002/SRR14924002/SRR14924002_2.fastq.gz', 'md5': '970b19f45d2017ee248455324a86b6c2', 'size': 9844555166}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924002/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924002/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924002/SRR14924002'}, {'url': 's3://sra-pub-run-5/SRR14924002/SRR14924002.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924002/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924002/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924002/SRR14924002'}, {'url': 'gs://sra-pub-run-5/SRR14924002/SRR14924002.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra61/SRR/014574/SRR14924002'}],121978173,17988779110,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924003,SRX11237269,SRP325759,SRS9283143,Illumina HiSeq 4000 paired end sequencing; GSM5402441: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/003/SRR14924003/SRR14924003_1.fastq.gz', 'md5': '589e410b2f475fc8e81b5edad30d0a88', 'size': 2762802164}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/003/SRR14924003/SRR14924003_2.fastq.gz', 'md5': '5f1c04e1682f076c7e17ad83f5fd71a3', 'size': 11146786980}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924003/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924003/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924003/SRR14924003'}, {'url': 's3://sra-pub-run-7/SRR14924003/SRR14924003.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924003/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924003/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924003/SRR14924003'}, {'url': 'gs://sra-pub-run-5/SRR14924003/SRR14924003.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra63/SRR/014574/SRR14924003'}],141399620,20851939187,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924004,SRX11237269,SRP325759,SRS9283143,Illumina HiSeq 4000 paired end sequencing; GSM5402441: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/004/SRR14924004/SRR14924004_1.fastq.gz', 'md5': '2ccd3bd4a741104f7827f99c20fbd1f7', 'size': 2031889887}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/004/SRR14924004/SRR14924004_2.fastq.gz', 'md5': '8dd058361fe1bbd5eaf8c97e92d75495', 'size': 8636735116}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924004/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924004/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924004/SRR14924004'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924004/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S3_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924004/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924004/SRR14924004'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra68/SRR/014574/SRR14924004'}],104136060,15358357716,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924005,SRX11237269,SRP325759,SRS9283143,Illumina HiSeq 4000 paired end sequencing; GSM5402441: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/005/SRR14924005/SRR14924005_1.fastq.gz', 'md5': '45ac85543ec35a3fd95ddca9cfdd6502', 'size': 2368003147}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/005/SRR14924005/SRR14924005_2.fastq.gz', 'md5': '929816094ecded8e2cf444c2e71686f4', 'size': 9940729416}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924005/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924005/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924005/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924005/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_1_S4_L001_R2_001.fastq.gz.1'}]",[],121425520,17907689506,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924006,SRX11237270,SRP325759,SRS9283145,NextSeq 550 paired end sequencing; GSM5402442: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/006/SRR14924006/SRR14924006_1.fastq.gz', 'md5': '650a3476ab69fd860c3b5679da9be3ca', 'size': 252871910}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/006/SRR14924006/SRR14924006_2.fastq.gz', 'md5': 'a987f26bd091de602340b38b92bfc3ec', 'size': 912890746}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924006/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924006/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924006/SRR14924006'}, {'url': 's3://sra-pub-run-4/SRR14924006/SRR14924006.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924006/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S1_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924006/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S1_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924006/SRR14924006'}, {'url': 'gs://sra-pub-run-11/SRR14924006/SRR14924006.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra27/SRR/014574/SRR14924006'}],13707812,2020696796,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924007,SRX11237270,SRP325759,SRS9283145,NextSeq 550 paired end sequencing; GSM5402442: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/007/SRR14924007/SRR14924007_1.fastq.gz', 'md5': 'ab4791980716583043f9d1993fabefa3', 'size': 255242179}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/007/SRR14924007/SRR14924007_2.fastq.gz', 'md5': '299a46e3d66e6abad272ef062bebec3e', 'size': 920939816}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924007/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924007/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924007/SRR14924007'}, {'url': 's3://sra-pub-run-9/SRR14924007/SRR14924007.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924007/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S2_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924007/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924007/SRR14924007'}, {'url': 'gs://sra-pub-run-4/SRR14924007/SRR14924007.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra43/SRR/014574/SRR14924007'}],13858297,2042859383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924008,SRX11237270,SRP325759,SRS9283145,NextSeq 550 paired end sequencing; GSM5402442: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/008/SRR14924008/SRR14924008_1.fastq.gz', 'md5': '58c2d1e0b7583cdecc57f75de5301beb', 'size': 5412945}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/008/SRR14924008/SRR14924008_2.fastq.gz', 'md5': 'eb8937adcb59e4484cec25dea51a5baf', 'size': 19605940}]","[{'url': 's3://sra-pub-src-10/SRR14924008/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S3_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR14924008/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S3_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14924008/SRR14924008'}, {'url': 's3://sra-pub-run-12/SRR14924008/SRR14924008.1'}]","[{'url': 'gs://sra-pub-src-6/SRR14924008/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S3_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR14924008/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S3_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR14924008/SRR14924008.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra43/SRR/014574/SRR14924008'}],294113,43358024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924009,SRX11237270,SRP325759,SRS9283145,NextSeq 550 paired end sequencing; GSM5402442: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/009/SRR14924009/SRR14924009_1.fastq.gz', 'md5': 'a2be70574065c43abecb5454246d9364', 'size': 216303869}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/009/SRR14924009/SRR14924009_2.fastq.gz', 'md5': '06b881abf80022033d4e8cff08b842fb', 'size': 784455984}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924009/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924009/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924009/SRR14924009'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924009/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S4_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924009/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_2_S4_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924009/SRR14924009'}]",[],11726015,1728541535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924010,SRX11237271,SRP325759,SRS9283144,NextSeq 550 paired end sequencing; GSM5402443: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/010/SRR14924010/SRR14924010_1.fastq.gz', 'md5': '59dd9f0219da5d094509480fdefdcb92', 'size': 380772952}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/010/SRR14924010/SRR14924010_2.fastq.gz', 'md5': '571fbe6996bf6827c25ca28c42b53345', 'size': 1387893299}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924010/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924010/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924010/SRR14924010'}, {'url': 's3://sra-pub-run-13/SRR14924010/SRR14924010.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924010/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S5_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924010/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924010/SRR14924010'}, {'url': 'gs://sra-pub-run-1/SRR14924010/SRR14924010.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra61/SRR/014574/SRR14924010'}],20502870,3023053161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924011,SRX11237271,SRP325759,SRS9283144,NextSeq 550 paired end sequencing; GSM5402443: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/011/SRR14924011/SRR14924011_1.fastq.gz', 'md5': '29f223e347b1de4b36dc96d3c95610fb', 'size': 247510380}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/011/SRR14924011/SRR14924011_2.fastq.gz', 'md5': '74d971bafe850cdbefb5a26c1bd4c97d', 'size': 902887556}]","[{'url': 's3://sra-pub-src-16/SRR14924011/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14924011/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S6_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14924011/SRR14924011'}, {'url': 's3://sra-pub-run-3/SRR14924011/SRR14924011.1'}]","[{'url': 'gs://sra-pub-src-10/SRR14924011/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14924011/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S6_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR14924011/SRR14924011.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra46/SRR/014574/SRR14924011'}],13362819,1970278742,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924012,SRX11237271,SRP325759,SRS9283144,NextSeq 550 paired end sequencing; GSM5402443: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/012/SRR14924012/SRR14924012_1.fastq.gz', 'md5': 'a67903955dff2989e6b9dd5a02c0b3da', 'size': 321304436}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/012/SRR14924012/SRR14924012_2.fastq.gz', 'md5': 'f06be32ed2842c0a6bf8edba101a1b68', 'size': 1169147447}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924012/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924012/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924012/SRR14924012'}, {'url': 's3://sra-pub-run-4/SRR14924012/SRR14924012.1'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924012/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S7_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924012/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924012/SRR14924012'}, {'url': 'gs://sra-pub-run-11/SRR14924012/SRR14924012.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra58/SRR/014574/SRR14924012'}],17286853,2548867221,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14924013,SRX11237271,SRP325759,SRS9283144,NextSeq 550 paired end sequencing; GSM5402443: scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3; Danio rerio; RNA-Seq,,2021-11-13,2021-11-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/013/SRR14924013/SRR14924013_1.fastq.gz', 'md5': '9ff58cbc111120062434e30ff9813c81', 'size': 475278442}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR149/013/SRR14924013/SRR14924013_2.fastq.gz', 'md5': '6e1c1736ce96a3197039203d6cdfb405', 'size': 1730296342}]","[{'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924013/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/sra-src/SRR14924013/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-sars-cov2.s3.amazonaws.com/run/SRR14924013/SRR14924013'}]","[{'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924013/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S8_L001_R1_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/sra-src/SRR14924013/scRNAseq_Sox10_Cre_bact_BtR_150dpf_rep_3_S8_L001_R2_001.fastq.gz.1'}, {'url': 'https://storage.googleapis.com/nih-sequence-read-archive/run/SRR14924013/SRR14924013'}]",[],25468573,3755115104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741032,SRX10128164,SRP237632,SRS8282572,NextSeq 500 paired end sequencing; GSM5091916: ESI-017; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/032/SRR13741032/SRR13741032.fastq.gz', 'md5': '8934352b4f23e760bb72961671fae4d3', 'size': 12086184640}]","[{'url': 's3://sra-pub-src-11/SRR13741032/ESI-017_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR13741032/ESI-017_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR13741032/ESI-017_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR13741032/ESI-017_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR13741032/ESI-017_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR13741032/ESI-017_L001_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741032/SRR13741032.1'}],256784552,23367394232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=ESI-017_L001_I1.fastq.gz --read2PairFiles=ESI-017_L001_R1.fastq.gz --read3PairFiles=ESI-017_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741033,SRX10128164,SRP237632,SRS8282572,NextSeq 500 paired end sequencing; GSM5091916: ESI-017; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/033/SRR13741033/SRR13741033.fastq.gz', 'md5': 'bfb45d9ad641917f53a95a8c7fbe3c6f', 'size': 12200859269}]","[{'url': 's3://sra-pub-src-14/SRR13741033/ESI-017_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR13741033/ESI-017_L002_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR13741033/ESI-017_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR13741033/ESI-017_L002_R1.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741033/SRR13741033.1'}],260150486,23673694226,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=ESI-017_L002_I1.fastq.gz --read2PairFiles=ESI-017_L002_R1.fastq.gz --read3PairFiles=ESI-017_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741034,SRX10128165,SRP237632,SRS8282573,NextSeq 500 paired end sequencing; GSM5091917: hESDC-M1; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/034/SRR13741034/SRR13741034.fastq.gz', 'md5': '4916120784fbc11bab9351c3bf875923', 'size': 2037606673}]","[{'url': 's3://sra-pub-src-17/SRR13741034/hESDC-M1_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR13741034/hESDC-M1_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR13741034/hESDC-M1_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR13741034/hESDC-M1_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR13741034/hESDC-M1_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR13741034/hESDC-M1_L001_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR13741034/SRR13741034.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741034/SRR13741034.1'}],54419044,3156304552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M1_L001_I1.fastq.gz --read2PairFiles=hESDC-M1_L001_R1.fastq.gz --read3PairFiles=hESDC-M1_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741035,SRX10128165,SRP237632,SRS8282573,NextSeq 500 paired end sequencing; GSM5091917: hESDC-M1; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/035/SRR13741035/SRR13741035.fastq.gz', 'md5': 'c7848079676392da056a641bae68e7a0', 'size': 2085152077}]","[{'url': 's3://sra-pub-src-18/SRR13741035/hESDC-M1_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13741035/hESDC-M1_L002_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13741035/hESDC-M1_L002_R2.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13741035/SRR13741035'}, {'url': 's3://sra-pub-run-13/SRR13741035/SRR13741035.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741035/hESDC-M1_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741035/hESDC-M1_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741035/hESDC-M1_L002_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13741035/SRR13741035.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741035/SRR13741035.1'}],55358757,3210807906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M1_L002_I1.fastq.gz --read2PairFiles=hESDC-M1_L002_R1.fastq.gz --read3PairFiles=hESDC-M1_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741036,SRX10128165,SRP237632,SRS8282573,NextSeq 500 paired end sequencing; GSM5091917: hESDC-M1; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/036/SRR13741036/SRR13741036.fastq.gz', 'md5': '5c42bf4a77ab4267dea033fee416a75e', 'size': 2071394285}]","[{'url': 's3://sra-pub-src-18/SRR13741036/hESDC-M1_L003_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741036/hESDC-M1_L003_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741036/hESDC-M1_L003_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741036/hESDC-M1_L003_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741036/hESDC-M1_L003_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741036/hESDC-M1_L003_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR13741036/SRR13741036.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741036/SRR13741036.1'}],55043287,3192510646,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M1_L003_I1.fastq.gz --read2PairFiles=hESDC-M1_L003_R1.fastq.gz --read3PairFiles=hESDC-M1_L003_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741037,SRX10128165,SRP237632,SRS8282573,NextSeq 500 paired end sequencing; GSM5091917: hESDC-M1; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/037/SRR13741037/SRR13741037.fastq.gz', 'md5': '22825968c10070690be90ae78a16a4a0', 'size': 2036252174}]","[{'url': 's3://sra-pub-src-11/SRR13741037/hESDC-M1_L004_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR13741037/hESDC-M1_L004_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR13741037/hESDC-M1_L004_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR13741037/hESDC-M1_L004_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR13741037/hESDC-M1_L004_R2.fastq.gz.1'}]",[],54205713,3143931354,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M1_L004_I1.fastq.gz --read2PairFiles=hESDC-M1_L004_R1.fastq.gz --read3PairFiles=hESDC-M1_L004_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741038,SRX10128166,SRP237632,SRS8282574,NextSeq 500 paired end sequencing; GSM5091918: hESDC-M2; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/038/SRR13741038/SRR13741038.fastq.gz', 'md5': 'f8cda04aea928a2e030f3f194e054b7c', 'size': 1327709479}]","[{'url': 's3://sra-pub-src-16/SRR13741038/hESDC-M2_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741038/hESDC-M2_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741038/hESDC-M2_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR13741038/hESDC-M2_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR13741038/hESDC-M2_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR13741038/hESDC-M2_L001_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741038/SRR13741038.1'}],35213881,2042405098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M2_L001_I1.fastq.gz --read2PairFiles=hESDC-M2_L001_R1.fastq.gz --read3PairFiles=hESDC-M2_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741039,SRX10128166,SRP237632,SRS8282574,NextSeq 500 paired end sequencing; GSM5091918: hESDC-M2; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/039/SRR13741039/SRR13741039.fastq.gz', 'md5': '04d24f97b557c6a3c31fc9eceaedf557', 'size': 1360065684}]","[{'url': 's3://sra-pub-src-8/SRR13741039/hESDC-M2_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR13741039/hESDC-M2_L002_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR13741039/hESDC-M2_L002_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR13741039/hESDC-M2_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR13741039/hESDC-M2_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR13741039/hESDC-M2_L002_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741039/SRR13741039.1'}],35877771,2080910718,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M2_L002_I1.fastq.gz --read2PairFiles=hESDC-M2_L002_R1.fastq.gz --read3PairFiles=hESDC-M2_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741040,SRX10128166,SRP237632,SRS8282574,NextSeq 500 paired end sequencing; GSM5091918: hESDC-M2; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/040/SRR13741040/SRR13741040.fastq.gz', 'md5': '1576e4e74eaef79dd643f788904f5fba', 'size': 1348468044}]","[{'url': 's3://sra-pub-src-15/SRR13741040/hESDC-M2_L003_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741040/hESDC-M2_L003_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741040/hESDC-M2_L003_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741040/hESDC-M2_L003_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741040/hESDC-M2_L003_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741040/hESDC-M2_L003_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741040/SRR13741040.1'}],35599205,2064753890,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M2_L003_I1.fastq.gz --read2PairFiles=hESDC-M2_L003_R1.fastq.gz --read3PairFiles=hESDC-M2_L003_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741041,SRX10128166,SRP237632,SRS8282574,NextSeq 500 paired end sequencing; GSM5091918: hESDC-M2; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/041/SRR13741041/SRR13741041.fastq.gz', 'md5': 'edfa5e9e60342a1a8b84ed54c51cfb31', 'size': 1326640224}]","[{'url': 's3://sra-pub-src-15/SRR13741041/hESDC-M2_L004_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741041/hESDC-M2_L004_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741041/hESDC-M2_L004_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741041/hESDC-M2_L004_R1.fastq.gz.1'}]",[],35088175,2035114150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hESDC-M2_L004_I1.fastq.gz --read2PairFiles=hESDC-M2_L004_R1.fastq.gz --read3PairFiles=hESDC-M2_L004_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15964630,SRX12254437,SRP337784,SRS10230009,Illumina HiSeq 4000 paired end sequencing; GSM5587035: trps1:eGFP-enriched; Danio rerio; RNA-Seq,,2022-01-06,2022-01-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/030/SRR15964630/SRR15964630_1.fastq.gz', 'md5': 'f5a7723aa328c909fc3e5ffdb998d550', 'size': 2856679421}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/030/SRR15964630/SRR15964630_2.fastq.gz', 'md5': '57448cbab223d343cd658941a63fd8f0', 'size': 12242255216}]","[{'url': 's3://sra-pub-src-8/SRR15964630/trps1enriched-1_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15964630/trps1enriched-1_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15964630/SRR15964630'}, {'url': 's3://sra-pub-run-11/SRR15964630/SRR15964630.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15964630/trps1enriched-1_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15964630/trps1enriched-1_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR15964630/SRR15964630.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15964/SRR15964630/SRR15964630.1'}],145963727,21524957734,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15964631,SRX12254437,SRP337784,SRS10230009,Illumina HiSeq 4000 paired end sequencing; GSM5587035: trps1:eGFP-enriched; Danio rerio; RNA-Seq,,2022-01-06,2022-01-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/031/SRR15964631/SRR15964631_1.fastq.gz', 'md5': '5edbe84ca655f1231d973db5958d073a', 'size': 3920326403}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/031/SRR15964631/SRR15964631_2.fastq.gz', 'md5': 'ca25dafcfc0ca3b0c4e627723daa1b3b', 'size': 16982032114}]","[{'url': 's3://sra-pub-src-3/SRR15964631/trps1enriched-2_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15964631/trps1enriched-2_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15964631/SRR15964631'}, {'url': 's3://sra-pub-run-5/SRR15964631/SRR15964631.1'}]","[{'url': 'gs://sra-pub-src-4/SRR15964631/trps1enriched-2_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR15964631/trps1enriched-2_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR15964631/SRR15964631.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15964/SRR15964631/SRR15964631.1'}],200298691,29538626136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15964632,SRX12254437,SRP337784,SRS10230009,Illumina HiSeq 4000 paired end sequencing; GSM5587035: trps1:eGFP-enriched; Danio rerio; RNA-Seq,,2022-01-06,2022-01-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/032/SRR15964632/SRR15964632_1.fastq.gz', 'md5': 'a8934e0a9540d1600fc893e1c4b8bdb4', 'size': 2492531851}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/032/SRR15964632/SRR15964632_2.fastq.gz', 'md5': '38a2aad55772a2cf4c8831aae87ae1eb', 'size': 10444478280}]","[{'url': 's3://sra-pub-src-4/SRR15964632/trps1enriched-3_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR15964632/trps1enriched-3_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15964632/SRR15964632'}, {'url': 's3://sra-pub-run-11/SRR15964632/SRR15964632.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15964632/trps1enriched-3_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15964632/trps1enriched-3_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15964632/SRR15964632.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15964/SRR15964632/SRR15964632.1'}],127723979,18834117972,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15964633,SRX12254437,SRP337784,SRS10230009,Illumina HiSeq 4000 paired end sequencing; GSM5587035: trps1:eGFP-enriched; Danio rerio; RNA-Seq,,2022-01-06,2022-01-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/033/SRR15964633/SRR15964633_1.fastq.gz', 'md5': '5851c413c02f77bb1537132b19a439b5', 'size': 3246477529}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR159/033/SRR15964633/SRR15964633_2.fastq.gz', 'md5': '7aa1ff9d25f12135d9efe0e7c3b9558d', 'size': 13812334871}]","[{'url': 's3://sra-pub-src-3/SRR15964633/trps1enriched-4_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR15964633/trps1enriched-4_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15964633/SRR15964633'}]","[{'url': 'gs://sra-pub-src-4/SRR15964633/trps1enriched-4_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15964633/trps1enriched-4_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18355759,SRX14491059,SRP364615,SRS12291117,NextSeq 500 paired end sequencing; GSM5957782: T1DM_Uninjured; Mus musculus; RNA-Seq,,2022-03-22,2022-03-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR183/SRR18355759/T1MD_U_possorted_genome_bam.bam.1', 'md5': 'a7d151c947f67e8ec6b2f7064e5f7f43', 'size': 8068171684}]","[{'url': 'https://sra-pub-src-1.s3.amazonaws.com/SRR18355759/T1MD_U_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18355759/SRR18355759'}]",[{'url': 'gs://sra-pub-src-1/SRR18355759/T1MD_U_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra6/SRZ/018355/SRR18355759/T1MD_U_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18355760,SRX14491058,SRP364615,SRS12291115,NextSeq 500 paired end sequencing; GSM5957780: Control_Uninjured; Mus musculus; RNA-Seq,,2022-03-22,2022-03-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR183/SRR18355760/Ctrl_U_possorted_genome_bam.bam.1', 'md5': 'cb38e190cd97f1fa56e38a395b6267f9', 'size': 11236705073}]","[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR18355760/Ctrl_U_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18355760/SRR18355760'}]",[{'url': 'gs://sra-pub-src-2/SRR18355760/Ctrl_U_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra76/SRZ/018355/SRR18355760/Ctrl_U_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18355761,SRX14491057,SRP364615,SRS12291114,NextSeq 500 paired end sequencing; GSM5957781: Control_Injured; Mus musculus; RNA-Seq,,2022-03-22,2022-03-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR183/SRR18355761/Ctrl_I_possorted_genome_bam.bam.1', 'md5': 'c1701dfb603d00e0c001a5cb477a01c0', 'size': 12608782424}]","[{'url': 'https://sra-pub-src-1.s3.amazonaws.com/SRR18355761/Ctrl_I_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18355761/SRR18355761'}]",[{'url': 'gs://sra-pub-src-1/SRR18355761/Ctrl_I_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra73/SRZ/018355/SRR18355761/Ctrl_I_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18355762,SRX14491056,SRP364615,SRS12291116,NextSeq 500 paired end sequencing; GSM5957783: T1DM_Injured; Mus musculus; RNA-Seq,,2022-03-22,2022-03-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR183/SRR18355762/T1MD_I_possorted_genome_bam.bam.1', 'md5': 'b2f423a31eaf3f04f08b5d31f92bc858', 'size': 11037297418}]","[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR18355762/T1MD_I_possorted_genome_bam.bam.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18355762/SRR18355762'}]",[{'url': 'gs://sra-pub-src-2/SRR18355762/T1MD_I_possorted_genome_bam.bam.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra31/SRZ/018355/SRR18355762/T1MD_I_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475511,SRX10823751,SRP319066,SRS8908204,NextSeq 500 paired end sequencing; GSM5287500: M1; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/011/SRR14475511/SRR14475511.fastq.gz', 'md5': 'a861d596c8b33b567ee2c3f9439b3af6', 'size': 937300410}]","[{'url': 's3://sra-pub-src-10/SRR14475511/M1_S1_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR14475511/M1_S1_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR14475511/M1_S1_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR14475511/M1_S1_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR14475511/M1_S1_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR14475511/M1_S1_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475511/SRR14475511.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M1_S1_L001_I1_001.fastq.gz --read2PairFiles=M1_S1_L001_R1_001.fastq.gz --read3PairFiles=M1_S1_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475512,SRX10823751,SRP319066,SRS8908204,NextSeq 500 paired end sequencing; GSM5287500: M1; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/012/SRR14475512/SRR14475512.fastq.gz', 'md5': '35fc2a01b47bdc58915764c9a915fe7d', 'size': 936381032}]","[{'url': 's3://sra-pub-src-16/SRR14475512/M1_S1_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475512/M1_S1_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475512/M1_S1_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR14475512/M1_S1_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475512/M1_S1_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475512/M1_S1_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475512/SRR14475512.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M1_S1_L002_I1_001.fastq.gz --read2PairFiles=M1_S1_L002_R1_001.fastq.gz --read3PairFiles=M1_S1_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475513,SRX10823751,SRP319066,SRS8908204,NextSeq 500 paired end sequencing; GSM5287500: M1; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/013/SRR14475513/SRR14475513.fastq.gz', 'md5': '1befaada71dbfedb29cf02d63ecb87c4', 'size': 942949541}]","[{'url': 's3://sra-pub-src-9/SRR14475513/M1_S1_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14475513/M1_S1_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14475513/M1_S1_L003_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475513/SRR14475513'}, {'url': 's3://sra-pub-run-8/SRR14475513/SRR14475513.1'}]","[{'url': 'gs://sra-pub-src-7/SRR14475513/M1_S1_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14475513/M1_S1_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14475513/M1_S1_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR14475513/SRR14475513.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra71/SRR/014136/SRR14475513'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M1_S1_L003_I1_001.fastq.gz --read2PairFiles=M1_S1_L003_R1_001.fastq.gz --read3PairFiles=M1_S1_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475514,SRX10823751,SRP319066,SRS8908204,NextSeq 500 paired end sequencing; GSM5287500: M1; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/014/SRR14475514/SRR14475514.fastq.gz', 'md5': 'ad957ff1fdb790f15e474faab9228a79', 'size': 944751981}]","[{'url': 's3://sra-pub-src-17/SRR14475514/M1_S1_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14475514/M1_S1_L004_R1_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR14475514/M1_S1_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475514/M1_S1_L004_R1_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M1_S1_L004_I1_001.fastq.gz --read2PairFiles=M1_S1_L004_R1_001.fastq.gz --read3PairFiles=M1_S1_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475515,SRX10823752,SRP319066,SRS8908205,NextSeq 500 paired end sequencing; GSM5287501: M3; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/015/SRR14475515/SRR14475515.fastq.gz', 'md5': '24efbf73d2e181fc4c5a3e127ca24282', 'size': 562046273}]","[{'url': 's3://sra-pub-src-16/SRR14475515/M3_S5_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475515/M3_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475515/M3_S5_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR14475515/M3_S5_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475515/M3_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475515/M3_S5_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475515/SRR14475515.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M3_S5_L001_I1_001.fastq.gz --read2PairFiles=M3_S5_L001_R1_001.fastq.gz --read3PairFiles=M3_S5_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475516,SRX10823752,SRP319066,SRS8908205,NextSeq 500 paired end sequencing; GSM5287501: M3; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/016/SRR14475516/SRR14475516.fastq.gz', 'md5': '7941c4cf3af3b16b249717f7f9833fd6', 'size': 561399474}]","[{'url': 's3://sra-pub-src-7/SRR14475516/M3_S5_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14475516/M3_S5_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14475516/M3_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475516/SRR14475516'}, {'url': 's3://sra-pub-run-11/SRR14475516/SRR14475516.1'}]","[{'url': 'gs://sra-pub-src-15/SRR14475516/M3_S5_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR14475516/M3_S5_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR14475516/M3_S5_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14475516/SRR14475516.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra30/SRR/014136/SRR14475516'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M3_S5_L002_I1_001.fastq.gz --read2PairFiles=M3_S5_L002_R1_001.fastq.gz --read3PairFiles=M3_S5_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475517,SRX10823752,SRP319066,SRS8908205,NextSeq 500 paired end sequencing; GSM5287501: M3; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/017/SRR14475517/SRR14475517.fastq.gz', 'md5': 'aa8f1b2784665ec75ed410231b99384b', 'size': 561397353}]","[{'url': 's3://sra-pub-src-17/SRR14475517/M3_S5_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14475517/M3_S5_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14475517/M3_S5_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR14475517/M3_S5_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14475517/M3_S5_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14475517/M3_S5_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475517/SRR14475517.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M3_S5_L003_I1_001.fastq.gz --read2PairFiles=M3_S5_L003_R1_001.fastq.gz --read3PairFiles=M3_S5_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475518,SRX10823752,SRP319066,SRS8908205,NextSeq 500 paired end sequencing; GSM5287501: M3; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/018/SRR14475518/SRR14475518.fastq.gz', 'md5': '811ca807f666e255e46ac3b333c0e7a2', 'size': 560997907}]","[{'url': 's3://sra-pub-src-7/SRR14475518/M3_S5_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14475518/M3_S5_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR14475518/M3_S5_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475518/SRR14475518'}]","[{'url': 'gs://sra-pub-src-15/SRR14475518/M3_S5_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14475518/M3_S5_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14475518/M3_S5_L004_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M3_S5_L004_I1_001.fastq.gz --read2PairFiles=M3_S5_L004_R1_001.fastq.gz --read3PairFiles=M3_S5_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475519,SRX10823753,SRP319066,SRS8908206,NextSeq 500 paired end sequencing; GSM5287502: M4; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/019/SRR14475519/SRR14475519.fastq.gz', 'md5': '4a30904c10f1c26d9d2144ed8cad723d', 'size': 812836104}]","[{'url': 's3://sra-pub-src-11/SRR14475519/M4_S6_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14475519/M4_S6_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14475519/M4_S6_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR14475519/M4_S6_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14475519/M4_S6_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14475519/M4_S6_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475519/SRR14475519.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M4_S6_L001_I1_001.fastq.gz --read2PairFiles=M4_S6_L001_R1_001.fastq.gz --read3PairFiles=M4_S6_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475520,SRX10823753,SRP319066,SRS8908206,NextSeq 500 paired end sequencing; GSM5287502: M4; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/020/SRR14475520/SRR14475520.fastq.gz', 'md5': 'cdcd2525ebfa0fc5a33ed0aa6d581317', 'size': 811746572}]","[{'url': 's3://sra-pub-src-16/SRR14475520/M4_S6_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475520/M4_S6_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475520/M4_S6_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475520/SRR14475520'}, {'url': 's3://sra-pub-run-7/SRR14475520/SRR14475520.1'}]","[{'url': 'gs://sra-pub-src-10/SRR14475520/M4_S6_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475520/M4_S6_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475520/M4_S6_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR14475520/SRR14475520.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra2/SRR/014136/SRR14475520'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M4_S6_L002_I1_001.fastq.gz --read2PairFiles=M4_S6_L002_R1_001.fastq.gz --read3PairFiles=M4_S6_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475521,SRX10823753,SRP319066,SRS8908206,NextSeq 500 paired end sequencing; GSM5287502: M4; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/021/SRR14475521/SRR14475521.fastq.gz', 'md5': '1ee8da59415950ac7c6cb914e1d9ccda', 'size': 815294415}]","[{'url': 's3://sra-pub-src-15/SRR14475521/M4_S6_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14475521/M4_S6_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14475521/M4_S6_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR14475521/M4_S6_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14475521/M4_S6_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14475521/M4_S6_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475521/SRR14475521.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M4_S6_L003_I1_001.fastq.gz --read2PairFiles=M4_S6_L003_R1_001.fastq.gz --read3PairFiles=M4_S6_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475522,SRX10823753,SRP319066,SRS8908206,NextSeq 500 paired end sequencing; GSM5287502: M4; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/022/SRR14475522/SRR14475522.fastq.gz', 'md5': '02cb1193f3119f1b474ba1f0c36e6df7', 'size': 816552572}]","[{'url': 's3://sra-pub-src-9/SRR14475522/M4_S6_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14475522/M4_S6_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14475522/M4_S6_L004_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475522/SRR14475522'}]","[{'url': 'gs://sra-pub-src-7/SRR14475522/M4_S6_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475522/M4_S6_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475522/M4_S6_L004_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M4_S6_L004_I1_001.fastq.gz --read2PairFiles=M4_S6_L004_R1_001.fastq.gz --read3PairFiles=M4_S6_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475523,SRX10823754,SRP319066,SRS8908207,NextSeq 500 paired end sequencing; GSM5287503: M5; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/023/SRR14475523/SRR14475523.fastq.gz', 'md5': 'afe220f535ef0375c1ba03c522935c69', 'size': 1108762957}]","[{'url': 's3://sra-pub-src-15/SRR14475523/M5_S2_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14475523/M5_S2_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR14475523/M5_S2_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475523/SRR14475523'}, {'url': 's3://sra-pub-run-5/SRR14475523/SRR14475523.1'}]","[{'url': 'gs://sra-pub-src-5/SRR14475523/M5_S2_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14475523/M5_S2_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR14475523/M5_S2_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR14475523/SRR14475523.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra77/SRR/014136/SRR14475523'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M5_S2_L001_I1_001.fastq.gz --read2PairFiles=M5_S2_L001_R1_001.fastq.gz --read3PairFiles=M5_S2_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475524,SRX10823754,SRP319066,SRS8908207,NextSeq 500 paired end sequencing; GSM5287503: M5; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/024/SRR14475524/SRR14475524.fastq.gz', 'md5': 'f76c249a30572d52148881d2c36dc9aa', 'size': 1106645146}]","[{'url': 's3://sra-pub-src-9/SRR14475524/M5_S2_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14475524/M5_S2_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR14475524/M5_S2_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR14475524/M5_S2_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14475524/M5_S2_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR14475524/M5_S2_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475524/SRR14475524.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M5_S2_L002_I1_001.fastq.gz --read2PairFiles=M5_S2_L002_R1_001.fastq.gz --read3PairFiles=M5_S2_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475526,SRX10823754,SRP319066,SRS8908207,NextSeq 500 paired end sequencing; GSM5287503: M5; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/026/SRR14475526/SRR14475526.fastq.gz', 'md5': 'a1ceea649b5151e86a06e16bf9436577', 'size': 1109069043}]","[{'url': 's3://sra-pub-src-7/SRR14475526/M5_S2_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR14475526/M5_S2_L004_R1_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR14475526/M5_S2_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR14475526/M5_S2_L004_R1_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M5_S2_L004_I1_001.fastq.gz --read2PairFiles=M5_S2_L004_R1_001.fastq.gz --read3PairFiles=M5_S2_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475527,SRX10823755,SRP319066,SRS8908208,NextSeq 500 paired end sequencing; GSM5287504: M7; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/027/SRR14475527/SRR14475527.fastq.gz', 'md5': '2f6bd4f14e4b9b404a2fa0f748d9afd6', 'size': 1031583188}]","[{'url': 's3://sra-pub-src-14/SRR14475527/M7_S3_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475527/M7_S3_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475527/M7_S3_L001_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-6/SRR14475527/SRR14475527.1'}]","[{'url': 'gs://sra-pub-src-18/SRR14475527/M7_S3_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14475527/M7_S3_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14475527/M7_S3_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-9/SRR14475527/SRR14475527.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra56/SRR/014136/SRR14475527'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M7_S3_L001_I1_001.fastq.gz --read2PairFiles=M7_S3_L001_R1_001.fastq.gz --read3PairFiles=M7_S3_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475527,SRX10823755,SRP319066,SRS8908208,NextSeq 500 paired end sequencing; GSM5287504: M7; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/027/SRR14475527/SRR14475527.fastq.gz', 'md5': '2f6bd4f14e4b9b404a2fa0f748d9afd6', 'size': 1031583188}]","[{'url': 's3://sra-pub-src-14/SRR14475527/M7_S3_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475527/M7_S3_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475527/M7_S3_L001_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-6/SRR14475527/SRR14475527.1'}]","[{'url': 'gs://sra-pub-src-18/SRR14475527/M7_S3_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14475527/M7_S3_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14475527/M7_S3_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-9/SRR14475527/SRR14475527.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra56/SRR/014136/SRR14475527'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M7_S3_L001_I1_001.fastq.gz --read2PairFiles=M7_S3_L001_R1_001.fastq.gz --read3PairFiles=M7_S3_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475528,SRX10823755,SRP319066,SRS8908208,NextSeq 500 paired end sequencing; GSM5287504: M7; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/028/SRR14475528/SRR14475528.fastq.gz', 'md5': '8055ae31c17c90704e35d327b4066782', 'size': 1029937948}]","[{'url': 's3://sra-pub-src-4/SRR14475528/M7_S3_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14475528/M7_S3_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14475528/M7_S3_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-11/SRR14475528/M7_S3_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14475528/M7_S3_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14475528/M7_S3_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475528/SRR14475528.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M7_S3_L002_I1_001.fastq.gz --read2PairFiles=M7_S3_L002_R1_001.fastq.gz --read3PairFiles=M7_S3_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475529,SRX10823755,SRP319066,SRS8908208,NextSeq 500 paired end sequencing; GSM5287504: M7; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/029/SRR14475529/SRR14475529.fastq.gz', 'md5': 'bd2a440a199042416552030ccc08f418', 'size': 1035073974}]","[{'url': 's3://sra-pub-src-11/SRR14475529/M7_S3_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14475529/M7_S3_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14475529/M7_S3_L003_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-13/SRR14475529/SRR14475529.1'}]","[{'url': 'gs://sra-pub-src-17/SRR14475529/M7_S3_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR14475529/M7_S3_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR14475529/M7_S3_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR14475529/SRR14475529.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra46/SRR/014136/SRR14475529'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M7_S3_L003_I1_001.fastq.gz --read2PairFiles=M7_S3_L003_R1_001.fastq.gz --read3PairFiles=M7_S3_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475530,SRX10823755,SRP319066,SRS8908208,NextSeq 500 paired end sequencing; GSM5287504: M7; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/030/SRR14475530/SRR14475530.fastq.gz', 'md5': '4b62d1d05438595b014e7a3c09517d92', 'size': 1036966368}]","[{'url': 's3://sra-pub-src-17/SRR14475530/M7_S3_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14475530/M7_S3_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14475530/M7_S3_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR14475530/M7_S3_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475530/M7_S3_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475530/M7_S3_L004_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M7_S3_L004_I1_001.fastq.gz --read2PairFiles=M7_S3_L004_R1_001.fastq.gz --read3PairFiles=M7_S3_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475531,SRX10823756,SRP319066,SRS8908209,NextSeq 500 paired end sequencing; GSM5287505: M9; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/031/SRR14475531/SRR14475531.fastq.gz', 'md5': 'd7fe557ee3fa81e03dcebc5a847d80f2', 'size': 555836565}]","[{'url': 's3://sra-pub-src-5/SRR14475531/M9_S4_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14475531/M9_S4_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14475531/M9_S4_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR14475531/M9_S4_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR14475531/M9_S4_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14475531/M9_S4_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475531/SRR14475531.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M9_S4_L001_I1_001.fastq.gz --read2PairFiles=M9_S4_L001_R1_001.fastq.gz --read3PairFiles=M9_S4_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475532,SRX10823756,SRP319066,SRS8908209,NextSeq 500 paired end sequencing; GSM5287505: M9; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/032/SRR14475532/SRR14475532.fastq.gz', 'md5': '7402feb235a89f1bedb67e6770696ceb', 'size': 555283464}]","[{'url': 's3://sra-pub-src-14/SRR14475532/M9_S4_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475532/M9_S4_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475532/M9_S4_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR14475532/M9_S4_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14475532/M9_S4_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14475532/M9_S4_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475532/SRR14475532.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M9_S4_L002_I1_001.fastq.gz --read2PairFiles=M9_S4_L002_R1_001.fastq.gz --read3PairFiles=M9_S4_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475533,SRX10823756,SRP319066,SRS8908209,NextSeq 500 paired end sequencing; GSM5287505: M9; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/033/SRR14475533/SRR14475533.fastq.gz', 'md5': '053eb043692bc188b3be90b80d9c12cf', 'size': 560732885}]","[{'url': 's3://sra-pub-src-16/SRR14475533/M9_S4_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475533/M9_S4_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR14475533/M9_S4_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR14475533/M9_S4_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475533/M9_S4_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR14475533/M9_S4_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475533/SRR14475533.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M9_S4_L003_I1_001.fastq.gz --read2PairFiles=M9_S4_L003_R1_001.fastq.gz --read3PairFiles=M9_S4_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475534,SRX10823756,SRP319066,SRS8908209,NextSeq 500 paired end sequencing; GSM5287505: M9; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/034/SRR14475534/SRR14475534.fastq.gz', 'md5': 'b9e4cbe53b0a65689297b54e8147d971', 'size': 562549905}]","[{'url': 's3://sra-pub-src-9/SRR14475534/M9_S4_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14475534/M9_S4_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR14475534/M9_S4_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR14475534/M9_S4_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475534/M9_S4_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR14475534/M9_S4_L004_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M9_S4_L004_I1_001.fastq.gz --read2PairFiles=M9_S4_L004_R1_001.fastq.gz --read3PairFiles=M9_S4_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475535,SRX10823757,SRP319066,SRS8908210,NextSeq 500 paired end sequencing; GSM5287506: M10; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/035/SRR14475535/SRR14475535.fastq.gz', 'md5': '03567a92d3c0a5705dd6d95f20577297', 'size': 514940664}]","[{'url': 's3://sra-pub-src-5/SRR14475535/M10_S7_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14475535/M10_S7_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR14475535/M10_S7_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR14475535/SRR14475535'}, {'url': 's3://sra-pub-run-2/SRR14475535/SRR14475535.1'}]","[{'url': 'gs://sra-pub-src-18/SRR14475535/M10_S7_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14475535/M10_S7_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14475535/M10_S7_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR14475535/SRR14475535.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra53/SRR/014136/SRR14475535'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M10_S7_L001_I1_001.fastq.gz --read2PairFiles=M10_S7_L001_R1_001.fastq.gz --read3PairFiles=M10_S7_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475536,SRX10823757,SRP319066,SRS8908210,NextSeq 500 paired end sequencing; GSM5287506: M10; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/036/SRR14475536/SRR14475536.fastq.gz', 'md5': '02041a93ddc9c626dd689e6153f8acc8', 'size': 514029342}]","[{'url': 's3://sra-pub-src-8/SRR14475536/M10_S7_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14475536/M10_S7_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14475536/M10_S7_L002_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR14475536/M10_S7_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14475536/M10_S7_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14475536/M10_S7_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475536/SRR14475536.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M10_S7_L002_I1_001.fastq.gz --read2PairFiles=M10_S7_L002_R1_001.fastq.gz --read3PairFiles=M10_S7_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475537,SRX10823757,SRP319066,SRS8908210,NextSeq 500 paired end sequencing; GSM5287506: M10; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/037/SRR14475537/SRR14475537.fastq.gz', 'md5': '1a089a253bd3216853ee5d508dc20cf4', 'size': 515799899}]","[{'url': 's3://sra-pub-src-8/SRR14475537/M10_S7_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14475537/M10_S7_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14475537/M10_S7_L003_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-3/SRR14475537/SRR14475537.1'}]","[{'url': 'gs://sra-pub-src-12/SRR14475537/M10_S7_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14475537/M10_S7_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14475537/M10_S7_L003_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-4/SRR14475537/SRR14475537.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra35/SRR/014136/SRR14475537'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M10_S7_L003_I1_001.fastq.gz --read2PairFiles=M10_S7_L003_R1_001.fastq.gz --read3PairFiles=M10_S7_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475538,SRX10823757,SRP319066,SRS8908210,NextSeq 500 paired end sequencing; GSM5287506: M10; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/038/SRR14475538/SRR14475538.fastq.gz', 'md5': 'a9de74fb6b8ec22f5739d42a471d4a76', 'size': 517003457}]","[{'url': 's3://sra-pub-src-11/SRR14475538/M10_S7_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR14475538/M10_S7_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR14475538/M10_S7_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-17/SRR14475538/M10_S7_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14475538/M10_S7_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR14475538/M10_S7_L004_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M10_S7_L004_I1_001.fastq.gz --read2PairFiles=M10_S7_L004_R1_001.fastq.gz --read3PairFiles=M10_S7_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475539,SRX10823758,SRP319066,SRS8908211,NextSeq 500 paired end sequencing; GSM5287507: M12; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/039/SRR14475539/SRR14475539.fastq.gz', 'md5': 'af7ae7e8b203ed2eb8de5ea77fb779a1', 'size': 581517911}]","[{'url': 's3://sra-pub-src-13/SRR14475539/M12_S8_L001_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14475539/M12_S8_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR14475539/M12_S8_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR14475539/M12_S8_L001_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14475539/M12_S8_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR14475539/M12_S8_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475539/SRR14475539.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M12_S8_L001_I1_001.fastq.gz --read2PairFiles=M12_S8_L001_R1_001.fastq.gz --read3PairFiles=M12_S8_L001_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475540,SRX10823758,SRP319066,SRS8908211,NextSeq 500 paired end sequencing; GSM5287507: M12; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/040/SRR14475540/SRR14475540.fastq.gz', 'md5': 'dc4eec10e7b13b6ebcd93ae2b576b482', 'size': 581201430}]","[{'url': 's3://sra-pub-src-14/SRR14475540/M12_S8_L002_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475540/M12_S8_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR14475540/M12_S8_L002_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-run-6/SRR14475540/SRR14475540.1'}]","[{'url': 'gs://sra-pub-src-4/SRR14475540/M12_S8_L002_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR14475540/M12_S8_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR14475540/M12_S8_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-9/SRR14475540/SRR14475540.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra80/SRR/014136/SRR14475540'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M12_S8_L002_I1_001.fastq.gz --read2PairFiles=M12_S8_L002_R1_001.fastq.gz --read3PairFiles=M12_S8_L002_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475541,SRX10823758,SRP319066,SRS8908211,NextSeq 500 paired end sequencing; GSM5287507: M12; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/041/SRR14475541/SRR14475541.fastq.gz', 'md5': '52eb9f9848585a82036c4831826bb8ac', 'size': 583542819}]","[{'url': 's3://sra-pub-src-15/SRR14475541/M12_S8_L003_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR14475541/M12_S8_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR14475541/M12_S8_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR14475541/M12_S8_L003_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR14475541/M12_S8_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR14475541/M12_S8_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR014/14475/SRR14475541/SRR14475541.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M12_S8_L003_I1_001.fastq.gz --read2PairFiles=M12_S8_L003_R1_001.fastq.gz --read3PairFiles=M12_S8_L003_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14475542,SRX10823758,SRP319066,SRS8908211,NextSeq 500 paired end sequencing; GSM5287507: M12; Mus musculus; RNA-Seq,fastq-load.py,2022-04-04,2022-04-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/042/SRR14475542/SRR14475542.fastq.gz', 'md5': '847101d21f76750947a321476b3013ac', 'size': 584569535}]","[{'url': 's3://sra-pub-src-8/SRR14475542/M12_S8_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR14475542/M12_S8_L004_R1_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR14475542/M12_S8_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR14475542/M12_S8_L004_R1_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=M12_S8_L004_I1_001.fastq.gz --read2PairFiles=M12_S8_L004_R1_001.fastq.gz --read3PairFiles=M12_S8_L004_R2_001.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18458443,SRX14591080,SRP365553,SRS12361204,Illumina NovaSeq 6000 paired end sequencing; GSM5968658: ACL-201118-T-10XSC3; Homo sapiens; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/043/SRR18458443/SRR18458443_1.fastq.gz', 'md5': '603ac710127fa54a5cd42c3251ee1e4d', 'size': 1537067944}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/043/SRR18458443/SRR18458443_2.fastq.gz', 'md5': 'b72438c84ee927a28ef50ce1ad980565', 'size': 5153810722}]","[{'url': 's3://sra-pub-src-8/SRR18458443/ZXL-201112-T10_S12_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR18458443/ZXL-201112-T10_S12_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18458443/SRR18458443'}]","[{'url': 'gs://sra-pub-src-15/SRR18458443/ZXL-201112-T10_S12_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR18458443/ZXL-201112-T10_S12_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra78/SRR/018025/SRR18458443'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18458444,SRX14591079,SRP365553,SRS12361203,Illumina NovaSeq 6000 paired end sequencing; GSM5968657: ACL-201120-T; Homo sapiens; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/044/SRR18458444/SRR18458444_1.fastq.gz', 'md5': '10be6491652bb2a09e0421bdfb0026b9', 'size': 1629801095}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/044/SRR18458444/SRR18458444_2.fastq.gz', 'md5': 'a4940855762e139dc0fcedd979b11ffd', 'size': 5357637730}]","[{'url': 's3://sra-pub-src-6/SRR18458444/TFCC-L-R_S28_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR18458444/TFCC-L-R_S28_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18458444/SRR18458444'}]","[{'url': 'gs://sra-pub-src-12/SRR18458444/TFCC-L-R_S28_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR18458444/TFCC-L-R_S28_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra38/SRR/018025/SRR18458444'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18458445,SRX14591078,SRP365553,SRS12361202,Illumina NovaSeq 6000 paired end sequencing; GSM5968656: ACL-T-201116-10XSC3; Homo sapiens; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/045/SRR18458445/SRR18458445_1.fastq.gz', 'md5': 'acbd494feeba59c954596c3fb3d43218', 'size': 1653334016}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/045/SRR18458445/SRR18458445_2.fastq.gz', 'md5': 'b1d2c8386785243e3626b4609ad21c27', 'size': 5429526162}]","[{'url': 's3://sra-pub-src-10/SRR18458445/ACL-201116-1-10XSC3_S32_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR18458445/ACL-201116-1-10XSC3_S32_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18458445/SRR18458445'}]","[{'url': 'gs://sra-pub-src-6/SRR18458445/ACL-201116-1-10XSC3_S32_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR18458445/ACL-201116-1-10XSC3_S32_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra3/SRR/018025/SRR18458445'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18458446,SRX14591077,SRP365553,SRS12361201,Illumina NovaSeq 6000 paired end sequencing; GSM5968655: ACL-201120; Homo sapiens; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/046/SRR18458446/SRR18458446_1.fastq.gz', 'md5': '7e1e544e2dfef2e4b8469538e07f3651', 'size': 1135419078}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/046/SRR18458446/SRR18458446_2.fastq.gz', 'md5': '697fc54fe61f259d25a863166eaa5249', 'size': 3701452482}]","[{'url': 's3://sra-pub-src-8/SRR18458446/SL-201112_S41_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR18458446/SL-201112_S41_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18458446/SRR18458446'}]","[{'url': 'gs://sra-pub-src-15/SRR18458446/SL-201112_S41_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR18458446/SL-201112_S41_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra38/SRR/018025/SRR18458446'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18458447,SRX14591076,SRP365553,SRS12361200,Illumina NovaSeq 6000 paired end sequencing; GSM5968654: ACL-201112-R; Homo sapiens; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/047/SRR18458447/SRR18458447_1.fastq.gz', 'md5': 'e24ff1511cd7855b907244a6ed2ab5a2', 'size': 1247746574}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/047/SRR18458447/SRR18458447_2.fastq.gz', 'md5': '099382411d334e28d5ed41b91da871fc', 'size': 4138591190}]","[{'url': 's3://sra-pub-src-17/SRR18458447/ACL-201112-R_S40_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR18458447/ACL-201112-R_S40_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18458447/SRR18458447'}]","[{'url': 'gs://sra-pub-src-4/SRR18458447/ACL-201112-R_S40_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR18458447/ACL-201112-R_S40_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra34/SRR/018025/SRR18458447'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18458448,SRX14591075,SRP365553,SRS12361199,Illumina NovaSeq 6000 paired end sequencing; GSM5968653: ACL-201112-L; Homo sapiens; RNA-Seq,fastq-load.py,2022-05-02,2022-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/048/SRR18458448/SRR18458448_1.fastq.gz', 'md5': 'a8d0a7bf6b052bace5ff609d1b6ea2a1', 'size': 1425616823}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR184/048/SRR18458448/SRR18458448_2.fastq.gz', 'md5': 'ccd5ba1d5ddb49e7452703d728827e83', 'size': 4703841536}]","[{'url': 's3://sra-pub-src-13/SRR18458448/ACL-201112-L_S36_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR18458448/ACL-201112-L_S36_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18458448/SRR18458448'}]","[{'url': 'gs://sra-pub-src-5/SRR18458448/ACL-201112-L_S36_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR18458448/ACL-201112-L_S36_L002_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra76/SRR/018025/SRR18458448'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985028,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/008/SRR8985028/SRR8985028_1.fastq.gz', 'md5': '026a6884255403d890f49052a2f99406', 'size': '1051226206'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/008/SRR8985028/SRR8985028_2.fastq.gz', 'md5': '3a174a46e22b0d24ad02afa46b58b02d', 'size': '2003001703'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985029,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/009/SRR8985029/SRR8985029_1.fastq.gz', 'md5': 'f868e84ad1ee6dbdeebfbb94cb525861', 'size': '1151889606'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/009/SRR8985029/SRR8985029_2.fastq.gz', 'md5': 'fcade21e3f80d4d2868c73a83f43b4de', 'size': '2160152306'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985030,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/000/SRR8985030/SRR8985030_1.fastq.gz', 'md5': '34fe7e8f24e01cfd8086646a56762d61', 'size': '1115962656'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/000/SRR8985030/SRR8985030_2.fastq.gz', 'md5': '916de48f4d083760a536cb9c50b8cc28', 'size': '2107496547'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985031,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/001/SRR8985031/SRR8985031_1.fastq.gz', 'md5': 'de3095ce76e53bd6cd54a5ce2c86d1c0', 'size': '1092437112'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/001/SRR8985031/SRR8985031_2.fastq.gz', 'md5': 'ce05baa82c7e85f8091940dedc15d57e', 'size': '2067861653'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985032,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/002/SRR8985032/SRR8985032_1.fastq.gz', 'md5': '88f4812c4b2321f820a8beed05aab5c2', 'size': '766487330'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/002/SRR8985032/SRR8985032_2.fastq.gz', 'md5': '4033a87c0a4ba1f08a31ea235b5cabb1', 'size': '1544521436'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985033,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/003/SRR8985033/SRR8985033_1.fastq.gz', 'md5': '08e6d49802f9263e51fbef45db22f9da', 'size': '743032206'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/003/SRR8985033/SRR8985033_2.fastq.gz', 'md5': '0be62bd32c6ef98a4b133fda75d7a2c4', 'size': '1510312551'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985034,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/004/SRR8985034/SRR8985034_1.fastq.gz', 'md5': 'e12ecd02255ef629000d14642dba0793', 'size': '687440799'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/004/SRR8985034/SRR8985034_2.fastq.gz', 'md5': 'dea552af4ee78fde9b4973ea54ac3f54', 'size': '1399015123'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985035,,,,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764290,NextSeq 500 paired end sequencing; GSM3738693: HH25 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698684,HH25 scRNA-seq,Gallus gallus,Developing hindlimb,,,360282893,30263763012,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/005/SRR8985035/SRR8985035_1.fastq.gz', 'md5': '857045f1dda224821d9cf016cb10b041', 'size': '782543998'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/005/SRR8985035/SRR8985035_2.fastq.gz', 'md5': '0d1dcb16a4886b788700607cd296da28', 'size': '1568853418'}]",,,,,,,,,,,,,,HH25,Whole autopod,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985039,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/009/SRR8985039/SRR8985039_1.fastq.gz', 'md5': '46179697ea3158ef35c48f21dbc6f4bf', 'size': '1363471989'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/009/SRR8985039/SRR8985039_2.fastq.gz', 'md5': '660e2dc1f3bd4d624436cce7bbc4f93a', 'size': '2595334385'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985040,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/000/SRR8985040/SRR8985040_1.fastq.gz', 'md5': 'db7a7afa82498942f7d509df9f347f0c', 'size': '1473527496'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/000/SRR8985040/SRR8985040_2.fastq.gz', 'md5': '825726a8fe095f8570574efff69eeedb', 'size': '2762235098'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985041,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/001/SRR8985041/SRR8985041_1.fastq.gz', 'md5': 'f698a6a7230b91a73b82eef2d0b251a3', 'size': '1436492424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/001/SRR8985041/SRR8985041_2.fastq.gz', 'md5': '51d9f3f71e8163719bba18eea1dd082f', 'size': '2711596874'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985042,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/002/SRR8985042/SRR8985042_1.fastq.gz', 'md5': '62a0d6e516702ac1e5476d60bb8c68f5', 'size': '1406570311'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/002/SRR8985042/SRR8985042_2.fastq.gz', 'md5': '6d08aeca187f519f96d16ab6bd2f2b40', 'size': '2660844898'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985043,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/003/SRR8985043/SRR8985043_1.fastq.gz', 'md5': 'ed665f7648b2a6fb27c7a0ea84ba747e', 'size': '1006127721'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/003/SRR8985043/SRR8985043_2.fastq.gz', 'md5': '9705b0bcc2167b82073437ab1c90b66d', 'size': '2026315263'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985044,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/004/SRR8985044/SRR8985044_1.fastq.gz', 'md5': 'de665104603d8097daa6c9857ade6910', 'size': '976198360'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/004/SRR8985044/SRR8985044_2.fastq.gz', 'md5': 'ba7001f6b7caaef6e8b1426c2d5c98dd', 'size': '1984374684'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985045,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/005/SRR8985045/SRR8985045_1.fastq.gz', 'md5': '1f0ace431964b67822bb4688c2ffd19e', 'size': '907742978'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/005/SRR8985045/SRR8985045_2.fastq.gz', 'md5': '11e738decbab3e5f09493a89f06fd11d', 'size': '1848495993'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8985046,,,,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,,,,,,,,,,SRX5764292,NextSeq 500 paired end sequencing; GSM3738695: HH31 scRNA-seq; Gallus gallus; RNA-Seq,ILLUMINA,NextSeq 500,SRP194133,"Single cell transcriptomes of developing chicken hind limbs at stages HH25, HH29 and HH31","We sequenced 17'628 cells coming from three key developmental stages of chicken autopod patterning. We identified 23 cell populations with distinct transcriptional profiles, including essential populations like the apical ectodermal ridge. We also inferred gene co-expression modules that coincide with distinct tissue types across developmental time, and used them to track patterning-relevant cell populations of the forming digits. The supplementary file contains processed UMI count matrices, which also include meta data of each cell, e.g. cluster. Overall design: Droplet-based single cell RNA-seq of dissociated developing limbs of chicken at three different stages",SRS4698686,HH31 scRNA-seq,Gallus gallus,Developing hindlimb,,,470013518,39481135512,2019-05-10,2019-05-11,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/006/SRR8985046/SRR8985046_1.fastq.gz', 'md5': 'e6b3e1b5c6338d20a498e9b9d6cfffc8', 'size': '1019522209'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR898/006/SRR8985046/SRR8985046_2.fastq.gz', 'md5': '73aa6a218a88928c134f7149dc0f0b62', 'size': '2043578279'}]",,,,,,,,,,,,,,HH31,Tip of digit 4,10x v2,Two combined sequencing runs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901267,,,,HiSeq X Ten paired end sequencing; GSM4274188: CS13_limbbud_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569445,HiSeq X Ten paired end sequencing; GSM4274188: CS13_limbbud_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005478,CS13_limbbud_10x,Homo sapiens,human embryonic cells,,,437337924,132076053048,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/067/SRR10901267/SRR10901267_1.fastq.gz', 'md5': 'ad6a6b69a3f966e4e2df21ca84ef6161', 'size': '39249600927'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/067/SRR10901267/SRR10901267_2.fastq.gz', 'md5': 'e1a73de27372e9aa60e0d5128ffc230c', 'size': '37147253353'}]",Limb bud,Week 5 (CS13),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901268,,,,HiSeq X Ten paired end sequencing; GSM4274189: CS15_limbbud_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569446,HiSeq X Ten paired end sequencing; GSM4274189: CS15_limbbud_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005479,CS15_limbbud_10x,Homo sapiens,human embryonic cells,,,449676843,135802406586,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/068/SRR10901268/SRR10901268_1.fastq.gz', 'md5': 'c38cfba2a9371a7135878e587064fb90', 'size': '39795060909'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/068/SRR10901268/SRR10901268_2.fastq.gz', 'md5': '5b650bf1ee97961b254cde75842ab18e', 'size': '39843144868'}]",Limb bud,Week 5 (CS15),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10901269,,,,HiSeq X Ten paired end sequencing; GSM4274190: CS15(2)_limbbud_10x; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7569447,HiSeq X Ten paired end sequencing; GSM4274190: CS15(2)_limbbud_10x; Homo sapiens; RNA-Seq,ILLUMINA,HiSeq X Ten,SRP242103,Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses,"Mapping the transcriptional landscape of human embryonic skeletogenesis at single-cell resolution during limb bud and primary ossification center (POC) formation. We found significant heterogeneity of stromal cells within the limb bud mesenchyme that specified proximal-distal and anterior-posterior patterning. Embryonic skeletal stem and progenitor cells first appeared during POC formation, which were highly enriched by CADM1 expression and could differentiate into osteoblasts, chondrocytes and periosteal mesenchymal stromal cells. Overall design: We performed droplet-based scRNA-seq of 42,857 cells to firstly construct a molecular landscape of skeletogenesis in human embryos",SRS6005480,CS15(2)_limbbud_10x,Homo sapiens,human embryonic cells,,,437556484,132142058168,2021-01-25,2021-01-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/069/SRR10901269/SRR10901269_1.fastq.gz', 'md5': '525cfeeed363018aea92a6af631a0117', 'size': '39155785669'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/069/SRR10901269/SRR10901269_2.fastq.gz', 'md5': '43e2f8b2ae45397640789c64d683290b', 'size': '38718190936'}]",Limb bud,Week 5 (CS15),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745783,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227224: E11.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421171,Illumina NovaSeq 6000 paired end sequencing; GSM4227224: E11.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867775,E11.5,Mus musculus,hindlimb,,C57BL/6,535973448,48773583768,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/083/SRR10745783/SRR10745783.fastq.gz', 'md5': '0cef67d083a901ca15968e1cc8a084c8', 'size': '12535143247'}]",hindlimb,embryonic day 11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745784,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227224: E11.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421171,Illumina NovaSeq 6000 paired end sequencing; GSM4227224: E11.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867775,E11.5,Mus musculus,hindlimb,,C57BL/6,535973448,48773583768,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/084/SRR10745784/SRR10745784.fastq.gz', 'md5': '957e3f12f9b9c1c6846e9255e62e5626', 'size': '12356696271'}]",hindlimb,embryonic day 11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745785,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227225: E13.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421172,Illumina NovaSeq 6000 paired end sequencing; GSM4227225: E13.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867776,E13.5,Mus musculus,hindlimb,,C57BL/6,533520106,48550329646,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/085/SRR10745785/SRR10745785.fastq.gz', 'md5': '7ea6831e342b368cf0da8474836d174c', 'size': '12160306330'}]",hindlimb,embryonic day 13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745786,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227225: E13.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421172,Illumina NovaSeq 6000 paired end sequencing; GSM4227225: E13.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867776,E13.5,Mus musculus,hindlimb,,C57BL/6,533520106,48550329646,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/086/SRR10745786/SRR10745786.fastq.gz', 'md5': '496b70b4d3090d47f0fbc141944976e1', 'size': '11987502247'}]",hindlimb,embryonic day 13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745787,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227226: E15.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421173,Illumina NovaSeq 6000 paired end sequencing; GSM4227226: E15.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867777,E15.5,Mus musculus,hindlimb,,C57BL/6,516620667,47012480697,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/087/SRR10745787/SRR10745787.fastq.gz', 'md5': '14620746919d6fa8e545ddc5e20f41e0', 'size': '11730747706'}]",hindlimb,embryonic day 15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745788,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227226: E15.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421173,Illumina NovaSeq 6000 paired end sequencing; GSM4227226: E15.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867777,E15.5,Mus musculus,hindlimb,,C57BL/6,516620667,47012480697,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/088/SRR10745788/SRR10745788.fastq.gz', 'md5': 'f7cc76aee653bed0d5ee71e796b8f4eb', 'size': '11568611597'}]",hindlimb,embryonic day 15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745789,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227227: E18.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421174,Illumina NovaSeq 6000 paired end sequencing; GSM4227227: E18.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867778,E18.5,Mus musculus,hindlimb,,C57BL/6,543074582,49419786962,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/089/SRR10745789/SRR10745789.fastq.gz', 'md5': 'b74d0e37e1bf5f73fcade5f4ff8cde72', 'size': '12385132524'}]",hindlimb,embryonic day 18.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10745790,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4227227: E18.5; Mus musculus; RNA-Seq,,,,,,,,,,SRX7421174,Illumina NovaSeq 6000 paired end sequencing; GSM4227227: E18.5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP238355,Single cell RNA-sequencing reveals cellular heterogeneity and trajectories of lineage specification during murine embryonic limb development,"The coordinated spatial and temporal regulation of gene expression in the murine hindlimb determines the identity of mesenchymal progenitors and the development of diversity of musculoskeletal tissues they form. Hindlimb development has historically been studied with lineage tracing of individual genes selected a priori, or at the bulk tissue level, which does not allow for the determination of single cell transcriptional programs yielding mature cell types and tissues. To identify the cellular trajectories of lineage specification during limb bud development, we used single cell mRNA sequencing (scRNA-seq) to profile the developing murine hindlimb between embryonic days (E)11.5-E18.5. We found cell type heterogeneity at all time points, and the expected cell types that form the mouse hindlimb. In addition, we used RNA fluorescence in situ hybridization (FISH) to examine the spatial locations of cell types and cell trajectories to understand the ancestral continuum of cell maturation. This data provides a resource for the transcriptional program of hindlimb development that will support future studies of musculoskeletal development and generate hypotheses for tissue regeneration. Overall design: Four samples from murine embryonic hindlimb tissue at E11.5, E13.5, E15.5, and E18.5",SRS5867778,E18.5,Mus musculus,hindlimb,,C57BL/6,543074582,49419786962,2019-12-22,2019-12-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/090/SRR10745790/SRR10745790.fastq.gz', 'md5': 'dffb59947a338155dd99b961a8fe87b0', 'size': '12214964925'}]",hindlimb,embryonic day 18.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752712,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230227: muscle_L; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427502,Illumina HiSeq 2500 paired end sequencing; GSM4230227: muscle_L; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873472,muscle_L,Mus musculus,Mouse Lung Alveolar Macrophage,,C57 BL/6J,226835777,22229906146,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/012/SRR10752712/SRR10752712.fastq.gz', 'md5': 'e1833d1180dc9852b7ea488b5c9f9126', 'size': '6223182334'}]",Lung,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752713,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230227: muscle_L; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427502,Illumina HiSeq 2500 paired end sequencing; GSM4230227: muscle_L; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873472,muscle_L,Mus musculus,Mouse Lung Alveolar Macrophage,,C57 BL/6J,226835777,22229906146,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/013/SRR10752713/SRR10752713.fastq.gz', 'md5': '8fdfbfeedb15d6fa30f8c994e938389d', 'size': '6194957004'}]",Lung,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752714,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230227: muscle_L; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427502,Illumina HiSeq 2500 paired end sequencing; GSM4230227: muscle_L; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873472,muscle_L,Mus musculus,Mouse Lung Alveolar Macrophage,,C57 BL/6J,226835777,22229906146,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/014/SRR10752714/SRR10752714.fastq.gz', 'md5': '229308dfcce5bc1d7c7489fdb87f6f6d', 'size': '6182917568'}]",Lung,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741042,SRX10128167,SRP237632,SRS8282575,NextSeq 500 paired end sequencing; GSM5091919: hBM-MSC-M; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/042/SRR13741042/SRR13741042.fastq.gz', 'md5': '72c9b3f0fc69ebd862b96bdda8fc9045', 'size': 2517764276}]","[{'url': 's3://sra-pub-src-9/SRR13741042/hBM-MSC-M_L001_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR13741042/hBM-MSC-M_L001_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR13741042/hBM-MSC-M_L001_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR13741042/hBM-MSC-M_L001_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR13741042/hBM-MSC-M_L001_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR13741042/hBM-MSC-M_L001_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741042/SRR13741042.1'}],70687640,3958507840,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hBM-MSC-M_L001_I1.fastq.gz --read2PairFiles=hBM-MSC-M_L001_R1.fastq.gz --read3PairFiles=hBM-MSC-M_L001_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741043,SRX10128167,SRP237632,SRS8282575,NextSeq 500 paired end sequencing; GSM5091919: hBM-MSC-M; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/043/SRR13741043/SRR13741043.fastq.gz', 'md5': 'fb9e0049a360051aa14917433c32a60b', 'size': 2505790266}]","[{'url': 's3://sra-pub-src-16/SRR13741043/hBM-MSC-M_L002_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741043/hBM-MSC-M_L002_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741043/hBM-MSC-M_L002_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13741043/hBM-MSC-M_L002_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741043/hBM-MSC-M_L002_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741043/hBM-MSC-M_L002_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741043/SRR13741043.1'}],70506318,3948353808,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hBM-MSC-M_L002_I1.fastq.gz --read2PairFiles=hBM-MSC-M_L002_R1.fastq.gz --read3PairFiles=hBM-MSC-M_L002_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741044,SRX10128167,SRP237632,SRS8282575,NextSeq 500 paired end sequencing; GSM5091919: hBM-MSC-M; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/044/SRR13741044/SRR13741044.fastq.gz', 'md5': 'f606e918ce2626d78b85af81cdc8523f', 'size': 2584490164}]","[{'url': 's3://sra-pub-src-16/SRR13741044/hBM-MSC-M_L003_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741044/hBM-MSC-M_L003_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR13741044/hBM-MSC-M_L003_R2.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR13741044/SRR13741044'}, {'url': 's3://sra-pub-run-11/SRR13741044/SRR13741044.1'}]","[{'url': 'gs://sra-pub-src-18/SRR13741044/hBM-MSC-M_L003_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR13741044/hBM-MSC-M_L003_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13741044/hBM-MSC-M_L003_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR13741044/SRR13741044.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13741/SRR13741044/SRR13741044.1'}],72394493,4054091608,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hBM-MSC-M_L003_I1.fastq.gz --read2PairFiles=hBM-MSC-M_L003_R1.fastq.gz --read3PairFiles=hBM-MSC-M_L003_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13741045,SRX10128167,SRP237632,SRS8282575,NextSeq 500 paired end sequencing; GSM5091919: hBM-MSC-M; Homo sapiens; RNA-Seq,fastq-load.py,2021-12-13,2021-12-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/045/SRR13741045/SRR13741045.fastq.gz', 'md5': '2874acd09b9cda6e6b45ffa1d4bb7cbc', 'size': 2523063680}]","[{'url': 's3://sra-pub-src-15/SRR13741045/hBM-MSC-M_L004_I1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR13741045/hBM-MSC-M_L004_R1.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR13741045/hBM-MSC-M_L004_I1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR13741045/hBM-MSC-M_L004_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-17/SRR13741045/hBM-MSC-M_L004_R2.fastq.gz.1'}]",[],71095262,3981334672,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--platform=Illumina --readTypes=TTB --read1PairFiles=hBM-MSC-M_L004_I1.fastq.gz --read2PairFiles=hBM-MSC-M_L004_R1.fastq.gz --read3PairFiles=hBM-MSC-M_L004_R2.fastq.gz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764272,SRX10150778,SRP307529,SRS8303091,Illumina HiSeq 4000 paired end sequencing; GSM5100204: H1 MSC + C1 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/072/SRR13764272/SRR13764272_1.fastq.gz', 'md5': 'a3dcafa96145ba65c6b5a9eab1b36594', 'size': 807565786}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/072/SRR13764272/SRR13764272_2.fastq.gz', 'md5': '43e2e79a553fefc9755d41878fb0ecec', 'size': 3287395267}]","[{'url': 's3://sra-pub-src-17/SRR13764272/GHO-2_S2_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR13764272/GHO-2_S2_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-5/SRR13764272/GHO-2_S2_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR13764272/GHO-2_S2_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764272/SRR13764272.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764273,SRX10150778,SRP307529,SRS8303091,Illumina HiSeq 4000 paired end sequencing; GSM5100204: H1 MSC + C1 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/073/SRR13764273/SRR13764273_1.fastq.gz', 'md5': 'd3c19670c76bdfc2abc0f8d9a5658710', 'size': 838346458}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/073/SRR13764273/SRR13764273_2.fastq.gz', 'md5': '5a829092b9dfb658fd7670f00f8557bf', 'size': 3588597434}]","[{'url': 's3://sra-pub-src-11/SRR13764273/GHO-2_S2_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR13764273/GHO-2_S2_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR13764273/GHO-2_S2_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR13764273/GHO-2_S2_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764273/SRR13764273.1'}],48167901,6069155526,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764274,SRX10150778,SRP307529,SRS8303091,Illumina HiSeq 4000 paired end sequencing; GSM5100204: H1 MSC + C1 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/074/SRR13764274/SRR13764274_1.fastq.gz', 'md5': 'd36e7b6def62fbc6b966c4347b2edee5', 'size': 1560731275}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/074/SRR13764274/SRR13764274_2.fastq.gz', 'md5': '74b5ba965a5afdea0986df297852d2b9', 'size': 6620824543}]","[{'url': 's3://sra-pub-src-16/SRR13764274/GHO-2_S2_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR13764274/GHO-2_S2_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-15/SRR13764274/GHO-2_S2_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR13764274/GHO-2_S2_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR013/13764/SRR13764274/SRR13764274.1'}],88936838,11206041588,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13764275,SRX10150778,SRP307529,SRS8303091,Illumina HiSeq 4000 paired end sequencing; GSM5100204: H1 MSC + C1 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-16,2022-02-17,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/075/SRR13764275/SRR13764275_1.fastq.gz', 'md5': 'c11c4bd02826326f047ea7889acf47d5', 'size': 1595094322}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/075/SRR13764275/SRR13764275_2.fastq.gz', 'md5': 'a461b2ccca58e67f859959057cb934a1', 'size': 6412244833}]",[{'url': 's3://sra-pub-src-12/SRR13764275/GHO-2_S2_L003_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-7/SRR13764275/GHO-2_S2_L003_R1_001.fastq.gz.1'}],[],91053568,11472749568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390122,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/022/SRR15390122/SRR15390122_1.fastq.gz', 'md5': 'b30ef2536670559bafda39cffde33331', 'size': 535098486}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/022/SRR15390122/SRR15390122_2.fastq.gz', 'md5': 'a626dd1555d8dad5d3d3ed0829f16858', 'size': 2060619441}]","[{'url': 's3://sra-pub-src-9/SRR15390122/HOU-11_S9_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390122/HOU-11_S9_L001_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390122/HOU-11_S9_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390122/HOU-11_S9_L001_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390122/SRR15390122.1'}],29783862,3812334336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390123,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/023/SRR15390123/SRR15390123_1.fastq.gz', 'md5': '21ef2fe0e9985f5ac83383f06885796f', 'size': 535744202}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/023/SRR15390123/SRR15390123_2.fastq.gz', 'md5': 'a054a97e06fa7939266dd2b6000469b4', 'size': 2064252021}]","[{'url': 's3://sra-pub-src-8/SRR15390123/HOU-11_S9_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR15390123/HOU-11_S9_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390123/SRR15390123'}, {'url': 's3://sra-pub-run-2/SRR15390123/SRR15390123.1'}]","[{'url': 'gs://sra-pub-src-11/SRR15390123/HOU-11_S9_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-11/SRR15390123/HOU-11_S9_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-11/SRR15390123/SRR15390123.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra16/SRR/015029/SRR15390123'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390124,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/024/SRR15390124/SRR15390124_1.fastq.gz', 'md5': 'b184ee771037d852c209b5161c5759dd', 'size': 541163015}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/024/SRR15390124/SRR15390124_2.fastq.gz', 'md5': '57e78fa79caed5a7e40bf7a427fca282', 'size': 2068807805}]","[{'url': 's3://sra-pub-src-18/SRR15390124/HOU-11_S9_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390124/HOU-11_S9_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390124/HOU-11_S9_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390124/HOU-11_S9_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390124/SRR15390124.1'}],29957232,3834525696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390125,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/025/SRR15390125/SRR15390125_1.fastq.gz', 'md5': 'fb43654b13c3294ea2aed48f1d74a397', 'size': 542068447}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/025/SRR15390125/SRR15390125_2.fastq.gz', 'md5': 'ee6b5ad1cd6adc0909b514f493327749', 'size': 2059650734}]","[{'url': 's3://sra-pub-src-13/SRR15390125/HOU-11_S9_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-13/SRR15390125/HOU-11_S9_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-3/SRR15390125/HOU-11_S9_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-3/SRR15390125/HOU-11_S9_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390125/SRR15390125.1'}],30116537,3854916736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390126,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/026/SRR15390126/SRR15390126_1.fastq.gz', 'md5': '4854f6410b29c3f76c85c11b0f49385d', 'size': 525755138}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/026/SRR15390126/SRR15390126_2.fastq.gz', 'md5': '47eb0ae8b3e99ca10a3efeb6136215d6', 'size': 1969643879}]","[{'url': 's3://sra-pub-src-12/SRR15390126/HOU-11_S9_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390126/HOU-11_S9_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390126/HOU-11_S9_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390126/HOU-11_S9_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390126/SRR15390126.1'}],29282603,3748173184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390127,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/027/SRR15390127/SRR15390127_1.fastq.gz', 'md5': '9e547c15e185a8855c0ad3e61d5081c0', 'size': 515414364}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/027/SRR15390127/SRR15390127_2.fastq.gz', 'md5': '33261d73d412db09de9d56d39784844a', 'size': 1945475995}]","[{'url': 's3://sra-pub-src-12/SRR15390127/HOU-11_S9_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-14/SRR15390127/HOU-11_S9_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390127/SRR15390127'}, {'url': 's3://sra-pub-run-12/SRR15390127/SRR15390127.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390127/HOU-11_S9_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR15390127/HOU-11_S9_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR15390127/SRR15390127.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390127'}],28572847,3657324416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390128,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/028/SRR15390128/SRR15390128_1.fastq.gz', 'md5': 'ecbc977dc5330da1ceb9f1c393422432', 'size': 525368560}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/028/SRR15390128/SRR15390128_2.fastq.gz', 'md5': 'a70f1f694bb8904cb0a99369b646f8a9', 'size': 1996634619}]","[{'url': 's3://sra-pub-src-15/SRR15390128/HOU-11_S9_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390128/HOU-11_S9_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390128/SRR15390128'}, {'url': 's3://sra-pub-run-4/SRR15390128/SRR15390128.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15390128/HOU-11_S9_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390128/HOU-11_S9_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR15390128/SRR15390128.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/015029/SRR15390128'}],28376599,3632204672,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390129,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/029/SRR15390129/SRR15390129_1.fastq.gz', 'md5': 'e34ae79086a43fc78495089a648707b2', 'size': 514849772}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/029/SRR15390129/SRR15390129_2.fastq.gz', 'md5': 'c4e87f3548fe265f4d9ce0ffc5a2ddfa', 'size': 1983573859}]","[{'url': 's3://sra-pub-src-16/SRR15390129/HOU-11_S9_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390129/HOU-11_S9_L008_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390129/HOU-11_S9_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390129/HOU-11_S9_L008_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390129/SRR15390129.1'}],27947329,3577258112,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390130,SRX11692400,SRP331750,SRS9723996,Illumina HiSeq 4000 paired end sequencing; GSM5510239: H3 MSC + C3 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/030/SRR15390130/SRR15390130_1.fastq.gz', 'md5': '3675c53dc60c4f869f0967bb2a9bd5dc', 'size': 524271903}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/030/SRR15390130/SRR15390130_2.fastq.gz', 'md5': 'cc435ab0e3266564283830fbb7b5ef78', 'size': 1988129967}]","[{'url': 's3://sra-pub-src-6/SRR15390130/HOU-11_S9_L009_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR15390130/HOU-11_S9_L009_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390130/SRR15390130'}]","[{'url': 'gs://sra-pub-src-8/SRR15390130/HOU-11_S9_L009_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR15390130/HOU-11_S9_L009_R2_001.fastq.gz.1'}]",[],29235814,3742184192,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390149,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/049/SRR15390149/SRR15390149_1.fastq.gz', 'md5': 'a46e0561cb3a080e795bb2b96ab7b4c0', 'size': 560710455}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/049/SRR15390149/SRR15390149_2.fastq.gz', 'md5': '72241e64348b9b61c245ccdf4487d6cf', 'size': 2196622565}]","[{'url': 's3://sra-pub-src-10/SRR15390149/HOU-6_S5_L001_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15390149/HOU-6_S5_L001_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390149/SRR15390149'}, {'url': 's3://sra-pub-run-9/SRR15390149/SRR15390149.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15390149/HOU-6_S5_L001_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15390149/HOU-6_S5_L001_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-6/SRR15390149/SRR15390149.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra73/SRR/015029/SRR15390149'}],31510060,4033287680,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390150,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/050/SRR15390150/SRR15390150_1.fastq.gz', 'md5': 'd1caa188cd3714471b5e0e2d525430bf', 'size': 558876578}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/050/SRR15390150/SRR15390150_2.fastq.gz', 'md5': '420b24b7652e63b1acfb8542f1ab5886', 'size': 2193851211}]","[{'url': 's3://sra-pub-src-18/SRR15390150/HOU-6_S5_L002_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390150/HOU-6_S5_L002_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390150/SRR15390150'}, {'url': 's3://sra-pub-run-3/SRR15390150/SRR15390150.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390150/HOU-6_S5_L002_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390150/HOU-6_S5_L002_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-12/SRR15390150/SRR15390150.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra39/SRR/015029/SRR15390150'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390151,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/051/SRR15390151/SRR15390151_1.fastq.gz', 'md5': '9a210a1196d29068a4f1bd42933f26ac', 'size': 565804725}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/051/SRR15390151/SRR15390151_2.fastq.gz', 'md5': 'ba4f2698b4c149e9ab702af06bef2426', 'size': 2201805077}]","[{'url': 's3://sra-pub-src-18/SRR15390151/HOU-6_S5_L003_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390151/HOU-6_S5_L003_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390151/HOU-6_S5_L003_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390151/HOU-6_S5_L003_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390151/SRR15390151.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390152,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/052/SRR15390152/SRR15390152_1.fastq.gz', 'md5': 'e1de643d4aaec0f5ee987855f949b384', 'size': 566787196}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/052/SRR15390152/SRR15390152_2.fastq.gz', 'md5': 'd72917132e9dfdaa0c15b9305490842d', 'size': 2194577774}]","[{'url': 's3://sra-pub-src-17/SRR15390152/HOU-6_S5_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390152/HOU-6_S5_L004_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390152/HOU-6_S5_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390152/HOU-6_S5_L004_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390152/SRR15390152.1'}],31798855,4070253440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390153,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/053/SRR15390153/SRR15390153_1.fastq.gz', 'md5': 'b4b33adf8ee3a2767011ac50fce6a0de', 'size': 553050087}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/053/SRR15390153/SRR15390153_2.fastq.gz', 'md5': '3b6c1f30300cc66f3073f2edfbd233d7', 'size': 2099658480}]","[{'url': 's3://sra-pub-src-18/SRR15390153/HOU-6_S5_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR15390153/HOU-6_S5_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-13/SRR15390153/HOU-6_S5_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-13/SRR15390153/HOU-6_S5_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390153/SRR15390153.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390154,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/054/SRR15390154/SRR15390154_1.fastq.gz', 'md5': '1b0571c13838fcdf4d3899519dbf4230', 'size': 543094965}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/054/SRR15390154/SRR15390154_2.fastq.gz', 'md5': '5c3ef2d36821b10e1ca203ba0c86c945', 'size': 2076847476}]","[{'url': 's3://sra-pub-src-3/SRR15390154/HOU-6_S5_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR15390154/HOU-6_S5_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390154/SRR15390154'}, {'url': 's3://sra-pub-run-11/SRR15390154/SRR15390154.1'}]","[{'url': 'gs://sra-pub-src-5/SRR15390154/HOU-6_S5_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR15390154/HOU-6_S5_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390154/SRR15390154.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra54/SRR/015029/SRR15390154'}],30374338,3887915264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390155,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/055/SRR15390155/SRR15390155_1.fastq.gz', 'md5': 'fcb108bc65a2b443bc118c1e05dfa312', 'size': 362742976}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/055/SRR15390155/SRR15390155_2.fastq.gz', 'md5': 'bf648f8852bbde819174af3fcdff1def', 'size': 1411765406}]","[{'url': 's3://sra-pub-src-12/SRR15390155/HOU-6_S5_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR15390155/HOU-6_S5_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390155/SRR15390155'}, {'url': 's3://sra-pub-run-12/SRR15390155/SRR15390155.1'}]","[{'url': 'gs://sra-pub-src-14/SRR15390155/HOU-6_S5_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR15390155/HOU-6_S5_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR15390155/SRR15390155.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra17/SRR/015029/SRR15390155'}],19987645,2558418560,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390156,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/056/SRR15390156/SRR15390156_1.fastq.gz', 'md5': '9e53774870807a77a3ee188a76697e48', 'size': 357074701}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/056/SRR15390156/SRR15390156_2.fastq.gz', 'md5': '28e23ae6aba317a74b043cc17f06da3b', 'size': 1402991384}]","[{'url': 's3://sra-pub-src-17/SRR15390156/HOU-6_S5_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR15390156/HOU-6_S5_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390156/SRR15390156'}, {'url': 's3://sra-pub-run-11/SRR15390156/SRR15390156.1'}]","[{'url': 'gs://sra-pub-src-7/SRR15390156/HOU-6_S5_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR15390156/HOU-6_S5_L008_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR15390156/SRR15390156.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/015029/SRR15390156'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390157,SRX11692403,SRP331750,SRS9723999,Illumina HiSeq 4000 paired end sequencing; GSM5510242: H4 MSC + C4 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/057/SRR15390157/SRR15390157_1.fastq.gz', 'md5': '01b9fb2065bad099225595623ffe2d44', 'size': 551218627}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/057/SRR15390157/SRR15390157_2.fastq.gz', 'md5': '2fb8a9a16cd43e40d07e8b360de40f3f', 'size': 2118371936}]",[{'url': 's3://sra-pub-src-10/SRR15390157/HOU-6_S5_L009_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-9/SRR15390157/HOU-6_S5_L009_R1_001.fastq.gz.1'}],[],31020124,3970575872,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390171,SRX11692406,SRP331750,SRS9724002,Illumina HiSeq 4000 paired end sequencing; GSM5510245: H5 MSC + C5 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/071/SRR15390171/SRR15390171_1.fastq.gz', 'md5': 'fd03a854ea7ba03c5212831c5f87ffe6', 'size': 1046551909}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/071/SRR15390171/SRR15390171_2.fastq.gz', 'md5': 'f24776fe385bada66044bcfd4a81cd05', 'size': 3998700053}]","[{'url': 's3://sra-pub-src-9/SRR15390171/HOU-19_S3_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR15390171/HOU-19_S3_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-16/SRR15390171/HOU-19_S3_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-16/SRR15390171/HOU-19_S3_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390171/SRR15390171.1'}],58106790,7437669120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390172,SRX11692406,SRP331750,SRS9724002,Illumina HiSeq 4000 paired end sequencing; GSM5510245: H5 MSC + C5 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/072/SRR15390172/SRR15390172_1.fastq.gz', 'md5': '2f4076eec87799e4ef4275bc2f6e7fc4', 'size': 1013849547}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/072/SRR15390172/SRR15390172_2.fastq.gz', 'md5': '5113f90b9a8874e081b60677f040a49f', 'size': 3947693235}]","[{'url': 's3://sra-pub-src-15/SRR15390172/HOU-19_S3_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR15390172/HOU-19_S3_L006_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15390172/HOU-19_S3_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR15390172/HOU-19_S3_L006_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390172/SRR15390172.1'}],57614250,7374624000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390173,SRX11692406,SRP331750,SRS9724002,Illumina HiSeq 4000 paired end sequencing; GSM5510245: H5 MSC + C5 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/073/SRR15390173/SRR15390173_1.fastq.gz', 'md5': '2a78cf73085e01ed86cbe0145811699d', 'size': 1303489925}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/073/SRR15390173/SRR15390173_2.fastq.gz', 'md5': 'c9130e08476ca716695e7e08f7dbcf3c', 'size': 4835061523}]","[{'url': 's3://sra-pub-src-10/SRR15390173/HOU-19_S3_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-10/SRR15390173/HOU-19_S3_L007_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-9/SRR15390173/HOU-19_S3_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-9/SRR15390173/HOU-19_S3_L007_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR015/15390/SRR15390173/SRR15390173.1'}],71684378,9175600384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390174,SRX11692406,SRP331750,SRS9724002,Illumina HiSeq 4000 paired end sequencing; GSM5510245: H5 MSC + C5 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-22,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/074/SRR15390174/SRR15390174_1.fastq.gz', 'md5': '3e0fe3799febc9e66fc0e38cbbe6a39e', 'size': 1017601918}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/074/SRR15390174/SRR15390174_2.fastq.gz', 'md5': '84c32b22ef8c884df75fb24d61608fb7', 'size': 3804320386}]",[{'url': 's3://sra-pub-src-17/SRR15390174/HOU-19_S3_L008_R1_001.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-7/SRR15390174/HOU-19_S3_L008_R1_001.fastq.gz.1'}],[],56821270,7273122560,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390183,SRX11692409,SRP331750,SRS9724005,Illumina HiSeq 4000 paired end sequencing; GSM5510248: H6 MSC + C6 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/083/SRR15390183/SRR15390183_1.fastq.gz', 'md5': 'c09bc6118971d36c2b2280ff24c998b4', 'size': 1355414654}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/083/SRR15390183/SRR15390183_2.fastq.gz', 'md5': 'a2e93b40271888a974d714b717466025', 'size': 5139031673}]","[{'url': 's3://sra-pub-src-6/SRR15390183/HOU-20_S4_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-6/SRR15390183/HOU-20_S4_L005_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390183/SRR15390183'}, {'url': 's3://sra-pub-run-8/SRR15390183/SRR15390183.1'}]","[{'url': 'gs://sra-pub-src-8/SRR15390183/HOU-20_S4_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR15390183/HOU-20_S4_L005_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-1/SRR15390183/SRR15390183.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra53/SRR/015029/SRR15390183'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390184,SRX11692409,SRP331750,SRS9724005,Illumina HiSeq 4000 paired end sequencing; GSM5510248: H6 MSC + C6 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/084/SRR15390184/SRR15390184_1.fastq.gz', 'md5': '3d7a86e082a675a326c79490444b5a04', 'size': 690158947}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/084/SRR15390184/SRR15390184_2.fastq.gz', 'md5': 'd5d7c38085c6b9f84f156330e7db989b', 'size': 2667048545}]","[{'url': 's3://sra-pub-src-15/SRR15390184/HOU-20_S4_L006_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR15390184/HOU-20_S4_L006_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390184/SRR15390184'}, {'url': 's3://sra-pub-run-4/SRR15390184/SRR15390184.1'}]","[{'url': 'gs://sra-pub-src-6/SRR15390184/HOU-20_S4_L006_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR15390184/HOU-20_S4_L006_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-5/SRR15390184/SRR15390184.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra34/SRR/015029/SRR15390184'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390185,SRX11692409,SRP331750,SRS9724005,Illumina HiSeq 4000 paired end sequencing; GSM5510248: H6 MSC + C6 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/085/SRR15390185/SRR15390185_1.fastq.gz', 'md5': 'd98a7fd6f5fac4a9100d1bbe1454a7ad', 'size': 878861482}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/085/SRR15390185/SRR15390185_2.fastq.gz', 'md5': 'e60a5dc3f414b8d44b9f248752fbc0e8', 'size': 3213553791}]","[{'url': 's3://sra-pub-src-16/SRR15390185/HOU-20_S4_L007_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-16/SRR15390185/HOU-20_S4_L007_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390185/SRR15390185'}, {'url': 's3://sra-pub-run-13/SRR15390185/SRR15390185.1'}]","[{'url': 'gs://sra-pub-src-10/SRR15390185/HOU-20_S4_L007_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR15390185/HOU-20_S4_L007_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-run-2/SRR15390185/SRR15390185.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra32/SRR/015029/SRR15390185'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR15390186,SRX11692409,SRP331750,SRS9724005,Illumina HiSeq 4000 paired end sequencing; GSM5510248: H6 MSC + C6 MSC; Pan troglodytes; Homo sapiens; RNA-Seq,,2022-02-17,2022-03-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/086/SRR15390186/SRR15390186_1.fastq.gz', 'md5': 'b5307c2ee62ecc76c709c51e87b1c6ff', 'size': 1312680691}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR153/086/SRR15390186/SRR15390186_2.fastq.gz', 'md5': '8f4bf8b27505a4d16fc67edc68e1dbb0', 'size': 4865100789}]","[{'url': 's3://sra-pub-src-11/SRR15390186/HOU-20_S4_L008_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR15390186/HOU-20_S4_L008_R2_001.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR15390186/SRR15390186'}]","[{'url': 'gs://sra-pub-src-18/SRR15390186/HOU-20_S4_L008_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-18/SRR15390186/HOU-20_S4_L008_R2_001.fastq.gz.1'}]",[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753170,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/070/SRR10753170/SRR10753170_1.fastq.gz', 'md5': '6b0b7fa19a7f804b23cf5b35aeea0f00', 'size': '86858399'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/070/SRR10753170/SRR10753170_2.fastq.gz', 'md5': 'f57a35894d85e033cf192f95510b0e34', 'size': '89662517'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753171,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/071/SRR10753171/SRR10753171_1.fastq.gz', 'md5': '9821e1188366d7f6a0d6f44eff7be019', 'size': '83771818'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/071/SRR10753171/SRR10753171_2.fastq.gz', 'md5': 'a440ccd8944de548b3a8ff26fcd7768e', 'size': '86469847'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753172,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/072/SRR10753172/SRR10753172_1.fastq.gz', 'md5': '84539876db09ea7138353b190ad248bc', 'size': '95817241'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/072/SRR10753172/SRR10753172_2.fastq.gz', 'md5': '647661f35ff4773fbb4642adc83f3643', 'size': '97318631'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753173,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/073/SRR10753173/SRR10753173_1.fastq.gz', 'md5': '880efed1d1b7123dd589cb9e9f0175c8', 'size': '90376806'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/073/SRR10753173/SRR10753173_2.fastq.gz', 'md5': 'fe164662d57c4623d105c17c02647691', 'size': '93592769'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753174,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/074/SRR10753174/SRR10753174_1.fastq.gz', 'md5': 'f85dd2090ed8de47d9448f940841b10a', 'size': '89094214'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/074/SRR10753174/SRR10753174_2.fastq.gz', 'md5': 'df51afb7c23a00b51a2c34dbd3451cea', 'size': '91409942'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753175,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/075/SRR10753175/SRR10753175_1.fastq.gz', 'md5': '16c40aea883dc114b39bf724936fa359', 'size': '114041199'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/075/SRR10753175/SRR10753175_2.fastq.gz', 'md5': 'da2f46c4fd47c4a66e3ce475aca0b149', 'size': '116874602'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753176,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/076/SRR10753176/SRR10753176_1.fastq.gz', 'md5': 'add152c724ae7aaf3ac048cb63ce66dd', 'size': '90741034'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/076/SRR10753176/SRR10753176_2.fastq.gz', 'md5': 'c91c1e8960a166d330ece20cdc972ac9', 'size': '94582437'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753177,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/077/SRR10753177/SRR10753177_1.fastq.gz', 'md5': '09e8959d5b5d6c8b32c5e35962400345', 'size': '98682429'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/077/SRR10753177/SRR10753177_2.fastq.gz', 'md5': 'c0c4f274fb4ada8010fdc66e9b145cc0', 'size': '100864230'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753178,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/078/SRR10753178/SRR10753178_1.fastq.gz', 'md5': 'ff50e600aaa363a4c5aaf70dce7c1ed6', 'size': '90134514'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/078/SRR10753178/SRR10753178_2.fastq.gz', 'md5': 'ab417397d4304ba8ff5619809b2a7abb', 'size': '93731699'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753179,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/079/SRR10753179/SRR10753179_1.fastq.gz', 'md5': '612e1aafaca555571abcba77f08f4e28', 'size': '101406385'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/079/SRR10753179/SRR10753179_2.fastq.gz', 'md5': '72495db08f14af32bd86ff8bf843f0a0', 'size': '103807004'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753180,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/080/SRR10753180/SRR10753180_1.fastq.gz', 'md5': 'cd594425f0015af460253814575b206e', 'size': '106341481'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/080/SRR10753180/SRR10753180_2.fastq.gz', 'md5': 'aeb2b322be619afe6a654380a131010e', 'size': '108163182'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753181,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/081/SRR10753181/SRR10753181_1.fastq.gz', 'md5': '96566bf2ec5129a304c92d1ec600fa5b', 'size': '73220708'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/081/SRR10753181/SRR10753181_2.fastq.gz', 'md5': '0f03f8a394d6507e051fe9baf17915f8', 'size': '75211485'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753182,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/082/SRR10753182/SRR10753182_1.fastq.gz', 'md5': 'a42d9b3104f1217a1847237c76425ec7', 'size': '34846379'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/082/SRR10753182/SRR10753182_2.fastq.gz', 'md5': 'bb995a51e1e14b3e0b22c51eed77c890', 'size': '36152332'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753183,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/083/SRR10753183/SRR10753183_1.fastq.gz', 'md5': 'fb3cdcc5b8168a5373a5e47983c4a90b', 'size': '78897829'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/083/SRR10753183/SRR10753183_2.fastq.gz', 'md5': 'a4d8631cff64bbc4cb9244639a1901c7', 'size': '81401642'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753184,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/084/SRR10753184/SRR10753184_1.fastq.gz', 'md5': 'ca218c6f11123b02670a0b6fb6752633', 'size': '90626289'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/084/SRR10753184/SRR10753184_2.fastq.gz', 'md5': 'c203706b722707d6ccbf7a3263445304', 'size': '93750713'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753185,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/085/SRR10753185/SRR10753185_1.fastq.gz', 'md5': '21d782b1997896372cacedcd5736fd63', 'size': '61317886'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/085/SRR10753185/SRR10753185_2.fastq.gz', 'md5': 'fcd2f4215c13230db547a2b6566261af', 'size': '62882481'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753186,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/086/SRR10753186/SRR10753186_1.fastq.gz', 'md5': 'f0383b6df96f7b134cbfb330ac0df758', 'size': '112575560'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/086/SRR10753186/SRR10753186_2.fastq.gz', 'md5': 'c6a96562e69ae2d404d096621a3a0186', 'size': '115620994'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753187,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/087/SRR10753187/SRR10753187_1.fastq.gz', 'md5': '0ac9a07708007075a08ef73a6ad030e5', 'size': '105377144'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/087/SRR10753187/SRR10753187_2.fastq.gz', 'md5': '02a7b8ae8a5f7c3efa356844fa317e18', 'size': '108637452'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753188,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/088/SRR10753188/SRR10753188_1.fastq.gz', 'md5': 'b33c43a99ca0b30c871334c93b6b8f76', 'size': '111356889'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/088/SRR10753188/SRR10753188_2.fastq.gz', 'md5': '05139d41cc42e18d8b1278354a94a56c', 'size': '113801627'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753189,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/089/SRR10753189/SRR10753189_1.fastq.gz', 'md5': '862a76af6a3c9b961d8edc57f530ac8c', 'size': '114592171'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/089/SRR10753189/SRR10753189_2.fastq.gz', 'md5': '9aa4478f1d20604e06b06c68838f770c', 'size': '117454678'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753190,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/090/SRR10753190/SRR10753190_1.fastq.gz', 'md5': '0f2c592611e4cf20524918cd70d392d7', 'size': '107646333'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/090/SRR10753190/SRR10753190_2.fastq.gz', 'md5': '6151a1ca47c94b897285555aeee36352', 'size': '111451478'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753191,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/091/SRR10753191/SRR10753191_1.fastq.gz', 'md5': 'f296c559dfe0e487b1cdcfd64632598b', 'size': '98840347'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/091/SRR10753191/SRR10753191_2.fastq.gz', 'md5': '5892eac5eac63701f755bb2395c7b458', 'size': '101714466'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753192,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/092/SRR10753192/SRR10753192_1.fastq.gz', 'md5': 'd736e89870a5be3d48f8af4f64051257', 'size': '101426494'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/092/SRR10753192/SRR10753192_2.fastq.gz', 'md5': '0cfb8363ffc975e2030ea43db62ae914', 'size': '105115064'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753193,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/093/SRR10753193/SRR10753193_1.fastq.gz', 'md5': 'a5c6c01efc7f938431657f4ce085596a', 'size': '95212326'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/093/SRR10753193/SRR10753193_2.fastq.gz', 'md5': '030bad800ec2e208fe3549e19cc7db4f', 'size': '97848767'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753194,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/094/SRR10753194/SRR10753194_1.fastq.gz', 'md5': '4bebbbd496d9bda803c3fdc4aed7c52a', 'size': '93715410'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/094/SRR10753194/SRR10753194_2.fastq.gz', 'md5': 'b32347d22e8793ab88be08dbedf72f75', 'size': '96878166'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753195,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/095/SRR10753195/SRR10753195_1.fastq.gz', 'md5': 'dee5e7dd42d26124804da5c3a3b6a3a9', 'size': '102719046'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/095/SRR10753195/SRR10753195_2.fastq.gz', 'md5': '728bf9c28078eb54fcf50f344459e39e', 'size': '104954204'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753196,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/096/SRR10753196/SRR10753196_1.fastq.gz', 'md5': 'fb0a1dde07c5e397689a747e63a604d3', 'size': '108241489'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/096/SRR10753196/SRR10753196_2.fastq.gz', 'md5': 'd78946cbc933e9cc4424d0cae6060724', 'size': '111678126'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753197,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/097/SRR10753197/SRR10753197_1.fastq.gz', 'md5': '6808ff0021f6c171a2dc5caa66ec263a', 'size': '99708533'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/097/SRR10753197/SRR10753197_2.fastq.gz', 'md5': '9ccb2d83ce59e09fe880527ad34b00d5', 'size': '102624679'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753198,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/098/SRR10753198/SRR10753198_1.fastq.gz', 'md5': '488f86a1b09ee9f39698725ba627e177', 'size': '113509865'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/098/SRR10753198/SRR10753198_2.fastq.gz', 'md5': '91d31307280c5ff2b46d7cecac5edd11', 'size': '115632674'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753199,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/099/SRR10753199/SRR10753199_1.fastq.gz', 'md5': '4dc5cf70096122a04576769782c96d91', 'size': '105071162'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/099/SRR10753199/SRR10753199_2.fastq.gz', 'md5': '4b94b1b8ff8ca6aa859f3e309160efc2', 'size': '109768542'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753200,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/000/SRR10753200/SRR10753200_1.fastq.gz', 'md5': 'b15215627e7799ab4b64f6c29dc3bf07', 'size': '64304399'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/000/SRR10753200/SRR10753200_2.fastq.gz', 'md5': 'f50d1796c83febe3765ef2ad296062f1', 'size': '65662172'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753201,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/001/SRR10753201/SRR10753201_1.fastq.gz', 'md5': 'fd17b463b1e5cb8ce94f5ee2bc52ed7e', 'size': '114080772'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/001/SRR10753201/SRR10753201_2.fastq.gz', 'md5': '2221172f34e54f674835c499cd1903c2', 'size': '117681574'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753202,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/002/SRR10753202/SRR10753202_1.fastq.gz', 'md5': 'dfcb892ec7ba25d0496440d62016cd7b', 'size': '86193526'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/002/SRR10753202/SRR10753202_2.fastq.gz', 'md5': '80ec58cc58b8e118c5bb412c9b7e7241', 'size': '88963953'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753203,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/003/SRR10753203/SRR10753203_1.fastq.gz', 'md5': '3abb1a81567a5c9a88c6d16608f10a8f', 'size': '57135462'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/003/SRR10753203/SRR10753203_2.fastq.gz', 'md5': '69d5b1b22ee99a79b0664a067f2fb400', 'size': '59132195'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753204,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/004/SRR10753204/SRR10753204_1.fastq.gz', 'md5': '11eb76aad9bafa7a8bcbdefe98679dc0', 'size': '116808084'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/004/SRR10753204/SRR10753204_2.fastq.gz', 'md5': '2f47b73c1b8348f9d80112b87b85f23b', 'size': '119914550'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753205,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/005/SRR10753205/SRR10753205_1.fastq.gz', 'md5': '27aaec3d3f469c3c29a51d6c5a3a3902', 'size': '19965526'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/005/SRR10753205/SRR10753205_2.fastq.gz', 'md5': '4bc55c9498fd6fcfd1199cf145917271', 'size': '20967619'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753206,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/006/SRR10753206/SRR10753206_1.fastq.gz', 'md5': '778389d8810c4e01c95ffbbcdad594f0', 'size': '124064991'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/006/SRR10753206/SRR10753206_2.fastq.gz', 'md5': '4f5b6dfafe1da129331d1edbc380c956', 'size': '126799258'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753207,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/007/SRR10753207/SRR10753207_1.fastq.gz', 'md5': '7f3d4b8ed1bc2a9aa32e86c0e80408c8', 'size': '91544386'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/007/SRR10753207/SRR10753207_2.fastq.gz', 'md5': 'a3b64518150fa669c5deeabc9c5ece53', 'size': '94153555'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753208,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/008/SRR10753208/SRR10753208_1.fastq.gz', 'md5': '27841a387eeb1777f2299ea4cc8b2c98', 'size': '93107943'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/008/SRR10753208/SRR10753208_2.fastq.gz', 'md5': '1e6ee53bf3a1bf79de59f2f9db6fd7d1', 'size': '96667392'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753209,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/009/SRR10753209/SRR10753209_1.fastq.gz', 'md5': 'ddac5026814096481b0ef3960ec975af', 'size': '96508376'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/009/SRR10753209/SRR10753209_2.fastq.gz', 'md5': '808320d5740b5a7bbc22fab76b19768b', 'size': '99239711'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753210,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/010/SRR10753210/SRR10753210_1.fastq.gz', 'md5': '2ee60fe0b35b2d66c5221e120dd84a54', 'size': '134686597'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/010/SRR10753210/SRR10753210_2.fastq.gz', 'md5': '990ff935223cd51d964a929e5c85831f', 'size': '138060466'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753211,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/011/SRR10753211/SRR10753211_1.fastq.gz', 'md5': 'b47aaff1772e080fcd468f96b808875b', 'size': '143521139'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/011/SRR10753211/SRR10753211_2.fastq.gz', 'md5': '154e1342bf366df9e90ba50eafdbd6fa', 'size': '148265958'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753212,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/012/SRR10753212/SRR10753212_1.fastq.gz', 'md5': '9d896572fd30be4254c5781dc1c41ee3', 'size': '78997217'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/012/SRR10753212/SRR10753212_2.fastq.gz', 'md5': 'f37e3130d0d8b3eff6c5f5e6386457f5', 'size': '80649669'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753213,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/013/SRR10753213/SRR10753213_1.fastq.gz', 'md5': '09844a74775cdc81aa360cb0c0b49ad4', 'size': '73886159'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/013/SRR10753213/SRR10753213_2.fastq.gz', 'md5': 'd93ce86cc526d15ea92b450be5933995', 'size': '75815683'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753214,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/014/SRR10753214/SRR10753214_1.fastq.gz', 'md5': 'b02a5f99acecbf08c0d908ea576fc4ed', 'size': '107491382'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/014/SRR10753214/SRR10753214_2.fastq.gz', 'md5': '15d411a9ba780b0dc2fd6f6cc24f754c', 'size': '110669408'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753215,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/015/SRR10753215/SRR10753215_1.fastq.gz', 'md5': 'aa29602a91cb509b143bade8261bf776', 'size': '109959387'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/015/SRR10753215/SRR10753215_2.fastq.gz', 'md5': '65fe9c9d11c049f62d63ccd3b94eb533', 'size': '112860499'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753216,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/016/SRR10753216/SRR10753216_1.fastq.gz', 'md5': '2ab649560ea750c0da9761f26727aa65', 'size': '105167121'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/016/SRR10753216/SRR10753216_2.fastq.gz', 'md5': '5195342c4d2e75a5c26f4c0ddfcfd434', 'size': '108407629'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753217,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427898,Illumina HiSeq 2500 paired end sequencing; GSM4230286: Jul11_2016_15-18ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873831,Jul11_2016_15-18ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,83234327,12485149050,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/017/SRR10753217/SRR10753217_1.fastq.gz', 'md5': 'b281fd8b52a8ad6b3f9f7827704d9d04', 'size': '86180890'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/017/SRR10753217/SRR10753217_2.fastq.gz', 'md5': 'f5151d101b86420201ce67d28a0b217b', 'size': '89155472'}]",,15-18 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753218,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/018/SRR10753218/SRR10753218_1.fastq.gz', 'md5': '98c3bdaea35bc6d3eba17148246055db', 'size': '104794332'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/018/SRR10753218/SRR10753218_2.fastq.gz', 'md5': '427aba3359a09567763063c50456905f', 'size': '108192106'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753219,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/019/SRR10753219/SRR10753219_1.fastq.gz', 'md5': 'ad6a22020ffd138cfdd3df633d7c5644', 'size': '89461695'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/019/SRR10753219/SRR10753219_2.fastq.gz', 'md5': 'ff69deda52b2652eea4f96c863b000b0', 'size': '91821084'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753220,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/020/SRR10753220/SRR10753220_1.fastq.gz', 'md5': 'fc38650592fc738cef02243c4ab68664', 'size': '92521034'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/020/SRR10753220/SRR10753220_2.fastq.gz', 'md5': '883c18dcb4d86edba369d28a7307a0e7', 'size': '95069277'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753221,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/021/SRR10753221/SRR10753221_1.fastq.gz', 'md5': '997113ac1cd3a154c787c341fd80a7e5', 'size': '101417481'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/021/SRR10753221/SRR10753221_2.fastq.gz', 'md5': 'f00288416259b167a0af9962326ed5a3', 'size': '105887050'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753222,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/022/SRR10753222/SRR10753222_1.fastq.gz', 'md5': 'dc665384dc912760bb2f9a4eaafb8c58', 'size': '120893629'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/022/SRR10753222/SRR10753222_2.fastq.gz', 'md5': '449b271765e84fdebb690f108d971b26', 'size': '124945738'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753223,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/023/SRR10753223/SRR10753223_1.fastq.gz', 'md5': 'b80a8b3f5fadd7e701edd4ff51c45b62', 'size': '144071373'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/023/SRR10753223/SRR10753223_2.fastq.gz', 'md5': 'cbd63c6351a26f3f7d2753cab1372262', 'size': '148849074'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753224,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/024/SRR10753224/SRR10753224_1.fastq.gz', 'md5': 'd467ae7204be9a17962d0767696ea3ff', 'size': '97642618'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/024/SRR10753224/SRR10753224_2.fastq.gz', 'md5': '76237b3793cb2bdcc62bbaf9f281b73d', 'size': '101303285'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753225,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/025/SRR10753225/SRR10753225_1.fastq.gz', 'md5': '47a6804de29f979443e9b9aa1b6e0ac7', 'size': '117947134'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/025/SRR10753225/SRR10753225_2.fastq.gz', 'md5': '43708d45af93659acd7c56922617b9f5', 'size': '122740326'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753226,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/026/SRR10753226/SRR10753226_1.fastq.gz', 'md5': '0c74ad54e764627b9862d04eec1f3e2b', 'size': '87118026'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/026/SRR10753226/SRR10753226_2.fastq.gz', 'md5': '3490438257985450725ad7b12446fdcb', 'size': '90082452'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753227,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/027/SRR10753227/SRR10753227_1.fastq.gz', 'md5': 'b54af358c114afc1d22034fae5d26a42', 'size': '73661563'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/027/SRR10753227/SRR10753227_2.fastq.gz', 'md5': '7a742bb542cddbf5de91b425b584aa3c', 'size': '75351519'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753228,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/028/SRR10753228/SRR10753228_1.fastq.gz', 'md5': '792177770a620f5671f253eaede1f8c7', 'size': '140122355'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/028/SRR10753228/SRR10753228_2.fastq.gz', 'md5': '6efd9da59cdd906e2a82ca2fd3b9d12d', 'size': '144037140'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753229,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/029/SRR10753229/SRR10753229_1.fastq.gz', 'md5': '7b93bc1f5cb965497fba577aa7dce35a', 'size': '98920125'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/029/SRR10753229/SRR10753229_2.fastq.gz', 'md5': '22a893d6cb8737f645a90dc5d1f4f605', 'size': '102485841'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753230,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/030/SRR10753230/SRR10753230_1.fastq.gz', 'md5': '37be32749b3bc8ada2c19734883da1f3', 'size': '118359566'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/030/SRR10753230/SRR10753230_2.fastq.gz', 'md5': 'f97bbb7d4db52e4ab6f4bcc00b9295dc', 'size': '123492156'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753231,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/031/SRR10753231/SRR10753231_1.fastq.gz', 'md5': '74c65ef893b0958bb38052772f2e0bee', 'size': '105322321'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/031/SRR10753231/SRR10753231_2.fastq.gz', 'md5': '0f47b2a747a49e1970b6acc88a629f45', 'size': '108493521'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753232,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/032/SRR10753232/SRR10753232_1.fastq.gz', 'md5': '3ea0656e675eb001e12b2524c485308a', 'size': '104597044'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/032/SRR10753232/SRR10753232_2.fastq.gz', 'md5': '3892bc3b85cbe5850905d14ed327a41e', 'size': '108187575'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753233,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/033/SRR10753233/SRR10753233_1.fastq.gz', 'md5': '6f23d3dd6311e5dd714b75dcf98cb790', 'size': '117233242'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/033/SRR10753233/SRR10753233_2.fastq.gz', 'md5': 'e7dadbcb864e063d0882d2c57e79ccbf', 'size': '122402144'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753234,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/034/SRR10753234/SRR10753234_1.fastq.gz', 'md5': '2b09750b3737448a1265bbbb0978e0c3', 'size': '109714047'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/034/SRR10753234/SRR10753234_2.fastq.gz', 'md5': '78432e86a3683a477297af3e4b0aa6e5', 'size': '112281858'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753235,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/035/SRR10753235/SRR10753235_1.fastq.gz', 'md5': '8aca9a66d938d2362382b550d6dbc922', 'size': '66049667'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/035/SRR10753235/SRR10753235_2.fastq.gz', 'md5': '388a6be44eb0dd5d5866460a8582c244', 'size': '68613311'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753236,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/036/SRR10753236/SRR10753236_1.fastq.gz', 'md5': '13b301183e5d1e4914f871d159cb722c', 'size': '102303570'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/036/SRR10753236/SRR10753236_2.fastq.gz', 'md5': 'a3b083554d27cec76d82a85277801578', 'size': '104437224'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753237,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/037/SRR10753237/SRR10753237_1.fastq.gz', 'md5': 'd94cd77d33c51d3c39aae400b7bc35ae', 'size': '127985103'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/037/SRR10753237/SRR10753237_2.fastq.gz', 'md5': '5e4c581182029578e5e2ac6a9e31233c', 'size': '131593605'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753238,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/038/SRR10753238/SRR10753238_1.fastq.gz', 'md5': 'fb9b9790e65d571165ff1c6fea4e7b01', 'size': '107046265'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/038/SRR10753238/SRR10753238_2.fastq.gz', 'md5': '9ae4306c2f08527bf25c5236f637890c', 'size': '111610273'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753239,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/039/SRR10753239/SRR10753239_1.fastq.gz', 'md5': '780f3231ce13ef3b8636e7a01223c6f5', 'size': '106387924'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/039/SRR10753239/SRR10753239_2.fastq.gz', 'md5': 'a164ebf86c22e2cf18ccd10dd7fa533c', 'size': '110209738'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753240,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/040/SRR10753240/SRR10753240_1.fastq.gz', 'md5': 'bcfee97a389fcf48c5296231846fc3a1', 'size': '87243936'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/040/SRR10753240/SRR10753240_2.fastq.gz', 'md5': '2c38dd598f1d2c693263f7981a981ceb', 'size': '89250440'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753241,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/041/SRR10753241/SRR10753241_1.fastq.gz', 'md5': '2602a61244db134bc0f1fb74b0804c4d', 'size': '128424221'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/041/SRR10753241/SRR10753241_2.fastq.gz', 'md5': 'fe2fd864c81ce2e76d235efad9c62ef2', 'size': '134095964'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753242,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/042/SRR10753242/SRR10753242_1.fastq.gz', 'md5': '82206b600dfdbd1b1505d4d7a065fdbd', 'size': '114143241'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/042/SRR10753242/SRR10753242_2.fastq.gz', 'md5': 'd289c270ccd8c0d3ada07437bd323f42', 'size': '121716151'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753243,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/043/SRR10753243/SRR10753243_1.fastq.gz', 'md5': '237261504a48b8e2918cfa2445598b8d', 'size': '137916305'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/043/SRR10753243/SRR10753243_2.fastq.gz', 'md5': '10ceefdcf7eacd4978248ea0fb89ac94', 'size': '141672455'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753244,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/044/SRR10753244/SRR10753244_1.fastq.gz', 'md5': '52c635d087803ca08c5a44af59338ca1', 'size': '110486795'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/044/SRR10753244/SRR10753244_2.fastq.gz', 'md5': 'f5c0fef952fde82eaed7efe05c041385', 'size': '114306822'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753245,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/045/SRR10753245/SRR10753245_1.fastq.gz', 'md5': 'b32ee7b26d99a618cb2fc83de3bc896f', 'size': '113388093'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/045/SRR10753245/SRR10753245_2.fastq.gz', 'md5': 'ecc0c7e605e6a9023279a33d1db190fa', 'size': '116829470'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753246,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/046/SRR10753246/SRR10753246_1.fastq.gz', 'md5': 'a03b69f3223628e4c2af9c5d71048707', 'size': '74927038'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/046/SRR10753246/SRR10753246_2.fastq.gz', 'md5': 'fed01b13d357bf5692ce36eb01ba63b6', 'size': '76980908'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753247,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/047/SRR10753247/SRR10753247_1.fastq.gz', 'md5': 'a41636827878318004c42a2804aef039', 'size': '107761992'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/047/SRR10753247/SRR10753247_2.fastq.gz', 'md5': '1ca1676199c2893fe6b81f5d24f7521f', 'size': '112648195'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753248,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/048/SRR10753248/SRR10753248_1.fastq.gz', 'md5': 'c6a4ea121c0fb01e838a45e9abe32d85', 'size': '109382034'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/048/SRR10753248/SRR10753248_2.fastq.gz', 'md5': 'c9b78544122ade907e38230c2c096673', 'size': '113484594'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753249,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/049/SRR10753249/SRR10753249_1.fastq.gz', 'md5': '8200d73d39d1eb18b11a2af4cebfca79', 'size': '121134183'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/049/SRR10753249/SRR10753249_2.fastq.gz', 'md5': '3b7eecae61c0d0d963e5bed585c3c35d', 'size': '124991238'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753250,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/050/SRR10753250/SRR10753250_1.fastq.gz', 'md5': '177a0e0b9b4502babf580a7b9f818487', 'size': '118751271'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/050/SRR10753250/SRR10753250_2.fastq.gz', 'md5': 'a260edf059b65684b41b737ffd5aafb5', 'size': '122790562'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753251,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/051/SRR10753251/SRR10753251_1.fastq.gz', 'md5': '350beade3564279fb6be0f680e895804', 'size': '99148883'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/051/SRR10753251/SRR10753251_2.fastq.gz', 'md5': '7a2ea312d04f8ea14ae5377e4c6eb7b0', 'size': '103837130'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753252,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/052/SRR10753252/SRR10753252_1.fastq.gz', 'md5': 'b180baff25db7c28f6c79d4c5e900a4e', 'size': '127915031'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/052/SRR10753252/SRR10753252_2.fastq.gz', 'md5': '585306ff0f89921db85ce32642e83234', 'size': '131153108'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753253,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/053/SRR10753253/SRR10753253_1.fastq.gz', 'md5': 'c960769c6504c037f6a3100749971c98', 'size': '110181360'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/053/SRR10753253/SRR10753253_2.fastq.gz', 'md5': '05f9105d888baa491b2ea5569a2dafdd', 'size': '114202434'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753254,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/054/SRR10753254/SRR10753254_1.fastq.gz', 'md5': 'e8fe8f16f88a16ac9e93a2f2678032f4', 'size': '93338161'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/054/SRR10753254/SRR10753254_2.fastq.gz', 'md5': 'fb9c0661002b567fc7033a3cf442145d', 'size': '96694660'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753255,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/055/SRR10753255/SRR10753255_1.fastq.gz', 'md5': '6c839d256ae5e5116c841fb03204f8f1', 'size': '139010803'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/055/SRR10753255/SRR10753255_2.fastq.gz', 'md5': '6647db404871b05db01fb35833c7e19f', 'size': '142267343'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753256,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/056/SRR10753256/SRR10753256_1.fastq.gz', 'md5': 'b14857706a8aeca380a79747e5c1e175', 'size': '103398951'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/056/SRR10753256/SRR10753256_2.fastq.gz', 'md5': '5e2020702b77377bc0c22ec383466ac8', 'size': '108795178'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753257,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/057/SRR10753257/SRR10753257_1.fastq.gz', 'md5': 'a73b98fbcbe5d3a1c996ed2023281f5f', 'size': '106691658'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/057/SRR10753257/SRR10753257_2.fastq.gz', 'md5': 'e45309abcd575833b8dd27fca0ca1ee4', 'size': '110334804'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753258,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/058/SRR10753258/SRR10753258_1.fastq.gz', 'md5': '1594c107e3f0c5958f711c82eac24b42', 'size': '103194285'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/058/SRR10753258/SRR10753258_2.fastq.gz', 'md5': '2cac8f8c5961d2a133de1e41cae9bff2', 'size': '106292617'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753259,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/059/SRR10753259/SRR10753259_1.fastq.gz', 'md5': 'a2e9ce7ed4759be2a4614ecd1f24677c', 'size': '117083206'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/059/SRR10753259/SRR10753259_2.fastq.gz', 'md5': '0c5b8732abe92b50cdece06e60dde224', 'size': '121221285'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753260,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/060/SRR10753260/SRR10753260_1.fastq.gz', 'md5': 'f50ca33483c681b94f7c34ef4e143b5a', 'size': '8740678'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/060/SRR10753260/SRR10753260_2.fastq.gz', 'md5': '287470e57e1f58d7c8f73609e1256487', 'size': '9085012'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753261,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/061/SRR10753261/SRR10753261_1.fastq.gz', 'md5': '8f5e505418a8164e5c94056e71cb3f5e', 'size': '113075756'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/061/SRR10753261/SRR10753261_2.fastq.gz', 'md5': '051532949624e5eec92a63322b0abc67', 'size': '116185906'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753262,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/062/SRR10753262/SRR10753262_1.fastq.gz', 'md5': '1f260cfb6eda2b5d005d4c26993f9ec5', 'size': '128652862'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/062/SRR10753262/SRR10753262_2.fastq.gz', 'md5': '80d1474d297c2e9dca869a9de3c1507b', 'size': '133054256'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753263,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/063/SRR10753263/SRR10753263_1.fastq.gz', 'md5': 'f5ecdadf82ae36f7f8086e34ec074e82', 'size': '115326934'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/063/SRR10753263/SRR10753263_2.fastq.gz', 'md5': 'b280b30072f37eee8450fbf94a38e491', 'size': '119014867'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753264,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/064/SRR10753264/SRR10753264_1.fastq.gz', 'md5': '91a4d837a9bfe5a3a63c41483abe3d83', 'size': '124196637'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/064/SRR10753264/SRR10753264_2.fastq.gz', 'md5': '759bf47f7a8aea4033d775d2893ddbcd', 'size': '127635541'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10753265,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,,,,,,,,,,SRX7427899,Illumina HiSeq 2500 paired end sequencing; GSM4230287: Aug1_2016_20ss_etv2gfp; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238479,Single-cell transcriptomic analysis of embryonic vasculogenesis identifies the conversion of Etv2-deficient vascular progenitors into skeletal muscle,"During vertebrate embryogenesis, vascular endothelial cells originate in the lateral plate mesoderm (LPM) next to the progenitors of skeletal muscle. It is currently not clear what prevents vascular progenitors from responding to the adjacent signals that promote muscle development. An ETS transcription factor Etv2 functions as an evolutionarily conserved master regulator of vasculogenesis. Here we performed single-cell transcriptomic analysis of hematovascular development in wild-type and etv2 mutant zebrafish embryos. Distinct transcriptional signatures of different types of hematopoietic and vascular progenitors were identified using an etv2ci32Gt gene trap line, in which Gal4 transcriptional activator has integrated into the etv2 gene locus. Unexpectedly, a cell population with the skeletal muscle signature was observed in etv2-deficient embryos. We demonstrate that multiple etv2ci32Gt; UAS:GFP cells migrate into the somites, elongate and differentiate as skeletal muscle cells instead of contributing to vasculature in etv2-deficient embryos. Wnt and FGF signaling promoted the differentiation of these putative multipotent etv2 progenitor cells into skeletal muscle cells. We conclude that etv2 actively represses muscle differentiation in vascular progenitors, thus locking these cells into vascular endothelial fate. We also identified the transcriptional signature of putative multipotent progenitors within the LPM that may give rise to vascular progenitor and skeletal muscle cells. Finally, we demonstrate that arterial progenitors co-express multiple arterial and venous markers during early stages of vasculogenesis, suggesting multi-potency of early vascular progenitors.These findings will be important in understanding the ontogeny of different mesodermal lineages and will help in designing in vitro differentiation strategies to generate vascular, muscle and other types of progenitors for therapeutic purposes. Overall design: 96 cells 48 cells each",SRS5873832,Aug1_2016_20ss_etv2gfp,Danio rerio,Vascular Endothelial Cells,,,93658206,14048730900,2020-03-23,2020-03-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/065/SRR10753265/SRR10753265_1.fastq.gz', 'md5': '56c4386ea1d7abe3d9305834e9199010', 'size': '96118174'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/065/SRR10753265/SRR10753265_2.fastq.gz', 'md5': 'db31077cdc9b81b2b73be012ab27d3bb', 'size': '99839623'}]",,20 somite stage,,,,Vascular Endothelial Cells,,,,,,,,,,,,Tg(-2.3 etv2:GFP)zf372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16681976,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5664292: runx2b+/+ scRNA-seq; Danio rerio; RNA-Seq,,,,,,,,,,SRX12882564,Illumina NovaSeq 6000 paired end sequencing; GSM5664292: runx2b+/+ scRNA-seq; Danio rerio; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP344071,Single-cell transcriptomes and runx2b-/- mutants reveal the genetic signatures of intermuscular bone formation in teleosts,"Purpose: Intermuscular bones (IBs) are hard spicules, mainly existing in the myosepta of recent vertebrates. This evolutionary trait has puzzled biologists and consumers, and the molecular basis of IB development remains unclear. The goals of this study are to acquire characteristic single-cell maps of gene expression landscapes and lineages and to elucidate the differentiation trajectory of cell clusters related to IB formation and obtain the key regulated gene of IB formation. Methods: The scRNA-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish were generated, using the 10X Genomics Chromium system. The bulk RNA-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish were generated, using mirVana miRNA ISOlation Kit. The scRNA-seq data were filted and clsutered by the Seurat package. The cell differentiation trajectorie was constructed, using Monocle analysis. Runx2b knockdown was preformed by RNA interference and runx2b was inducted by neuropeptide substance P. qRTPCR validation was performed using SYBR Green assays. The mutant zebrafish lines were constructed, using cripsr cas9 technology.The Phenotypic observation was perfomed by Hematoxylin and Eosin (HE), Alizarin red, masson trichrome staining and mico-CT. The nutritent content was also obtained including fatty acid content and anio acid content. Results: we reveal that teleost fish IBs originate from tendons in the skeletal muscle and that the differentiation trajectory from tendon progenitors and defined runx2b as the key rugulated gene of IB formaiton, using cripsr cas9 technology. Conclusions: This study is the first to reveal that teleost fish IBs originate from tendons in the skeletal muscle and that the differentiation trajectory from tendon progenitors to the osteoblast lineage is key for IB formation. Large-scale gene function analysis using CRISPR-Cas9 identified the decisive role of runx2b in IB formation. The loss of runx2b significantly restricted osteoblast differentiation and inhibited IB formation, which potentially provides a basis for breeding strains of fish without IBs to improve the safe consumption and economic value of many aquaculture species and in this way, boost the proportion of fish for the supply of animal protein worldwide (Fig. 6). For this reason, we needed to verify that the content of fatty acid in the runx2b-/- mutant was higher than that in runx2b+/+ fish, as well as the expression of key genes related to IBs in the runx2b-/- and runx2b+/+ strains obtained by scRNA-seq data. This study also provides materials and directions for further study to clarify the specific regulatory mechanism of IB formation and will help to discover more specific genetic resources that can be used for IB trait improvement in fish. Overall design: the scRNA-seq and bulk-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish",SRS10825216,runx2b+/+ scRNA-seq,Danio rerio,muscle and IB,,Tg (sp7/eGFP) transgenic line,,,2021-11-05,2021-11-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR166/076/SRR16681976/SRR16681976_1.fastq.gz', 'md5': '9c2c1c1a5645b4d6e10872e9730d098c', 'size': '25876198592'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR166/076/SRR16681976/SRR16681976_2.fastq.gz', 'md5': 'd91349a125dc46f10c20ba6759837a87', 'size': '19457661698'}]",muscle and IB,,,,,,wild type,60 dpf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16681977,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5664293: runx2b-/- scRNA-seq; Danio rerio; RNA-Seq,,,,,,,,,,SRX12882565,Illumina NovaSeq 6000 paired end sequencing; GSM5664293: runx2b-/- scRNA-seq; Danio rerio; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP344071,Single-cell transcriptomes and runx2b-/- mutants reveal the genetic signatures of intermuscular bone formation in teleosts,"Purpose: Intermuscular bones (IBs) are hard spicules, mainly existing in the myosepta of recent vertebrates. This evolutionary trait has puzzled biologists and consumers, and the molecular basis of IB development remains unclear. The goals of this study are to acquire characteristic single-cell maps of gene expression landscapes and lineages and to elucidate the differentiation trajectory of cell clusters related to IB formation and obtain the key regulated gene of IB formation. Methods: The scRNA-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish were generated, using the 10X Genomics Chromium system. The bulk RNA-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish were generated, using mirVana miRNA ISOlation Kit. The scRNA-seq data were filted and clsutered by the Seurat package. The cell differentiation trajectorie was constructed, using Monocle analysis. Runx2b knockdown was preformed by RNA interference and runx2b was inducted by neuropeptide substance P. qRTPCR validation was performed using SYBR Green assays. The mutant zebrafish lines were constructed, using cripsr cas9 technology.The Phenotypic observation was perfomed by Hematoxylin and Eosin (HE), Alizarin red, masson trichrome staining and mico-CT. The nutritent content was also obtained including fatty acid content and anio acid content. Results: we reveal that teleost fish IBs originate from tendons in the skeletal muscle and that the differentiation trajectory from tendon progenitors and defined runx2b as the key rugulated gene of IB formaiton, using cripsr cas9 technology. Conclusions: This study is the first to reveal that teleost fish IBs originate from tendons in the skeletal muscle and that the differentiation trajectory from tendon progenitors to the osteoblast lineage is key for IB formation. Large-scale gene function analysis using CRISPR-Cas9 identified the decisive role of runx2b in IB formation. The loss of runx2b significantly restricted osteoblast differentiation and inhibited IB formation, which potentially provides a basis for breeding strains of fish without IBs to improve the safe consumption and economic value of many aquaculture species and in this way, boost the proportion of fish for the supply of animal protein worldwide (Fig. 6). For this reason, we needed to verify that the content of fatty acid in the runx2b-/- mutant was higher than that in runx2b+/+ fish, as well as the expression of key genes related to IBs in the runx2b-/- and runx2b+/+ strains obtained by scRNA-seq data. This study also provides materials and directions for further study to clarify the specific regulatory mechanism of IB formation and will help to discover more specific genetic resources that can be used for IB trait improvement in fish. Overall design: the scRNA-seq and bulk-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish",SRS10825217,runx2b-/- scRNA-seq,Danio rerio,muscle and IB,,Tg (sp7/eGFP) transgenic line,,,2021-11-05,2021-11-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR166/077/SRR16681977/SRR16681977_1.fastq.gz', 'md5': '971f79e7906b782c1237691fc4744372', 'size': '29167046405'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR166/077/SRR16681977/SRR16681977_2.fastq.gz', 'md5': '54c4208eca691dad79e8c6dac16de9d3', 'size': '22005591801'}]",muscle and IB,,,,,,runx2b-/-,60 dpf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18689889,SRX14790887,SRP368339,SRS12549768,Illumina NovaSeq 6000 paired end sequencing; GSM6035365: WB; Gallus gallus; RNA-Seq,,2022-04-14,2022-04-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR186/089/SRR18689889/SRR18689889_1.fastq.gz', 'md5': 'f5eb369b9d4a7cf428ee1f9376259a77', 'size': 36544290880}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR186/089/SRR18689889/SRR18689889_2.fastq.gz', 'md5': '85132e409793349938b4a5d44a7b40e7', 'size': 39685630664}]","[{'url': 's3://sra-pub-src-18/SRR18689889/WB1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR18689889/WB1_R2.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18689889/SRR18689889'}]","[{'url': 'gs://sra-pub-src-6/SRR18689889/WB1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-6/SRR18689889/WB1_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra50/SRR/018251/SRR18689889'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18689890,SRX14790886,SRP368339,SRS12549767,Illumina NovaSeq 6000 paired end sequencing; GSM6035364: NORM; Gallus gallus; RNA-Seq,,2022-04-14,2022-04-14,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR186/090/SRR18689890/SRR18689890_1.fastq.gz', 'md5': 'a71d687676ab2277fde290621900be96', 'size': 36802155993}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR186/090/SRR18689890/SRR18689890_2.fastq.gz', 'md5': 'e642768977cd4cdbfb4a8bddc8b2552d', 'size': 39737983529}]","[{'url': 's3://sra-pub-src-11/SRR18689890/NOR1_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-11/SRR18689890/NOR1_R2.fastq.gz.1'}, {'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR18689890/SRR18689890'}]","[{'url': 'gs://sra-pub-src-5/SRR18689890/NOR1_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR18689890/NOR1_R2.fastq.gz.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra64/SRR/018251/SRR18689890'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897760,,,,NextSeq 500 paired end sequencing; GSM4272893: hu07_021219; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566587,NextSeq 500 paired end sequencing; GSM4272893: hu07_021219; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002992,hu07_021219,Homo sapiens,Flexor hallucis longus,,,205111188,17024228604,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/060/SRR10897760/SRR10897760_1.fastq.gz', 'md5': 'c2d6d629984a68481cbbd25e64653d2c', 'size': '4816064719'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/060/SRR10897760/SRR10897760_2.fastq.gz', 'md5': '9815a0953d9747131e79037bf2c00e09', 'size': '7848854661'}]",Flexor hallucis longus,,,,,,,71,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897761,,,,NextSeq 500 paired end sequencing; GSM4272894: hu01_061419; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566588,NextSeq 500 paired end sequencing; GSM4272894: hu01_061419; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002993,hu01_061419,Homo sapiens,Right serratus,,,186309991,15463729253,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/061/SRR10897761/SRR10897761_1.fastq.gz', 'md5': '966998b4f5cb31b4d84838a2dafca4d8', 'size': '4355909688'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/061/SRR10897761/SRR10897761_2.fastq.gz', 'md5': 'dcb260c2641165d238cd9009404314ee', 'size': '7238559816'}]",Right serratus,,,,,,,74,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897762,,,,NextSeq 500 paired end sequencing; GSM4272895: hu02_062419; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566589,NextSeq 500 paired end sequencing; GSM4272895: hu02_062419; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002994,hu02_062419,Homo sapiens,Flexor hallucis longus,,,224127206,18602558098,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/062/SRR10897762/SRR10897762_1.fastq.gz', 'md5': '09677babc0fa84cc9b66435220947c88', 'size': '5096253366'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/062/SRR10897762/SRR10897762_2.fastq.gz', 'md5': '7fc591068e841c76970e2e887d907bfb', 'size': '7895906465'}]",Flexor hallucis longus,,,,,,,54,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897763,,,,NextSeq 500 paired end sequencing; GSM4272896: hu03_062719; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566590,NextSeq 500 paired end sequencing; GSM4272896: hu03_062719; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002995,hu03_062719,Homo sapiens,Orbicularis oris,,,221645556,18396581148,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/063/SRR10897763/SRR10897763_1.fastq.gz', 'md5': '1b15b4492874db07d3aba6986cc43aa5', 'size': '4882841084'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/063/SRR10897763/SRR10897763_2.fastq.gz', 'md5': 'ee39d71c28838b12d768c73c8bda6cf4', 'size': '7988824993'}]",Orbicularis oris,,,,,,,74,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897764,,,,NextSeq 500 paired end sequencing; GSM4272897: hu04_080619; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566591,NextSeq 500 paired end sequencing; GSM4272897: hu04_080619; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002996,hu04_080619,Homo sapiens,Eye lid,,,210524102,17473500466,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/064/SRR10897764/SRR10897764_1.fastq.gz', 'md5': '301d07fef5c76080a5eedf6551a6a3dc', 'size': '4744778657'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/064/SRR10897764/SRR10897764_2.fastq.gz', 'md5': '0a11d7b98ac2518f7056111d741d5f11', 'size': '7739658658'}]",Eye lid,,,,,,,77,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897765,,,,NextSeq 500 paired end sequencing; GSM4272898: hu08_092618; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566592,NextSeq 500 paired end sequencing; GSM4272898: hu08_092618; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002997,hu08_092618,Homo sapiens,Left vastus lateralis,,,235694063,19798301292,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/065/SRR10897765/SRR10897765_1.fastq.gz', 'md5': '2fa6995c5db5f0b1dd997ce06580f1c0', 'size': '5231716230'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/065/SRR10897765/SRR10897765_2.fastq.gz', 'md5': '66fc791b068d7fce5e4c7bb084aca5cb', 'size': '9454881727'}]",Left vastus lateralis,,,,,,,54,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897766,,,,NextSeq 500 paired end sequencing; GSM4272899: hu09_092718; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566593,NextSeq 500 paired end sequencing; GSM4272899: hu09_092718; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002998,hu09_092718,Homo sapiens,Left external oblique,,,230378709,19351811556,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/066/SRR10897766/SRR10897766_1.fastq.gz', 'md5': '952b4edc66c219d43af5c577e6e84c8e', 'size': '5229819273'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/066/SRR10897766/SRR10897766_2.fastq.gz', 'md5': 'a429600d2c8c712c4cd74439b3215c3c', 'size': '9480789761'}]",Left external oblique,,,,,,,70,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897767,,,,NextSeq 500 paired end sequencing; GSM4272900: hu10_101018; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566594,NextSeq 500 paired end sequencing; GSM4272900: hu10_101018; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6002999,hu10_101018,Homo sapiens,Left rectus abdominus,,,272220748,22866542832,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/067/SRR10897767/SRR10897767_1.fastq.gz', 'md5': '080d2b8e5b0841f7bdd040733b855c88', 'size': '6038975801'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/067/SRR10897767/SRR10897767_2.fastq.gz', 'md5': 'e0df63a5c5c1d518c2b08de64a26575a', 'size': '10977572235'}]",Left rectus abdominus,,,,,,,43,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897768,,,,NextSeq 500 paired end sequencing; GSM4272901: hu05_111418; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566595,NextSeq 500 paired end sequencing; GSM4272901: hu05_111418; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6003000,hu05_111418,Homo sapiens,Trapezius,,,242900230,20160719090,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/068/SRR10897768/SRR10897768_1.fastq.gz', 'md5': '5f726b59b21b2071989163a816ec34c7', 'size': '5609176862'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/068/SRR10897768/SRR10897768_2.fastq.gz', 'md5': '0b2cda6dade3c922fadbd1948d03c972', 'size': '8555300910'}]",Trapezius,,,,,,,62,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10897769,,,,NextSeq 500 paired end sequencing; GSM4272902: hu06_120518; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7566596,NextSeq 500 paired end sequencing; GSM4272902: hu06_120518; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP242029,Single-cell transcriptomic atlas of human donor muscle tissue,The overall objective of the study was to survey the cellular and gene expression heterogeneity of human muscle tissue by single-cell RNA-sequencing. Overall design: We report a series of single-cell transcriptomic datasets of human donor muscle tissue produced using the Chromium 10X technology.,SRS6003001,hu06_120518,Homo sapiens,Right external oblique,,,237257755,19692393665,2020-06-03,2020-06-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/069/SRR10897769/SRR10897769_1.fastq.gz', 'md5': '3aa3e79d207a5315a960a915ef15cf1a', 'size': '5507397277'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/069/SRR10897769/SRR10897769_2.fastq.gz', 'md5': 'd0e468e31e3790e31a4f9b9691216909', 'size': '8679883298'}]",Right external oblique,,,,,,,81,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759043,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098737: OldHM1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145787,Illumina NovaSeq 6000 paired end sequencing; GSM5098737: OldHM1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298591,OldHM1,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/043/SRR13759043/SRR13759043_1.fastq.gz', 'md5': '5f970f66d04142ccd848d5735534f73b', 'size': '26965262307'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/043/SRR13759043/SRR13759043_2.fastq.gz', 'md5': '722e7a180e40c606443dad4965577225', 'size': '28080665963'}]",Skeletal muscle,,,,,,,75,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759044,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098738: OldHM2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145788,Illumina NovaSeq 6000 paired end sequencing; GSM5098738: OldHM2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298593,OldHM2,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/044/SRR13759044/SRR13759044_1.fastq.gz', 'md5': 'a3f13dfe6def474877fde7d686eb7c3a', 'size': '22959812312'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/044/SRR13759044/SRR13759044_2.fastq.gz', 'md5': '732eb0db539996120d72acc41cf28201', 'size': '23854654010'}]",Skeletal muscle,,,,,,,76,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759045,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098739: OldHM3; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145789,Illumina NovaSeq 6000 paired end sequencing; GSM5098739: OldHM3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298592,OldHM3,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/045/SRR13759045/SRR13759045_1.fastq.gz', 'md5': '38cdab012193de21ae3394e830c065e4', 'size': '23947171864'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/045/SRR13759045/SRR13759045_2.fastq.gz', 'md5': 'f4cd13c9a4767b2d8b0928726a4f5441', 'size': '24695962653'}]",Skeletal muscle,,,,,,,75,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759046,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098740: OldHM4; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145790,Illumina NovaSeq 6000 paired end sequencing; GSM5098740: OldHM4; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298594,OldHM4,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/046/SRR13759046/SRR13759046_1.fastq.gz', 'md5': '26dc9fe6ffdd11ab1571be95efce54b1', 'size': '29337147250'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/046/SRR13759046/SRR13759046_2.fastq.gz', 'md5': '919716499df7da90fbc44f51e95f1408', 'size': '30344707922'}]",Skeletal muscle,,,,,,,79,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759047,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098741: YouHM5; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145791,Illumina NovaSeq 6000 paired end sequencing; GSM5098741: YouHM5; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298595,YouHM5,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/047/SRR13759047/SRR13759047_1.fastq.gz', 'md5': '58c0dd510e2e5b73fce7180eec90e01d', 'size': '33656651728'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/047/SRR13759047/SRR13759047_2.fastq.gz', 'md5': '9b415b0786ea2ea90a3b796d4362685f', 'size': '34897540736'}]",Skeletal muscle,,,,,,,20,,,,,,,,,,,Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759048,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098742: OldHM6; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145792,Illumina NovaSeq 6000 paired end sequencing; GSM5098742: OldHM6; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298596,OldHM6,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/048/SRR13759048/SRR13759048_1.fastq.gz', 'md5': '9f037b37fd68a2f3a7df400789faa496', 'size': '31469485099'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/048/SRR13759048/SRR13759048_2.fastq.gz', 'md5': '6e00fb4b51736a455ef5f8a05c338a23', 'size': '32261947768'}]",Skeletal muscle,,,,,,,82,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759049,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098743: OldHM7; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145793,Illumina NovaSeq 6000 paired end sequencing; GSM5098743: OldHM7; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298597,OldHM7,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/049/SRR13759049/SRR13759049_1.fastq.gz', 'md5': '618152ced06e0aaec55f3be9c2c4487e', 'size': '27252945875'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/049/SRR13759049/SRR13759049_2.fastq.gz', 'md5': '36a992e6fec7b6b64b6630ec171f6880', 'size': '27823970989'}]",Skeletal muscle,,,,,,,72,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759050,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098744: YouHM8; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145794,Illumina NovaSeq 6000 paired end sequencing; GSM5098744: YouHM8; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298598,YouHM8,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/050/SRR13759050/SRR13759050_1.fastq.gz', 'md5': 'c5b13c882f9670fd5c6ac013f1ca0fca', 'size': '28413928141'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/050/SRR13759050/SRR13759050_2.fastq.gz', 'md5': 'cecb8af368fe7caa9d36b232ddafda91', 'size': '29184315185'}]",Skeletal muscle,,,,,,,21,,,,,,,,,,,Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759051,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098745: OldHM9; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145795,Illumina NovaSeq 6000 paired end sequencing; GSM5098745: OldHM9; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298599,OldHM9,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/051/SRR13759051/SRR13759051_1.fastq.gz', 'md5': '1bf2438d2b11ba4e4b2befec87c5382f', 'size': '25755300137'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/051/SRR13759051/SRR13759051_2.fastq.gz', 'md5': '7774e033e12aeeac06a513a88226c1f5', 'size': '26640576369'}]",Skeletal muscle,,,,,,,70,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759052,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098746: YouHM10; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145796,Illumina NovaSeq 6000 paired end sequencing; GSM5098746: YouHM10; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298600,YouHM10,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/052/SRR13759052/SRR13759052_1.fastq.gz', 'md5': '18f2e19162bebf2cde0e5f7d6eca94d2', 'size': '20892305650'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/052/SRR13759052/SRR13759052_2.fastq.gz', 'md5': 'ae1120409622dfafe08a0d52ab0bf6bc', 'size': '21615191356'}]",Skeletal muscle,,,,,,,21,,,,,,,,,,,Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759053,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098747: OldHM11; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145797,Illumina NovaSeq 6000 paired end sequencing; GSM5098747: OldHM11; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298603,OldHM11,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/053/SRR13759053/SRR13759053_1.fastq.gz', 'md5': 'c51f654c87d04584fb93da858e32fd16', 'size': '23645164432'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/053/SRR13759053/SRR13759053_2.fastq.gz', 'md5': 'e27b3f9ca188bd864f737ef2359de45f', 'size': '24479741189'}]",Skeletal muscle,,,,,,,75,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759054,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098748: OldHM12; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145798,Illumina NovaSeq 6000 paired end sequencing; GSM5098748: OldHM12; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298602,OldHM12,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/054/SRR13759054/SRR13759054_1.fastq.gz', 'md5': 'e23d2b625f5b04c1dc84d19f74b1dbdf', 'size': '24424340908'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/054/SRR13759054/SRR13759054_2.fastq.gz', 'md5': '7d6212ac69d11541fce8fa8349f5ad6d', 'size': '25309165224'}]",Skeletal muscle,,,,,,,72,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759055,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098749: YouHM13; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145799,Illumina NovaSeq 6000 paired end sequencing; GSM5098749: YouHM13; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298601,YouHM13,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/055/SRR13759055/SRR13759055_1.fastq.gz', 'md5': 'f902e32ea0f9206c682071a61e752ff6', 'size': '24006256490'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/055/SRR13759055/SRR13759055_2.fastq.gz', 'md5': '10dcfd65ac4ea6472b703373fcc3da20', 'size': '24842715039'}]",Skeletal muscle,,,,,,,19,,,,,,,,,,,Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759056,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098750: OldHM15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145800,Illumina NovaSeq 6000 paired end sequencing; GSM5098750: OldHM15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298604,OldHM15,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/056/SRR13759056/SRR13759056_1.fastq.gz', 'md5': '8f1037a23ff78e28e60053bf2d0c6f4c', 'size': '25341929478'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/056/SRR13759056/SRR13759056_2.fastq.gz', 'md5': '03763ad55dd90e884d30f84fb8e738b8', 'size': '26228864782'}]",Skeletal muscle,,,,,,,79,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759057,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098751: YouHM21; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145801,Illumina NovaSeq 6000 paired end sequencing; GSM5098751: YouHM21; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298605,YouHM21,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/057/SRR13759057/SRR13759057_1.fastq.gz', 'md5': 'c54af03aa1be6b8d5f23d820ab5e6440', 'size': '14059244833'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/057/SRR13759057/SRR13759057_2.fastq.gz', 'md5': 'a949fb5310a3dc790c71c72a25eb0a18', 'size': '34770381370'}]",Skeletal muscle,,,,,,,22,,,,,,,,,,,Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759058,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098752: YouHM22; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145802,Illumina NovaSeq 6000 paired end sequencing; GSM5098752: YouHM22; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298606,YouHM22,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/058/SRR13759058/SRR13759058_1.fastq.gz', 'md5': 'b43934869871a6888e793375575aaa33', 'size': '14072343498'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/058/SRR13759058/SRR13759058_2.fastq.gz', 'md5': 'f10924c1571e3daf7edfc48a48b3b457', 'size': '34124094661'}]",Skeletal muscle,,,,,,,21,,,,,,,,,,,Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13759059,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5098753: OldHM23; Homo sapiens; RNA-Seq,,,,,,,,,,SRX10145803,Illumina NovaSeq 6000 paired end sequencing; GSM5098753: OldHM23; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP307390,Single-nuclei profiling of aged skeletal muscle,"Aging is accompanied by a loss of muscle mass and function, termed sarcopenia, causing numerous morbidities and economic burdens in human populations. Mechanisms implicated in age-related sarcopenia include inflammation, muscle stem cell depletion, mitochondrial dysfunction and loss of motor neurons, but whether there are key drivers of sarcopenia is not yet known. To gain deeper insights into age-related sarcopenia, we performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17). Using this combined approach, we discovered novel changes in gene expression that occur with age and sarcopenia in multiple cell types comprising mature skeletal muscle. Notably, we found increased expression of the genes MYH8 and PDK4, and decreased expression of the gene IGFN1, in old muscle. We also identified a small population of nuclei that express CDKN1A, present only in aged samples, consistent with P21CIP1 senescence in this subpopulation. Our findings identify unique cellular sub-populations populations in aged and sarcopenic skeletal muscle, which will facilitate the development of new therapeutic strategies to combat age-related sarcopenia. Overall design: We performed transcriptome profiling on lower limb muscle biopsies from 72 young, old and sarcopenic subjects using bulk RNA-seq (N = 72) and single-nuclei RNA-seq (N = 17).",SRS8298607,OldHM23,Homo sapiens,Skeletal muscle,,,,,2022-04-01,2022-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/059/SRR13759059/SRR13759059_1.fastq.gz', 'md5': 'cca38b847e1979d19ac1314de047d9c3', 'size': '12991633186'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/059/SRR13759059/SRR13759059_2.fastq.gz', 'md5': '4a5961a1131115b80622892dae090dc9', 'size': '31889519876'}]",Skeletal muscle,,,,,,,90,,,,,,,,,,,Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11107252,,,,NextSeq 500 paired end sequencing; GSM4319248: Uninjured Control; Mus musculus; RNA-Seq,,,,,,,,,,SRX7744923,NextSeq 500 paired end sequencing; GSM4319248: Uninjured Control; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP249928,Single Cell RNAseq on whole muscle one day after injury and uninjured control,Cellular landscape changes drastically after injury Overall design: The Tibialis Anterior (TA) muscle was injected with barium chloride and collected 24 hours after.,SRS6165328,Uninjured Control,Mus musculus,Tibialis Anterior muscle,,C57B/6,,,2020-05-07,2020-05-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR111/SRR11107252/Uninjured_control.bam', 'md5': '37005ebbb303c5df7ebdb3b66066759f', 'size': '21361750269'}]",Tibialis Anterior muscle,,,,,,,young (12 weeks),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11107253,,,,NextSeq 500 paired end sequencing; GSM4319249: Injured (1d); Mus musculus; RNA-Seq,,,,,,,,,,SRX7744924,NextSeq 500 paired end sequencing; GSM4319249: Injured (1d); Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP249928,Single Cell RNAseq on whole muscle one day after injury and uninjured control,Cellular landscape changes drastically after injury Overall design: The Tibialis Anterior (TA) muscle was injected with barium chloride and collected 24 hours after.,SRS6165329,Injured (1d),Mus musculus,Tibialis Anterior muscle,,C57B/6,,,2020-05-07,2020-05-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR111/SRR11107253/Injured_1d.bam', 'md5': 'a2940d11525ca3d06b9c02ed67c44333', 'size': '24543291763'}]",Tibialis Anterior muscle,,,,,,,young (12 weeks),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478037,,,,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971937,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227600,TA_WT snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,224161378,27347688116,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/037/SRR12478037/SRR12478037.fastq.gz', 'md5': '7f87f95d3875d599f65fa0034698add9', 'size': '4059235376'}]",Tibialis Anterior (TA) muscle,,,,,,WT,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478038,,,,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971937,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227600,TA_WT snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,224161378,27347688116,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/038/SRR12478038/SRR12478038.fastq.gz', 'md5': '4a1e4ee720093b0ff6b485f3d6202a3d', 'size': '4058902858'}]",Tibialis Anterior (TA) muscle,,,,,,WT,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478039,,,,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971937,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227600,TA_WT snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,224161378,27347688116,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/039/SRR12478039/SRR12478039.fastq.gz', 'md5': 'dd64fd22579d8d39dcf7066b0759d05d', 'size': '4178384965'}]",Tibialis Anterior (TA) muscle,,,,,,WT,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478040,,,,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971937,NextSeq 500 paired end sequencing; GSM4732631: TA_WT snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227600,TA_WT snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,224161378,27347688116,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/040/SRR12478040/SRR12478040.fastq.gz', 'md5': 'a1bec5dca6a464c62cc49391d6918949', 'size': '4113197699'}]",Tibialis Anterior (TA) muscle,,,,,,WT,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478041,,,,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971938,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227598,TA_D51 snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,230677525,28142658050,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/041/SRR12478041/SRR12478041.fastq.gz', 'md5': '4bcc5e187e6ad5124c0744f041fc128f', 'size': '3933867662'}]",Tibialis Anterior (TA) muscle,,,,,,Delta 51,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478042,,,,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971938,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227598,TA_D51 snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,230677525,28142658050,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/042/SRR12478042/SRR12478042.fastq.gz', 'md5': '266c933cc92e442b5c46a21a8dcd5c32', 'size': '3935028880'}]",Tibialis Anterior (TA) muscle,,,,,,Delta 51,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478043,,,,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971938,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227598,TA_D51 snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,230677525,28142658050,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/043/SRR12478043/SRR12478043.fastq.gz', 'md5': '0ef047356b14841e2d210c8b3b3a6d5a', 'size': '4050264594'}]",Tibialis Anterior (TA) muscle,,,,,,Delta 51,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12478044,,,,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,,,,,,,,,,SRX8971938,NextSeq 500 paired end sequencing; GSM4732632: TA_D51 snRNA-seq; Mus musculus; OTHER,ILLUMINA,NextSeq 500,SRP278115,Single nucleus RNA-seq analysis of the TA muscles from WT and Dmd Exon 51 Knockout mice,"Duchenne muscular dystrophy (DMD) is a fatal muscle disorder characterized by cycles of degeneration and regeneration of multinucleated myofibers and pathological activation of a variety of other associated cell types. Here, we describe the creation of a new mouse model of DMD caused by deletion of exon 51 of the dystrophin gene, which represents a prevalent mutation in humans. To understand the transcriptional abnormalities and heterogeneity associated with the nuclei of myofibers, as well as other mononucleated cell types that contribute to DMD disease pathogenesis, we performed single nucleus transcriptomics of skeletal muscle of mice with exon 51 deletion. Our results reveal distinctive and previously unrecognized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative transcriptional pathways underlying DMD pathogenesis. Our findings provide new insights into the molecular underpinnings of DMD, controlled by the transcriptional activity of different types of muscle and nonmuscle nuclei. Overall design: Nuclei were isolated from TA muscles of 1 month old WT or DMD ?Ex51 mice, and subjected to single nucleus RNA-seq using 10xGenomics Chromium platform.",SRS7227598,TA_D51 snRNA-seq,Mus musculus,Tibialis Anterior (TA) muscle,,C57BL6,230677525,28142658050,2020-11-07,2020-11-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/044/SRR12478044/SRR12478044.fastq.gz', 'md5': 'c160043f5431a87d59e73b52b98aafac', 'size': '3985929646'}]",Tibialis Anterior (TA) muscle,,,,,,Delta 51,1 month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870267,,,,NextSeq 500 paired end sequencing; GSM4259468: D0_FACS_01; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540258,NextSeq 500 paired end sequencing; GSM4259468: D0_FACS_01; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241203,Single-cell transcriptomic atlas of FACS-sorted mouse muscle tissue cells,We report a series of single-cell transcriptomic datasets of FACS-sorted mouse muscle tissue cells from injured muscle produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of FACS-sorted mouse muscle cell populations at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978833,D0_FACS_01,Mus musculus,Tibialis anterior muscle,,,135955654,7885427932,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/067/SRR10870267/SRR10870267.fastq.gz', 'md5': '90a9dd228f8feca29e454a1538e0d3a6', 'size': '6270739444'}]",,,,,,,C57Bl/6,4 month,female,,,,,,,,,,,No injury (Day 0),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870268,,,,NextSeq 500 paired end sequencing; GSM4259469: D0_FACS_02; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540259,NextSeq 500 paired end sequencing; GSM4259469: D0_FACS_02; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241203,Single-cell transcriptomic atlas of FACS-sorted mouse muscle tissue cells,We report a series of single-cell transcriptomic datasets of FACS-sorted mouse muscle tissue cells from injured muscle produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of FACS-sorted mouse muscle cell populations at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978834,D0_FACS_02,Mus musculus,Tibialis anterior muscle,,,333593961,19348449738,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/068/SRR10870268/SRR10870268.fastq.gz', 'md5': '259c0bebb645b3fd419309db6b3e5d01', 'size': '13091361108'}]",,,,,,,C57Bl/6,4 month,female,,,,,,,,,,,No injury (Day 0),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870269,,,,NextSeq 500 paired end sequencing; GSM4259470: D2_FACS; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540260,NextSeq 500 paired end sequencing; GSM4259470: D2_FACS; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241203,Single-cell transcriptomic atlas of FACS-sorted mouse muscle tissue cells,We report a series of single-cell transcriptomic datasets of FACS-sorted mouse muscle tissue cells from injured muscle produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of FACS-sorted mouse muscle cell populations at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978835,D2_FACS,Mus musculus,Tibialis anterior muscle,,,,,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/069/SRR10870269/SRR10870269.fastq.gz', 'md5': 'cce5ab03a26fdfcebcffa91282bc3d8a', 'size': '19718328891'}]",,,,,,,C57Bl/6,7 month,female,,,,,,,,,,,"Notexin, day 2 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870270,,,,NextSeq 500 paired end sequencing; GSM4259471: D5_FACS; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540261,NextSeq 500 paired end sequencing; GSM4259471: D5_FACS; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241203,Single-cell transcriptomic atlas of FACS-sorted mouse muscle tissue cells,We report a series of single-cell transcriptomic datasets of FACS-sorted mouse muscle tissue cells from injured muscle produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of FACS-sorted mouse muscle cell populations at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978836,D5_FACS,Mus musculus,Tibialis anterior muscle,,,262009279,15196538182,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/070/SRR10870270/SRR10870270.fastq.gz', 'md5': '051828a72f3d5305b3ecffab51b7004e', 'size': '11128542524'}]",,,,,,,C57Bl/6,4 month,female,,,,,,,,,,,"Notexin, day 5 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870271,,,,NextSeq 500 paired end sequencing; GSM4259472: D7_FACS; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540262,NextSeq 500 paired end sequencing; GSM4259472: D7_FACS; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241203,Single-cell transcriptomic atlas of FACS-sorted mouse muscle tissue cells,We report a series of single-cell transcriptomic datasets of FACS-sorted mouse muscle tissue cells from injured muscle produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of FACS-sorted mouse muscle cell populations at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978837,D7_FACS,Mus musculus,Tibialis anterior muscle,,,211374617,12259727786,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/071/SRR10870271/SRR10870271.fastq.gz', 'md5': '96d878ad9218cdd40c6e796a2722ad26', 'size': '9214364250'}]",,,,,,,C57Bl/6,4 month,male,,,,,,,,,,,"Notexin, day 7 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870296,,,,NextSeq 500 paired end sequencing; GSM4259473: D0_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540275,NextSeq 500 paired end sequencing; GSM4259473: D0_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978850,D0_A,Mus musculus,Tibialis anterior muscle,,,228700456,13264626448,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/096/SRR10870296/SRR10870296.fastq.gz', 'md5': '0c58dadee77b4bde2e612ba1e2b85c75', 'size': '9784133433'}]",,,,,,,C57Bl/6,7 months,female,,,,,,,,,,,No injury (Day 0),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870297,,,,NextSeq 500 paired end sequencing; GSM4259474: D0_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540276,NextSeq 500 paired end sequencing; GSM4259474: D0_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978851,D0_B,Mus musculus,Tibialis anterior muscle,,,256778531,14893154798,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/097/SRR10870297/SRR10870297.fastq.gz', 'md5': 'b50b80d7e01c927c40aec514cdacff5a', 'size': '10749732990'}]",,,,,,,C57Bl/6,7 months,female,,,,,,,,,,,No injury (Day 0),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870299,,,,NextSeq 500 paired end sequencing; GSM4259476: D2_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540278,NextSeq 500 paired end sequencing; GSM4259476: D2_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978853,D2_C,Mus musculus,Tibialis anterior muscle,,,143080183,8298650614,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/099/SRR10870299/SRR10870299.fastq.gz', 'md5': '9b0a5e02cccc61426e947d319d264ce6', 'size': '6623363463'}]",,,,,,,C57Bl/6,4 months,female,,,,,,,,,,,"Notexin, day 2 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870300,,,,NextSeq 500 paired end sequencing; GSM4259477: D2_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540279,NextSeq 500 paired end sequencing; GSM4259477: D2_D; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978854,D2_D,Mus musculus,Tibialis anterior muscle,,,243114255,14100626790,2020-01-12,2020-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/000/SRR10870300/SRR10870300.fastq.gz', 'md5': '05d3765ad1386509ddac765b9ff8d549', 'size': '10167155762'}]",,,,,,,C57Bl/6,4 months,female,,,,,,,,,,,"Notexin, day 2 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870301,,,,NextSeq 500 paired end sequencing; GSM4259478: D5_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540280,NextSeq 500 paired end sequencing; GSM4259478: D5_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978855,D5_A,Mus musculus,Tibialis anterior muscle,,,360147131,20888533598,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/001/SRR10870301/SRR10870301.fastq.gz', 'md5': 'a06f2c3bba20fa715921cadfd950a519', 'size': '16631561089'}]",,,,,,,C57Bl/6,4 months,male,,,,,,,,,,,"Notexin, day 5 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870302,,,,NextSeq 500 paired end sequencing; GSM4259479: D5_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540281,NextSeq 500 paired end sequencing; GSM4259479: D5_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978856,D5_B,Mus musculus,Tibialis anterior muscle,,,219020687,12703199846,2020-01-12,2020-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/002/SRR10870302/SRR10870302.fastq.gz', 'md5': '8547a343c77b0fd5f53ceccc388adc81', 'size': '10253443615'}]",,,,,,,C57Bl/6,4 months,female,,,,,,,,,,,"Notexin, day 5 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870303,,,,NextSeq 500 paired end sequencing; GSM4259480: D5_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540282,NextSeq 500 paired end sequencing; GSM4259480: D5_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978857,D5_C,Mus musculus,Tibialis anterior muscle,,,214150304,12420717632,2020-01-12,2020-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/003/SRR10870303/SRR10870303.fastq.gz', 'md5': 'e3f0485b16ef641fc11a09aa5d81f0da', 'size': '10211603008'}]",,,,,,,C57Bl/6,4 months,male,,,,,,,,,,,"Notexin, day 5 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870304,,,,NextSeq 500 paired end sequencing; GSM4259481: D7_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540283,NextSeq 500 paired end sequencing; GSM4259481: D7_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978858,D7_C,Mus musculus,Tibialis anterior muscle,,,199316776,11560373008,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/004/SRR10870304/SRR10870304.fastq.gz', 'md5': '3e1074a2954573c619ab5e244c43e1f8', 'size': '9420752978'}]",,,,,,,C57Bl/6,4 months,female,,,,,,,,,,,"Notexin, day 7 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10870305,,,,NextSeq 500 paired end sequencing; GSM4259482: D7_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX7540284,NextSeq 500 paired end sequencing; GSM4259482: D7_D; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP241205,Single-cell transcriptomic atlas of the mouse regenerating muscle tissue,We report a series of single-cell transcriptomic datasets of the mouse regenerating muscle tissue produced using the Chromium 10X technology. Overall design: The overall objective of the study was to generate a transcriptomic atlas of the distinct cell populations in the mouse muscle at different timepoints post notexin-injury using single-cell RNA-sequencing.,SRS5978859,D7_D,Mus musculus,Tibialis anterior muscle,,,250241224,14513990992,2020-01-12,2020-01-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/005/SRR10870305/SRR10870305.fastq.gz', 'md5': '79886f40161c7b183155c09598926522', 'size': '10532579143'}]",,,,,,,C57Bl/6,4 months,male,,,,,,,,,,,"Notexin, day 7 post-injury",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12820638,,,,NextSeq 500 paired end sequencing; GSM4831162: D2_Ev3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9288317,NextSeq 500 paired end sequencing; GSM4831162: D2_Ev3; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP287306,Single-cell transcriptomic sampling of regenerating mouse muscle tissue,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium v3 platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7515740,D2_Ev3,Mus musculus,Tibialis anterior muscle,,,208607334,11473403370,2020-10-15,2020-10-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR128/038/SRR12820638/SRR12820638.fastq.gz', 'md5': 'c2fed4401e6fc1c5b345058f622efd81', 'size': '8185548961'}]",,,,,,,C57Bl/6,7 months,female,,,,,,,,,,,Notexin injury (Day 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12820639,,,,NextSeq 500 paired end sequencing; GSM4831163: D7_Ev3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9288318,NextSeq 500 paired end sequencing; GSM4831163: D7_Ev3; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP287306,Single-cell transcriptomic sampling of regenerating mouse muscle tissue,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium v3 platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7515741,D7_Ev3,Mus musculus,Tibialis anterior muscle,,,205196263,11285794465,2020-10-15,2020-10-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR128/039/SRR12820639/SRR12820639.fastq.gz', 'md5': '59a5e9a2870baf2b0c07075a9052dfb4', 'size': '7741262195'}]",,,,,,,C57Bl/6,7 months,female,,,,,,,,,,,Notexin injury (Day 7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602275,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614992: total_muscle_wt_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402237,Illumina HiSeq 3000 paired end sequencing; GSM3614992: total_muscle_wt_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388158,total_muscle_wt_rep1,Mus musculus,muscle,,C56BL/6J,361275794,35405027812,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/005/SRR8602275/SRR8602275.fastq.gz', 'md5': 'd0508ab0789619b7c91343ce0d47d013', 'size': '26060715175'}]",muscle,,,,,total muscle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602276,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614993: total_muscle_wt_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402238,Illumina HiSeq 3000 paired end sequencing; GSM3614993: total_muscle_wt_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388159,total_muscle_wt_rep2,Mus musculus,muscle,,C56BL/6J,381305415,37367930670,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/006/SRR8602276/SRR8602276.fastq.gz', 'md5': 'de9d19b409cd68d07a0c099f586a7a3f', 'size': '27604016848'}]",muscle,,,,,total muscle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602277,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614994: homeostatic_MuSCs_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402239,Illumina HiSeq 3000 paired end sequencing; GSM3614994: homeostatic_MuSCs_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388160,homeostatic_MuSCs_rep1,Mus musculus,muscle,,C56BL/6J,386480806,37875118988,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/007/SRR8602277/SRR8602277.fastq.gz', 'md5': '08206ca9487c4321edef39d41b609957', 'size': '27799087318'}]",muscle,,,,,FACS Isolated Muscle satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602278,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614995: homeostatic_MuSCs_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402240,Illumina HiSeq 3000 paired end sequencing; GSM3614995: homeostatic_MuSCs_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388161,homeostatic_MuSCs_rep2,Mus musculus,muscle,,C56BL/6J,379911198,37231297404,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/008/SRR8602278/SRR8602278.fastq.gz', 'md5': '8051641be535ac3a92a6808fd32b10cd', 'size': '26223266161'}]",muscle,,,,,FACS Isolated Muscle satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602279,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614996: inj_60h_MuSCs_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402241,Illumina HiSeq 3000 paired end sequencing; GSM3614996: inj_60h_MuSCs_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388162,inj_60h_MuSCs_rep1,Mus musculus,muscle,,C56BL/6J,430999987,42237998726,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/009/SRR8602279/SRR8602279.fastq.gz', 'md5': '490c760b2a9150241ba0e797bb24b499', 'size': '28838113108'}]",muscle,,,,,Post injury (60h) FACS Isolated Muscle satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602280,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614997: inj_60h_MuSCs_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402242,Illumina HiSeq 3000 paired end sequencing; GSM3614997: inj_60h_MuSCs_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388163,inj_60h_MuSCs_rep2,Mus musculus,muscle,,C56BL/6J,452646301,44359337498,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/000/SRR8602280/SRR8602280.fastq.gz', 'md5': '9aa40cd4864997b9cd052541205ebbbf', 'size': '30162716109'}]",muscle,,,,,Post injury (60h) FACS Isolated Muscle satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8602281,,,,Illumina HiSeq 3000 paired end sequencing; GSM3614998: Primary_MB; Mus musculus; RNA-Seq,,,,,,,,,,SRX5402243,Illumina HiSeq 3000 paired end sequencing; GSM3614998: Primary_MB; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 3000,SRP186474,Single-cell analysis of homeostatic and regenerative adult skeletal muscle stem cells,"Skeletal muscle stem cells (MuSCs) ensure the formation and homeostasis of skeletal muscle and are responsible for its growth and repair processes. For repair to occur, MuSCs must exit from quiescence, abandon their niche and asymmetrically and symmetrically divide to reconstitute the stem cell pool and give rise to muscle progenitors, respectively. The transcriptomes of pooled MuSCs have provided a rich source of information for describing the genetic programs underlying distinct static cell states; however, bulk microarray and RNA-seq afford only averaged gene expression profiles, which blur the heterogeneity and developmental dynamics of asynchronous MuSC populations. The granularity required to identify distinct cell types, states, and their dynamics can be provided by single-cell analysis.  We were able to compare the transcriptomes of thousands of MuSCs and primary myoblasts isolated from homeostatic or regenerating muscles by single-cell RNA- sequencing. Using computational approaches, we could reconstruct dynamic trajectories and place, in a pseudotemporal manner, the transcriptomes of individual MuSC within these trajectories. This approach allowed for the identification of distinct clusters of MuSCs and primary myoblasts with partially overlapping but distinct transcriptional signatures, as well as the description of metabolic pathways associated with defined MuSC states. Overall design: Single cells suspentions were loaded into 10X Genomics for single cells transcriptome analysis using 10 X Genomics single cells RNAseq kit v2.2",SRS4388164,Primary_MB,Mus musculus,muscle,,C56BL/6J,376423939,36889546022,2019-03-09,2019-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR860/001/SRR8602281/SRR8602281.fastq.gz', 'md5': 'b91bfeb4da500c493b4008f8bacd2bff', 'size': '26708637748'}]",muscle,,,,,FACS Isolated Muscle satellite cells cultured for 4-5 passages on collagen coated plates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11729338,,,,NextSeq 500 paired end sequencing; GSM4522962: snRNA-seq_Soleus; Mus musculus; RNA-Seq,,,,,,,,,,SRX8288537,NextSeq 500 paired end sequencing; GSM4522962: snRNA-seq_Soleus; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP260473,Single-nucleus RNA-seq and FISH reveal coordinated transcriptional activity in mammalian myofibers,"Skeletal muscle fibers are large syncytia but it is currently unknown whether gene expression is coordinately regulated in their numerous nuclei. By snRNA-seq and snATAC-seq, we showed that slow, fast, myotendinous and neuromuscular junction myonuclei each have different transcriptional programs, associated with distinct chromatin states and combinations of transcription factors. In adult mice, identified myofiber types predominantly express either a slow or one of the three fast isoforms of Myosin heavy chain (MYH) proteins, while a small number of hybrid fibers can express more than one MYH. By snRNA-seq and FISH, we showed that the majority of myonuclei within a myofiber are synchronized, coordinately expressing only one fast Myh isoform with a preferential pane of muscle-specific genes. Importantly, this coordination of expression occurs early during post-natal development and depends on innervation. These findings highlight a unique mechanism of coordination of gene expression in a syncytium. Overall design: Single nuclei RNA-seq and single nuclei ATAC-seq",SRS6610269,snRNA-seq_Soleus,Mus musculus,Adult skeletal muscle,,C57Bl6N,313243332,26312439888,2020-05-09,2020-05-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/038/SRR11729338/SRR11729338_1.fastq.gz', 'md5': '0e2928a704c82e3c44a02c795bae1ea5', 'size': '6567900287'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/038/SRR11729338/SRR11729338_2.fastq.gz', 'md5': '16316141a62d9f65b39874ea8cfd0431', 'size': '10796776079'}]",Soleus,,,,,,,2 months,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11729339,,,,NextSeq 500 paired end sequencing; GSM4522963: snRNA-seq_Quadriceps; Mus musculus; RNA-Seq,,,,,,,,,,SRX8288538,NextSeq 500 paired end sequencing; GSM4522963: snRNA-seq_Quadriceps; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP260473,Single-nucleus RNA-seq and FISH reveal coordinated transcriptional activity in mammalian myofibers,"Skeletal muscle fibers are large syncytia but it is currently unknown whether gene expression is coordinately regulated in their numerous nuclei. By snRNA-seq and snATAC-seq, we showed that slow, fast, myotendinous and neuromuscular junction myonuclei each have different transcriptional programs, associated with distinct chromatin states and combinations of transcription factors. In adult mice, identified myofiber types predominantly express either a slow or one of the three fast isoforms of Myosin heavy chain (MYH) proteins, while a small number of hybrid fibers can express more than one MYH. By snRNA-seq and FISH, we showed that the majority of myonuclei within a myofiber are synchronized, coordinately expressing only one fast Myh isoform with a preferential pane of muscle-specific genes. Importantly, this coordination of expression occurs early during post-natal development and depends on innervation. These findings highlight a unique mechanism of coordination of gene expression in a syncytium. Overall design: Single nuclei RNA-seq and single nuclei ATAC-seq",SRS6610270,snRNA-seq_Quadriceps,Mus musculus,Adult skeletal muscle,,C57Bl6N,285704138,23999147592,2020-05-09,2020-05-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/039/SRR11729339/SRR11729339_1.fastq.gz', 'md5': '5401f8aa72ff2685ea45c9d2d69bb246', 'size': '5995439902'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/039/SRR11729339/SRR11729339_2.fastq.gz', 'md5': '1adf91f9651d837f400d4bb00a4aae01', 'size': '9946218791'}]",Quadriceps,,,,,,,2 months,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11729340,,,,NextSeq 500 paired end sequencing; GSM4522964: snRNA-seq_Tibialis; Mus musculus; RNA-Seq,,,,,,,,,,SRX8288539,NextSeq 500 paired end sequencing; GSM4522964: snRNA-seq_Tibialis; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP260473,Single-nucleus RNA-seq and FISH reveal coordinated transcriptional activity in mammalian myofibers,"Skeletal muscle fibers are large syncytia but it is currently unknown whether gene expression is coordinately regulated in their numerous nuclei. By snRNA-seq and snATAC-seq, we showed that slow, fast, myotendinous and neuromuscular junction myonuclei each have different transcriptional programs, associated with distinct chromatin states and combinations of transcription factors. In adult mice, identified myofiber types predominantly express either a slow or one of the three fast isoforms of Myosin heavy chain (MYH) proteins, while a small number of hybrid fibers can express more than one MYH. By snRNA-seq and FISH, we showed that the majority of myonuclei within a myofiber are synchronized, coordinately expressing only one fast Myh isoform with a preferential pane of muscle-specific genes. Importantly, this coordination of expression occurs early during post-natal development and depends on innervation. These findings highlight a unique mechanism of coordination of gene expression in a syncytium. Overall design: Single nuclei RNA-seq and single nuclei ATAC-seq",SRS6610271,snRNA-seq_Tibialis,Mus musculus,Adult skeletal muscle,,C57Bl6N,236767499,19888469916,2020-05-09,2020-05-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/040/SRR11729340/SRR11729340_1.fastq.gz', 'md5': '374160bfa8478cb65cfc7570e6b42551', 'size': '4593797375'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/040/SRR11729340/SRR11729340_2.fastq.gz', 'md5': '0cb6c141eb57d22373d65b20a23c0760', 'size': '7551207781'}]",Tibialis,,,,,,,2 months,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11729341,,,,NextSeq 500 paired end sequencing; GSM4522965: snRNA-seq_Mix; Mus musculus; RNA-Seq,,,,,,,,,,SRX8288540,NextSeq 500 paired end sequencing; GSM4522965: snRNA-seq_Mix; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP260473,Single-nucleus RNA-seq and FISH reveal coordinated transcriptional activity in mammalian myofibers,"Skeletal muscle fibers are large syncytia but it is currently unknown whether gene expression is coordinately regulated in their numerous nuclei. By snRNA-seq and snATAC-seq, we showed that slow, fast, myotendinous and neuromuscular junction myonuclei each have different transcriptional programs, associated with distinct chromatin states and combinations of transcription factors. In adult mice, identified myofiber types predominantly express either a slow or one of the three fast isoforms of Myosin heavy chain (MYH) proteins, while a small number of hybrid fibers can express more than one MYH. By snRNA-seq and FISH, we showed that the majority of myonuclei within a myofiber are synchronized, coordinately expressing only one fast Myh isoform with a preferential pane of muscle-specific genes. Importantly, this coordination of expression occurs early during post-natal development and depends on innervation. These findings highlight a unique mechanism of coordination of gene expression in a syncytium. Overall design: Single nuclei RNA-seq and single nuclei ATAC-seq",SRS6610272,snRNA-seq_Mix,Mus musculus,Adult skeletal muscle,,C57Bl6N,276487223,23224926732,2020-05-09,2020-05-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/041/SRR11729341/SRR11729341_1.fastq.gz', 'md5': '6a75f1f462a358c18d2569b29f5ecf06', 'size': '5486003913'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR117/041/SRR11729341/SRR11729341_2.fastq.gz', 'md5': '2b4558f044de01180b50160d6e19e967', 'size': '9179108223'}]",Gastrocnemius+Plantaris+Soleus+Tibilais+EDL,,,,,,,2 months,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769478,,,,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240090,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473145,Muscle Cells,Mus musculus,muscle endothelial cells,no treatment,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/078/SRR12769478/SRR12769478_1.fastq.gz', 'md5': 'a662fb17bb810b9139e840b239dca3a4', 'size': '753412370'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/078/SRR12769478/SRR12769478_2.fastq.gz', 'md5': '14226895aaa6f5e7240ea095935bafbd', 'size': '2497717140'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769479,,,,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240090,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473145,Muscle Cells,Mus musculus,muscle endothelial cells,no treatment,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/079/SRR12769479/SRR12769479_1.fastq.gz', 'md5': 'facf11d2f1c2c8b5c89895699ce222e0', 'size': '786827924'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/079/SRR12769479/SRR12769479_2.fastq.gz', 'md5': '273202f4b2e868eeec52a2ed115ade69', 'size': '2621619716'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769480,,,,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240090,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473145,Muscle Cells,Mus musculus,muscle endothelial cells,no treatment,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/080/SRR12769480/SRR12769480_1.fastq.gz', 'md5': '6459890a285ca7c22e56ba2c3ba2220b', 'size': '672380808'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/080/SRR12769480/SRR12769480_2.fastq.gz', 'md5': '302fee27e229eaa72578760515d18191', 'size': '2264168055'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769481,,,,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240090,NextSeq 500 paired end sequencing; GSM4816918: Muscle Cells; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473145,Muscle Cells,Mus musculus,muscle endothelial cells,no treatment,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/081/SRR12769481/SRR12769481_1.fastq.gz', 'md5': '0b7de25dd974b9aedaaf3d3bb524990c', 'size': '780849688'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/081/SRR12769481/SRR12769481_2.fastq.gz', 'md5': 'd8f6eae05c4ad7d3de4b88f3df4b385b', 'size': '2580786633'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769482,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4816919: Sedentary; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240091,Illumina NovaSeq 6000 paired end sequencing; GSM4816919: Sedentary; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473146,Sedentary,Mus musculus,muscle endothelial cells,single house sedentary,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/082/SRR12769482/SRR12769482_1.fastq.gz', 'md5': '58b7af23c57c0fbba691ce7f86f5a862', 'size': '2422189285'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/082/SRR12769482/SRR12769482_2.fastq.gz', 'md5': '02b4b2e1c62bbbb5e50f79d11b397cdf', 'size': '5752458819'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769483,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4816919: Sedentary; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240091,Illumina NovaSeq 6000 paired end sequencing; GSM4816919: Sedentary; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473146,Sedentary,Mus musculus,muscle endothelial cells,single house sedentary,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/083/SRR12769483/SRR12769483_1.fastq.gz', 'md5': 'df0b221b747f67645e51faacec4550d1', 'size': '2392473886'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/083/SRR12769483/SRR12769483_2.fastq.gz', 'md5': '000b2efc58720b45501277ff80588846', 'size': '5673588280'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769484,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4816920: 2weeks_run; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240092,Illumina NovaSeq 6000 paired end sequencing; GSM4816920: 2weeks_run; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473147,2weeks_run,Mus musculus,muscle endothelial cells,single house voluntary running 14 days,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/084/SRR12769484/SRR12769484_1.fastq.gz', 'md5': 'c0fb272cd474555e245465e265b22602', 'size': '2132309156'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/084/SRR12769484/SRR12769484_2.fastq.gz', 'md5': '63f3bacbdf7c610859b98c6c473fe448', 'size': '5083066944'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12769485,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4816920: 2weeks_run; Mus musculus; RNA-Seq,,,,,,,,,,SRX9240092,Illumina NovaSeq 6000 paired end sequencing; GSM4816920: 2weeks_run; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP286306,Single cell RNA sequencing of skeletal muscle endothelial cells in sedentary and exercised mice,"Skeleteal muscle is composed of different fiber types, which classically have been defined by their myosin heavy chain content, but they also substantially differ in their metabolic properties and the nutrients they use for energy generation. Within skeletal muscle, blood vessels (endothelium) lie in parallel with muscle fibers. What is less well described is whether the functional properties of muscle ECs (mECs) are dependent on the specific fiber (and thus microenvironment) they interact with. Furthermore, the mechanisms of exercise-induced vascular expansion however are poorly understood. Here, we use single cell RNA sequencing to map angiodiversity in skeletal muscle and investigate the mechanism of excercise induced muscle angiogensis. Overall design: 1. Single cell RNA sequencing of endothelial cell that FACS sorted from gastrocnemius muscle of wild type C57BL6N mice. 2. Compare scRNAseq data of ECs isolated from the gastrocnemius of sedentary mice versus 14 days exercised (voluntary running) mice.",SRS7473147,2weeks_run,Mus musculus,muscle endothelial cells,single house voluntary running 14 days,C57BL/6N,,,2021-06-17,2021-06-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/085/SRR12769485/SRR12769485_1.fastq.gz', 'md5': 'f75105e393b63d043e034a4795ad9f0e', 'size': '2099183387'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/085/SRR12769485/SRR12769485_2.fastq.gz', 'md5': '31f4410288102de35aeb13239df4a880', 'size': '4997124478'}]",gastrocnemius muscle,,,,,endothelial cells (EC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12734271,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4805565: Hindlimb skeletal muscle stromal cells; Mus musculus; RNA-Seq,,,,,,,,,,SRX9207535,Illumina NovaSeq 6000 paired end sequencing; GSM4805565: Hindlimb skeletal muscle stromal cells; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP285675,Single cell RNA-sequencing of murine dermal cells and hindlimb skeletal muscle stromal cells.,"Traumatic injury often results in muscle loss and impairment, which is worsened under aged and diseased conditions. Activation of resident stem cells or transplantation of myogenic stem cells can promote muscle regeneration. However, major challenges remain in harvesting sufficient autologous myogenic stem cells and expanding such cells efficiently for muscle regeneration therapies. Here, we identified a chemical cocktail that selectively induced a robust expansion of myogenic stem cells from readily-obtainable dermal cells and from muscle stromal cells. By differential plating and lineage tracing, we showed that Pax7+ cells were the major source for chemical-induced myogenic stem cells (CiMCs). We further performed single-cell RNA sequencing (scRNA-seq) analysis to characterize the transcriptomic profile of CiMCs and demonstrate a specific expansion of myogenic cells from heterogeneous dermal cell population. Upon transplantation into the injured muscle, CiMCs were efficiently engrafted and improved functional muscle regeneration in both adult and aged mice. In addition, CiMC transplantation rescued muscle function in mice with Duchenne muscular dystrophy (DMD). Furthermore, an in situ therapeutic modality using this cocktail was developed by loading the chemical cocktail into injectable nanoparticles, which enabled a sustained release of the cocktail in injured muscle and a local expansion of resident satellite cells for muscle regeneration in adult and aged mice. These findings will lead to the development of novel in vitro and in situ stem cell therapies for effective skeletal muscle repair. Overall design: Freshly isolated neonatal dermal cells, neonatal dermal cells treated with FR medium for 3 days, adult dermal cells treated with FR medium for 3 days and freshly isolated adult hindlimb skeletal muscle stromal cells were subjected to single cell RNA sequencing. FR medium is 20 M F, 20 M R, 50 g/ml AA, and 50 ng/ml bFGF in high-glucose DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin.",SRS7442445,Hindlimb skeletal muscle stromal cells,Mus musculus,Adult hindlimb muscle,,C57BL/6,194578885,23154887315,2020-09-29,2020-09-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/071/SRR12734271/SRR12734271_1.fastq.gz', 'md5': '3ac1358a7e4fcb64b71315f4dbbab0fe', 'size': '3645927796'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/071/SRR12734271/SRR12734271_2.fastq.gz', 'md5': '009f5f058ee38be4d886f681f70890b1', 'size': '8677204234'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8352705,,,,NextSeq 500 paired end sequencing; GSM3520458: Uninjured_WT_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5163634,NextSeq 500 paired end sequencing; GSM3520458: Uninjured_WT_1; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP133163,Combination of high-dimensional approaches for skeletal muscle tissue cartography,"The regenerative capacity of skeletal muscle relies on muscle stem cells (MuSCs, or satellite cells) and its niche interactions with different neighboring cells. To understand the cellular diversity within adult skeletal muscle tissue, we harvested mononuclear cells from hindlimb skeletal muscles, sorted into single cells and profiled them by single-cell RNA-seq. To further understand and compare the expression profile between MuSCs and a novel smooth-muscle/mesenchymal-like cells (SMMCs) population,  we isolated the two cell types by FACS and profiled them respectively by bulk RNA-seq. Overall design: (scRNA-seq) Mononuclear cells from hindlimb skeletal muscle from wild type mouse were profiled by taking advantage of 10X Chromium platform. (bulk RNA-seq) MuSCs and SMMCs cell population were isolated from hindlimb skeletal muscle from wild type mouse. Their polyA+ RNA were profiled using Smart-seq2.",SRS4172659,Uninjured_WT_1,Mus musculus,Skeletal muscle,,C57BL/6,514303302,77659798602,2019-03-31,2019-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR835/005/SRR8352705/SRR8352705.fastq.gz', 'md5': '12b8c3503f5f42b023b4b1eecb382569', 'size': '41988038057'}]",Skeletal muscle,,,,,,wild type,2 months old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8352706,,,,NextSeq 500 paired end sequencing; GSM3520459: Uninjured_WT_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5163635,NextSeq 500 paired end sequencing; GSM3520459: Uninjured_WT_2; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP133163,Combination of high-dimensional approaches for skeletal muscle tissue cartography,"The regenerative capacity of skeletal muscle relies on muscle stem cells (MuSCs, or satellite cells) and its niche interactions with different neighboring cells. To understand the cellular diversity within adult skeletal muscle tissue, we harvested mononuclear cells from hindlimb skeletal muscles, sorted into single cells and profiled them by single-cell RNA-seq. To further understand and compare the expression profile between MuSCs and a novel smooth-muscle/mesenchymal-like cells (SMMCs) population,  we isolated the two cell types by FACS and profiled them respectively by bulk RNA-seq. Overall design: (scRNA-seq) Mononuclear cells from hindlimb skeletal muscle from wild type mouse were profiled by taking advantage of 10X Chromium platform. (bulk RNA-seq) MuSCs and SMMCs cell population were isolated from hindlimb skeletal muscle from wild type mouse. Their polyA+ RNA were profiled using Smart-seq2.",SRS4172660,Uninjured_WT_2,Mus musculus,Skeletal muscle,,C57BL/6,494287765,61785970625,2019-03-31,2019-04-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR835/006/SRR8352706/SRR8352706.fastq.gz', 'md5': '10d343af31afee9d747a9c910cdbdcc0', 'size': '29808384170'}]",Skeletal muscle,,,,,,wild type,2 months old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974736,SRX13165591,SRP346726,SRS11096672,Illumina NovaSeq 6000 paired end sequencing; GSM5694401: SRSF2f/f/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],"[{'url': 's3://sra-pub-src-15/SRR16974736/R21040850-OES210731150-OES210731150-01_combined_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-15/SRR16974736/R21040850-OES210731150-OES210731150-01_combined_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-12/SRR16974736/R21040850-OES210731150-OES210731150-01_combined_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-12/SRR16974736/R21040850-OES210731150-OES210731150-01_combined_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR016/16974/SRR16974736/SRR16974736.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974737,SRX13165591,SRP346726,SRS11096672,Illumina NovaSeq 6000 paired end sequencing; GSM5694401: SRSF2f/f/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],"[{'url': 's3://sra-pub-src-12/SRR16974737/R21040850-OES210731150-OES210731150-02_combined_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-12/SRR16974737/R21040850-OES210731150-OES210731150-02_combined_R2.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR16974737/R21040850-OES210731150-OES210731150-02_combined_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR16974737/R21040850-OES210731150-OES210731150-02_combined_R2.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-hup-1/SRR016/16974/SRR16974737/SRR16974737.1'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974738,SRX13165591,SRP346726,SRS11096672,Illumina NovaSeq 6000 paired end sequencing; GSM5694401: SRSF2f/f/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],"[{'url': 's3://sra-pub-src-5/SRR16974738/R21040850-OES210731150-OES210731150-03_combined_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR16974738/R21040850-OES210731150-OES210731150-03_combined_R2.fastq.gz.1'}, {'url': 's3://sra-pub-run-2/SRR16974738/SRR16974738.1'}]","[{'url': 'gs://sra-pub-src-14/SRR16974738/R21040850-OES210731150-OES210731150-03_combined_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR16974738/R21040850-OES210731150-OES210731150-03_combined_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR16974738/SRR16974738.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra52/SRR/016576/SRR16974738'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974739,SRX13165591,SRP346726,SRS11096672,Illumina NovaSeq 6000 paired end sequencing; GSM5694401: SRSF2f/f/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],[{'url': 's3://sra-pub-src-4/SRR16974739/R21040850-OES210731150-OES210731150-04_combined_R1.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-4/SRR16974739/R21040850-OES210731150-OES210731150-04_combined_R1.fastq.gz.1'}],[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974740,SRX13165592,SRP346726,SRS11096673,Illumina NovaSeq 6000 paired end sequencing; GSM5694402: SRSF2f/w/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],"[{'url': 's3://sra-pub-src-11/SRR16974740/R21040851-OES210732150-OES210732150-01_combined_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-17/SRR16974740/R21040851-OES210732150-OES210732150-01_combined_R2.fastq.gz.1'}, {'url': 's3://sra-pub-run-10/SRR16974740/SRR16974740.1'}]","[{'url': 'gs://sra-pub-src-7/SRR16974740/R21040851-OES210732150-OES210732150-01_combined_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR16974740/R21040851-OES210732150-OES210732150-01_combined_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-10/SRR16974740/SRR16974740.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra70/SRR/016576/SRR16974740'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974741,SRX13165592,SRP346726,SRS11096673,Illumina NovaSeq 6000 paired end sequencing; GSM5694402: SRSF2f/w/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],"[{'url': 's3://sra-pub-src-3/SRR16974741/R21040851-OES210732150-OES210732150-02_combined_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-3/SRR16974741/R21040851-OES210732150-OES210732150-02_combined_R2.fastq.gz.1'}, {'url': 's3://sra-pub-run-3/SRR16974741/SRR16974741.1'}]","[{'url': 'gs://sra-pub-src-15/SRR16974741/R21040851-OES210732150-OES210732150-02_combined_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR16974741/R21040851-OES210732150-OES210732150-02_combined_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-13/SRR16974741/SRR16974741.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra16/SRR/016576/SRR16974741'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974742,SRX13165592,SRP346726,SRS11096673,Illumina NovaSeq 6000 paired end sequencing; GSM5694402: SRSF2f/w/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],"[{'url': 's3://sra-pub-src-5/SRR16974742/R21040851-OES210732150-OES210732150-03_combined_R1.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR16974742/R21040851-OES210732150-OES210732150-03_combined_R2.fastq.gz.1'}, {'url': 's3://sra-pub-run-2/SRR16974742/SRR16974742.1'}]","[{'url': 'gs://sra-pub-src-14/SRR16974742/R21040851-OES210732150-OES210732150-03_combined_R1.fastq.gz.1'}, {'url': 'gs://sra-pub-src-14/SRR16974742/R21040851-OES210732150-OES210732150-03_combined_R2.fastq.gz.1'}, {'url': 'gs://sra-pub-run-7/SRR16974742/SRR16974742.1'}]",[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra59/SRR/016576/SRR16974742'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16974743,SRX13165592,SRP346726,SRS11096673,Illumina NovaSeq 6000 paired end sequencing; GSM5694402: SRSF2f/w/Myf5-Cre/tdT; Mus musculus; RNA-Seq,,2022-04-26,2022-04-26,[],[{'url': 's3://sra-pub-src-12/SRR16974743/R21040851-OES210732150-OES210732150-04_combined_R1.fastq.gz.1'}],[{'url': 'gs://sra-pub-src-8/SRR16974743/R21040851-OES210732150-OES210732150-04_combined_R1.fastq.gz.1'}],[],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13844629,,,,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10225404,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP309090,Single cell RNA sequencing of the limb myotendionous junction,"Vertebrate muscles and tendons are derived from distinct embryonic origins yet they must interact in order to facilitate muscle contraction and body movements. How robust muscle tendon junctions (MTJs) form to be able to withstand contraction forces is still not understood. Using techniques at a single cell resolution we reexamined the classical view of distinct identities for the tissues composing the musculoskeletal system. We identified fibroblasts that have switched on a myogenic program and demonstrate these dual identity cells fuse into the developing muscle fibers along the MTJs facilitating the introduction of fibroblast-specific transcripts into the elongating myofibers. We suggest this mechanism resulting in a hybrid muscle fiber, primarily along the fiber tips, enables a smooth transition from muscle fiber characteristics towards tendon features essential for forming robust MTJs. We propose that dual characteristics of junctional cells could be a common mechanism for generating stable interactions between tissues throughout the musculoskeletal system. Overall design: We report the single cell RNA sequencing from the region of a P0 myotendinous junction taken from forelimbs",SRS8367830,WT MTJ scRNAseq,Mus musculus,single cells from the MTJ region,,C57BL/6,512140670,29704158860,2021-03-05,2021-03-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR138/029/SRR13844629/SRR13844629.fastq.gz', 'md5': '68fb977447c2897117821c847707b435', 'size': '5657570287'}]",limb myotendinous junction,,,,,fibroblasts and myoblast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13844630,,,,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10225404,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP309090,Single cell RNA sequencing of the limb myotendionous junction,"Vertebrate muscles and tendons are derived from distinct embryonic origins yet they must interact in order to facilitate muscle contraction and body movements. How robust muscle tendon junctions (MTJs) form to be able to withstand contraction forces is still not understood. Using techniques at a single cell resolution we reexamined the classical view of distinct identities for the tissues composing the musculoskeletal system. We identified fibroblasts that have switched on a myogenic program and demonstrate these dual identity cells fuse into the developing muscle fibers along the MTJs facilitating the introduction of fibroblast-specific transcripts into the elongating myofibers. We suggest this mechanism resulting in a hybrid muscle fiber, primarily along the fiber tips, enables a smooth transition from muscle fiber characteristics towards tendon features essential for forming robust MTJs. We propose that dual characteristics of junctional cells could be a common mechanism for generating stable interactions between tissues throughout the musculoskeletal system. Overall design: We report the single cell RNA sequencing from the region of a P0 myotendinous junction taken from forelimbs",SRS8367830,WT MTJ scRNAseq,Mus musculus,single cells from the MTJ region,,C57BL/6,512140670,29704158860,2021-03-05,2021-03-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR138/030/SRR13844630/SRR13844630.fastq.gz', 'md5': '3477375916ecd37d87c6364519e9930b', 'size': '5664324311'}]",limb myotendinous junction,,,,,fibroblasts and myoblast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13844631,,,,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10225404,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP309090,Single cell RNA sequencing of the limb myotendionous junction,"Vertebrate muscles and tendons are derived from distinct embryonic origins yet they must interact in order to facilitate muscle contraction and body movements. How robust muscle tendon junctions (MTJs) form to be able to withstand contraction forces is still not understood. Using techniques at a single cell resolution we reexamined the classical view of distinct identities for the tissues composing the musculoskeletal system. We identified fibroblasts that have switched on a myogenic program and demonstrate these dual identity cells fuse into the developing muscle fibers along the MTJs facilitating the introduction of fibroblast-specific transcripts into the elongating myofibers. We suggest this mechanism resulting in a hybrid muscle fiber, primarily along the fiber tips, enables a smooth transition from muscle fiber characteristics towards tendon features essential for forming robust MTJs. We propose that dual characteristics of junctional cells could be a common mechanism for generating stable interactions between tissues throughout the musculoskeletal system. Overall design: We report the single cell RNA sequencing from the region of a P0 myotendinous junction taken from forelimbs",SRS8367830,WT MTJ scRNAseq,Mus musculus,single cells from the MTJ region,,C57BL/6,512140670,29704158860,2021-03-05,2021-03-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR138/031/SRR13844631/SRR13844631.fastq.gz', 'md5': '68bc3134daac5fed3e3ed74285724207', 'size': '5753529417'}]",limb myotendinous junction,,,,,fibroblasts and myoblast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13844632,,,,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10225404,NextSeq 500 paired end sequencing; GSM5129995: WT MTJ scRNAseq; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP309090,Single cell RNA sequencing of the limb myotendionous junction,"Vertebrate muscles and tendons are derived from distinct embryonic origins yet they must interact in order to facilitate muscle contraction and body movements. How robust muscle tendon junctions (MTJs) form to be able to withstand contraction forces is still not understood. Using techniques at a single cell resolution we reexamined the classical view of distinct identities for the tissues composing the musculoskeletal system. We identified fibroblasts that have switched on a myogenic program and demonstrate these dual identity cells fuse into the developing muscle fibers along the MTJs facilitating the introduction of fibroblast-specific transcripts into the elongating myofibers. We suggest this mechanism resulting in a hybrid muscle fiber, primarily along the fiber tips, enables a smooth transition from muscle fiber characteristics towards tendon features essential for forming robust MTJs. We propose that dual characteristics of junctional cells could be a common mechanism for generating stable interactions between tissues throughout the musculoskeletal system. Overall design: We report the single cell RNA sequencing from the region of a P0 myotendinous junction taken from forelimbs",SRS8367830,WT MTJ scRNAseq,Mus musculus,single cells from the MTJ region,,C57BL/6,512140670,29704158860,2021-03-05,2021-03-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR138/032/SRR13844632/SRR13844632.fastq.gz', 'md5': '290478339ee6a21de59dfd6f59a2b4ae', 'size': '5660635424'}]",limb myotendinous junction,,,,,fibroblasts and myoblast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6998056,,,,Illumina HiSeq 2500 paired end sequencing; GSM3097061: N_plus_CTX_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX3932538,Illumina HiSeq 2500 paired end sequencing; GSM3097061: N_plus_CTX_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP139922,sc-RNA sequencing of skeletal muscle macrophages during T. gondii infection and injury,"The proper coordination of macrophages is essential for skeletal muscle repair. However, the full heterogenity of macrophages responding to injury has yet to be elucidated on the single-cell level. Furthermore, chronic inflammation may shift macrophage heterogeneity at steady-state and affect the generation of heterogeneity necessary for tissue repair. We use scRNA-sequencing to determine the heterogeneity of skeletal muscle macrophages during infection and wound repair (uninfected and infected). We identify multiple transcriptionally distinct macrophage subsets during injury in uninfected mice as well as during infection at steady-state. Interestingly, in response to injury, infected skeletal muscle macrophages fail to generate certain subsets of reparative macrophages in a timely fashion. Overall design: 8-12 week old C57BL/6 mice were orally infected with 5 ME49 T.gondii cysts and allowed to reach d24 post-infection to establish chronicity. Age and sex-matched uninfected and infected mice were given cardiotoxin naja pallida i.m. in one leg at 24 days post-infection. Contralateral leg was used as an uninjured control. Muscles were harvested at 4 days-post injury and prepared into a single cell suspension. Single cell suspensions were bulk sorted for macrophages by 7AAD-CD45+CD64+MerTK+ cells. Sorted cells from each group was individually assessed for and loaded onto the 10X Genomics Chromium platform for single-cell capture. cDNA libraries were constructed and subsequently sequenced on the Illumina platform. Experimental groups were performed in duplicate.",SRS3165512,N_plus_CTX_rep1,Mus musculus,Hindlimb muscle,,C57BL/6,155777402,17135514220,2018-10-05,2018-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA688/SRA688834/bam/N_plus_CTX_rep1_possorted_genome_bam.bam', 'md5': '4aaaf244f94bcd8cce5c70d8fbddc832', 'size': '40830046216'}]",skeletal muscle,,,,,macrophage,,,,,,,,,,,,,,,7AAD-CD45+CD64+MerTK+,4 days post-CTX,not infected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6998057,,,,Illumina HiSeq 2500 paired end sequencing; GSM3097062: N_plus_CTX_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX3932539,Illumina HiSeq 2500 paired end sequencing; GSM3097062: N_plus_CTX_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP139922,sc-RNA sequencing of skeletal muscle macrophages during T. gondii infection and injury,"The proper coordination of macrophages is essential for skeletal muscle repair. However, the full heterogenity of macrophages responding to injury has yet to be elucidated on the single-cell level. Furthermore, chronic inflammation may shift macrophage heterogeneity at steady-state and affect the generation of heterogeneity necessary for tissue repair. We use scRNA-sequencing to determine the heterogeneity of skeletal muscle macrophages during infection and wound repair (uninfected and infected). We identify multiple transcriptionally distinct macrophage subsets during injury in uninfected mice as well as during infection at steady-state. Interestingly, in response to injury, infected skeletal muscle macrophages fail to generate certain subsets of reparative macrophages in a timely fashion. Overall design: 8-12 week old C57BL/6 mice were orally infected with 5 ME49 T.gondii cysts and allowed to reach d24 post-infection to establish chronicity. Age and sex-matched uninfected and infected mice were given cardiotoxin naja pallida i.m. in one leg at 24 days post-infection. Contralateral leg was used as an uninjured control. Muscles were harvested at 4 days-post injury and prepared into a single cell suspension. Single cell suspensions were bulk sorted for macrophages by 7AAD-CD45+CD64+MerTK+ cells. Sorted cells from each group was individually assessed for and loaded onto the 10X Genomics Chromium platform for single-cell capture. cDNA libraries were constructed and subsequently sequenced on the Illumina platform. Experimental groups were performed in duplicate.",SRS3165514,N_plus_CTX_rep2,Mus musculus,Hindlimb muscle,,C57BL/6,45007692,4950846120,2018-10-05,2018-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA688/SRA688834/bam/N_plus_CTX_rep2_possorted_genome_bam.bam', 'md5': '533a7585be72fe29fafa3748fb0dae72', 'size': '12111896737'}]",skeletal muscle,,,,,macrophage,,,,,,,,,,,,,,,7AAD-CD45+CD64+MerTK+,4 days post-CTX,not infected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6998058,,,,Illumina HiSeq 2500 paired end sequencing; GSM3097063: Inf_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX3932540,Illumina HiSeq 2500 paired end sequencing; GSM3097063: Inf_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP139922,sc-RNA sequencing of skeletal muscle macrophages during T. gondii infection and injury,"The proper coordination of macrophages is essential for skeletal muscle repair. However, the full heterogenity of macrophages responding to injury has yet to be elucidated on the single-cell level. Furthermore, chronic inflammation may shift macrophage heterogeneity at steady-state and affect the generation of heterogeneity necessary for tissue repair. We use scRNA-sequencing to determine the heterogeneity of skeletal muscle macrophages during infection and wound repair (uninfected and infected). We identify multiple transcriptionally distinct macrophage subsets during injury in uninfected mice as well as during infection at steady-state. Interestingly, in response to injury, infected skeletal muscle macrophages fail to generate certain subsets of reparative macrophages in a timely fashion. Overall design: 8-12 week old C57BL/6 mice were orally infected with 5 ME49 T.gondii cysts and allowed to reach d24 post-infection to establish chronicity. Age and sex-matched uninfected and infected mice were given cardiotoxin naja pallida i.m. in one leg at 24 days post-infection. Contralateral leg was used as an uninjured control. Muscles were harvested at 4 days-post injury and prepared into a single cell suspension. Single cell suspensions were bulk sorted for macrophages by 7AAD-CD45+CD64+MerTK+ cells. Sorted cells from each group was individually assessed for and loaded onto the 10X Genomics Chromium platform for single-cell capture. cDNA libraries were constructed and subsequently sequenced on the Illumina platform. Experimental groups were performed in duplicate.",SRS3165513,Inf_rep1,Mus musculus,Hindlimb muscle,,C57BL/6,16497599,1814735890,2018-10-05,2018-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA688/SRA688834/bam/Inf_rep1_possorted_genome_bam.bam', 'md5': 'e83e8a3a0f2e267b02fa2a60d3adcb1d', 'size': '4905098684'}]",skeletal muscle,,,,,macrophage,,,,,,,,,,,,,,,7AAD-CD45+CD64+MerTK+,No CTX,T. gondii infected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6998059,,,,Illumina HiSeq 2500 paired end sequencing; GSM3097064: Inf_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX3932541,Illumina HiSeq 2500 paired end sequencing; GSM3097064: Inf_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP139922,sc-RNA sequencing of skeletal muscle macrophages during T. gondii infection and injury,"The proper coordination of macrophages is essential for skeletal muscle repair. However, the full heterogenity of macrophages responding to injury has yet to be elucidated on the single-cell level. Furthermore, chronic inflammation may shift macrophage heterogeneity at steady-state and affect the generation of heterogeneity necessary for tissue repair. We use scRNA-sequencing to determine the heterogeneity of skeletal muscle macrophages during infection and wound repair (uninfected and infected). We identify multiple transcriptionally distinct macrophage subsets during injury in uninfected mice as well as during infection at steady-state. Interestingly, in response to injury, infected skeletal muscle macrophages fail to generate certain subsets of reparative macrophages in a timely fashion. Overall design: 8-12 week old C57BL/6 mice were orally infected with 5 ME49 T.gondii cysts and allowed to reach d24 post-infection to establish chronicity. Age and sex-matched uninfected and infected mice were given cardiotoxin naja pallida i.m. in one leg at 24 days post-infection. Contralateral leg was used as an uninjured control. Muscles were harvested at 4 days-post injury and prepared into a single cell suspension. Single cell suspensions were bulk sorted for macrophages by 7AAD-CD45+CD64+MerTK+ cells. Sorted cells from each group was individually assessed for and loaded onto the 10X Genomics Chromium platform for single-cell capture. cDNA libraries were constructed and subsequently sequenced on the Illumina platform. Experimental groups were performed in duplicate.",SRS3165515,Inf_rep2,Mus musculus,Hindlimb muscle,,C57BL/6,54232345,5965557950,2018-10-05,2018-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA688/SRA688834/bam/Inf_rep2_possorted_genome_bam.bam', 'md5': '318fa4726b19b53b0edec11fc0ffd2b5', 'size': '16667690610'}]",skeletal muscle,,,,,macrophage,,,,,,,,,,,,,,,7AAD-CD45+CD64+MerTK+,No CTX,T. gondii infected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6998060,,,,Illumina HiSeq 2500 paired end sequencing; GSM3097065: Inf_plus_CTX_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX3932542,Illumina HiSeq 2500 paired end sequencing; GSM3097065: Inf_plus_CTX_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP139922,sc-RNA sequencing of skeletal muscle macrophages during T. gondii infection and injury,"The proper coordination of macrophages is essential for skeletal muscle repair. However, the full heterogenity of macrophages responding to injury has yet to be elucidated on the single-cell level. Furthermore, chronic inflammation may shift macrophage heterogeneity at steady-state and affect the generation of heterogeneity necessary for tissue repair. We use scRNA-sequencing to determine the heterogeneity of skeletal muscle macrophages during infection and wound repair (uninfected and infected). We identify multiple transcriptionally distinct macrophage subsets during injury in uninfected mice as well as during infection at steady-state. Interestingly, in response to injury, infected skeletal muscle macrophages fail to generate certain subsets of reparative macrophages in a timely fashion. Overall design: 8-12 week old C57BL/6 mice were orally infected with 5 ME49 T.gondii cysts and allowed to reach d24 post-infection to establish chronicity. Age and sex-matched uninfected and infected mice were given cardiotoxin naja pallida i.m. in one leg at 24 days post-infection. Contralateral leg was used as an uninjured control. Muscles were harvested at 4 days-post injury and prepared into a single cell suspension. Single cell suspensions were bulk sorted for macrophages by 7AAD-CD45+CD64+MerTK+ cells. Sorted cells from each group was individually assessed for and loaded onto the 10X Genomics Chromium platform for single-cell capture. cDNA libraries were constructed and subsequently sequenced on the Illumina platform. Experimental groups were performed in duplicate.",SRS3165516,Inf_plus_CTX_rep1,Mus musculus,Hindlimb muscle,,C57BL/6,30633382,3369672020,2018-10-05,2018-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA688/SRA688834/bam/Inf_plus_CTX_rep1_possorted_genome_bam.bam', 'md5': '7141099adcf6c945923aa84d6dc8de53', 'size': '8385655287'}]",skeletal muscle,,,,,macrophage,,,,,,,,,,,,,,,7AAD-CD45+CD64+MerTK+,4 days post-CTX,T. gondii infected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6998061,,,,Illumina HiSeq 2500 paired end sequencing; GSM3097066: Inf_plus_CTX_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX3932543,Illumina HiSeq 2500 paired end sequencing; GSM3097066: Inf_plus_CTX_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP139922,sc-RNA sequencing of skeletal muscle macrophages during T. gondii infection and injury,"The proper coordination of macrophages is essential for skeletal muscle repair. However, the full heterogenity of macrophages responding to injury has yet to be elucidated on the single-cell level. Furthermore, chronic inflammation may shift macrophage heterogeneity at steady-state and affect the generation of heterogeneity necessary for tissue repair. We use scRNA-sequencing to determine the heterogeneity of skeletal muscle macrophages during infection and wound repair (uninfected and infected). We identify multiple transcriptionally distinct macrophage subsets during injury in uninfected mice as well as during infection at steady-state. Interestingly, in response to injury, infected skeletal muscle macrophages fail to generate certain subsets of reparative macrophages in a timely fashion. Overall design: 8-12 week old C57BL/6 mice were orally infected with 5 ME49 T.gondii cysts and allowed to reach d24 post-infection to establish chronicity. Age and sex-matched uninfected and infected mice were given cardiotoxin naja pallida i.m. in one leg at 24 days post-infection. Contralateral leg was used as an uninjured control. Muscles were harvested at 4 days-post injury and prepared into a single cell suspension. Single cell suspensions were bulk sorted for macrophages by 7AAD-CD45+CD64+MerTK+ cells. Sorted cells from each group was individually assessed for and loaded onto the 10X Genomics Chromium platform for single-cell capture. cDNA libraries were constructed and subsequently sequenced on the Illumina platform. Experimental groups were performed in duplicate.",SRS3165517,Inf_plus_CTX_rep2,Mus musculus,Hindlimb muscle,,C57BL/6,16593857,1825324270,2018-10-05,2018-10-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA688/SRA688834/bam/Inf_plus_CTX_rep2_possorted_genome_bam.bam', 'md5': '87236c8269af82befc23e7c96edfd906', 'size': '4600693752'}]",skeletal muscle,,,,,macrophage,,,,,,,,,,,,,,,7AAD-CD45+CD64+MerTK+,4 days post-CTX,T. gondii infected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874104,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260192: Y1_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543861,Illumina NovaSeq 6000 paired end sequencing; GSM4260192: Y1_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981902,Y1_LRC_Q,Mus musculus,Young 1 Quiescent LRC,,,217766519,19598986710,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/004/SRR10874104/SRR10874104.fastq.gz', 'md5': 'c075904ad687cc2f87dcc27a75475220', 'size': '5196575846'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874105,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260192: Y1_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543861,Illumina NovaSeq 6000 paired end sequencing; GSM4260192: Y1_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981902,Y1_LRC_Q,Mus musculus,Young 1 Quiescent LRC,,,217766519,19598986710,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/005/SRR10874105/SRR10874105.fastq.gz', 'md5': '3b3c25bcb26f1c70f68fcc2a3810cf7d', 'size': '5057551440'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874106,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260193: Y1_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543862,Illumina NovaSeq 6000 paired end sequencing; GSM4260193: Y1_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981903,Y1_LRC_A,Mus musculus,Young 1 Activated LRC,,,485787286,43720855740,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/006/SRR10874106/SRR10874106.fastq.gz', 'md5': '9c4af45fd89a948a63c655b12e12fac1', 'size': '11682670492'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874107,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260193: Y1_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543862,Illumina NovaSeq 6000 paired end sequencing; GSM4260193: Y1_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981903,Y1_LRC_A,Mus musculus,Young 1 Activated LRC,,,485787286,43720855740,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/007/SRR10874107/SRR10874107.fastq.gz', 'md5': 'a4956433e2be495b4bb63691a3240eb1', 'size': '11430222735'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874108,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260194: Y2_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543863,Illumina NovaSeq 6000 paired end sequencing; GSM4260194: Y2_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981904,Y2_LRC_Q,Mus musculus,Young 2 Quiescent LRC,,,160930015,14483701350,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/008/SRR10874108/SRR10874108.fastq.gz', 'md5': 'e53a0c2828dc054f8ae2d87cc94112f1', 'size': '3852312627'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874109,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260194: Y2_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543863,Illumina NovaSeq 6000 paired end sequencing; GSM4260194: Y2_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981904,Y2_LRC_Q,Mus musculus,Young 2 Quiescent LRC,,,160930015,14483701350,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/009/SRR10874109/SRR10874109.fastq.gz', 'md5': '780f351e38e416da7edadc14634db39c', 'size': '3765051902'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874110,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260195: Y2_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543864,Illumina NovaSeq 6000 paired end sequencing; GSM4260195: Y2_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981905,Y2_LRC_A,Mus musculus,Young 2 Activated LRC,,,594493286,53504395740,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/010/SRR10874110/SRR10874110.fastq.gz', 'md5': '0f651beab02f381f4aede887f093bc4e', 'size': '14051516662'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874111,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260195: Y2_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543864,Illumina NovaSeq 6000 paired end sequencing; GSM4260195: Y2_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981905,Y2_LRC_A,Mus musculus,Young 2 Activated LRC,,,594493286,53504395740,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/011/SRR10874111/SRR10874111.fastq.gz', 'md5': '65be5d24f53dfd3676119a03e067dd25', 'size': '13671636525'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874112,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260196: Y1_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543865,Illumina NovaSeq 6000 paired end sequencing; GSM4260196: Y1_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981906,Y1_nonLRC_Q,Mus musculus,Young 1 Quiescent nonLRC,,,152864446,13757800140,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/012/SRR10874112/SRR10874112.fastq.gz', 'md5': '283be394f00c22813bb0f486bff7c8c3', 'size': '3628962283'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874113,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260196: Y1_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543865,Illumina NovaSeq 6000 paired end sequencing; GSM4260196: Y1_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981906,Y1_nonLRC_Q,Mus musculus,Young 1 Quiescent nonLRC,,,152864446,13757800140,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/013/SRR10874113/SRR10874113.fastq.gz', 'md5': '397518f0201734ebb4f165900c1cc190', 'size': '3554848661'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874114,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260197: Y1_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543866,Illumina NovaSeq 6000 paired end sequencing; GSM4260197: Y1_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981907,Y1_nonLRC_A,Mus musculus,Young 1 Activated nonLRC,,,537812349,48403111410,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/014/SRR10874114/SRR10874114.fastq.gz', 'md5': '3de22e5b729880f08df7dff79e8ab299', 'size': '12697360200'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874115,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260197: Y1_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543866,Illumina NovaSeq 6000 paired end sequencing; GSM4260197: Y1_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981907,Y1_nonLRC_A,Mus musculus,Young 1 Activated nonLRC,,,537812349,48403111410,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/015/SRR10874115/SRR10874115.fastq.gz', 'md5': '6c94d0b62cb90a416883d912e13f8071', 'size': '12339372038'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874116,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260198: Y2_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543867,Illumina NovaSeq 6000 paired end sequencing; GSM4260198: Y2_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981909,Y2_nonLRC_Q,Mus musculus,Young 2 Quiescent nonLRC,,,179809514,16182856260,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/016/SRR10874116/SRR10874116.fastq.gz', 'md5': '68c6d4742b877aa29056608fc3e7fe3c', 'size': '4266450594'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874117,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260198: Y2_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543867,Illumina NovaSeq 6000 paired end sequencing; GSM4260198: Y2_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981909,Y2_nonLRC_Q,Mus musculus,Young 2 Quiescent nonLRC,,,179809514,16182856260,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/017/SRR10874117/SRR10874117.fastq.gz', 'md5': '9d59e74df5fac51807350a89c2bc85c9', 'size': '4184683446'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874118,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260199: Y2_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543868,Illumina NovaSeq 6000 paired end sequencing; GSM4260199: Y2_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981908,Y2_nonLRC_A,Mus musculus,Young 2 Activated nonLRC,,,544043688,48963931920,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/018/SRR10874118/SRR10874118.fastq.gz', 'md5': '1e8634675a18079c2307d3d31693e5f2', 'size': '12832155340'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874119,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260199: Y2_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543868,Illumina NovaSeq 6000 paired end sequencing; GSM4260199: Y2_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981908,Y2_nonLRC_A,Mus musculus,Young 2 Activated nonLRC,,,544043688,48963931920,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/019/SRR10874119/SRR10874119.fastq.gz', 'md5': '9ecb3f92ea5fa8be2b7e1799582a464a', 'size': '12523396869'}]",,,,,,muscle stem cells from limb muscle,,3 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874120,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260200: A1_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543869,Illumina NovaSeq 6000 paired end sequencing; GSM4260200: A1_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981910,A1_LRC_Q,Mus musculus,Aged 1 Quiescent LRC,,,54454854,4900936860,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/020/SRR10874120/SRR10874120.fastq.gz', 'md5': 'aa2db98035e7028012effd30bfcd8703', 'size': '1271584804'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874121,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260200: A1_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543869,Illumina NovaSeq 6000 paired end sequencing; GSM4260200: A1_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981910,A1_LRC_Q,Mus musculus,Aged 1 Quiescent LRC,,,54454854,4900936860,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/021/SRR10874121/SRR10874121.fastq.gz', 'md5': 'ca604f5154a6ff8ca898677e44bbad4e', 'size': '1285103554'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874122,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260201: A1_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543870,Illumina NovaSeq 6000 paired end sequencing; GSM4260201: A1_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981911,A1_LRC_A,Mus musculus,Aged 1 Activated LRC,,,106537356,9588362040,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/022/SRR10874122/SRR10874122.fastq.gz', 'md5': '8010b1870ec25d6f4038b84db5f9f9b6', 'size': '2498813611'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874123,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260201: A1_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543870,Illumina NovaSeq 6000 paired end sequencing; GSM4260201: A1_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981911,A1_LRC_A,Mus musculus,Aged 1 Activated LRC,,,106537356,9588362040,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/023/SRR10874123/SRR10874123.fastq.gz', 'md5': '00e1dca69fc5de37f9fb8e6dfe49a70b', 'size': '2484748353'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874124,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260202: A2_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543871,Illumina NovaSeq 6000 paired end sequencing; GSM4260202: A2_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981912,A2_LRC_Q,Mus musculus,Aged 2 Quiescent LRC,,,74937437,6744369330,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/024/SRR10874124/SRR10874124.fastq.gz', 'md5': 'ce01618f723f4f6c4577aaa07f52dfc1', 'size': '1759745707'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874125,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260202: A2_LRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543871,Illumina NovaSeq 6000 paired end sequencing; GSM4260202: A2_LRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981912,A2_LRC_Q,Mus musculus,Aged 2 Quiescent LRC,,,74937437,6744369330,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/025/SRR10874125/SRR10874125.fastq.gz', 'md5': '260deea035ebbdf00ee8f00b652ec58b', 'size': '1769439727'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,LRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874126,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260203: A2_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543872,Illumina NovaSeq 6000 paired end sequencing; GSM4260203: A2_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981913,A2_LRC_A,Mus musculus,Aged 2 Activated LRC,,,136090574,12248151660,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/026/SRR10874126/SRR10874126.fastq.gz', 'md5': 'dadcfc85f3c57d7d871e2ac8f01eb771', 'size': '3165241228'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874127,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260203: A2_LRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543872,Illumina NovaSeq 6000 paired end sequencing; GSM4260203: A2_LRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981913,A2_LRC_A,Mus musculus,Aged 2 Activated LRC,,,136090574,12248151660,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/027/SRR10874127/SRR10874127.fastq.gz', 'md5': 'da7ae2834147ea2f3add3db2be4d08d3', 'size': '3143014251'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,LRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874128,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260204: A1_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543873,Illumina NovaSeq 6000 paired end sequencing; GSM4260204: A1_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981914,A1_nonLRC_Q,Mus musculus,Aged 1 Quiescent nonLRC,,,225563000,20300670000,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/028/SRR10874128/SRR10874128.fastq.gz', 'md5': 'f4bcbd87aefe3ae4dee3d537687fed2c', 'size': '5366930821'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874129,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260204: A1_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543873,Illumina NovaSeq 6000 paired end sequencing; GSM4260204: A1_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981914,A1_nonLRC_Q,Mus musculus,Aged 1 Quiescent nonLRC,,,225563000,20300670000,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/029/SRR10874129/SRR10874129.fastq.gz', 'md5': '4d1a5670a5136169bdb60cbf2ed9e9a2', 'size': '5261397302'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874130,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260205: A1_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543874,Illumina NovaSeq 6000 paired end sequencing; GSM4260205: A1_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981915,A1_nonLRC_A,Mus musculus,Aged 1 Activated nonLRC,,,331417670,29827590300,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/030/SRR10874130/SRR10874130.fastq.gz', 'md5': '9e262a10e7f215e56c957898e2364022', 'size': '15393122644'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874131,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260205: A1_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543874,Illumina NovaSeq 6000 paired end sequencing; GSM4260205: A1_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981915,A1_nonLRC_A,Mus musculus,Aged 1 Activated nonLRC,,,331417670,29827590300,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/031/SRR10874131/SRR10874131.fastq.gz', 'md5': '29fe060075833436c6797ef6d3d88d4b', 'size': '15191778462'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874132,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260206: A2_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543875,Illumina NovaSeq 6000 paired end sequencing; GSM4260206: A2_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981916,A2_nonLRC_Q,Mus musculus,Aged 2 Quiescent nonLRC,,,137894932,12410543880,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/032/SRR10874132/SRR10874132.fastq.gz', 'md5': 'ed97ffeaea68b11d5b3316c27288ad81', 'size': '3266970134'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874133,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260206: A2_nonLRC_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543875,Illumina NovaSeq 6000 paired end sequencing; GSM4260206: A2_nonLRC_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981916,A2_nonLRC_Q,Mus musculus,Aged 2 Quiescent nonLRC,,,137894932,12410543880,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/033/SRR10874133/SRR10874133.fastq.gz', 'md5': 'ecb83831b5a17b8cf3ad92e39d58df24', 'size': '3227956757'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,0 hours,nonLRC,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874134,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260207: A2_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543876,Illumina NovaSeq 6000 paired end sequencing; GSM4260207: A2_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981917,A2_nonLRC_A,Mus musculus,Aged 2 Activated nonLRC,,,152665068,13739856120,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/034/SRR10874134/SRR10874134.fastq.gz', 'md5': '84cffeafb375d82ce37751fbe7256100', 'size': '3597760076'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10874135,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4260207: A2_nonLRC_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX7543876,Illumina NovaSeq 6000 paired end sequencing; GSM4260207: A2_nonLRC_A; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP241629,Aging induces aberrant state transition kinetics in murine muscle stem cells,"Label retaining and non-retaining muscle stem cells from young and aged H2B-GFP+/-;rtTA+/- were profiled by single cell RNA-seq at two timepoints Overall design: 2 young (3 mo) and 2 aged (20 mo) H2B-GFP+/-;rtTA were labeled to track proliferative history by pulsing DOX in development (E10.5-E16.5). Label retaining and non-retaining cells were isolated from these animals by FACS. A set of cells from each animal was profiled immediately, while another set of cells was activated for 18 hours in vitro (10% HS, DMEM, culture plastic + sarcoma derived ECM) prior to profiling. Single cell RNA-seq was performed following the 10X Chromium Single Cell v2 kit.",SRS5981917,A2_nonLRC_A,Mus musculus,Aged 2 Activated nonLRC,,,152665068,13739856120,2020-02-19,2020-02-20,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR108/035/SRR10874135/SRR10874135.fastq.gz', 'md5': '3c545baee1808c85573df2dee7035967', 'size': '3552908640'}]",,,,,,muscle stem cells from limb muscle,,20 months,,,,,,,,,,,,,,,,18 hours,nonLRC,activated,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080211,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310251: Aged 1 Pre-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719263,Illumina HiSeq 2500 paired end sequencing; GSM4310251: Aged 1 Pre-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141574,Aged 1 Pre-differentiation,Mus musculus,Limb muscle,,C57BL/6J,84788139,7715720649,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/011/SRR11080211/SRR11080211.fastq.gz', 'md5': '0821d41839f5c92538e90048acad3b3e', 'size': '5671701705'}]",Limb muscle,,,,,Contains the total muscle mononuclear cell population,,20 months,,,,,,,,,,,,,,,,,,,Freshly-isolated 0 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080212,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310252: Aged 2 Pre-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719264,Illumina HiSeq 2500 paired end sequencing; GSM4310252: Aged 2 Pre-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141575,Aged 2 Pre-differentiation,Mus musculus,Limb muscle,,C57BL/6J,97965450,8914855950,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/012/SRR11080212/SRR11080212.fastq.gz', 'md5': 'a6904d9a37f46370a6db96e2a88d7f6b', 'size': '6404329702'}]",Limb muscle,,,,,Contains the total muscle mononuclear cell population,,20 months,,,,,,,,,,,,,,,,,,,Freshly-isolated 0 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080213,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310253: Young 1 Pre-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719265,Illumina HiSeq 2500 paired end sequencing; GSM4310253: Young 1 Pre-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141576,Young 1 Pre-differentiation,Mus musculus,Limb muscle,,C57BL/6J,72785098,6623443918,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/013/SRR11080213/SRR11080213.fastq.gz', 'md5': '21db2682f94882ee0fe22168e4a75653', 'size': '4961291989'}]",Limb muscle,,,,,Contains the total muscle mononuclear cell population,,3 months,,,,,,,,,,,,,,,,,,,Freshly-isolated 0 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080214,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310254: Young 2 Pre-differenitation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719266,Illumina HiSeq 2500 paired end sequencing; GSM4310254: Young 2 Pre-differenitation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141577,Young 2 Pre-differenitation,Mus musculus,Limb muscle,,C57BL/6J,89748533,8167116503,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/014/SRR11080214/SRR11080214.fastq.gz', 'md5': '366fedbd818371f88be95a8bee2c3778', 'size': '6021179208'}]",Limb muscle,,,,,Contains the total muscle mononuclear cell population,,3 months,,,,,,,,,,,,,,,,,,,Freshly-isolated 0 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080215,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310255: Aged 1 Post-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719267,Illumina HiSeq 2500 paired end sequencing; GSM4310255: Aged 1 Post-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141578,Aged 1 Post-differentiation,Mus musculus,Limb muscle,,C57BL/6J,70671504,6431106864,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/015/SRR11080215/SRR11080215.fastq.gz', 'md5': '476b5fcc6676670f743a582959b04ad4', 'size': '4824638184'}]",Limb muscle,,,,,Contains differentiated muscle stem cells and fibro/adipose progenitors,,20 months,,,,,,,,,,,,,,,,,,,Differentiated 60 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080216,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310256: Aged 2 Post-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719268,Illumina HiSeq 2500 paired end sequencing; GSM4310256: Aged 2 Post-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141579,Aged 2 Post-differentiation,Mus musculus,Limb muscle,,C57BL/6J,57426854,5225843714,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/016/SRR11080216/SRR11080216.fastq.gz', 'md5': '4461ae4f683449669c8f3ef0e547457f', 'size': '3952775496'}]",Limb muscle,,,,,Contains differentiated muscle stem cells and fibro/adipose progenitors,,20 months,,,,,,,,,,,,,,,,,,,Differentiated 60 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080217,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310257: Young 1 Post-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719269,Illumina HiSeq 2500 paired end sequencing; GSM4310257: Young 1 Post-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141580,Young 1 Post-differentiation,Mus musculus,Limb muscle,,C57BL/6J,52125130,4743386830,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/017/SRR11080217/SRR11080217.fastq.gz', 'md5': 'd4d17d25c6dfb2acfbb88d83c84f0ce9', 'size': '3693889840'}]",Limb muscle,,,,,Contains differentiated muscle stem cells and fibro/adipose progenitors,,3 months,,,,,,,,,,,,,,,,,,,Differentiated 60 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11080218,,,,Illumina HiSeq 2500 paired end sequencing; GSM4310258: Young 2 Post-differentiation; Mus musculus; RNA-Seq,,,,,,,,,,SRX7719270,Illumina HiSeq 2500 paired end sequencing; GSM4310258: Young 2 Post-differentiation; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP249325,Differentiation reveals the plasticity of age-related change in murine muscle progenitors,"Skeletal muscle experiences a decline in lean mass and regenerative potential with age, in part due to intrinsic changes in progenitor cells. However, it remains unclear if age-related changes in progenitors persist across a differentiation trajectory or if new age-related changes manifest in differentiated cells. To investigate this possibility, we performed single cell RNA-seq on muscle mononuclear cells from young and aged mice and profiled muscle stem cells (MuSCs) and fibro/adipose progenitors (FAPs) after differentiation. Differentiation increased the magnitude of age-related change in MuSCs and FAPs, but also masked a subset of age-related changes present in progenitors. Using a dynamical systems approach and RNA velocity, we found that aged MuSCs follow the same differentiation trajectory as young cells, but stall in differentiation near a commitment decision. Our results suggest that age-related changes are plastic across differentiation trajectories and that fate commitment decisions are delayed in aged myogenic cells. Overall design: Muscle mononuclear cells were isolated from 2 young (3 m.o.) and 2 aged (20 m.o.) C57Bl/6 mice. All cells in the muscle mononuclear compartment were transcriptionally profiled immediately after isolation using the 10X Chromium Single Cell Transcriptome v3 technology. Muscle stem cells and fibro/adipose progenitors were additionally profiled both  after a differentiation challenge using the same library preparation method.",SRS6141581,Young 2 Post-differentiation,Mus musculus,Limb muscle,,C57BL/6J,86138814,7838632074,2021-04-17,2021-04-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR110/018/SRR11080218/SRR11080218.fastq.gz', 'md5': 'd294924f081a524da8d9df736a1d1f22', 'size': '5911888661'}]",Limb muscle,,,,,Contains differentiated muscle stem cells and fibro/adipose progenitors,,3 months,,,,,,,,,,,,,,,,,,,Differentiated 60 hours,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610659,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059685: Aged Uninjured MuSCs [d0_Aged]; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004691,Illumina NovaSeq 6000 paired end sequencing; GSM5059685: Aged Uninjured MuSCs [d0_Aged]; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173889,Aged Uninjured MuSCs [d0_Aged],Mus musculus,TA and EDL muscle,,C57BL6J,220974675,24307214250,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/059/SRR13610659/SRR13610659.fastq.gz', 'md5': '98c0595447a632ad5c728f16ee88be28', 'size': '13377705983'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610659/sample_d0_aged.bam', 'md5': '3e1dbcbd222707ab842a136a73bfd849', 'size': '31314329928'}]",,,,,,,,22-24 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610660,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059686: Aged MuSCs 3dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004692,Illumina NovaSeq 6000 paired end sequencing; GSM5059686: Aged MuSCs 3dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173890,Aged MuSCs 3dpi,Mus musculus,TA and EDL muscle,,C57BL6J,258324242,28415666620,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/060/SRR13610660/SRR13610660.fastq.gz', 'md5': '159f746f78caffbe6871d381f09a9c6d', 'size': '10343932882'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610660/sample_d3_aged.bam', 'md5': '6e7ff8108abde88ecd93368216e448c0', 'size': '26863308431'}]",,,,,,,,22-24 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610661,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059687: Aged MuSCs 7dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004693,Illumina NovaSeq 6000 paired end sequencing; GSM5059687: Aged MuSCs 7dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173891,Aged MuSCs 7dpi,Mus musculus,TA and EDL muscle,,C57BL6J,199618213,22956094495,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/061/SRR13610661/SRR13610661.fastq.gz', 'md5': 'fa83aa1f7e66fcba40319352517aaeba', 'size': '9913557513'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610661/sample_d7_aged.bam', 'md5': 'b6cfafcc7508cedcb523cf771724bc52', 'size': '23590003320'}]",,,,,,,,22-24 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610662,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059688: Aged Uninjured MuSCs [d0_Geriatric]; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004694,Illumina NovaSeq 6000 paired end sequencing; GSM5059688: Aged Uninjured MuSCs [d0_Geriatric]; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173892,Aged Uninjured MuSCs [d0_Geriatric],Mus musculus,TA and EDL muscle,,C57BL6J,172045302,19785209730,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/062/SRR13610662/SRR13610662.fastq.gz', 'md5': '8232bb99084d2b6bc3aed349ec85054b', 'size': '10881071149'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610662/sample_geriatric.bam', 'md5': 'fbdc5657135d6987c6afaf921bd3a537', 'size': '24539535232'}]",,,,,,,,26 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610663,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059689: Young Uninjured MuSCs [d0_Young]; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004695,Illumina NovaSeq 6000 paired end sequencing; GSM5059689: Young Uninjured MuSCs [d0_Young]; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173893,Young Uninjured MuSCs [d0_Young],Mus musculus,TA and EDL muscle,,C57BL6J,174572573,20250418468,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/063/SRR13610663/SRR13610663.fastq.gz', 'md5': '880e54a1c5363708884b1fd07ed12207', 'size': '11355307978'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610663/sample_d0_young.bam', 'md5': '6601e61c7e8a018b92f3a2d1f60d2fd7', 'size': '24307437422'}]",,,,,,,,3-4 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610664,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059690: SOD1 Rescue MuSCs; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004696,Illumina NovaSeq 6000 paired end sequencing; GSM5059690: SOD1 Rescue MuSCs; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173894,SOD1 Rescue MuSCs,Mus musculus,TA and EDL muscle,,SynTgSod1-/-,223449309,33740845659,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/064/SRR13610664/SRR13610664.fastq.gz', 'md5': '9d198302ed78cb107d921d12b7887400', 'size': '10579941842'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610664/sample_sod1res.bam', 'md5': '9d35f881474de5a5df8d3ae8b8aec8b3', 'size': '22118558002'}]",,,,,,,,10-12 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610665,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059691: SOD1 Knockout MuSCs; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004697,Illumina NovaSeq 6000 paired end sequencing; GSM5059691: SOD1 Knockout MuSCs; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173895,SOD1 Knockout MuSCs,Mus musculus,TA and EDL muscle,,Sod1-/-,189203978,21758457470,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/065/SRR13610665/SRR13610665.fastq.gz', 'md5': '28161af68b11f7006333917ae8502022', 'size': '11528669727'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610665/sample_sod1ko.bam', 'md5': 'afb6207b60ae0e7571b27b0acb08b958', 'size': '24284990789'}]",,,,,,,,10-12 months,,,,,,,,,,,,,,,,,,,,v3,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610666,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059692: Aged Uninjured MuSCs [d0_Aged_v2]; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004698,Illumina NovaSeq 6000 paired end sequencing; GSM5059692: Aged Uninjured MuSCs [d0_Aged_v2]; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173896,Aged Uninjured MuSCs [d0_Aged_v2],Mus musculus,TA and EDL muscle,,C57BL6J,128854574,17266512916,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/066/SRR13610666/SRR13610666.fastq.gz', 'md5': 'bddb5349569aef4af24540d09ff09564', 'size': '20093040797'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610666/sample_d0_aged_v2.bam', 'md5': '5d5ee75e37c6eb8150165c4fdd1592ca', 'size': '30152581707'}]",,,,,,,,22-24 months,,,,,,,,,,,,,,,,,,,,v2,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13610667,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5059693: Young Uninjured MuSCs [d0_Young_v2]; Mus musculus; RNA-Seq,,,,,,,,,,SRX10004699,Illumina NovaSeq 6000 paired end sequencing; GSM5059693: Young Uninjured MuSCs [d0_Young_v2]; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP304270,Muscle Stem Cell Response to Perturbations of the Neuromuscular Junction Are Attenuated With Aging,"During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function, which is often associated with denervation and a loss of muscle stem cells (MuSCs). A relationship between MuSCs and innervation has not been established however. Herein, we administered neuromuscular trauma to a MuSC lineage tracing model and observed a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ). In aging and in a model of neuromuscular degeneration (Sod1-/-), this localized engraftment behavior was reduced. Genetic rescue of motor neurons in Sod1-/- mice reestablished integrity of the NMJ and partially restored MuSC ability to engraft into NMJ proximal positions. Using single cell RNA-sequencing of MuSCs, we demonstrate that a subset of MuSCs are molecularly distinguishable from MuSCs responding to myofiber injury. These data reveal unique features of MuSCs that respond to synaptic perturbations caused by aging and other stressors. Overall design: C57BL/6J wild-type female mice were obtained from Charles River Breeding Laboratories, the National Institute on Aging, or from a breeding colony at the University of Michigan (UM). All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. All procedures were approved by the University Committee on the Use and Care of Animals at UM and were in accordance with the U.S. National Institute of Health (NIH). Young female mice (4-6 months) and aged female mice (20-24 months) were randomly assigned to one of five groups: uninjured, day 3, and day 7 injured (n=4 per group). To induce skeletal muscle injury, mice were first anesthetized with 2% isoflurane and administered a 1.2% barium chloride (BaCl2) solution injected intramuscularly into several points of the tibialis anterior and gastrocnemius muscles for a total of 80 L per hindlimb.",SRS8173897,Young Uninjured MuSCs [d0_Young_v2],Mus musculus,TA and EDL muscle,,C57BL6J,90843813,12173070942,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/067/SRR13610667/SRR13610667.fastq.gz', 'md5': '7005cd500c77131e8f0a6129fe36535f', 'size': '13899503867'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR136/SRR13610667/sample_d0_young_v2.bam', 'md5': '6b3cc42b559fa5f486bb85af74913607', 'size': '20318057850'}]",,,,,,,,3-4 months,,,,,,,,,,,,,,,,,,,,v2,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263443,SRX9693938,SRP298260,SRS7890810,Illumina NovaSeq 6000 paired end sequencing; GSM4977800: Uninjured; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263443/uninjured_possorted_genome_bam.bam.1', 'md5': '4db4db0cda874381dc234ede893e7810', 'size': 27130645419}]",[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR13263443/uninjured_possorted_genome_bam.bam.1'}],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra22/SRZ/013263/SRR13263443/uninjured_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263444,SRX9693939,SRP298260,SRS7890811,Illumina NovaSeq 6000 paired end sequencing; GSM4977801: VML_D7_2mm; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263444/VML_D7_2mm_possorted_genome_bam.bam.1', 'md5': 'cd21295ac5ed8df7411faa5e52dafc14', 'size': 26909378850}]",[{'url': 'https://sra-pub-src-2.s3.amazonaws.com/SRR13263444/VML_D7_2mm_possorted_genome_bam.bam.1'}],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra65/SRZ/013263/SRR13263444/VML_D7_2mm_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263445,SRX9693940,SRP298260,SRS7890812,Illumina NovaSeq 6000 paired end sequencing; GSM4977802: VML_D7_3mm_F; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263445/VML_D7_3mm_F_possorted_genome_bam.bam.1', 'md5': 'c34b3be6b4404294d7df42e54d2193f5', 'size': 28672590890}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra69/SRZ/013263/SRR13263445/VML_D7_3mm_F_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263446,SRX9693941,SRP298260,SRS7890813,Illumina NovaSeq 6000 paired end sequencing; GSM4977803: VML_D7_3mm_M; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263446/VML_D7_3mm_M_possorted_genome_bam.bam.1', 'md5': '25dbf641ef6829b1459ccf3823f9bb82', 'size': 34533975453}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra69/SRZ/013263/SRR13263446/VML_D7_3mm_M_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263447,SRX9693942,SRP298260,SRS7890814,Illumina NovaSeq 6000 paired end sequencing; GSM4977804: VML_D14_2mm; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263447/VML_D14_2mm_possorted_genome_bam.bam.1', 'md5': '0d1caa42ac6bf4f31ed3318cfb2683aa', 'size': 36815347856}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra4/SRZ/013263/SRR13263447/VML_D14_2mm_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263448,SRX9693943,SRP298260,SRS7890815,Illumina NovaSeq 6000 paired end sequencing; GSM4977805: VML_D14_3mm; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263448/VML_D14_3mm_possorted_genome_bam.bam.1', 'md5': 'd5c84e9a374ed9ce5a180640adfb4dc8', 'size': 33510546640}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra42/SRZ/013263/SRR13263448/VML_D14_3mm_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263449,SRX9693944,SRP298260,SRS7890816,Illumina NovaSeq 6000 paired end sequencing; GSM4977806: VML_D28_2mm; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263449/VML_D28_2mm_possorted_genome_bam.bam.1', 'md5': '11280e1600fc7c1bbca95c156a6a682d', 'size': 29099467915}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra22/SRZ/013263/SRR13263449/VML_D28_2mm_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13263450,SRX9693945,SRP298260,SRS7890817,Illumina NovaSeq 6000 paired end sequencing; GSM4977807: VML_D28_3mm; Mus musculus; RNA-Seq,,2022-04-07,2022-04-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR132/SRR13263450/VML_D28_3mm_possorted_genome_bam.bam.1', 'md5': 'e9406c3351d587f5a0e75c8737d2cf93', 'size': 24310502079}]",[],[],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra42/SRZ/013263/SRR13263450/VML_D28_3mm_possorted_genome_bam.bam'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mm10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715805,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473682,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122664,Pax7Hi,Mus musculus,Satellite cells,,C57BL6:SJL/J,458443291,137532987300,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/005/SRR9715805/SRR9715805_1.fastq.gz', 'md5': 'b2fc85fd187f11df03af7900548d8226', 'size': '9776052572'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/005/SRR9715805/SRR9715805_2.fastq.gz', 'md5': '03ee55b5f290e6c5f223e4da3b1870ee', 'size': '9746885752'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Hi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715806,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473682,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122664,Pax7Hi,Mus musculus,Satellite cells,,C57BL6:SJL/J,458443291,137532987300,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/006/SRR9715806/SRR9715806_1.fastq.gz', 'md5': 'f0172647ed2a3e3d72b46e1c143676be', 'size': '8339617223'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/006/SRR9715806/SRR9715806_2.fastq.gz', 'md5': 'ec7eaeda27492da2d6e994e0b6369a0c', 'size': '8325197457'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Hi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715807,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473682,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122664,Pax7Hi,Mus musculus,Satellite cells,,C57BL6:SJL/J,458443291,137532987300,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/007/SRR9715807/SRR9715807_1.fastq.gz', 'md5': 'b1d7c9b8185b2d3f2b70a932e7a6f0a5', 'size': '13306096701'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/007/SRR9715807/SRR9715807_2.fastq.gz', 'md5': '4acb823e1aaa511d571fd092bd53daa7', 'size': '13346753808'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Hi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715808,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473682,Illumina NovaSeq 6000 paired end sequencing; GSM3955372: Pax7Hi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122664,Pax7Hi,Mus musculus,Satellite cells,,C57BL6:SJL/J,458443291,137532987300,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/008/SRR9715808/SRR9715808_1.fastq.gz', 'md5': 'bb21c34258c2729547f0d85fd9b016d8', 'size': '10067019778'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/008/SRR9715808/SRR9715808_2.fastq.gz', 'md5': '28dd4a083016d1af63ea1c434ac9716f', 'size': '10027226405'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Hi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715810,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/000/SRR9715810/SRR9715810_1.fastq.gz', 'md5': '0e4e65c8b913a9bd9296d7041f63a8eb', 'size': '9125065880'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/000/SRR9715810/SRR9715810_2.fastq.gz', 'md5': '29f840b4cabd43a2191b1ee088e279da', 'size': '9162135924'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715811,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/001/SRR9715811/SRR9715811_1.fastq.gz', 'md5': '3f3cd707ac24d1969a22803ba3c757ff', 'size': '9910886850'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/001/SRR9715811/SRR9715811_2.fastq.gz', 'md5': 'c4be7862e1f5bd35f9a797b1dbdcbae8', 'size': '10029780180'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715812,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/002/SRR9715812/SRR9715812_1.fastq.gz', 'md5': '867fc0a0f8b922bcc1c41c082bf81eba', 'size': '10033427722'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/002/SRR9715812/SRR9715812_2.fastq.gz', 'md5': '310f245a817ca7d137642ec7654f1fd5', 'size': '10081229419'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715813,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/003/SRR9715813/SRR9715813_1.fastq.gz', 'md5': 'bd4781cdb37f3ae58d8d5f281a1589fc', 'size': '13890265669'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/003/SRR9715813/SRR9715813_2.fastq.gz', 'md5': '2658641090cad0e953d6a073620bb65b', 'size': '14169357463'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715814,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/004/SRR9715814/SRR9715814_1.fastq.gz', 'md5': 'c29988d607ed2b1d0b78c4767bcae494', 'size': '14075371013'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/004/SRR9715814/SRR9715814_2.fastq.gz', 'md5': '05a62dda21c25d6e593a94fc16ef57fe', 'size': '14288855441'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715815,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/005/SRR9715815/SRR9715815_1.fastq.gz', 'md5': '34ea74cb0d880adf8a82607204ccdb3e', 'size': '7718531141'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/005/SRR9715815/SRR9715815_2.fastq.gz', 'md5': '30805ae81722ad8d2cfdcf96fcfdd1fe', 'size': '7849302736'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715816,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473683,Illumina NovaSeq 6000 paired end sequencing; GSM3955373: Pax7Mi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122665,Pax7Mi,Mus musculus,Satellite cells,,C57BL6:SJL/J,800784514,240235354200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/006/SRR9715816/SRR9715816_1.fastq.gz', 'md5': '31899e75389e56dfec36705fb8d5021a', 'size': '7847982301'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/006/SRR9715816/SRR9715816_2.fastq.gz', 'md5': '3c463bead373d0100aa6e307cb46d107', 'size': '7924399851'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Mi,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715817,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/007/SRR9715817/SRR9715817_1.fastq.gz', 'md5': 'cef77140f275a6f305c613575953a870', 'size': '14134641906'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/007/SRR9715817/SRR9715817_2.fastq.gz', 'md5': '45d8e1a4a8e6a41da41b6cc062eb6059', 'size': '14386471771'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715818,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/008/SRR9715818/SRR9715818_1.fastq.gz', 'md5': '75db820df7b1a71d08ba2d132d0aeb8f', 'size': '13470807965'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/008/SRR9715818/SRR9715818_2.fastq.gz', 'md5': '5387523510e1832d753d6438990f2b8f', 'size': '13377863374'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715819,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/009/SRR9715819/SRR9715819_1.fastq.gz', 'md5': '7612abe4cd1c40b9527cc1bb4386a642', 'size': '8360090714'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/009/SRR9715819/SRR9715819_2.fastq.gz', 'md5': '08e3aa2700e73505a51ba1233295c9f6', 'size': '8478164377'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715820,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/000/SRR9715820/SRR9715820_1.fastq.gz', 'md5': '2bf7d2ad027ba0df149204f68db7f6f3', 'size': '7986893597'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/000/SRR9715820/SRR9715820_2.fastq.gz', 'md5': '2ff56c72765abcae1546d6510298b109', 'size': '7911308047'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715821,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/001/SRR9715821/SRR9715821_1.fastq.gz', 'md5': 'e526cabf9e63b03022242f1957d3648c', 'size': '9440299346'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/001/SRR9715821/SRR9715821_2.fastq.gz', 'md5': 'c82d171399cf7b69ae5ea3ab6aaa214f', 'size': '9731718333'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715822,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/002/SRR9715822/SRR9715822_1.fastq.gz', 'md5': '68a50ff5543672d117b9aab0a27b11b8', 'size': '9031286708'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/002/SRR9715822/SRR9715822_2.fastq.gz', 'md5': '56c854d8fc30216c0309ddab406731fc', 'size': '9165635838'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715823,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/003/SRR9715823/SRR9715823_1.fastq.gz', 'md5': '645e801e4ff60c309c7db82f0108521c', 'size': '8863990390'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/003/SRR9715823/SRR9715823_2.fastq.gz', 'md5': '3890cd1f49e068610ccfeeca8cfa6ca3', 'size': '9025464541'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR9715824,,,,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,,,,,,,,,,SRX6473684,Illumina NovaSeq 6000 paired end sequencing; GSM3955374: Pax7Lo; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP215427,Muscle-secreted G-CSF as a metabolic niche factor ameliorates loss of muscle stem cell in aged mice (scRNA-seq),"Function and number of muscle stem cells (satellite cells, SCs) declines with muscle aging. Although SCs are heterogeneous and different subpopulations have been identified, it remains unknown if a specific subpopulation of muscle SCs selectively decreases during aging. Here, we find Pax7Hi cells are dramatically reduced in aged mice and this aged-dependent loss of Pax7Hi cells is metabolically mediated by myofiber-secreted granulocyte-colony stimulating factor G-CSF as the Pax7Hi SCs are replenished by exercise-induced G-CSF in aged mice. Mechanistically, we show that transcription of G-CSF (Csf3) gene in myofibers is regulated by MyoD in a metabolism-dependent manner and the myofibers-secreted G-CSF acts as a metabolic niche factor required for establishing and maintaining the Pax7Hi SC subpopulation in adult and physiological aged mice by promoting the asymmetric division of Pax7Hi and Pax7Mi SCs. Together, our findings uncover a metabolic niche role of muscle metabolism in regulating Pax7 SC heterogeneity in mice. Overall design: Three subpopulations of satellite cells (Pax7Hi, Pax7Mi and Pax7Lo) were isolated by FACS based on levels of GFP (Pax7) from tibialis anterior muscle of Pax7-nGFP transgenic mice and subjected to single cell RNA sequencing (scRNA-Seq).",SRS5122666,Pax7Lo,Mus musculus,Satellite cells,,C57BL6:SJL/J,893743904,268123171200,2019-09-06,2019-09-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/004/SRR9715824/SRR9715824_1.fastq.gz', 'md5': 'c093a592d7551ed50e2c62296e2514f5', 'size': '8458953159'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR971/004/SRR9715824/SRR9715824_2.fastq.gz', 'md5': '213e57a10a6c3d2db5fd0a0cea0ce171', 'size': '8417640217'}]",tibialis anterior muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,Pax7Lo,,,,,,,,,,,,,,,,,,,,,,,,
SRR10906901,,,,Illumina HiSeq 2500 paired end sequencing; 10x scRNA-Seq of Cd8+  T cells from the ischemic muscles of Lepr db/+,,,,,,,,,,SRX7575055,Illumina HiSeq 2500 paired end sequencing; 10x scRNA-Seq of Cd8+  T cells from the ischemic muscles of Lepr db/+,ILLUMINA,Illumina HiSeq 2500,SRP242500,CD8+ T-cell plasticity regulates vascular regeneration in type-2 diabetes,"The subsets of CD8+ T-cells regulating tissue repair and regeneration have not been studied. To delineate the heterogeneity of CD8+ T-cells in non-lymphoid tissues of Lepr db/+ and Lepr db/db mice, we performed large-scale, droplet-based single-cell transcriptomic profiling. We purified about ~ 1,000 CD45+CD3+CD8+ T-cells from the ischemic muscles of Lepr db/+ and Lepr db/db, respectively, at day 7 after injury. After filtering, we obtained 934 and 768 cells from Lepr db/+ and Lepr db/db, respectively; and performed unsupervised analysis.",SRS6009743,Cd8+ T cells from the ischemic muscles of Lepr db/+,Mus musculus,,,Lepr db/+,103452654,12828129096,2020-01-18,2020-01-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/001/SRR10906901/SRR10906901_1.fastq.gz', 'md5': '418479768a75d52ae93cd3468a113434', 'size': '2829866863'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/001/SRR10906901/SRR10906901_2.fastq.gz', 'md5': '64cfbe1d443a071187d33aba5256dceb', 'size': '8097631889'}]",Cd8+ T cells,,,,,,,6 weeks,,,,,,,,,,,,,,,,,,,,,,male,Cd8+ T cells,Model organism or animal,,,,,,,,,,,,,,,,,,,,,
SRR10906902,,,,Illumina HiSeq 2500 paired end sequencing; 10x scRNA-Seq of Cd8+ T cells from the ischemic muscles of Lepr db/db,,,,,,,,,,SRX7575054,Illumina HiSeq 2500 paired end sequencing; 10x scRNA-Seq of Cd8+ T cells from the ischemic muscles of Lepr db/db,ILLUMINA,Illumina HiSeq 2500,SRP242500,CD8+ T-cell plasticity regulates vascular regeneration in type-2 diabetes,"The subsets of CD8+ T-cells regulating tissue repair and regeneration have not been studied. To delineate the heterogeneity of CD8+ T-cells in non-lymphoid tissues of Lepr db/+ and Lepr db/db mice, we performed large-scale, droplet-based single-cell transcriptomic profiling. We purified about ~ 1,000 CD45+CD3+CD8+ T-cells from the ischemic muscles of Lepr db/+ and Lepr db/db, respectively, at day 7 after injury. After filtering, we obtained 934 and 768 cells from Lepr db/+ and Lepr db/db, respectively; and performed unsupervised analysis.",SRS6009742,Cd8+ T cells from the ischemic muscles of Lepr db/db,Mus musculus,,,Lepr db/db,99882433,12385421692,2020-01-18,2020-01-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/002/SRR10906902/SRR10906902_1.fastq.gz', 'md5': '0f090c7eb211e7ab7338d16388cd0629', 'size': '2729037175'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/002/SRR10906902/SRR10906902_2.fastq.gz', 'md5': '2626e761687817eded82d7f66348a809', 'size': '7868092493'}]",Cd8+ T cells,,,,,,,6 weeks,,,,,,,,,,,,,,,,,,,,,,male,Cd8+ T cells,Model organism or animal,,,,,,,,,,,,,,,,,,,,,
SRR14061694,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5208913: SAT_PBS scRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10436278,Illumina NovaSeq 6000 paired end sequencing; GSM5208913: SAT_PBS scRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP311970,Single-cell profiling of skeletal muscle reveals a novel senolytic target; CRYAB,"Skeletal muscle mass and function decline with aging, a process known as sarcopenia, and is linked to functional alterations of critical cell types within mature muscle, including fibro-adipogenic progenitors (FAPs) and satellite cells (SCs). Senescence is a form of cellular arrest linked with degenerative diseases of aging, and is thought to be a key driver of aging pathophysiology. We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis. Using molecular and cellular approaches, we identified the small alpha crystalline heat shock protein CRYAB as a novel senolytic target. We targeted CRYAB using chemical inhibitor screening to identify 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis as a potent senolytic capable of killing senescent cells. We validated the potential of 25HC as a senolytic in both mouse and human cells, and in vivo in several tissues including muscle and fat. 25HC treatment therefore represents a potential new class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver. Overall design: We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis",SRS8569737,SAT_PBS scRNA-seq,Mus musculus,Satellite cells,PBS,,,,2022-01-19,2022-01-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/094/SRR14061694/SRR14061694_1.fastq.gz', 'md5': '724d651bb7852349807ee8c264b172b5', 'size': '6954130438'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/094/SRR14061694/SRR14061694_2.fastq.gz', 'md5': '04c2b6becbd2deb87ac7e0024f9c0f41', 'size': '6492009783'}]",,,,,,Satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14061695,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5208914: SAT_DOXO scRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10436279,Illumina NovaSeq 6000 paired end sequencing; GSM5208914: SAT_DOXO scRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP311970,Single-cell profiling of skeletal muscle reveals a novel senolytic target; CRYAB,"Skeletal muscle mass and function decline with aging, a process known as sarcopenia, and is linked to functional alterations of critical cell types within mature muscle, including fibro-adipogenic progenitors (FAPs) and satellite cells (SCs). Senescence is a form of cellular arrest linked with degenerative diseases of aging, and is thought to be a key driver of aging pathophysiology. We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis. Using molecular and cellular approaches, we identified the small alpha crystalline heat shock protein CRYAB as a novel senolytic target. We targeted CRYAB using chemical inhibitor screening to identify 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis as a potent senolytic capable of killing senescent cells. We validated the potential of 25HC as a senolytic in both mouse and human cells, and in vivo in several tissues including muscle and fat. 25HC treatment therefore represents a potential new class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver. Overall design: We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis",SRS8569736,SAT_DOXO scRNA-seq,Mus musculus,Satellite cells,DOXO,,,,2022-01-19,2022-01-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/095/SRR14061695/SRR14061695_1.fastq.gz', 'md5': '9540052900534ae945bb6c8e7e62ad5d', 'size': '6828018829'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/095/SRR14061695/SRR14061695_2.fastq.gz', 'md5': '23ac17ec82ed55bb42dab3d4d685eb46', 'size': '6440472954'}]",,,,,,Satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14061696,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5208915: SAT_DABT scRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10436280,Illumina NovaSeq 6000 paired end sequencing; GSM5208915: SAT_DABT scRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP311970,Single-cell profiling of skeletal muscle reveals a novel senolytic target; CRYAB,"Skeletal muscle mass and function decline with aging, a process known as sarcopenia, and is linked to functional alterations of critical cell types within mature muscle, including fibro-adipogenic progenitors (FAPs) and satellite cells (SCs). Senescence is a form of cellular arrest linked with degenerative diseases of aging, and is thought to be a key driver of aging pathophysiology. We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis. Using molecular and cellular approaches, we identified the small alpha crystalline heat shock protein CRYAB as a novel senolytic target. We targeted CRYAB using chemical inhibitor screening to identify 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis as a potent senolytic capable of killing senescent cells. We validated the potential of 25HC as a senolytic in both mouse and human cells, and in vivo in several tissues including muscle and fat. 25HC treatment therefore represents a potential new class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver. Overall design: We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis",SRS8569738,SAT_DABT scRNA-seq,Mus musculus,Satellite cells,DOXO_ABT,,,,2022-01-19,2022-01-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/096/SRR14061696/SRR14061696_1.fastq.gz', 'md5': 'e5d5ce9d1d8e11e26b60682d53d962c8', 'size': '6672356303'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/096/SRR14061696/SRR14061696_2.fastq.gz', 'md5': '944c440ae9f6d39bda28068e977d1899', 'size': '6240851631'}]",,,,,,Satellite cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14061697,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5208916: FAP_PBS scRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10436281,Illumina NovaSeq 6000 paired end sequencing; GSM5208916: FAP_PBS scRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP311970,Single-cell profiling of skeletal muscle reveals a novel senolytic target; CRYAB,"Skeletal muscle mass and function decline with aging, a process known as sarcopenia, and is linked to functional alterations of critical cell types within mature muscle, including fibro-adipogenic progenitors (FAPs) and satellite cells (SCs). Senescence is a form of cellular arrest linked with degenerative diseases of aging, and is thought to be a key driver of aging pathophysiology. We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis. Using molecular and cellular approaches, we identified the small alpha crystalline heat shock protein CRYAB as a novel senolytic target. We targeted CRYAB using chemical inhibitor screening to identify 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis as a potent senolytic capable of killing senescent cells. We validated the potential of 25HC as a senolytic in both mouse and human cells, and in vivo in several tissues including muscle and fat. 25HC treatment therefore represents a potential new class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver. Overall design: We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis",SRS8569739,FAP_PBS scRNA-seq,Mus musculus,Fibro-adipogenic progenitors,PBS,,,,2022-01-19,2022-01-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/097/SRR14061697/SRR14061697_1.fastq.gz', 'md5': '8c265a3bd01c037aae7bd0e0f13f6a3a', 'size': '6727332853'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/097/SRR14061697/SRR14061697_2.fastq.gz', 'md5': 'a31bddae8dff8ecbd91269e68fc915a8', 'size': '8095120496'}]",,,,,,Fibro-adipogenic progenitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14061698,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5208917: FAP_DOXO scRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10436282,Illumina NovaSeq 6000 paired end sequencing; GSM5208917: FAP_DOXO scRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP311970,Single-cell profiling of skeletal muscle reveals a novel senolytic target; CRYAB,"Skeletal muscle mass and function decline with aging, a process known as sarcopenia, and is linked to functional alterations of critical cell types within mature muscle, including fibro-adipogenic progenitors (FAPs) and satellite cells (SCs). Senescence is a form of cellular arrest linked with degenerative diseases of aging, and is thought to be a key driver of aging pathophysiology. We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis. Using molecular and cellular approaches, we identified the small alpha crystalline heat shock protein CRYAB as a novel senolytic target. We targeted CRYAB using chemical inhibitor screening to identify 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis as a potent senolytic capable of killing senescent cells. We validated the potential of 25HC as a senolytic in both mouse and human cells, and in vivo in several tissues including muscle and fat. 25HC treatment therefore represents a potential new class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver. Overall design: We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis",SRS8569740,FAP_DOXO scRNA-seq,Mus musculus,Fibro-adipogenic progenitors,DOXO,,,,2022-01-19,2022-01-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/098/SRR14061698/SRR14061698_1.fastq.gz', 'md5': '122d8cd32c9bdd0a207a4024497774b1', 'size': '6881601258'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/098/SRR14061698/SRR14061698_2.fastq.gz', 'md5': '1f4facb28a8d149f35343b6a5c8405b9', 'size': '8138897327'}]",,,,,,Fibro-adipogenic progenitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14061699,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5208918: FAP_DABT scRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX10436283,Illumina NovaSeq 6000 paired end sequencing; GSM5208918: FAP_DABT scRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP311970,Single-cell profiling of skeletal muscle reveals a novel senolytic target; CRYAB,"Skeletal muscle mass and function decline with aging, a process known as sarcopenia, and is linked to functional alterations of critical cell types within mature muscle, including fibro-adipogenic progenitors (FAPs) and satellite cells (SCs). Senescence is a form of cellular arrest linked with degenerative diseases of aging, and is thought to be a key driver of aging pathophysiology. We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis. Using molecular and cellular approaches, we identified the small alpha crystalline heat shock protein CRYAB as a novel senolytic target. We targeted CRYAB using chemical inhibitor screening to identify 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis as a potent senolytic capable of killing senescent cells. We validated the potential of 25HC as a senolytic in both mouse and human cells, and in vivo in several tissues including muscle and fat. 25HC treatment therefore represents a potential new class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver. Overall design: We utilized single-cell RNA sequencing to identify novel targets in isolated FAPs and SCs which potentiate senescent cell killing - a process termed senolysis",SRS8569741,FAP_DABT scRNA-seq,Mus musculus,Fibro-adipogenic progenitors,DOXO_ABT,,,,2022-01-19,2022-01-19,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/099/SRR14061699/SRR14061699_1.fastq.gz', 'md5': '3da765c674868c638e76c07ff816f11c', 'size': '7022830342'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR140/099/SRR14061699/SRR14061699_2.fastq.gz', 'md5': '880b062985521f6e7988eadbabf89067', 'size': '8481880108'}]",,,,,,Fibro-adipogenic progenitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR7541458,SRX4408985,SRP154457,SRS3562629,NextSeq 500 paired end sequencing; GSM3293675: P1_Quiescent_HighGlucose; Mus musculus; RNA-Seq,,2021-07-24,2021-07-24,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR754/008/SRR7541458/SRR7541458_1.fastq.gz', 'md5': '4c8db3a36033590448c476e8a9b465a3', 'size': 2818152323}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR754/008/SRR7541458/SRR7541458_2.fastq.gz', 'md5': '56ae40eb004f4de1feddebcacafa1b15', 'size': 9909956813}]",[{'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR7541458/SRR7541458'}],[{'url': 'gs://sra-pub-run-8/SRR7541458/SRR7541458.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra67/SRR/007364/SRR7541458'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR7541459,SRX4408986,SRP154457,SRS3562630,NextSeq 500 paired end sequencing; GSM3293676: P2_LowGlucose_Galactose; Mus musculus; RNA-Seq,,2021-07-24,2021-07-24,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR754/009/SRR7541459/SRR7541459_1.fastq.gz', 'md5': '11499d8016814f3c2e0eba6b02aa5e24', 'size': 3722265200}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR754/009/SRR7541459/SRR7541459_2.fastq.gz', 'md5': '9f5ab2149c42102e24f94ff9b8c118b4', 'size': 12934758868}]",[{'url': 'https://sra-pub-run-odp.s3.amazonaws.com/sra/SRR7541459/SRR7541459'}],[{'url': 'gs://sra-pub-run-5/SRR7541459/SRR7541459.1'}],[{'url': 'https://sra-download.ncbi.nlm.nih.gov/traces/sra67/SRR/007364/SRR7541459'}],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143337,,,,NextSeq 500 paired end sequencing; GSM4944170: Old_D0_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583818,NextSeq 500 paired end sequencing; GSM4944170: Old_D0_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787307,Old_D0_A,Mus musculus,Tibialis anterior muscle,,C57BL/6J,,,2021-09-30,2021-10-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/037/SRR13143337/SRR13143337.fastq.gz', 'md5': '1cfe1ee72c9b1907db37b5f5998b2efa', 'size': '7580912676'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Uninjured,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143338,,,,NextSeq 500 paired end sequencing; GSM4944171: Old_D0_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583819,NextSeq 500 paired end sequencing; GSM4944171: Old_D0_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787306,Old_D0_B,Mus musculus,Tibialis anterior muscle,,C57BL/6J,213603503,11748192665,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/038/SRR13143338/SRR13143338.fastq.gz', 'md5': 'd55c83ab9ab7fe5bf15b641f49b546b5', 'size': '7859323759'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Uninjured,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143339,,,,NextSeq 500 paired end sequencing; GSM4944172: Old_D0_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583820,NextSeq 500 paired end sequencing; GSM4944172: Old_D0_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787308,Old_D0_C,Mus musculus,Tibialis anterior muscle,,C57BL/6J,241443986,13279419230,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/039/SRR13143339/SRR13143339.fastq.gz', 'md5': '15261a98a1bed60d89a44353e65a99f6', 'size': '8693462150'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Uninjured,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143340,,,,NextSeq 500 paired end sequencing; GSM4944173: Old_D0_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583821,NextSeq 500 paired end sequencing; GSM4944173: Old_D0_D; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787309,Old_D0_D,Mus musculus,Tibialis anterior muscle,,C57BL/6J,231312136,12722167480,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/040/SRR13143340/SRR13143340.fastq.gz', 'md5': '5e9194fd2f598c339909543c201c1c68', 'size': '8370224485'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Uninjured,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143341,,,,NextSeq 500 paired end sequencing; GSM4944174: Old_D1_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583822,NextSeq 500 paired end sequencing; GSM4944174: Old_D1_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787312,Old_D1_A,Mus musculus,Tibialis anterior muscle,,C57BL/6J,217571492,11966432060,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/041/SRR13143341/SRR13143341.fastq.gz', 'md5': '5f5ffac28bb69010ff8b3bd580700e22', 'size': '8600493805'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143342,,,,NextSeq 500 paired end sequencing; GSM4944175: Old_D1_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583823,NextSeq 500 paired end sequencing; GSM4944175: Old_D1_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787311,Old_D1_B,Mus musculus,Tibialis anterior muscle,,C57BL/6J,235715851,12964371805,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/042/SRR13143342/SRR13143342.fastq.gz', 'md5': 'e3993fba3fedbe6f65ab452fe009e026', 'size': '8718105522'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143343,,,,NextSeq 500 paired end sequencing; GSM4944176: Old_D2_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583824,NextSeq 500 paired end sequencing; GSM4944176: Old_D2_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787310,Old_D2_A,Mus musculus,Tibialis anterior muscle,,C57BL/6J,208162289,11448925895,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/043/SRR13143343/SRR13143343.fastq.gz', 'md5': 'a8d2d89b08fb2b0e75fe254086c7d4a7', 'size': '8625271346'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143344,,,,NextSeq 500 paired end sequencing; GSM4944177: Old_D2_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583825,NextSeq 500 paired end sequencing; GSM4944177: Old_D2_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787316,Old_D2_B,Mus musculus,Tibialis anterior muscle,,C57BL/6J,201426817,11078474935,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/044/SRR13143344/SRR13143344.fastq.gz', 'md5': '5872859cd2f49dd6d570f9d27ea7ff5a', 'size': '8336043437'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143345,,,,NextSeq 500 paired end sequencing; GSM4944178: Old_D2_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583826,NextSeq 500 paired end sequencing; GSM4944178: Old_D2_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787313,Old_D2_C,Mus musculus,Tibialis anterior muscle,,C57BL/6J,247925961,13635927855,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/045/SRR13143345/SRR13143345.fastq.gz', 'md5': '92ee579e73191dc728c6e7d40d4d7f79', 'size': '9854519950'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143346,,,,NextSeq 500 paired end sequencing; GSM4944179: Old_D3_5_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583827,NextSeq 500 paired end sequencing; GSM4944179: Old_D3_5_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787314,Old_D3_5_A,Mus musculus,Tibialis anterior muscle,,C57BL/6J,237688454,13072864970,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/046/SRR13143346/SRR13143346.fastq.gz', 'md5': 'f40fde69b03e922941dff2c9a38e2af3', 'size': '9481442861'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 3.5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143347,,,,NextSeq 500 paired end sequencing; GSM4944180: Old_D3_5_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583828,NextSeq 500 paired end sequencing; GSM4944180: Old_D3_5_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787315,Old_D3_5_B,Mus musculus,Tibialis anterior muscle,,C57BL/6J,243593946,13397667030,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/047/SRR13143347/SRR13143347.fastq.gz', 'md5': '4d88cf24362fd72a8899b6cb2be22ff0', 'size': '9747529956'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 3.5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143348,,,,NextSeq 500 paired end sequencing; GSM4944181: Old_D5_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583829,NextSeq 500 paired end sequencing; GSM4944181: Old_D5_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787317,Old_D5_A,Mus musculus,Tibialis anterior muscle,,C57BL/6J,209372090,11515464950,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/048/SRR13143348/SRR13143348.fastq.gz', 'md5': '6aa477b638391186ba4213404b1c919b', 'size': '8001427324'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143349,,,,NextSeq 500 paired end sequencing; GSM4944182: Old_D5_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583830,NextSeq 500 paired end sequencing; GSM4944182: Old_D5_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787319,Old_D5_B,Mus musculus,Tibialis anterior muscle,,C57BL/6J,232733532,12800344260,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/049/SRR13143349/SRR13143349.fastq.gz', 'md5': 'b7ffaec2f22b9c5456b373cca1258977', 'size': '9130286000'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143350,,,,NextSeq 500 paired end sequencing; GSM4944183: Old_D5_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583831,NextSeq 500 paired end sequencing; GSM4944183: Old_D5_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787318,Old_D5_C,Mus musculus,Tibialis anterior muscle,,C57BL/6J,249961550,13747885250,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/050/SRR13143350/SRR13143350.fastq.gz', 'md5': 'fefff6eec5087572c5749fdd7fa9c1b4', 'size': '10010637566'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143351,,,,NextSeq 500 paired end sequencing; GSM4944184: Old_D7_A; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583832,NextSeq 500 paired end sequencing; GSM4944184: Old_D7_A; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787320,Old_D7_A,Mus musculus,Tibialis anterior muscle,,C57BL/6J,233069557,12818825635,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/051/SRR13143351/SRR13143351.fastq.gz', 'md5': '953e91201f475d718c82baad5146b9fe', 'size': '8783733853'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143352,,,,NextSeq 500 paired end sequencing; GSM4944185: Old_D7_B; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583833,NextSeq 500 paired end sequencing; GSM4944185: Old_D7_B; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787321,Old_D7_B,Mus musculus,Tibialis anterior muscle,,C57BL/6J,233027168,12816494240,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/052/SRR13143352/SRR13143352.fastq.gz', 'md5': '6b66a565e2930384d3ccbc23797c6cf4', 'size': '9467958363'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143353,,,,NextSeq 500 paired end sequencing; GSM4944186: Old_D7_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583834,NextSeq 500 paired end sequencing; GSM4944186: Old_D7_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787322,Old_D7_C,Mus musculus,Tibialis anterior muscle,,C57BL/6J,125950889,6927298895,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/053/SRR13143353/SRR13143353.fastq.gz', 'md5': '189f476e10d51640c20be90964d8ce83', 'size': '4810396702'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143354,,,,NextSeq 500 paired end sequencing; GSM4944187: Old_D1_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583835,NextSeq 500 paired end sequencing; GSM4944187: Old_D1_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787323,Old_D1_C,Mus musculus,Tibialis anterior muscle,,C57BL/6J,84265554,4634605470,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/054/SRR13143354/SRR13143354.fastq.gz', 'md5': 'a163028d2eb1940dffabe78f06aa3f33', 'size': '3467307704'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143355,,,,NextSeq 500 paired end sequencing; GSM4944188: Old_D1_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583836,NextSeq 500 paired end sequencing; GSM4944188: Old_D1_D; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787324,Old_D1_D,Mus musculus,Tibialis anterior muscle,,C57BL/6J,89811671,4939641905,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/055/SRR13143355/SRR13143355.fastq.gz', 'md5': '56e91513ff57a568abf30ddb75df937e', 'size': '3677559187'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143356,,,,NextSeq 500 paired end sequencing; GSM4944189: Old_D3_5_C; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583837,NextSeq 500 paired end sequencing; GSM4944189: Old_D3_5_C; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787325,Old_D3_5_C,Mus musculus,Tibialis anterior muscle,,C57BL/6J,127444271,7009434905,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/056/SRR13143356/SRR13143356.fastq.gz', 'md5': '9a0f41b92da7391f5b91ccde796cb8f2', 'size': '5210103272'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 3.5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13143357,,,,NextSeq 500 paired end sequencing; GSM4944190: Old_D3_5_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX9583838,NextSeq 500 paired end sequencing; GSM4944190: Old_D3_5_D; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP294168,Single-cell transcriptomic sampling of regenerating aged mouse hindlimb muscle,We report a series of single-cell transcriptomic datasets of regenerating mouse muscle tissue generated with the 10x Genomics Chromium platform. Overall design: The overall objective of the study was to generate a high-resolution transcriptomic reference of the distinct cell populations in the mouse muscle at different timepoints after notexin-injury.,SRS7787326,Old_D3_5_D,Mus musculus,Tibialis anterior muscle,,C57BL/6J,95648813,5260684715,2021-09-30,2021-11-18,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/057/SRR13143357/SRR13143357.fastq.gz', 'md5': '26cf38fc9c5a39acc057a200033be608', 'size': '3901326137'}]",Tibialis anterior muscle,,,,,,,20 months,female,,,,,,,,,,,Notexin injury (Day 3.5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10275413,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120117: 042201_non-inj; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988624,Illumina NovaSeq 6000 paired end sequencing; GSM4120117: 042201_non-inj; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511292,042201_non-inj,Mus musculus,tibialis anterior non-injured SM,,C5BL/6,296321876,89489206552,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/013/SRR10275413/SRR10275413_1.fastq.gz', 'md5': 'e60468a1c7d8433e8914048c36dca036', 'size': '23187866242'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/013/SRR10275413/SRR10275413_2.fastq.gz', 'md5': 'c49928baaea70963810799a1a2cd0e71', 'size': '21151444673'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR10275414,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120118: 042202_0-5dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988625,Illumina NovaSeq 6000 paired end sequencing; GSM4120118: 042202_0-5dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511293,042202_0-5dpi,Mus musculus,tibialis anterior 0.5 days post CTX injury,,C5BL/6,333185326,100621968452,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/014/SRR10275414/SRR10275414_1.fastq.gz', 'md5': 'bce00e16f85d9d1ab389757bb0e168fc', 'size': '26162853788'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/014/SRR10275414/SRR10275414_2.fastq.gz', 'md5': 'a83f07a90540706358c7f2f4d5d6568f', 'size': '23521148063'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR10275415,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120119: 042203_2-0dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988626,Illumina NovaSeq 6000 paired end sequencing; GSM4120119: 042203_2-0dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511294,042203_2-0dpi,Mus musculus,tibialis anterior 2 days post CTX injury,,C5BL/6,295253495,89166555490,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/015/SRR10275415/SRR10275415_1.fastq.gz', 'md5': 'c5d9008d763fa49a663d2a9d438e8fad', 'size': '22960132796'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/015/SRR10275415/SRR10275415_2.fastq.gz', 'md5': 'eedfac5ab449c93bb8e4c6d229e311d6', 'size': '20792747281'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR10275416,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120120: 042204_3-5dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988627,Illumina NovaSeq 6000 paired end sequencing; GSM4120120: 042204_3-5dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511295,042204_3-5dpi,Mus musculus,tibialis anterior 3.5 days post CTX injury,,C5BL/6,271849553,82098565006,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/016/SRR10275416/SRR10275416_1.fastq.gz', 'md5': '4aeccb6c83e4c1bf753f7d1ad48361f4', 'size': '21417157369'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/016/SRR10275416/SRR10275416_2.fastq.gz', 'md5': 'c1b72eea296b5f5d682917c34ebc5455', 'size': '19252233317'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR10275417,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120121: 042205_5dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988628,Illumina NovaSeq 6000 paired end sequencing; GSM4120121: 042205_5dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511296,042205_5dpi,Mus musculus,tibialis anterior 5 days post CTX injury,,C5BL/6,288831077,87226985254,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/017/SRR10275417/SRR10275417_1.fastq.gz', 'md5': '58bd609c37dd5bd46b5a1edb493af234', 'size': '22503614599'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/017/SRR10275417/SRR10275417_2.fastq.gz', 'md5': 'aa83247cfcba9dd9c43899d0791239fd', 'size': '20045149657'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR10275418,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120122: 042206_10dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988629,Illumina NovaSeq 6000 paired end sequencing; GSM4120122: 042206_10dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511297,042206_10dpi,Mus musculus,tibialis anterior 10 days post CTX injury,,C5BL/6,294517873,88944397646,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/018/SRR10275418/SRR10275418_1.fastq.gz', 'md5': 'c8b19536417dab84ee45f89a70feffb5', 'size': '23034413167'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/018/SRR10275418/SRR10275418_2.fastq.gz', 'md5': 'f5d5a99edeb3ef5bdeda4992f035d9f8', 'size': '21036249357'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR10275419,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4120123: 042207_21dpi; Mus musculus; RNA-Seq,,,,,,,,,,SRX6988630,Illumina NovaSeq 6000 paired end sequencing; GSM4120123: 042207_21dpi; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP225546,10X skeletal muscle regeneration scRNA-seq,"Single-cell RNA sequencing of cells dissociated from skeletal muscle at discrete regeneration timepoints to reveal transcriptional identities of contributors to skeletal muscle regeneration. Overall design: Tibialis anterior muscle from C5Bl6 WT male mice were injected with cardiotoxin to induce muscle injury and collected at  at 0.5, 2, 3.5, 5, 10, 21 days post injury and a non-injured sample. Muscle was digested with collagenase and dispase to dissociate single cells, stained with a cell viability marker and subjected to FACS to generate single cell suspensions. Single cell suspensions were loaded onto the 10X Genomics Platform and processed according to the manufacturer's instructions. Each sample is an individual time point, n=3 male mice combined per time point. The regen_data.rds file is list of two annotated data frames, of which each item contains the merged dataset with all cells from all timepoints. Item [1] which contains the RNA counts while item [2] contains the SCT normalized values. Columns are the samples, rows and the gene values and the metadata is structures accordingly.",SRS5511298,042207_21dpi,Mus musculus,tibialis anterior 21 days post CTX injury,,C5BL/6,295070709,89111354118,2020-03-27,2020-03-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/019/SRR10275419/SRR10275419_1.fastq.gz', 'md5': '69d99a1c4b1bb0b886426cc1fc223c62', 'size': '23193300454'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/019/SRR10275419/SRR10275419_2.fastq.gz', 'md5': 'f1c7b97c8dca927b130dd122c2f949ca', 'size': '21090708267'}]",,,,,,,,3 months,male,,,,,,,,,,,,,,,,,,,,,,,,n=3,,,,,,,,,,,,,,,,,,,,
SRR11336245,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418991: WT tibialis anterior 24 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939762,Illumina NovaSeq 6000 paired end sequencing; GSM4418991: WT tibialis anterior 24 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330487,WT tibialis anterior 24 months 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,434172871,39509731261,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/045/SRR11336245/SRR11336245.fastq.gz', 'md5': '5fd869d41c441b968e72b86e780e4e1b', 'size': '9079801331'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,24 months,434 million reads,,,,,,,,,,,,,,,,,,
SRR11336246,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418991: WT tibialis anterior 24 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939762,Illumina NovaSeq 6000 paired end sequencing; GSM4418991: WT tibialis anterior 24 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330487,WT tibialis anterior 24 months 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,434172871,39509731261,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/046/SRR11336246/SRR11336246.fastq.gz', 'md5': '8fca0b5d82719b657c0bcf5925c55d78', 'size': '9009270605'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,24 months,434 million reads,,,,,,,,,,,,,,,,,,
SRR11336247,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418992: C57BL/6 WT tibialis anterior 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939763,Illumina NovaSeq 6000 paired end sequencing; GSM4418992: C57BL/6 WT tibialis anterior 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330488,C57BL/6 WT tibialis anterior 5 months 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,419264392,38153059672,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/047/SRR11336247/SRR11336247.fastq.gz', 'md5': '31280c7de4ae0e1cf5ce954914e6c709', 'size': '8792227349'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,5 months,419 million reads,,,,,,,,,,,,,,,,,,
SRR11336248,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418992: C57BL/6 WT tibialis anterior 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939763,Illumina NovaSeq 6000 paired end sequencing; GSM4418992: C57BL/6 WT tibialis anterior 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330488,C57BL/6 WT tibialis anterior 5 months 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,419264392,38153059672,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/048/SRR11336248/SRR11336248.fastq.gz', 'md5': '09ed3cf7e4c54b48b7e6a647876273c1', 'size': '8786949745'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,5 months,419 million reads,,,,,,,,,,,,,,,,,,
SRR11336249,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418993: C57BL/6 WT tibialis anterior 30 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939764,Illumina NovaSeq 6000 paired end sequencing; GSM4418993: C57BL/6 WT tibialis anterior 30 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330489,C57BL/6 WT tibialis anterior 30 months 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,474364363,43167157033,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/049/SRR11336249/SRR11336249.fastq.gz', 'md5': '770671ccd13f0ffdefa8468c0bb7f96b', 'size': '9639762941'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,30 months,474 million reads,,,,,,,,,,,,,,,,,,
SRR11336250,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418993: C57BL/6 WT tibialis anterior 30 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939764,Illumina NovaSeq 6000 paired end sequencing; GSM4418993: C57BL/6 WT tibialis anterior 30 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330489,C57BL/6 WT tibialis anterior 30 months 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,474364363,43167157033,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/050/SRR11336250/SRR11336250.fastq.gz', 'md5': '3e1aaf64b8f9dc8164aa264ac59cdf24', 'size': '9661137842'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,30 months,474 million reads,,,,,,,,,,,,,,,,,,
SRR11336251,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418994: C57BL/6 WT tibialis anterior postnatal day 10 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939765,Illumina NovaSeq 6000 paired end sequencing; GSM4418994: C57BL/6 WT tibialis anterior postnatal day 10 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330490,C57BL/6 WT tibialis anterior postnatal day 10 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,1013802046,92255986186,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/051/SRR11336251/SRR11336251.fastq.gz', 'md5': '4817b3ee93c5ae9b423a15ec83e5d0ad', 'size': '21420595579'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,day 10,"1,013 million reads",,,,,,,,,,,,,,,,,,
SRR11336252,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418994: C57BL/6 WT tibialis anterior postnatal day 10 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939765,Illumina NovaSeq 6000 paired end sequencing; GSM4418994: C57BL/6 WT tibialis anterior postnatal day 10 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330490,C57BL/6 WT tibialis anterior postnatal day 10 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,1013802046,92255986186,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/052/SRR11336252/SRR11336252.fastq.gz', 'md5': '05ce57b3fff77cfdf5716557565f361e', 'size': '21527201845'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,day 10,"1,013 million reads",,,,,,,,,,,,,,,,,,
SRR11336253,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418995: C57BL/6 WT tibialis anterior postnatal day 21 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939766,Illumina NovaSeq 6000 paired end sequencing; GSM4418995: C57BL/6 WT tibialis anterior postnatal day 21 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330491,C57BL/6 WT tibialis anterior postnatal day 21 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,433191955,39420467905,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/053/SRR11336253/SRR11336253.fastq.gz', 'md5': 'e34c0e6ee15619c570bdd33f66847ed0', 'size': '9131519868'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,day 21,433 million reads,,,,,,,,,,,,,,,,,,
SRR11336254,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418995: C57BL/6 WT tibialis anterior postnatal day 21 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939766,Illumina NovaSeq 6000 paired end sequencing; GSM4418995: C57BL/6 WT tibialis anterior postnatal day 21 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330491,C57BL/6 WT tibialis anterior postnatal day 21 10X snRNA-seq,Mus musculus,Tibialis anterior muscle,,C57BL/6,433191955,39420467905,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/054/SRR11336254/SRR11336254.fastq.gz', 'md5': 'bff3b49dbb6688eaf85fbf192b9830d4', 'size': '9153469751'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,day 21,433 million reads,,,,,,,,,,,,,,,,,,
SRR11336255,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418996: C57BL/6 WT soleus 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939767,Illumina NovaSeq 6000 paired end sequencing; GSM4418996: C57BL/6 WT soleus 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330492,C57BL/6 WT soleus 5 months 10X snRNA-seq,Mus musculus,Soleus muscle,,C57BL/6,356409209,32433238019,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/055/SRR11336255/SRR11336255.fastq.gz', 'md5': '0fea137de7735e141d8b9fc3e315cb24', 'size': '7804362098'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,5 months,356 million reads,,,,,,,,,,,,,,,,,,
SRR11336256,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4418996: C57BL/6 WT soleus 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX7939767,Illumina NovaSeq 6000 paired end sequencing; GSM4418996: C57BL/6 WT soleus 5 months 10X snRNA-seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP253104,Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers,"While the majority of cells contain a single nucleus, cell types such as trophoblasts, osteoclasts, and skeletal myofibers require multinucleation. One advantage of multinucleation can be the assignment of distinct functions to different nuclei, but comprehensive interrogation of transcriptional heterogeneity within multinucleated tissues has been challenging due to the presence of a shared cytoplasm. Here, we utilized single-nucleus RNA-sequencing (snRNA-seq) to determine the extent of transcriptional diversity within multinucleated skeletal myofibers. Nuclei from mouse skeletal muscle were profiled across the lifespan, which revealed the emergence of distinct myonuclear populations in postnatal development and their reactivation in aging muscle. Our datasets also provided a platform for discovery of novel genes associated with rare specialized regions of the muscle cell, including markers of the myotendinous junction and functionally validated factors expressed at the neuromuscular junction. These findings reveal that myonuclei within syncytial muscle fibers possess distinct transcriptional profiles that regulate muscle biology. Overall design: Single-nucleus RNA-seq of tibialis anteior muscle of BL6 wild-type mice across the lifespan: 10 days, 21 days, 5 months (TA and soleus), 24 months, 30 months",SRS6330492,C57BL/6 WT soleus 5 months 10X snRNA-seq,Mus musculus,Soleus muscle,,C57BL/6,356409209,32433238019,2020-10-12,2020-10-13,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR113/056/SRR11336256/SRR11336256.fastq.gz', 'md5': '238fd7280b47c30655360fc658a99eb1', 'size': '7820434955'}]",Whole skeletal muscle,,,,,,Wild-type,,,,,,,,,,,,,,,,,,,,,,,,,,,5 months,356 million reads,,,,,,,,,,,,,,,,,,
SRR11574458,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142660,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505605,Mus musculus,Mus musculus,,,C57Bl6/J,286678379,34114727101,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/058/SRR11574458/SRR11574458_1.fastq.gz', 'md5': 'd8fa75e8907146adb5f2b080a188751c', 'size': '1019372558'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/058/SRR11574458/SRR11574458_2.fastq.gz', 'md5': 'a92686e04fef8058801c4fb093043c6c', 'size': '2404947390'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,Denervated,3days,,,,,,,,,,,,,,,
SRR11574459,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142659,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505604,Mus musculus,Mus musculus,,,C57Bl6/J,438563295,52189032105,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/059/SRR11574459/SRR11574459_1.fastq.gz', 'md5': '325a39fcbd0f2d5a8dfe101b30772250', 'size': '1875018588'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/059/SRR11574459/SRR11574459_2.fastq.gz', 'md5': '2803d98230474a6e8f24fc2db4a974b0', 'size': '4423261221'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,CTR,,,,,,,,,,,,,,,,
SRR11574460,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142658,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505604,Mus musculus,Mus musculus,,,C57Bl6/J,438563295,52189032105,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/060/SRR11574460/SRR11574460_1.fastq.gz', 'md5': '031e658290f1141e3c560584db01cccd', 'size': '2102874652'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/060/SRR11574460/SRR11574460_2.fastq.gz', 'md5': 'e71fdc71cc64b40810fd4b1b217a8f36', 'size': '4924908617'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,CTR,,,,,,,,,,,,,,,,
SRR11574461,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142657,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505604,Mus musculus,Mus musculus,,,C57Bl6/J,438563295,52189032105,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/061/SRR11574461/SRR11574461_1.fastq.gz', 'md5': 'b3cf94e366a6e10a406b853bc68ba0b0', 'size': '1692102299'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/061/SRR11574461/SRR11574461_2.fastq.gz', 'md5': '5315fb154af9de2270a66640ee54f419', 'size': '3949831212'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,CTR,,,,,,,,,,,,,,,,
SRR11574462,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142656,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505605,Mus musculus,Mus musculus,,,C57Bl6/J,286678379,34114727101,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/062/SRR11574462/SRR11574462_1.fastq.gz', 'md5': 'b3c3bdfb0796b61929b774ad75d0c353', 'size': '1382259078'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/062/SRR11574462/SRR11574462_2.fastq.gz', 'md5': '6e54754cc1f4b0d91c09b043f79f99ac', 'size': '3285880322'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,Denervated,3days,,,,,,,,,,,,,,,
SRR11574463,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142655,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505605,Mus musculus,Mus musculus,,,C57Bl6/J,286678379,34114727101,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/063/SRR11574463/SRR11574463_1.fastq.gz', 'md5': '99a923e5949aee83eea83d97f7a30943', 'size': '1141842169'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/063/SRR11574463/SRR11574463_2.fastq.gz', 'md5': '2793975a38f177ef86458a1a11fe60bd', 'size': '2706343367'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,Denervated,3days,,,,,,,,,,,,,,,
SRR11574464,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142654,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505605,Mus musculus,Mus musculus,,,C57Bl6/J,286678379,34114727101,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/064/SRR11574464/SRR11574464_1.fastq.gz', 'md5': '56b60c09b2cb04ce854032b1f4d4cc8c', 'size': '1491437852'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/064/SRR11574464/SRR11574464_2.fastq.gz', 'md5': '745d75cef23dc570c8ccd9fc27299aab', 'size': '3546898202'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,Denervated,3days,,,,,,,,,,,,,,,
SRR11574465,,,,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,,,,,,,,,,SRX8142653,Illumina NovaSeq 6000 paired end sequencing; Single-Cells RNA sequencing of mouse Itga7+Sca1-Ln-Cells,ILLUMINA,Illumina NovaSeq 6000,SRP257509,Role of ITGA7 positive muscle derived cells in denervation,Single Cells RNA-seq analysis of ITGA7 positive cells derived from denervated muscle,SRS6505604,Mus musculus,Mus musculus,,,C57Bl6/J,438563295,52189032105,2021-03-09,2021-03-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/065/SRR11574465/SRR11574465_1.fastq.gz', 'md5': '7617075f0f42313c564f67b1a0745fab', 'size': '2137594762'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/065/SRR11574465/SRR11574465_2.fastq.gz', 'md5': '6fa1f89efdf358d1be0a6088aa5690a8', 'size': '5071658327'}]",skeltal muscle,,,,,,,3 month,,,,,,,,,,,,,,,,,,,,,,male,Itga7+Sca1-Ln-,Model organism or animal,,,,FACS,CTR,,,,,,,,,,,,,,,,
SRR12282456,,,,Illumina HiSeq 2500 paired end sequencing; GSM4681739: MuSC 90 percent library; Mus musculus; RNA-Seq,,,,,,,,,,SRX8785880,Illumina HiSeq 2500 paired end sequencing; GSM4681739: MuSC 90 percent library; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP273166,Long and short-read single cell RNA-seq profiling of mouse muscle stem cells,Single cell RNA-seq was used to identify the gene expression signatures and transcript isoforms that distinguish quiescent and activated muscle stem cells in mouse. Overall design: Quiescent skeletal muscle stem cells isolated from uninjured muscles and activated muscle stem cells isolated post injury were profiled using the Chromium platform (10x Genomics) with sequencing from both short-read (Illumina) and long-read (Nanopore) technologies.,SRS7054507,MuSC 90 percent library,Mus musculus,Skeletal muscle stem cell,,,178403116,44600779000,2020-07-23,2020-07-24,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/056/SRR12282456/SRR12282456_1.fastq.gz', 'md5': '07da8b79e425d7b0af11e6304727387b', 'size': '11863815035'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/056/SRR12282456/SRR12282456_2.fastq.gz', 'md5': '62677381e03c4bca977c62fcd3201f91', 'size': '17407510257'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,YFP sorted Quiescent and activated muscle stem cells,bases 1 to 16 on R1,bases 17 to 26 on R1,,,,,,,,,,,,
SRR6664634,,,,NextSeq 500 paired end sequencing; GSM2976778: Single cell RNA-seq tdTomato MPs quiescent; Mus musculus; RNA-Seq,,,,,,,,,,SRX3641495,NextSeq 500 paired end sequencing; GSM2976778: Single cell RNA-seq tdTomato MPs quiescent; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP132021,Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury,"After tissue injury mesenchymal progenitors undergo a transient proliferative expansion, morphological transition and migration from their perivascular niche. To gain transcriptomic insights into the MP function in regeneration, a muscle-injury model was employed to activate MPs and follow their contribution to tissue regeneration. To compliment the population RNA seq profile previously obtained and to uncover the suspected heterogeneity of MPs in this context, tdTomato positive cells from selected timepoints were profiled by single cell RNA sequencing. Overall design: Single cell RNA-seq analyes of enriched mesenchymal progenitors at selected timepoints during skeletal muscle regeneration.",SRS2907691,Single cell RNA-seq tdTomato MPs quiescent,Mus musculus,Mesenchymal Progenitors,,C57BL/6J,73457332,4260525256,2019-12-07,2019-12-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR666/SRR6664634/qsnt.bam', 'md5': '40eb203330ab98e67f85a37dbbad5ec9', 'size': '11568528992'}]",Whole hindlimb muscle,,,,,Mesenchymal Progenitors,,,,,,,,,,,,,,,,,,,,,quiescent,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6664635,,,,NextSeq 500 paired end sequencing; GSM2976779: Single cell RNA-seq tdTomato MPs 1 day post notexin injury; Mus musculus; RNA-Seq,,,,,,,,,,SRX3641496,NextSeq 500 paired end sequencing; GSM2976779: Single cell RNA-seq tdTomato MPs 1 day post notexin injury; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP132021,Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury,"After tissue injury mesenchymal progenitors undergo a transient proliferative expansion, morphological transition and migration from their perivascular niche. To gain transcriptomic insights into the MP function in regeneration, a muscle-injury model was employed to activate MPs and follow their contribution to tissue regeneration. To compliment the population RNA seq profile previously obtained and to uncover the suspected heterogeneity of MPs in this context, tdTomato positive cells from selected timepoints were profiled by single cell RNA sequencing. Overall design: Single cell RNA-seq analyes of enriched mesenchymal progenitors at selected timepoints during skeletal muscle regeneration.",SRS2907692,Single cell RNA-seq tdTomato MPs 1 day post notexin injury,Mus musculus,Mesenchymal Progenitors,,C57BL/6J,149851612,8691393496,2019-12-07,2019-12-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR666/SRR6664635/d1.bam', 'md5': '4bca5309a50fc871e8073969c6cd1293', 'size': '28471125535'}]",Whole hindlimb muscle,,,,,Mesenchymal Progenitors,,,,,,,,,,,,,,,,,,,,,1 day post notexin injury,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6664636,,,,NextSeq 500 paired end sequencing; GSM2976780: Single cell RNA-seq tdTomato MPs 2 day post notexin injury; Mus musculus; RNA-Seq,,,,,,,,,,SRX3641497,NextSeq 500 paired end sequencing; GSM2976780: Single cell RNA-seq tdTomato MPs 2 day post notexin injury; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP132021,Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury,"After tissue injury mesenchymal progenitors undergo a transient proliferative expansion, morphological transition and migration from their perivascular niche. To gain transcriptomic insights into the MP function in regeneration, a muscle-injury model was employed to activate MPs and follow their contribution to tissue regeneration. To compliment the population RNA seq profile previously obtained and to uncover the suspected heterogeneity of MPs in this context, tdTomato positive cells from selected timepoints were profiled by single cell RNA sequencing. Overall design: Single cell RNA-seq analyes of enriched mesenchymal progenitors at selected timepoints during skeletal muscle regeneration.",SRS2907693,Single cell RNA-seq tdTomato MPs 2 day post notexin injury,Mus musculus,Mesenchymal Progenitors,,C57BL/6J,138315687,8022309846,2019-12-07,2019-12-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR666/SRR6664636/d2.bam', 'md5': 'd496e9e2dd14a03e2ceaf13a3b091d46', 'size': '26638184289'}]",Whole hindlimb muscle,,,,,Mesenchymal Progenitors,,,,,,,,,,,,,,,,,,,,,2 day post notexin injury,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6664637,,,,NextSeq 500 paired end sequencing; GSM2976781: Single cell RNA-seq tdTomato MPs 4 day post notexin injury; Mus musculus; RNA-Seq,,,,,,,,,,SRX3641498,NextSeq 500 paired end sequencing; GSM2976781: Single cell RNA-seq tdTomato MPs 4 day post notexin injury; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP132021,Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury,"After tissue injury mesenchymal progenitors undergo a transient proliferative expansion, morphological transition and migration from their perivascular niche. To gain transcriptomic insights into the MP function in regeneration, a muscle-injury model was employed to activate MPs and follow their contribution to tissue regeneration. To compliment the population RNA seq profile previously obtained and to uncover the suspected heterogeneity of MPs in this context, tdTomato positive cells from selected timepoints were profiled by single cell RNA sequencing. Overall design: Single cell RNA-seq analyes of enriched mesenchymal progenitors at selected timepoints during skeletal muscle regeneration.",SRS2907694,Single cell RNA-seq tdTomato MPs 4 day post notexin injury,Mus musculus,Mesenchymal Progenitors,,C57BL/6J,151113072,8764558176,2019-12-07,2019-12-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR666/SRR6664637/d4.bam', 'md5': '403e72d5d70c7a51ca9bca53ac879aeb', 'size': '26533173367'}]",Whole hindlimb muscle,,,,,Mesenchymal Progenitors,,,,,,,,,,,,,,,,,,,,,4 day post notexin injury,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6664638,,,,NextSeq 500 paired end sequencing; GSM2976782: Single cell RNA-seq tdTomato MPs 14 day post notexin injury; Mus musculus; RNA-Seq,,,,,,,,,,SRX3641499,NextSeq 500 paired end sequencing; GSM2976782: Single cell RNA-seq tdTomato MPs 14 day post notexin injury; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP132021,Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury,"After tissue injury mesenchymal progenitors undergo a transient proliferative expansion, morphological transition and migration from their perivascular niche. To gain transcriptomic insights into the MP function in regeneration, a muscle-injury model was employed to activate MPs and follow their contribution to tissue regeneration. To compliment the population RNA seq profile previously obtained and to uncover the suspected heterogeneity of MPs in this context, tdTomato positive cells from selected timepoints were profiled by single cell RNA sequencing. Overall design: Single cell RNA-seq analyes of enriched mesenchymal progenitors at selected timepoints during skeletal muscle regeneration.",SRS2907695,Single cell RNA-seq tdTomato MPs 14 day post notexin injury,Mus musculus,Mesenchymal Progenitors,,C57BL/6J,147360589,8546914162,2019-12-07,2019-12-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR666/SRR6664638/d14.bam', 'md5': '9ad6ea0971bd8047f6987eb45aa17129', 'size': '24331271233'}]",Whole hindlimb muscle,,,,,Mesenchymal Progenitors,,,,,,,,,,,,,,,,,,,,,14 day post notexin injury,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10186720,,,,Illumina HiSeq 2000 paired end sequencing; GSM4096943: ECM; Mus musculus; RNA-Seq,,,,,,,,,,SRX6907242,Illumina HiSeq 2000 paired end sequencing; GSM4096943: ECM; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP223292,Interleukin-36y-producing macrophages drive IL-17-mediated fibrosis.,"Biomaterials induce an immune response and mobilization of macrophages, yet identification and phenotypic characterization of functional macrophage subsets in vivo remain limited. We performed single-cell RNA sequencing analysis on macrophages sorted from either a biologic matrix [urinary bladder matrix (UBM)] or synthetic biomaterial [polycaprolactone (PCL)]. Implantation of UBM promotes tissue repair through generation of a tissue environment characterized by a T helper 2 (Th2)/interleukin (IL)4 immune profile, whereas PCL induces a standard foreign body response characterized by Th17/IL-17 and fibrosis. Unbiased clustering and pseudotime analysis revealed distinct macrophage subsets responsible for antigen presentation, chemoattraction, and phagocytosis, as well as a small population with expression profiles of both dendritic cells and skeletal muscle after UBM implantation. In the PCL tissue environment, we identified a CD9 hi+ IL-36y + macrophage subset that expressed Th17-associated molecules. These macrophages were virtually absent in mice lacking the IL-17 receptor, suggesting that they might be involved in IL-17dependent immune and autoimmune responses. Identification and comparison of the unique phenotypical and functional macrophage subsets in mouse and human tissue samples suggest broad relevance of the new classification. These distinct macrophage subsets demonstrate previously unrecognized myeloid phenotypes involved in different tissue responses and provide targets for potential therapeutic modulation in tissue repair and pathology. Overall design: Macrophages were sorted from mice quadriceps 1 week after undergoing volumetric muscle loss surgery with treatment of urinary bladder matrix, polycaprolactone, or saline. After sorting, cells were encapsulated using the 10x Chromium single cell RNA sequencing platform. Library prep followed the 10x 3' v2 protocol and were sequenced using an Illumina HiSeq 2000. Alignment was performed using 10x recommendations with the CellRanger software package to generate a counts matrix. Clusters of cells were determined using Seurat. In particular, data from the three conditions were pooled, normalized, and scaled. PCA was performed and used for clustering with a graph based method (shared nearest neighbor with the Louvaine method for community detection).",SRS5439062,ECM,Mus musculus,ECM,urinary bladder matrix,,103386422,10131869356,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR101/SRR10186720/ECM_possorted_genome_bam.bam.1', 'md5': '545c6d48289dfc17aef11cb2cab54f59', 'size': '34418291187'}]",,,,,,macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10186721,,,,Illumina HiSeq 2000 paired end sequencing; GSM4096944: saline; Mus musculus; RNA-Seq,,,,,,,,,,SRX6907243,Illumina HiSeq 2000 paired end sequencing; GSM4096944: saline; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP223292,Interleukin-36y-producing macrophages drive IL-17-mediated fibrosis.,"Biomaterials induce an immune response and mobilization of macrophages, yet identification and phenotypic characterization of functional macrophage subsets in vivo remain limited. We performed single-cell RNA sequencing analysis on macrophages sorted from either a biologic matrix [urinary bladder matrix (UBM)] or synthetic biomaterial [polycaprolactone (PCL)]. Implantation of UBM promotes tissue repair through generation of a tissue environment characterized by a T helper 2 (Th2)/interleukin (IL)4 immune profile, whereas PCL induces a standard foreign body response characterized by Th17/IL-17 and fibrosis. Unbiased clustering and pseudotime analysis revealed distinct macrophage subsets responsible for antigen presentation, chemoattraction, and phagocytosis, as well as a small population with expression profiles of both dendritic cells and skeletal muscle after UBM implantation. In the PCL tissue environment, we identified a CD9 hi+ IL-36y + macrophage subset that expressed Th17-associated molecules. These macrophages were virtually absent in mice lacking the IL-17 receptor, suggesting that they might be involved in IL-17dependent immune and autoimmune responses. Identification and comparison of the unique phenotypical and functional macrophage subsets in mouse and human tissue samples suggest broad relevance of the new classification. These distinct macrophage subsets demonstrate previously unrecognized myeloid phenotypes involved in different tissue responses and provide targets for potential therapeutic modulation in tissue repair and pathology. Overall design: Macrophages were sorted from mice quadriceps 1 week after undergoing volumetric muscle loss surgery with treatment of urinary bladder matrix, polycaprolactone, or saline. After sorting, cells were encapsulated using the 10x Chromium single cell RNA sequencing platform. Library prep followed the 10x 3' v2 protocol and were sequenced using an Illumina HiSeq 2000. Alignment was performed using 10x recommendations with the CellRanger software package to generate a counts matrix. Clusters of cells were determined using Seurat. In particular, data from the three conditions were pooled, normalized, and scaled. PCA was performed and used for clustering with a graph based method (shared nearest neighbor with the Louvaine method for community detection).",SRS5439063,saline,Mus musculus,saline,saline,,22176345,2173281810,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR101/SRR10186721/saline_possorted_genome_bam.bam.1', 'md5': '2a39e2ba90711043b48928ea77dca56f', 'size': '5777589354'}]",,,,,,macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10186722,,,,Illumina HiSeq 2000 paired end sequencing; GSM4096945: PCL; Mus musculus; RNA-Seq,,,,,,,,,,SRX6907244,Illumina HiSeq 2000 paired end sequencing; GSM4096945: PCL; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP223292,Interleukin-36y-producing macrophages drive IL-17-mediated fibrosis.,"Biomaterials induce an immune response and mobilization of macrophages, yet identification and phenotypic characterization of functional macrophage subsets in vivo remain limited. We performed single-cell RNA sequencing analysis on macrophages sorted from either a biologic matrix [urinary bladder matrix (UBM)] or synthetic biomaterial [polycaprolactone (PCL)]. Implantation of UBM promotes tissue repair through generation of a tissue environment characterized by a T helper 2 (Th2)/interleukin (IL)4 immune profile, whereas PCL induces a standard foreign body response characterized by Th17/IL-17 and fibrosis. Unbiased clustering and pseudotime analysis revealed distinct macrophage subsets responsible for antigen presentation, chemoattraction, and phagocytosis, as well as a small population with expression profiles of both dendritic cells and skeletal muscle after UBM implantation. In the PCL tissue environment, we identified a CD9 hi+ IL-36y + macrophage subset that expressed Th17-associated molecules. These macrophages were virtually absent in mice lacking the IL-17 receptor, suggesting that they might be involved in IL-17dependent immune and autoimmune responses. Identification and comparison of the unique phenotypical and functional macrophage subsets in mouse and human tissue samples suggest broad relevance of the new classification. These distinct macrophage subsets demonstrate previously unrecognized myeloid phenotypes involved in different tissue responses and provide targets for potential therapeutic modulation in tissue repair and pathology. Overall design: Macrophages were sorted from mice quadriceps 1 week after undergoing volumetric muscle loss surgery with treatment of urinary bladder matrix, polycaprolactone, or saline. After sorting, cells were encapsulated using the 10x Chromium single cell RNA sequencing platform. Library prep followed the 10x 3' v2 protocol and were sequenced using an Illumina HiSeq 2000. Alignment was performed using 10x recommendations with the CellRanger software package to generate a counts matrix. Clusters of cells were determined using Seurat. In particular, data from the three conditions were pooled, normalized, and scaled. PCA was performed and used for clustering with a graph based method (shared nearest neighbor with the Louvaine method for community detection).",SRS5439064,PCL,Mus musculus,PCL,polycaprolactone,,104961036,10286181528,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR101/SRR10186722/PCL_possorted_genome_bam.bam.1', 'md5': '29441ee5ccf0cc13ab45ea4218a28703', 'size': '31796894402'}]",,,,,,macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10969329,,,,Illumina HiSeq 4000 sequencing; GSM4284747: d3IR1; Mus musculus; RNA-Seq,,,,,,,,,,SRX7634928,Illumina HiSeq 4000 sequencing; GSM4284747: d3IR1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP245347,Myeloid cell analysis during a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.,"Myeloid cells are critical to the development of fibrosis following muscle injury, however, the mechanism of their role in fibrosis formation remains unclear. Here we demonstrate that myeloid cell-derived TGF-1 signaling is increased in a pro-fibrotic ischemia-reperfusion and cardiotoxin (IR/CTX) muscle injury model. This study analyzes scRNAsequencing from the fibrotic region after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury. Overall design: We used 10X genomics to perform single cell sequencing of cells from the fibrotic area after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.",SRS6065657,d3IR1,Mus musculus,day 3 IR/CTX injury,,,113569005,13060435575,2020-01-29,2020-01-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR109/SRR10969329/d3_IR1_bam.bam.1', 'md5': '628600020e6e56233e7ee460609c3cca', 'size': '24980434291'}]",Tibialis anterior,,,,,,,,,,,,,,,,,,day 3 IR/CTX injury,,,,,,,,,,,,,,,,,,,,,,,10ul of cardiotoxin (3mg/mL),,,,,,,,,,,
SRR10969330,,,,Illumina HiSeq 4000 sequencing; GSM4284748: d3IR2; Mus musculus; RNA-Seq,,,,,,,,,,SRX7634929,Illumina HiSeq 4000 sequencing; GSM4284748: d3IR2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP245347,Myeloid cell analysis during a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.,"Myeloid cells are critical to the development of fibrosis following muscle injury, however, the mechanism of their role in fibrosis formation remains unclear. Here we demonstrate that myeloid cell-derived TGF-1 signaling is increased in a pro-fibrotic ischemia-reperfusion and cardiotoxin (IR/CTX) muscle injury model. This study analyzes scRNAsequencing from the fibrotic region after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury. Overall design: We used 10X genomics to perform single cell sequencing of cells from the fibrotic area after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.",SRS6065659,d3IR2,Mus musculus,day 3 IR/CTX injury,,,82657030,9505558450,2020-01-29,2020-01-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR109/SRR10969330/d3_IR2_possorted_genome_bam.bam.1', 'md5': '673ae9cf727fbc57b75d205f228c1e32', 'size': '20950723788'}]",Tibialis anterior,,,,,,,,,,,,,,,,,,day 3 IR/CTX injury,,,,,,,,,,,,,,,,,,,,,,,10ul of cardiotoxin (3mg/mL),,,,,,,,,,,
SRR10969331,,,,Illumina HiSeq 4000 sequencing; GSM4284749: d3IR3; Mus musculus; RNA-Seq,,,,,,,,,,SRX7634930,Illumina HiSeq 4000 sequencing; GSM4284749: d3IR3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP245347,Myeloid cell analysis during a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.,"Myeloid cells are critical to the development of fibrosis following muscle injury, however, the mechanism of their role in fibrosis formation remains unclear. Here we demonstrate that myeloid cell-derived TGF-1 signaling is increased in a pro-fibrotic ischemia-reperfusion and cardiotoxin (IR/CTX) muscle injury model. This study analyzes scRNAsequencing from the fibrotic region after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury. Overall design: We used 10X genomics to perform single cell sequencing of cells from the fibrotic area after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.",SRS6065660,d3IR3,Mus musculus,day 3 IR/CTX injury,,,100695763,11580012745,2020-01-29,2020-01-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR109/SRR10969331/d3_IR3_possorted_genome_bam.bam.1', 'md5': '276fbbdf764147539d8d8783c7bd163e', 'size': '23388274579'}]",Tibialis anterior,,,,,,,,,,,,,,,,,,day 3 IR/CTX injury,,,,,,,,,,,,,,,,,,,,,,,10ul of cardiotoxin (3mg/mL),,,,,,,,,,,
SRR11007782,,,,Illumina HiSeq 4000 sequencing; GSM4284745: d0IR1; Mus musculus; RNA-Seq,,,,,,,,,,SRX7634926,Illumina HiSeq 4000 sequencing; GSM4284745: d0IR1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP245347,Myeloid cell analysis during a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.,"Myeloid cells are critical to the development of fibrosis following muscle injury, however, the mechanism of their role in fibrosis formation remains unclear. Here we demonstrate that myeloid cell-derived TGF-1 signaling is increased in a pro-fibrotic ischemia-reperfusion and cardiotoxin (IR/CTX) muscle injury model. This study analyzes scRNAsequencing from the fibrotic region after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury. Overall design: We used 10X genomics to perform single cell sequencing of cells from the fibrotic area after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.",SRS6065656,d0IR1,Mus musculus,day 0 control,,,74383220,8554070300,2020-01-29,2020-01-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR110/SRR11007782/d0IR1_bam.bam', 'md5': 'b94e3306757df584ddeb178b9a1c7629', 'size': '25273251283'}]",Tibialis anterior,,,,,,,,,,,,,,,,,,day 0 control,,,,,,,,,,,,,,,,,,,,,,,none,,,,,,,,,,,
SRR11007783,,,,Illumina HiSeq 4000 sequencing; GSM4284746: d0IR2; Mus musculus; RNA-Seq,,,,,,,,,,SRX7634927,Illumina HiSeq 4000 sequencing; GSM4284746: d0IR2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP245347,Myeloid cell analysis during a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.,"Myeloid cells are critical to the development of fibrosis following muscle injury, however, the mechanism of their role in fibrosis formation remains unclear. Here we demonstrate that myeloid cell-derived TGF-1 signaling is increased in a pro-fibrotic ischemia-reperfusion and cardiotoxin (IR/CTX) muscle injury model. This study analyzes scRNAsequencing from the fibrotic region after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury. Overall design: We used 10X genomics to perform single cell sequencing of cells from the fibrotic area after a pro-fibrotic ischemia-reperfusion and cardiotoxin muscle injury.",SRS6065658,d0IR2,Mus musculus,day 0 control,,,75026745,8628075675,2020-01-29,2020-01-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR110/SRR11007783/d0IR2_bam.bam', 'md5': '6269effe9d13eb4d93a9e87e539f6e0b', 'size': '24191727284'}]",Tibialis anterior,,,,,,,,,,,,,,,,,,day 0 control,,,,,,,,,,,,,,,,,,,,,,,none,,,,,,,,,,,
SRR6835866,,,,Illumina NovaSeq 6000 sequencing; GSM3040912: library 10X_P7_14; Mus musculus; RNA-Seq,,,,,,,,,,SRX3791785,Illumina NovaSeq 6000 sequencing; GSM3040912: library 10X_P7_14; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP131661,Tabula Muris: Transcriptomic characterization of 20 organs and tissues from Mus musculus at single cell resolution,We have created a resource of single cell transcriptome data from the model organism Mus musculus. Contributor: The Tabula Muris Consortium The full list of contributors to this dataset can be found in the corresponding publication. Overall design: Single cell RNA sequencing of single cells across 20 tissues of 3 month aged mice,SRS3044258,library 10X_P7_14,Mus musculus,Muscle,,C57BL/6 NIA,119078472,10717062480,2018-03-21,2018-03-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA653/SRA653146/bam/10X_P7_14.bam', 'md5': '6ee7da59fe5207caea5576d70a85d328', 'size': '18456255557'}]",Muscle,,,,,,,3 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR6835867,,,,Illumina NovaSeq 6000 sequencing; GSM3040913: library 10X_P7_15; Mus musculus; RNA-Seq,,,,,,,,,,SRX3791786,Illumina NovaSeq 6000 sequencing; GSM3040913: library 10X_P7_15; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP131661,Tabula Muris: Transcriptomic characterization of 20 organs and tissues from Mus musculus at single cell resolution,We have created a resource of single cell transcriptome data from the model organism Mus musculus. Contributor: The Tabula Muris Consortium The full list of contributors to this dataset can be found in the corresponding publication. Overall design: Single cell RNA sequencing of single cells across 20 tissues of 3 month aged mice,SRS3044259,library 10X_P7_15,Mus musculus,Muscle,,C57BL/6 NIA,96287458,8665871220,2018-03-21,2018-03-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/SRA653/SRA653146/bam/10X_P7_15.bam', 'md5': 'c505e5087dca33580a8f622d09ac5c05', 'size': '14742852909'}]",Muscle,,,,,,,3 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8832578,,,,Illumina HiSeq 2500 paired end sequencing; GSM3692304: No Injury; Mus musculus; RNA-Seq,,,,,,,,,,SRX5620858,Illumina HiSeq 2500 paired end sequencing; GSM3692304: No Injury; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP190027,Single-cell skeletal muscle satellite cells and endothelial cells during homeostasis and regeneration,"We performed single cell RNA sequencing on muscle satellite cells (MuSCs) and endothelial cells (ECs) isolated from mouse hind limb muscle from both basal condition and 3-days post CTX injury to look at both quiescent and activated SCs from mice expressing genetic reporters (Pax7CreERT2:R26RtdT:Flk1GFP) by FACS. We could reliably find injury and activated SC as judged by side and forward scatter. We FACS isolated cells from both days separately and spiked in 20% of the ECs into the SCs, and performed single cell RNA-seq for each time point. We performed extensive sequencing averaging more than 300K read/cell. We were able to align the data and overlap the basal and injured cells and able to deconvolve the quiescent SCs from the activated and more differentiated MuSCs, ECs  and contaminating cell types from gene signatures. Overall design: Cells for single cell sequencing were obtained from Pax7tdT:Flk1GFP mice hind limb muscles following enzymatic digestion as previously described (Liu et al., 2015). Dead cells were excluded from the analysis using ZombieNIR (Biolegends, 423105). TdTomato+ and GFP+ cells were sorted individually and then 20% of GFP+ cells were spiked into 80% TdTomato+. We loaded ~5,000 cells into 1 channel of the Chromium system for each of these samples and prepared libraries according to the manufacturer's protocol using version 2.0 chemistry (10x Genomics). Following capture and lysis, we synthesized cDNA and amplified for 12 cycles as per the manufacturer's protocol (10X Genomics). The amplified cDNA was used to construct Illumina sequencing libraries that were each sequenced on one lane of an Illumina HiSeq 2500 machine. We used Cell Ranger 2.0 (10X Genomics) to process raw sequencing data. This pipeline converted Illumina basecall files to fastq format, aligned sequencing reads to the mm10 transcriptome using the STAR aligner, quantified the expression of transcripts in each cell using Chromium barcodes.",SRS4566017,No Injury,Mus musculus,TA muscle,,Pax7tdT:Flk1GFP,263056727,25779559246,2019-04-02,2020-05-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR883/008/SRR8832578/SRR8832578.fastq.gz', 'md5': '3bc8e3e6917a282a55ea2204da4cc34d', 'size': '21969597251'}]",hind limb muscles,,,,,,,10 weeks,male,,,,,,,No Injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8832579,,,,Illumina HiSeq 2500 paired end sequencing; GSM3692305: 3d CTX injury; Mus musculus; RNA-Seq,,,,,,,,,,SRX5620859,Illumina HiSeq 2500 paired end sequencing; GSM3692305: 3d CTX injury; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP190027,Single-cell skeletal muscle satellite cells and endothelial cells during homeostasis and regeneration,"We performed single cell RNA sequencing on muscle satellite cells (MuSCs) and endothelial cells (ECs) isolated from mouse hind limb muscle from both basal condition and 3-days post CTX injury to look at both quiescent and activated SCs from mice expressing genetic reporters (Pax7CreERT2:R26RtdT:Flk1GFP) by FACS. We could reliably find injury and activated SC as judged by side and forward scatter. We FACS isolated cells from both days separately and spiked in 20% of the ECs into the SCs, and performed single cell RNA-seq for each time point. We performed extensive sequencing averaging more than 300K read/cell. We were able to align the data and overlap the basal and injured cells and able to deconvolve the quiescent SCs from the activated and more differentiated MuSCs, ECs  and contaminating cell types from gene signatures. Overall design: Cells for single cell sequencing were obtained from Pax7tdT:Flk1GFP mice hind limb muscles following enzymatic digestion as previously described (Liu et al., 2015). Dead cells were excluded from the analysis using ZombieNIR (Biolegends, 423105). TdTomato+ and GFP+ cells were sorted individually and then 20% of GFP+ cells were spiked into 80% TdTomato+. We loaded ~5,000 cells into 1 channel of the Chromium system for each of these samples and prepared libraries according to the manufacturer's protocol using version 2.0 chemistry (10x Genomics). Following capture and lysis, we synthesized cDNA and amplified for 12 cycles as per the manufacturer's protocol (10X Genomics). The amplified cDNA was used to construct Illumina sequencing libraries that were each sequenced on one lane of an Illumina HiSeq 2500 machine. We used Cell Ranger 2.0 (10X Genomics) to process raw sequencing data. This pipeline converted Illumina basecall files to fastq format, aligned sequencing reads to the mm10 transcriptome using the STAR aligner, quantified the expression of transcripts in each cell using Chromium barcodes.",SRS4566019,3d CTX injury,Mus musculus,TA muscle,,Pax7tdT:Flk1GFP,240480350,23567074300,2019-04-02,2020-05-04,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR883/009/SRR8832579/SRR8832579.fastq.gz', 'md5': '0725d6b9ccc0211c2ce0cc892987eef3', 'size': '18921478212'}]",hind limb muscles,,,,,,,10 weeks,male,,,,,,,3d CTX injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752709,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230226: muscle_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427501,Illumina HiSeq 2500 paired end sequencing; GSM4230226: muscle_D; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873471,muscle_D,Mus musculus,Mouse Diaphragm Muscle Macrophage,,C57 BL/6J,191242704,18741784992,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/009/SRR10752709/SRR10752709.fastq.gz', 'md5': '7a7e9c6b44b8a1969d1328726d6e20f9', 'size': '5319549958'}]",Diaphragm,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752710,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230226: muscle_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427501,Illumina HiSeq 2500 paired end sequencing; GSM4230226: muscle_D; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873471,muscle_D,Mus musculus,Mouse Diaphragm Muscle Macrophage,,C57 BL/6J,191242704,18741784992,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/010/SRR10752710/SRR10752710.fastq.gz', 'md5': '56176c1f33b88a9a862190349e2e57ac', 'size': '5296096522'}]",Diaphragm,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752711,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230226: muscle_D; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427501,Illumina HiSeq 2500 paired end sequencing; GSM4230226: muscle_D; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873471,muscle_D,Mus musculus,Mouse Diaphragm Muscle Macrophage,,C57 BL/6J,191242704,18741784992,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/011/SRR10752711/SRR10752711.fastq.gz', 'md5': 'f1b50b69d54e903a7e0f29ab09c96c89', 'size': '5287109677'}]",Diaphragm,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752718,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230229: muscle_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427504,Illumina HiSeq 2500 paired end sequencing; GSM4230229: muscle_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873474,muscle_Q,Mus musculus,Mouse Quadriceps Muscle Macrophage,,C57 BL/6J,281107608,27548545584,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/018/SRR10752718/SRR10752718.fastq.gz', 'md5': '829a27d18ff0fb2016d876feb859e026', 'size': '7812570648'}]",Quadriceps,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752719,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230229: muscle_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427504,Illumina HiSeq 2500 paired end sequencing; GSM4230229: muscle_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873474,muscle_Q,Mus musculus,Mouse Quadriceps Muscle Macrophage,,C57 BL/6J,281107608,27548545584,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/019/SRR10752719/SRR10752719.fastq.gz', 'md5': 'adc7d80ea4a3b3f9d581290574082c02', 'size': '7766024363'}]",Quadriceps,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752720,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230229: muscle_Q; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427504,Illumina HiSeq 2500 paired end sequencing; GSM4230229: muscle_Q; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873474,muscle_Q,Mus musculus,Mouse Quadriceps Muscle Macrophage,,C57 BL/6J,281107608,27548545584,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/020/SRR10752720/SRR10752720.fastq.gz', 'md5': 'cf88193406557c3d0e31cad00a36619f', 'size': '7757290237'}]",Quadriceps,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10764954,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232371: satellite cells, 0dpi-ActD; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438905,"Illumina HiSeq 4000 paired end sequencing; GSM4232371: satellite cells, 0dpi-ActD; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883559,"satellite cells, 0dpi-ActD",Mus musculus,satellite cells,,,803271267,99605637108,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/054/SRR10764954/SRR10764954_1.fastq.gz', 'md5': 'a917b5c88b3d9748970ba848b47966d9', 'size': '7095142523'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/054/SRR10764954/SRR10764954_2.fastq.gz', 'md5': '04eafb7a00944594c3dd5895279597c9', 'size': '26474081232'}]",,,,,,,,,,,,,,,,,,,,,,,,0dpi,,,,,,,,,,,,,,,,,,,none,no,,,,,,,,,
SRR10764955,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232371: satellite cells, 0dpi-ActD; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438905,"Illumina HiSeq 4000 paired end sequencing; GSM4232371: satellite cells, 0dpi-ActD; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883559,"satellite cells, 0dpi-ActD",Mus musculus,satellite cells,,,803271267,99605637108,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/055/SRR10764955/SRR10764955_1.fastq.gz', 'md5': '5bf20a262f096411835d2cd0c122b416', 'size': '6965994363'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/055/SRR10764955/SRR10764955_2.fastq.gz', 'md5': '64826c3f141a3852d13ab98362d5b6ab', 'size': '25525620128'}]",,,,,,,,,,,,,,,,,,,,,,,,0dpi,,,,,,,,,,,,,,,,,,,none,no,,,,,,,,,
SRR10764956,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232372: satellite cells, 4dpi-ActD; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438906,"Illumina HiSeq 4000 paired end sequencing; GSM4232372: satellite cells, 4dpi-ActD; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883560,"satellite cells, 4dpi-ActD",Mus musculus,satellite cells,,,741000511,91884063364,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/056/SRR10764956/SRR10764956_1.fastq.gz', 'md5': 'aaaff0037c0a55d56dc70b9c82e28292', 'size': '6884085836'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/056/SRR10764956/SRR10764956_2.fastq.gz', 'md5': 'fd180a3c43583ef1722e59080f64c2b1', 'size': '25725447433'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,none,no,,,,,,,,,
SRR10764957,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232372: satellite cells, 4dpi-ActD; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438906,"Illumina HiSeq 4000 paired end sequencing; GSM4232372: satellite cells, 4dpi-ActD; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883560,"satellite cells, 4dpi-ActD",Mus musculus,satellite cells,,,741000511,91884063364,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/057/SRR10764957/SRR10764957_1.fastq.gz', 'md5': '04abcd19fd17d4de3779cd9eee1326e0', 'size': '6822535635'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/057/SRR10764957/SRR10764957_2.fastq.gz', 'md5': '9c1930b2bda53af7f100ddc5f01d1f45', 'size': '25132058858'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,none,no,,,,,,,,,
SRR10764958,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232373: satellite cells, 0dpi+ActD+aRW; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438907,"Illumina HiSeq 4000 paired end sequencing; GSM4232373: satellite cells, 0dpi+ActD+aRW; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883561,"satellite cells, 0dpi+ActD+aRW",Mus musculus,satellite cells,,,358045016,44397581984,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/058/SRR10764958/SRR10764958_1.fastq.gz', 'md5': '70a1963b39ae50a20408964ef0d348b8', 'size': '6588365014'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/058/SRR10764958/SRR10764958_2.fastq.gz', 'md5': '57851699ba66dc2e8c121a06891ef862', 'size': '23661441971'}]",,,,,,,,,,,,,,,,,,,,,,,,0dpi,,,,,,,,,,,,,,,,,,,aRW,yes,,,,,,,,,
SRR10764959,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232374: satellite cells, 0dpi+ActD+aN2; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438908,"Illumina HiSeq 4000 paired end sequencing; GSM4232374: satellite cells, 0dpi+ActD+aN2; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883562,"satellite cells, 0dpi+ActD+aN2",Mus musculus,satellite cells,,,341032542,42288035208,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/059/SRR10764959/SRR10764959_1.fastq.gz', 'md5': '678d5649f33afa6c623af8be971ecc49', 'size': '6359217691'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/059/SRR10764959/SRR10764959_2.fastq.gz', 'md5': '556a5285bbef60d7abf0670f9c50733b', 'size': '22625219244'}]",,,,,,,,,,,,,,,,,,,,,,,,0dpi,,,,,,,,,,,,,,,,,,,aN2,yes,,,,,,,,,
SRR10764960,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232375: satellite cells, 4dpi+ActD+aRW-1; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438909,"Illumina HiSeq 4000 paired end sequencing; GSM4232375: satellite cells, 4dpi+ActD+aRW-1; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883563,"satellite cells, 4dpi+ActD+aRW-1",Mus musculus,satellite cells,,,291847618,36189104632,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/060/SRR10764960/SRR10764960_1.fastq.gz', 'md5': '633dc8a2709fbb3017f80e3120acb70b', 'size': '5655576694'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/060/SRR10764960/SRR10764960_2.fastq.gz', 'md5': '7096481d62bb1da927faa98e9817f418', 'size': '19354024832'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aRW,yes,,,,,,,,,
SRR10764961,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232376: satellite cells, 4dpi+ActD+aRW-2; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438910,"Illumina HiSeq 4000 paired end sequencing; GSM4232376: satellite cells, 4dpi+ActD+aRW-2; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883564,"satellite cells, 4dpi+ActD+aRW-2",Mus musculus,satellite cells,,,340936689,42276149436,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/061/SRR10764961/SRR10764961_1.fastq.gz', 'md5': 'c596e57eecb4acbd2579c2150c82d1ba', 'size': '6372803806'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/061/SRR10764961/SRR10764961_2.fastq.gz', 'md5': '0ac5cb9e294f79355f954a5b16de61ac', 'size': '22059542842'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aRW,yes,,,,,,,,,
SRR10764962,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232377: satellite cells, 4dpi-ActD+aRW; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438911,"Illumina HiSeq 4000 paired end sequencing; GSM4232377: satellite cells, 4dpi-ActD+aRW; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883565,"satellite cells, 4dpi-ActD+aRW",Mus musculus,satellite cells,,,305772674,37915811576,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/062/SRR10764962/SRR10764962_1.fastq.gz', 'md5': 'f9ee0f9570f14236bb727661a0fdbbed', 'size': '5858909922'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/062/SRR10764962/SRR10764962_2.fastq.gz', 'md5': '011809bb85885846c0246d80d9597aad', 'size': '20436396078'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aRW,no,,,,,,,,,
SRR10764963,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232378: satellite cells, 4dpi+ActD+aN2; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438912,"Illumina HiSeq 4000 paired end sequencing; GSM4232378: satellite cells, 4dpi+ActD+aN2; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883566,"satellite cells, 4dpi+ActD+aN2",Mus musculus,satellite cells,,,309419907,38368068468,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/063/SRR10764963/SRR10764963_1.fastq.gz', 'md5': 'b062a6a44f692df0a4d6bdd5f89f3c14', 'size': '5924448644'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/063/SRR10764963/SRR10764963_2.fastq.gz', 'md5': '79e47a53eaabea83186e9180028ad300', 'size': '20519013714'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aN2,yes,,,,,,,,,
SRR10764964,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232379: satellite cells, 4dpi-ActD+aN2; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438913,"Illumina HiSeq 4000 paired end sequencing; GSM4232379: satellite cells, 4dpi-ActD+aN2; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883567,"satellite cells, 4dpi-ActD+aN2",Mus musculus,satellite cells,,,324252329,40207288796,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/064/SRR10764964/SRR10764964_1.fastq.gz', 'md5': '29c1bf8e55a655118be3aefbb654f7ca', 'size': '6103486862'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/064/SRR10764964/SRR10764964_2.fastq.gz', 'md5': '3aba32f5e94270ea08db44e72c9dfbb4', 'size': '21120520328'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aN2,no,,,,,,,,,
SRR10764965,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232380: satellite cells, 4dpi+ActD+aDll1-1; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438914,"Illumina HiSeq 4000 paired end sequencing; GSM4232380: satellite cells, 4dpi+ActD+aDll1-1; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883568,"satellite cells, 4dpi+ActD+aDll1-1",Mus musculus,satellite cells,,,375106649,46513224476,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/065/SRR10764965/SRR10764965_1.fastq.gz', 'md5': 'aadb932d3f2970ae156270e43e36422e', 'size': '6588379658'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/065/SRR10764965/SRR10764965_2.fastq.gz', 'md5': 'd4485eef788b70d81b3e1f2a15d4c827', 'size': '24756911131'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aDll1,yes,,,,,,,,,
SRR10764966,,,,"Illumina HiSeq 4000 paired end sequencing; GSM4232381: satellite cells, 4dpi+ActD+aDll1-2; Mus musculus; RNA-Seq",,,,,,,,,,SRX7438915,"Illumina HiSeq 4000 paired end sequencing; GSM4232381: satellite cells, 4dpi+ActD+aDll1-2; Mus musculus; RNA-Seq",ILLUMINA,Illumina HiSeq 4000,SRP238712,DELTA1/NOTCH2-mediated signaling regulates muscle stem cell self-renewal,"How satellite cells and their progenitors balance differentiation and self-renewal to achieve sustainable tissue regeneration is not well understood. A major roadblock to understanding satellite cell fate decisions has been the difficulty to study this process in vivo. By visualizing expression dynamics of myogenic transcription factors during early regeneration in vivo, we identified the time point at which cells undergo decisions to differentiate or self-renew. Single-cell RNA sequencing revealed heterogeneity of satellite cells during both muscle homeostasis and regeneration, including a subpopulation enriched in Notch2 receptor expression. Furthermore, we reveal that differentiating cells express the Dll1 ligand. Using antagonistic antibodies we demonstrate that the DLL1 and NOTCH2 signaling pair is required for satellite cell self-renewal. Thus, differentiating cells provide the self-renewing signal during regeneration, enabling proportional regeneration in response to injury while maintaining the satellite cell pool. These findings have implications for therapeutic control of muscle regeneration. Overall design: Single-cell RNA-seq study of mouse satellite cells during homeostasis and regeneration at 4 days post injury, including after treatment with antagonistic antibodies against Notch2 (aN2), Dll1 (aDll1) or control antibody (aRW)",SRS5883569,"satellite cells, 4dpi+ActD+aDll1-2",Mus musculus,satellite cells,,,384817254,47717339496,2019-12-26,2019-12-26,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/066/SRR10764966/SRR10764966_1.fastq.gz', 'md5': 'ff4e35bd1ccc37a7679d0c561df331cd', 'size': '6675441768'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/066/SRR10764966/SRR10764966_2.fastq.gz', 'md5': '1dc61b4787f4eb90885723430c0881f7', 'size': '25085306085'}]",,,,,,,,,,,,,,,,,,,,,,,,4dpi,,,,,,,,,,,,,,,,,,,aDll1,yes,,,,,,,,,
SRR11574539,SRX8142725,SRP257517,SRS6505676,Illumina HiSeq 4000 paired end sequencing; Single-cell RNA-seq on muscle resident cells from tibialis anterior muscle of mice 1 month post-sepsis,,2020-06-01,2020-06-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/039/SRR11574539/SRR11574539_1.fastq.gz', 'md5': '11e96e1baa34e22ecd0a1282afaef1fb', 'size': 1714857878}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/039/SRR11574539/SRR11574539_2.fastq.gz', 'md5': 'a8b91b1caf86c09689f81436026af79d', 'size': 15428846392}]","[{'url': 's3://sra-pub-src-8/SRR11574539/Muscle_1_month_S2_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-7/SRR11574539/Muscle_1_month_S2_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-18/SRR11574539/Muscle_1_month_S2_L004_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-8/SRR11574539/Muscle_1_month_S2_L005_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-5/SRR11574539/Muscle_1_month_S2_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-4/SRR11574539/Muscle_1_month_S2_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-8/SRR11574539/Muscle_1_month_S2_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-7/SRR11574539/Muscle_1_month_S2_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-15/SRR11574539/Muscle_1_month_S2_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-8/SRR11574539/Muscle_1_month_S2_L005_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-5/SRR11574539/Muscle_1_month_S2_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-4/SRR11574539/Muscle_1_month_S2_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR11574539/SRR11574539.1'}],243789316,26573035444,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11574540,SRX8142724,SRP257517,SRS6505675,Illumina HiSeq 4000 paired end sequencing; Single-cell RNA-seq on muscle resident cells from tibialis anterior muscle of mice 1 day post-sepsis,,2020-06-01,2020-06-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/040/SRR11574540/SRR11574540_1.fastq.gz', 'md5': '5ec3a0eb866a3bed68ef19f5a229cc19', 'size': 1653034676}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/040/SRR11574540/SRR11574540_2.fastq.gz', 'md5': 'c7ae18063d7296e4b8acc8080029e28c', 'size': 15577663577}]","[{'url': 's3://sra-pub-src-9/SRR11574540/Muscle_1_day_S1_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574540/Muscle_1_day_S1_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574540/Muscle_1_day_S1_L004_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574540/Muscle_1_day_S1_L005_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574540/Muscle_1_day_S1_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574540/Muscle_1_day_S1_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR11574540/Muscle_1_day_S1_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574540/Muscle_1_day_S1_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574540/Muscle_1_day_S1_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574540/Muscle_1_day_S1_L005_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574540/Muscle_1_day_S1_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574540/Muscle_1_day_S1_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-19/SRR11574540/SRR11574540.1'}],232767975,25371709275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11574541,SRX8142723,SRP257517,SRS6505674,Illumina HiSeq 4000 paired end sequencing; Single-cell RNA-seq on muscle resident cells from tibialis anterior muscle of control mice,,2020-06-01,2020-06-01,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/041/SRR11574541/SRR11574541_1.fastq.gz', 'md5': 'f1a979249504dfa1e13c1890fadce0dc', 'size': 1590895312}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR115/041/SRR11574541/SRR11574541_2.fastq.gz', 'md5': 'c0bad1392b03075ccb8ecd580339002d', 'size': 14664582064}]","[{'url': 's3://sra-pub-src-9/SRR11574541/Muscle_0_days_S3_L004_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574541/Muscle_0_days_S3_L004_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574541/Muscle_0_days_S3_L004_R2_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574541/Muscle_0_days_S3_L005_I1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574541/Muscle_0_days_S3_L005_R1_001.fastq.gz.1'}, {'url': 's3://sra-pub-src-9/SRR11574541/Muscle_0_days_S3_L005_R2_001.fastq.gz.1'}]","[{'url': 'gs://sra-pub-src-10/SRR11574541/Muscle_0_days_S3_L004_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574541/Muscle_0_days_S3_L004_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574541/Muscle_0_days_S3_L004_R2_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574541/Muscle_0_days_S3_L005_I1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574541/Muscle_0_days_S3_L005_R1_001.fastq.gz.1'}, {'url': 'gs://sra-pub-src-10/SRR11574541/Muscle_0_days_S3_L005_R2_001.fastq.gz.1'}]",[{'url': 'https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-run-21/SRR11574541/SRR11574541.1'}],222199966,24219796294,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143068,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779412,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195952,Muscle-M-Y,Rattus norvegicus,Muscle,,,363294339,108988301700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/068/SRR11143068/SRR11143068_1.fastq.gz', 'md5': '693943ca0ba6f9af9b3873e51ae375f3', 'size': '11822748564'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/068/SRR11143068/SRR11143068_2.fastq.gz', 'md5': '84295c85ee620508e0983a79717c5eec', 'size': '9257646051'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143069,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779412,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195952,Muscle-M-Y,Rattus norvegicus,Muscle,,,363294339,108988301700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/069/SRR11143069/SRR11143069_1.fastq.gz', 'md5': '61bbaa2fac06b26a5859363e66aa1de8', 'size': '5600288341'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/069/SRR11143069/SRR11143069_2.fastq.gz', 'md5': 'eb1958c91ab2ca4880819d376b536e12', 'size': '4450048131'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143070,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779412,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195952,Muscle-M-Y,Rattus norvegicus,Muscle,,,363294339,108988301700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/070/SRR11143070/SRR11143070_1.fastq.gz', 'md5': '09143297a0ec1be2c277d15b93468a48', 'size': '6376963379'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/070/SRR11143070/SRR11143070_2.fastq.gz', 'md5': 'c4f8e881eb56a1c45b5f134685e95c65', 'size': '5164652319'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143071,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779412,Illumina HiSeq 2000 paired end sequencing; GSM4331858: Muscle-M-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195952,Muscle-M-Y,Rattus norvegicus,Muscle,,,363294339,108988301700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/071/SRR11143071/SRR11143071_1.fastq.gz', 'md5': '82212f565616e4c2a12a830e6bdd976f', 'size': '6533677267'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/071/SRR11143071/SRR11143071_2.fastq.gz', 'md5': 'f5f71deac6210a897ff1e66f3b31d28a', 'size': '5159792931'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143072,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779413,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195954,Muscle-M-O,Rattus norvegicus,Muscle,,,367868127,110360438100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/072/SRR11143072/SRR11143072_1.fastq.gz', 'md5': 'dfed8c0e4b81f2c673b97db1da5519ff', 'size': '7448354206'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/072/SRR11143072/SRR11143072_2.fastq.gz', 'md5': '92a108e81c11cb989cdbfa0c71f37915', 'size': '5490211530'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143073,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779413,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195954,Muscle-M-O,Rattus norvegicus,Muscle,,,367868127,110360438100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/073/SRR11143073/SRR11143073_1.fastq.gz', 'md5': '9b3614f1af21d90b227fab607e1ba4d5', 'size': '7382286333'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/073/SRR11143073/SRR11143073_2.fastq.gz', 'md5': '6ee6283651d9f4bdc88a58e9fc4317bf', 'size': '5456288947'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143074,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779413,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195954,Muscle-M-O,Rattus norvegicus,Muscle,,,367868127,110360438100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/074/SRR11143074/SRR11143074_1.fastq.gz', 'md5': '82212097a1c2e4cf37b880f0664a1b73', 'size': '7487106177'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/074/SRR11143074/SRR11143074_2.fastq.gz', 'md5': '703f572d726b0b20ca9c45bce5747ca4', 'size': '5483145569'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143075,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779413,Illumina HiSeq 2000 paired end sequencing; GSM4331859: Muscle-M-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195954,Muscle-M-O,Rattus norvegicus,Muscle,,,367868127,110360438100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/075/SRR11143075/SRR11143075_1.fastq.gz', 'md5': 'b2c383cd5a0a7adcce2750f13840bd7e', 'size': '7897794942'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/075/SRR11143075/SRR11143075_2.fastq.gz', 'md5': 'f864cf799f15f6344d806b74741581a8', 'size': '6089563346'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143076,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779414,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195953,Muscle-M-CR,Rattus norvegicus,Muscle,,,387335639,116200691700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/076/SRR11143076/SRR11143076_1.fastq.gz', 'md5': 'ddabe7138ddff9a600cc89c62d646739', 'size': '8039713129'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/076/SRR11143076/SRR11143076_2.fastq.gz', 'md5': '829b14c0dfeec907c464401119782cdc', 'size': '5730698089'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143077,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779414,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195953,Muscle-M-CR,Rattus norvegicus,Muscle,,,387335639,116200691700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/077/SRR11143077/SRR11143077_1.fastq.gz', 'md5': '444f145f1af85fb0445f7e2f3c53e3a9', 'size': '4378937326'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/077/SRR11143077/SRR11143077_2.fastq.gz', 'md5': '3a35b8500e57397a9c32978e65c49f01', 'size': '3072500952'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143078,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779414,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195953,Muscle-M-CR,Rattus norvegicus,Muscle,,,387335639,116200691700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/078/SRR11143078/SRR11143078_1.fastq.gz', 'md5': 'e6144e98999f8f486013d49c380a5ebe', 'size': '10174104851'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/078/SRR11143078/SRR11143078_2.fastq.gz', 'md5': 'b15d1844786c8a541eeebc651ba977a5', 'size': '7235999635'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143079,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779414,Illumina HiSeq 2000 paired end sequencing; GSM4331860: Muscle-M-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195953,Muscle-M-CR,Rattus norvegicus,Muscle,,,387335639,116200691700,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/079/SRR11143079/SRR11143079_1.fastq.gz', 'md5': '753dc41386e094e9bc39c4aefe7826c0', 'size': '9805637068'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/079/SRR11143079/SRR11143079_2.fastq.gz', 'md5': '92347d8b46e2a079e32796857bb05c28', 'size': '7069454594'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143080,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779415,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195955,Muscle-F-Y,Rattus norvegicus,Muscle,,,342050348,102615104400,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/080/SRR11143080/SRR11143080_1.fastq.gz', 'md5': 'e10f29bf20d87043cfcc755a65f24cda', 'size': '9713258163'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/080/SRR11143080/SRR11143080_2.fastq.gz', 'md5': '84a4886468a2b71fa989fb0347788c79', 'size': '7336814460'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143081,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779415,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195955,Muscle-F-Y,Rattus norvegicus,Muscle,,,342050348,102615104400,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/081/SRR11143081/SRR11143081_1.fastq.gz', 'md5': '1de7701540a68cc3d49a28b33b5805d0', 'size': '7882100083'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/081/SRR11143081/SRR11143081_2.fastq.gz', 'md5': 'ecad6439bdfdd1a32f4ef4234991efbf', 'size': '5927797650'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143082,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779415,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195955,Muscle-F-Y,Rattus norvegicus,Muscle,,,342050348,102615104400,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/082/SRR11143082/SRR11143082_1.fastq.gz', 'md5': 'e2fe378bc6b76f56ccd6d3c311e7a002', 'size': '6670462124'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/082/SRR11143082/SRR11143082_2.fastq.gz', 'md5': '4f7b29bb4e294385c1d8c1265190eaf6', 'size': '5051574349'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143083,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779415,Illumina HiSeq 2000 paired end sequencing; GSM4331861: Muscle-F-Y; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195955,Muscle-F-Y,Rattus norvegicus,Muscle,,,342050348,102615104400,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/083/SRR11143083/SRR11143083_1.fastq.gz', 'md5': '599fcba3b747ccbf8593a6314d125a43', 'size': '4325230773'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/083/SRR11143083/SRR11143083_2.fastq.gz', 'md5': 'e363e65ab653b03edc941ad14d592cd4', 'size': '3328723836'}]",Skeletal muscle,,,,,,,,,,,,,Y-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143084,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779416,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195956,Muscle-F-O,Rattus norvegicus,Muscle,,,375637427,112691228100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/084/SRR11143084/SRR11143084_1.fastq.gz', 'md5': '12f0609b64ca0c1cd64152d0a8bbc091', 'size': '6076227668'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/084/SRR11143084/SRR11143084_2.fastq.gz', 'md5': 'de6e91f67b78d86ae01a15597565d862', 'size': '4649746906'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143085,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779416,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195956,Muscle-F-O,Rattus norvegicus,Muscle,,,375637427,112691228100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/085/SRR11143085/SRR11143085_1.fastq.gz', 'md5': 'c9aa5448284c058e84d70117cf5dd463', 'size': '8808193270'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/085/SRR11143085/SRR11143085_2.fastq.gz', 'md5': '79cba04a86a0a2eb69a19bd1dce4f2f6', 'size': '6741358465'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143086,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779416,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195956,Muscle-F-O,Rattus norvegicus,Muscle,,,375637427,112691228100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/086/SRR11143086/SRR11143086_1.fastq.gz', 'md5': 'bb3234273a3448b0d6df7920fb5d2f48', 'size': '7221003868'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/086/SRR11143086/SRR11143086_2.fastq.gz', 'md5': '37164b96019699d877bddad3084fc576', 'size': '5494886390'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143087,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779416,Illumina HiSeq 2000 paired end sequencing; GSM4331862: Muscle-F-O; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195956,Muscle-F-O,Rattus norvegicus,Muscle,,,375637427,112691228100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/087/SRR11143087/SRR11143087_1.fastq.gz', 'md5': '7cca43949ac893d35f25fcac8e0929a5', 'size': '8844270861'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/087/SRR11143087/SRR11143087_2.fastq.gz', 'md5': 'c0c39d2f285892933e124279cbd43523', 'size': '6606454008'}]",Skeletal muscle,,,,,,,,,,,,,O-AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143088,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779417,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195957,Muscle-F-CR,Rattus norvegicus,Muscle,,,365254557,109576367100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/088/SRR11143088/SRR11143088_1.fastq.gz', 'md5': 'dcb790c65ab1f5bac0bad491b7f8de5c', 'size': '11570898705'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/088/SRR11143088/SRR11143088_2.fastq.gz', 'md5': 'd605d94db99a2008d16171824d6abe78', 'size': '8867608405'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143089,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779417,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195957,Muscle-F-CR,Rattus norvegicus,Muscle,,,365254557,109576367100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/089/SRR11143089/SRR11143089_1.fastq.gz', 'md5': 'b503e41899604504b8164d1600af118c', 'size': '6698839786'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/089/SRR11143089/SRR11143089_2.fastq.gz', 'md5': 'e99e0b328adade4484fdaa8a4789edc5', 'size': '5132092418'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143090,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779417,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195957,Muscle-F-CR,Rattus norvegicus,Muscle,,,365254557,109576367100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/090/SRR11143090/SRR11143090_1.fastq.gz', 'md5': '2a9c8df4b8718fcbe704cefbf9307a83', 'size': '8524566289'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/090/SRR11143090/SRR11143090_2.fastq.gz', 'md5': 'b2ea0e33d2852ff826f5f6a0760285e2', 'size': '6737205039'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR11143091,,,,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX7779417,Illumina HiSeq 2000 paired end sequencing; GSM4331863: Muscle-F-CR; Rattus norvegicus; RNA-Seq,ILLUMINA,Illumina HiSeq 2000,SRP222987,Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging,"Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides  multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging. Overall design: Single-cell and single-nucleus RNA sequencing for 210K cells/nuclei from 9 kinds of tissues of rats",SRS6195957,Muscle-F-CR,Rattus norvegicus,Muscle,,,365254557,109576367100,2020-02-23,2020-02-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/091/SRR11143091/SRR11143091_1.fastq.gz', 'md5': '90465211e4fe84eb1cead28a5a9939ea', 'size': '3244972377'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR111/091/SRR11143091/SRR11143091_2.fastq.gz', 'md5': '930c56300f2923679a5c380f87446945', 'size': '2489875349'}]",Skeletal muscle,,,,,,,,,,,,,O-CR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR18278840,,,,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416679,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225905,scRNAseq DIA DMD 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/040/SRR18278840/SRR18278840.fastq.gz', 'md5': 'c29943ee401025691d586289c59092f5', 'size': '4767453790'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Duchenne muscular dystrophy (DMD),Total cells from diaphragm,,,,,,,
SRR18278841,,,,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416679,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225905,scRNAseq DIA DMD 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/041/SRR18278841/SRR18278841.fastq.gz', 'md5': '05c86bb2ec9431d6d72e215ca8f30eba', 'size': '4751534094'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Duchenne muscular dystrophy (DMD),Total cells from diaphragm,,,,,,,
SRR18278842,,,,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416679,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225905,scRNAseq DIA DMD 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/042/SRR18278842/SRR18278842.fastq.gz', 'md5': 'fc9fcb97bccfa07181dc5b3c28a5200b', 'size': '4741071924'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Duchenne muscular dystrophy (DMD),Total cells from diaphragm,,,,,,,
SRR18278843,,,,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416679,NextSeq 550 paired end sequencing; GSM5941721: scRNAseq DIA DMD 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225905,scRNAseq DIA DMD 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/043/SRR18278843/SRR18278843.fastq.gz', 'md5': 'be3826069df25ad05a570713056752b3', 'size': '4732342113'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Duchenne muscular dystrophy (DMD),Total cells from diaphragm,,,,,,,
SRR18278844,,,,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416678,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225904,scRNAseq DIA WT 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/044/SRR18278844/SRR18278844.fastq.gz', 'md5': '42b660d75363dcb483a1668f2f16ac88', 'size': '3340689637'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,wild-type,Total cells from diaphragm,,,,,,,
SRR18278845,,,,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416678,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225904,scRNAseq DIA WT 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/045/SRR18278845/SRR18278845.fastq.gz', 'md5': '99a8e2bcf1756f27c07ed3942098bb11', 'size': '3278810715'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,wild-type,Total cells from diaphragm,,,,,,,
SRR18278845,,,,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416678,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225904,scRNAseq DIA WT 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/045/SRR18278845/SRR18278845.fastq.gz', 'md5': '99a8e2bcf1756f27c07ed3942098bb11', 'size': '3278810715'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,wild-type,Total cells from diaphragm,,,,,,,
SRR18278847,,,,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,,,,,,,,,,SRX14416678,NextSeq 550 paired end sequencing; GSM5941720: scRNAseq DIA WT 12months; Rattus norvegicus; RNA-Seq,ILLUMINA,NextSeq 550,SRP363212,scRNAseq RAT DIA WT and DMD 12months,"Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials. Overall design: RAT Diaphragm WT and DMD 12months",SRS12225904,scRNAseq DIA WT 12months,Rattus norvegicus,"Diaphragm, muscle",,,,,2022-03-16,2022-03-16,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR182/047/SRR18278847/SRR18278847.fastq.gz', 'md5': '9c17d6153e6ac27e9854d3ed18e3d618', 'size': '3424602627'}]",,,,,,,,12 months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,wild-type,Total cells from diaphragm,,,,,,,
SRR14854694,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173098,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231407,SJRHB030680_X1_organoid,Homo sapiens,Organoid,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/094/SRR14854694/SRR14854694.fastq.gz', 'md5': 'decd00aa597d0e8be6bdaee5e93ca7f6', 'size': '8007221908'}]",organoid,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854693,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173098,Illumina NovaSeq 6000 paired end sequencing; GSM5390515: SJRHB030680_X1_organoid; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231407,SJRHB030680_X1_organoid,Homo sapiens,Organoid,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/093/SRR14854693/SRR14854693.fastq.gz', 'md5': '03cead505d8dba663428d3aea484c1ce', 'size': '7928134583'}]",organoid,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10914868,,,,Illumina HiSeq 4000 paired end sequencing; GSM4276650: Day 50 NM organoid 4; Homo sapiens; RNA-Seq,,,,,,,,,,SRX7582270,Illumina HiSeq 4000 paired end sequencing; GSM4276650: Day 50 NM organoid 4; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP188565,Self-organizing human trunk 3D neuromuscular organoids,"Neuromuscular networks assemble during early human embryonic development and are essential for the control of body movement. Previous neuromuscular junction modeling efforts using human pluripotent stem cells (hPSCs) generated either spinal cord neurons or skeletal muscles in monolayer culture. Here, we use hPSC-derived axial stem cells, the building blocks of the posterior body, to simultaneously generate spinal cord neurons and skeletal muscle cells that self-organize to generate human neuromuscular organoids (NMOs) that can be maintained in 3D for several months. Single-cell RNA-sequencing of individual organoids revealed reproducibility across experiments and enabled the tracking of the neural and mesodermal differentiation trajectories as organoids developed and matured. NMOs contain functional neuromuscular junctions supported by terminal Schwann cells. They contract and develop central pattern generator-like neuronal circuits. Finally, we successfully use NMOs to recapitulate key aspects of myasthenia gravis pathology, thus highlighting the significant potential of NMOs for modeling neuromuscular diseases in the future. Overall design: We have analyzed single cells from 10 organoids at Day 5. The organoids were separated in two samples (5 pooled organoids each) and labelled with different indexes. In total 5,135 cells were analyzed with a median of 3,333 genes per cell. For Day 50 we analyzed 4 organoids. One sample consisted of one organoid analyzed independently, and the other Day 50 sample consisted of 3 organoids tagged with different indexes. In total 17,294 cells were analyzed with a median of 2,343 genes per cell.",SRS6015922,Day 50 NM organoid 4,Homo sapiens,Neuromuscular organoid,,,331850027,32521302646,2020-01-21,2020-01-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR109/068/SRR10914868/SRR10914868.fastq.gz', 'md5': '70fcf8925eca39417c7e6617d582ad82', 'size': '25044093640'}]",Neuromuscular organoid. Time point: 50 days differentiated.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752715,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230228: muscle_P; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427503,Illumina HiSeq 2500 paired end sequencing; GSM4230228: muscle_P; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873473,muscle_P,Mus musculus,Mouse Peritoneal Macrophage,,C57 BL/6J,198951391,19497236318,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/015/SRR10752715/SRR10752715.fastq.gz', 'md5': '1120a796b5842bf77ebdd60147aa48ba', 'size': '5515291617'}]",Peritoneal,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752716,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230228: muscle_P; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427503,Illumina HiSeq 2500 paired end sequencing; GSM4230228: muscle_P; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873473,muscle_P,Mus musculus,Mouse Peritoneal Macrophage,,C57 BL/6J,198951391,19497236318,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/016/SRR10752716/SRR10752716.fastq.gz', 'md5': '03b2b5b6e4b36c3120f742633ac60cd6', 'size': '5485202792'}]",Peritoneal,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10752717,,,,Illumina HiSeq 2500 paired end sequencing; GSM4230228: muscle_P; Mus musculus; RNA-Seq,,,,,,,,,,SRX7427503,Illumina HiSeq 2500 paired end sequencing; GSM4230228: muscle_P; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP238469,Heterogeneous Origins and Functions of Mouse Skeletal Muscle Resident Macrophages,"Tissue resident macrophages can arise from either embryonic or adult hematopoiesis and play important roles in a wide range of biological processes, such as tissue remodeling during organogenesis, tissue homeostasis in the steady state, tissue repair following injury, and immune response to pathogens. Although the origins and tissue-specific functions of resident macrophages have been extensively studied in many other tissues, they are not well characterized in skeletal muscle. In the present study, we have characterized for the first time the ontogeny of skeletal muscle resident macrophages, showing evidence that they arise from both embryonic hematopoietic progenitors, including yolk sac primitive macrophages and fetal liver monocytes, and adult bone marrow hematopoietic stem cells. Single cell-based transcriptome analysis revealed that skeletal muscle resident macrophages were highly distinctive from resident macrophages in other tissues, expressing a specific set of transcription factors and containing functionally diverse subsets correlating to their origins. They appear more active in maintaining tissue homeostasis and promoting muscle growth and regeneration. Overall design: Skeletal muscle resident macrophages from quadriceps and diaphragm, as well as peritoneal macrophages and lung alveolar macrophages, of 8 weeks old C57 BL/6J mice were sorted by flow cytometry and were then subjected to single cell-based RNA sequencing.",SRS5873473,muscle_P,Mus musculus,Mouse Peritoneal Macrophage,,C57 BL/6J,198951391,19497236318,2020-07-30,2020-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR107/017/SRR10752717/SRR10752717.fastq.gz', 'md5': '45456786d860cbbe4c801876f88ec482', 'size': '5481981054'}]",Peritoneal,,,,,Macrophage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8078715,,,,Illumina HiSeq 2500 paired end sequencing; GSM3436818: Adult satellite cells single-cell RNA-Seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX4905902,Illumina HiSeq 2500 paired end sequencing; GSM3436818: Adult satellite cells single-cell RNA-Seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP166131,Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftment [RNA-seq],"Optimal cell-based therapies for the treatment of muscle degenerative disorders should not only regenerate fibers, but provide a quiescent satellite cell pool ensuring long-term maintenance and regeneration. Conditional expression of Pax3/Pax7 in differentiating pluripotent stem cells (PSC) allows the generation of myogenic progenitors endowed with satellite cell-like abilities.  To identify the molecular determinants underlying their regenerative potential, we performed transcriptome analyses of these cells along with primary myogenic cells from several developmental stages. Here we show that in vitro generated PSC-derived myogenic progenitors possess a molecular signature similar to embryonic/fetal myoblasts. However, compared to fetal myoblasts, following transplantation they show superior myofiber engraftment and ability to seed the satellite cell niche, respond to multiple re-injuries and contribute to long-term regeneration. Upon engraftment, the transcriptome of Pax3/Pax7-induced PSC-derived myogenic progenitors changes dramatically, acquiring similarity to that of satellite cells, particularly in genes involved in extracellular matrix remodeling. Single cell profiling reveals that these changes are induced, not selected, by the in vivo environment.  These findings demonstrate that Pax3/Pax7-induced PSC-derived myogenic progenitors possess proliferative and migratory abilities characteristic of earlier developmental stages, and an intrinsic ability to respond to environmental cues upon skeletal muscle regeneration. Overall design: Three replicates of each sample (iPax3 and iPax7 myogenic progenitors) were analyzed and compared to reference developmental samples embryonic and fetal myoblasts, and neonatal satellite cells (three rep each). Transcriptome profiling of iPax3/7 cells injected in vivo and re-isolated was then compared to adult satellite cells (3 reps each); finally, iPax3 cells were subjected to single-cell RNA-Seq and compared to single-cell RNA-Seq of adult satellite cells.",SRS3952114,Adult satellite cells single-cell RNA-Seq,Mus musculus,mouse Tibialis anterior,,Pax7-ZsGreen,164135118,16085241564,2019-02-15,2019-02-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR807/005/SRR8078715/SRR8078715.fastq.gz', 'md5': '7ccbb46719da799bac1b7fa35b9f44f6', 'size': '7562577143'}]",,,,,,mouse myogenic progenitors,,3 months-old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8078716,,,,Illumina HiSeq 2500 paired end sequencing; GSM3436819: iPax3 single-cell RNA-Seq; Mus musculus; RNA-Seq,,,,,,,,,,SRX4905903,Illumina HiSeq 2500 paired end sequencing; GSM3436819: iPax3 single-cell RNA-Seq; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP166131,Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftment [RNA-seq],"Optimal cell-based therapies for the treatment of muscle degenerative disorders should not only regenerate fibers, but provide a quiescent satellite cell pool ensuring long-term maintenance and regeneration. Conditional expression of Pax3/Pax7 in differentiating pluripotent stem cells (PSC) allows the generation of myogenic progenitors endowed with satellite cell-like abilities.  To identify the molecular determinants underlying their regenerative potential, we performed transcriptome analyses of these cells along with primary myogenic cells from several developmental stages. Here we show that in vitro generated PSC-derived myogenic progenitors possess a molecular signature similar to embryonic/fetal myoblasts. However, compared to fetal myoblasts, following transplantation they show superior myofiber engraftment and ability to seed the satellite cell niche, respond to multiple re-injuries and contribute to long-term regeneration. Upon engraftment, the transcriptome of Pax3/Pax7-induced PSC-derived myogenic progenitors changes dramatically, acquiring similarity to that of satellite cells, particularly in genes involved in extracellular matrix remodeling. Single cell profiling reveals that these changes are induced, not selected, by the in vivo environment.  These findings demonstrate that Pax3/Pax7-induced PSC-derived myogenic progenitors possess proliferative and migratory abilities characteristic of earlier developmental stages, and an intrinsic ability to respond to environmental cues upon skeletal muscle regeneration. Overall design: Three replicates of each sample (iPax3 and iPax7 myogenic progenitors) were analyzed and compared to reference developmental samples embryonic and fetal myoblasts, and neonatal satellite cells (three rep each). Transcriptome profiling of iPax3/7 cells injected in vivo and re-isolated was then compared to adult satellite cells (3 reps each); finally, iPax3 cells were subjected to single-cell RNA-Seq and compared to single-cell RNA-Seq of adult satellite cells.",SRS3952115,iPax3 single-cell RNA-Seq,Mus musculus,PSC-derived myogenic progenitors,,,205209792,20110559616,2019-02-15,2019-02-15,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR807/006/SRR8078716/SRR8078716.fastq.gz', 'md5': '97b60b7492c7dcd12f7d93df95d86b6d', 'size': '9801259152'}]",,,,,,ES-derived myogenic progenitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12734268,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4805558: Neonatal dermal cells; Mus musculus; RNA-Seq,,,,,,,,,,SRX9207532,Illumina NovaSeq 6000 paired end sequencing; GSM4805558: Neonatal dermal cells; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP285675,Single cell RNA-sequencing of murine dermal cells and hindlimb skeletal muscle stromal cells.,"Traumatic injury often results in muscle loss and impairment, which is worsened under aged and diseased conditions. Activation of resident stem cells or transplantation of myogenic stem cells can promote muscle regeneration. However, major challenges remain in harvesting sufficient autologous myogenic stem cells and expanding such cells efficiently for muscle regeneration therapies. Here, we identified a chemical cocktail that selectively induced a robust expansion of myogenic stem cells from readily-obtainable dermal cells and from muscle stromal cells. By differential plating and lineage tracing, we showed that Pax7+ cells were the major source for chemical-induced myogenic stem cells (CiMCs). We further performed single-cell RNA sequencing (scRNA-seq) analysis to characterize the transcriptomic profile of CiMCs and demonstrate a specific expansion of myogenic cells from heterogeneous dermal cell population. Upon transplantation into the injured muscle, CiMCs were efficiently engrafted and improved functional muscle regeneration in both adult and aged mice. In addition, CiMC transplantation rescued muscle function in mice with Duchenne muscular dystrophy (DMD). Furthermore, an in situ therapeutic modality using this cocktail was developed by loading the chemical cocktail into injectable nanoparticles, which enabled a sustained release of the cocktail in injured muscle and a local expansion of resident satellite cells for muscle regeneration in adult and aged mice. These findings will lead to the development of novel in vitro and in situ stem cell therapies for effective skeletal muscle repair. Overall design: Freshly isolated neonatal dermal cells, neonatal dermal cells treated with FR medium for 3 days, adult dermal cells treated with FR medium for 3 days and freshly isolated adult hindlimb skeletal muscle stromal cells were subjected to single cell RNA sequencing. FR medium is 20 M F, 20 M R, 50 g/ml AA, and 50 ng/ml bFGF in high-glucose DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin.",SRS7442442,Neonatal dermal cells,Mus musculus,Neonatal skin,,C57BL/6,233594586,27797755734,2020-09-29,2020-09-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/068/SRR12734268/SRR12734268_1.fastq.gz', 'md5': '8a2d9eb9bf55e9c8ba86d8da200db303', 'size': '4395203215'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/068/SRR12734268/SRR12734268_2.fastq.gz', 'md5': '0ed6cb26202c515e73b8c0858269eaac', 'size': '10346693801'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12734269,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4805560: Neonatal dermal cells with FR treatment; Mus musculus; RNA-Seq,,,,,,,,,,SRX9207533,Illumina NovaSeq 6000 paired end sequencing; GSM4805560: Neonatal dermal cells with FR treatment; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP285675,Single cell RNA-sequencing of murine dermal cells and hindlimb skeletal muscle stromal cells.,"Traumatic injury often results in muscle loss and impairment, which is worsened under aged and diseased conditions. Activation of resident stem cells or transplantation of myogenic stem cells can promote muscle regeneration. However, major challenges remain in harvesting sufficient autologous myogenic stem cells and expanding such cells efficiently for muscle regeneration therapies. Here, we identified a chemical cocktail that selectively induced a robust expansion of myogenic stem cells from readily-obtainable dermal cells and from muscle stromal cells. By differential plating and lineage tracing, we showed that Pax7+ cells were the major source for chemical-induced myogenic stem cells (CiMCs). We further performed single-cell RNA sequencing (scRNA-seq) analysis to characterize the transcriptomic profile of CiMCs and demonstrate a specific expansion of myogenic cells from heterogeneous dermal cell population. Upon transplantation into the injured muscle, CiMCs were efficiently engrafted and improved functional muscle regeneration in both adult and aged mice. In addition, CiMC transplantation rescued muscle function in mice with Duchenne muscular dystrophy (DMD). Furthermore, an in situ therapeutic modality using this cocktail was developed by loading the chemical cocktail into injectable nanoparticles, which enabled a sustained release of the cocktail in injured muscle and a local expansion of resident satellite cells for muscle regeneration in adult and aged mice. These findings will lead to the development of novel in vitro and in situ stem cell therapies for effective skeletal muscle repair. Overall design: Freshly isolated neonatal dermal cells, neonatal dermal cells treated with FR medium for 3 days, adult dermal cells treated with FR medium for 3 days and freshly isolated adult hindlimb skeletal muscle stromal cells were subjected to single cell RNA sequencing. FR medium is 20 M F, 20 M R, 50 g/ml AA, and 50 ng/ml bFGF in high-glucose DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin.",SRS7442444,Neonatal dermal cells with FR treatment,Mus musculus,Neonatal skin,,C57BL/6,223728398,26623679362,2020-09-29,2020-09-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/069/SRR12734269/SRR12734269_1.fastq.gz', 'md5': '127116640487c1c2af4ac5f10fc845c8', 'size': '4204037167'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/069/SRR12734269/SRR12734269_2.fastq.gz', 'md5': 'f7c232686de4ba61dc45d90186decb56', 'size': '9921293903'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12734270,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4805563: Adult dermal cells with FR treatment; Mus musculus; RNA-Seq,,,,,,,,,,SRX9207534,Illumina NovaSeq 6000 paired end sequencing; GSM4805563: Adult dermal cells with FR treatment; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP285675,Single cell RNA-sequencing of murine dermal cells and hindlimb skeletal muscle stromal cells.,"Traumatic injury often results in muscle loss and impairment, which is worsened under aged and diseased conditions. Activation of resident stem cells or transplantation of myogenic stem cells can promote muscle regeneration. However, major challenges remain in harvesting sufficient autologous myogenic stem cells and expanding such cells efficiently for muscle regeneration therapies. Here, we identified a chemical cocktail that selectively induced a robust expansion of myogenic stem cells from readily-obtainable dermal cells and from muscle stromal cells. By differential plating and lineage tracing, we showed that Pax7+ cells were the major source for chemical-induced myogenic stem cells (CiMCs). We further performed single-cell RNA sequencing (scRNA-seq) analysis to characterize the transcriptomic profile of CiMCs and demonstrate a specific expansion of myogenic cells from heterogeneous dermal cell population. Upon transplantation into the injured muscle, CiMCs were efficiently engrafted and improved functional muscle regeneration in both adult and aged mice. In addition, CiMC transplantation rescued muscle function in mice with Duchenne muscular dystrophy (DMD). Furthermore, an in situ therapeutic modality using this cocktail was developed by loading the chemical cocktail into injectable nanoparticles, which enabled a sustained release of the cocktail in injured muscle and a local expansion of resident satellite cells for muscle regeneration in adult and aged mice. These findings will lead to the development of novel in vitro and in situ stem cell therapies for effective skeletal muscle repair. Overall design: Freshly isolated neonatal dermal cells, neonatal dermal cells treated with FR medium for 3 days, adult dermal cells treated with FR medium for 3 days and freshly isolated adult hindlimb skeletal muscle stromal cells were subjected to single cell RNA sequencing. FR medium is 20 M F, 20 M R, 50 g/ml AA, and 50 ng/ml bFGF in high-glucose DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin.",SRS7442443,Adult dermal cells with FR treatment,Mus musculus,Adult skin,,C57BL/6,229844337,27351476103,2020-09-29,2020-09-29,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/070/SRR12734270/SRR12734270_1.fastq.gz', 'md5': 'e6fbe864c91a8e387c751575c65beee4', 'size': '4320433523'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR127/070/SRR12734270/SRR12734270_2.fastq.gz', 'md5': '26b3b811c3f068c0a016d7a56a00ac51', 'size': '10164165013'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790640,,,,Illumina HiSeq 2500 sequencing; GSM5111192: Cervical_M+F_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175665,Illumina HiSeq 2500 sequencing; GSM5111192: Cervical_M+F_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324677,Cervical_M+F_rep1,Mus musculus,Cervical spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790640/Cervical_MF_raw.bam.1', 'md5': '803b2cd362e7b9fc102ab6de20f5519d', 'size': '5045398841'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,pooled male and female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790641,,,,Illumina HiSeq 2500 sequencing; GSM5111193: Thoracic_M+F_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175666,Illumina HiSeq 2500 sequencing; GSM5111193: Thoracic_M+F_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324679,Thoracic_M+F_rep1,Mus musculus,Thoracic spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790641/Thoracic_MF_raw.bam.1', 'md5': '4ff5443dd5986f644db72d7a75f2b765', 'size': '4953347772'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,pooled male and female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790642,,,,Illumina HiSeq 2500 sequencing; GSM5111194: Lumbar/Sacral_M+F_rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175667,Illumina HiSeq 2500 sequencing; GSM5111194: Lumbar/Sacral_M+F_rep1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324678,Lumbar/Sacral_M+F_rep1,Mus musculus,Lumbar and sacral spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790642/Lumbar_MF_raw.bam.1', 'md5': 'c92470f76630f10bda431c829062b58e', 'size': '4644466628'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,pooled male and female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790643,,,,Illumina HiSeq 2500 sequencing; GSM5111195: Cervical_M_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175668,Illumina HiSeq 2500 sequencing; GSM5111195: Cervical_M_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324680,Cervical_M_rep2,Mus musculus,Cervical spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790643/Cervical_M_raw.bam.1', 'md5': 'e4b4d988ad609113e92b8ead77aa2246', 'size': '10804497087'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790644,,,,Illumina HiSeq 2500 sequencing; GSM5111196: Thoracic_M_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175669,Illumina HiSeq 2500 sequencing; GSM5111196: Thoracic_M_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324681,Thoracic_M_rep2,Mus musculus,Thoracic spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790644/Thoracic_M_raw.bam.1', 'md5': '122e9e2ffb5ffe78a40bca438d1c4ac6', 'size': '10041073282'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790645,,,,Illumina HiSeq 2500 sequencing; GSM5111197: Lumbar/Sacral_M_rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175670,Illumina HiSeq 2500 sequencing; GSM5111197: Lumbar/Sacral_M_rep2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324683,Lumbar/Sacral_M_rep2,Mus musculus,Lumbar and sacral spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790645/Lumbar_M_raw.bam.1', 'md5': '4203e21dee389a5214561da2a6bef131', 'size': '9954356097'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790646,,,,Illumina HiSeq 2500 sequencing; GSM5111198: Cervical_F_rep3; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175671,Illumina HiSeq 2500 sequencing; GSM5111198: Cervical_F_rep3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324684,Cervical_F_rep3,Mus musculus,Cervical spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790646/Cervical_F_raw.bam.1', 'md5': '5a5b7a7751f6080e4b74d6a892ad81a6', 'size': '9813449015'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790647,,,,Illumina HiSeq 2500 sequencing; GSM5111199: Thoracic_F_rep3; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175672,Illumina HiSeq 2500 sequencing; GSM5111199: Thoracic_F_rep3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324682,Thoracic_F_rep3,Mus musculus,Thoracic spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790647/Thoracic_F_raw.bam.1', 'md5': '4367d58c56fbc29570e736dc5ada70fc', 'size': '10419965552'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13790648,,,,Illumina HiSeq 2500 sequencing; GSM5111200: Lumbar/Sacral_F_rep3; Mus musculus; RNA-Seq,,,,,,,,,,SRX10175673,Illumina HiSeq 2500 sequencing; GSM5111200: Lumbar/Sacral_F_rep3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP308350,Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord,"We developed a targeted single nucleus RNA sequencing approach to enrich and transcriptomically characterize cholinergic neurons of the adult mouse spinal cord. Our data expose markers for known classes of cholinergic neurons and their extremely rich diversity. Visceral/preganglionic motor neurons could be divided into more than a dozen transcriptomic classes with anatomically restricted localization along the spinal cord. The complexity of the skeletal motor neurons was also reflected in our analysis with alpha, gamma, and a third subtype clearly distinguished. We further identified previously unrecognized subtypes of cholinergic interneurons. Overall design: Cholinergic nuclei were enriched by FACS sorting of GFP+ nuclei from nuclear reporter mice and barcoded using 10X Genomics Chromium Single Cell Processor. Samples were run on an Illumina HiSeq2500.",SRS8324685,Lumbar/Sacral_F_rep3,Mus musculus,Lumbar and sacral spinal cord,,Chat-IRES-Cre::Sun1-sfGFP,,,2021-02-27,2021-03-03,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR137/SRR13790648/Lumbar_F_raw.bam.1', 'md5': '26c17b5615a7198f1335aab4f05f8b4b', 'size': '10087890897'}]",,,,,,,Chat-iCre: +/wt; SUN-SfGFP: +/wt,8 weeks,female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10239195,,,,Illumina HiSeq 2500 paired end sequencing; GSM4110112: BL6_Ach_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX6958376,Illumina HiSeq 2500 paired end sequencing; GSM4110112: BL6_Ach_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485200,BL6_Ach_1,Mus musculus,Achilles tendon,,,247012608,24207235584,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/095/SRR10239195/SRR10239195.fastq.gz', 'md5': 'eb9252e92cd0b678e7e4da87b53c0744', 'size': '18553408059'}]",,,,,,,C57Bl/6,6 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10239196,,,,Illumina HiSeq 2500 paired end sequencing; GSM4110113: BL6_Ach_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX6958377,Illumina HiSeq 2500 paired end sequencing; GSM4110113: BL6_Ach_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485201,BL6_Ach_2,Mus musculus,Achilles tendon,,,258373416,25320594768,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/096/SRR10239196/SRR10239196.fastq.gz', 'md5': 'ad052b2c808c1e6d62f3e0355d279c26', 'size': '18549976302'}]",,,,,,,C57Bl/6,6 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10239197,,,,Illumina HiSeq 2500 paired end sequencing; GSM4110114: BL6_Ach_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX6958378,Illumina HiSeq 2500 paired end sequencing; GSM4110114: BL6_Ach_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485202,BL6_Ach_3,Mus musculus,Achilles tendon,,,251649141,24661615818,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/097/SRR10239197/SRR10239197.fastq.gz', 'md5': 'a7fbbd140d0b12b101ad91f1fae06ebe', 'size': '18408018951'}]",,,,,,,C57Bl/6,6 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10239198,,,,Illumina HiSeq 2500 paired end sequencing; GSM4110115: BL6_Ach_4; Mus musculus; RNA-Seq,,,,,,,,,,SRX6958375,Illumina HiSeq 2500 paired end sequencing; GSM4110115: BL6_Ach_4; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP224632,Single cell transcriptional atlas of mouse Achilles tendons,We report a single cell transcriptome atlas of Achilles tendon from 6-week-old male C57Bl/6 mice using single cell RNA sequencing. Overall design: The overall objective of the study was to generate an atlas of the distinct cell populations in tendon using single cell RNA sequencing.,SRS5485199,BL6_Ach_4,Mus musculus,Achilles tendon,,,244113182,23923091836,2019-10-12,2019-10-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR102/098/SRR10239198/SRR10239198.fastq.gz', 'md5': '73f140714781ac3becd61e45433d54b6', 'size': '18731194141'}]",,,,,,,C57Bl/6,6 weeks,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12897911,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4859797: E13.5 Sox9+Scx+ attachment progenitors; Mus musculus; RNA-Seq,,,,,,,,,,SRX9362969,Illumina NovaSeq 6000 paired end sequencing; GSM4859797: E13.5 Sox9+Scx+ attachment progenitors; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP288558,Bi-fated tendon-to-bone attachment cells are regulated by shared enhancers and KLF transcription factors,"The connection between different tissues is vital for the development and function of all organs and systems. In the musculoskeletal system, the attachment of elastic tendons to stiff bones poses a mechanical challenge that is solved by the formation of a transitional tissue, which allows the transfer of muscle forces to the skeleton without tearing. Here, we show that tendon-to-bone attachment cells are bi-fated, activating a mixture of  chondrocyte and tenocyte transcriptomes, which is regulated by sharing regulatory elements with these cells and by Krppel-like factors transcription factors (KLF).  To uncover the molecular identity of attachment cells, we first applied high-throughput bulk and single-cell RNA sequencing to murine humeral attachment cells. The results, which were validated by in situ and single-molecule in situ hybridization, reveal that together with the expression of unique sets of genes, the attachment cells express hundreds of chondrogenic and tenogenic genes. In search for the underlying mechanism, we performed ATAC sequencing and found that attachment cells share a significant fraction of accessible intergenic chromatin areas with either tenocytes or chondrocytes. Epigenomic analysis further revealed transcriptional enhancer signatures for the majority of these regions. We then examined a subset of these regions using transgenic mouse enhancer reporter assay. Results verified the shared activity of some of these enhancers, supporting the possibility that the transcriptome of attachment cells is regulated by enhancers with shared activities in tenocytes or chondrocytes. Finally, integrative chromatin and motif analyses, as well as the transcriptome data, indicated that KLFs are regulators of attachment cells. Indeed, blocking the expression of Klf2 and Klf4 in the developing limb mesenchyme led to abnormal differentiation of attachment cells, establishing these factors as key regulators of the fate of these cells. In summary, our findings show how the molecular identity of bi-fated attachment cells enables the formation of the unique transitional tissue that connects tendon to bone. More broadly, we show how mixing the transcriptomes of two cell types through shared enhancers and a dedicated set of transcription factors can lead to the formation of a new cell fate that connects them. Overall design: Sox9+/Scx+ FACS-sorted attachment progenitors from E13.5 dissected forelimbs (proximal side). The cells were genetically co-labeled by Sox9-CreERT2;Rosa26-tdTomato+;ScxGFP+ and were prepared for 10x Chromium single-cell RNA-Seq.",SRS7585795,E13.5 Sox9+Scx+ attachment progenitors,Mus musculus,"FACS-sorted attachment progenitors from 4 dissected proximal side of the forelimb from E13.5 Sox9-CreER, tdTomato and Scx-GFP mice",,C57BL/6,290931175,23856356350,2021-02-03,2021-02-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR128/011/SRR12897911/SRR12897911.fastq.gz', 'md5': 'd4504fbc08dda47ca514d2310615a205', 'size': '6600647565'}]",Proximal Forelimb,,,,,,,Embryonic Day 13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12897912,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4859797: E13.5 Sox9+Scx+ attachment progenitors; Mus musculus; RNA-Seq,,,,,,,,,,SRX9362969,Illumina NovaSeq 6000 paired end sequencing; GSM4859797: E13.5 Sox9+Scx+ attachment progenitors; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP288558,Bi-fated tendon-to-bone attachment cells are regulated by shared enhancers and KLF transcription factors,"The connection between different tissues is vital for the development and function of all organs and systems. In the musculoskeletal system, the attachment of elastic tendons to stiff bones poses a mechanical challenge that is solved by the formation of a transitional tissue, which allows the transfer of muscle forces to the skeleton without tearing. Here, we show that tendon-to-bone attachment cells are bi-fated, activating a mixture of  chondrocyte and tenocyte transcriptomes, which is regulated by sharing regulatory elements with these cells and by Krppel-like factors transcription factors (KLF).  To uncover the molecular identity of attachment cells, we first applied high-throughput bulk and single-cell RNA sequencing to murine humeral attachment cells. The results, which were validated by in situ and single-molecule in situ hybridization, reveal that together with the expression of unique sets of genes, the attachment cells express hundreds of chondrogenic and tenogenic genes. In search for the underlying mechanism, we performed ATAC sequencing and found that attachment cells share a significant fraction of accessible intergenic chromatin areas with either tenocytes or chondrocytes. Epigenomic analysis further revealed transcriptional enhancer signatures for the majority of these regions. We then examined a subset of these regions using transgenic mouse enhancer reporter assay. Results verified the shared activity of some of these enhancers, supporting the possibility that the transcriptome of attachment cells is regulated by enhancers with shared activities in tenocytes or chondrocytes. Finally, integrative chromatin and motif analyses, as well as the transcriptome data, indicated that KLFs are regulators of attachment cells. Indeed, blocking the expression of Klf2 and Klf4 in the developing limb mesenchyme led to abnormal differentiation of attachment cells, establishing these factors as key regulators of the fate of these cells. In summary, our findings show how the molecular identity of bi-fated attachment cells enables the formation of the unique transitional tissue that connects tendon to bone. More broadly, we show how mixing the transcriptomes of two cell types through shared enhancers and a dedicated set of transcription factors can lead to the formation of a new cell fate that connects them. Overall design: Sox9+/Scx+ FACS-sorted attachment progenitors from E13.5 dissected forelimbs (proximal side). The cells were genetically co-labeled by Sox9-CreERT2;Rosa26-tdTomato+;ScxGFP+ and were prepared for 10x Chromium single-cell RNA-Seq.",SRS7585795,E13.5 Sox9+Scx+ attachment progenitors,Mus musculus,"FACS-sorted attachment progenitors from 4 dissected proximal side of the forelimb from E13.5 Sox9-CreER, tdTomato and Scx-GFP mice",,C57BL/6,290931175,23856356350,2021-02-03,2021-02-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR128/012/SRR12897912/SRR12897912.fastq.gz', 'md5': 'b59efd7b82fb7996da98cd276a07c170', 'size': '6517041714'}]",Proximal Forelimb,,,,,,,Embryonic Day 13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR10350308,,,,Illumina HiSeq 4000 paired end sequencing; GSM4141558: HODay0replicate4; Mus musculus; RNA-Seq,,,,,,,,,,SRX7060062,Illumina HiSeq 4000 paired end sequencing; GSM4141558: HODay0replicate4; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS5575536,HODay0replicate4,Mus musculus,Day 0,A partial-thickness scald burn injury was administered to animals,,,,2019-10-27,2019-10-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR103/SRR10350308/HODay0_sample4_bam_possorted_genome_bam.bam', 'md5': '68744e02c25df0173e80a07eeafba388', 'size': '14120434797'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 0,HO model (30% body surface area dorsal burn and Achilles tenotomy) was used in C57 and LysmCre/Tgfb1fx/fx mice,,,,,
SRR10350309,,,,Illumina HiSeq 4000 paired end sequencing; GSM4141559: HODay7replicate4; Mus musculus; RNA-Seq,,,,,,,,,,SRX7060063,Illumina HiSeq 4000 paired end sequencing; GSM4141559: HODay7replicate4; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS5575537,HODay7replicate4,Mus musculus,Day 7,A partial-thickness scald burn injury was administered to animals,,,,2019-10-27,2019-10-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR103/SRR10350309/HODay7_sample4_bam_possorted_genome_bam.bam', 'md5': '71ac206dd9a44f92c3f65a567aac4755', 'size': '34761163310'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,HO model (30% body surface area dorsal burn and Achilles tenotomy) was used in C57 and LysmCre/Tgfb1fx/fx mice,,,,,
SRR10350310,,,,Illumina HiSeq 4000 paired end sequencing; GSM4141560: HODay21replicate4; Mus musculus; RNA-Seq,,,,,,,,,,SRX7060064,Illumina HiSeq 4000 paired end sequencing; GSM4141560: HODay21replicate4; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS5575538,HODay21replicate4,Mus musculus,Day 21,A partial-thickness scald burn injury was administered to animals,,,,2019-10-27,2019-10-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR103/SRR10350310/HODay21_sample4_bam_possorted_genome_bam.bam', 'md5': '81c869ac6bef9af8fbb4e22dc75decc5', 'size': '19741971481'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 21,HO model (30% body surface area dorsal burn and Achilles tenotomy) was used in C57 and LysmCre/Tgfb1fx/fx mice,,,,,
SRR10350311,,,,Illumina HiSeq 4000 paired end sequencing; GSM4141561: HO_CD47 treatedreplicate4; Mus musculus; RNA-Seq,,,,,,,,,,SRX7060065,Illumina HiSeq 4000 paired end sequencing; GSM4141561: HO_CD47 treatedreplicate4; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS5575539,HO_CD47 treatedreplicate4,Mus musculus,CD47 treated,A partial-thickness scald burn injury was administered to animals; CD47 activating peptide (10mg/kg i.p. daily) treated 3 days prior to injury and 3 days after injury.,,,,2019-10-27,2019-10-27,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR103/SRR10350311/HO_CD47_sample4_bam_possorted_genome_bam.bam', 'md5': 'cc7c14d9b4965ba15f0c2fb3672a63aa', 'size': '42024151813'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site,HO model (30% body surface area dorsal burn and Achilles tenotomy) was used in C57 and LysmCre/Tgfb1fx/fx mice,,,,,
SRR8528186,,,,Illumina HiSeq 4000 sequencing; GSM3589975: HODay0replicate1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330770,Illumina HiSeq 4000 sequencing; GSM3589975: HODay0replicate1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325090,HODay0replicate1,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528186/HODay0replicate1.bam.1', 'md5': '94e4b55b8fa4893908ec6c80339c58f2', 'size': '20724811028'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528187,,,,Illumina HiSeq 4000 sequencing; GSM3589976: HODay0replicate2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330771,Illumina HiSeq 4000 sequencing; GSM3589976: HODay0replicate2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325091,HODay0replicate2,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528187/HODay0replicate2.bam.1', 'md5': '4654d509f7b3f354e88bb2d39fd3d96c', 'size': '23668426174'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528188,,,,Illumina HiSeq 4000 sequencing; GSM3589977: HODay0replicate3; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330772,Illumina HiSeq 4000 sequencing; GSM3589977: HODay0replicate3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325092,HODay0replicate3,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528188/HODay0replicate3.bam.1', 'md5': '60a57aa564ee7f2ae9287f52eaa2d7e3', 'size': '14048690652'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528189,,,,Illumina HiSeq 4000 sequencing; GSM3589978: HODay3replicate1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330773,Illumina HiSeq 4000 sequencing; GSM3589978: HODay3replicate1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325093,HODay3replicate1,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528189/HODay3replicate1.bam.1', 'md5': '91064c8832afb4cbc6346e90d3236265', 'size': '45774608848'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528190,,,,Illumina HiSeq 4000 sequencing; GSM3589979: HODay3replicate2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330774,Illumina HiSeq 4000 sequencing; GSM3589979: HODay3replicate2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325094,HODay3replicate2,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528190/HODay3replicate2.bam.1', 'md5': '328a8e1031ed98b02051544e7f1aa87c', 'size': '58015588127'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528191,,,,Illumina HiSeq 4000 sequencing; GSM3589980: HODay3replicate3; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330775,Illumina HiSeq 4000 sequencing; GSM3589980: HODay3replicate3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325095,HODay3replicate3,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528191/HODay3replicate3.bam.1', 'md5': '875edfd8266a52044aa2de36c8b407e6', 'size': '50950946470'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528192,,,,Illumina HiSeq 4000 sequencing; GSM3589981: HODay7replicate1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330776,Illumina HiSeq 4000 sequencing; GSM3589981: HODay7replicate1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325096,HODay7replicate1,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528192/HODay7replicate1.bam.1', 'md5': '58dd9f550f0a477f12db2a527b0a9b62', 'size': '48874196435'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528193,,,,Illumina HiSeq 4000 sequencing; GSM3589982: HODay7replicate2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330777,Illumina HiSeq 4000 sequencing; GSM3589982: HODay7replicate2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325097,HODay7replicate2,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528193/HODay7replicate2.bam.1', 'md5': '4986540c52af29525ccce3eb5492db7b', 'size': '31082066005'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528194,,,,Illumina HiSeq 4000 sequencing; GSM3589983: HODay7replicate3; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330778,Illumina HiSeq 4000 sequencing; GSM3589983: HODay7replicate3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325098,HODay7replicate3,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528194/HODay7replicate3.bam.1', 'md5': '35b6050960c77a0911d6aa4947ca4e56', 'size': '29980647011'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528195,,,,Illumina HiSeq 4000 sequencing; GSM3589984: HODay21replicate1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330779,Illumina HiSeq 4000 sequencing; GSM3589984: HODay21replicate1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325099,HODay21replicate1,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528195/HODay21replicate1.bam.1', 'md5': '72b8708dba786d61a4445507e52b0f9b', 'size': '17241151855'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528196,,,,Illumina HiSeq 4000 sequencing; GSM3589985: HODay21replicate2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330780,Illumina HiSeq 4000 sequencing; GSM3589985: HODay21replicate2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325100,HODay21replicate2,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528196/HODay21replicate2.bam.1', 'md5': '4ad9a2bd10601000e3ad9ff74a0c347f', 'size': '21205548499'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528197,,,,Illumina HiSeq 4000 sequencing; GSM3589986: HODay21replicate3; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330781,Illumina HiSeq 4000 sequencing; GSM3589986: HODay21replicate3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325101,HODay21replicate3,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528197/HODay21replicate3.bam.1', 'md5': '760b61f88bbb0bf9a3cf9af3f6f80fd9', 'size': '19363573358'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528198,,,,Illumina HiSeq 4000 sequencing; GSM3589987: HO_CD47 treatedreplicate1; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330782,Illumina HiSeq 4000 sequencing; GSM3589987: HO_CD47 treatedreplicate1; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325102,HO_CD47 treatedreplicate1,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals; CD47 activating peptide (10mg/kg i.p. daily) treated 3 days prior to injury and 3 days after injury.,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528198/HOCD47treatedreplicate1.bam.1', 'md5': '51212fed5b41e532bbcbf8c1f3899e46', 'size': '37215176671'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528199,,,,Illumina HiSeq 4000 sequencing; GSM3589988: HO_CD47 treatedreplicate2; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330783,Illumina HiSeq 4000 sequencing; GSM3589988: HO_CD47 treatedreplicate2; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325103,HO_CD47 treatedreplicate2,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals; CD47 activating peptide (10mg/kg i.p. daily) treated 3 days prior to injury and 3 days after injury.,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528199/HOCD47Teatedreplicate2.bam.1', 'md5': '08a2cf437d0308739da3655a7590b010', 'size': '32733743069'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR8528200,,,,Illumina HiSeq 4000 sequencing; GSM3589989: HO_CD47 treatedreplicate3; Mus musculus; RNA-Seq,,,,,,,,,,SRX5330784,Illumina HiSeq 4000 sequencing; GSM3589989: HO_CD47 treatedreplicate3; Mus musculus; RNA-Seq,ILLUMINA,Illumina HiSeq 4000,SRP183505,Role of myeloid cells in heterotopic ossification (HO) in a burn and incision-induced mouse model,"Despite the high frequency of musculoskeletal extremity trauma, little is known about the dynamics of the initial inflammatory response that can result in pathologic healing. Here, we assess the circulatory monocyte/macrophage recruitment to sites of pathologic extremity wound healing as seen with heterotopic ossification (HO). Using single cell transcriptome analyses at key time points, we identify distinct monocyte/macrophage subpopulations that are recruited to the site of HO formation and contribute to ectopic bone development through varied transforming growth factor-1 (Tgfb1) expression. Monocyte/macrophage specific deletion of Tgfb1 leads to altered function of macrophages and reduced HO. We further identify CD47 as a novel target for Tgfb1 regulation on monocytes/macrophages as CD47 activation leads to decreased expression of Tgfb1 in macrophages and systemic treatment with CD47 activating peptide results in attenuation of canonical TGFB1 signaling and HO. These findings elucidate the critical role of monocytes/macrophage subpopulations in aberrant wound healing and provide a novel therapeutic avenue. Overall design: We have used 10x Genomics to perform single cell sequencing on HO cells",SRS4325104,HO_CD47 treatedreplicate3,Mus musculus,Tenotomy site of a burn/tenotomy mouse,A partial-thickness scald burn injury was administered to animals; CD47 activating peptide (10mg/kg i.p. daily) treated 3 days prior to injury and 3 days after injury.,,,,2019-10-24,2019-10-25,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR852/SRR8528200/HOCD47treatedreplicate3.bam.1', 'md5': 'a171a101b221b3dc35b9ee6de6eb24ac', 'size': '43389505896'}]",,,,,,,,,,,,,,,,,,,,,,,,cells recruited to injury site at day 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854525,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173038,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231348,SJRHB031320_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/025/SRR14854525/SRR14854525.fastq.gz', 'md5': 'f7956086e77f262ca9d710e848dd383e', 'size': '6972329845'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854526,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173038,Illumina NovaSeq 6000 paired end sequencing; GSM5390456: SJRHB031320_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231348,SJRHB031320_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/026/SRR14854526/SRR14854526.fastq.gz', 'md5': 'e83d4f8b1c092ef082e9c58d89cab34f', 'size': '7008326129'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854527,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173039,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231349,SJRHB000026_R2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/027/SRR14854527/SRR14854527.fastq.gz', 'md5': 'ce2515cfefb5fa7f1ac522cd74d41236', 'size': '5791547987'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854528,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173039,Illumina NovaSeq 6000 paired end sequencing; GSM5390457: SJRHB000026_R2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231349,SJRHB000026_R2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/028/SRR14854528/SRR14854528.fastq.gz', 'md5': 'cb087cacdd5ef88d77168c7ba97e89fa', 'size': '5839487244'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854529,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173040,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231350,SJRHB000026_R3,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/029/SRR14854529/SRR14854529.fastq.gz', 'md5': '217e46144bfc439529b20f44c07a9132', 'size': '6927416208'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854530,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173040,Illumina NovaSeq 6000 paired end sequencing; GSM5390458: SJRHB000026_R3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231350,SJRHB000026_R3,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/030/SRR14854530/SRR14854530.fastq.gz', 'md5': '2f56c16a65586d5634f94a797c3c6e2c', 'size': '7033364638'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854531,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173041,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231351,SJRHB010927_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/031/SRR14854531/SRR14854531.fastq.gz', 'md5': '59423aa074f2018cf86e4c807b9278df', 'size': '6751032817'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854532,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173041,Illumina NovaSeq 6000 paired end sequencing; GSM5390459: SJRHB010927_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231351,SJRHB010927_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/032/SRR14854532/SRR14854532.fastq.gz', 'md5': 'cd14f5a34ea70c36905a922d8ca38f43', 'size': '6793068630'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854533,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173042,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231352,SJRHB010928_R1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/033/SRR14854533/SRR14854533.fastq.gz', 'md5': 'b4cd822d25a8c2d9910f978071b60a41', 'size': '10844115344'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854534,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173042,Illumina NovaSeq 6000 paired end sequencing; GSM5390460: SJRHB010928_R1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231352,SJRHB010928_R1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/034/SRR14854534/SRR14854534.fastq.gz', 'md5': 'fbd5f5f73db917eedb85c8a322d09668', 'size': '11295078279'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854535,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/035/SRR14854535/SRR14854535.fastq.gz', 'md5': 'd1214940ad1c6fd0c34e81ac9ad2355d', 'size': '3495259302'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854536,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/036/SRR14854536/SRR14854536.fastq.gz', 'md5': '0f7c1307155d8f08c9a9f4e093d46b34', 'size': '3477136510'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854537,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/037/SRR14854537/SRR14854537.fastq.gz', 'md5': 'b22c927ad4d124288f3b0cb580ac4d8a', 'size': '3548920714'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854538,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173044,Illumina NovaSeq 6000 paired end sequencing; GSM5390461: SJRHB011_D; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231354,SJRHB011_D,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/038/SRR14854538/SRR14854538.fastq.gz', 'md5': '3c4e68d23f7e6133eae725477ad220d5', 'size': '3574375609'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854539,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/039/SRR14854539/SRR14854539.fastq.gz', 'md5': '522fd560a52355167c6dd94cdf84bf8c', 'size': '4161853170'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854540,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/040/SRR14854540/SRR14854540.fastq.gz', 'md5': '99da4106fe778ca4bef2e0a8b6c5798c', 'size': '4144599954'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854541,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/041/SRR14854541/SRR14854541.fastq.gz', 'md5': '60b0a495e3bf2b6a1cee34da9905ab8a', 'size': '4215414194'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854542,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173045,Illumina NovaSeq 6000 paired end sequencing; GSM5390462: SJRHB012_R; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231355,SJRHB012_R,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/042/SRR14854542/SRR14854542.fastq.gz', 'md5': '003bc0d16d841c0b285e80c915334200', 'size': '4249511290'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854543,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/043/SRR14854543/SRR14854543.fastq.gz', 'md5': 'c5adb869714fec32b24e16290703268d', 'size': '4744987426'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854544,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/044/SRR14854544/SRR14854544.fastq.gz', 'md5': 'cf85b6779ec9c58ac453a10c0a8bff55', 'size': '4629948528'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854552,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/052/SRR14854552/SRR14854552.fastq.gz', 'md5': 'd48dbdae6b8578cb47d5876893c1f4d7', 'size': '4848941194'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854553,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173046,Illumina NovaSeq 6000 paired end sequencing; GSM5390463: SJRHB012_S; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231356,SJRHB012_S,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/053/SRR14854553/SRR14854553.fastq.gz', 'md5': '44596b47ae068a987cdc65c164c2457b', 'size': '4960995626'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854554,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173047,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231357,SJRHB012405_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/054/SRR14854554/SRR14854554.fastq.gz', 'md5': '7c5136f4cbf0792dae9f2441b942c1c7', 'size': '6331149775'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854555,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173047,Illumina NovaSeq 6000 paired end sequencing; GSM5390464: SJRHB012405_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231357,SJRHB012405_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/055/SRR14854555/SRR14854555.fastq.gz', 'md5': '6085aae78f9aca2e4651f086d20fda16', 'size': '6366561421'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854556,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173048,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231358,SJRHB013758_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/056/SRR14854556/SRR14854556.fastq.gz', 'md5': 'fd1ab564d003f93621cd63bf1342fcb1', 'size': '7062966570'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854557,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173048,Illumina NovaSeq 6000 paired end sequencing; GSM5390465: SJRHB013758_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231358,SJRHB013758_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/057/SRR14854557/SRR14854557.fastq.gz', 'md5': 'b9dcab66cc6d5e5832bdf5f1436d1cb2', 'size': '7125674107'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854558,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173049,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231359,SJRHB013758_D2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/058/SRR14854558/SRR14854558.fastq.gz', 'md5': '09ab9431a01689de33f98cee4fb8646e', 'size': '6021333474'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854559,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173049,Illumina NovaSeq 6000 paired end sequencing; GSM5390466: SJRHB013758_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231359,SJRHB013758_D2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/059/SRR14854559/SRR14854559.fastq.gz', 'md5': '2c0a453938179a82ea94aaf5313d446c', 'size': '6066473796'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854560,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173050,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231360,SJRHB049189_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/060/SRR14854560/SRR14854560.fastq.gz', 'md5': '07a7e6982908d46806e3585b8be54d18', 'size': '5383576544'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854561,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173050,Illumina NovaSeq 6000 paired end sequencing; GSM5390467: SJRHB049189_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231360,SJRHB049189_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/061/SRR14854561/SRR14854561.fastq.gz', 'md5': 'ceb8a1289d62f00882850404c01f0f18', 'size': '5419379662'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854562,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173051,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231361,SJRHB030680_R1_sn,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/062/SRR14854562/SRR14854562.fastq.gz', 'md5': '98bd5a27e84dae62f5b8ea5e319dc3c1', 'size': '5147172877'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854563,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173051,Illumina NovaSeq 6000 paired end sequencing; GSM5390468: SJRHB030680_R1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231361,SJRHB030680_R1_sn,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/063/SRR14854563/SRR14854563.fastq.gz', 'md5': '2bdb53e0bf72545cad81efcf3c03ebf8', 'size': '5140091051'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854564,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/064/SRR14854564/SRR14854564.fastq.gz', 'md5': 'bb34f5f7441a719622f4cf41774a8618', 'size': '3786641378'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854565,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/065/SRR14854565/SRR14854565.fastq.gz', 'md5': 'd6e4261019ac0d942db7f999b2327a18', 'size': '3715214753'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854566,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/066/SRR14854566/SRR14854566.fastq.gz', 'md5': 'c141894372a4d965e9aa5ff13d46257d', 'size': '3848335137'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854567,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173052,Illumina NovaSeq 6000 paired end sequencing; GSM5390469: SJRHB010468_D1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231362,SJRHB010468_D1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/067/SRR14854567/SRR14854567.fastq.gz', 'md5': '70f70b456f3041ef72182ba0b8991843', 'size': '3930973631'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854568,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173053,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231363,SJRHB013757_D2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/068/SRR14854568/SRR14854568.fastq.gz', 'md5': '9af57b00e09353d2dd4ece315616609f', 'size': '6099713873'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854569,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173053,Illumina NovaSeq 6000 paired end sequencing; GSM5390470: SJRHB013757_D2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231363,SJRHB013757_D2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/069/SRR14854569/SRR14854569.fastq.gz', 'md5': '4b14e4b27e16fcdea445538526ed3e31', 'size': '6118810908'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854570,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173054,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231364,SJRHB013759_A1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/070/SRR14854570/SRR14854570.fastq.gz', 'md5': '396fa704c6f4a0e8163b736e8ef4afcd', 'size': '6481085361'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854571,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173054,Illumina NovaSeq 6000 paired end sequencing; GSM5390471: SJRHB013759_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231364,SJRHB013759_A1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/071/SRR14854571/SRR14854571.fastq.gz', 'md5': 'b216962257ff5d92bd8f9254450763aa', 'size': '6515394578'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854572,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173055,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231365,SJRHB013759_A2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/072/SRR14854572/SRR14854572.fastq.gz', 'md5': 'b0b8c8347575c442a40ef9b3c5cffaf5', 'size': '6743016493'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854573,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173055,Illumina NovaSeq 6000 paired end sequencing; GSM5390472: SJRHB013759_A2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231365,SJRHB013759_A2,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/073/SRR14854573/SRR14854573.fastq.gz', 'md5': '7f5b42adfe462b0ee0973968bf12fd66', 'size': '6807456202'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854574,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173056,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231366,SJRHB046156_A1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/074/SRR14854574/SRR14854574.fastq.gz', 'md5': '757426c76606540cf15774a5962e6a0d', 'size': '5516595277'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854575,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173056,Illumina NovaSeq 6000 paired end sequencing; GSM5390473: SJRHB046156_A1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231366,SJRHB046156_A1,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/075/SRR14854575/SRR14854575.fastq.gz', 'md5': '6929783abd2af661bed71fd9a2012dee', 'size': '5545170980'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854576,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173057,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231367,SJRHB031320_D1_sn,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/076/SRR14854576/SRR14854576.fastq.gz', 'md5': 'f5ca820f5189279a6f8e3612648587ec', 'size': '4806693621'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854577,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173057,Illumina NovaSeq 6000 paired end sequencing; GSM5390474: SJRHB031320_D1_sn; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231367,SJRHB031320_D1_sn,Homo sapiens,Patient tumor,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/077/SRR14854577/SRR14854577.fastq.gz', 'md5': '4018c7587c1b706aba8b78bcd7ed7b83', 'size': '4826771575'}]",tumor,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818970,,,,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/070/SRR17818970/SRR17818970.fastq.gz', 'md5': '04dde173126b8dba2adfb3c286b4dd20', 'size': '5896718773'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818971,,,,NextSeq 500 sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/071/SRR17818971/SRR17818971.fastq.gz', 'md5': 'db7f0895b6a05be9f7c240a519ef01e8', 'size': '5951983457'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818972,,,,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/072/SRR17818972/SRR17818972.fastq.gz', 'md5': '6f4287f21bac2d958c5659c811317abe', 'size': '5828359971'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818973,,,,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980709,NextSeq 500 paired end sequencing; GSM5848676: 29806 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818032,29806 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/073/SRR17818973/SRR17818973.fastq.gz', 'md5': '20e942b62ec10f471cea18d09a393a94', 'size': '5963397085'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818974,,,,NextSeq 500 sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/074/SRR17818974/SRR17818974.fastq.gz', 'md5': 'ad4cc0ed9da97545574cd2ad1154bf5e', 'size': '6102431836'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818975,,,,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/075/SRR17818975/SRR17818975.fastq.gz', 'md5': '7288d480dad9304ccbcb0f1251d89a1e', 'size': '6141553107'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818976,,,,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/076/SRR17818976/SRR17818976.fastq.gz', 'md5': 'f636a4aeaee0479194d41235c9e749e8', 'size': '6145205179'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818977,,,,NextSeq 500 sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980708,NextSeq 500 paired end sequencing; GSM5848675: 21202 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818031,21202 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/077/SRR17818977/SRR17818977.fastq.gz', 'md5': '71e39fe049afabf2256298b1b43f6067', 'size': '6213816161'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818978,,,,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/078/SRR17818978/SRR17818978.fastq.gz', 'md5': '57220c6fa70772b72d6ea73079b2b43f', 'size': '4290451241'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818979,,,,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/079/SRR17818979/SRR17818979.fastq.gz', 'md5': '2f492bbc11a4d493cacd821b474bb212', 'size': '4429060772'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818980,,,,NextSeq 500 sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/080/SRR17818980/SRR17818980.fastq.gz', 'md5': '7a2b119bdd6fe1e4fdfcd13a5239bf6e', 'size': '4353100303'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818981,,,,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980707,NextSeq 500 paired end sequencing; GSM5848674: 20696 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818030,20696 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/081/SRR17818981/SRR17818981.fastq.gz', 'md5': 'a059754978c71fcfdcbb5af291eeb68a', 'size': '4505802337'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818982,,,,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/082/SRR17818982/SRR17818982.fastq.gz', 'md5': 'b9d5aef87716795276098ec2bc52f5d3', 'size': '5438883368'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818983,,,,NextSeq 500 sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/083/SRR17818983/SRR17818983.fastq.gz', 'md5': '930627d74d0b1f7eb8944a6478629785', 'size': '5559279295'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818984,,,,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/084/SRR17818984/SRR17818984.fastq.gz', 'md5': 'fb9887fca5fafb3eff4f7036bf6645fe', 'size': '5455332526'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818985,,,,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980706,NextSeq 500 paired end sequencing; GSM5848673: 20082 rhabdomyosarcoma primary patient sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818029,20082 rhabdomyosarcoma primary patient sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/085/SRR17818985/SRR17818985.fastq.gz', 'md5': 'd98983e45d3f44e8962be00c78e12ecd', 'size': '5572475120'}]",,,,,,Primary cell,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854578,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/078/SRR14854578/SRR14854578.fastq.gz', 'md5': 'd2499bc066c06b954144300b0a24a7cc', 'size': '2253904103'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854579,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/079/SRR14854579/SRR14854579.fastq.gz', 'md5': '5d85df3dc702a7fe57cf8000a780e36c', 'size': '767084943'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854580,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/080/SRR14854580/SRR14854580.fastq.gz', 'md5': 'b740054d5a542c701eaa8197661ba109', 'size': '401789770'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854581,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/081/SRR14854581/SRR14854581.fastq.gz', 'md5': '7a7a2d21bbc8fe5c98f25aa3dd1832b9', 'size': '512874737'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854582,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/082/SRR14854582/SRR14854582.fastq.gz', 'md5': 'b17616f9b6688b8dc24ddbd26e3da750', 'size': '225593811'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854583,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/083/SRR14854583/SRR14854583.fastq.gz', 'md5': 'd7b3c27a0f68389095dd95e6e48ae658', 'size': '289117528'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854584,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/084/SRR14854584/SRR14854584.fastq.gz', 'md5': '7bb58b6333adada3c005316da87bbc8d', 'size': '492875518'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854585,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/085/SRR14854585/SRR14854585.fastq.gz', 'md5': '8acf3f1e815c9a917413c1e869428a98', 'size': '630583233'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854586,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/086/SRR14854586/SRR14854586.fastq.gz', 'md5': 'b88ccc3d6c4ac30bba9e3e83bd11be17', 'size': '2313845630'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854587,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/087/SRR14854587/SRR14854587.fastq.gz', 'md5': '6deaf158e8802d7e40a4dfb962b50cd1', 'size': '1550164974'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854588,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/088/SRR14854588/SRR14854588.fastq.gz', 'md5': '0edddc0deb1b2b89e2ec65ebbbda7520', 'size': '1581922401'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854589,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/089/SRR14854589/SRR14854589.fastq.gz', 'md5': '3cd673ba8b21a11f01d1a2b0881fcbb0', 'size': '886485776'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854590,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/090/SRR14854590/SRR14854590.fastq.gz', 'md5': '7becce648d98344680548c4d2ba77cb7', 'size': '911872411'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854591,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/091/SRR14854591/SRR14854591.fastq.gz', 'md5': 'bc9f5581c99e0d6bfd91a65a4504393f', 'size': '1893240523'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854592,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/092/SRR14854592/SRR14854592.fastq.gz', 'md5': '387dead99b6dd6dede669d754c53145a', 'size': '1952280103'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854593,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173058,Illumina NovaSeq 6000 paired end sequencing; GSM5390475: SJRHB000026_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231369,SJRHB000026_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/093/SRR14854593/SRR14854593.fastq.gz', 'md5': 'eb8261f3f9a9ae91c6e5b10c6a70888f', 'size': '601427512'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854594,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390476: SJRHB000026_X2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173059,Illumina NovaSeq 6000 paired end sequencing; GSM5390476: SJRHB000026_X2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231368,SJRHB000026_X2,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/094/SRR14854594/SRR14854594.fastq.gz', 'md5': '5b10d267a8116ecff692aa15e9047d12', 'size': '26061600128'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854595,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173060,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231370,SJRHB010927_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/095/SRR14854595/SRR14854595.fastq.gz', 'md5': '082b43c27c4e5c8a95383395dbdd9a9d', 'size': '5721538234'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854596,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173060,Illumina NovaSeq 6000 paired end sequencing; GSM5390477: SJRHB010927_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231370,SJRHB010927_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/096/SRR14854596/SRR14854596.fastq.gz', 'md5': '45758381e93474570f4425336c340ec5', 'size': '5746902808'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854597,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173061,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231371,SJRHB010928_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/097/SRR14854597/SRR14854597.fastq.gz', 'md5': '7106baef8a3680dbd6dc4d49585906ba', 'size': '8087970031'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854598,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173061,Illumina NovaSeq 6000 paired end sequencing; GSM5390478: SJRHB010928_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231371,SJRHB010928_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/098/SRR14854598/SRR14854598.fastq.gz', 'md5': '244f7061c1c78d0ef5a3fcfa59595a02', 'size': '8114553408'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854599,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173062,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231372,SJRHB011_X,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/099/SRR14854599/SRR14854599.fastq.gz', 'md5': '70873b12b8cf7ee006b9e755d99d8d0d', 'size': '7041267272'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854600,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173062,Illumina NovaSeq 6000 paired end sequencing; GSM5390479: SJRHB011_X; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231372,SJRHB011_X,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/000/SRR14854600/SRR14854600.fastq.gz', 'md5': '092909a6bf1315bc2fabcb317bd8d9e5', 'size': '7018592380'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854601,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173063,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231374,SJRHB012_Y,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/001/SRR14854601/SRR14854601.fastq.gz', 'md5': '4a23f157492068515767496af3e09dce', 'size': '6454199786'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854602,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173063,Illumina NovaSeq 6000 paired end sequencing; GSM5390480: SJRHB012_Y; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231374,SJRHB012_Y,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/002/SRR14854602/SRR14854602.fastq.gz', 'md5': 'bd74dc94b449bbb131d4dc076ef08c2d', 'size': '6427046787'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854603,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390481: SJRHB012_Z; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173064,Illumina NovaSeq 6000 paired end sequencing; GSM5390481: SJRHB012_Z; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231373,SJRHB012_Z,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/003/SRR14854603/SRR14854603.fastq.gz', 'md5': 'd57dc4163ae227bf87cc937137391e1e', 'size': '17425444479'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854604,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173065,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231375,SJRHB012405_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/004/SRR14854604/SRR14854604.fastq.gz', 'md5': '836fdb6aba5be6a9edc421d214988f93', 'size': '8466509413'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854605,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173065,Illumina NovaSeq 6000 paired end sequencing; GSM5390482: SJRHB012405_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231375,SJRHB012405_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/005/SRR14854605/SRR14854605.fastq.gz', 'md5': '0936b1f5a266a5268c7da538b432e5b8', 'size': '8615953867'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854606,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173066,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231376,SJRHB013758_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/006/SRR14854606/SRR14854606.fastq.gz', 'md5': '3276929e937396175d4520d07677de22', 'size': '6018638316'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854607,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173066,Illumina NovaSeq 6000 paired end sequencing; GSM5390483: SJRHB013758_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231376,SJRHB013758_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/007/SRR14854607/SRR14854607.fastq.gz', 'md5': '28277192b534e4d44d7b78d8cdcc8a50', 'size': '5995218797'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854608,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173067,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231377,SJRHB013758_X2,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/008/SRR14854608/SRR14854608.fastq.gz', 'md5': 'c3ecc77423e2d5d1b5823a06db7b9fd7', 'size': '4202863281'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854609,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173067,Illumina NovaSeq 6000 paired end sequencing; GSM5390484: SJRHB013758_X2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231377,SJRHB013758_X2,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/009/SRR14854609/SRR14854609.fastq.gz', 'md5': '6c4eaa0784b867ec89d4ac0bb7cc2cc3', 'size': '4236164637'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854610,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173068,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231378,SJRHB049189_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/010/SRR14854610/SRR14854610.fastq.gz', 'md5': 'fcf706bfbd43c42aa437e557043e869b', 'size': '5010540054'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854611,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173068,Illumina NovaSeq 6000 paired end sequencing; GSM5390485: SJRHB049189_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231378,SJRHB049189_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/011/SRR14854611/SRR14854611.fastq.gz', 'md5': 'c92542924a190e417cade53b24733bee', 'size': '5031426986'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854612,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173069,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231380,SJRHB030680_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/012/SRR14854612/SRR14854612.fastq.gz', 'md5': '05496c5648528407718b7a39c7442313', 'size': '4260149316'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854613,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173069,Illumina NovaSeq 6000 paired end sequencing; GSM5390486: SJRHB030680_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231380,SJRHB030680_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/013/SRR14854613/SRR14854613.fastq.gz', 'md5': '96f1fde08e6190b42ba821422e4e0d0a', 'size': '4250962223'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854614,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173070,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231379,SJRHB010468_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/014/SRR14854614/SRR14854614.fastq.gz', 'md5': 'a772041f3296735cc839d6e0d54aab06', 'size': '6064553547'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854615,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173070,Illumina NovaSeq 6000 paired end sequencing; GSM5390487: SJRHB010468_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231379,SJRHB010468_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/015/SRR14854615/SRR14854615.fastq.gz', 'md5': '54028a5f854c1d8a99823107ac4f438c', 'size': '6095531689'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854616,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/016/SRR14854616/SRR14854616.fastq.gz', 'md5': 'de8a04f72f2c1eb992d9f0ab199bde2a', 'size': '4095551335'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854617,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/017/SRR14854617/SRR14854617.fastq.gz', 'md5': '183f9cdfabea9ae719af2acf2dff416f', 'size': '4091625501'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854618,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/018/SRR14854618/SRR14854618.fastq.gz', 'md5': '0409213ebbbde6c48fd0f367b5feb9b6', 'size': '4146324681'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854619,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173071,Illumina NovaSeq 6000 paired end sequencing; GSM5390488: SJRHB013757_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231381,SJRHB013757_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/019/SRR14854619/SRR14854619.fastq.gz', 'md5': 'c1978297b640fea113a491458e5365f7', 'size': '4164099186'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854620,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/020/SRR14854620/SRR14854620.fastq.gz', 'md5': 'a61c8ff7b1986271970747cc4207f8f9', 'size': '1538731731'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854621,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/021/SRR14854621/SRR14854621.fastq.gz', 'md5': '3f3baee3b7210b1b422db3f3e3d0bb43', 'size': '1618963544'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854622,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/022/SRR14854622/SRR14854622.fastq.gz', 'md5': '2d8847c145bc90141f1c94eb339c1863', 'size': '1587401053'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854623,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/023/SRR14854623/SRR14854623.fastq.gz', 'md5': '68defde8b2eee2ace173f84130dc58f7', 'size': '1667652732'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854624,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/024/SRR14854624/SRR14854624.fastq.gz', 'md5': '7c958c38a9202dd77dce9d2f658d2e30', 'size': '1934336231'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854625,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/025/SRR14854625/SRR14854625.fastq.gz', 'md5': '741d07424a8bc0627558521cbe05e6a1', 'size': '2034638561'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854626,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/026/SRR14854626/SRR14854626.fastq.gz', 'md5': '59b464ce477e8227b27392bc1cee67ad', 'size': '1010644582'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854627,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173072,Illumina NovaSeq 6000 paired end sequencing; GSM5390489: SJRHB013759_X14; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231382,SJRHB013759_X14,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/027/SRR14854627/SRR14854627.fastq.gz', 'md5': '92144304cef707d6eb1488aade74eac5', 'size': '1062943937'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854628,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/028/SRR14854628/SRR14854628.fastq.gz', 'md5': '23d0d9f2f7b3db4752023505575583a0', 'size': '3228241532'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854629,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/029/SRR14854629/SRR14854629.fastq.gz', 'md5': '7e7c9f395e6f5630ec951beabd76b90a', 'size': '3389766231'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854630,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/030/SRR14854630/SRR14854630.fastq.gz', 'md5': '1cde060f6870bffb0fad3ebfeabe6ded', 'size': '3084663298'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854631,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/031/SRR14854631/SRR14854631.fastq.gz', 'md5': '9ce4aa47f2dbc201825547604cfebadb', 'size': '3234771651'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854632,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/032/SRR14854632/SRR14854632.fastq.gz', 'md5': 'd4194b12d833e7c67cc61240689c2ad1', 'size': '4058767092'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854633,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/033/SRR14854633/SRR14854633.fastq.gz', 'md5': 'd8502a6ce669ac7daceb4a09703f2672', 'size': '4271604412'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854634,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/034/SRR14854634/SRR14854634.fastq.gz', 'md5': 'cc6a0d977a9fe0b79d37b3ada647614a', 'size': '2240234664'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854635,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173073,Illumina NovaSeq 6000 paired end sequencing; GSM5390490: SJRHB013759_X15; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231383,SJRHB013759_X15,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/035/SRR14854635/SRR14854635.fastq.gz', 'md5': 'b8f9cc930c41e9c0c8520a9bbd25eb10', 'size': '2351543458'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854636,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173074,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231384,SJRHB046156_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/036/SRR14854636/SRR14854636.fastq.gz', 'md5': '1da031a92aa8a45b2d3917ae46da1c1b', 'size': '5321682386'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854637,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173074,Illumina NovaSeq 6000 paired end sequencing; GSM5390491: SJRHB046156_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231384,SJRHB046156_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/037/SRR14854637/SRR14854637.fastq.gz', 'md5': '4230a55fde341c40950ff610c3ddf897', 'size': '5341527179'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854638,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173075,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231385,SJRHB031320_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/038/SRR14854638/SRR14854638.fastq.gz', 'md5': 'd7b12bf53e78971f00a5c641a44caa61', 'size': '4687979042'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854639,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173075,Illumina NovaSeq 6000 paired end sequencing; GSM5390492: SJRHB031320_X1; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231385,SJRHB031320_X1,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/039/SRR14854639/SRR14854639.fastq.gz', 'md5': 'a74c867c774e2315b36da5ca6c996dfc', 'size': '4672234940'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' scRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854695,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173099,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231409,SJRHB00026_X1_treat_day0,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/095/SRR14854695/SRR14854695.fastq.gz', 'md5': '0533d64e8ef534f31e0f4a63fc502e55', 'size': '5580010209'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854696,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173099,Illumina NovaSeq 6000 paired end sequencing; GSM5390516: SJRHB00026_X1_treat_day0; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231409,SJRHB00026_X1_treat_day0,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/096/SRR14854696/SRR14854696.fastq.gz', 'md5': 'cbf9958575d24b9574467c416a7dd74e', 'size': '5551901849'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854697,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173100,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231410,SJRHB00026_X1_treat_day3,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/097/SRR14854697/SRR14854697.fastq.gz', 'md5': '3abb3a0ba85d9a1fb9948a5f87da4a7e', 'size': '4367827841'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854698,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173100,Illumina NovaSeq 6000 paired end sequencing; GSM5390517: SJRHB00026_X1_treat_day3; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231410,SJRHB00026_X1_treat_day3,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/098/SRR14854698/SRR14854698.fastq.gz', 'md5': 'e873ed0a70b854b43490ed0b775f5188', 'size': '4367495379'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854699,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173101,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231411,SJRHB00026_X1_treat_day28,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/099/SRR14854699/SRR14854699.fastq.gz', 'md5': '2c0909a688db0af1213e211e6e7ab178', 'size': '5255981342'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14854700,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,,,,,,,,,,SRX11173101,Illumina NovaSeq 6000 paired end sequencing; GSM5390518: SJRHB00026_X1_treat_day28; Homo sapiens; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP319643,A single-cell/nucleus atlas of pediatric rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most soft tissue sarcoma of childhood and histologically mimics developing skeletal muscle. To better understand RMS, we performed single-cell RNA-seq of one embryonal subtype RMS (ERMS) and one alveolar subtype RMS (ARMS). We expanded our observations by performing single-nucleus RNA-seq of 18 patient tumors (12 ERMS, 6 ARMS). All 18 of these tumors were used to generate orthotopic patient-derived xenografts, and we performed single-cell RNA-seq of all 18 O-PDXs to compare heterogeneity between the original tumor and the patient-derived model. 15 of the O-PDXs underwent lentiviral barcoding, and lineage could be tracked using a separate dial-out PCR step during the single-cell RNA-seq workflow. We performed single-cell RNA-seq of an ex vivo organoid, showing that we can preserve heterogeneity in this model. We expanded our study to the epigenetic level by using single-cell ATAC-sequencing of 7 O-PDXs. Finally, we longitudinally tracked shifts in heterogeneity in an O-PDX model treated with chemotherapy. Overall design: We performed single-cell RNA-seq from 2 patient RMS tumors, 18 O-PDXs, and 1 organoid. Additionally, we performed single-nucleus RNA-seq from 18 patient RMS tumors and single-cell ATAC-seq from 7 O-PDXs. We also provide dialout PCR data from 15 RMS O-PDX that were used for lentiviral barcode experiments to track clonal lineages within O-PDXs.",SRS9231411,SJRHB00026_X1_treat_day28,Homo sapiens,Orthotopic patient-derived xenograft,,,,,2022-04-08,2022-04-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/000/SRR14854700/SRR14854700.fastq.gz', 'md5': '73acb6ed74ba981c260c4e86f6f3464a', 'size': '5238649453'}]",xenograft,,,,,,,,,,,,,,,10x genomics 3' snRNA-seq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818836,,,,NextSeq 500 sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,274599868,15102992740,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/036/SRR17818836/SRR17818836.fastq.gz', 'md5': '901bcc317599522e020ef1f7daaacf5f', 'size': '4857876270'}]",,,,,,mouse PDX sample,Mutation?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818837,,,,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,274599868,15102992740,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/037/SRR17818837/SRR17818837.fastq.gz', 'md5': 'e930d5963bce086f5bf4c3b047141630', 'size': '4925031043'}]",,,,,,mouse PDX sample,Mutation?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818838,,,,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,274599868,15102992740,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/038/SRR17818838/SRR17818838.fastq.gz', 'md5': '51650744688bc49f62917ac77b666c7f', 'size': '4941094757'}]",,,,,,mouse PDX sample,Mutation?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818839,,,,NextSeq 500 sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980727,NextSeq 500 paired end sequencing; GSM5848693: MSK74711 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818050,MSK74711 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,274599868,15102992740,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/039/SRR17818839/SRR17818839.fastq.gz', 'md5': '48aea2e9adefcddca51f0e1368012293', 'size': '5082307001'}]",,,,,,mouse PDX sample,Mutation?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818840,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/040/SRR17818840/SRR17818840_1.fastq.gz', 'md5': '60c61fe45fa505bc710015927dff6cc4', 'size': '1164142968'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/040/SRR17818840/SRR17818840_2.fastq.gz', 'md5': '4298b456c46711104cfa67744de5f37d', 'size': '1467778221'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818841,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/041/SRR17818841/SRR17818841_1.fastq.gz', 'md5': '512cb35c8325d7316cb4fc577da3447e', 'size': '1170063413'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/041/SRR17818841/SRR17818841_2.fastq.gz', 'md5': '73fc3403196ad07c814b6ad9c5faf5ff', 'size': '1499182149'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818842,,,,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/042/SRR17818842/SRR17818842_1.fastq.gz', 'md5': '99d0974d5e499dbe2c36add6e6785f96', 'size': '1054251293'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/042/SRR17818842/SRR17818842_2.fastq.gz', 'md5': 'b19147cbc153c03e76e0c3ad3449d13c', 'size': '1652209286'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818843,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/043/SRR17818843/SRR17818843_1.fastq.gz', 'md5': '1f22f1ce9d5a777f3e5e4c5a64a383d0', 'size': '254652982'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/043/SRR17818843/SRR17818843_2.fastq.gz', 'md5': '18460fe487e490963b37f18e23be8af4', 'size': '431081865'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818844,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/044/SRR17818844/SRR17818844_1.fastq.gz', 'md5': 'f3c36eefd1e4bbda5dc338efed0120b7', 'size': '1170397951'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/044/SRR17818844/SRR17818844_2.fastq.gz', 'md5': '6ebc31e4bc9ed9427ff1c51e662ff9a3', 'size': '1501598299'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818845,,,,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/045/SRR17818845/SRR17818845_1.fastq.gz', 'md5': 'a859915fc476b8ac9557573b992b1991', 'size': '1171094328'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/045/SRR17818845/SRR17818845_2.fastq.gz', 'md5': '7adcbd4e691891ea751c8bf087fbf7fa', 'size': '1518473813'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818846,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818846/SRR17818846_1.fastq.gz', 'md5': 'df571f4d31582a7f31c8b115425a7151', 'size': '1056779424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818846/SRR17818846_2.fastq.gz', 'md5': '966933ae0cbbb7b9015fa9674a4d8be0', 'size': '1687636860'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818847,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818847/SRR17818847_1.fastq.gz', 'md5': '062adb6fef35e0e79d70ccea56ff0e34', 'size': '218409188'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818847/SRR17818847_2.fastq.gz', 'md5': '2d82eae5e797c920f0ecb34bae4389f5', 'size': '372008413'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818848,,,,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818848/SRR17818848_1.fastq.gz', 'md5': '79e034e8e59bd739b7d6f34b49de5109', 'size': '1165822918'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818848/SRR17818848_2.fastq.gz', 'md5': '7bf893ad4d2e1b28b1c3b40a4e44f319', 'size': '1479211787'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818849,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818849/SRR17818849_1.fastq.gz', 'md5': 'e665e74a67bea1785881eff5bfcf7710', 'size': '1048194424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818849/SRR17818849_2.fastq.gz', 'md5': '09204b4f701f7d707c47845995013395', 'size': '1615775156'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818850,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818850/SRR17818850_1.fastq.gz', 'md5': '4384a2ae3ea39b866f4fc8a676287ead', 'size': '293645956'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818850/SRR17818850_2.fastq.gz', 'md5': 'e167fb040771554e3b0e48ae022e4b15', 'size': '494521721'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818851,,,,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818851/SRR17818851_1.fastq.gz', 'md5': 'bdb4e9379dc8e0cdde7a44668099b9aa', 'size': '1169386584'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818851/SRR17818851_2.fastq.gz', 'md5': '09dcaa9d1c7b911c5b9587fa6eaf778d', 'size': '1490895024'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818852,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818852/SRR17818852_1.fastq.gz', 'md5': 'c5dd58d675105f61960c34238bcaef46', 'size': '1170207937'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818852/SRR17818852_2.fastq.gz', 'md5': '231419e66c5c463e8c1f246edacd753f', 'size': '1507227458'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818853,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818853/SRR17818853_1.fastq.gz', 'md5': '8be959819ea038e8277bd99a439b5a52', 'size': '1052491592'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818853/SRR17818853_2.fastq.gz', 'md5': '3b20bfa8f701157e76a88bf7d5a20c5b', 'size': '1669598094'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818854,,,,NextSeq 500 sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17818854/SRR17818854_1.fastq.gz', 'md5': '8fa829aa61cd253aaba9fbe9a000691d', 'size': '243967872'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/054/SRR17818854/SRR17818854_2.fastq.gz', 'md5': 'e490c1305bcacf0c88e28a3e08b8b38c', 'size': '413428286'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818855,,,,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980726,NextSeq 500 paired end sequencing; GSM5848694: MSK82489 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818049,MSK82489 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,210135734,17344283747,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17818855/SRR17818855_1.fastq.gz', 'md5': '24918f0beed5fcefa61b5db225b6f7a1', 'size': '1168498680'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/055/SRR17818855/SRR17818855_2.fastq.gz', 'md5': '31c6be4ba77e4f93a0f335839314256c', 'size': '1485439187'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818859,,,,NextSeq 500 paired end sequencing; GSM5848692: MSK72117-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980725,NextSeq 500 paired end sequencing; GSM5848692: MSK72117-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818048,MSK72117-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,113818653,6260025915,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/059/SRR17818859/SRR17818859.fastq.gz', 'md5': 'd81d8b7c4272f8b86897d914b9daadf4', 'size': '3990568788'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818860,,,,NextSeq 500 sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17818860/SRR17818860.fastq.gz', 'md5': 'e0dc2b6cf88a949241396bda7748cff6', 'size': '6294867736'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818861,,,,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/061/SRR17818861/SRR17818861.fastq.gz', 'md5': '17dd0b8d46512b03a9fc31506ee559b6', 'size': '6293480037'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818862,,,,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/062/SRR17818862/SRR17818862.fastq.gz', 'md5': '04b65e622518b33a7e59e42c0ce20f4d', 'size': '6343960026'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818860,,,,NextSeq 500 sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/060/SRR17818860/SRR17818860.fastq.gz', 'md5': 'e0dc2b6cf88a949241396bda7748cff6', 'size': '6294867736'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818861,,,,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/061/SRR17818861/SRR17818861.fastq.gz', 'md5': '17dd0b8d46512b03a9fc31506ee559b6', 'size': '6293480037'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818862,,,,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/062/SRR17818862/SRR17818862.fastq.gz', 'md5': '04b65e622518b33a7e59e42c0ce20f4d', 'size': '6343960026'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818863,,,,NextSeq 500 sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980724,NextSeq 500 paired end sequencing; GSM5848691: MSK72117 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818047,MSK72117 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/063/SRR17818863/SRR17818863.fastq.gz', 'md5': '059248ce747ca440339e136a9a0f688c', 'size': '6346907658'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818864,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/064/SRR17818864/SRR17818864_1.fastq.gz', 'md5': '19473928eeb7aa5e8fb75c6618dccd3a', 'size': '1041390659'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/064/SRR17818864/SRR17818864_2.fastq.gz', 'md5': 'c38e5e370931235e64976c6c9aeb13b7', 'size': '1428881618'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818865,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/065/SRR17818865/SRR17818865_1.fastq.gz', 'md5': 'fc60671186ded38f1b80730388740ae6', 'size': '1053206339'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/065/SRR17818865/SRR17818865_2.fastq.gz', 'md5': '6562420f3468cd2ab07ccee90bc37327', 'size': '1426419580'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818866,,,,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/066/SRR17818866/SRR17818866_1.fastq.gz', 'md5': 'b39e4c0e55692aed914f58e55c2a3651', 'size': '1051244018'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/066/SRR17818866/SRR17818866_2.fastq.gz', 'md5': '06f023e1d5dac89cb896e0c0289d2c3b', 'size': '1434426125'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818867,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/067/SRR17818867/SRR17818867_1.fastq.gz', 'md5': '6024a89aeda6100fb3ced56e0a20c9cd', 'size': '768078165'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/067/SRR17818867/SRR17818867_2.fastq.gz', 'md5': 'd9a2bce0c609a9cd7078b89538ba8ccd', 'size': '1408208588'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818868,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/068/SRR17818868/SRR17818868_1.fastq.gz', 'md5': 'b6ca010adc9ffd013a92b6b555f60743', 'size': '1039946183'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/068/SRR17818868/SRR17818868_2.fastq.gz', 'md5': 'fc64ba97f47a98734b4bf515f0de85eb', 'size': '1437475418'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818869,,,,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/069/SRR17818869/SRR17818869_1.fastq.gz', 'md5': '3a22ada4f302d77f772e7a65b96e41f6', 'size': '800417173'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/069/SRR17818869/SRR17818869_2.fastq.gz', 'md5': '3f19cd29cddf0caee6f49add4b562a21', 'size': '1489787119'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818870,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/070/SRR17818870/SRR17818870_1.fastq.gz', 'md5': '1f34f22ff8252bb23b414092047db65d', 'size': '1045492188'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/070/SRR17818870/SRR17818870_2.fastq.gz', 'md5': 'a81bc718bcf80e6c3534c688baaffe13', 'size': '1473585013'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818871,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/071/SRR17818871/SRR17818871_1.fastq.gz', 'md5': '4980a66e1e32a80bd72a6374d6c18c15', 'size': '1043336720'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/071/SRR17818871/SRR17818871_2.fastq.gz', 'md5': '03b6b1b056e32c6c23d4695e78d0daa8', 'size': '1482218658'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818872,,,,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/072/SRR17818872/SRR17818872_1.fastq.gz', 'md5': 'ecee14e99bcb0c4c76b6952d72b18a07', 'size': '741582761'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/072/SRR17818872/SRR17818872_2.fastq.gz', 'md5': '6809b6f0dc97f1261643ae074e740405', 'size': '1430862706'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818873,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/073/SRR17818873/SRR17818873_1.fastq.gz', 'md5': '6f939e0625f57a0700219bf679a0bc98', 'size': '1048015601'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/073/SRR17818873/SRR17818873_2.fastq.gz', 'md5': 'f9cc6bfc39c635be2a84cb1e04df1825', 'size': '1459590559'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818874,,,,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/074/SRR17818874/SRR17818874_1.fastq.gz', 'md5': '95f8b525ae1e6a68f24134233c9be851', 'size': '1045959334'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/074/SRR17818874/SRR17818874_2.fastq.gz', 'md5': 'a7dc5afdb6a09fcd58c212f27f21577d', 'size': '1470477612'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818875,,,,NextSeq 500 sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980723,NextSeq 500 paired end sequencing; GSM5848690: MAST95 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818046,MAST95 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/075/SRR17818875/SRR17818875_1.fastq.gz', 'md5': '4bbc3abde8a10825a49262b36367a857', 'size': '652526349'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/075/SRR17818875/SRR17818875_2.fastq.gz', 'md5': '4ce030c0705726c88a4c8672cbe8c72f', 'size': '1272279109'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818876,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/076/SRR17818876/SRR17818876_1.fastq.gz', 'md5': 'e7ed2a420c214ab60e9cddda25e0258a', 'size': '1140281102'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/076/SRR17818876/SRR17818876_2.fastq.gz', 'md5': 'f9f3a5cecf9a5a494b108137139cf249', 'size': '1365548809'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818877,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/077/SRR17818877/SRR17818877_1.fastq.gz', 'md5': 'e2853c63314e9341a951a0187ccf1127', 'size': '1147668386'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/077/SRR17818877/SRR17818877_2.fastq.gz', 'md5': 'fbafe58fd84f2e72d20990e79044e4d9', 'size': '1394640229'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818878,,,,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/078/SRR17818878/SRR17818878_1.fastq.gz', 'md5': '11b2d8c4d6f97cda8b1115877c56c17d', 'size': '1061557422'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/078/SRR17818878/SRR17818878_2.fastq.gz', 'md5': '2d1a41c323728a7db40236be8b10e435', 'size': '1475102218'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818879,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/079/SRR17818879/SRR17818879_1.fastq.gz', 'md5': '5d7338102a5f5ffc58a4295ec1076112', 'size': '180107559'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/079/SRR17818879/SRR17818879_2.fastq.gz', 'md5': '382a17d7e869e2ac10a5b89bd8a13b8c', 'size': '299590094'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818880,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/080/SRR17818880/SRR17818880_1.fastq.gz', 'md5': 'd2dcd94b61c0513516e468e1717f7ca0', 'size': '1147507906'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/080/SRR17818880/SRR17818880_2.fastq.gz', 'md5': '79adc0502405c96d040e1f02ef7d1136', 'size': '1394963068'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818881,,,,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/081/SRR17818881/SRR17818881_1.fastq.gz', 'md5': 'e7c7e5748b92f943d335c8d853abb6ec', 'size': '1148956758'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/081/SRR17818881/SRR17818881_2.fastq.gz', 'md5': '97881d0b2b35949fc5664b54ade189f7', 'size': '1400773926'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818882,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/082/SRR17818882/SRR17818882_1.fastq.gz', 'md5': 'd1a500cf4364850f1fda425a142f7621', 'size': '1063381216'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/082/SRR17818882/SRR17818882_2.fastq.gz', 'md5': 'b1ed971965e79f6efcd686769df6a505', 'size': '1499859708'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818883,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/083/SRR17818883/SRR17818883_1.fastq.gz', 'md5': 'c1b4a1e64f759c9ba51abb68cec86c28', 'size': '152523800'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/083/SRR17818883/SRR17818883_2.fastq.gz', 'md5': 'e41481b1bcce02c333a7fbd7cd09d49a', 'size': '254192819'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818884,,,,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/084/SRR17818884/SRR17818884_1.fastq.gz', 'md5': '068da6ab3a1bf2744318877e3d45cd67', 'size': '1141721338'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/084/SRR17818884/SRR17818884_2.fastq.gz', 'md5': '72bf3b783976b00e708e6c017d8bb4ea', 'size': '1371739210'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818885,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/085/SRR17818885/SRR17818885_1.fastq.gz', 'md5': '04bf8701cd6d016d259cf55815a5e43f', 'size': '1056458320'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/085/SRR17818885/SRR17818885_2.fastq.gz', 'md5': '4c1cf025e1704ef5291438e2d6921f0c', 'size': '1441258710'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818886,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/086/SRR17818886/SRR17818886_1.fastq.gz', 'md5': '116b113bd7ff6e6d853bf56ed75984a4', 'size': '195609107'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/086/SRR17818886/SRR17818886_2.fastq.gz', 'md5': 'c16596ceb6e507ec8cf88e9cf0f99611', 'size': '323419880'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818887,,,,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/087/SRR17818887/SRR17818887_1.fastq.gz', 'md5': '496a60f1fbefd0249a536e7bac2a6e34', 'size': '1142918124'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/087/SRR17818887/SRR17818887_2.fastq.gz', 'md5': '4481a3d2f6b733c28a864265e21aec3d', 'size': '1386436484'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818888,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/088/SRR17818888/SRR17818888_1.fastq.gz', 'md5': 'af8657d1f8608e755ea84104f5182348', 'size': '1144161782'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/088/SRR17818888/SRR17818888_2.fastq.gz', 'md5': '4d5f9cd3526b5fc2761b5fe3a4d153e7', 'size': '1392054835'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818889,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/089/SRR17818889/SRR17818889_1.fastq.gz', 'md5': '221d5fa78ffee07c6a3f5370481fee3b', 'size': '1057384378'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/089/SRR17818889/SRR17818889_2.fastq.gz', 'md5': '58332cfd2895d48229062500b1e5c009', 'size': '1486519240'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818890,,,,NextSeq 500 sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/090/SRR17818890/SRR17818890_1.fastq.gz', 'md5': '27c6361b0e50f4c6dc735bc143d49131', 'size': '165816086'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/090/SRR17818890/SRR17818890_2.fastq.gz', 'md5': '4645deb7babb9cd0eff32550f1e35db3', 'size': '277111239'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818891,,,,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980722,NextSeq 500 paired end sequencing; GSM5848689: MAST85-r2-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818045,MAST85-r2-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/091/SRR17818891/SRR17818891_1.fastq.gz', 'md5': 'a7fb45599e98a26d7ee94141a00badae', 'size': '1145925727'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/091/SRR17818891/SRR17818891_2.fastq.gz', 'md5': '8e9e857c7e4013c648b5afb9459a6f9b', 'size': '1387669981'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818892,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/092/SRR17818892/SRR17818892_1.fastq.gz', 'md5': '9492d33346415700193604ea1716e058', 'size': '1097294647'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/092/SRR17818892/SRR17818892_2.fastq.gz', 'md5': '2880427bb0d2266201292552de70770c', 'size': '1255751822'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818893,,,,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/093/SRR17818893/SRR17818893_1.fastq.gz', 'md5': 'f8b7e9a9037d3f74c797f90c5d2603d4', 'size': '1107583455'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/093/SRR17818893/SRR17818893_2.fastq.gz', 'md5': '43314d4be2422acf19cb511eaf1ba983', 'size': '1286499493'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818894,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/094/SRR17818894/SRR17818894_1.fastq.gz', 'md5': 'aaf3c8ccbd10cd953e411e72db404e83', 'size': '1050213863'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/094/SRR17818894/SRR17818894_2.fastq.gz', 'md5': 'ab6f1a4e20d924275116122623091b48', 'size': '1341593546'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818895,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/095/SRR17818895/SRR17818895_1.fastq.gz', 'md5': '56425a943400af7f0989484daa658344', 'size': '154651162'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/095/SRR17818895/SRR17818895_2.fastq.gz', 'md5': '03c22912f6db48a657b4843fe0c92a42', 'size': '258759095'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818896,,,,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/096/SRR17818896/SRR17818896_1.fastq.gz', 'md5': 'a8a5322162dd79dee1ce1d356aee2f9b', 'size': '1040744850'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/096/SRR17818896/SRR17818896_2.fastq.gz', 'md5': '9c5e92795e34aba07ba6fd0c5ccc6fe2', 'size': '1307682149'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818897,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/097/SRR17818897/SRR17818897_1.fastq.gz', 'md5': 'ef19649458423ed9b4ee7cf59ea4ea05', 'size': '155058503'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/097/SRR17818897/SRR17818897_2.fastq.gz', 'md5': '2563bf21eca01e170a1fbdc392368cd7', 'size': '257545865'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818898,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/098/SRR17818898/SRR17818898_1.fastq.gz', 'md5': '80d4eb9a57f9b2fcf11369591724f14c', 'size': '1097488508'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/098/SRR17818898/SRR17818898_2.fastq.gz', 'md5': '4e8df43f7cc315d1f705a932aa6e57d6', 'size': '1275963595'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818899,,,,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/099/SRR17818899/SRR17818899_1.fastq.gz', 'md5': '7697b943065a30232d07fe7f9672ccf4', 'size': '1039896383'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/099/SRR17818899/SRR17818899_2.fastq.gz', 'md5': '93ec583750dde510b34be1c1a10aab32', 'size': '1330896526'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818900,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/000/SRR17818900/SRR17818900_1.fastq.gz', 'md5': '9f0502a7f940b6507fb4efdf96e50d68', 'size': '160452217'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/000/SRR17818900/SRR17818900_2.fastq.gz', 'md5': '06038f670fe53070b5e3a4fcd1e6848d', 'size': '270268529'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818901,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/001/SRR17818901/SRR17818901_1.fastq.gz', 'md5': 'c13b17ad96afccbb50ed864107e04bf0', 'size': '1106358802'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/001/SRR17818901/SRR17818901_2.fastq.gz', 'md5': 'bece7576a0dc7d696bee7265caae2c40', 'size': '1277820179'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818902,,,,NextSeq 500 sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/002/SRR17818902/SRR17818902_1.fastq.gz', 'md5': '01719000efc5153ff83eb577f23ca857', 'size': '1049472689'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/002/SRR17818902/SRR17818902_2.fastq.gz', 'md5': 'b24d024cddd2326d54bc1f936b368f98', 'size': '1340443737'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818903,,,,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980721,NextSeq 500 paired end sequencing; GSM5848688: MAST85-r2 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818044,MAST85-r2 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/003/SRR17818903/SRR17818903_1.fastq.gz', 'md5': 'f96aac86006237d287e75336be1c8ba7', 'size': '131872702'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/003/SRR17818903/SRR17818903_2.fastq.gz', 'md5': '31a4b70a10e38699510bd5bfab897c09', 'size': '219744114'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818904,,,,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/004/SRR17818904/SRR17818904.fastq.gz', 'md5': '8516b1b08c61b99a0362526de4bda8b1', 'size': '3242428293'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818905,,,,NextSeq 500 sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/005/SRR17818905/SRR17818905.fastq.gz', 'md5': '6c70d0cb367ee83db715bcd5c5f28276', 'size': '3249187050'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818906,,,,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/006/SRR17818906/SRR17818906.fastq.gz', 'md5': 'e491d1dfa6ba3622097423abd236c107', 'size': '3200218491'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818907,,,,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980720,NextSeq 500 paired end sequencing; GSM5848687: MAST85-r1 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818043,MAST85-r1 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/007/SRR17818907/SRR17818907.fastq.gz', 'md5': '8978f0b39d0708984ebadd23ef62f372', 'size': '3220543408'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818908,,,,NextSeq 500 sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/008/SRR17818908/SRR17818908.fastq.gz', 'md5': '4d9609498b0f3f84d9643c3bfb19ada5', 'size': '5549303802'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818909,,,,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/009/SRR17818909/SRR17818909.fastq.gz', 'md5': '964a3323b1bc44cf9dfc2c13c052a32c', 'size': '5616829106'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818910,,,,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/010/SRR17818910/SRR17818910.fastq.gz', 'md5': '28276c04cb9aba0cdf8e5a2a3dd249c6', 'size': '5611019004'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818911,,,,NextSeq 500 sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980719,NextSeq 500 paired end sequencing; GSM5848685: MAST139-SC PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818042,MAST139-SC PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/011/SRR17818911/SRR17818911.fastq.gz', 'md5': '4a3865573ab25647284d54be8d0491e7', 'size': '5685413352'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818912,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/012/SRR17818912/SRR17818912_1.fastq.gz', 'md5': '2954e1a663e5059b2748642c013686f8', 'size': '1146378392'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/012/SRR17818912/SRR17818912_2.fastq.gz', 'md5': '80047033df33ca9c7777ee1cbd10fd1d', 'size': '1641821516'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818913,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/013/SRR17818913/SRR17818913_1.fastq.gz', 'md5': '5338160248105b8742df5265f5078e14', 'size': '1152026112'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/013/SRR17818913/SRR17818913_2.fastq.gz', 'md5': '9f478db48aacbc099556c2398b377fd5', 'size': '1689981968'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818914,,,,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/014/SRR17818914/SRR17818914_1.fastq.gz', 'md5': 'd32ffad176a6092a629f847570a83dbd', 'size': '841952946'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/014/SRR17818914/SRR17818914_2.fastq.gz', 'md5': '4db6414fbf7b7d441e07fe326282ae47', 'size': '1851014823'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818915,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/015/SRR17818915/SRR17818915_1.fastq.gz', 'md5': '630fddfa811ea9c40e7574ca84ac80d5', 'size': '1158624706'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/015/SRR17818915/SRR17818915_2.fastq.gz', 'md5': 'ec1183602792ed2ca968363dbeeb0b3f', 'size': '1668062923'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818916,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/016/SRR17818916/SRR17818916_1.fastq.gz', 'md5': 'e615fc263ad9d9e46866b02b4345d2d8', 'size': '1145123320'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/016/SRR17818916/SRR17818916_2.fastq.gz', 'md5': '504e2a2be96f88774e5b13f7348e2598', 'size': '1647757155'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818917,,,,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/017/SRR17818917/SRR17818917_1.fastq.gz', 'md5': 'dc452f63e1b94797c0048a3af7c03c44', 'size': '990726504'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/017/SRR17818917/SRR17818917_2.fastq.gz', 'md5': '8219a6799879917c2f30fe649e88bba0', 'size': '1978019787'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818918,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/018/SRR17818918/SRR17818918_1.fastq.gz', 'md5': '97a0f9ca2e602a6794694615c60f6264', 'size': '164888085'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/018/SRR17818918/SRR17818918_2.fastq.gz', 'md5': '974348485ad76bf70ac82847b27cac90', 'size': '323280281'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818919,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/019/SRR17818919/SRR17818919_1.fastq.gz', 'md5': 'df1f38499c832ec9471187be5512ce16', 'size': '1149322556'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/019/SRR17818919/SRR17818919_2.fastq.gz', 'md5': '98fe4a3c0ec589ec4f84b2e62e969603', 'size': '1634606559'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818920,,,,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/020/SRR17818920/SRR17818920_1.fastq.gz', 'md5': '7fa009abae7ec44d30655721c776b828', 'size': '1147871524'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/020/SRR17818920/SRR17818920_2.fastq.gz', 'md5': '50fc9500117face3b381c2f099ba71c4', 'size': '1640482425'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818921,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/021/SRR17818921/SRR17818921_1.fastq.gz', 'md5': '3206a2d150a51049fec673abd1ee1aee', 'size': '1001203533'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/021/SRR17818921/SRR17818921_2.fastq.gz', 'md5': 'c8c0a44e5349d45ea575fd3f994e6529', 'size': '1934623256'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818922,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/022/SRR17818922/SRR17818922_1.fastq.gz', 'md5': '385993497b34701d6f03be0e936a80d7', 'size': '187857805'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/022/SRR17818922/SRR17818922_2.fastq.gz', 'md5': 'b219d6fb887c85092e49551af0b1b5bb', 'size': '361200105'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818923,,,,NextSeq 500 sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/023/SRR17818923/SRR17818923_1.fastq.gz', 'md5': '3b54946e50fd5df16ff7848ba0f6e635', 'size': '1155735055'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/023/SRR17818923/SRR17818923_2.fastq.gz', 'md5': 'aca9fd557254ea2c33612503cd2c8a39', 'size': '1684832189'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818936,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/036/SRR17818936/SRR17818936_1.fastq.gz', 'md5': '6f16b7b934b3bdc96266c823664f08bc', 'size': '1155184640'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/036/SRR17818936/SRR17818936_2.fastq.gz', 'md5': '44d8b6842b814238d9777e6efa6eadb9', 'size': '1670557227'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818937,,,,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980718,NextSeq 500 paired end sequencing; GSM5848686: MAST39 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818041,MAST39 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/037/SRR17818937/SRR17818937_1.fastq.gz', 'md5': '141930a9c3b8d42c43dd3defc063f136', 'size': '903403599'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/037/SRR17818937/SRR17818937_2.fastq.gz', 'md5': 'a6b209d8192733949c034c9611ae1297', 'size': '1870133755'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818924,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/024/SRR17818924/SRR17818924_1.fastq.gz', 'md5': '5716d0657c4b8041b71be707cdf5327d', 'size': '1098431276'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/024/SRR17818924/SRR17818924_2.fastq.gz', 'md5': '43fb005c1491eb50f3c752c2aa38fd8a', 'size': '1264560816'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818925,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/025/SRR17818925/SRR17818925_1.fastq.gz', 'md5': '9218985552b09838d436e90b81ea6f2a', 'size': '1105647711'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/025/SRR17818925/SRR17818925_2.fastq.gz', 'md5': '0eedb41f1705648c47769cb74e6010be', 'size': '1258858502'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818926,,,,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/026/SRR17818926/SRR17818926_1.fastq.gz', 'md5': '5ebae3eda7f2b8be80a6e5fadadb9178', 'size': '1049089219'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/026/SRR17818926/SRR17818926_2.fastq.gz', 'md5': 'b9e20f1d8a95f2a85fb5587afaba5031', 'size': '1308154415'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818927,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/027/SRR17818927/SRR17818927_1.fastq.gz', 'md5': '69a0a87a54ea4b76ebf3d186eefe2436', 'size': '177554932'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/027/SRR17818927/SRR17818927_2.fastq.gz', 'md5': 'dbd9e5a5e1e317e481adcad8afde4748', 'size': '290220812'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818928,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/028/SRR17818928/SRR17818928_1.fastq.gz', 'md5': '694b592774c079e6c1cda5968495345c', 'size': '1041152614'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/028/SRR17818928/SRR17818928_2.fastq.gz', 'md5': '0c751a7504844614a45a6020799155e6', 'size': '1306383716'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818929,,,,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/029/SRR17818929/SRR17818929_1.fastq.gz', 'md5': '6c8edb87625ca51511bbc89ade7dd95d', 'size': '198163902'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/029/SRR17818929/SRR17818929_2.fastq.gz', 'md5': 'd32548144ba291759cd931b64481affe', 'size': '326477456'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818930,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/030/SRR17818930/SRR17818930_1.fastq.gz', 'md5': 'c443f9a3ec6ef8f0d745d6e2bf21ae22', 'size': '1097908613'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/030/SRR17818930/SRR17818930_2.fastq.gz', 'md5': '4e4ea5dd58c3aeb83ff92b560e7cc8bb', 'size': '1259411940'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818931,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/031/SRR17818931/SRR17818931_1.fastq.gz', 'md5': 'b22c3fba0db0a2a1a5151e3626a2f097', 'size': '1053085498'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/031/SRR17818931/SRR17818931_2.fastq.gz', 'md5': 'b3e5a3c0c6e656194e3e8d8ecbb73084', 'size': '1292373878'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818932,,,,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/032/SRR17818932/SRR17818932_1.fastq.gz', 'md5': 'db3bfbf6f4a3afd0c4f8286306b13728', 'size': '216150345'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/032/SRR17818932/SRR17818932_2.fastq.gz', 'md5': '0d1067cf02448f3857109423250b5f36', 'size': '376930864'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818933,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/033/SRR17818933/SRR17818933_1.fastq.gz', 'md5': '76637f7591d8efd4c3c9db4149c90ea4', 'size': '1104924228'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/033/SRR17818933/SRR17818933_2.fastq.gz', 'md5': '84bf11e7f21e289f99533cd6ec2e2f0a', 'size': '1254322812'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818934,,,,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/034/SRR17818934/SRR17818934_1.fastq.gz', 'md5': 'b29dff9a2d332011e77def7e11cb3d59', 'size': '1049033097'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/034/SRR17818934/SRR17818934_2.fastq.gz', 'md5': '92470c7297c3dcd2259075104d1f28e5', 'size': '1305372743'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818935,,,,NextSeq 500 sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980717,NextSeq 500 paired end sequencing; GSM5848684: MAST139 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818040,MAST139 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/035/SRR17818935/SRR17818935_1.fastq.gz', 'md5': '1da3813f1c92c6054efe7e871d2d48ea', 'size': '169697630'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/035/SRR17818935/SRR17818935_2.fastq.gz', 'md5': '72f9a08d3dd6163742ab4d001214e89b', 'size': '276473511'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818938,,,,NextSeq 500 sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/038/SRR17818938/SRR17818938.fastq.gz', 'md5': '47307ed74d2ab8951f9b52cce5778e17', 'size': '5974378796'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818939,,,,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/039/SRR17818939/SRR17818939.fastq.gz', 'md5': '33b54bc3b549c04c798de2bec21ed3f1', 'size': '6083016323'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818940,,,,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/040/SRR17818940/SRR17818940.fastq.gz', 'md5': '511ad7c5852558be2f8e01ed6922492b', 'size': '6045090995'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818941,,,,NextSeq 500 sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980716,NextSeq 500 paired end sequencing; GSM5848683: MAST118 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818039,MAST118 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/041/SRR17818941/SRR17818941.fastq.gz', 'md5': 'a19e08713e7eeaad3749c3d43c94e8fc', 'size': '6160774510'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818946,,,,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818946/SRR17818946_1.fastq.gz', 'md5': '58c3121256eaee1894ba73bd22bd9579', 'size': '1055939202'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/046/SRR17818946/SRR17818946_2.fastq.gz', 'md5': '88401ceb7fa7be3d58b4f9943108c8ac', 'size': '1222493390'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818947,,,,NextSeq 500 sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818947/SRR17818947_1.fastq.gz', 'md5': '26c5725d6a98c362dbe69ee650727289', 'size': '1057744499'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/047/SRR17818947/SRR17818947_2.fastq.gz', 'md5': '0fd00a753a9d53e14d56bb8304d34cfb', 'size': '1229995412'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818948,,,,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818948/SRR17818948_1.fastq.gz', 'md5': '01e422002239238ae1c3f2b98bb3436e', 'size': '1063177482'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/048/SRR17818948/SRR17818948_2.fastq.gz', 'md5': '141cc967cb56671327870f57a335e54f', 'size': '1227402530'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818949,,,,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818949/SRR17818949_1.fastq.gz', 'md5': '19726e9744a4d04a1ddf725a96ba3093', 'size': '1065406237'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/049/SRR17818949/SRR17818949_2.fastq.gz', 'md5': 'c7d9ceddc16e2737d5aff8496d4cf0cf', 'size': '1240879047'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818950,,,,NextSeq 500 sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818950/SRR17818950_1.fastq.gz', 'md5': '1962645ca16ed37b458d0126ad7c4a4d', 'size': '843586235'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/050/SRR17818950/SRR17818950_2.fastq.gz', 'md5': 'a7244e26757edf8d4e247b98214a8220', 'size': '1107098843'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818951,,,,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818951/SRR17818951_1.fastq.gz', 'md5': '83dcd7fbbec5ee5e64ad09a1cfb277f7', 'size': '901510704'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/051/SRR17818951/SRR17818951_2.fastq.gz', 'md5': '52965fe3f7a19c41603e5dcf22783feb', 'size': '1193114539'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818952,,,,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818952/SRR17818952_1.fastq.gz', 'md5': '22cf62830a44c7265d67a13731953b5c', 'size': '824469894'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/052/SRR17818952/SRR17818952_2.fastq.gz', 'md5': 'd024e854c1643df337cda58376ede9d1', 'size': '1078794933'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR17818953,,,,NextSeq 500 sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,,,,,,,,,,SRX13980714,NextSeq 500 paired end sequencing; GSM5848682: MAST111 PDX sample; Homo sapiens; RNA-Seq,ILLUMINA,NextSeq 500,SRP357388,Stem cell and developmental hierarchies in rhabdomyosarcoma,"Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development.  We also identified common developmental stages at which tumor cells become arrested.  FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age.  FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease.  Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells. Overall design: Single cell RNA-seq profiling and lineage tracing of Rhabdomyosarcoma PDX, cell line and primary patient samples",SRS11818037,MAST111 PDX sample,Homo sapiens,Rhabdomyosarcoma,,,,,2022-02-06,2022-02-06,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818953/SRR17818953_1.fastq.gz', 'md5': '1f675be396f7d6c411d465da5f1b89f1', 'size': '860181604'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR178/053/SRR17818953/SRR17818953_2.fastq.gz', 'md5': 'c9aff929633524bad686f5d2c5687050', 'size': '1137345303'}]",,,,,,mouse PDX sample,Wild type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12067712,,,,Illumina HiSeq 2500 paired end sequencing; GSM4631066: Zf_30h_trunk; Danio rerio; RNA-Seq,,,,,,,,,,SRX8595501,Illumina HiSeq 2500 paired end sequencing; GSM4631066: Zf_30h_trunk; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP268312,Single-cell transcriptomic analysis 30 hpf Zebrafish trunks,"Here we performed single-cell RNAseq analysis of whole wildtype zebrafish trunks at 30hpf using 10x Genomics' Chromium platform. 22 distinct cell populations were identified, spanning all three embryonic germ layers. Overall design: Whole trunks excised from 30 embryos at 30 hpf were dissociated using a cold protease dissociation protocol. Barcoding of cells and and cDNA library construction was carried out using 10X Genomics' Chromium platform.",SRS6886082,Zf_30h_trunk,Danio rerio,Zebrafish Trunks,,,340642289,50074416483,2020-06-24,2020-06-24,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR120/012/SRR12067712/SRR12067712.fastq.gz', 'md5': 'a2fdf94e40f6055e3b2f592ace0b682e', 'size': '19111432678'}]",trunk,,,,,,wildtype,30 hpf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12067711,,,,Illumina HiSeq 2500 paired end sequencing; GSM4631066: Zf_30h_trunk; Danio rerio; RNA-Seq,,,,,,,,,,SRX8595501,Illumina HiSeq 2500 paired end sequencing; GSM4631066: Zf_30h_trunk; Danio rerio; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP268312,Single-cell transcriptomic analysis 30 hpf Zebrafish trunks,"Here we performed single-cell RNAseq analysis of whole wildtype zebrafish trunks at 30hpf using 10x Genomics' Chromium platform. 22 distinct cell populations were identified, spanning all three embryonic germ layers. Overall design: Whole trunks excised from 30 embryos at 30 hpf were dissociated using a cold protease dissociation protocol. Barcoding of cells and and cDNA library construction was carried out using 10X Genomics' Chromium platform.",SRS6886082,Zf_30h_trunk,Danio rerio,Zebrafish Trunks,,,340642289,50074416483,2020-06-24,2020-06-24,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR120/011/SRR12067711/SRR12067711.fastq.gz', 'md5': '112bc0b6bd82400ec96567386b4b36d7', 'size': '18546657077'}]",trunk,,,,,,wildtype,30 hpf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16681977,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5664293: runx2b-/- scRNA-seq; Danio rerio; RNA-Seq,,,,,,,,,,SRX12882565,Illumina NovaSeq 6000 paired end sequencing; GSM5664293: runx2b-/- scRNA-seq; Danio rerio; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP344071,Single-cell transcriptomes and runx2b-/- mutants reveal the genetic signatures of intermuscular bone formation in teleosts,"Purpose: Intermuscular bones (IBs) are hard spicules, mainly existing in the myosepta of recent vertebrates. This evolutionary trait has puzzled biologists and consumers, and the molecular basis of IB development remains unclear. The goals of this study are to acquire characteristic single-cell maps of gene expression landscapes and lineages and to elucidate the differentiation trajectory of cell clusters related to IB formation and obtain the key regulated gene of IB formation. Methods: The scRNA-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish were generated, using the 10X Genomics Chromium system. The bulk RNA-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish were generated, using mirVana miRNA ISOlation Kit. The scRNA-seq data were filted and clsutered by the Seurat package. The cell differentiation trajectorie was constructed, using Monocle analysis. Runx2b knockdown was preformed by RNA interference and runx2b was inducted by neuropeptide substance P. qRTPCR validation was performed using SYBR Green assays. The mutant zebrafish lines were constructed, using cripsr cas9 technology.The Phenotypic observation was perfomed by Hematoxylin and Eosin (HE), Alizarin red, masson trichrome staining and mico-CT. The nutritent content was also obtained including fatty acid content and anio acid content. Results: we reveal that teleost fish IBs originate from tendons in the skeletal muscle and that the differentiation trajectory from tendon progenitors and defined runx2b as the key rugulated gene of IB formaiton, using cripsr cas9 technology. Conclusions: This study is the first to reveal that teleost fish IBs originate from tendons in the skeletal muscle and that the differentiation trajectory from tendon progenitors to the osteoblast lineage is key for IB formation. Large-scale gene function analysis using CRISPR-Cas9 identified the decisive role of runx2b in IB formation. The loss of runx2b significantly restricted osteoblast differentiation and inhibited IB formation, which potentially provides a basis for breeding strains of fish without IBs to improve the safe consumption and economic value of many aquaculture species and in this way, boost the proportion of fish for the supply of animal protein worldwide (Fig. 6). For this reason, we needed to verify that the content of fatty acid in the runx2b-/- mutant was higher than that in runx2b+/+ fish, as well as the expression of key genes related to IBs in the runx2b-/- and runx2b+/+ strains obtained by scRNA-seq data. This study also provides materials and directions for further study to clarify the specific regulatory mechanism of IB formation and will help to discover more specific genetic resources that can be used for IB trait improvement in fish. Overall design: the scRNA-seq and bulk-seq profiles of 60 dpf wild-type zebrafish and 60 dpf runx2b-/- zebrafish",SRS10825217,runx2b-/- scRNA-seq,Danio rerio,muscle and IB,,Tg (sp7/eGFP) transgenic line,,,2021-11-05,2021-11-05,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR166/077/SRR16681977/SRR16681977_1.fastq.gz', 'md5': '971f79e7906b782c1237691fc4744372', 'size': '29167046405'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR166/077/SRR16681977/SRR16681977_2.fastq.gz', 'md5': '54c4208eca691dad79e8c6dac16de9d3', 'size': '22005591801'}]",muscle and IB,,,,,,runx2b-/-,60 dpf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13733760,,,,"NextSeq 500 paired end sequencing; GSM5090142: Forelimb, E4; Gallus gallus; RNA-Seq",,,,,,,,,,SRX10121386,"NextSeq 500 paired end sequencing; GSM5090142: Forelimb, E4; Gallus gallus; RNA-Seq",ILLUMINA,NextSeq 500,SRP306879,Unexpected contribution of fibroblasts to the muscle lineage during foetal myogenesis and role of BMP signalling in this process,"Purpose : Positional information driving limb muscle patterning is considered to be contained in lateral plate mesoderm-derived tissues, such as tendon or muscle connective tissue and not in myogenic cells themselves. The current consensus is that myogenic cells originate from somites, while connective tissue fibroblasts originate from the lateral plate mesoderm. We challenged this model by cell and genetic lineage tracing experiments and identified that a subpopulation of limb myogenic cells did not originate from somite or Pax3 lineage, but rather originated from the lateral plate mesoderm and were derived from Osr1 and Scx lineages. Results: Analysis of single-cell RNA-sequencing data obtained from limb cells at successive developmental stages identified a subpopulation of cells displaying a dual muscle and connective tissue signature, in addition to independent muscle and connective tissue populations. Active BMP signalling was detected in this junctional cell sub-population and at the tendon/muscle interface in developing limbs. BMP gain- and loss-of-function experiments performed in vivo and in vitro showed that this signalling pathway regulated a fibroblast-to-myoblast conversion. Conclusions: We propose that localised BMP signalling converts a subset of lateral plate mesoderm-derived fibroblasts to a myogenic fate and establishes a boundary of fibroblast-derived myonuclei at the tendon/muscle interface to control the muscle pattern during limb development and myotendinous formation. Overall design: Single cell mRNA profiles of whole forelimbs in wild type chicken embryos at three developmental stages (E4, E6 and E10)",SRS8276066,"GEO accession GSM5090142 is currently private and is scheduled to be released on Feb 17, 2022.",Gallus gallus,,,,137528893,16916053839,2021-05-07,2021-05-07,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/060/SRR13733760/SRR13733760_1.fastq.gz', 'md5': '337cc125d9154f18bc97980cc9da1309', 'size': '2758224107'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/060/SRR13733760/SRR13733760_2.fastq.gz', 'md5': 'b16a0c23f1c3616857a2ca567941b8e0', 'size': '8782360543'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13733761,,,,"NextSeq 500 paired end sequencing; GSM5090143: Forelimb, E6; Gallus gallus; RNA-Seq",,,,,,,,,,SRX10121387,"NextSeq 500 paired end sequencing; GSM5090143: Forelimb, E6; Gallus gallus; RNA-Seq",ILLUMINA,NextSeq 500,SRP306879,Unexpected contribution of fibroblasts to the muscle lineage during foetal myogenesis and role of BMP signalling in this process,"Purpose : Positional information driving limb muscle patterning is considered to be contained in lateral plate mesoderm-derived tissues, such as tendon or muscle connective tissue and not in myogenic cells themselves. The current consensus is that myogenic cells originate from somites, while connective tissue fibroblasts originate from the lateral plate mesoderm. We challenged this model by cell and genetic lineage tracing experiments and identified that a subpopulation of limb myogenic cells did not originate from somite or Pax3 lineage, but rather originated from the lateral plate mesoderm and were derived from Osr1 and Scx lineages. Results: Analysis of single-cell RNA-sequencing data obtained from limb cells at successive developmental stages identified a subpopulation of cells displaying a dual muscle and connective tissue signature, in addition to independent muscle and connective tissue populations. Active BMP signalling was detected in this junctional cell sub-population and at the tendon/muscle interface in developing limbs. BMP gain- and loss-of-function experiments performed in vivo and in vitro showed that this signalling pathway regulated a fibroblast-to-myoblast conversion. Conclusions: We propose that localised BMP signalling converts a subset of lateral plate mesoderm-derived fibroblasts to a myogenic fate and establishes a boundary of fibroblast-derived myonuclei at the tendon/muscle interface to control the muscle pattern during limb development and myotendinous formation. Overall design: Single cell mRNA profiles of whole forelimbs in wild type chicken embryos at three developmental stages (E4, E6 and E10)",SRS8276068,"Forelimb, E6",Gallus gallus,Limb,,,189263721,23279437683,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/061/SRR13733761/SRR13733761_1.fastq.gz', 'md5': '56de001326d1e0437ed3eb498d122317', 'size': '3818631232'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/061/SRR13733761/SRR13733761_2.fastq.gz', 'md5': 'd978dd9fc5794a730114969e484e02ef', 'size': '12122403275'}]",Forelimb,,,,,,,Embryonic day 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR13733762,,,,"NextSeq 500 paired end sequencing; GSM5090144: Forelimb, E10; Gallus gallus; RNA-Seq",,,,,,,,,,SRX10121388,"NextSeq 500 paired end sequencing; GSM5090144: Forelimb, E10; Gallus gallus; RNA-Seq",ILLUMINA,NextSeq 500,SRP306879,Unexpected contribution of fibroblasts to the muscle lineage during foetal myogenesis and role of BMP signalling in this process,"Purpose : Positional information driving limb muscle patterning is considered to be contained in lateral plate mesoderm-derived tissues, such as tendon or muscle connective tissue and not in myogenic cells themselves. The current consensus is that myogenic cells originate from somites, while connective tissue fibroblasts originate from the lateral plate mesoderm. We challenged this model by cell and genetic lineage tracing experiments and identified that a subpopulation of limb myogenic cells did not originate from somite or Pax3 lineage, but rather originated from the lateral plate mesoderm and were derived from Osr1 and Scx lineages. Results: Analysis of single-cell RNA-sequencing data obtained from limb cells at successive developmental stages identified a subpopulation of cells displaying a dual muscle and connective tissue signature, in addition to independent muscle and connective tissue populations. Active BMP signalling was detected in this junctional cell sub-population and at the tendon/muscle interface in developing limbs. BMP gain- and loss-of-function experiments performed in vivo and in vitro showed that this signalling pathway regulated a fibroblast-to-myoblast conversion. Conclusions: We propose that localised BMP signalling converts a subset of lateral plate mesoderm-derived fibroblasts to a myogenic fate and establishes a boundary of fibroblast-derived myonuclei at the tendon/muscle interface to control the muscle pattern during limb development and myotendinous formation. Overall design: Single cell mRNA profiles of whole forelimbs in wild type chicken embryos at three developmental stages (E4, E6 and E10)",SRS8276069,"Forelimb, E10",Gallus gallus,Limb,,,232544416,28602963168,2021-05-07,2021-05-08,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/062/SRR13733762/SRR13733762_1.fastq.gz', 'md5': '791b69c1738de91b357d5227dffc6839', 'size': '4701862144'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR137/062/SRR13733762/SRR13733762_2.fastq.gz', 'md5': 'a066df987866d1aa229381f1db12feac', 'size': '14750723416'}]",Forelimb,,,,,,,Embryonic day 10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16774171,,,,DNBSEQ-G400 paired end sequencing; GSM5672476: 2D expanded cells; Homo sapiens; RNA-Seq,,,,,,,,,,SRX12973435,DNBSEQ-G400 paired end sequencing; GSM5672476: 2D expanded cells; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914287,2D expanded cells,Homo sapiens,2D expanded CD56+ myogenic cells,,,,,2021-11-12,2021-11-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/071/SRR16774171/SRR16774171_1.fastq.gz', 'md5': 'ab658166a7f946ac03bf90c4415dafa7', 'size': '20240679790'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/071/SRR16774171/SRR16774171_2.fastq.gz', 'md5': '43eddfa343c7a8b532ec33217efeeb36', 'size': '42647741299'}]",,,,,,Primary CD56+ human myoblasts expanded for 5 passages with p38 inhibitor (SB203580),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16774172,,,,DNBSEQ-G400 paired end sequencing; GSM5672477: 3-day differentiated myobundles; Homo sapiens; RNA-Seq,,,,,,,,,,SRX12973436,DNBSEQ-G400 paired end sequencing; GSM5672477: 3-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914288,3-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,,,,2021-11-12,2021-11-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/072/SRR16774172/SRR16774172_1.fastq.gz', 'md5': '04d87086579568df82220f8e78fe1af4', 'size': '12819609108'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/072/SRR16774172/SRR16774172_2.fastq.gz', 'md5': '4336b96619d17121fca65ca8c92b344b', 'size': '20539958695'}]",,,,,,Cells dissociated from myobundles (4 days growth media followed by 3 days differentiation media),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16774173,,,,DNBSEQ-G400 paired end sequencing; GSM5672478: 9-day differentiated myobundles; Homo sapiens; RNA-Seq,,,,,,,,,,SRX12973437,DNBSEQ-G400 paired end sequencing; GSM5672478: 9-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914289,9-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,,,,2021-11-12,2021-11-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/073/SRR16774173/SRR16774173_1.fastq.gz', 'md5': '37869ee19ffee5c687fb7571f7527d66', 'size': '13378566042'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/073/SRR16774173/SRR16774173_2.fastq.gz', 'md5': 'e0d5c005fade9d9c8591b08684489252', 'size': '26468480837'}]",,,,,,Cells dissociated from myobundles (4 days growth media followed by 9 days differentiation media),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16774174,,,,DNBSEQ-G400 paired end sequencing; GSM5672479: 2 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,,,,,,,,,,SRX12973438,DNBSEQ-G400 paired end sequencing; GSM5672479: 2 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914290,2 days post injury of 7-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,,,,2021-11-12,2021-11-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/074/SRR16774174/SRR16774174_1.fastq.gz', 'md5': '89b96fd807aed86645dc2d11af8196ce', 'size': '11905358660'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/074/SRR16774174/SRR16774174_2.fastq.gz', 'md5': 'd97de4247309b78f3a60e2b78b4c72cd', 'size': '16613301777'}]",,,,,,"Cells dissociated from myobundles (4 days growth media, melittin-injured on day 7 of differentiation, samples isolated at 2 days post-injury). This sample is age-matched with d9.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR16774175,,,,DNBSEQ-G400 paired end sequencing; GSM5672480: 5 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,,,,,,,,,,SRX12973439,DNBSEQ-G400 paired end sequencing; GSM5672480: 5 days post injury of 7-day differentiated myobundles; Homo sapiens; RNA-Seq,DNBSEQ,DNBSEQ-G400,SRP344609,Three-dimensional tissue-engineered human skeletal muscle model of satellite cell quiescence,"In vivo, satellite cells (SCs) are essential for skeletal muscle repair. However, in vitro investigation of SC function is challenged by isolation-induced SC activation, loss of the native quiescent state, and differentiation to myoblasts. This study applies  tissue-engineered human skeletal muscle to track myoblast deactivation to 3D-SCs, which bear a quiescent phenotype, as well as examine melittin-induced injury response. Overall design: CD56+ sorted cells from human muscle were expanded for 5 passages (2D) and used to generate 3D engineered muscle (myobundles). After 4 days of 3D growth conditions, myobundles were differentiated for 3 days (d3), 9 days (d9), or melittin-injured at d7 and sampled 2 days post injury (i2) and 5 days post injury (i5). In the myobundle samples (d3,d9,i2,i5),  cells were dissociated from the myobundles before being subjected to single cell RNA-sequencing (scRNA-seq) using the 10x Genomics Chromium technology.",SRS10914291,5 days post injury of 7-day differentiated myobundles,Homo sapiens,dissociated 3D engineered tissue (myobundle),,,,,2021-11-12,2021-11-12,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/075/SRR16774175/SRR16774175_1.fastq.gz', 'md5': '8cbc6f3d681534e7c98a9e1253d3958a', 'size': '7127626025'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR167/075/SRR16774175/SRR16774175_2.fastq.gz', 'md5': '5bd5c5f3b9eaa1c31238e473c10ee0ec', 'size': '8760663748'}]",,,,,,"Cells dissociated from myobundles (4 days growth media, melittin-injured on day 7 of differentiation, samples isolated at 5 days post-injury)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12162989,,,,"NextSeq 500 paired end sequencing; GSM4658494: Human patients 1-3, hashed and pooled; Homo sapiens; RNA-Seq",,,,,,,,,,SRX8678480,"NextSeq 500 paired end sequencing; GSM4658494: Human patients 1-3, hashed and pooled; Homo sapiens; RNA-Seq",ILLUMINA,NextSeq 500,SRP270639,JUN promotes abdominal adhesions in mice and humans,"Adhesions are fibrotic scars that form between abdominal organs following surgery or infection, and may cause bowel obstruction, chronic pain, or infertility. Adhesions occur post-operatively in 50-90% of all open abdominal operations and as such, represent an enormous clinical problem impacting hundreds of millions of patients worldwide. Our understanding of the biology of adhesion formation is very limited, which explains why there are essentially no available treatments that prevent adhesions. In this study, we systemically analyzed abdominal adhesions in mouse and human tissues gene expression using bulk- and sc-RNA-seq technologies to characterize the fibroblasts responsible for this devastating pathology. Overall design: Mouse and human abdominal adhesion tissue transcriptomes were profiled using single cell RNA-sequencing. A total of 4 human samples and 2 pooled mouse samples were profiled.",SRS6957559,"Human patients 1-3, hashed and pooled",Homo sapiens,Human,,,,,2020-07-09,2020-07-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR121/SRR12162989/human_possorted_genome_bam.bam', 'md5': '61a1e5b16368aa195ab46f33f2d1f437', 'size': '14707198269'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,abdominal adhesion,,,,
SRR13268672,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/072/SRR13268672/SRR13268672_1.fastq.gz', 'md5': 'a21a676b839e29c51eafafd2f1f9ca19', 'size': '9269195879'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/072/SRR13268672/SRR13268672_2.fastq.gz', 'md5': 'd54b63bf4f576eaa5bc75dbcff927858', 'size': '8317206070'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268673,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/073/SRR13268673/SRR13268673_1.fastq.gz', 'md5': '15ff80bb6adc1b7f50cc51f692e218e2', 'size': '10724219181'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/073/SRR13268673/SRR13268673_2.fastq.gz', 'md5': 'd70474305d3d3b4c9dbeb7f20214312f', 'size': '9669556692'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268674,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/074/SRR13268674/SRR13268674_1.fastq.gz', 'md5': '489a2b8df86182a39151acf99656f104', 'size': '11086356893'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/074/SRR13268674/SRR13268674_2.fastq.gz', 'md5': 'c217b26ce6484a46e41ae60bc3c9ba5a', 'size': '9868311186'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268675,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698830,Illumina NovaSeq 6000 paired end sequencing; GSM4979413: BTS_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895117,BTS_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/075/SRR13268675/SRR13268675_1.fastq.gz', 'md5': '68e9af2ea06fd983dc9a5683b4f7cf6d', 'size': '8812254038'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/075/SRR13268675/SRR13268675_2.fastq.gz', 'md5': 'ab9db16ca564cec4000382c70ef0fc73', 'size': '7868222739'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268676,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/076/SRR13268676/SRR13268676_1.fastq.gz', 'md5': 'ce141707de38cf3968610a09ff6df059', 'size': '8723966178'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/076/SRR13268676/SRR13268676_2.fastq.gz', 'md5': '5873395049196a73f7882facc6093e3d', 'size': '7679486242'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268677,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/077/SRR13268677/SRR13268677_1.fastq.gz', 'md5': '96ba05cb2bd18a44119241c48c0c6552', 'size': '10797332478'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/077/SRR13268677/SRR13268677_2.fastq.gz', 'md5': 'a6c159a20347f9a423296325be9a4dfe', 'size': '9492385555'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268678,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/078/SRR13268678/SRR13268678_1.fastq.gz', 'md5': '9bfe9b06c48b1a7656cf72740a409011', 'size': '10111032065'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/078/SRR13268678/SRR13268678_2.fastq.gz', 'md5': '66ee6e10b521093afb464e29a7569a5f', 'size': '8991128350'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268679,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698831,Illumina NovaSeq 6000 paired end sequencing; GSM4979414: BTS_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895118,BTS_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/079/SRR13268679/SRR13268679_1.fastq.gz', 'md5': '32470ba435f4a115638001aaaddd325b', 'size': '8960864573'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/079/SRR13268679/SRR13268679_2.fastq.gz', 'md5': 'e8ba203349aa3c839690690b9d343217', 'size': '7886999110'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268680,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/080/SRR13268680/SRR13268680_1.fastq.gz', 'md5': 'fc0d7e84a9ac0d17c684ffde703af710', 'size': '8960435522'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/080/SRR13268680/SRR13268680_2.fastq.gz', 'md5': 'ac2dcd3668c272401bcbf86af0429165', 'size': '8047142349'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268681,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/081/SRR13268681/SRR13268681_1.fastq.gz', 'md5': '731c268066d8510e2c67efa64160c140', 'size': '10418903525'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/081/SRR13268681/SRR13268681_2.fastq.gz', 'md5': '12d6ce4a06eb0d9fc459c5029c4c4846', 'size': '9376729160'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268682,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/082/SRR13268682/SRR13268682_1.fastq.gz', 'md5': '80eed0810fd75f2652cfd9ec9595f732', 'size': '8269485424'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/082/SRR13268682/SRR13268682_2.fastq.gz', 'md5': '893a5eddd49ddede4a8eb2dded5fbfe9', 'size': '7407106093'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268683,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698832,Illumina NovaSeq 6000 paired end sequencing; GSM4979415: BTS_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895119,BTS_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with sham neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/083/SRR13268683/SRR13268683_1.fastq.gz', 'md5': '6353aafadd128ce390baad9048fd1438', 'size': '10650492999'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/083/SRR13268683/SRR13268683_2.fastq.gz', 'md5': '10099d1cb36ced23a1f808beac022ab2', 'size': '9454472500'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268685,,,,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698833,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895120,BTN_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/085/SRR13268685/SRR13268685_1.fastq.gz', 'md5': '693e1bff0ce4c6b98f1e849741fb1c3d', 'size': '9643195246'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/085/SRR13268685/SRR13268685_2.fastq.gz', 'md5': 'ee5150f4ea17cf567d00b1f7f6320b57', 'size': '8533529543'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268686,,,,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698833,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895120,BTN_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/086/SRR13268686/SRR13268686_1.fastq.gz', 'md5': '1f253b64a0c4441e32106b67d8878e7f', 'size': '12859261817'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/086/SRR13268686/SRR13268686_2.fastq.gz', 'md5': 'bc99c14797355adcb9443debce37abb9', 'size': '11560630542'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268687,,,,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698833,Illumina NovaSeq 6000 sequencing; GSM4979416: BTN_D7_1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895120,BTN_D7_1,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/087/SRR13268687/SRR13268687_1.fastq.gz', 'md5': 'b090769646f7a3d9718abc85a813f99f', 'size': '6895670921'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/087/SRR13268687/SRR13268687_2.fastq.gz', 'md5': '19c77db589425067565ae075dfcfe50c', 'size': '6120826112'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268688,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/088/SRR13268688/SRR13268688_1.fastq.gz', 'md5': 'c28ece9f40320ea776b14a795cff14aa', 'size': '9689936086'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/088/SRR13268688/SRR13268688_2.fastq.gz', 'md5': 'e2857e8789e4ace85d153d7bb29dd3a5', 'size': '8764648737'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268689,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/089/SRR13268689/SRR13268689_1.fastq.gz', 'md5': '7c48acb355badef8ccd7d9d57756a5fd', 'size': '9966196287'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/089/SRR13268689/SRR13268689_2.fastq.gz', 'md5': '651bee7272360e978d7e4dc79552216e', 'size': '8827326000'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268690,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/090/SRR13268690/SRR13268690_1.fastq.gz', 'md5': 'bb8906736a75d83e056ad81d63579121', 'size': '10707693136'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/090/SRR13268690/SRR13268690_2.fastq.gz', 'md5': '2ee7986d5bd0195651780676bc03f3a0', 'size': '9422966923'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268691,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698834,Illumina NovaSeq 6000 paired end sequencing; GSM4979417: BTN_D7_2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895121,BTN_D7_2,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/091/SRR13268691/SRR13268691_1.fastq.gz', 'md5': '09ac4ed0368b068f77379774c577c0b7', 'size': '8024786343'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/091/SRR13268691/SRR13268691_2.fastq.gz', 'md5': 'f7989487f4d093e683350b640d6fc369', 'size': '7095423738'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268692,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/092/SRR13268692/SRR13268692_1.fastq.gz', 'md5': '640e921722e085834096d8226498a863', 'size': '9065972139'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/092/SRR13268692/SRR13268692_2.fastq.gz', 'md5': 'cf4f043baa0fdcd06e01cd5da8f0124b', 'size': '8024800927'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268693,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/093/SRR13268693/SRR13268693_1.fastq.gz', 'md5': '58ecfdb2f170980ee676e1d3557bbc65', 'size': '10885732716'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/093/SRR13268693/SRR13268693_2.fastq.gz', 'md5': 'fb0cceacb09446d3019dc5e903665d2c', 'size': '9533097330'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268694,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/094/SRR13268694/SRR13268694_1.fastq.gz', 'md5': '07e91961faad6405739d81d17c1ee954', 'size': '9039052126'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/094/SRR13268694/SRR13268694_2.fastq.gz', 'md5': '2abbd5cc294a3eb3b14260e2d16062c2', 'size': '7910397241'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR13268695,,,,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,,,,,,,,,,SRX9698835,Illumina NovaSeq 6000 paired end sequencing; GSM4979418: BTN_D7_3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP298358,scRNA sequencing of cells harvested from the tendon injury site after a severe burn/tenotomy injury with and without sciatic neurectomy,"scRNA sequencing was performed on cells harvested from the injury site of mice that underwent a burn/tenotomy injury with sciatic neurectomy or sham neurectomy (skin incision) to study the role of nerves in the formation of heterotopic ossification and aberrant stem cell differentiation following traumatic injury. Overall design: C57B6 mice received pre-operative treatment with 0.06 mg/kg buprenorphine subcutaneously and were anesthetized with 2% isofluorane inhalation. A 10 mm longitudinal skin incision was made along the medial aspect of the left Achilles tendon. The Achilles tendon was separated from surrounding tissue and dissected at it's midsection. For the sciatic neurectomy, blunt dissection was performed through the biceps femoris to expose the sciatic nerve. The sciatic nerve was transected with reflection and suturing of the proximal nerve stump to the nearby semitendinosus muscle to prevent re-innervation.  As a control, sham nerve injuries consisted of surgical exposure of the sciatic nerve without transection. Incisions were sutured closed with 5-0 Vicryl suture. Tenotomy injury site, consisting of tissue from the Achilles' tendon insertion at the gastrocnemius to the distal tendon enthesis at the calcaneus and surrounding tissue, excluding bone and skin, was harvested 7 days after injury. Tissue samples were digested for 20 minutes in 750U/ml Type 1 Collagenase and 7U/ml Dispase II (Gibco) in Roswell Park Memorial Institute (RPMI) medium at 37C under constant agitation of 160rpm. Digestions were subsequently quenched with 2% FBS in PBS and filtered through 40m sterile strainers. Cells were then washed in 2% FBS in PBS, counted and resuspended at a concentration of 1000-1200 cells/ul. Cell viability was assessed with Trypan blue exclusion on a Countess II (Thermo Fisher Scientific) automated counter and only samples with >85% viability were used for scRNA sequencing. Enough reagent was taken to sequence the transcriptome of 5000 cells according to 10x guidelines. 100,000 remaining cells were used for nuclei isolation according to the 10X Nuclei Isolation for Single Cell ATAC Sequencing protocol (available on their website).",SRS7895122,BTN_D7_3,Mus musculus,Day 7 post Burn/Tenotomy with neurectomy injury site,,C57B6,,,2021-05-02,2021-05-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/095/SRR13268695/SRR13268695_1.fastq.gz', 'md5': '350111c70ae4a323728a2a14cc21656c', 'size': '8950010625'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/095/SRR13268695/SRR13268695_2.fastq.gz', 'md5': 'b134a0c81aee78d87dd9f8ae9ea1b27f', 'size': '7828048144'}]",tendon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tendon injury site,,,
SRR12507504,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743488: 1_iPS; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998538,Illumina HiSeq 2500 paired end sequencing; GSM4743488: 1_iPS; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251319,1_iPS,Homo sapiens,induced pluripotent stem cell,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/004/SRR12507504/SRR12507504.fastq.gz', 'md5': 'e1d61b64bf8d605e943364d49faccb0f', 'size': '20300987846'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Human iPS cell line, 1231A3",,
SRR12507505,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743489: 2_PSM; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998539,Illumina HiSeq 2500 paired end sequencing; GSM4743489: 2_PSM; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251320,2_PSM,Homo sapiens,presomitic mesoderm,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/005/SRR12507505/SRR12507505.fastq.gz', 'md5': '9126059e7f85742c8d7225e9e35a0c11', 'size': '19010223331'}]",,,,,,iPS-derived presomitic mesoderm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507506,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743490: 3_SM; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998540,Illumina HiSeq 2500 paired end sequencing; GSM4743490: 3_SM; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251321,3_SM,Homo sapiens,somitic mesoderm,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/006/SRR12507506/SRR12507506.fastq.gz', 'md5': '3fcb4bb72ded9710b402c717bcaffba4', 'size': '19437371422'}]",,,,,,iPS-derived somitic mesoderm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507507,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743491: 4_SCL; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998541,Illumina HiSeq 2500 paired end sequencing; GSM4743491: 4_SCL; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251322,4_SCL,Homo sapiens,sclerotome,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/007/SRR12507507/SRR12507507.fastq.gz', 'md5': 'a1e6199d9ba0287b48b9183dc408a11b', 'size': '21980806931'}]",,,,,,iPS-derived sclerotome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507508,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743492: 5_SYN_day2; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998542,Illumina HiSeq 2500 paired end sequencing; GSM4743492: 5_SYN_day2; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251323,5_SYN_day2,Homo sapiens,syndetome,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/008/SRR12507508/SRR12507508.fastq.gz', 'md5': '47e3574b69e9d8b567e8e0af2ac64260', 'size': '18487761933'}]",,,,,,iPS-derived syndetome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507509,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743493: 6_SYN_day4; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998543,Illumina HiSeq 2500 paired end sequencing; GSM4743493: 6_SYN_day4; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251324,6_SYN_day4,Homo sapiens,syndetome,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/009/SRR12507509/SRR12507509.fastq.gz', 'md5': '3771b0f41fb484e33a24d5ee15ddb297', 'size': '16654876929'}]",,,,,,iPS-derived syndetome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507510,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743494: 7_SYN_day6; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998544,Illumina HiSeq 2500 paired end sequencing; GSM4743494: 7_SYN_day6; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251325,7_SYN_day6,Homo sapiens,syndetome,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/010/SRR12507510/SRR12507510.fastq.gz', 'md5': '6beb786490fe1f5952009087826b3f47', 'size': '16484355134'}]",,,,,,iPS-derived syndetome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507511,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743495: 8_SYN_day8; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998545,Illumina HiSeq 2500 paired end sequencing; GSM4743495: 8_SYN_day8; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251326,8_SYN_day8,Homo sapiens,syndetome,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/011/SRR12507511/SRR12507511.fastq.gz', 'md5': '16b0b6a055e62ad5fe883b33baf4d0f6', 'size': '16925590015'}]",,,,,,iPS-derived syndetome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12507512,,,,Illumina HiSeq 2500 paired end sequencing; GSM4743496: 9_primary_tenocyte; Homo sapiens; RNA-Seq,,,,,,,,,,SRX8998546,Illumina HiSeq 2500 paired end sequencing; GSM4743496: 9_primary_tenocyte; Homo sapiens; RNA-Seq,ILLUMINA,Illumina HiSeq 2500,SRP278617,Grafting induced pluripotent stem cells-derived tenocytes contribute to recovery of motor function after Achilles tendon rupture in rat [single cell RNAseq],"Self-renewal of tendons is rare since the vascular formation inside is extremely poor, thus reconstructive surgery using autologous tendons has been often taken place in the case of severe injury. However, the rate of re-injury after surgery is relatively high, and collection of autologous tendons leads muscle weakness which results in prolonged rehabilitation. Here, we introduce the induced pluripotent stem cells (iPSCs)-based technology aiming at developing a new therapeutic option after tendon injury. We derived tenocytes from human iPSCs by recapitulating the normal progression of step-wise narrowing fate decisions in the vertebrate embryo. We used single-cell RNA sequencing to analyze the developmental trajectory of iPSCs-derived tenocytes. Overall design: Single cell rnaseq analysis of the developmental trajectory of iPSC-derived tenocytes",SRS7251327,9_primary_tenocyte,Homo sapiens,tenocyte,,,,,2021-07-21,2021-07-21,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR125/012/SRR12507512/SRR12507512.fastq.gz', 'md5': 'a2269cf195d9b6cac1aa6495987ccb6c', 'size': '18616617775'}]",,,,,,primary tenocyte,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14699776,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350789: WT1; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037855,Illumina NovaSeq 6000 paired end sequencing; GSM5350789: WT1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107266,WT1,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/076/SRR14699776/SRR14699776_1.fastq.gz', 'md5': 'c9545190dd1e859216b14f0568642db8', 'size': '678427032'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/076/SRR14699776/SRR14699776_2.fastq.gz', 'md5': '8611c054ed18abdc8d5126b3bd555dbe', 'size': '717325107'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699777,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350789: WT1; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037855,Illumina NovaSeq 6000 paired end sequencing; GSM5350789: WT1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107266,WT1,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/077/SRR14699777/SRR14699777_1.fastq.gz', 'md5': '78ad8316b3cd24159b7e71ead034b7f7', 'size': '680192859'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/077/SRR14699777/SRR14699777_2.fastq.gz', 'md5': '84d541dd1afa44f96a1006e3af2d76fb', 'size': '719514132'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699778,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350790: WT2; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037856,Illumina NovaSeq 6000 paired end sequencing; GSM5350790: WT2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107268,WT2,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/078/SRR14699778/SRR14699778_1.fastq.gz', 'md5': 'bcc46010e7f6b67f4f1d01a764fb0011', 'size': '603498489'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/078/SRR14699778/SRR14699778_2.fastq.gz', 'md5': 'd4c009afd57ac7d3fffcd89c57d64997', 'size': '635190159'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699779,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350790: WT2; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037856,Illumina NovaSeq 6000 paired end sequencing; GSM5350790: WT2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107268,WT2,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/079/SRR14699779/SRR14699779_1.fastq.gz', 'md5': '28674aa28743941a1659336a6eebf9e4', 'size': '605581329'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/079/SRR14699779/SRR14699779_2.fastq.gz', 'md5': 'dd2f73ca6c5fc9983a725eac7478f72f', 'size': '637485877'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699780,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350791: WT3; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037857,Illumina NovaSeq 6000 paired end sequencing; GSM5350791: WT3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107267,WT3,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/080/SRR14699780/SRR14699780_1.fastq.gz', 'md5': 'efe156c45a193bea190b9dab48126b68', 'size': '651591243'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/080/SRR14699780/SRR14699780_2.fastq.gz', 'md5': 'f9317765a50a39bd9d989d6e72def93f', 'size': '686911510'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699781,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350791: WT3; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037857,Illumina NovaSeq 6000 paired end sequencing; GSM5350791: WT3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107267,WT3,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/081/SRR14699781/SRR14699781_1.fastq.gz', 'md5': '9961999e3e0c8055dfbe2dcdf7acbef9', 'size': '653463729'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/081/SRR14699781/SRR14699781_2.fastq.gz', 'md5': 'df2a81bb277cdf993342398d8dd24729', 'size': '688965087'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699782,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350792: WT4; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037858,Illumina NovaSeq 6000 paired end sequencing; GSM5350792: WT4; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107269,WT4,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/082/SRR14699782/SRR14699782_1.fastq.gz', 'md5': '69354c04cb63fc9a0cb05a556a0443dc', 'size': '646324775'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/082/SRR14699782/SRR14699782_2.fastq.gz', 'md5': 'e0eb663f4d72fb34ebe22852d094787e', 'size': '681377739'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699783,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350792: WT4; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037858,Illumina NovaSeq 6000 paired end sequencing; GSM5350792: WT4; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107269,WT4,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/083/SRR14699783/SRR14699783_1.fastq.gz', 'md5': 'a0150af989db104d799bb4cf0861cbe4', 'size': '646776104'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/083/SRR14699783/SRR14699783_2.fastq.gz', 'md5': '407a6bd9bd6d61a86fb88a80cd504e93', 'size': '681899187'}]",muscle,,,,,,wild type,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699784,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350793: IL17ra-/- 1; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037859,Illumina NovaSeq 6000 paired end sequencing; GSM5350793: IL17ra-/- 1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107270,IL17ra-/- 1,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/084/SRR14699784/SRR14699784_1.fastq.gz', 'md5': '631176b7614f4b97c9640ab3b4a5c5db', 'size': '692048050'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/084/SRR14699784/SRR14699784_2.fastq.gz', 'md5': 'ae60587481abfe65443ac10ad82fdd3e', 'size': '730550514'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699785,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350793: IL17ra-/- 1; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037859,Illumina NovaSeq 6000 paired end sequencing; GSM5350793: IL17ra-/- 1; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107270,IL17ra-/- 1,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/085/SRR14699785/SRR14699785_1.fastq.gz', 'md5': '4ccbb5cd70292fc41ecaf53b6f2000dc', 'size': '693777423'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/085/SRR14699785/SRR14699785_2.fastq.gz', 'md5': '4b90399f9f0f75949e00e97ef0b6080e', 'size': '732681564'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699786,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350794: IL17ra-/- 2; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037860,Illumina NovaSeq 6000 paired end sequencing; GSM5350794: IL17ra-/- 2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107271,IL17ra-/- 2,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/086/SRR14699786/SRR14699786_1.fastq.gz', 'md5': '4822fe8810d9c5cfe88caa8a82b8b3f0', 'size': '811565346'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/086/SRR14699786/SRR14699786_2.fastq.gz', 'md5': 'b951f832879d75d43dc30767b6438ddb', 'size': '852011027'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699787,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350794: IL17ra-/- 2; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037860,Illumina NovaSeq 6000 paired end sequencing; GSM5350794: IL17ra-/- 2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107271,IL17ra-/- 2,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/087/SRR14699787/SRR14699787_1.fastq.gz', 'md5': '5356aef3738215751dc8daf5181996a1', 'size': '818068673'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/087/SRR14699787/SRR14699787_2.fastq.gz', 'md5': '963c35c4373b982e7f0d58d376a09fdd', 'size': '858968117'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699789,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350795: IL17ra-/- 3; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037861,Illumina NovaSeq 6000 paired end sequencing; GSM5350795: IL17ra-/- 3; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107272,IL17ra-/- 3,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/089/SRR14699789/SRR14699789_1.fastq.gz', 'md5': 'bdc04cf855dc958939ef85beae9c12a6', 'size': '789080596'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/089/SRR14699789/SRR14699789_2.fastq.gz', 'md5': '4b02159780c43ae70a486e3228cd7bbd', 'size': '824817170'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699790,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350796: IL17ra-/- 4; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037862,Illumina NovaSeq 6000 paired end sequencing; GSM5350796: IL17ra-/- 4; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107273,IL17ra-/- 4,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/090/SRR14699790/SRR14699790_1.fastq.gz', 'md5': '94c281f9a8ba3de05e19774ad10736f9', 'size': '615311040'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/090/SRR14699790/SRR14699790_2.fastq.gz', 'md5': '20d67e0a21dc55ab477fc6a241373f75', 'size': '643406111'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699791,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350796: IL17ra-/- 4; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037862,Illumina NovaSeq 6000 paired end sequencing; GSM5350796: IL17ra-/- 4; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107273,IL17ra-/- 4,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/091/SRR14699791/SRR14699791_1.fastq.gz', 'md5': '1fcff22b1b92f8db4a6bf1320c16c6de', 'size': '619385671'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/091/SRR14699791/SRR14699791_2.fastq.gz', 'md5': 'e858b1f36165fd575111c4ed1133df93', 'size': '647871348'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699792,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350797: IL17ra-/- 5; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037863,Illumina NovaSeq 6000 paired end sequencing; GSM5350797: IL17ra-/- 5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107274,IL17ra-/- 5,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/092/SRR14699792/SRR14699792_1.fastq.gz', 'md5': 'c4d0ce5814f2f7573b748224bf4a3bdc', 'size': '677683055'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/092/SRR14699792/SRR14699792_2.fastq.gz', 'md5': '06a82843a7141203c3a20e5cf8fd650c', 'size': '700544999'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR14699793,,,,Illumina NovaSeq 6000 paired end sequencing; GSM5350797: IL17ra-/- 5; Mus musculus; RNA-Seq,,,,,,,,,,SRX11037863,Illumina NovaSeq 6000 paired end sequencing; GSM5350797: IL17ra-/- 5; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP322111,A single-cell atlas of the microenvironment of implanted biomaterials and computational analysis of the transcriptional signalling networks [bulk RNA-seq],"The understanding of the foreign-body responses to implanted biomaterials would benefit from the reconstruction of intracellular and intercellular signalling networks in the microenvironment surrounding the implant. Here, by leveraging single-cell RNA-sequencing data from 42,156 cells harvested from the site of implantation of either polycaprolactone or an extracellular-matrix-derived scaffold in a mouse model of volumetric muscle loss, we report a computational analysis of intercellular-signalling networks reconstructed from data of transcription-factor activation. We found that intercellular signalling networks can be clustered into modules associated with specific cell subsets, and that biomaterial-specific responses can be characterized by interactions between signalling modules for immune, fibroblast and tissue-specific cells. In a Il17ra/ knockout mouse model, we validated that predicted IL-17-linked transcriptional targets led to concomitant changes in gene expression. Moreover, we identified cell subsets that had not been implicated in the responses to implanted biomaterials. Single-cell atlases of the cellular responses to implanted biomaterials will facilitate the design of implantable biomaterials and the understanding of the ensuing cellular responses. Overall design: Triplicate of animals given volumetric muscle loss in wild type C57BL/6 or IL17ra knockout animals.",SRS9107274,IL17ra-/- 5,Mus musculus,Quadriceps,,C57BL/6,,,2021-08-02,2021-08-02,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/093/SRR14699793/SRR14699793_1.fastq.gz', 'md5': '1fbe6f11018e9c97dff50df9b740d259', 'size': '683529914'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR146/093/SRR14699793/SRR14699793_2.fastq.gz', 'md5': '91e835e810e814864c6f6c8bb59888e9', 'size': '706939282'}]",muscle,,,,,,IL17ra -/-,6 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Saline,1 week post surgery
SRR12162990,,,,NextSeq 500 paired end sequencing; GSM4658495: Mouse Adh 1; Mus musculus; RNA-Seq,,,,,,,,,,SRX8678481,NextSeq 500 paired end sequencing; GSM4658495: Mouse Adh 1; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP270639,JUN promotes abdominal adhesions in mice and humans,"Adhesions are fibrotic scars that form between abdominal organs following surgery or infection, and may cause bowel obstruction, chronic pain, or infertility. Adhesions occur post-operatively in 50-90% of all open abdominal operations and as such, represent an enormous clinical problem impacting hundreds of millions of patients worldwide. Our understanding of the biology of adhesion formation is very limited, which explains why there are essentially no available treatments that prevent adhesions. In this study, we systemically analyzed abdominal adhesions in mouse and human tissues gene expression using bulk- and sc-RNA-seq technologies to characterize the fibroblasts responsible for this devastating pathology. Overall design: Mouse and human abdominal adhesion tissue transcriptomes were profiled using single cell RNA-sequencing. A total of 4 human samples and 2 pooled mouse samples were profiled.",SRS6957560,Mouse Adh 1,Mus musculus,POD2 mice,,,,,2020-07-09,2020-07-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR121/SRR12162990/POD2_possorted_genome_bam.bam', 'md5': 'c03cbac65430ad885bfdc438677f36fc', 'size': '10708114450'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,abdominal adhesion,,,,
SRR12162991,,,,NextSeq 500 paired end sequencing; GSM4658496: Mouse Adh 2; Mus musculus; RNA-Seq,,,,,,,,,,SRX8678482,NextSeq 500 paired end sequencing; GSM4658496: Mouse Adh 2; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP270639,JUN promotes abdominal adhesions in mice and humans,"Adhesions are fibrotic scars that form between abdominal organs following surgery or infection, and may cause bowel obstruction, chronic pain, or infertility. Adhesions occur post-operatively in 50-90% of all open abdominal operations and as such, represent an enormous clinical problem impacting hundreds of millions of patients worldwide. Our understanding of the biology of adhesion formation is very limited, which explains why there are essentially no available treatments that prevent adhesions. In this study, we systemically analyzed abdominal adhesions in mouse and human tissues gene expression using bulk- and sc-RNA-seq technologies to characterize the fibroblasts responsible for this devastating pathology. Overall design: Mouse and human abdominal adhesion tissue transcriptomes were profiled using single cell RNA-sequencing. A total of 4 human samples and 2 pooled mouse samples were profiled.",SRS6957561,Mouse Adh 2,Mus musculus,POD7 mice,,,,,2020-07-09,2020-07-09,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR121/SRR12162991/POD7_possorted_genome_bam.bam', 'md5': '7a38145eb39968d4d9a6f61f9f03a10a', 'size': '11832771945'}]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,abdominal adhesion,,,,
SRR12492376,,,,NextSeq 500 paired end sequencing; GSM4735397: rbGFP rep1; Mus musculus; RNA-Seq,,,,,,,,,,SRX8983991,NextSeq 500 paired end sequencing; GSM4735397: rbGFP rep1; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP278393,Regional specialization and fate specification of mesenchymal stromal cells in skeletal development [scRNA-seq],"To identify cellular heterogeneity and molecular signatures of bone marrow stromal (BMSCs) cells, we performed scRNA-seq of non-hematopoietic stromal cells from 3-week-old mice. In addition, to gain further insight into MSC differentiation in vivo, Pdgfrb-CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double transgenic mice were treated with tamoxifen at P1-3 and sacrificed at P21 for the isolation of GFP+ cells from long bone followed by scRNA-seq analysis. Overall design: Single cell -RNA sequencing of non-hematopoietic  bone stromal cells (BSC) postnatal day 21 old bone and PdgfrbCre-R26 mTmG GFP+ sorted cells using  10X genomics.",SRS7238321,rbGFP rep1,Mus musculus,PdgfrbCre GFP+ cells,,C57BL/6 : PdgfrbCreERT2; R26 mTmG,,,2020-08-23,2020-08-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/076/SRR12492376/SRR12492376_1.fastq.gz', 'md5': 'a77c03730bd1df1c16433e9db2abbd0a', 'size': '3780656051'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/076/SRR12492376/SRR12492376_2.fastq.gz', 'md5': '6297695f79f2da2e1d412b743c2c6b9d', 'size': '11913898064'}]",Bone,,,,,PdgfrbCre GFP+ cells,,postnatal day 21,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR12492377,,,,NextSeq 500 paired end sequencing; GSM4735398: rbGFP rep2; Mus musculus; RNA-Seq,,,,,,,,,,SRX8983992,NextSeq 500 paired end sequencing; GSM4735398: rbGFP rep2; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP278393,Regional specialization and fate specification of mesenchymal stromal cells in skeletal development [scRNA-seq],"To identify cellular heterogeneity and molecular signatures of bone marrow stromal (BMSCs) cells, we performed scRNA-seq of non-hematopoietic stromal cells from 3-week-old mice. In addition, to gain further insight into MSC differentiation in vivo, Pdgfrb-CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double transgenic mice were treated with tamoxifen at P1-3 and sacrificed at P21 for the isolation of GFP+ cells from long bone followed by scRNA-seq analysis. Overall design: Single cell -RNA sequencing of non-hematopoietic  bone stromal cells (BSC) postnatal day 21 old bone and PdgfrbCre-R26 mTmG GFP+ sorted cells using  10X genomics.",SRS7238322,rbGFP rep2,Mus musculus,PdgfrbCre GFP+ cells,,C57BL/6 : PdgfrbCreERT2; R26 mTmG,,,2020-08-23,2020-08-23,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/077/SRR12492377/SRR12492377_1.fastq.gz', 'md5': '6463a949ce97cf0ed6fe7c88e57fe429', 'size': '3607176995'}, {'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR124/077/SRR12492377/SRR12492377_2.fastq.gz', 'md5': '46b5cb8530ce88cf2ca9a4f73f95bc80', 'size': '11261744398'}]",Bone,,,,,PdgfrbCre GFP+ cells,,postnatal day 21,male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092514,,,,NextSeq 500 sequencing; GSM5217005: primary_fSCs; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466192,NextSeq 500 sequencing; GSM5217005: primary_fSCs; Mus musculus; RNA-Seq,ILLUMINA,NextSeq 500,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596486,primary_fSCs,Mus musculus,skeletal muscle tissue,not cultured in vitro (freshly isolated from in vivo),,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092514/primary_fSCs.bam', 'md5': 'b8655dd5fd459305331ce402d6aaaf16', 'size': '19960144980'}]",Skeletal muscles (8-10 weeks age of mice),,,,,muscle stem cells freshly isolated from skeletal muscles,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092515,,,,Illumina NovaSeq 6000 sequencing; GSM5217006: expanded_cSCs; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466193,Illumina NovaSeq 6000 sequencing; GSM5217006: expanded_cSCs; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596487,expanded_cSCs,Mus musculus,skeletal muscle tissue,cultured in satellite cell medium for 6 days,,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092515/expanded_cSCs.bam', 'md5': '7e43918aac9d6cd0b6dac705231427c6', 'size': '11355473474'}]",Skeletal muscles (8-10 weeks age of mice),,,,,muscle stem cells cultured in vitro for 6 days,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092516,,,,Illumina NovaSeq 6000 sequencing; GSM5217007: diff_cSCs; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466194,Illumina NovaSeq 6000 sequencing; GSM5217007: diff_cSCs; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596488,diff_cSCs,Mus musculus,skeletal muscle tissue,cultured in satellite cell medium for 4 days then cultured in differentiating medium for 2 days,,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092516/diff_cSCs.bam', 'md5': '719566a2b50569cf073964646d508d2a', 'size': '19183268806'}]",Skeletal muscles (8-10 weeks age of mice),,,,,muscle stem cells cultured in vitro for 2 days with horse serum,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092517,,,,Illumina NovaSeq 6000 sequencing; GSM5217008: MEF_Day0; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466195,Illumina NovaSeq 6000 sequencing; GSM5217008: MEF_Day0; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596489,MEF_Day0,Mus musculus,E13.5,cultured in MEF medium for 2 days,,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092517/MEF_Day0.bam', 'md5': 'de478c9da7b7da988f741080bce94992', 'size': '15826512790'}]",E13.5 embryo,,,,,Mouse embryonic fibroblasts (MEFs),C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092518,,,,Illumina NovaSeq 6000 sequencing; GSM5217009: MEF_Dox_Day2; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466196,Illumina NovaSeq 6000 sequencing; GSM5217009: MEF_Dox_Day2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596490,MEF_Dox_Day2,Mus musculus,E13.5,overexpressing MyoD for 2 days,,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092518/MEF_Dox_Day2.bam', 'md5': '9a4fab57c0a33a0cc6b6b6af987ead86', 'size': '16309022729'}]",E13.5 embryo,,,,,Myocytes/Myotubes derived from MEFs,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092519,,,,Illumina NovaSeq 6000 sequencing; GSM5217010: MEF_DoxFRG_Day2; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466197,Illumina NovaSeq 6000 sequencing; GSM5217010: MEF_DoxFRG_Day2; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596491,MEF_DoxFRG_Day2,Mus musculus,E13.5,"overexpressing MyoD in the presense of Forskolin, Repsox and GSK3 inhibitor (FRG) for 2 days",,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092519/MEF_DoxFRG_Day2.bam', 'md5': '5dfcd96e2e1aac3e88ef0b678fa56c58', 'size': '16176558736'}]",E13.5 embryo,,,,,Muscle progenitor cells/Myocytes/Myotubes derived from MEFs,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092520,,,,Illumina NovaSeq 6000 sequencing; GSM5217011: MEF_DoxFRG_Day8; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466198,Illumina NovaSeq 6000 sequencing; GSM5217011: MEF_DoxFRG_Day8; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596492,MEF_DoxFRG_Day8,Mus musculus,E13.5,"overexpressing MyoD in the presense of Forskolin, Repsox and GSK3 inhibitor (FRG) for 8 days",,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092520/MEF_DoxFRG_Day8.bam', 'md5': 'f556c4d4b30b0bc360fbb21be6e79b5f', 'size': '20312135416'}]",E13.5 embryo,,,,,Muscle progenitor cells/Myocytes/Myotubes derived from MEFs,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092521,,,,Illumina NovaSeq 6000 sequencing; GSM5217012: MEF_Dox_Day4; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466199,Illumina NovaSeq 6000 sequencing; GSM5217012: MEF_Dox_Day4; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596493,MEF_Dox_Day4,Mus musculus,E13.5,overexpressing MyoD for 4 days,,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092521/MEF_Dox_Day4.bam', 'md5': '78dabbbca516869d98fa5c732d4d15cf', 'size': '14951281470'}]",E13.5 embryo,,,,,Myocytes/Myotubes derived from MEFs,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092522,,,,Illumina NovaSeq 6000 sequencing; GSM5217013: MEF_DoxFRG_Day4; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466200,Illumina NovaSeq 6000 sequencing; GSM5217013: MEF_DoxFRG_Day4; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596494,MEF_DoxFRG_Day4,Mus musculus,E13.5,"overexpressing MyoD in the presense of Forskolin, Repsox and GSK3 inhibitor (FRG) for 4 days",,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092522/MEF_DoxFRG_Day4.bam', 'md5': '15dff54ab471735da3cec8732b6eef2e', 'size': '14474994215'}]",E13.5 embryo,,,,,Muscle progenitor cells/Myocytes/Myotubes derived from MEFs,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRR14092523,,,,Illumina NovaSeq 6000 sequencing; GSM5217014: iMPCs; Mus musculus; RNA-Seq,,,,,,,,,,SRX10466201,Illumina NovaSeq 6000 sequencing; GSM5217014: iMPCs; Mus musculus; RNA-Seq,ILLUMINA,Illumina NovaSeq 6000,SRP312561,Dissecting mechanisms by which MyoD and small molecules convert fibroblasts to muscle progenitor cells,"The generation of myotubes from fibroblasts upon forced MyoD expression is a classic example of factor-induced reprogramming in mammals. We recently discovered that additional modulation of signaling pathways with small molecules facilitates reprogramming to more primitive induced muscle progenitor cells (iMPCs). However, the mechanisms by which a single transcription factor drives differentiated cells into distinct developmental states remain unknown. We therefore dissected the transcriptional and epigenetic dynamics of fibroblasts undergoing MyoD-dependent reprogramming to either myotubes or iMPCs using a novel MyoD transgenic model. To this end, we performed single cell RNA sequencing for Pax7-nGFP positive iMPCs/satellite cells and cells undergoing dedifferentiation (i.e. Dox+FRG) or transdifferentiation (i.e. Dox) Our analyses elucidate the role of MyoD in myogenic reprogramming and derive general principles by which transcription factors and signaling pathways cooperate to rewire cell identity. Our results may also inform on potential therapeutic applications of direct reprogramming. Overall design: single cell RNA-seq was performed for 10 samples",SRS8596495,iMPCs,Mus musculus,E13.5,"overexpressing MyoD in the presense of Forskolin, Repsox and GSK3 inhibitor (FRG) for 10 days, Pax7-nGFP sorted by FACS",,,,2021-07-29,2021-07-31,"[{'url': 'ftp://ftp.sra.ebi.ac.uk/vol1/run/SRR140/SRR14092523/iMPCs.bam', 'md5': '37abe9a448202bc964eb933dd7278a44', 'size': '16418448643'}]",E13.5 embryo,,,,,Muscle progenitor cells derived from MEFs,C57BL6J/129Sv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
